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Open Meetings
Statewide agencies and regional agencies that extend into four or more counties post
meeting notices with the Secretary of State.
Meeting agendas are available on the Texas Register's Internet site:
http://www.sos.state.tx.us/open/index.shtml
Members of the public also may view these notices during regular office hours from a
computer terminal in the lobby of the James Earl Rudder Building, 1019 Brazos (corner
of 11th Street and Brazos) Austin, Texas.  To request a copy by telephone, please call
463-5561 in Austin. For out-of-town callers our toll-free number is 800-226-7199. Or
request a copy by email: register@sos.state.tx.us
For items not available here, contact the agency directly. Items not found here:
• minutes of meetings
• agendas for local government bodies and regional agencies that extend into fewer
than four counties
• legislative meetings not subject to the open meetings law
The Office of the Attorney General offers information about the open meetings law,
including Frequently Asked Questions, the Open Meetings Act Handbook, and Open
Meetings Opinions.
http://www.oag.state.tx.us/opinopen/opengovt.shtml
The Attorney General's Open Government Hotline is 512-478-OPEN (478-6736) or toll-
free at (877) OPEN TEX (673-6839).
Additional information about state government may be found here:
http://www.state.tx.us/
...
Meeting Accessibility. Under the Americans with Disabilities Act, an individual with a
disability must have equal opportunity for effective communication and participation in
public meetings. Upon request, agencies must provide auxiliary aids and services, such as
interpreters for the deaf and hearing impaired, readers, large print or Braille documents.
In determining type of auxiliary aid or service, agencies must give primary consideration
to the individual's request. Those requesting auxiliary aids or services should notify the
contact person listed on the meeting notice several days before the meeting by mail,




The Honorable Keri Roberts
Mills County Attorney
Post Ofce Box 160
Goldthwaite, Texas 76844
Re: Whether a county may fund a water district (RQ-0615-GA)
Briefs requested by October 1, 2007
RQ-0616-GA
Requestor:
The Honorable Kim Brimer
Chair, Committee on Administration
Texas State Senate
Post Ofce Box 12068
Austin, Texas 78711
Re Whether "document fees" constitute part of an automotive shop’s
worker’s lien (Request No. 0616-GA)
Briefs requested by October 1, 2007
RQ-0617-GA
Requestor:
The Honorable Richard L. "Rick" Hardcastle
Chair, Committee on Energy Resources
Texas House of Representatives
P.O. Box 2910
Austin, Texas 78768-2910
Re: Whether a state agency must use an average of 100 Mcf per day
of natural gas in order to qualify for the exemption provided by section
104.202 of the Utilities Code (RQ-0617-GA)
Briefs requested by October 4, 2007
For further information, please access the Web site at




Of¿ce of the Attorney General
Filed: September 4, 2007
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TITLE 1. ADMINISTRATION
PART 10. DEPARTMENT OF
INFORMATION RESOURCES




(Editor’s note: The text of the following section proposed for repeal
will not be published. The section may be examined in the ofces of the
Department of Information Resources or in the Texas Register ofce,
Room 245, James Earl Rudder Building, 1019 Brazos Street, Austin.)
The Department of Information Resources (department or DIR)
proposes the repeal of 1 TAC §201.19, concerning establish-
ment of quality assurance guidelines for projects in Texas state
agencies. Section 201.19, which established DIR model qual-
ity assurance guidelines for agencies to develop internal qual-
ity assurance procedures, will be superseded by proposed new
project management practices rules at 1 TAC Chapter 216, pub-
lished separately.
Dustin Lanier, Director of Policy, Planning and Measurement for
the department, has determined that there will be no scal impli-
cations for state and local governments as a result of repealing
the rule.
Mr. Lanier has also determined that for each year of the rst ve
years the proposed repeal is in effect the public will benet from
the repeal, because the rule is being replaced with new project
management practices rules. There are no anticipated economic
costs to individuals or small businesses.
Comments on the proposed repeal of 1 TAC §201.19 may be
submitted to Renée Mauzy, General Counsel, Department of In-
formation Resources, 300 West 15th Street, Suite 1300, Austin,
Texas 78701, renee.mauzy@dir.state.tx.us for 30 days following
publication of this repeal.
The repeal is proposed pursuant to §2054.052(a), Texas Gov-
ernment Code, which authorizes the department to adopt rules
necessary to implement its responsibilities under the Information
Management Resources Act, and pursuant to §2054.153, Texas
Government Code, which requires the department to adopt rules
that establish guidelines for project management practices.
No other statutes are affected by repeal of this rule.
§201.19. Establishment of Quality Assurance Guidelines for Projects
in Texas State Agencies.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Department of Information Resources
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-4700
CHAPTER 216. PROJECT MANAGEMENT
PRACTICES
The Department of Information Resources (department) pro-
poses new 1 TAC Chapter 216, Subchapter A, §§216.1 - 216.3;
Subchapter B §§216.10 - 216.12; and Subchapter C §§216.20
- 216.22, concerning project management practices applicable
to state agencies and institutions of higher education. The
rules are promulgated to implement Section 6 of House Bill
1789, 80th Legislative Session, which amended §§2054.151 -
2054.157, Texas Government Code, relating to project manage-
ment practices. Section 2054.153, Texas Government Code,
requires the department to adopt rules that establish guidelines
for project management practices. The proposed rules are
further authorized by §2054.052(a), Texas Government Code,
which authorizes the department to adopt rules necessary to
implement its responsibilities under the Information Resources
Management Act. In a separate rulemaking, the department
will propose the repeal of 1 TAC §201.19, concerning quality
assurance guidelines.
Section 216.1 sets forth applicable terms and technologies for
project management practices. Section 216.2 denes state
agencies, other than institutions of higher education. Section
216.3 denes institutions of higher education.
Section 216.10 requires each agency to have a policy that com-
municates an agency-wide approach for project management
practices. Section 216.11 requires each agency to manage infor-
mation resources projects based on project management prac-
tices that meet certain criteria. Section 216.12 requires each
agency to identify and adopt one or more standards to meet
project management requirements in certain knowledge areas.
Section 216.20 requires each institution of higher education to
have a policy that communicates an institution-wide approach
for project management practices. Section 216.21 requires each
institution of higher education to manage information resources
projects based on project management practices that meet cer-
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tain criteria. Section 216.22 requires each institution of higher
education to identify and adopt one or more standards to meet
project management requirements in certain knowledge areas.
Because the proposed rules apply to institutions of higher edu-
cation, the department, in consultation with the Information Tech-
nology Council for Higher Education, prepared an analysis of the
impact of the rules that included consideration of the require-
ments in §2054.121(c), Texas Government Code. Issues and
concerns regarding the potential impact of the rules on higher
education, student populations and federal grant requirements
were identied, including: (1) the proposed rules require ap-
proval by the agency head. Institutions of higher education re-
quire such policies be approved by someone other than the head
of the institution; (2) the term "integration" should be claried;
and (3) certain denitions should be revised. The department
proposed alternatives to address the issues, which were accept-
able to the Information Technology Council for Higher Education,
including: (1) authorizing the approval of the project manage-
ment practices by the institution of higher education’s president,
chancellor or designee; (2) eliminating use of the term "integra-
tion"; and (3) explaining that certain denitions were statutorily
required and could be addressed legislatively in the future.
Dustin Lanier, Director of Policy, Planning and Measurement for
the department, has determined that for the rst ve-year period
the proposed rules are in effect there will be varying scal impli-
cations for state government as a result of enforcing or admin-
istering the proposed rules. Agencies and institutions of higher
education with existing project management practices that sat-
isfy requirements will have no scal impact. Agencies and insti-
tutions of higher education that choose to use project manage-
ment practices from another agency or institution of higher edu-
cation will have minimal scal impact. Such impact may vary
based on the adjustments to the policy the agency or institu-
tion of higher education makes. Agencies that choose to fully
develop project management practices may have considerable
scal impact depending on the approach, stafng requirements
and agency needs.
Mr. Lanier has also determined that for each year of the rst
ve years the proposed rules are in effect the public benets an-
ticipated as a result of enforcing or administering the rules will
be more effective use of public and nancial resources and im-
proved delivery of technology projects among affected govern-
mental entities. There are no anticipated economic costs to per-
sons or small businesses required to comply with the proposed
rules.
Comments on the proposed rules may be submitted to Renée
Mauzy, General Counsel, Department of Information Re-
sources, 300 West 15th Street, 13th Floor, Austin, Texas 78701,
renee.mauzy@dir.state.tx.us for 30 days following publication.
SUBCHAPTER A. DEFINITIONS
1 TAC §§216.1 - 216.3
The new rules are proposed under §2054.153(a), Texas Gov-
ernment Code, which requires the department to adopt rules
that establish guidelines for project management practices and
§2054.052(a), Texas Government Code, which authorizes the
department to adopt rules necessary to implement its responsi-
bilities under the Information Resources Management Act.
No other statutes are affected by these rules.
§216.1. Applicable Terms and Technologies for Project Management
Practices.
The following words and terms, when used with this chapter, shall have
the following meanings, unless the context clearly indicates otherwise.
(1) Agency head--Top-most senior manager with oper-
ational accountability for an agency, such as an executive director,
commissioner, university president, university chancellor, comptroller,
or board president.
(2) Component--Elements of project management prac-
tices such as project management methodologies, tools, techniques,
and methods for integration with other similar or related disciplines
that inuence information resources project delivery.
(3) Department--Department of Information Resources.
(4) Information resources--Procedures, equipment, and
software that are employed, designed, built, operated, and main-
tained to collect, record, process, store, retrieve, display, and transmit
information, and associated personnel including consultants and
contractors.
(5) Information resources technologies--Data processing
and telecommunications hardware, software, services, supplies, per-
sonnel, facility resources, maintenance, and training.
(6) Process--Series of steps and strategies used to achieve
specic goals and results.
(7) Methodology--Set of inter-related processes, tasks, ac-
tivities, or principles that can be scaled and applied to a specic sit-
uation; provides a list of activities, indicates how to accomplish the
activities, and identies who executes the activities and when.
(8) Project--A program to provide information resources
technologies support to functions within or among elements of a state
agency, which should be characterized by well-dened parameters,
specic objectives, common benets, planned activities, a scheduled
completion date, and an established budget with a specied source of
funding.
(9) Project management practices--Documented and re-
peatable methods that a state agency uses to apply knowledge, skills,
tools, and techniques to satisfy project activity requirements.
(10) Standard--A denition, format, or specication that
has been approved by a recognized, formal, national and international
standards organization or is accepted as a de facto standard by the in-
dustry.
§216.2. State Agency.
A department, commission, board, ofce, council, authority, or other
agency, other than an institution of higher education, in the executive
or judicial branch of state government that is created by the constitution
or a statute of this state.
§216.3. Institution of Higher Education.
A university system or institution of higher education as dened by
§61.003, Education Code.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Department of Information Resources
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-4700
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SUBCHAPTER B. PROJECT MANAGEMENT
PRACTICES FOR STATE AGENCIES
1 TAC §§216.10 - 216.12
The new rules are proposed under §2054.153(a), Texas Gov-
ernment Code, which requires the department to adopt rules
that establish guidelines for project management practices and
§2054.052(a), Texas Government Code, which authorizes the
department to adopt rules necessary to implement its responsi-
bilities under the Information Resources Management Act.
No other statutes are affected by these rules.
§216.10. Policy.
Each state agency shall institute, approve, and publish an operating pro-
cedure that communicates an agency-wide approach for project man-
agement practices. At a minimum, the operating procedure will:
(1) Identify components and general use of project man-
agement practices, citing sources of reusable components adopted from
another agency or institution of higher education that satisfy require-
ments specied under §216.11 of this subchapter; and
(2) Be approved by the agency head or designee.
§216.11. Requirements.
Each state agency shall manage information resources projects based
on project management practices that meet the following criteria:
(1) Include a method for delivery of information resources
projects that solve business problems;
(2) Include a method for governing application of project
management practices;
(3) Be documented, repeatable, and include a single refer-
ence source (e.g., handbook, guide, repository) that communicates how
to effectively apply use of the project management practices compo-
nents;
(4) Include a project classication method developed by
DIR (see http://www.dir.state.tx.us/projectdelivery/projectmgmt/clas-
sify/index.htm), the agency, or another source that:
(A) Distinguishes and categorizes projects according to
level of complexity and risk (e.g., technology, size, budget, time to
deliver); and
(B) Denes how to use the project classication method
to establish, scale, and execute the appropriate level of processes;
(5) Include a method to periodically review, assess, mon-
itor, and measure the impact of project management practices on the
agency’s ability to achieve its core mission;
(6) Align with use of the Texas Project Delivery Frame-
work;
(7) Accommodate use of other practices and methods that
intersect with application of project management practices; and
(8) Be reviewed and updated at least annually to help en-
sure continuous process improvement.
§216.12. Standards.
Each state agency shall identify and adopt one or more standards as a
basis for project management practices to meet project requirements in








(8) risk management; and
(9) procurement (acquisition) management.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Department of Information Resources
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-4700
SUBCHAPTER C. PROJECT MANAGEMENT
PRACTICES FOR INSTITUTIONS OF HIGHER
EDUCATION
1 TAC §§216.20 - 216.22
The new rules are proposed under §2054.153(a), Texas Gov-
ernment Code, which requires the department to adopt rules
that establish guidelines for project management practices and
§2054.052(a), Texas Government Code, which authorizes the
department to adopt rules necessary to implement its responsi-
bilities under the Information Resources Management Act.
No other statutes are affected by these rules.
§216.20. Policy.
Each institution of higher education shall institute, approve, and pub-
lish an operating procedure that communicates an institution-wide ap-
proach for project management practices. At a minimum, the operating
procedure will:
(1) Identify components and general use of project man-
agement practices, citing sources of reusable components adopted from
a state agency or another institution of higher education that satisfy re-
quirements specied under §216.21 of this subchapter; and
(2) Be approved by the president or chancellor of the insti-
tution of higher education or designee.
§216.21. Requirements.
Each institution of higher education shall manage information re-
sources projects based on project management practices that meet the
following criteria:
(1) Include a method for delivery of information resources
projects that solve business problems;
(2) Include a method for governing application of project
management practices;
(3) Be documented, repeatable, and include a single refer-
ence source (e.g., handbook, guide, repository) that communicates how
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to effectively apply use of the project management practices compo-
nents;
(4) Include a project classication method developed by
DIR (see http://www.dir.state.tx.us/projectdelivery/projectmgmt/clas-
sify/index.htm ), the institution of higher education, or another source
that:
(A) Distinguishes and categorizes projects according to
level of complexity and risk (e.g., technology, size, budget, time to
deliver); and
(B) Denes how to use the project classication method
to establish, scale, and execute the appropriate level of processes;
(5) Include a method to periodically review, assess, mon-
itor, and measure the impact of project management practices on the
institution of higher education’s ability to achieve its core mission;
(6) Align with use of the Texas Project Delivery Frame-
work;
(7) Accommodate use of other practices and methods that
intersect with application of project management practices; and
(8) Be reviewed and updated at least annually to help en-
sure continuous process improvement.
§216.22. Standards.
Each institution of higher education shall identify and adopt one or
more standards as a basis for project management practices to meet








(8) risk management; and
(9) procurement (acquisition) management.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Department of Information Resources
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-4700
PART 15. TEXAS HEALTH AND
HUMAN SERVICES COMMISSION
CHAPTER 358. MEDICAID ELIGIBILITY
SUBCHAPTER E. INCOME
1 TAC §358.450
Pursuant to House Bill 52, 80th Legislature, Regular Session,
2007, which amends §32.024(w) of the Human Resources Code,
the Texas Health and Human Services Commission (HHSC) pro-
poses to amend §358.450(h), relating to General Principles Con-
cerning Income. The purpose of this amendment is to clarify that
HHSC is the entity responsible for setting the personal needs al-
lowance for Medicaid recipients who are residents of long-term
care facilities and shall set it in accordance with §32.024(w), Hu-
man Resources Code.
Background and Justication
House Bill 52, amending §32.024(w), Human Resources Code,
increased the minimum amount that can be set for the personal
needs allowance from $45 to $60. The personal needs al-
lowance, established under federal law, is the amount of income
an individual in a long-term care facility may retain to purchase
goods and services. The proposed amendment to §358.450(h)
deletes the current minimum amount of $45 and permits HHSC’s
Executive Commissioner to set the personal needs allowance
at an amount consistent with §32.024(w), Human Resources
Code, without the need for future amendments to the rule should
the statutory minimum change. The statutory increase of the
minimum amount for the personal needs allowance aligns the
statute with current practice.
The proposed amendment also deletes language in subsection
(h), which is no longer applicable, indicating that the effective
date of subsection (h) had been September 1, 2003.
Analysis of §358.450
The proposed amendment provides that HHSC’s Executive
Commissioner shall set the personal needs allowance in ac-
cordance with §32.024 of the Human Resources Code. The
proposed amendment also replaces a reference to the Depart-
ment of Human Services Commissioner with a reference to the
Health and Human Services Executive Commissioner as the
ofcial who sets the amount of the personal needs allowance.
The proposed amendment deletes the reference to $45 as the
minimum amount for the personal needs allowance.
Fiscal Note
Thomas M. Suehs, Deputy Executive Commissioner for Finan-
cial Services, has determined that during the rst ve-year period
the proposed amendment is in effect, there will be no scal im-
plications for state government. The personal needs allowance
is currently set at $60. No policy changes are required. No au-
tomation changes are required. The proposed rule change will
not result in any scal implications for local health and human
services agencies. Local governments will not incur additional
costs.
Small and Micro-business Impact Analysis
Mr. Suehs has also determined that there will be no effect on
small or micro businesses as a result of enforcing or administer-
ing the proposed amendment, as they will not be required to al-
ter their business practices. There are no anticipated economic
costs to persons who are required to comply with the proposed
amendment. There is no anticipated negative impact on local
employment.
Public Benet
Anne Heiligenstein, Deputy Executive Commissioner for Social
Services, has determined that for each of the rst ve years the
proposed amendment is in effect, the public will benet from the
adoption of the amended rule. The anticipated public benet of
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the proposed amendment is that the personal needs allowance
amount for Medicaid residents in long-term care facilities will not
be less than $60 a month.
Regulatory Analysis
HHSC has determined that this proposal is not a "major environ-
mental rule" as dened by §2001.0225 of the Texas Government
Code. "Major environmental rule" is dened to mean a rule the
specic intent of which is to protect the environment or reduce
risks to human health from environmental exposure and that may
adversely affect in a material way the economy, a sector of the
economy, productivity, competition, jobs, the environment, or the
public health and safety of a state or a sector of the state. This
proposal is not specically intended to protect the environment
or reduce risks to human health from environmental exposure.
Takings Impact Assessment
HHSC has determined that this proposal does not restrict or limit
an owner’s right to his or her property that would otherwise exist
in the absence of government action and, therefore, does not
constitute a taking under §2007.043 of the Government Code.
Public Comment
Written comments on the proposal may be submitted to
Dee Church at Mail Code 2090, P.O. Box 12668, Austin,
Texas 78711-2668, by fax to (512) 206-5211, or by e-mail to
dee.church@hhsc.state.tx.us within 30 days of publication of
the proposal in the Texas Register.
Statutory Authority
This amendment is proposed under the Texas Government
Code, §531.033, which provides the Executive Commissioner
of HHSC with broad rulemaking authority; and the Human
Resources Code, §32.021, and the Texas Government Code,
§531.021(a), which provide HHSC with the authority to adminis-
ter the federal medical assistance (Medicaid) program in Texas.
The proposed new rule affects the Human Resources Code,
Chapter 32, and the Texas Government Code, Chapter 531. No
other statutes, articles, or codes are affected by this proposal.
§358.450. General Principles Concerning Income.
(a) - (g) (No change.)
(h) A personal needs allowance (PNA) is an amount of a
client’s income that a client in an institutional setting may retain for
his personal use. It will not be applied against the costs of medical
assistance furnished in the facility. Each client [Clients] in an insti-
tutional setting [settings and each spouse in couple cases] may retain
a PNA in an amount set by the executive commissioner of the Health
and Human Services Commission in accordance with Chapter 32 of
the Texas Human Resources Code. [of no less than $45. This amount
will be set by the commissioner of DHS.] For SSI clients who receive
the $30 reduced federal benet, the [commissioner will set a] state will
issue a supplement to allow for a PNA at the minimum level set by
the executive commissioner [of $45 for personal needs. The effective
date of this section is September 1, 2003].
(i) (No change.)
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Texas Health and Human Services Commission
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 424-6900
TITLE 16. ECONOMIC REGULATION
PART 4. TEXAS DEPARTMENT OF
LICENSING AND REGULATION
CHAPTER 73. ELECTRICIANS
16 TAC §§73.10, 73.20 - 73.22, 73.24, 73.25, 73.40, 73.51,
73.52, 73.54, 73.80, 73.90
The Texas Department of Licensing and Regulation ("Depart-
ment") proposes amendments to existing rules at 16 Texas Ad-
ministrative Code, §§73.10, 73.20, 73.21, 73.22, 73.24, 73.25,
73.40, 73.51, 73.52, 73.80, and 73.90; and new rule §73.54 re-
garding the electricians program.
These rules are necessary to implement the provisions of Sen-
ate Bill 1222 adopted by the 80th Legislature providing for licen-
sure of residential appliance installers and residential appliance
installation contractors. The rules are claried in that the supervi-
sory responsibilities of contractors are more clearly dened and
requirements for maintenance of records are set out. Provisions
of the rules that were adopted to implement grandfathering pro-
visions of the original statute are deleted as they no longer apply.
Section 73.10(6) is amended to add electrical sign contractors
to the denition of general supervision. Section 73.10(7) is
amended to add a requirement that the on-site supervising
licensee must be on the job site when electrical work is being
performed. Section 73.10(17) is amended by deleting language
referring to replacement of raceways, conductors, disconnecting
means or service feeder components thereby broadening the
scope of work a maintenance electrician may perform. Section
73.10(18) is amended by adding language to make it clear
that sign electricians may work on pole lighting in parking lots.
Section 73.10(19) is amended to add the phrase, "or authorized
representatives" to the list of persons who may perform elec-
trical work on an electrical equipment manufacturer’s products
without being licensed. This amendment will bring the rule
into compliance with the provisions of Senate Bill 1222. New
§73.10(23) is added to describe the scope of work for residential
appliance installers. New §73.10(24) is added to describe the
scope of work for a residential appliance installation contractor.
New §73.10(25) is added to clarify ambiguities in the statutory
denition of residential appliance. The new sections are added
to bring the rules into compliance with the provisions of Senate
Bill 1222.
Section 73.20(a)(1) is amended to add residential appliance in-
stallers to the list of individual applicants who must pass an ex-
amination. Section 73.20(e) is amended to add references to
statutory §§1305.1615, 1305.1617 and 1305.1618.
Section 73.21(b)(1) is deleted since it sets a deadline for ap-
plying for licensure of electricians by grandfathering that has al-
ready passed. New §73.21(b)(2) has been added to set out the
requirements for licensure as an appliance installer without pass-
ing an examination as provided in Section 8 of Senate Bill 1222.
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Section 73.22(d) is amended to add residential appliance instal-
lation contractors to the prohibition against contractors using a
license number that is not assigned to them.
Section 73.24(a) is amended to add sign electricians and appli-
ance installers to the list of individual licensees that are eligible
for licensure by reciprocity if they are licensed in a state with
which Texas has a reciprocity agreement. Section 73.24(b) is
amended to slightly alter the focus of the section. As amended,
it provides that the examination is waived if the Executive Direc-
tor determines that an applicant has demonstrated that he meets
the requirements of §73.21(b) rather than providing that the Ex-
ecutive Director may waive the examination if he determines that
the provisions of §73.21 have been met. Section 73.24(c) is
amended to more clearly set out what is required of applicants
in subsections (c)(1) and (c)(2). Subsection (c)(3) is deleted as
it related to proof required to obtain licensure by a grandfather-
ing provision that no longer applies. Subsections (d) and (e) are
deleted for the same reason that subsection (c)(3) is deleted.
Section 73.25(d) is amended by deleting the phrase, "for one
renewal". Subsections (h) and (i) are deleted since they relate
to timing provisions that are no longer effective.
Section 73.40(a) is amended to add a reference to residential
appliance installation contractors to require that they have the
same insurance coverage that electrical and electrical sign con-
tractors must have.
Section 73.51(b) is amended to change a contractor’s respon-
sibility for electrical work it performs to responsibility for work
performed on the contractor’s behalf. New §73.51(d) is added
to require a contractor to maintain its employment records and
records of work performed on its behalf and to make them avail-
able to the Department. New §73.51(e) is added to state that
both a contractor and the contractor’s designated master are re-
sponsible for the supervision of all licensees working on the con-
tractor’s behalf.
Section 73.52(b) is amended to change a sign contractor’s re-
sponsibility for electrical sign work it performs to responsibility
for work performed on the contractor’s behalf. New §73.52(d) is
added to require a contractor to maintain its employment records
and records of work performed on its behalf and to make them
available to the Department. New §73.52(e) is added to state
that both a contractor and the contractor’s designated master
are responsible for the supervision of all licensees working on
the contractor’s behalf.
New §73.54 is added to set out responsibilities of residential ap-
pliance installation contractors in the same fashion that §73.51
and §73.52 set out responsibilities of electrical contractors and
electrical sign contractors. The structure of all three rule sections
is similar.
Section 73.80 is amended by adding paragraphs (11) and (12)
to establish application and renewal fees for appliance installers,
$40.00, and appliance installation contractors, $125.00.
Section 73.90 is amended to delete language that refers to rules
currently found in 16 Texas Administrative Code, Chapter 60.
William H. Kuntz, Jr., Executive Director, has determined that
for the rst ve-year period the proposed amendments and new
rules are in effect there will be no cost to state or local govern-
ment as a result of enforcing or administering the amendments
or new rules
Mr. Kuntz also has determined that for each year of the rst
ve-year period the amendments and new rules are in effect,
the public benet will be that the provisions of Senate Bill 1222,
80th Legislature given effect in the rules and the rules will more
clearly dene contractor requirements.
There will be some economic costs imposed on persons and
businesses that must be licensed under these rules that im-
plement the provisions of Senate Bill 1222, 80th Legislature.
Also, residential appliance installation contractors will have to
purchase insurance to comply with these rules.
Comments on the proposal may be submitted to Caroline
Jackson, Legal Assistant, General Counsel’s Ofce, Texas
Department of Licensing and Regulation, P.O. Box 12157,
Austin, Texas 78711, or facsimile (512) 475-3032, or electron-
ically: erule.comments@license.state.tx.us. The deadline for
comments is 30 days after publication in the Texas Register.
The amendments and new rules are proposed under Texas Oc-
cupations Code, Chapter 1305 and Chapter 51, which autho-
rizes the Department to adopt rules as necessary to implement
this chapter and any other law establishing a program regulated
by the Department.
The statutory provisions affected by the proposal are those set
forth in Texas Occupations Code, Chapter 1305 and Chapter 51.
No other statutes, articles, or codes are affected by the proposal.
§73.10. Denitions.
The following words and terms, when used in this chapter, have the
following meanings, unless the context clearly indicates otherwise.
(1) Assumed name--A name used by a business as dened
in the Business and Commerce Code, Title 4, Chapter 36, Subchapter
A, §36.02.
(2) Business afliation--The business organization to
which a master licensee may assign his or her license.
(3) Employee--An individual who performs tasks assigned
to him by his employer. The employee is subject to the deduction of
social security and federal income taxes from his pay. An employee
may be full time, part time, or seasonal.
(4) Employer--One who employs the services of employ-
ees, pays their wages, deducts the required social security and federal
income taxes from the employee’s pay, and directs and controls the em-
ployee’s performance.
(5) Filed--A document is deemed to have been led with
the department on the date that the document has been received by the
department or, if the document has been mailed to the department, the
date a postmark is applied to the document by the U.S. Postal Service.
(6) General Supervision--Exercise of oversight by a mas-
ter electrician on behalf of an electrical contractor, or electrical sign
contractor, or by a master sign electrician on behalf of an electrical
sign contractor of performance by all classes of electrical licensees of
electrical work bearing responsibility for the work’s compliance with
applicable codes under Texas Occupations Code, Chapter 1305.
(7) On-Site Supervision--Exercise of supervision of elec-
trical work or electrical sign work by a licensed individual other than
an electrical apprentice. Continuous supervision of an electrical ap-
prentice is not required, though the on-site supervising licensee is re-
sponsible for review and inspection of the electrical apprentice’s work
to ensure compliance with any applicable codes or standards.
32 TexReg 6230 September 14, 2007 Texas Register
(8) Electrical Contractor--A person, or entity, licensed as
an electrical contractor, that is in the business of performing "Electrical
Contracting" as dened by Texas Occupations Code, §1305.002(5).
(9) Master Electrician--An individual, licensed as a master
electrician, who on behalf of an electrical contractor, electrical sign
contractor, or employing governmental entity, performs "Electrical
Work" as dened by Texas Occupations Code, §1305.002(11).
(10) Journeyman Electrician--An individual, licensed as a
journeyman electrician, who works under the general supervision of a
master electrician, on behalf of an electrical contractor, or employing
governmental entity, while performing "Electrical Work" as dened by
Texas Occupations Code, §1305.002(11).
(11) Electrical Apprentice--An individual, licensed as
an apprentice who works under the on-site supervision of a master
electrician, a journeyman electrician, or a residential wireman, on
behalf of an electrical contractor, or employing governmental entity
performing "Electrical Work" as dened by Texas Occupations Code,
§1305.002(11).
(12) Electrical Sign Contractor--A person, or entity,
licensed as an electrical sign contractor, that is in the business of
performing "Electrical Sign Contracting" as dened by Texas Occu-
pations Code, §1305.002(9).
(13) Master Sign Electrician--An individual, licensed as a
master sign electrician, who, on behalf of an electrical sign contractor,
performs "Electrical Sign Work" as dened in paragraph (18) of this
section.
(14) Journeyman Sign Electrician--An individual, licensed
as a journeyman sign electrician, who works under the general super-
vision of a master electrician or a master sign electrician, on behalf of
an electrical sign contractor, while performing "Electrical Sign Work"
as dened in paragraph (18) of this section.
(15) Residential Wireman--An individual, licensed as a
residential wireman, who works under the general supervision of a
master electrician, on behalf of an electrical contractor, or employing
governmental entity, while performing electrical work that is limited
to electrical installations in single family and multifamily dwellings
not exceeding four stories, as dened by Texas Occupations Code,
§1305.002(13).
(16) Maintenance Electrician--An individual, licensed as a
maintenance electrician, who works under the general supervision of a
master electrician, on behalf of an electrical contractor, or employing
governmental entity and performs "Electrical Maintenance Work" as
dened in paragraph (17) of this section.
(17) Electrical Maintenance Work--The replacement, or re-
pair of existing electrical appurtenances, apparatus, equipment, ma-
chinery, or controls used in connection with the use of electrical energy
in, on, outside, or attached to a building, residence, structure, property,
or premises. All replacements or repairs must be of the same rating
and type as the existing installation. No improvements may be made
that are necessary to comply with applicable codes under Texas Oc-
cupations Code, Chapter 1305. Electrical maintenance work does not
include [the replacement of any raceways, conductors, disconnecting
means, or service feeder components. It also does not include] the in-
stallation of any new electrical appurtenances, apparatus, equipment,
machinery, or controls beyond the scope of any existing electrical in-
stallation.
(18) Electrical Sign Work--Any labor or material used in
manufacturing, installing, maintaining, extending, connecting or re-
connecting an electrical wiring system and its appurtenances, apparatus
or equipment used in connection with signs, outline lighting, awnings,
signals, light emitting diodes, and the repair of existing outdoor elec-
tric discharge lighting, including parking lot pole lighting. This also
includes the installation of an electrical service integral to an isolated
sign and/or outline lighting installation
(19) Work Involved in the Manufacture of Electrical
Equipment--Work involved in the manufacture of electrical equipment
includes on and off-site manufacture, commissioning, testing, cali-
bration, coordination, troubleshooting, evaluation, repair or retrots
with components of the same ampacity, maintenance and servicing of
electrical equipment within their enclosures performed by authorized
employees, or authorized representatives of electrical equipment
manufacturers and limited to the type of products they manufacture.
(20) Electrical Sign Apprentice--An individual, licensed as
an electrical sign apprentice who works under the on-site supervision
of a master electrician, a master sign electrician, or a journeyman sign
electrician, on behalf of an electrical sign contractor performing "Elec-
trical Sign Work" as dened by these rules.
(21) A Principal Place of Business--For purposes of these
rules, a contractor has a principal place of business in another state or
territory or foreign country if the contractor is doing business in Texas
without complying with all applicable Texas statutes and the contractor
conducts substantial business in another state, territory or country while
business conducted by the contractor in Texas is minimal.
(22) On-the-job Training--Training or experience perform-
ing electrical work as dened by Occupations Code §1305.002(11).
(23) Residential Appliance Installer--An individual,
licensed as a residential appliance installer, who on behalf of a res-
idential appliance installation contractor, performs electrical work
that is limited to residential appliance installation as dened by Texas
Occupations Code, §1305.002(12-e).
(24) Residential Appliance Installation Contractor--A per-
son or entity licensed as a residential appliance installation contractor,
that is in the business of residential appliance installation as dened by
Texas Occupations Code §1305.002(12-d).
(25) Residential Appliance--A unit of electrical equipment
that is designed and installed in a dwelling by direct connection to an
existing electrical circuit to perform a specic function such as water
heating, for example. The term does not include general use equipment,
such as an electric motor, for example, that is not designed for a specic
function, nor does it include luminaries or suspended paddle fans.
§73.20. Licensing Requirements--Applicant and Experience Re-
quirements.
(a) An applicant for a license must submit the required fees
with a completed application and the appropriate attachments:
(1) Applicants for Master Electrician, Master Sign Electri-
cian, Journeyman Electrician, Journeyman Sign Electrician, Residen-
tial Wireman, [and] Maintenance Electrician, and Residential Appli-
ance Installer licenses must submit proof of a passing grade on the ac-
cepted examination.
(2) Applicants for contractor’s licenses must submit proof
of general liability insurance and either workers’ compensation insur-
ance or a certicate of authority to self insure, or a statement that the
applicant has elected not to obtain workers’ compensation insurance
pursuant to Subchapter A, Chapter 406, Labor Code, with the initial
and renewal applications.
(b) An applicant must complete all requirements within one
year of the date the application is led.
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(c) Except as provided by §73.24, each individual applicant
must pass all parts of a Department accepted examination, and provide
proof of a passing grade, before the applicant will be licensed. To be
accepted, an examination must have been taken and passed no more
than two years before the date of the application.
(d) For purposes of this chapter, 2,000 hours of on the job train-
ing shall equal one year of on the job training. On the job training must
be established by letter(s) setting out dates of employment from per-
sons who either employed or supervised the applicant or as required by
the application. Letters must include the name and license type of the
supervising person.
(e) Each applicant must meet the applicable eligibility require-
ments as set forth in the Occupations Code, §§1305.153-1305.1618
[§§1305.153-1305.161].
(f) Obtaining a license by fraud or false representation is
grounds for denial, suspension, or revocation of a license and/or an
administrative penalty.
§73.21. Licensing Requirements--Examinations.
(a) To obtain by examination a license issued under this chap-
ter, an individual applicant must successfully complete an examination
approved by the Executive Director of the Texas Department of Licens-
ing and Regulation.
(b) To obtain a license without examination, an applicant must
either;
[(1) le a completed application and the provisions of Sec-
tion 12, House Bill 1317 of the 79th Legislative Session and §73.24
must be met on or before December 31, 2005; or,]
(1) [(2)] have been licensed for the preceding year by a mu-
nicipality or regional licensing authority that has terminated its licens-
ing program and have applied for a state issued license within ninety
days of the date the program stopped issuing or renewing licenses; or
(2) be an applicant for licensure as a residential appliance
installer, and
(A) have completed 4,000 hours of electrical work, or
appliance installation work under the supervision of a master electri-
cian; and
(B) apply for licensure no later than June 1, 2008.
§73.22. Licensing Requirements--General.
(a) A license issued under this chapter is valid for one year
from the date of issuance and must be renewed annually.
(b) A person shall not perform work requiring a license under
Title 8, Occupations Code, Chapter 1305 with an expired license.
(c) Falsication of information on an application or cheating
on an examination is grounds for denial, suspension, or revocation of
a license and/or an administrative penalty.
(d) An electrical contractor, [or] an electrical sign contractor,
or a residential appliance installation contractor shall not use a license
number that is not assigned to that contractor by the Department.
(e) A license is not transferable.
(f) Altering a license in any way is prohibited and is grounds
for a sanction and/or penalty.
(g) If a licensee contracts with a general contractor or a home
warranty company to provide installation or service that requires a li-
cense under the Act, the licensee remains responsible for the integrity
of that work.
(h) A person using the license of another person or allowing
another person to use his license shall be subject to license denial, sus-
pension, or revocation and/or assessment of an administrative penalty.
§73.24. Licensing Requirements--Waiver of Examination Require-
ments.
(a) An applicant who is licensed in another state that has en-
tered into a reciprocity agreement with Texas regarding licensure of
electricians, sign electricians, or residential appliance installers may
obtain an equivalent license in Texas without passing the examination,
provided that all other licensure requirements are met.
(b) The [Executive Director may waive the] examination re-
quirement is waived if, based upon acceptable proof, the Executive
Director determines that the provisions of §73.21(b) [§73.21] are met.
(c) Acceptable proof of an applicant’s qualications must be
presented on a form prescribed by the Department that [may include
any or all of the following]:
(1) [a form prescribed by the Department that] certies
completion of the required hours of on-the-job training under the
supervision of a master electrician or master sign electrician as appro-
priate, or [.]
(2) is [a form prescribed by the Department and] completed
by the municipality or region in which the applicant was licensed for
at least one year.
[(3) a transcript, diploma or certicate evidencing gradua-
tion from an applicable apprenticeship program with the required num-
ber of hours of job-related education. The apprenticeship program must
be approved and registered by the U.S. Department of Labor, Bureau
of Apprenticeship and Training or other organizations recognized by
the Department]
[(d) An applicant applying for licensure in an area in which a
municipal or regional licensing program exists and who works in the
area, without passing an examination, may obtain a state issued license
that is equivalent to the municipal or regional license held at the time
of application.]
[(e) An applicant who lives and works in an area where no mu-
nicipal or regional licensing program exists, without passing an exami-
nation, may obtain a state issued master electrician’s license or a master
sign electrician’s license if the applicant has 20,000 hours of on-the-job
electrical experience acquired while working in an area where no mu-
nicipal or regional licensing program existed while under the supervi-
sion of a master electrician recognized by the department.]
§73.25. Continuing Education.
(a) Terms used in this section have the meanings assigned by
Chapter 59 of this title, unless the context indicates otherwise.
(b) To renew a license listed in Texas Occupations Code,
§1305.168(a), an individual licensee must complete four hours of
continuing education in courses approved by the department.
(c) The continuing education hours must have been completed
within the term of the current license, in the case of a timely renewal.
For a late renewal, the continuing education hours must have been com-
pleted within one year prior to the date of renewal.
(d) A licensee may not receive continuing education credit for
attending the same course more than once [for one renewal].
(e) For each annual renewal, an individual licensee must com-
plete a course, or combination of courses, dedicated to instruction in:
(1) the National Electrical Code, as adopted under Title 8,
Occupations Code §1305.101, or the current version of the National
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Electrical Code, as approved by the National Fire Protection Associa-
tion; and
(2) state law and rules that regulate the conduct of li-
censees.
(f) A licensee shall retain a copy of the certicate of comple-
tion for a course for one year after the date of completion. In conduct-
ing any inspection or investigation of the licensee, the department may
examine the licensee’s records to determine compliance with this sub-
section.
(g) To be approved under Chapter 59 of this title, a provider’s
course must be dedicated to instruction in:
(1) the National Electrical Code, as adopted under Title 8,
Occupations Code §1305.101, or the current version of the National
Electrical Code, as approved by the National Fire Protection Associa-
tion; and/or
(2) state law and rules that regulate the conduct of li-
censees.
[(h) If a provider les a course approval application prior to
January 1, 2005 and the department subsequently approves the course,
a provider may submit to the department a completion report for hours
of instruction completed from March 1, 2004 to the course approval
date. The completion report must be submitted on the appropriate de-
partment-approved form. Continuing education credit will be awarded
to a participant under this subsection if the provider submits sufcient
documentation to satisfy the department that the hours of instruction
offered prior to the course approval date were substantially similar to
the course subsequently approved by the department.]
[(i) Section 59.51(d) of this title does not apply to hours of
instruction or courses completed prior to the course approval date under
subsection (h) of this section.]
§73.40. Insurance Requirements.
(a) Electrical contractors, [and] electrical sign contractors, and
residential appliance installation contractors are required to maintain at
least the minimum general liability insurance coverages at all times to
satisfy proof of nancial responsibility.
(1) The insurance must: be at least $300,000 per occur-
rence (combined for property damage and bodily injury);
(2) be at least $600,000 aggregate (total amount the policy
will pay for property damage and bodily injury coverage); and
(3) be at least $300,000 aggregate for products and com-
pleted operations.
(b) A license applicant or licensee shall le with the Depart-
ment a completed certicate of insurance or other evidence satisfactory
to the Department when applying for initial and renewal licenses and
upon request of the Department.
(c) Proof of the required general liability and workers’ com-
pensation insurance can be submitted on an industry standard certi-
cate of insurance form with a 30 day cancellation notice. Workers’
compensation coverage may be established by a certicate of authority
to self insure, or an applicant may state that it has elected not to obtain
workers’ compensation coverage.
(d) A licensed contractor shall furnish the name of the insur-
ance carrier, policy number, name, address, and telephone number of
the insurance agent with whom the contracting company is insured to
any customer who requests it.
(e) Insurance must be obtained from an admitted company or
an eligible surplus lines carrier, as dened in the Texas Insurance Code,
Chapter 981, or other insurance companies that are rated by A.M. Best
Company as B+ or higher.
§73.51. Electrical Contractors’ Responsibilities.
(a) A licensed electrical contractor shall display its name and
license number on both sides of each vehicle owned or operated by the
business and used in the conduct of electrical work. Lettering shall be
of a contrasting color and at least two inches in height. The license
number shall be preceded by the letters "TECL".
(b) All of a contractor’s non-exempt electrical work shall be
performed by licensed individuals. A contractor is responsible for com-
pliance with applicable codes for all such electrical work performed on
its behalf [it performs].
(c) The electrical contractor’s name, address, phone num-
ber, and license number shall appear on all proposals, invoices,
and written contracts proposed by the contractor. The following
information: "Regulated by The Texas Department of Licensing and
Regulation, P.O. Box 12157, Austin, Texas 78711, 1-800-803-9202,
512-463-6599; website: www.license.state.tx.us/complaints" shall be
listed on invoices and written contracts.
(d) A licensed electrical contractor shall maintain employee
records and records of all work performed on its behalf for a period of
four years after completion of the work, and shall make those records
available to the Department at the contractor’s place of business during
normal business hours for inspection and copying.
(e) A licensed electrical contractor and its designated master
electrician are responsible for supervision of all licensees performing
work on behalf of the contractor to assure compliance with applicable
statutes and rules and in particular, standards of conduct set out in these
rules.
§73.52. Electrical Sign Contractors’ Responsibilities.
(a) A licensed electrical sign contractor shall display its name
and license number on both sides of each vehicle owned or operated by
the business and used in the conduct of electrical sign work. Lettering
shall be of a contrasting color and at least two inches in height. The
license number shall be preceded by the letters "TSCL".
(b) All of a contractor’s non-exempt electrical sign work shall
be performed by licensed individuals. A contractor is responsible for
compliance with applicable codes for all such electrical sign work per-
formed on its behalf [it performs].
(c) The electrical sign contractor’s name, address, phone num-
ber, and license number shall appear on all proposals, invoices, and
written contracts proposed by the contractor. The following informa-
tion: "Regulated by The Texas Department of Licensing and Regula-
tion, P.O. Box 12157, Austin, Texas 78711, 1-800-803-9202, 512-463-
6599; website: www.license.state.tx.us/complaints" shall be listed on
invoices and written contracts.
(d) A licensed electrical sign contractor shall maintain em-
ployee records and records of all work performed on its behalf for a
period of four years after completion of the work, and shall make those
records available to the Department at the contractor’s place of busi-
ness during normal business hours for inspection and copying.
(e) A licensed electrical sign contractor and its designated
master electrician or master sign electrician are responsible for super-
vision of all licensees performing work on behalf of the contractor to
assure compliance with applicable statutes and rules and in particular,
standards of conduct set out in these rules.
§73.54. Residential Appliance Installation Contractors’ Responsibil-
ities.
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(a) A licensed residential appliance installation contractor
shall display its name and license number on both sides of each
vehicle owned or operated by the business and used in the conduct
of residential appliance installation work. Lettering shall be of a
contrasting color and at least two inches in height. The license number
shall be preceded by the letters "TICL".
(b) All of a contractor’s non-exempt residential appliance in-
stallation work shall be performed by licensed individuals. A contrac-
tor is responsible for compliance with applicable codes for all such res-
idential appliance installation work performed on its behalf.
(c) The residential appliance installation contractor’s name,
address, phone number, and license number shall appear on all
proposals, invoices, and written contracts proposed by the con-
tractor. The following information: "Regulated by The Texas
Department of Licensing and Regulation, P.O. Box 12157, Austin,
Texas 78711, 1-800-803-9202, 512-463-6599; website: www.li-
cense.state.tx.us/complaints" shall be listed on invoices and written
contracts.
(d) A licensed residential appliance installation contractor
shall maintain employee records and records of all work performed on
its behalf for a period of four years after completion of the work, and
shall make those records available to the Department at the contrac-
tor’s place of business during normal business hours for inspection
and copying.
(e) A licensed residential appliance installation contractor and
its designated appliance installer are responsible for supervision of all
licensees performing work on behalf of the contractor to assure com-
pliance with applicable statutes and rules and in particular, standards
of conduct set out in these rules.
§73.80. Fees.
(a) Application and renewal fees:
(1) Master Electrician--$65
(2) Master Sign Electrician--$65
(3) Journeyman Electrician--$40




(8) Electrical Sign Contractor--$125
(9) Electrical Apprentice--$20
(10) Electrical Sign Apprentice--$20
(11) Residential Appliance Installer--$40
(12) Residential Appliance Installation Contractor--$125
(b) Late Renewal Fees. Late renewal fees for licenses issued
under this chapter are provided under §60.83 of this title (relating to
Late Renewal Fees).
(c) Revised or duplicate license fees:
(1) All licenses except as set out below--$25
(2) Electrical Apprentice--$20
(3) Electrical Sign Apprentice--$20
(d) All fees are non-refundable.
§73.90. Sanctions--Administrative Sanctions/Penalties.
If a person violates any provision of Title 8, Occupations Code, Chapter
1305, any provision of Title 16, Texas Administrative Code, Chapter
73, or any provision of an order of the Executive Director or Commis-
sion, proceedings may be instituted to impose administrative penalties,
administrative sanctions, or both administrative penalties and sanctions
in accordance with the provisions of Title 8, [Texas Civil Statutes,
Chapter 1305, Texas] Occupations Code, Chapters [Chapter] 51 and
1305 [; and Title 16, Texas Administrative Code, Chapter 60].
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704062
William H. Kuntz, Jr.
Executive Director
Texas Department of Licensing and Regulation
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-4765
TITLE 19. EDUCATION
PART 2. TEXAS EDUCATION AGENCY






The Texas Education Agency (TEA) proposes new §89.1701,
concerning the dropout prevention strategy plan. The proposed
new section would implement the requirements of the Texas Ed-
ucation Code (TEC), §29.918, as added by House Bill (HB) 2237,
80th Texas Legislature, 2007, which requires the commissioner
by rule to establish procedures through which districts with a high
dropout rate will submit a plan detailing the manner in which the
compensatory education allotment and the high school allotment
will be used as part of a dropout prevention strategy.
HB 2237, 80th Texas Legislature, 2007, added the TEC,
§29.918, requiring districts with a high dropout rate to develop
a dropout prevention strategy plan. This plan must detail the
manner in which a district will use its resources, specically the
compensatory education allotment and the high school allot-
ment, to contribute to the district’s dropout prevention strategy.
The compensatory education allotment, established through the
TEC, §42.152, provides an annual allotment to districts based
on the number of economically disadvantaged students enrolled
at campuses in the district. The compensatory education allot-
ment is intended to increase the academic achievement and
high school completion rates for at-risk students. Similarly, the
high school allotment, as detailed in the TEC, §42.2516(b)(3),
provides funding to districts to improve graduation and college
readiness rates for Texas secondary school students.
In addition to a dropout prevention strategy plan, the Legisla-
ture, in previous legislation, mandated that certain districts de-
velop two other plans--a school improvement plan and a plan to
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increase college enrollment--both of which may address issues
related to a district’s dropout rate. Under the TEC, §39.1323, a
campus with a specic state accountability rating is required to
work with a campus intervention team and to design a school
improvement plan addressing factors contributing to the cam-
pus’ rating as academically unacceptable. In addition, under the
TEC, §29.904, a campus with a low college-going rate is required
to enter into an agreement with a nearby institution of higher ed-
ucation to develop a plan to increase the percentage of its grad-
uating seniors enrolling in an institution of higher education. The
newly mandated requirement for a dropout prevention strategy
plan offers an opportunity to coordinate these three plans, where
appropriate.
The proposed new 19 TAC §89.1701, Dropout Prevention Strat-
egy Plan, would implement the TEC, §29.918, relative to the
dropout prevention strategies. The proposed new rule would
establish applicable denitions and specify that affected districts
would be identied and notied annually of the requirement to
submit a dropout prevention strategy plan. The proposal would
also address coordination of a dropout prevention strategy plan
with a plan to increase college enrollment and with a school im-
provement plan. Submission of a plan by a school district and
review of a plan by the TEA are also addressed as well as condi-
tions under which the commissioner of education could impose
sanctions.
Barbara Knaggs, acting senior advisor for education initiatives,
has determined that for the rst ve-year period the new section
is in effect there will be no scal implications for state and local
government as a result of enforcing or administering the new
section.
Ms. Knaggs has determined that for each year of the rst ve
years the new section is in effect the public benet anticipated as
a result of enforcing the new section will be that districts with high
dropout rates will create and implement plans that will strategi-
cally coordinate resources to enact dropout prevention strate-
gies. Both the public and students will benet from dropout pre-
vention strategies because more students will graduate ready to
enter college and the workforce. There will be no effect on small
businesses. There is no anticipated economic cost to persons
who are required to comply with the new section.
The public comment period on the proposal begins September
14, 2007, and ends October 14, 2007. Comments on the
proposal may be submitted to Cristina De La Fuente-Valadez,
Policy Coordination Division, Texas Education Agency,
1701 North Congress Avenue, Austin, Texas 78701, (512)
475-1497. Comments may also be submitted electronically to
rules@tea.state.tx.us or faxed to (512) 463-0028. All requests
for a public hearing on the proposed new section submitted
under the Administrative Procedure Act must be received by
the commissioner of education not more than 15 calendar days
after notice of the proposal has been published in the Texas
Register.
The new section is proposed under the Texas Education Code,
§29.918, which authorizes the commissioner to adopt rules to
administer dropout prevention strategies.
The new section implements the Texas Education Code,
§29.918.
§89.1701. Dropout Prevention Strategy Plan.
(a) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Compensatory education allotment--Funds allocated
under the Texas Education Code (TEC), §42.152.
(2) Dropout prevention strategy plan--The document pre-
pared for submission to the Texas Education Agency (TEA) in compli-
ance with the TEC, §29.918, and in accordance with specications set
forth in subsection (e) of this section.
(3) High school allotment--Funds allocated under the TEC,
§42.2516(b)(3).
(4) Plan to increase college enrollment--The document pre-
pared in compliance with the TEC, §29.904, for submission to the TEA
by a district ranked among the lowest 10% of districts, based on its
college-going rate. A district’s college-going rate is calculated as the
percentage of its graduating class enrolled in higher education the fall
after completing high school.
(5) School district--For the purposes of this section, the
denition of school district includes an open-enrollment charter school.
(6) School improvement plan--The document prepared for
submission to the TEA by a school district in compliance with the TEC,
§39.1323, or by a school district with a campus rated academically
unacceptable for failure to meet the required performance standards
set forth in the TEC, §39.073.
(b) Identication of districts with a high dropout rate. In accor-
dance with the TEC, §29.918(a), a school district with a high dropout
rate, as dened by the commissioner of education, shall be identied
and notied annually of the requirement to submit a dropout preven-
tion strategy plan as specied by this section.
(c) Coordination with statutory requirement to submit a plan to
increase college enrollment. If a school district is required by statute to
submit both a dropout prevention strategy plan and a plan to increase
college enrollment, the school district must describe in its dropout pre-
vention strategy plan how the activities identied in both plans will be
coordinated.
(d) Coordination with statutory requirement to submit a school
improvement plan.
(1) If a school district is required by statute to submit both
a school improvement plan due to failure to meet the required perfor-
mance standard regarding dropout rates or completion rates as well as
a dropout prevention strategy plan, then the school district may request
that its school improvement plan be used to satisfy the requirements of
both statutes. To exercise this option, a school district superintendent
must submit a request in writing to the commissioner of education for
approval.
(2) A school improvement plan used to satisfy the statu-
tory requirements of both plans, as provided in paragraph (1) of this
subsection, must clearly identify those programs and activities to be
funded with compensatory education allotment and high school allot-
ment funds.
(e) Dropout prevention strategy plan specications.
(1) A school district identied as having a high dropout rate
under subsection (b) of this section shall submit a dropout prevention
strategy plan to the commissioner describing the manner in which it in-
tends to use its compensatory education allocation and high school al-
location funds for the purpose of developing and implementing dropout
prevention strategies.
(2) A school district’s dropout prevention strategy plan
shall include the following components:
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(A) analysis of factors that have had an impact on the
school district or campus dropout rate using evaluation and needs as-
sessment data available to the school district;
(B) description of programs and activities designed to
reduce the school district and campus dropout rate to be funded in
whole or in part with compensatory education allotment funds;
(C) description of programs and activities identied in
§61.1093 of this title (relating to Use of Funds) designed to reduce the
school district and campus dropout rate to be funded in whole or in part
with high school allotment funds;
(D) quantiable benchmarks to measure evidence of
change;
(E) resources to be used in implementing programs and
activities identied in subparagraphs (B) and (C) of this paragraph;
(F) timeline for initiation of activities identied in sub-
paragraphs (B) and (C) of this paragraph; and
(G) description of how activities will be coordinated
with those identied in the school district’s plan to increase college
enrollment, if the school district is required by the TEC, §29.904, to
submit such a plan.
(3) The dropout prevention strategy plan shall include re-
search-based programs and activities.
(f) Dropout prevention strategy plan submission. In accor-
dance with the TEC, §29.918(a), a school district shall submit its
dropout prevention strategy plan not later than December 1 of each
school year preceding the school year in which the school district will
receive the compensatory education allotment or high school allot-
ment. The plan shall be submitted to the TEA in a manner determined
by the commissioner.
(g) Dropout prevention strategy plan approval. In accordance
with the TEC, §29.918(b), review of district dropout prevention strat-
egy plans shall be completed by the commissioner not later than March
1 of the school year preceding the school year in which the district
will receive the compensatory education allotment or high school al-
lotment. Until a district receives commissioner approval in writing for
its dropout prevention strategy plan, a district may not spend or obli-
gate more than 25% of the district’s compensatory education allotment
or high school allotment funds as set forth in the TEC, §29.918(b).
(h) Sanctions. The commissioner may impose sanctions under
the TEC, §39.131 or §39.1321, if the district:
(1) fails to submit its dropout prevention strategy plan by
December 1;
(2) submits a dropout prevention strategy plan that fails to
meet the plan specications set forth in subsection (e) of this section;
or
(3) spends or obligates compensatory education allotment
or high school allotment funds in excess of 25% of the allotment
amount prior to receiving approval of the dropout prevention strategy
plan by the commissioner.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704056
Cristina De La Fuente-Valadez
Director, Policy Coordination
Texas Education Agency
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-1497
CHAPTER 103. HEALTH AND SAFETY
SUBCHAPTER AA. COMMISSIONER’S
RULES CONCERNING PHYSICAL FITNESS
19 TAC §103.1001
The Texas Education Agency (TEA) proposes new §103.1001,
concerning student physical tness assessment. The proposed
new section would adopt in rule the requirement that school dis-
tricts and open-enrollment charter schools shall assess student
physical tness. The proposal would implement rule action re-
quired by Senate Bill (SB) 530, 80th Texas Legislature, 2007.
Through SB 530, the 80th Texas Legislature added the Texas
Education Code (TEC), Chapter 38, Health and Safety, Sub-
chapter C, Physical Fitness Assessment, requiring school dis-
tricts to annually assess the physical tness of students enrolled
in Grades 3-12. TEC, §38.102, requires the commissioner of ed-
ucation to adopt an assessment instrument to be used by school
districts in assessing student physical tness. The statute also
identies specic factors the instrument must assess and re-
quires criterion-referenced standards specic to a student’s age
and gender based on the physical tness level required for good
health.
Proposed new 19 TAC Chapter 103, Subchapter AA, §103.1001,
would implement the TEC, §38.102, by adopting a rule that spec-
ies that the commissioner of education shall determine the as-
sessment instrument to be used by school districts and open-en-
rollment charter schools to assess the physical tness of stu-
dents. The proposed new rule would also address student ex-
emptions.
Local school districts will be required to collect, maintain, and
submit specied physical tness assessment data. Through a
separate rulemaking process, the TEA will propose rules relating
to the collection and analysis of aggregated data on the tness
assessment components in compliance with SB 530.
Jeff Kloster, associate commissioner for health, safety, and
school readiness, has determined that for the rst ve-year
period the new section is in effect there will be no scal implica-
tions for state and local government as a result of enforcing or
administering the new section.
Mr. Kloster has determined that for each year of the rst ve
years the new section is in effect the public and student ben-
et anticipated as a result of enforcing the new section will be
increasing public awareness of quality physical education pro-
grams, emphasizing the importance of community and school-
based support of school health programming, and bringing fo-
cus on resources and funding for school-based physical activ-
ity and health education programs. The proposal would also
strengthen physical education and physical activity programs to
ensure health improvement among the student population, in-
cluding a gradual reduction in childhood obesity and Type II dia-
betes. There will be no effect on small businesses. There is no
anticipated economic cost to persons who are required to com-
ply with the new section.
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The public comment period on the proposal begins September
14, 2007, and ends October 14, 2007. Comments on the
proposal may be submitted to Cristina De La Fuente-Valadez,
Policy Coordination Division, Texas Education Agency,
1701 North Congress Avenue, Austin, Texas 78701, (512)
475-1497. Comments may also be submitted electronically to
rules@tea.state.tx.us or faxed to (512) 463-0028. All requests
for a public hearing on the proposed new section submitted
under the Administrative Procedure Act must be received by
the commissioner of education not more than 15 calendar days
after notice of the proposal has been published in the Texas
Register.
The new section is proposed under the Texas Education Code,
§38.102, which authorizes the commissioner to adopt by rule an
assessment instrument to be used by a school district in assess-
ing student physical tness. Texas Education Code, §38.106,
authorizes the commissioner to adopt rules necessary to imple-
ment the Texas Education Code, Chapter 38, Subchapter C.
The new section implements the Texas Education Code,
§38.102 and §38.106.
§103.1001. Student Physical Fitness Assessment.
(a) In accordance with the Texas Education Code (TEC),
Chapter 38, Subchapter C, each school district and open-enrollment
charter school shall annually assess the physical tness of students
enrolled in Grades 3-12.
(b) Each student must be assessed based on factors related to
student health, including the factors specied in the TEC, §38.102, un-
less a particular factor is inappropriate for that student because of a
health classication as dened in 19 TAC §74.31 of this title (relating
to Health Classications for Physical Education).
(c) The assessment that each school district and open-enroll-
ment charter school shall use to assess student physical tness will be
the assessment instrument selected by the commissioner of education
through a request for offers process.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704057
Cristina De La Fuente-Valadez
Director, Policy Coordination
Texas Education Agency
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-1497
TITLE 22. EXAMINING BOARDS
PART 9. TEXAS MEDICAL BOARD
CHAPTER 162. SUPERVISION OF MEDICAL
SCHOOL STUDENTS
22 TAC §162.1
The Texas Medical Board proposes an amendment to §162.1,
concerning Supervision of Medical Students.
The amendment updates the name of the Texas Medical Board.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously proposes the rule review of Chapter
162, Supervision of Medical School Students.
Robert D. Simpson, General Counsel, Texas Medical Board, has
determined that for the rst ve-year period the amendment is in
effect there will be no scal implications to state or local govern-
ment as a result of enforcing the section as proposed. There
will be no effect to individuals required to comply with the rule as
proposed.
Mr. Simpson also has determined that for each year of the rst
ve years the amendment as proposed is in effect the public ben-
et anticipated as a result of enforcing the section will be an up-
dated rule. There will be no effect on small or micro businesses.
Comments on the proposal may be submitted to Sally Durocher,
P.O. Box 2018, Austin, Texas 78768-2018. A public hearing will
be held at a later date.
The amendment is proposed under the authority of the Texas Oc-
cupations Code Annotated, §153.001, which provides authority
for the Texas Medical Board to adopt rules and bylaws as neces-
sary to: govern its own proceedings; perform its duties; regulate
the practice of medicine in this state; enforce this subtitle; and
establish rules related to licensure.
Texas Occupations Code Annotated, §152.001 is affected by the
proposal.
§162.1. Supervision of Medical Students.
Only a physician with a current and unrestricted Texas medical license
may supervise a medical student if the medical student meets the fol-
lowing criteria:
(1) is enrolled at a Texas medical school;
(2) is a student at a medical school located outside Texas
and is enrolled as a visiting student at a Texas medical school; or
(3) will receive supervised medical education in a Texas
hospital or teaching institution sponsoring or participating in a program
of graduate medical education accredited by the Accrediting Council
for Graduate Medical Education, the American Osteopathic Associa-
tion, or the Texas Medical Board [State Board of Medical Examiners]
in the same subject as the medical or osteopathic medical education in
which the hospital or teaching institution has an agreement with the
applicant’s school.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704022
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 305-7016
CHAPTER 173. PHYSICIAN PROFILES
22 TAC §§173.1, 173.2, 173.5
The Texas Medical Board proposes amendments to §§173.1,
173.2, and 173.5, concerning Physician Proles.
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The amendments update the name of the Texas Medical Board,
set grounds for disciplinary action to include the omission of re-
quired information when providing physician prole information,
and establish when the Board will amend a physician’s prole.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously proposes the rule review of Chapter
173, Physician Proles.
Robert D. Simpson, General Counsel, Texas Medical Board, has
determined that for the rst ve-year period the amendments are
in effect there will be no scal implications to state or local gov-
ernment as a result of enforcing the sections as proposed. There
will be no effect to individuals required to comply with the rules
as proposed.
Mr. Simpson also has determined that for each year of the rst
ve years the amendments as proposed are in effect the public
benet anticipated as a result of enforcing the sections will give
the public more accurate prole information regarding licensees.
There will be no effect on small or micro businesses.
Comments on the proposal may be submitted to Sally Durocher,
P.O. Box 2018, Austin, Texas 78768-2018. A public hearing will
be held at a later date.
The amendments are proposed under the authority of the Texas
Occupations Code Annotated, §153.001 and §154.006, which
provide authority for the Texas Medical Board to adopt rules and
bylaws as necessary to: govern its own proceedings; perform
its duties; regulate the practice of medicine in this state; enforce
this subtitle; and establish rules related to licensure.
No other statutes, articles are codes are affected by the pro-
posal.
§173.1. Prole Contents.
(a) The Texas Medical Board [State Board of Medical Exam-
iners] (the "board") shall develop and make available to the public a
comprehensive prole of each licensed physician electronically via the
Internet or in paper format upon request.
(b) The prole of each licensed physician shall contain the fol-
lowing information listed in paragraphs (1) - (25) of this subsection:
(1) full name;
(2) place of birth if the physician requests that it be in-
cluded in the physician’s prole;
(3) gender;
(4) ethnic origin if the physician requests that it be included
in the physician’s prole;
(5) name of each medical school attended and the dates of:
(A) graduation; or
(B) Fifth Pathway designation and completion of the
Fifth Pathway Program;
(6) a description of all graduate medical education in the
United States or Canada, including:
(A) beginning and ending dates;
(B) program name;
(C) city and state of program;
(D) type of training (internship, residency or fellow-
ship); and
(E) specialty of program;
(7) any specialty certication held by the physician and is-
sued by a board that is a member of the American Board of Medical
Specialties or the Bureau of Osteopathic Specialists;
(8) primary and secondary specialties practiced, as desig-
nated by the physician;
(9) the number of years the physician has actively practiced
medicine in:
(A) the United States or Canada; and
(B) Texas;
(10) the original date of issuance of the physician’s Texas
medical license;
(11) the expiration date of the physician’s registration per-
mit;
(12) the physician’s current registration, disciplinary and
licensure statuses;
(13) the name and city of each hospital in Texas in which
the physician has privileges;
(14) the physician’s primary practice location (street ad-
dress, city, state and zip code);
(15) the type of language translating services, including
translating services for a person with impairment of hearing, that the
physician provides at the physician’s primary practice location;
(16) whether the physician participates in the Medicaid
program;
(17) whether the physician’s patient service areas are ac-
cessible to disabled persons, as dened by federal law;
(18) a description of any conviction for an offense consti-
tuting a felony, a Class A or Class B misdemeanor, or a Class C mis-
demeanor involving moral turpitude;
(19) a description of any charges reported to the board to
which the physician has pleaded no contest, for which the physician is
the subject of deferred adjudication or pretrial diversion, or in which
sufcient facts of guilt were found and the matter was continued by a
court of competent jurisdiction;
(20) a description of any public board action against the
physician;
(21) a description of any disciplinary action against the
physician by a medical licensing board of another state;
(22) a description of the nal resolution taken by the board
on medical malpractice claims or complaints required to be opened by
the board under the Medical Practice Act (the "Act"), Tex. Occ. Code
Ann. §164.201;
(23) a description of any formal complaint issued by the
board’s staff against the physician and initiated and led with the State
Ofce of Administrative Hearings under §164.005 of the Act and the
status of the complaint;
(24) a description of a maximum of ve awards, honors,
publications or academic appointments submitted by the physician,
each no longer than 120 characters; and
(25) a description of any medical malpractice claim against
the physician, not including a description of any offers by the physician
to settle the claim, for which the physician was found liable, a jury
awarded monetary damages to the claimant, and the award has been
determined to be nal and not subject to further appeal.
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§173.2. Prole Update and Correction Form.
(a) The board shall develop a Prole Update and Correction
Form (the "Form") which allows for corrections and/or updates to the
prole information to be made by the physician. The physician must
submit all changes to prole information upon this Form, or indicate
on the Form that no changes are necessary. The Form shall contain the
date the information will be made available to the public and will allow
the physician to request a copy of the physician’s prole. Upon such
request, and when the prole information has been updated, the board
shall provide a copy to the physician. The Form will be made available
in hard copy and on the Internet.
(b) Compliance with the request for information from the
board is mandatory. Failure to return the completed Form to the board
shall be considered non-compliance. Non-compliance shall result in
nonrenewal of the physician’s license until such time as the physician
provides the requested information.
(c) Submission of false or misleading information or omission
of required information by the physician shall be considered grounds
for disciplinary action.
(d) All data contained in the prole shall indicate the source
of the data and the last update date.
§173.5. Updates to the Physician’s Prole Due to Information Re-
ceived by a Third Party.
(a) When the board is notied by a third party of a change in
prole information for a physician, the board shall send a copy of the
Form to the physician with the changes noted. The physician shall have
one month in which to correct factual errors or dispute the information.
(b) Amendments to a physician’s prole shall be made by the
board when:
(1) the board receives information from non-governmental
third-parties that has been veried by the board and contradicts infor-
mation reported on a physician’s prole;
(2) the board receives information from state or federal
governmental authorities regarding criminal convictions described in
§173.1(b)(18) of this title (relating to Prole Contents);
(3) the board determines that information provided on a
physician’s prole would violate state or federal condentiality laws;
or
(4) the board otherwise determines that information pro-
vided on a physician’s prole is false or misleading.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704023
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 305-7016
CHAPTER 196. VOLUNTARY RELINQUISH-
MENT OR SURRENDER OF A MEDICAL
LICENSE
22 TAC §196.2, §196.3
The Texas Medical Board proposes amendments to §196.2 and
§196.3, concerning Surrender Associated with Disciplinary Ac-
tion and Surrender Associated with Impairment.
The amendments update the section titles for §196.4 and §167.5
which are referenced in the chapter.
Elsewhere in this issue of the Texas Register, the Texas Medi-
cal Board contemporaneously proposes the rule review of Chap-
ter 196, Voluntary Relinquishment or Surrender of a Medical Li-
cense.
Robert D. Simpson, General Counsel, Texas Medical Board, has
determined that for the rst ve-year period the amendments are
in effect there will be no scal implications to state or local gov-
ernment as a result of enforcing the sections as proposed. There
will be no effect to individuals required to comply with the rules
as proposed.
Mr. Simpson also has determined that for each year of the rst
ve years the amendments as proposed are in effect the public
benet anticipated as a result of enforcing the sections will be
updated rules. There will be no effect on small or micro busi-
nesses.
Comments on the proposal may be submitted to Sally Durocher,
P.O. Box 2018, Austin, Texas 78768-2018. A public hearing will
be held at a later date.
The amendments are proposed under the authority of the Texas
Occupations Code Annotated, §153.001, which provides author-
ity for the Texas Medical Board to adopt rules and bylaws as
necessary to: govern its own proceedings; perform its duties;
regulate the practice of medicine in this state; enforce this subti-
tle; and establish rules related to licensure.
No other statutes, articles are codes are affected by the pro-
posal.
§196.2. Surrender Associated with Disciplinary Action.
(a) When a licensee has surrendered his or her Texas medical
license in lieu of a hearing or further investigation of alleged violations
of the Medical Practice Act ("the Act"), Title 3 Subtitle B Tex. Occ.
Code, and its subsequent amendments, such a surrender shall be con-
sidered surrender associated with a disciplinary action.
(b) If the surrender of a Texas medical license was associated
with disciplinary action, the Texas medical license shall not be returned
to the licensee if the board’s order on the merits of the disciplinary ac-
tion is inconsistent with the return of that license. In addition to re-
quirements set out in §196.4 of this chapter (relating to Relicensure
after Relinquishment or Surrender of License [Reapplication for Li-
censure After Surrender of License]), a licensee who reapplies for li-
censure must demonstrate that the licensee’s return to the practice is in
the best interest of the public as dened under §167.5 of this title (re-
lating to Best Interests of the Public [Reinstatement and Reissuance]).
(c) If a licensee agrees to permanently surrender his or her li-
cense in lieu of disciplinary action, the licensee forfeits all rights to
apply for any type of licensure with the board.
§196.3. Surrender Associated with Impairment.
(a) When a licensee who, by reason of impairment from ill-
ness, drunkenness, excessive use of drugs, narcotics, chemicals, or any
other type of substance or as a result of any mental or physical condi-
tion, is unable to treat patients with reasonable skill and safety and sur-
renders his or her Texas medical license, that surrender shall be deemed
a surrender associated with impairment.
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(b) A Texas medical license surrendered in accordance with
this section shall not be returned to a licensee until after the board has
determined that:
(1) the licensee is competent to resume practice based on
adequate medical and treatment information provided to the board; and
(2) the licensee’s return to the practice is in the best inter-
est of the public as dened under §167.5 of this title (relating to Best
Interests of the Public [Reinstatement and Reissuance]).
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704024
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 305-7016
CHAPTER 198. UNLICENSED PRACTICE
22 TAC §198.2, §198.3
The Texas Medical Board proposes amendments to §198.2 and
§198.3, concerning Complaints and Investigation of Complaints.
The amendments update the name of the Texas Department of
State Health Services and provides cite to Chapter 187 of the
Board’s rules.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously proposes the rule review of Chapter
198, Unlicensed Practice.
Robert D. Simpson, General Counsel, Texas Medical Board, has
determined that for the rst ve-year period the amendments are
in effect there will be no scal implications to state or local gov-
ernment as a result of enforcing the sections as proposed. There
will be no effect to individuals required to comply with the rules
as proposed.
Mr. Simpson also has determined that for each year of the rst
ve years the amendments as proposed are in effect the public
benet anticipated as a result of enforcing the sections will be
updated rules. There will be no effect on small or micro busi-
nesses.
Comments on the proposal may be submitted to Sally Durocher,
P.O. Box 2018, Austin, Texas 78768-2018. A public hearing will
be held at a later date.
The amendments are proposed under the authority of the Texas
Occupations Code Annotated, §153.001, which provides author-
ity for the Texas Medical Board to adopt rules and bylaws as
necessary to: govern its own proceedings; perform its duties;
regulate the practice of medicine in this state; enforce this subti-
tle; and establish rules related to licensure.
No other statutes, articles are codes are affected by the pro-
posal.
§198.2. Complaints.
(a) Complaints to the board regarding the unlicensed practice
of medicine and other violations of the Medical Practice Act, a rule
adopted by the board, or another statute relating to the practice of
medicine by a person who is not licensed by the board or the perfor-
mance of any medical procedure without the required permit, regis-
tration, or license shall be routed to one or more of the following for
appropriate handling including further investigation, cease and desist
proceedings, criminal prosecution, and/or injunctive relief:
(1) the Investigation Division of the Board;
(2) the Ofce of the Attorney General;
(3) the Texas Department of Public Safety;
(4) the United States Drug Enforcement Administration;
(5) the Texas Department of State Health Services
[Health];
(6) the local district or county attorney’s ofce with juris-
diction;
(7) the local law enforcement agency;
(8) any state or federal licensing board or other agency
which maintains jurisdiction over a person who is the subject of the
complaint.
(b) In any instance in which the board may have concurrent
jurisdiction with another agency over the subject of a complaint under
this section, the board may pursue further investigation and appropriate
action before or after routing the complaint to another agency.
(c) The routing of a complaint to another agency as provided
by this section shall be in writing unless to do so is likely to jeopardize
any further investigation, prosecution, or injunctive relief.
§198.3. Investigation of Complaints.
(a) A complaint or information that a person has committed a
violation under this Chapter shall be processed in a manner similar to
a complaint against a licensee (see Chapter 178 of this title (relating to
Complaints)).
(b) After sufcient information and evidence has been gath-
ered, a committee of board employees designated by the Executive
Director, which may include the Executive Director, shall determine
whether the information and evidence gathered indicate that a viola-
tion has occurred.
(c) If the committee of board employees determines that the in-
formation and evidence gathered indicate that a violation has occurred,
the committee may recommend that a formal complaint be led with
the State Ofce of Administrative Hearings, providing notice and op-
portunity for a hearing as provided in Chapter 187, Subchapter C of
this title (relating to Formal Board Proceedings at SOAH).
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704025
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 305-7016
CHAPTER 199. PUBLIC INFORMATION
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22 TAC §§199.1, 199.3 - 199.5
The Texas Medical Board proposes amendments to §§199.1 and
199.3 - 199.5, concerning Public Information.
The amendments provide that the Public Information committee
is responsible for the Board’s website, update the names of the
Texas Medical Board, correctly cites to the Ofce of the Attorney
General in relation to charges for copies of public records, and
species that physicians who have any ownership interested in
a niche hospital must report that interest to the Department of
State Health Services.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously proposes the rule review of Chapter
199, Public Information.
Robert D. Simpson, General Counsel, Texas Medical Board, has
determined that for the rst ve-year period the amendments are
in effect there will be no scal implications to state or local gov-
ernment as a result of enforcing the sections as proposed. There
will be no effect to individuals required to comply with the rules
as proposed.
Mr. Simpson also has determined that for each year of the rst
ve years the amendments as proposed are in effect the public
benet anticipated as a result of enforcing the sections will be
updated rules. There will be no effect on small or micro busi-
nesses.
Comments on the proposal may be submitted to Sally Durocher,
P.O. Box 2018, Austin, Texas 78768-2018. A public hearing will
be held at a later date.
The amendments are proposed under the authority of the Texas
Occupations Code Annotated, §153.001, which provides author-
ity for the Texas Medical Board to adopt rules and bylaws as
necessary to: govern its own proceedings; perform its duties;
regulate the practice of medicine in this state; enforce this subti-
tle; and establish rules related to licensure.
No other statutes, articles are codes are affected by the pro-
posal.
§199.1. Public Information/Prole Committee.
(a) The board shall maintain the Public Information/Prole
Committee as a standing and permanent committee of the board.
(b) As set forth in Chapter 161 of this title (relating to General
Provisions), the responsibilities and authority of the Public Informa-
tion/Prole Committee include those duties and powers set forth below
and in this chapter, as well as such other responsibilities and authority
which the board from time to time may delegate:
(1) develop informational brochures for distribution to the
public;
(2) review and make recommendations to the board in re-
gard to press releases, newsletters, and other publications;
(3) exhibit display booths at conventions;
(4) study and make recommendations to the board regard-
ing all aspects of public information or public relations;
(5) make recommendations to the board regarding matters
brought to the attention of the Public Information/Prole Committee;
and [.]
(6) maintain a website that includes information required
by statute and that is easily accessible to the public.
§199.3. Requests for Information.
(a) The public may obtain copies of board newsletters,
brochures, pamphlets, press releases and other board publications
by written request to the attention of the Public Information/Prole
Committee at the board’s current mailing address or by electronic mail
to the board’s designated email address [public information ofcer].
(b) Public records of the board may be obtained to the extent
allowed by law through a written request pursuant to the Public Infor-
mation Act of Texas submitted to the attention of the Manager, Public
Information at the board’s current mailing address, by fax, or by elec-
tronic mail to the board’s designated email address.
(c) The provision of written materials or records provided pur-
suant to a request made under this chapter shall be subject to applicable
charges under this title and state law.
§199.4. Charges for Copies of Public Records.
(a) Charges. The charge to any person requesting copies of
any public record of the Texas Medical Board [State Board of Medical
Examiners] will be the charges established by the Ofce of the Attorney
General [Texas Building and Procurement Commission].
(b) Routine items. All charges for routinely requested items
shall be based upon the charges established by the Ofce of the Attor-
ney General [Texas Building and Procurement Commission]. A current
price list may be requested from the Customer Affairs Division of the
Board. Upon written request, the board shall provide copies of rou-
tinely requested items, which shall include, but not be limited to, the
following:
(1) Board Rules;
(2) Medical Practice Act;
(3) Microche with complete physician information:
(A) individual order;
(B) year subscription;









(c) Certied copies. Upon written request, the Texas Medi-
cal Board [State Board of Medical Examiners] will certify any public
records of the board. The cost for certifying copies of public records
provided pursuant to the Texas Public Information [Open Records] Act
shall be $5.00 per record or document. This cost shall be in addition
to any other costs charged for providing the requested document or
record, including, but not limited to, copying, retrieving, or mailing of
the document or record.
(d) Waiver of charges. Copies of public records shall be fur-
nished without charge or at a reduced charge if the executive director
determines that waiver or reduction of the fee is in the public interest,
and that furnishing the information can be considered as primarily ben-
eting the general public.
§199.5. Notice of Ownership Interest in a Niche Hospital.
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(a) A physician shall notify the Department of State Health
Services of any [an] ownership interest held by the physician in a niche
hospital as required by §162.052 of the Act.
(b) In this section, "niche hospital," as dened by §105.002,
Tex. Occ. Code, means a hospital that:
(1) classies at least two-thirds of the hospital’s Medicare
patients or, if data is available, all patients:
(A) in not more than two major diagnosis-related
groups; or
(B) in surgical diagnosis-related groups;




(D) women’s health; and
(3) is not:
(A) a public hospital;
(B) a hospital for which the majority of inpatient claims
are for major diagnosis-related groups relating to rehabilitation, psychi-
atry, alcohol and drug treatment, or children or newborns; or
(C) a hospital with fewer than 10 claims per bed per
year.
(c) The board hereby adopts by reference the Disclosure and
Consent Form, which shall be published on the board’s web site and
may be examined and copies obtained at the ofces of the board.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704026
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 305-7016




The Texas State Board of Pharmacy proposes amendments to
§295.8, concerning Continuing Education Requirements. The
proposed amendments, if adopted, will allow pharmacist to ob-
tain continuing education credit for taking and successfully pass-
ing the initial Geriatric Pharmacy Practice certication examina-
tion administered by the Commission for Certication in Geriatric
Pharmacy.
Gay Dodson, R.Ph., Executive Director/Secretary, has deter-
mined that, for the rst ve-year period the amendments are in
effect, there will be no scal implications for state or local gov-
ernment as a result of enforcing or administering the amended
rule.
Ms. Dodson has determined that, for each year of the rst ve-
year period the amendments will be in effect, the public benet
anticipated as a result of enforcing the amended rule will be to
ensure pharmacists have obtained continuing education credit
relative to the practice of pharmacy. There is no scal impact for
individuals, small or large businesses or to other entities which
are required to comply with this amended section.
Comments on the proposed amendments may be submitted to
Allison Benz, R.Ph., M.S., Director of Professional Services,
Texas State Board of Pharmacy, 333 Guadalupe Street, Suite
3-600, Austin, Texas 78701, FAX (512) 305-8082. Comments
must be received by 5:00 p.m., October 15, 2007.
The amendments are proposed under §§551.002, 554.051, and
559.052 of the Texas Pharmacy Act (Chapters 551 - 566 and 568
- 569, Texas Occupations Code). The Board interprets §551.002
as authorizing the agency to protect the public through the ef-
fective control and regulation of the practice of pharmacy. The
Board interprets §554.051(a) as authorizing the agency to adopt
rules for the proper administration and enforcement of the Act.
The Board interprets §559.052 as authorizing the Board to adopt
rules regarding the approval of providers of continuing educa-
tion.
The statutes affected by the amendments: Chapters 551 - 566
and 568 - 569, Texas Occupations Code.
§295.8. Continuing Education Requirements.
(a) - (d) (No change.)
(e) Approved Programs.
(1) - (8) (No change.)
(9) Pharmacists shall receive credit for three contact hours
(0.3 CEUs) toward their continuing education requirements for taking
and successfully passing the initial Geriatric Pharmacy Practice certi-
cation examination administered by the Commission for Certication
in Geriatric Pharmacy. Proof of successfully passing the examination
shall be a certicate issued by the Commission for Certication in Geri-
atric Pharmacy.
(10) [(9)] Upon demonstrated need the board may estab-
lish criteria to approve programs presented by non-ACPE approved
providers.
(f) - (g) (No change.)
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Texas State Board of Pharmacy
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 305-8028
PART 27. BOARD OF TAX
PROFESSIONAL EXAMINERS
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CHAPTER 623. REGISTRATION AND
CERTIFICATION
22 TAC §623.4
The Board of Tax Professional Examiners proposes an amend-
ment to §623.4 Persons Permitted To Register. This amendment
is intended to ensure that there is a thorough review of the past
behavior of certain persons who may reapply for registration by
the Board after a period of "inactivity."
Mr. David Montoya, Executive Director for the Board of Tax Pro-
fessional Examiners has determined the probable economic cost
to persons required to comply with the amendment for the rst
ve years will be zero because the amendment merely provides
for a more thorough review of the reinstatement application.
Mr. David Montoya also has determined that for each year of the
rst ve years the amendment as proposed is in effect the public
benet anticipated as a result of enforcing the section will be to
conform the board rule to better protect the public. There will be
no effect on small or micro businesses.
The Board requests comments on the substance and effect of
the proposed amendment from any interested person. Com-
ments must be received at the Board no later than noon on Oc-
tober 28, 2007. Comments should be addressed to David E.
Montoya, Executive Director, Texas State Board of Tax Profes-
sional Examiners, 333 Guadalupe, Tower II, Suite 520, Austin,
Texas 78701 or faxed to his attention at (512) 305-7304.
The Board specically invites comments from the public on the
issues of whether or not the proposed amendment will have an
adverse economic effect on small business; if the amendment is
believed to have such an effect, then how may the Board legally
and feasibly reduce that effect considering the purpose of the
statute under which the amendment is to be adopted; and if the
amendment is believed to have such an effect.
The amendment is proposed under the authority of Texas Civil
Statutes Occupations Code, Chapter 1151 Property Taxation
Professional Certication Act, which provide the Board of Tax
Professional Examiners with the authority to promulgate rules
consistent with the Statute.
No other article, statute or code is affected by this proposed
amendment.
§623.4. Persons Permitted To Register.
(a) No person shall be permitted to register who is not required
to register. There shall be no registration categories involving asso-
ciates, nonparticipating, etc. Registrants must be actively engaged in
appraising, assessing/collecting, or collecting for an appraisal district
or taxing unit in the state.
(b) If a registrant becomes inactive under subsection (a) of this
section because the registrant in a criminal case pleads guilty, is con-
victed, or is given deferred adjudication of an offense or offenses that
if pursued through the complaint procedure would have resulted in re-
vocation, the board may upon complaint brought before it by the ex-
ecutive director, a board member, or a citizen of the state revoke the
registrants license so that the registrant may not apply for registration
for a period of three years as provided in §629.4(a). Such a revocation
procedure shall be summary in nature with the registrant being given
an opportunity to appear before a meeting of the full board with coun-
sel.
(c) If it comes to the attention of a board member or the exec-
utive director that a registrant may have committed an act that could
have resulted in disciplinary action by the board, but the registrant is
inactive as a result of the operation of subsection (a) of this section,
the board may proceed through its regular complaint and disciplinary
procedures to determine whether an appropriate discipline should be
recorded in the registrant’s le at the board’s ofce.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Board of Tax Professional Examiners
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 305-7300
TITLE 25. HEALTH SERVICES
PART 1. DEPARTMENT OF STATE
HEALTH SERVICES
CHAPTER 157. EMERGENCY MEDICAL
CARE
SUBCHAPTER C. EMERGENCY MEDICAL
SERVICES TRAINING AND COURSE
APPROVAL
25 TAC §157.39
The Executive Commissioner of the Health and Human Services
Commission on behalf of the Department of State Health Ser-
vices (department) proposes new §157.39, concerning the reg-
ulation of emergency medical services (EMS) providers.
BACKGROUND AND PURPOSE
The new section will create an EMS training program that afl-
iated EMS personnel may use to assure and maintain ongoing
professional competency. Health and Safety Code, Chapter 773,
Subchapter A, requires the department to approve EMS training
programs and to regulate EMS providers and EMS personnel in
their providing for the prompt and efcient transportation of sick
and injured patients, after necessary stabilization, and to encour-
age public access to that transportation in each area of the state.
This rule was developed with input from EMS stakeholders and
the Governor’s EMS and Trauma Advisory Council (GETAC).
SECTION-BY-SECTION SUMMARY
This section establishes eligibility requirements and minimum
training standards that a Texas licensed EMS provider must
have and maintain to receive approval by the department for
the provider to conduct a Comprehensive Clinical Management
Program (CCMP) for Texas certied or licensed EMS personnel
employed by or afliated with that EMS provider, such that
those personnel can become recertied or relicensed pursuant
to §157.34(b)(5) of this title. The training program will assure
that EMS personnel afliated with the EMS provider conduct-
ing the CCMP will receive continuing EMS education, quality
improvement, intensied individualized monitoring, mentoring,
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assessment and ongoing professional development as required
by the standards outlined in this section.
FISCAL NOTE
Renee Clack, Section Director, Health Care Quality Section, has
determined that for each year of the rst ve years the section
is in effect, there will be no scal implications to state or local
governments as a result of enforcing or administering the section
as proposed.
SMALL AND MICRO-BUSINESS IMPACT ANALYSIS
Ms. Clack has also determined that there will be no effect on
small businesses or micro-businesses required to comply with
the section as proposed. This was determined by interpreta-
tion of the rule that small businesses and micro-businesses will
not be required to alter their business practices in order to com-
ply with the section. This is a completely voluntary option for
EMS recertication and there are no anticipated economic costs
to persons not wishing to comply with the section as proposed.
There is no anticipated negative impact on local employment.
PUBLIC BENEFIT
In addition, Ms. Clack has also determined that for each year of
the rst ve years the section is in effect, the public will benet
from adoption of the section. The public benet anticipated as
a result of enforcing or administering the section is to improve
public health and safety through the encouragement of improve-
ments to EMS personnel selection and training practices, and
enhanced medical direction interaction.
REGULATORY ANALYSIS
The department has determined that this proposal is not a
"major environmental rule" as dened by Government Code,
§2001.0225. "Major environmental rule" is dened to mean a
rule the specic intent of which is to protect the environment
or reduce risk to human health from environmental exposure
and that may adversely affect, in a material way, the economy,
a sector of the economy, productivity, competition, jobs, the
environment or the public health and safety of a state or a
sector of the state. This proposal is not specically intended to
protect the environment or reduce risks to human health from
environmental exposure.
TAKINGS IMPACT ASSESSMENT
The department has determined that the proposed new rule does
not restrict or limit an owner’s right to his or her property that
would otherwise exist in the absence of government action and,
therefore, does not constitute a taking under Government Code,
§2007.043.
PUBLIC COMMENT
Comments on the proposal may be submitted to Steve
Janda, Director, Ofce of EMS/Trauma Systems Coordination,
Health Care Quality Section, Division of Regulatory Ser-
vices, Department of State Health Services, 1100 West 49th
Street, Austin, Texas 78756, (512) 834-6700 or by email to
Steve.Janda@dshs.state.tx.us. Comments will be accepted
for 30 days following publication of the proposal in the Texas
Register.
LEGAL CERTIFICATION
The Department of State Health Services General Counsel, Lisa
Hernandez, certies that the proposed rule has been reviewed
by legal counsel and found to be within the state agencies’ au-
thority to adopt.
STATUTORY AUTHORITY
The new section is authorized by Health and Safety Code,
§773.071, which allows the department to set fees in amounts
necessary for the department to administer this subchapter; and
Government Code, §531.0055, and Health and Safety Code,
§1001.075, which authorize the Executive Commissioner of the
Health and Human Services Commission to adopt rules and
policies necessary for the operation and provision of health and
human services by the department and for the administration of
Health And Safety Code, Chapter 1001.
The proposed new section affects the Health and Safety Code,
Chapters 773, and 1001; and Government Code, Chapter 531.
§157.39. Comprehensive Clinical Management Program Approval.
(a) Purpose and Scope. This section establishes eligibility
requirements and minimum training standards that a Texas licensed
emergency medical services (EMS) provider must have and maintain
to receive approval by the department for the provider to conduct
a Comprehensive Clinical Management Program for Texas certied
or licensed EMS personnel employed by or afliated with that EMS
provider, such that those personnel can become recertied or relicensed
pursuant to §157.34(b)(5) of this title (relating to Recertication).
The program will assure that EMS personnel afliated with the EMS
provider conducting the program will receive continuing EMS edu-
cation, quality improvement, intensied individualized monitoring,
mentoring, assessment and ongoing professional development as
required by the standards outlined in this section.
(b) Denitions.
(1) CCMP--A comprehensive clinical management pro-
gram is a recertication training program conducted by a licensed
EMS provider for EMS personnel employed by or afliated with the
EMS provider such that the EMS personnel can meet recertication or
relicensure requirements as outlined in §157.34(b)(5) of this title.
(2) CCMP Coordinator--Person responsible for the admin-
istrative functions of the CCMP program. However, the EMS provider,
approved to conduct a CCMP, is the person or entity having the ulti-
mate and overall responsibility for continually meeting state require-
ments for CCMP approval.
(3) Credentialing Process--The process by which an EMS
provider continually veries and assesses the qualications and com-
petencies of EMS personnel to provide patient care services.
(4) CCMP Survey Organization--A department recognized
organization, which manages a CCMP survey team comprised of mem-
bers as described and referenced in subsection (f) of this section for the
purpose of conducting a survey, based upon the standards outlined in
this section, of EMS providers seeking CCMP approval.
(5) Preceptor--A person who holds a department EMS per-
sonnel certicate or license or other licensed medical professional ap-
proved by the medical director and who is employed by or volunteers
for an EMS provider to train and evaluate EMS personnel.
(6) Quality Improvement Process--An ongoing system that
includes retrospective review, concurrent review, and prospective fore-
casting of clinical care. Quality improvement also combines a circular
response through measurement of identied goals and sentinel events
identifying opportunities for improvement, reeducation, process de-
sign, and measurement of corrective efforts.
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(7) Self Study--A document developed by the EMS
provider that outlines its planning, preparation and qualications to
conduct a CCMP and include 6 months of operational data.
(8) Survey--The onsite visit(s) conducted by a department
recognized CCMP survey organization that evaluates an EMS provider
applying for department approval to conduct a CCMP.
(9) Sentinel Event--An unexpected event that triggers, or
has the potential to trigger, an immediate investigation and/or response.
This event usually relates to the care of a patient or the well-being of
EMS personnel, such that the event causes or has the potential to cause
death, serious physical or psychological injury to either the patient or
the EMS personnel or the public.
(c) CCMP Eligibility Requirements.
(1) The applicant must hold a current Texas EMS provider
license, continuously valid for at least 5 years prior to the date of the
application.
(2) The applicant must not have received a department dis-
ciplinary sanction as an EMS provider, not including a reprimand or an
administrative penalty of $2000 or less, during the 2 years immediately
preceding the application ling date.
(3) Any physician who the applicant has employed or con-
tracted with to function as its medical director or as its full-time or
part-time consultant, must be in good standing with the Texas Medical
Board or predecessor agency to practice medicine in Texas.
(4) A person holding more than one EMS provider license
that is applying for department approval to conduct a CCMP shall be
required to apply separately for each of its licenses. A CCMP approval
will only be allowed per one EMS provider license. A CCMP may
not extend beyond one EMS provider license and its afliated First
Responder Organization(s).
(5) Although an EMS provider approved to conduct a
CCMP may require the EMS personnel, employed by or afliated
with that provider, to participate in and to meet the objectives of its
own CCMP, those personnel may still utilize another option, listed
in §157.34(b) of this title, to achieve individual EMS personnel state
recertication or relicensure.
(6) The applicant must have submitted no less than two
years of required data, prior to the initial CCMP survey, to the Texas
EMS/Trauma Registry.
(d) Application Process for CCMP Approval.
(1) A sufciently complete application shall include:
(A) a full non-refundable CCMP approval application
fee payment of $60.00;
(B) department application form with all elds cor-
rectly and legibly lled in, dated, and signed with original signatures
of the EMS director, CCMP coordinator, and EMS provider’s medical
director; and
(C) all required documents to include an accurate and
complete CCMP self-study. This self-study shall be submitted in an
electronic format as required and described by the department and shall
sufciently and accurately address those topics outlined in subsection
(h) of this section.
(2) Initial Application Form Review Period. Within 30
days from the date the department receives an initial written applica-
tion for CCMP approval from an applicant, the department will send
to the applicant a written notice that either the application form is
complete and accepted for ling, or the application form is incomplete,
and noting the application’s deciencies and the additional information
required for the application to be accepted for ling.
(3) Continuing Application Form Review Period. Within
14 days from the date that the department receives any written infor-
mation from the applicant that attempts to respond to an earlier depart-
ment notice of any application deciencies and notice of the need for
additional information to resolve the deciencies, the department will
send the applicant a written notice that either the application form is
nally complete and accepted for ling or that the application form is
still incomplete, and specifying any remaining application deciencies
and the additional information required for it to be accepted for ling.
(4) Final Application Form Review Period. Within 14 days
from the date that the department receives from the applicant the last
item or piece of information to resolve all previously noted deciencies
necessary to complete the application, the department will send writ-
ten notice to the applicant that the application is nally complete and
accepted for ling.
(5) Failure to Correct Application Form Deciencies. If
the department does not receive from an applicant the items or infor-
mation requested by the department to correct the deciencies in the
application form by the 10th day after the date that the department has
sent written notice to the applicant noting that the application form is
incomplete for ling and noting the application’s deciencies and the
additional information required for it to be accepted for ling, then the
application is deemed to be withdrawn and void. The application fee
will not be refunded.
(6) Initiation of Survey. After the department noties ap-
plicant that the application form is sufciently complete and is accepted
for ling, the EMS provider can initiate the survey process to be con-
ducted by a department recognized CCMP survey organization.
(7) Final Period for Full Application Review. The nal pe-
riod for full application review will begin on the date that the depart-
ment timely receives from the applicant’s survey organization a true
and correct written survey report, the department’s review of which
will be the last stage of the application review process, and end on the
date that the department sends written notice to the applicant that the
application for CCMP approval is granted, or that it proposes to deny
the application. This period is 60 days.
(8) CCMP Approval Period. The department’s grant of ap-
proval to an EMS provider to conduct a CCMP will be valid for four
years from the date that approval is granted, unless the EMS provider
later surrenders its CCMP approval or the department revokes the ap-
proval.
(e) Application Process to Renew CCMP Approval.
(1) No later than the 120th day prior to the expiration date
of the existing CCMP approval, an EMS provider, who is requesting
renewal of CCMP approval, shall:
(A) timely le a sufciently completed renewal appli-
cation form according to the application ling process, as described in
subsection (d) of this section;
(B) have been timely re-surveyed by a department rec-
ognized CCMP survey organization, in advance to allow for report sub-
mission described in subparagraph (C) of this paragraph; and
(C) ensure that the CCMP survey organization, that has
conducted the survey, has led with the department and that the de-
partment has received from the survey organization a complete survey
report.
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(2) If a renewal applicant meets the requirements in sub-
section (1) of this section no later than the 120th day prior to the ex-
piration date of its existing CCMP approval, the existing CCMP ap-
proval does not expire until the applicant’s eligibility for renewal of
its CCMP approval has been nally determined, as described in Texas
Government Code, §2001.054. If the department provides the appli-
cant with a written notice proposing the denial of its renewal appli-
cation or placement of limitations upon the renewal of approval, and
if the department timely receives from the applicant a written request
for an administrative appeal hearing to contest the proposed denial or
limitation, the existing CCMP approval does not expire until the last
day for the applicant to seek a state district court judicial review of the
agency order or a later date xed by order of the reviewing court.
(3) If a renewal applicant fails to meet the requirements in
subsection (1) of this section, no later than 120 days prior to the expira-
tion date of its existing CCMP approval, the existing CCMP approval
expires on its expiration date.
(4) Any EMS personnel that are participating in the appli-
cant’s existing CCMP may lose their eligibility to renew their individ-
ual EMS certications or licenses under §157.34(b)(5) of this title, af-
ter the expiration date of the existing approved CCMP within which the
EMS personnel are participating. If a CCMP approval expires, as set
forth in paragraphs (2) or (3) of this subsection, EMS personnel who
continue to participate with that CCMP after its expiration date will no
longer be allowed credit toward continuing education hours needed for
certication or licensure renewal, unless approved by the department.
(f) CCMP Survey.
(1) The applicant shall seek review and approval of its self-
study by a department recognized CCMP survey organization.
(2) The applicant shall notify the department of the date the
survey will begin, the name of the CCMP survey organization, the com-
position of the survey team, and the names of the survey team members,
no later than the 30th day prior to the date the CCMP survey will begin.
(3) The applicant shall be responsible for any cost and ex-
penses associated with the survey.
(4) The department, at its discretion, may assign a depart-
ment staff member and/or appoint an observer to accompany the survey
team.
(5) The survey team shall contain members that have a
multi-disciplinary background to include at a minimum: one EMS
medical director, one EMS educator and one EMS administrator. The
department may require additional surveyors and surveyors with other
professional backgrounds, depending upon, but not limited to, the type
of EMS provider, the kind of population it serves, and factors noted
in the self-study. If such is required, the department will notify the
applicant of the additional required surveyors within 20 days after the
date that the department has notied the applicant that its application
is complete and accepted for ling.
(6) All members of the survey team, except department
staff, shall come from a Trauma Service Area that the applicant is not
afliated with and at least 100 miles from the provider unless other-
wise approved by the department at least 20 days before the date the
survey is to begin. There shall be no direct business or patient care rela-
tionship or any potential conict of interest between the CCMP survey
members, or any of the individual survey members’ places of employ-
ment or afliation with a volunteer EMS provider, and the applicant
being surveyed. The survey team shall not be composed solely with
members from a single EMS provider.
(7) Department recognized survey organization team
members at minimum shall:
(A) have at least ve years experience in active man-
agement and leadership of an EMS system using CCMP principles;
(B) be currently employed with or volunteering for, and
be actively managing within an EMS system using CCMP principles;
(C) have adequate direct experience in assisting an
EMS provider in preparing for a CCMP survey and in obtaining
CCMP approval; and
(D) have completed a department-approved CCMP sur-
vey course and/or participation in a survey internship.
(8) The department at its discretion may exempt survey
team members from having to meet the requirements noted in para-
graph (7)(A), (B) or (C) of this subsection, if the number of qualied
survey team members in the applicant’s general geographical area is in-
adequate to form a survey team. The CCMP survey organization must
make a written request showing sufcient cause for the department to
grant an exemption.
(9) The survey organization with its survey team members
shall professionally and accurately evaluate and make written ndings
of the EMS provider’s ability to effectively meet and maintain CCMP
standards described in subsection (h) of this section.
(g) Survey Documentation and Reporting Timetable.
(1) The survey organization shall utilize the department’s
CCMP survey form and shall provide the department and the provider
with an accurate and complete written survey report, signed by all sur-
vey team members, regarding its evaluation of the applicant’s compli-
ance with CCMP standards, no later than 30th calendar day after the
completion date of the survey.
(2) The CCMP survey(s), and the resulting survey docu-
mentation, and the applicant’s CCMP survey organization’s submis-
sion of the survey report and related documentation to the department
shall be completed no later than two years after the date the department
sent notice to the applicant that its application was accepted for ling.
Failure to timely complete all of the above within two years from the
date that the department sent notice to the applicant that its application
was accepted for ling will be deemed to be a withdrawal of the EMS
provider’s application for CCMP approval.
(3) The department reserves the right to request from the
applicant, and the applicant shall be obligated to produce no later than
the 10th day after having received such request, true and correct copies
of any survey reports that the applicant received from its survey organi-
zation related to any initial surveys, conducted prior to any nal survey.
(4) CCMP Final Survey Report. The survey report, com-
pleted by the department recognized CCMP survey organization, shall
accurately document the survey organization’s ndings and its evalu-
ation of the EMS provider’s ability to effectively meet the minimum
standards required to obtain and to maintain CCMP department ap-
proval as outlined in subsection (h) of this section.
(h) CCMP Minimum Standards. To receive and maintain de-
partment approval to conduct a CCMP, an EMS provider shall:
(1) assure that an initial assessment of new EMS personnel
has been conducted by providing documentation of:
(A) a written assessment of didactic knowledge evalu-
ation, specic to the certication level of the applicant and focusing
on the clinical information (evaluation cannot be the department or
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NREMT exam, and should utilize numeric scoring - not pass/fail - to
assess individuals’ level of preparedness);
(B) a situation-based practical evaluation;
(C) a background investigation process of EMS person-
nel, which includes verication of certication/licensure and adminis-
trative/disciplinary history through the department, work history and
driving record;
(D) a detailed job description; and
(E) a screening process to ensure the minimum require-
ments are met, and which includes signicant medical director involve-
ment.
(2) credential EMS personnel by providing documentation
of:
(A) a state certication/licensure verication process;
(B) a process for EMS personnel to demonstrate skills
prociency to the satisfaction of the medical director;
(C) a process for reintegration (i.e. bringing an individ-
ual from inactive or administrative status back into active practice in
the eld);
(D) a process for bi-annual eld evaluation by a precep-
tor (eld training ofcer or similar position) which includes demon-
stration of adequate patient care and scene control skills, appropriate
conduct for EMS personnel, etc.; and
(E) a policy that denes the EMS personnel covered by
the CCMP program (only individuals credentialed by the medical di-
rector will be eligible for renewal through §157.34(b)(5) of this title).
(3) assure and maintain a preceptor selection, development
and training process; developed with the medical director’s input and
approval.
(4) assure EMS personnel internship by providing docu-
mentation of:
(A) a process in which interns ride as a third person until
the preceptor establishes the intern has met pre-established competen-
cies as dened by the medical director;
(B) a process in which interns ride as the second person
until the preceptor establishes the intern has met prerequisites for inde-
pendent duty as determined by the medical director;
(C) a process in which the intern must demonstrate pro-
ciency to at least two different preceptors;
(D) a process in which the intern evaluates the intern-
ship program; and
(E) a process in which the medical director reviews and
ensures that all predetermined competencies are met before being re-
leased from internship.
(5) assure and maintain professional development of EMS
personnel by maintaining and providing documentation:
(A) of professional development training of EMS per-
sonnel in the following amounts per year: EMT-P--24 hours, EMT-I--
20 hours, EMT--16 hours, ECA--10 hours;
(B) that other staff (ight nurses and communications
personnel) are required to obtain at least the minimum continuing ed-
ucation hours as directed by the appropriate certifying or licensing au-
thority;
(C) that EMS personnel receive continuing education
on at least a semiannual or quarterly basis;
(D) that the continuing education instruction spans
the three learning domains which include cognitive, affective and
psychomotor;
(E) that demonstrates programmatic strengths and per-
formance improvement plans for weaknesses;
(F) that the continuing education clinical content is de-
ned and approved by the medical director;
(G) that 50% of the continuing education is in-person
training; and
(H) of consistent instructional delivery by all instruc-
tors.
(6) assure and maintain protocol/standard of care manage-
ment by providing documentation of:
(A) ongoing protocol review, updated according to cur-
rent literature, practice techniques, executed and approved by the med-
ical director;
(B) a process for assessing the relative benet from pro-
tocol revisions;
(C) a process for protocol knowledge assessment
among EMS personnel protocol assessment that reects the ongoing
protocol review and revision, with structure and content dened and
approved by the medical director, and a dened remediation process
with established timelines;
(D) a process for protocol criteria to be jointly dened
by the medical director and EMS provider administration; and
(E) a reassessment/re-education process and timeline
that clearly identies the criteria for identication of weakness and
successful completion of re-education; or revocation of credentials if
unsuccessful.
(7) assure and maintain a quality improvement program by
providing documentation of:
(A) a ve component problem-solving process with the
following components: assessment, goal setting, plan development,
intervention, and progress evaluation;
(B) an assessment of the provider’s daily activities;
(C) measurable clinical indicators that are regularly as-
sessed for compliance with established thresholds;
(D) an appropriate, organized and prioritized monitor-
ing and evaluation system for compliance with documentation stan-
dards, correct protocol selection and appropriate patient care;
(E) assessment of key performance indicators such as
personnel/stafng, response and averaging with correct statistical mon-
itoring, clinical care (skills performance, protocol selection, patient
assessment, etc.), customer relations program, education, administra-
tive/operational policies;
(F) a monthly random chart review of all runs (at least
5% or 30, whichever is greater) for compliance with documentation
standards, correct protocol selection, and appropriate patient care;
(G) an annual cardiac arrest survival analysis in accor-
dance with current acceptable criteria; and
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(H) tracking individual performance of skills (5 mini-
mum), appropriate for that level of certication or licensure, for each
EMS personnel.
(8) assure and maintain a complaint resolution
process/management by providing documentation of:
(A) a centralized location for receiving complaints;
(B) an established triage process to appropriately direct
complaint resolution to potential disciplinary or quality improvement
avenues;
(C) a process that ensures the timely reporting of any
rule or law violations to appropriate licensing and government author-
ities; and
(D) a process to track/trend the nature of each complaint
and feed data into a quality improvement program.
(9) assure and maintain a system to respond to sentinel
event response process/management; by providing documentation of:
(A) a process to appropriately direct the response to
emergency problems such as equipment failures, supply deciency,
medication errors, eet failures, etc.;
(B) appropriate record-keeping and tracking of sentinel
events; and
(C) a process to investigate sentinel events which in-
volves the appropriate parties.
(10) assure and maintain an ongoing corrective action
process by providing documentation of:
(A) annual documentation of the results of the quality
improvement efforts and formal complaint tracking process, including
content of continuing education or individual training sessions to re-
solve identied deciencies;
(B) evidence to resolve and reassess identied decien-
cies;
(C) a process to determine whether deciencies are in-
dividual or system oriented;
(D) a developed reporting structure that includes a pub-
lic performance report;
(E) a policy and methods regarding privilege/conden-
tiality;
(F) a process of remediation and improvement strate-
gies which comply with DSHS continuing education requirements, as
appropriate; and
(G) evidence of medical director involvement in the
process.
(11) assure committee(s) are established and maintained to
identify, plan, implement and evaluate opportunities to improve perfor-
mance in all areas of the EMS system.
(12) assure that the medical director qualications, expe-
rience, involvement and responsibilities are maintained by providing
documentation that the medical director:
(A) is registered as the EMS provider’s medical director
with the department;
(B) meets requirements of 22 TAC, Chapter 197 (relat-
ing to Emergency Medical Service) of the Texas Medical Board;
(C) is an active participant in the local Regional Advi-
sory Committee; and
(D) has completed a course in EMS medical direction.
(13) assure that the CCMP coordinator qualications, ex-
perience, involvement and responsibilities are maintained by providing
documentation that:
(A) the CCMP coordinator is responsible for the admin-
istrative functions of the CCMP program;
(B) the dedication of staff time is sufcient to fulll the
programmatic requirements of the CCMP;
(C) a CCMP organizational chart clearly describes the
administrative reporting structure of the CCMP program;
(D) there is evidence to demonstrate that quality im-
provement experience and/or training is sufcient to implement and
maintain CCMP standards; and
(E) shall complete a department approved CCMP work-
shop of at least 8 hours.
(i) Probation, Suspension, Revocation or Denial of Initial or
Renewal CCMP Approval. The department may probate, suspend, re-
voke, or deny initial or renewal approval for an EMS provider to con-
duct a CCMP for, but not limited to, the following noted reasons:
(1) the EMS provider fails to meet or maintain the CCMP
minimum standards or the eligibility requirements, outlined in this sec-
tion;
(2) the EMS Provider fails to meet or maintain those re-
sponsibilities required or standards, outlined in §157.11 of this title (re-
lating to Requirements for an EMS Provider);
(3) the EMS provider falsies or makes misrepresentations
in any documentations communications regarding its applications
seeking department approval to conduct a CCMP;
(4) the provider falsies or makes misrepresentations in
any documentations or communications regarding its conducting a
CCMP; or
(5) the EMS provider is found to have committed any of
the violations, outlined in §157.16 of this title (relating to Emergency
Suspension, Suspension, Probation, Revocation or Denial of a Provider
License) that serves as a basis for such department disciplinary actions
as: a reprimand, a monetary administrative penalty assessment, EMS
provider license suspension, probated suspension of an EMS provider
license, revocation of license, emergency suspension of license.
(j) Appeal Procedure for Proposed Denial, Probated Suspen-
sion, Suspension, or Revocation of CCMP Approval.
(1) If the department proposes to deny, suspend, or revoke
its approval given for an EMS provider to conduct a CCMP, the depart-
ment will send written notication of such to the EMS provider’s last
known address as shown in the current records of the department. The
notice will state the alleged facts or conduct to warrant the proposed
action and state that the EMS provider may request an administrative
hearing.
(2) An EMS provider’s request for an administrative ap-
peal hearing to contest the proposed action shall be in writing and sub-
mitted to the department within 15 days after the date that the depart-
ment sent written notice to the EMS provider of the department’s pro-
posed action. The appeal hearing shall be conducted pursuant to the
Administrative Procedure Act, Government Code, Chapter 2001.
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(3) If the department does not receive a written notice of
its request for an administrative appeal hearing from the EMS provider
by the 15th day after the date the department sent written notice to the
EMS provider of the department’s proposed action, the EMS provider
is deemed to have waived the opportunity for a hearing and the depart-
ment may take the proposed action.
(k) Probation. The department may probate the suspension of
approval of a CCMP and specify terms and conditions of any probated
suspension accessed.
(l) Surrender of CCMP Approval.
(1) An EMS provider shall use a department approved sur-
render form to document its surrender to the department of its CCMP
approval.
(2) An EMS provider’s surrender of a CCMP approval to
the department shall not deprive the department of jurisdiction in regard
to any disciplinary action against the EMS provider.
(3) In the event that any department proposed disciplinary
against the EMS provider is pending or is reasonably imminent, the
EMS provider must acknowledge that the surrender of its CCMP ap-
proval constitutes a plea of "no contest" to the allegations upon which
the proposed disciplinary action is predicated.
(m) Reapplication After Surrender, Denial, or Revocation. An
EMS provider, whose EMS provider license or approval to conduct a
CCMP has either been surrendered while disciplinary action is pending
or is reasonably imminent or which has been denied or revoked, cannot
apply for, nor receive, approval to conduct a CCMP until 2 years after
the date of the denial, revocation or such surrender of the EMS provider
license or CCMP approval. An EMS provider who les an application
for CCMP approval at least 2 years after the date of such surrender,
denial or revocation of its previous EMS provider license or CCMP
approval, shall provide evidence, and have the burden to show, that
the reasons for the earlier denial, revocation, or such surrender of its
previous EMS provider license or CCMP approval, no longer exists.
(n) Notication of Disposition. A summary of the de-
partment’s order, outlining the nal disposition of any proposed
disciplinary action and the basis for such may be placed upon the
department’s website. A copy of such order may be sent to the licensed
EMS provider, and the medical director.
(o) Medical Director Attestation of CCMP Participation.
With regard to EMS personnel, employed by or afliated with an EMS
provider having approval to conduct a CCMP, the EMS provider’s
medical director shall timely provide to such EMS personnel a docu-
ment, signed and dated by the medical director, attesting to such EMS
personnel’s participation in that CCMP.
(1) The document shall acknowledge that the EMS person-
nel is currently participating in the CCMP and shall specify the amount
of time, including the beginning date that the EMS personnel partici-
pated in the CCMP.
(2) For those personnel who leave the CCMP the medical
director within 30 days of their departure (or sooner, if needed) shall
provide to the EMS personnel documentation, attesting to such EMS
personnel’s participation in that CCMP and attesting to the amount of
time, including the beginning date and ending date, that the EMS per-
sonnel participated in the CCMP.
(3) Those EMS personnel, who have departed from an ap-
proved CCMP and who are making application for recertication or
relicensure, wholly or partly through §157.34(b)(5) of this title, utiliz-
ing a medical director’s signed document that attests to the EMS per-
sonnel’s participation in a CCMP, will be given by the department a
prorated continuing education credit, in six month increments, for the
amount of time the person was participating in a CCMP.
(4) Those continuing education credit hours, used to satisfy
those continuing education requirements of a CCMP by EMS personnel
who have departed from that CCMP, cannot be credited or used again
to supplement any remaining number of continuing education hours
needed by EMS personnel to gain recertication or relicensure. Only
continuing education hours gained by EMS personnel that were not
used to satisfy a CCMP’s requirements can be used to supplement the
department’s recertication or relicensure requirements.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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CHAPTER 289. RADIATION CONTROL
The Executive Commissioner of the Health and Human Services
Commission on behalf of the Department of State Health Ser-
vices (department) proposes the repeal of §289.3, concerning in-
frasonic, sonic, and ultrasonic radiation (acoustic radiation), the
proposed amendment of §289.130 concerning the radiation ad-
visory board, the proposed amendment of §289.205, concern-
ing hearing and enforcement procedures, the proposed repeal
of §289.257, and proposed new §289.257 concerning packag-
ing and transportation of radioactive material.
BACKGROUND AND PURPOSE
The proposed repeal of §289.3 removes an unnecessary regu-
lation. This regulation has not been updated since 1975 and is
not used in the regulatory duties of the department.
The proposed amendment to §289.130 provides corrections and
clarications due to the reorganization that created the depart-
ment as well as the removal of some redundancy with the Health
and Safety Code.
The proposed amendment to §289.205 provides corrections and
clarications. Information intended to clarify the denitions of
severity levels of violations, the response to notices of violation,
and the criteria used in elevating or reducing severity levels has
been added.
The proposed repeal of and proposed new §289.257 are nec-
essary to modify transportation requirements for shipment of ra-
dioactive material. Most of these requirements are items of com-
patibility with the United States Nuclear Regulatory Commission
(NRC) and, as an agreement state with the NRC, Texas must
adopt them.
Government Code, §2001.039, requires that each state agency
review and consider for readoption each rule adopted by that
agency pursuant to the Government Code, Chapter 2001 (Ad-
ministrative Procedure Act). Section 289.3 has been reviewed;
and the department has determined that the reasons for adopt-
ing the section no longer exist, and the rule on this subject is
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not needed. Sections 289.130, 289.205 and 289.257 have been
reviewed; and the department has determined that the reasons
for adopting these sections continue to exist because rules on
these subjects are needed.
SECTION-BY-SECTION SUMMARY
The proposed repeal of §289.3 is necessary because the ultra-
sonic, infrasonic, and sonic radiation technology addressed in
the rule is not regulated by the department. The rule has not
been enforced by the department for more than 20 years.
The proposed revisions to §289.130 are necessary to delete ref-
erences to the Texas Board of Health, which no longer exists and
to provide the appropriate references to the Texas Health and
Human Services Commission, the department, and the Railroad
Commission of Texas. These changes are made in §289.130(c),
§289.130(d)(1), and new §289.130(m)(1) and (2).
Information is deleted from §289.130(d) to limit repetition of in-
formation from the Health and Safety Code.
Current §289.130(e), concerning the Radiation Advisory Board
review and duration section, is deleted because in 2003 the
Executive Commissioner of the Health and Human Services
Commission exempted the Radiation Advisory Board from
abolition based on legislation that authorized the Executive
Commissioner to exempt certain advisory bodies from aboli-
tion. Subsequent subsections are renumbered. The change is
reected in new §289.130(e) - (o).
Proposed new §289.130(e) adds the complete reference to the
Health and Safety Code for consistency.
Proposed new §289.130(h)(2) deletes the requirement of spe-
cic efforts necessary for department staff in making the required
meeting arrangements because this requirement is no longer
valid.
In proposed new §289.130(k)(5)(A), reference to the "Texas
Board of Health" was deleted as a correction because the Board
no longer exists.
In proposed new §289.130(n), "the department" replaces "Texas
Board of Health" to clarify to whom the required reports shall be
led. In addition, "Commissioner of the department or his de-
signee" replaces "Texas Board of Health" as to whom the ad-
visory board should le its annual report and details on the re-
quired report were eliminated to allow for exibility.
The proposed revisions to §289.205 are necessary because the
current rule did not clearly convey the requirements for respond-
ing to a notice of violation in §289.205(i) or the criteria used
to elevate or reduce severity levels in §289.205(k). Through-
out §289.205, the word "under" was replaced with the words "in
accordance with" to comply with Texas Register form and style
suggestions. The change is reected in §289.205(c), (g)(1)(A),
(i)(6), (j)(3)(D), (l)(3), and (m)(5).
The denition of "administrative penalty" in §289.205(b)(1) was
revised to add "Texas Radiation Control" before "Act" to state
the complete title of the referenced Act and "(Act)" was added
after "Act" to specify the acronym that will be used throughout
the section for simplication. The denitions in §289.205(b)(3)
and (7) are revised to replace the word "under" with the words "in
accordance with" to comply with Texas Register form and style
suggestions.
Section §289.205(b)(12) adds the words "prepared by the de-
partment" after the word "statement" to clarify who is responsible
for preparing the written statement described in this denition.
In addition, the requirement for a person who receives the no-
tice to provide a written statement is deleted within the denition
because this requirement is a compliance procedure and was,
therefore, moved to §289.205(i)(1) which addresses the compli-
ance procedures.
In §289.205(i)(5) and (6), the term "enforcement conference" is
deleted in the rule and replaced with "informal meeting" to re-
ect the denition. Section 289.205(i)(7) replaces the word "ac-
corded" with the word "afforded" for clarication.
Section 289.205(j)(3)(C) deletes the phrase "severity levels
and" in front of the word "percentages" and the phrase "of
base amounts" is added after the word "percentages" as a
correction so as to properly state the purpose of the regulation.
The percentages in the table are the items being adjusted in
this paragraph, not the severity levels. The words "for each
violation" are added after the word "penalty" in §289.205(j)(3)(D)
to clarify that the penalty assessed takes into account each
violation. In addition, the term "Ofce of General Counsel" is
replaced with "department" in §289.205(j)(4) to clarify who is
responsible for conducting settlement negotiations.
In §289.205(k)(1)(A) - (C) clarifying language is added to assist
in the understanding of categories of severity levels of violations.
Section 289.205(k)(3)(A) and (B) replaces the word "Violations"
with the words "Severity levels" for clarication and to be consis-
tent with the paragraph title. In addition, §289.205(k)(3)(A)(iv)
adds the words "or grossly negligent" after the word "willful" and
deletes the language that attempted to explain when a violation
was deemed willful in order to add clarity. A new clause is added
to §289.205(k)(3)(A) and (B) to include other mitigating factors
to the list of reasons when a severity level may be elevated to a
higher severity level.
Concerning proposed new §289.257, the revision incorporates
requirements that are items of compatibility with the NRC and
Texas must adopt them. Changes from the proposed repealed





ity levels, exempt quantities and the addition of sections regard-
ing exemption from classication as ssile material, and general
licensing information for transporting ssile material.
FISCAL IMPACT
Susan E. Tennyson, Section Director, Environmental and Con-
sumer Safety Section, has determined that, for each year of the
rst ve-year period that the sections are in effect, there will be
no scal implications to the state or local government as a result
of enforcing and administering the sections as proposed.
SMALL AND MICRO-BUSINESS IMPACT ANALYSIS
Ms. Tennyson has also determined that there will be no effect on
small businesses or micro-businesses required to comply with
the sections as proposed. This was determined by interpreta-
tion of the rules that small businesses and micro-businesses will
not be required to alter their business practices in order to com-
ply with the sections. There are no anticipated economic costs
to persons who are required to comply with the sections as pro-
posed. There is no anticipated negative impact on local employ-
ment.
PUBLIC BENEFIT
In addition, Ms. Tennyson has also determined that, for each
year of the rst ve years the sections are in effect, the pub-
lic will benet from adoption of the sections. The public benet
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anticipated as the result of administering §289.130 is to provide
for the department to receive expert advice on radiation issues
and, therefore, continue to protect the public from unnecessary
exposure to radiation. The public benet anticipated as a result
of enforcing or administering §289.205 is to ensure continued
protection of the public, workers, and the environment from un-
necessary exposure to radiation by ensuring that the department
is able to properly enforce the state’s radiation protection rules.
The public benet anticipated as a result of enforcing or adminis-
tering §289.257 is to ensure continued provision of safe, proper
transportation of radioactive materials within the state of Texas
in order to continue to properly protect the public, workers, and
the environment from unnecessary exposure to radiation. There
is no longer a public benet from §289.3; therefore, it is being
repealed.
REGULATORY ANALYSIS
The department has determined that this proposal is not a
"major environmental rule" as dened by Government Code,
§2001.0225. "Major environmental rule" is dened to mean a
rule the specic intent of which is to protect the environment
or reduce risk to human health from environmental exposure
and that may adversely affect, in a material way, the economy,
a sector of the economy, productivity, competition, jobs, the
environment, or the public health and safety of a state or a
sector of the state.
TAKINGS IMPACT ASSESSMENT
The department has determined that the proposal does not
restrict or limit an owner’s right to his or her property that
would otherwise exist in the absence of government action and,
therefore, does not constitute a taking under Government Code,
§2007.043.
PUBLIC COMMENT
Comments on the proposal may be submitted to Cindy Card-
well, Radiation Group, Policy/Standards/Quality Assurance Unit,
Division for Regulatory Services, Environmental and Consumer
Safety Section, Department of State Health Services, 1100 West
49th Street, Austin, Texas 78756, (512) 834-6770, extension
2239, or by e-mail to Cindy.Cardwell@dshs.state.tx.us. Com-
ments will be accepted for 30 days following publication of the
proposal in the Texas Register.
PUBLIC HEARING
A public hearing to receive comments on the proposal will
be scheduled after publication in the Texas Register and
will be held at the Department of State Health Services, Ex-
change Building, 8407 Wall Street, Austin, Texas 78754. The
meeting date will be posted on the Radiation Control web-
site (www.dshs.state.tx.us/radiation). Please contact Cindy
Cardwell at (512) 834-6770, extension 2239, or Cindy.Card-
well@dshs.state.tx.us if you have questions.
LEGAL CERTIFICATION
The Department of State Health Services General Counsel, Lisa
Hernandez, certies that the proposed rules have been reviewed
by legal counsel and found to be within the state agencies’ au-
thority to adopt.
SUBCHAPTER A. CONTROL OF RADIATION
25 TAC §289.3
(Editor’s note: The text of the following section proposed for repeal
will not be published. The section may be examined in the ofces of
the Department of State Health Services or in the Texas Register ofce,
Room 245, James Earl Rudder Building, 1019 Brazos Street, Austin.)
STATUTORY AUTHORITY
The proposed repeal is authorized by Health and Safety Code,
§401.051, which provides the Executive Commissioner of the
Health and Human Services Commission with authority to adopt
rules and guidelines relating to the control of radiation and
Government Code, §531.0055, and Health and Safety Code,
§1001.075, which authorize the Executive Commissioner of the
Health and Human Services Commission to adopt rules and
policies for the operation and provision of health and human
services by the department and for the administration of Health
and Safety Code, Chapter 1001. The review of the rule imple-
ments Government Code, §2001.039.
The proposed repeal affects the Health and Safety Code, Chap-
ters 401 and 1001; and Government Code, Chapter 531.
§289.3. Control of Infrasonic, Sonic, and Ultrasonic Radiation.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Department of State Health Services
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 458-7111 x6972
SUBCHAPTER C. TEXAS REGULATIONS
FOR CONTROL OF RADIATION
25 TAC §289.130
STATUTORY AUTHORITY
The proposed amendment is authorized by Health and Safety
Code, §401.051, which provides the Executive Commissioner
of the Health and Human Services Commission with authority
to adopt rules and guidelines relating to the control of radia-
tion and Government Code, §531.0055, and Health and Safety
Code, §1001.075, which authorize the Executive Commissioner
of the Health and Human Services Commission to adopt rules
and policies for the operation and provision of health and human
services by the department and for the administration of Health
and Safety Code, Chapter 1001. The review of the rule imple-
ments Government Code, §2001.039.
The proposed amendment affects the Health and Safety Code,
Chapters 401 and 1001; and Government Code, Chapter 531.
§289.130. Radiation Advisory Board.
(a) - (b) (No change.)
(c) Purpose. The purpose of the board is to provide advice
to the Executive Commissioner of the Texas Health and Human Ser-
vices Commission (Executive Commissioner) [Texas Board of Health],
the Texas Department of State Health Services’ [Texas Department of
Health’s] (department) radiation program, the Texas Commission on
Environmental Quality, the Railroad Commission of Texas, and other
state entities in the area of state radiation policies and programs.
(d) Tasks.
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[(1)] The board shall advise the Executive Commissioner
[Texas Board of Health] in accordance with Health and Safety Code,
§401.019 [and the department’s radiation program concerning rules re-
lating to state regulation of radiation].
[(2) The board shall:]
[(A) review and evaluate policies and programs of the
state relating to radiation;]
[(B) make recommendations and furnish technical ad-
vice as may be required on matters relating to development, use, and
regulation of sources of radiation to the department, the Texas Com-
mission on Environmental Quality, the Railroad Commission of Texas,
and other state entities; and]
[(C) review proposed rules and guidelines of any state
agency relating to regulation of sources of radiation and recommend
changes in proposed or existing rules and guidelines relating to sources
of radiation.]
[(e) Review and duration. By September 1, 2007, the Texas
Board of Health will initiate and complete a review of the board to
determine whether a recommendation should be made to appropriate
government ofcials to continue the board, consolidate the board with
another advisory board or committee, or abolish the board.]
(e) [(f)] Composition. The board shall be composed of 18
members appointed by the governor. The composition of the board
shall include representatives from those areas as delineated in [Chap-
ter 401 of the] Health and Safety Code, §401.015.
(f) [(g)] Terms of ofce. The term of ofce of each member
shall be six years. Members shall serve after expiration of their term
until a replacement is appointed.
(1) Members shall be appointed for staggered terms so that
the terms of a substantial equivalent number of members will expire at
the discretion of the governor.
(2) If a vacancy occurs, a person shall be appointed by the
governor to serve the unexpired portion of that term.
(g) [(h)] Ofcers. The board shall elect a chairman, vice-chair-
man and secretary at its rst meeting after August 31st of each year.
(1) Each ofcer shall serve until the next regular election
of ofcers.
(2) The chairman shall preside at all board meetings at
which he or she is in attendance, call meetings in accordance with this
section, appoint subcommittees of the board as necessary, and cause
proper reports to be made to the board. The chairman may serve as an
ex-ofcio member of any subcommittee of the board.
(3) The vice-chairman shall perform the duties of the chair-
man in case of the absence or disability of the chairman. In case the
ofce of chairman becomes vacant, the vice-chairman will serve until
a successor is elected to complete the unexpired portion of the term of
the ofce of chairman.
(4) A vacancy which occurs in the ofces of chairman,
vice-chairman or secretary may be lled at the next board meeting.
(h) [(i)] Meetings. The board shall meet quarterly on dates set
by the board to conduct board business.
(1) A special meeting may be called by the chairman or at
least ve members of the board.
(2) Meeting arrangements shall be made by department
staff. [Department staff shall contact board members to determine
availability for a meeting date and place.]
(3) The advisory board is not a "governmental body" as de-
ned in the Open Meetings Act. However, in order to promote public
participation, each meeting of the board shall be announced and con-
ducted in accordance with the Open Meetings Act, Texas Government
Code, Chapter 551, with the exception that the provisions allowing ex-
ecutive sessions shall not apply.
(4) Each member of the board shall be informed of a board
meeting in a timely manner.
(5) A simple majority of the members of the board shall
constitute a quorum for the purpose of transacting ofcial business.
(6) The board [Board] is authorized to transact ofcial
business only when in a legally constituted meeting with quorum
present.
(7) The agenda for each board meeting shall include an
item entitled public comment under which any person will be allowed
to address the board on matters relating to board business. The chair-
man may establish procedures for public comment, including a time
limit on each comment.
(i) [(j)] Attendance. Members shall attend board meetings as
scheduled. Members shall attend meetings of subcommittees to which
the member is assigned.
(1) A member shall notify the chairman or appropriate de-
partment staff if he or she is unable to attend a scheduled meeting.
(2) It is grounds for removal from the board if a member
cannot discharge the member’s duties for a substantial part of the term
for which the member is appointed because of illness or disability, or
is absent from more than half of the board meetings during a calendar
year without an excuse approved by a majority vote of the advisory
board.
(3) The validity of an action of the board is not affected by
the fact that it is taken when a ground for removal of a member exists.
(j) [(k)] Staff. Staff support for the board shall be provided by
the department.
(k) [(l)] Procedures. Roberts Rules of Order, Newly Revised,
shall be the basis of parliamentary decisions except where otherwise
provided by law or rule.
(1) Any action taken by the board must be approved by a
majority vote of the members present once quorum is established.
(2) Each member shall have one vote.
(3) A member may not authorize another individual to rep-
resent the member by proxy.
(4) The board shall make decisions in the discharge of its
duties without discrimination based on any person’s race, creed, gen-
der, religion, national origin, age, physical condition, or economic sta-
tus.
(5) Minutes of each board meeting shall be taken by de-
partment staff.
(A) A summary of the meeting shall be provided to [the
Texas Board of Health and] each member of the board within 30 days
of each meeting.
(B) After approval by the board, the minutes shall be
signed by the secretary.
(l) [(m)] Subcommittees. The board may establish subcom-
mittees as necessary to assist the board in carrying out its duties.
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(1) The chairman shall appoint members of the board to
serve on subcommittees and to act as subcommittee chairpersons. The
chairman may also appoint nonmembers of the board to serve on sub-
committees as the need for additional expertise arises.
(2) Subcommittees shall meet when called by the subcom-
mittee chairperson or when so directed by the board.
(3) A subcommittee chairperson shall make regular reports
to the board at each board meeting or in interim written reports as
needed. The reports shall include an executive summary or minutes
of each subcommittee meeting.
(m) [(n)] Statement by members.
(1) The Executive Commissioner [Texas Board of Health],
the department, and the board shall not be bound in any way by any
statement or action on the part of any board member except when a
statement or action is in pursuit of specic instructions from the Exec-
utive Commissioner [Texas Board of Health], department, or board.
(2) The board and its members may not participate in leg-
islative activity in the name of the Executive Commissioner [Texas
Board of Health] or the department except with approval through the
department’s legislative process. Board members are not prohibited
from representing the board’s decisions, themselves, or other entities
in the legislative process.
(3) A board member should not accept or solicit any benet
that might reasonably tend to inuence the member in the discharge of
the member’s ofcial duties.
(4) A board member should not disclose condential infor-
mation acquired through his or her board membership.
(5) A board member should not knowingly solicit, accept,
or agree to accept any benet for having exercised the member’s ofcial
powers or duties in favor of another person.
(6) A board member who has a personal or private interest
in a matter pending before the board shall publicly disclose the fact in a
board meeting and may not vote or otherwise participate in the matter.
The phrase "personal or private interest" means the board member has
a direct pecuniary interest in the matter but does not include the board
member’s engagement in a profession, trade, or occupation when the
member’s interest is the same as all others similarly engaged in the
profession, trade, or occupation.
(n) [(o)] Reports to the department [Texas Board of Health].
The board shall le an annual written report with the Commissioner of
the department or his designee [Texas Board of Health].
[(1) The report shall list the meeting dates of the board and
any subcommittees, the attendance records of its members, a brief de-
scription of actions taken by the board, a description of how the board
has accomplished the tasks given to the board by the Texas Board of
Health, the status of any rules which were recommended by the board
to the Texas Board of Health, and anticipated activities of the board for
the next year.]
[(2) The report shall identify the costs related to the board’s
existence, including the cost of department staff time spent in support
of the board’s activities and the source of funds used to support the
board’s activities.]
[(3) The report shall cover the meetings and activities in
the immediate preceding 12 months and shall be led with the Texas
Board of Health each September. It shall be signed by the chairman
and appropriate department staff.]
(o) [(p)] Reimbursement for expenses. In accordance with the
requirements set forth in the Government Code, Chapter 2110, a board
member may receive reimbursement for the member’s expenses in-
curred for each day the member engages in ofcial board business.
(1) No compensatory per diem shall be paid to board mem-
bers unless required by law, but members shall be reimbursed for travel,
meals, lodging, and incidental expenses in accordance with the General
Appropriations Act.
(2) A board member who is an employee of a state agency,
other than the department, may not receive reimbursement for expenses
from the department if he or she is reimbursed by that state agency.
(3) A nonmember of the board who is appointed to serve
on a subcommittee may not receive reimbursement for expenses from
the department.
(4) Each member who is to be reimbursed for expenses
shall submit to staff the member’s receipts for expenses and any re-
quired ofcial forms no later than 14 days after each board meeting.
(5) Requests for reimbursement of expenses shall be made
on ofcial state travel vouchers prepared by department staff.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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The proposed amendment is authorized by Health and Safety
Code, §401.051, which provides the Executive Commissioner
of the Health and Human Services Commission with authority
to adopt rules and guidelines relating to the control of radia-
tion and Government Code, §531.0055, and Health and Safety
Code, §1001.075, which authorize the Executive Commissioner
of the Health and Human Services Commission to adopt rules
and policies for the operation and provision of health and human
services by the department and for the administration of Health
and Safety Code, Chapter 1001. The review of the rule imple-
ments Government Code, §2001.039.
The proposed amendment affects the Health and Safety Code,
Chapters 401 and 1001 and Government Code, Chapter 531.
§289.205. Hearing and Enforcement Procedures.
(a) (No change.)
(b) Denitions. The following words and terms when used
in this chapter shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Administrative penalty--A monetary penalty assessed
by the agency in accordance with the Texas Radiation Control Act
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(Act), §401.384, to emphasize the need for lasting remedial action and
to deter future violations.
(2) (No change.)
(3) Applicant--A person seeking a license, certicate of
registration, accreditation of mammography facility, or industrial
radiographer certication, issued in accordance with [under] the
provisions of the Act and the requirements in this chapter.
[(4) Board--The Texas Board of Health.]
(4) [(5)] Certied industrial radiographer--An individual
who meets the denition of radiographer as stated in §289.255(c) of
this title (relating to Radiation Safety Requirements and Licensing and
Registration Procedures for Industrial Radiography).
(5) [(6)] Commissioner--The [Texas] commissioner of the
Texas Department of State Health Services [health].
(6) [(7)] Contested case--A proceeding in which the
agency determines the legal rights, duties, or privileges of a party after
an opportunity for adjudicative hearing.
(7) [(8)] Director--The director of the radiation control
program in accordance with [under] the agency’s jurisdiction.
(8) [(9)] Enforcement conference--A meeting held by the
agency with a person to discuss the following:
(A) safety, safeguards, or environmental problems;
(B) compliance with regulatory, license condition, or
registration condition requirements;
(C) proposed corrective measures including, but not
limited to, schedules for implementation; and
(D) enforcement options available to the agency.
(9) [(10)] Hearing--A proceeding to examine an applica-
tion or other matter before the agency in order to adjudicate rights, du-
ties, or privileges.
(10) [(11)] Interested person--A person who participates
in a hearing concerning a contested case but who is not admitted as a
party by the ALJ.
(11) [(12)] Major amendment--An amendment to a license
issued in accordance with the requirements of §289.260 of this title
(relating to Licensing of Uranium Recovery and Byproduct Material
Disposal Facilities) that:
(A) reects a transfer of ownership of the licensed fa-
cility;
(B) authorizes enlargement of the licensed area beyond
the boundaries of the existing license;
(C) authorizes a change of the method specied in
the license for disposal of byproduct material as dened in the Act,
§401.003(3)(B); or
(D) grants an exemption from any provision of
§289.260 of this title.
(12) [(13)] Notice of violation--A written statement pre-
pared by the department of one or more alleged infringements of a
legally binding requirement. [The notice requires the person receiv-
ing the notice to provide a written statement describing the following:]
[(A) corrective steps taken by the person and the results
achieved;]
[(B) corrective steps to be taken to prevent recurrence;
and]
[(C) the projected date for achieving full compliance.
The agency may require responses to notices of violation to be under
oath.]
(13) [(14)] Order--A specic directive contained in a legal
document issued by the agency.
(14) [(15)] Party--A person designated as such by the ALJ.
A party may consist of the following:
(A) the agency;
(B) an applicant, licensee, registrant, accredited mam-
mography facility, or certied industrial radiographer; and
(C) any person affected.
(15) [(16)] Person affected--A person who demonstrates
that the person has suffered or will suffer actual injury or economic
damage and, if the person is not a local government, is:
(A) a resident of a county, or a county adjacent to the
county, in which radioactive material is or will be located; or
(B) doing business or has a legal interest in land in the
county or adjacent county.
(16) [(17)] Preliminary report--A document prepared by
the agency containing the following:
(A) a statement of facts on which the agency bases the
conclusion that a violation has occurred;
(B) recommendations that an administrative penalty be
imposed on the person charged;
(C) recommendations for the amount of that proposed
penalty; and
(D) a statement that the person charged has a right to a
hearing on the occurrence of the violation, the amount of the penalty,
or both.
(17) [(18)] Radiation and Perpetual Care Account--An ac-
count established for the purposes described in the Act, §401.305.
(18) [(19)] Requestor--A person claiming party status as a
person affected.
(19) [(20)] Severity level--A classication of violations
based on relative seriousness of each violation and the signicance of
the effect of the violation on the occupational or public health or safety
or the environment.
(20) [(21)] Violation--An infringement of any rule, license
or registration condition, order of the agency, or any provision of the
Act.
(c) Procedures for licensing actions in accordance with [under]
the Act, §401.054.
(1) - (5) (No change.)
(d) - (f) (No change.)
(g) Revocation of accreditation of mammography facilities.
(1) An accreditation of a mammography facility may be
revoked, for any of the following:
(A) any material false statement in the application or
any statement of fact required in accordance with [under provision of]
the Act;
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(B) - (C) (No change.)
(2) - (3) (No change.)
(h) (No change.)
(i) Compliance procedures for licensees, registrants, certied
industrial radiographers, and other persons.
(1) A licensee, registrant, certied industrial radiographer,
or other person who commits a violation(s) will be issued a notice of
violation. The person receiving the notice shall provide the agency with
a written statement and supporting documentation by the date stated in
the notice describing the following:
(A) steps taken by the person and the results achieved;
(B) corrective steps to be taken to prevent recurrence;
and
(C) the date when full compliance was or is expected to
be achieved. The agency may require responses to notices of violation
to be under oath.
(2) - (4) (No change.)
(5) When the agency determines that the action provided
for in paragraph (8) of this subsection or subsection (j) of this section
is not to be taken immediately, the agency may offer the licensee, reg-
istrant, or certied industrial radiographer an opportunity to attend an
informal meeting [enforcement conference] to discuss the following
with the agency:
(A) - (B) (No change.)
(6) Notice of any informal meeting [enforcement confer-
ence] shall be delivered by personal service, or certied mail, addressed
to the last known address. An informal meeting [enforcement confer-
ence] is not a prerequisite for the action to be taken in accordance with
[under] paragraph (8) of this subsection or subsection (j) of this section.
(7) Except in cases in which the occupational and public
health, [interest,] or safety requires otherwise, no license, certicate of
registration, or industrial radiographer certication shall be modied,
suspended, or revoked unless, prior to the institution of proceedings
therefore, facts or conduct that may warrant such action shall have been
called to the attention of the licensee, registrant, or certied industrial
radiographer in writing, and the licensee, registrant, or certied indus-
trial radiographer shall have been afforded [accorded] an opportunity
to demonstrate compliance with all lawful requirements.
(8) - (9) (No change.)
(j) Assessment of administrative penalties.
(1) - (2) (No change.)
(3) Application of administrative penalties. The agency
may impose differing levels of penalties for different severity level vi-
olations and different classes of users as follows.
(A) - (B) (No change.)
(C) Adjustments to the [severity levels and] percent-
ages of base amounts in Table IB may be made for the presence or
absence of the following factors:
(i) - (vi) (No change.)
(D) The penalty for each violation may be in an amount
not to exceed $10,000 a day for a person who violates the Act or a rule,
order, license or registration issued in accordance with [under] the Act.
Each day a violation continues may be considered a separate violation
for purposes of penalty assessment.
(4) The department [Ofce of General Counsel] may con-
duct settlement negotiations.
(k) Severity levels of violations for licensees, registrants, cer-
tied industrial radiographers, or other persons.
(1) Violations for licensees, registrants, certied industrial
radiographers, or other persons shall be categorized by one of the fol-
lowing severity levels.
(A) Severity level I are violations that are most signi-
cant and may have a signicant negative impact on occupational and/or
public health and safety or on the environment. Severity level I viola-
tions are most signicant and may have a signicant negative impact
by increasing the risk of unauthorized use of radioactive material that
would be detrimental to public health and safety.
(B) Severity level II are violations that are very signif-
icant and may have a negative impact on occupational and/or public
health and safety or on the environment. Severity level II violations
are very signicant and may have a negative impact by increasing the
risk of unauthorized use of radioactive material that would be detri-
mental to public health and safety.
(C) Severity level III are violations that are signicant
and which, if not corrected, could threaten occupational and/or public
health and safety or the environment. Severity level III are signicant
and, if not corrected, could increase the risk of unauthorized use of ra-
dioactive material that would be detrimental to public health and safety.
(D) - (E) (No change.)
(2) (No change.)
(3) Criteria to elevate or reduce severity levels.
(A) Severity levels [Violations] may be elevated to a
higher severity level for the following reasons:
(i) - (iii) (No change.)
(iv) a violation was willful or grossly negligent;
[. This means the violation was the result of careless regard for
requirements, deception, or other indications of willfulness by the
licensee/registrant or employees of the licensee/registrant, or certied
industrial radiographer; or]
(v) compliance history; or [.]
(vi) other mitigating factors.
(B) Severity levels [Violations] may be reduced to a
lower level for the following reasons:
(i) the licensee/registrant identied and corrected
the violation prior to the agency inspection; [or]
(ii) the licensee/registrant’s actions corrected the vi-
olation and prevented recurrence; or [.]
(iii) other mitigating factors.
(4) (No change.)
(l) Impoundment of sources of radiation.
(1) - (2) (No change.)
(3) If agency action is necessary to protect the public health
and safety, no prior notice need be given the owner or possessor. If
agency action is not necessary to protect the public health and safety,
the agency will give written notice to the owner and/or the possessor
of the impounded source of radiation of the intention to dispose of the
source of radiation. Notice shall be the same as provided in subsec-
tion (i)(8) of this section. The owner or possessor shall have 30 days
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from the date of personal service or mailing to request a hearing in ac-
cordance with [under] the Formal Hearing Procedures, §§1.21, 1.23,
1.25, and 1.27 of this title, and in accordance with subsection (i)(9) of
this section, concerning the intention of the agency. If no hearing is
requested within that period of time, the agency may take the contem-
plated action, and such action is nal.
(4) - (5) (No change.)
(m) Emergency orders.
(1) - (4) (No change.)
(5) The agency shall use any security provided by a
licensee in accordance with [under] the Act to pay toward the costs of
such actions and corrective measures taken. If the cost of actions and
corrective measures require more funds than the security has provided,
the agency shall request the Attorney General to seek reimbursement
from the licensee or person causing the threat.
(A) - (B) (No change.)
(6) (No change.)
(n) (No change.)
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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SUBCHAPTER F. LICENSE REGULATIONS
25 TAC §289.257
(Editor’s note: The text of the following section proposed for repeal
will not be published. The section may be examined in the ofces of
the Department of State Health Services or in the Texas Register ofce,
Room 245, James Earl Rudder Building, 1019 Brazos Street, Austin.)
STATUTORY AUTHORITY
The proposed repeal is authorized by Health and Safety Code,
§401.051, which provides the Executive Commissioner of the
Health and Human Services Commission with authority to adopt
rules and guidelines relating to the control of radiation, and
Government Code, §531.0055, and Health and Safety Code,
§1001.075, which authorize the Executive Commissioner of the
Health and Human Services Commission to adopt rules and
policies for the operation and provision of health and human
services by the department and for the administration of Health
and Safety Code, Chapter 1001. The review of the rule imple-
ments Government Code, §2001.039.
The proposed repeal affects the Health and Safety Code, Chap-
ters 401 and 1001, and Government Code, Chapter 531.
§289.257. Packaging and Transportation of Radioactive Material.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Department of State Health Services
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 458-7111 x6972
25 TAC §289.257
STATUTORY AUTHORITY
The proposed new section is authorized by Health and Safety
Code, §401.051, which provides the Executive Commissioner
of the Health and Human Services Commission with authority
to adopt rules and guidelines relating to the control of radia-
tion, and Government Code, §531.0055, and Health and Safety
Code, §1001.075, which authorize the Executive Commissioner
of the Health and Human Services Commission to adopt rules
and policies for the operation and provision of health and human
services by the department and for the administration of Health
and Safety Code, Chapter 1001. The review of the rule imple-
ments Government Code, §2001.039.
The proposed new section affects the Health and Safety Code,
Chapters 401 and 1001, and Government Code, Chapter 531.
§289.257. Packaging and Transportation of Radioactive Material.
(a) Purpose.
(1) This section establishes requirements for packaging,
preparation for shipment, and transportation of radioactive material
including radioactive waste.
(2) The packaging and transport of radioactive material are
also subject to the requirements of §289.201 of this title (relating to
General Provisions for Radioactive Material), §289.202 of this title
(relating to Standards for Protection Against Radiation from Radioac-
tive Materials), §289.203 of this title (relating to Notices, Instructions,
and Reports to Workers; Inspections), §289.204 of this title (relating
to Fees for Certicates of Registration, Radioactive Material Licenses,
Emergency Planning and Implementation, and Other Regulatory Ser-
vices), §289.205 of this title (relating to Hearing and Enforcement Pro-
cedures), §289.251 of this title (relating to Exemptions, General Li-
censes, and General License Acknowledgements), §289.252 of this ti-
tle (relating to Licensing of Radioactive Material), §289.254 of this title
(relating to Licensing of Radioactive Waste Processing and Storage Fa-
cilities), §289.256 of this title (relating to Medical and Veterinary Use
of Radioactive Material, and §289.260 of this title (relating to Licens-
ing of Uranium Recovery and Byproduct Material Disposal Facilities)
and to the regulations of other agencies (e.g., the United States Depart-
ment of Transportation (DOT) and the United States Postal Service)
having jurisdiction over means of transport. The requirements of this
section are in addition to, and not in substitution for, other require-
ments.
(b) Scope.
(1) The requirements of this section apply to any licensee
authorized by a specic or general license issued by the agency to re-
ceive, possess, use, or transfer radioactive material, if the licensee de-
livers that material to a carrier for transport, transports the material out-
side the site of usage as specied in the agency license, or transports
that material on public highways. No provision of this section autho-
rizes possession of radioactive material.
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(2) Exemptions from the requirements for a license in sub-
section (c) of this section are specied in subsection (f) of this sec-
tion. The general license in subsection (i) of this section requires that
a United States Nuclear Regulatory Commission (NRC) certicate of
compliance or other package approval be issued for the package to be
used in accordance with the general license. The transport of radioac-
tive material or delivery of radioactive material to a carrier for trans-
port is subject to the operating controls and procedural requirements of
subsections (l) - (q) of this section and to the general provisions of sub-
sections (a) - (e) of this section, including DOT regulations referenced
in subsection (e) of this section.
(c) Requirement for license. Except as authorized in a general
or specic license issued by the agency, or as exempted in accordance
with this section, no licensee may transport radioactive material or de-
liver radioactive material to a carrier for transport.
(d) Denitions. The following words and terms when used in
this section shall have the following meaning, unless the context clearly
indicates otherwise. To ensure compatibility with international trans-
portation standards, all limits in this section are given in terms of dual
units: The International System of Units (SI) followed or preceded by
United States (U.S.) standard or customary units. The U.S. customary
units are not exact equivalents, but are rounded to a convenient value,
providing a functionally equivalent unit. For the purpose of this sec-
tion, SI units shall be used.
(1) A
1
--The maximum activity of special form radioactive
material permitted in a Type A package. This value is either listed in
Table 257-3 of subsection (aa)(6) of this section, or may be derived




--The maximum activity of radioactive material,
other than special form, low specic activity (LSA) and surface
contaminated object (SCO) material, permitted in a Type A package.
This value is either listed in Table 257-3 of subsection (aa)(6) of this
section, or may be derived in accordance with the procedure prescribed
in subsection (aa) of this section.
(3) BRC Forms 540, 540A, 541, 541A, 542, and 542A--Of-
cial agency forms referenced in subsection (bb) of this section which
includes the information required by DOT in Title 49, Code of Fed-
eral Regulations (CFR), Part 172. BRC Form 541B contains addi-
tional information for low-level radioactive waste (LLRW) shipments
to a Texas LLRW disposal facility. Licensees need not use originals
of these forms as long as any substitute forms are equivalent to the
original documentation in respect to content, clarity, size, and location
of information. Upon agreement between the shipper and consignee,
BRC Forms 541 (and 541A and 541B) and BRC Forms 542 (and 542A)
may be completed, transmitted, and stored in electronic media. The
electronic media shall have the capability for producing legible, accu-
rate, and complete records in the format of the uniform manifest.
(4) Carrier--A person engaged in the transportation of pas-
sengers or property by land or water as a common, contract, or private
carrier, or by civil aircraft.
(5) Certicate holder--A person who has been issued a cer-
ticate of compliance or other package approval by the agency.
(6) Certicate of compliance--The certicate issued by the
NRC that approves the design of a package for the transportation of
radioactive materials.
(7) Chelating agent--Amine polycarboxylic acids (e.g.,
EDTA, DTPA), hydroxy-carboxylic acids, and polycarboxylic acids
(e.g., citric acid, carbolic acid, and glucinic acid).
(8) Chemical description--A description of the principal
chemical characteristics of a LLRW.
(9) Consignee--The designated receiver of the shipment of
low-level radioactive waste.
(10) Consignment--each shipment of a package or groups
of packages or load of radioactive material offered by a shipper for
transport.
(11) Containment system--The assembly of components of
the packaging intended to retain the radioactive material during trans-
port.
(12) Conveyance--For transport on:
(A) public highway or rail by transport vehicle or large
freight container;
(B) water by vessel, or any hold, compartment, or de-
ned deck area of a vessel including any transport vehicle on board the
vessel; and
(C) aircraft.
(13) Criticality Safety Index (CSI)--The dimensionless
number (rounded up to the next tenth) assigned to and placed on the
label of a ssile material package, to designate the degree of control
of accumulation of packages containing ssile material during trans-
portation. Determination of the criticality safety index is described in
subsection (i) of this section and Title 10, CFR, §71.59.
(14) Decontamination facility--A facility operating in ac-
cordance with an NRC, agreement state, or agency license whose prin-
cipal purpose is decontamination of equipment or materials to accom-
plish recycle, reuse, or other waste management objectives, and, for
purposes of this section, is not considered to be a consignee for LLRW
shipments.
(15) Deuterium--For the purposes of this section, this
means deuterium and any deuterium compound, including heavy wa-
ter, in which the ratio of deuterium atoms to hydrogen atoms exceeds
1:5000.
(16) Disposal container--A transport container principally
used to conne LLRW during disposal operations at a land disposal
facility (also see denition for high integrity container). Note that for
some shipments, the disposal container may be the transport package.
(17) Environmental Protection Agency (EPA) identi-
cation number--The number received by a transporter following
application to the administrator of EPA as required by Title 40, CFR,
Part 263.
(18) Exclusive use--The sole use by a single consignor of a
conveyance for which all initial, intermediate, and nal loading and un-
loading are carried out in accordance with the direction of the consignor
or consignee. The consignor and the carrier shall ensure that any load-
ing or unloading is performed by personnel having radiological training
and resources appropriate for safe handling of the consignment. The
consignor shall issue specic instructions, in writing, for maintenance
of exclusive use shipment controls, and include them with the shipping
paper information provided to the carrier by the consignor.
(19) Fissile material--The radionuclides plutonium-239,
plutonium-241, uranium-233, uranium-235, or any combination of
these radionuclides. Fissile material means the ssile nuclides them-
selves, not material containing ssile nuclides. Unirradiated natural
uranium and depleted uranium, and natural uranium or depleted ura-
nium that has been irradiated in thermal reactors only are not included
in this denition. Agency jurisdiction extends only to special nuclear
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material in quantities not sufcient to form a "critical mass" as dened
in §289.201(b) of this title. Certain exclusions from ssile material
controls are provided in subsection (h) of this section.
(20) Generator--A licensee operating in accordance with
an NRC, agreement state, or agency license who:
(A) is a waste generator as dened in this section; or
(B) is the licensee to whom waste can be attributed
within the context of the Low-Level Radioactive Waste Policy Amend-
ments Act of 1985 (e.g., waste generated as a result of decontamination
or recycle activities).
(21) Graphite--For the purposes of this section, this means
graphite with a boron equivalent content of less than ve parts per mil-
lion and density greater than 1.5 grams per cubic centimeter.
(22) High integrity container (HIC)--A container com-
monly designed to meet the structural stability requirements of Title
10, CFR, §61.56, and to meet DOT requirements for a Type A package.
(23) Industrial package (IP)--A packaging that, together
with its low specic activity (LSA) material or surface contaminated
object (SCO) contents, meets the requirements of Title 49, CFR,
§173.410 and §173.411. Industrial packages are categorized in Title
49, CFR, §173.411 as either:
(A) Industrial package Type 1 (IP-1);
(B) Industrial package Type 2 (IP-2); or
(C) Industrial package Type 3 (IP-3).
(24) Low-level radioactive waste (LLRW)--Radioactive
material that meets the following criteria:
(A) LLRW is radioactive material that is:
(i) discarded or unwanted and is not exempt by rule
adopted in accordance with the Texas Radiation Control Act (Act),
Health and Safety Code, §401.106;
(ii) waste, as that term is dened in Title 10, CFR,
§61.2; and
(iii) subject to:
(I) concentration limits established in Title 10,
CFR §61.55, or compatible rules adopted by the agency or the Texas
Commission on Environmental Quality (TCEQ), as applicable; and
(II) disposal criteria established in Title 10, CFR,
or established by the agency or TCEQ, as applicable.
(B) LLRW does not include:
(i) high-level radioactive waste as dened in Title
10, CFR, §60.2;
(ii) spent nuclear fuel as dened in Title 10, CFR,
§72.3;
(iii) byproduct material dened in the Act, Health
and Safety Code, §401.003(3)(B);
(iv) naturally occurring radioactive material
(NORM) waste that is not oil and gas NORM waste;
(v) oil and gas NORM waste; or
(vi) transuranics greater than 100 nanocuries per
gram.
(25) Low specic activity (LSA) material--Radioactive
material with limited specic activity which is nonssile or is excepted
in accordance with subsection (h) of this section, and which satises
the following descriptions and limits set forth. Shielding materials
surrounding the LSA material may not be considered in determining
the estimated average specic activity of the package contents. LSA
material shall be in one of the following three groups:
(A) LSA-I.
(i) Ores containing only naturally occurring
radionuclides (e.g., uranium, thorium) and uranium or thorium con-
centrates of such ores which are not intended to be processed for the
use of these radionuclides; or
(ii) Solid unirradiated natural uranium or depleted
uranium or natural thorium or their solid or liquid compounds or mix-
tures; or




(iv) Other radioactive material (e.g.: mill tailings,
contaminated earth, concrete, rubble, other debris, and activated mate-
rial) in which the radioactivity is distributed throughout, and the esti-
mated average specic activity does not exceed 30 times the value for
exempt material activity concentration determined in accordance with
subsection (aa) of this section.
(B) LSA-II.
(i) Water with tritium concentration up to 0.8 ter-
abecquerel per liter (TBq/l) (20.0 curies per liter (Ci/l)); or
(ii) Other material in which the radioactivity is dis-
tributed throughout, and the average specic activity does not exceed
10-4 A
2
/g for solids and gases, and 10-5 A
2
/g for liquids.
(C) LSA-III. Solids (e.g., consolidated wastes, acti-
vated materials), excluding powders, that satisfy the requirements of
Title 10, CFR, §71.77 in which:
(i) the radioactive material is distributed throughout
a solid or a collection of solid objects, or is essentially uniformly dis-
tributed in a solid compact binding agent (such as concrete, bitumen,
ceramic, etc.); and
(ii) the radioactive material is relatively insoluble,
or it is intrinsically contained in a relatively insoluble material, so that,
even with a loss of packaging, the loss of radioactive material per pack-




(iii) the average specic activity of the solid does not
exceed 2 x 10-3 A
2
/g.
(26) Low toxicity alpha emitters--Natural uranium,
depleted uranium, natural thorium; uranium-235, uranium-238, tho-
rium-232, thorium-228 or thorium-230 when contained in ores or
physical or chemical concentrates or tailings; or alpha emitters with a
half-life of less than ten days.
(27) Maximum normal operating pressure--The maximum
gauge pressure that would develop in the containment system in a pe-
riod of one year under the heat condition specied in Title 10, CFR,
§71.71(c)(1), in the absence of venting, external cooling by an ancil-
lary system, or operational controls during transport.
(28) Natural thorium--Thorium with the naturally occur-
ring distribution of thorium isotopes (essentially 100 weight percent
thorium-232).
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(29) Normal form radioactive material--Radioactive mate-
rial that has not been demonstrated to qualify as special form radioac-
tive material.
(30) Package--The packaging together with its radioactive
contents as presented for transport.
(A) Fissile material package, Type AF package, Type
BF package, Type B(U)F package, or Type B(M)F package--A ssile
material packaging together with its ssile material contents.
(B) Type A package--A Type A packaging together
with its radioactive contents. A Type A package is dened and shall
comply with the DOT regulations in Title 49, CFR, Part 173.
(C) Type B package--A Type B packaging together with
its radioactive contents. On approval by the NRC, a Type B package
design is designated by NRC as B(U) unless the package has a max-
imum normal operating pressure of more than 700 kilopascals (kPa)
(100 pounds per square inch (lb/in2)) gauge or a pressure relief device
that would allow the release of radioactive material to the environment
under the tests specied in Title 10, CFR, §71.73 (hypothetical acci-
dent conditions), in which case it will receive a designation B(M). B(U)
refers to the need for unilateral approval of international shipments;
B(M) refers to the need for multilateral approval of international ship-
ments. There is no distinction made in how packages with these des-
ignations may be used in domestic transportation. To determine their
distinction for international transportation, see DOT regulations in Ti-
tle 49, CFR, Part 173. A Type B package approved before September
6, 1983, was designated only as Type B. Limitations on its use are spec-
ied in Title 10, CFR, §71.19.
(31) Packaging--The assembly of components necessary to
ensure compliance with the packaging requirements of this section. It
may consist of one or more receptacles, absorbent materials, spacing
structures, thermal insulation, radiation shielding, and devices for cool-
ing or absorbing mechanical shocks. The vehicle, tie-down system, and
auxiliary equipment may be designated as part of the packaging.
(32) Physical description--The items called for on BRC
Form 541 to describe a LLRW.
(33) Residual waste--LLRW resulting from processing or
decontamination activities that cannot be easily separated into distinct
batches attributable to specic waste generators. This waste is attrib-
utable to the processor or decontamination facility, as applicable.
(34) Shipper--The licensed entity (i.e., the waste generator,
waste collector, or waste processor) who offers LLRW for transporta-
tion, typically consigning this type of waste to a licensed waste collec-
tor, waste processor, or land disposal facility operator. This denition
applies only to shipments of LLRW shipped to a Texas LLRW disposal
facility.
(35) Site of usage--The licensee’s facility, including all
buildings and structures between which radioactive material is trans-
ported and all roadways that are not within the public domain on
which radioactive material can be transported.
(36) Specic activity of a radionuclide--The radioactivity
of the radionuclide per unit mass of that nuclide. The specic activity of
a material in which the radionuclide is essentially uniformly distributed
is the radioactivity per unit mass of the material.
(37) Spent nuclear fuel or spent fuel--Fuel that has been
withdrawn from a nuclear reactor following irradiation, has undergone
at least one year’s decay since being used as a source of energy in
a power reactor, and has not been chemically separated into its con-
stituent elements by reprocessing. Spent fuel includes the special nu-
clear material, byproduct material, source material, and other radioac-
tive materials associated with fuel assemblies.
(38) Surface contaminated object (SCO)--A solid object
that is not itself classed as radioactive material, but which has radioac-
tive material distributed on any of its surfaces. A SCO shall be in one
of the following two groups with surface activity not exceeding the
following limits:
(A) SCO-I--A solid object on which:
(i) the non-xed contamination on the accessible
surface averaged over 300 square centimeters (cm2) (or the area of the
surface if less than 300 cm2) does not exceed 4 becquerels per square
centimeter (Bq/cm2) (10-4 microcurie per square centimeter (µCi/cm2))
for beta and gamma and low toxicity alpha emitters, or 4 x 10-1 Bq/cm2
(10-5 µCi/cm2) for all other alpha emitters;
(ii) the xed contamination on the accessible surface
averaged over 300 cm2 (or the area of the surface if less than 300 cm2)
does not exceed 4 x 104 Bq/cm2 (1 µCi/cm2) for beta and gamma and
low toxicity alpha emitters, or 4 x 103 Bq/cm2 (10-1 µCi/cm2) for all
other alpha emitters; and
(iii) the non-xed contamination plus the xed con-
tamination on the inaccessible surface averaged over 300 cm2 (or the
area of the surface if less than 300 cm2) does not exceed 4 x 104 Bq/cm2
(1 µCi/cm2) for beta and gamma and low toxicity alpha emitters, or 4
x 103 Bq/cm2 (10-1 µCi/cm2) for all other alpha emitters.
(B) SCO-II--A solid object on which the limits for
SCO-I are exceeded and on which the following limits are not ex-
ceeded:
(i) the non-xed contamination on the accessible
surface averaged over 300 cm2 (or the area of the surface if less than
300 cm2) does not exceed 400 Bq/cm2 (10-2 µCi/cm2) for beta and
gamma and low toxicity alpha emitters or 40 Bq/cm2 (10-3 µCi/cm2)
for all other alpha emitters;
(ii) the xed contamination on the accessible surface
averaged over 300 cm2 (or the area of the surface if less than 300 cm2)
does not exceed 8 x 105 Bq/cm2 (20 µCi/cm2) for beta and gamma and
low toxicity alpha emitters, or 8 x 104 Bq/cm2 (2 µCi/cm2) for all other
alpha emitters; and
(iii) the non-xed contamination plus the xed con-
tamination on the inaccessible surface averaged over 300 cm2 (or the
area of the surface if less than 300 cm2) does not exceed 8 x 105 Bq/cm2
(20 µCi/cm2) for beta and gamma and low toxicity alpha emitters, or 8
x 104 Bq/cm2 (2 µCi/cm2) for all other alpha emitters.
(39) Uniform Low-Level Radioactive Waste Manifest or
uniform manifest--The combination of BRC Forms 540, 541, and, if
necessary, 542, and their respective continuation sheets as needed, or
equivalent.
(40) Unirradiated uranium--Uranium containing not more
than 2 x 103 Bq of plutonium per gram of uranium-235, not more than
9 x 106 Bq of ssion products per gram of uranium-235, and not more
than 5 x 10-3 g of uranium-236 per gram of uranium-235.
(41) Uranium--Natural, depleted, enriched:
(A) Natural uranium--Uranium with the naturally oc-
curring distribution of uranium isotopes (approximately 0.711 weight
percent uranium-235, and the remainder by weight essentially uranium-
238).
(B) Depleted uranium--Uranium containing less ura-
nium-235 than the naturally occurring distribution of uranium isotopes.
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(C) Enriched uranium--Uranium containing more ura-
nium-235 than the naturally occurring distribution of uranium isotopes.
(42) Waste collector--An entity, operating in accordance
with an NRC, agreement state, or agency license, whose principal pur-
pose is to collect and consolidate waste generated by others, and to
transfer this waste, without processing or repackaging the collected
waste, to another licensed waste collector, licensed waste processor,
or licensed land disposal facility.
(43) Waste description--The physical, chemical and radio-
logical description of a LLRW as called for on BRC Form 541.
(44) Waste generator--An entity, operating in accordance
with an NRC, agreement state, or agency license, who:
(A) possesses any material or component that contains
radioactivity or is radioactively contaminated for which the licensee
foresees no further use; and
(B) transfers this material or component to a licensed
land disposal facility or to a licensed waste collector or processor for
handling or treatment prior to disposal. A licensee performing process-
ing or decontamination services may be a waste generator if the transfer
of LLRW from its facility is dened as residual waste.
(45) Waste processor--An entity, operating in accordance
with an NRC or agreement state license, whose principal purpose is
to process, repackage, or otherwise treat LLRW or waste generated
by others prior to eventual transfer of waste to a licensed LLRW land
disposal facility.
(46) Waste type--A waste within a disposal container hav-
ing a unique physical description (i.e., a specic waste descriptor code
or description; or a waste sorbed on or solidied in a specically-de-
ned media).
(e) Transportation of radioactive material.
(1) Each licensee who transports radioactive material out-
side the site of usage as specied in the agency license, transports on
public highways, or delivers radioactive material to a carrier for trans-
port, shall comply with the applicable requirements of the DOT regu-
lations in Title 49, CFR, Part 107, Parts 171 - 189 and 390 - 397 ap-
propriate to the mode of transport. The licensee shall particularly note
DOT regulations in the following areas:
(A) Packaging--Title 49, CFR, Part 173: Subparts A, B,
and I.
(B) Marking and labeling--Title 49, CFR, Part 172:
Subpart D, and §§172.400 - 172.407 and §§172.436 - 172.441 of
Subpart E.
(C) Placarding--Title 49, CFR, Part 172: Subpart F, es-
pecially §§172.500 - 172.519 and §172.556, and Appendices B and C.
(D) Accident reporting--Title 49, CFR, Part 171:
§171.15 and §171.16.
(E) Shipping papers and emergency information--Title
49, CFR, Part 172: Subparts C and G.
(F) Hazardous material employee training--Title 49,
CFR, Part 172: Subpart H.
(G) Hazardous material shipper/carrier registration--Ti-
tle 49, CFR, Part 107: Subpart G.
(H) Security Plans--Title 49, CFR, Part 172: Subpart I.
(2) The licensee shall also note DOT regulations pertaining
to the following modes of transportation:
(A) Rail: Title 49, CFR Part 174: Subparts A through
D and K.
(B) Air: Title 49, CFR Part 175.
(C) Vessel: Title 49, CFR Part 176: Subparts A through
F and M.
(D) Public Highway: Title 49, CFR Part 177 and Parts
390 through 397.
(3) If DOT regulations are not applicable to a shipment of
radioactive material (i.e. DOT does not have jurisdiction), the licensee
shall conform to DOT standards and requirements specied in para-
graph (1) of this subsection to the same extent as if the shipment or
transportation were subject to DOT regulations. A request for modi-
cation, waiver, or exemption from those requirements shall be led and
approved by the agency. Any notication referred to in those require-
ments, shall be submitted to the agency.
(f) Exemption for low-level radioactive materials.
(1) A licensee is exempt from all requirements of this sec-
tion with respect to shipment or carriage of the following low-level
materials:
(A) Natural material and ores containing naturally oc-
curring radionuclides that are not intended to be processed for use of
these radionuclides, provided the activity concentration of the material
does not exceed 10 times the values specied in Table 257-4 of sub-
section (aa)(7) of this section.
(B) Materials for which the activity concentration is not
greater than the activity concentration values specied in Table 257-
4 of subsection (aa)(7) of this section, or for which the consignment
activity is not greater than the limit for an exempt consignment found
in Table 257-4 of subsection (aa)(7) of this section.
(2) Common and contract carriers, freight forwarders, and
warehousemen, who are subject to the rules and regulations of the DOT
or the United States Postal Service (Title 39, CFR, Parts 14 and 15), are
exempt from these regulations to the extent that they transport or store
sources of radiation in the regular course of their carriage for another
or storage incident thereto. Private carriers who are subject to the rules
and regulations of the DOT are exempted from these regulations to
the extent that they transport sources of radiation. Common, contract,
and private carriers who are not subject to the rules and regulations of
the DOT or the United States Postal Service are subject to applicable
sections of these regulations.
(3) Persons who discard licensed material in accordance
with §289.202(fff) of this title are exempt from all requirements of this
section.
(g) Exemption of physicians. Any physician licensed by a
State to dispense drugs in the practice of medicine is exempt from Title
10, CFR, §71.5 with respect to transport by the physician of licensed
material for use in the practice of medicine. However, any physician
operating under this exemption shall be licensed under Title 10, CFR,
Part 35 or the equivalent agreement state regulations.
(h) Exemption from classication as ssile material. Fissile
materials meeting the requirements of at least one of the paragraphs (1)
through (6) of this subsection are exempt from classication as ssile
material and from the ssile material package standards of Title 10,
CFR §71.55 and §71.59, but are subject to all other requirements of
this section, except as noted.
(1) An individual package containing 2 grams or less ssile
material.
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(2) Individual or bulk packaging containing 15 grams or
less of ssile material provided the package has at least 200 grams
of solid nonssile material for every gram of ssile material. Lead,
beryllium, graphite, and hydrogenous material enriched in deuterium
may be present in the package but shall not be included in determining
the required mass for solid nonssile material.
(3) Solid ssile material commingled with solid non-ssile
material.
(A) Low concentrations of solid ssile material com-
mingled with solid nonssile material provided:
(i) that there is at least 2000 grams of solid nonssile
material for every gram of ssile material, and
(ii) there is no more than 180 grams of ssile mate-
rial distributed within 360 kg of contiguous non-ssile material.
(B) Lead, beryllium, graphite, and hydrogenous mate-
rial enriched in deuterium may be present in the package but shall not
be included in determining the required mass of solid nonssile mate-
rial.
(4) Uranium enriched in uranium-235 to a maximum of 1%
by weight, and with total plutonium and uranium-233 content of up to
1% of the mass of uranium-235, provided that the mass of any beryl-
lium, graphite, and hydrogenous material enriched in deuterium con-
stitutes less than 5 percent of the uranium mass.
(5) Liquid solutions of uranyl nitrate enriched in uranium-
235 to a maximum of 2 percent by mass, with a total plutonium and
uranium-233 content not exceeding 0.002 percent of the mass of ura-
nium, and with a minimum nitrogen to uranium atomic ratio (N/U) of
2. The material shall be contained in at least a DOT Type A package.
(6) Packages containing, individually, a total plutonium
mass of not more than 1000 grams, of which not more than 20 per-
cent by mass may consist of plutonium-239, plutonium-241, or any
combination of these radionuclides.
(i) General license.
(1) NRC-approved package.
(A) A general license is issued to any licensee of the
agency to transport, or to deliver to a carrier for transport, radioactive
material in a package for which a license, certicate of compliance
(CoC), or other approval has been issued by the NRC.
(B) This general license applies only to a licensee who
has a quality assurance program approved by the NRC as satisfying the
provisions of Title 10, CFR, Part 71, Subpart H.
(C) This general license applies only to a licensee who
meets the following requirements:
(i) has a copy of the CoC or other approval by the
NRC of the package, and has the drawings and other documents refer-
enced in the approval relating to the use and maintenance of the pack-
aging and to the actions to be taken before shipment; and
(ii) complies with the terms and conditions of the
specic license, certicate, or other approval by the NRC, as applica-
ble, and the applicable requirements of Title 10, CFR, Part 71, Subparts
A, G, and H; and
(iii) Before the licensee’s rst use of the package,
submits in writing to: ATTN: Document Control Desk, Director, Spent
Fuel Project Ofce, Ofce of Nuclear Material Safety and Safeguards,
using an appropriate method listed in Title 10, CFR, Part 71, the li-
censee’s name and license number and the package identication num-
ber specied in the package approval.
(D) This general license applies only when the package
approval authorizes use of the package in accordance with this general
license.
(E) For a Type B or ssile material package, the design
of which was approved by NRC before April 1, 1996, the general li-
cense is subject to the additional restrictions of paragraph (2) of this
subsection.
(F) For radiography containers, a program for transport
container inspection and maintenance limited to radiographic exposure
devices, source changers, or packages transporting these devices and
meeting the requirements of §289.255(m)(2)(B) of this title (relating
to Radiation Safety Requirements and Licensing and Registration Pro-
cedures for Industrial Radiography), is deemed to satisfy the require-
ments of subparagraph (B) of this paragraph.
(2) Previously approved package.
(A) A Type B package previously approved by the
NRC, but not designated as B(U), B(M), B(U)F or B(M)F in the
identication number of the NRC certicate of compliance, or Type
AF packages approved by the NRC prior to September 6, 1983, may
be used in accordance with the general license of paragraph (1) of this
subsection with the following additional conditions:
(i) fabrication of the packaging was satisfactorily
completed before August 31, 1986, as demonstrated by application of
its model number in accordance with subsection (k)(3) of this section;
(ii) a serial number that uniquely identies each
packaging which conforms to the approved design is assigned to, and
legibly and durably marked on, the outside of each packaging ; and
(iii) subparagraph (A) of this paragraph expires Oc-
tober 1, 2008.
(B) A Type B(U) package, a Type B(M) package, or a
ssile material package, previously approved by the NRC but without
the designation "-85" in the identication number of the NRC CoC,
may be used in accordance with the general license of paragraph (1) of
this subsection with the following additional conditions:
(i) fabrication of the package is satisfactorily com-
pleted by April 1, 1999, as demonstrated by application of its model
number in accordance with subsection (k)(3) of this section;
(ii) a package used for a shipment to a location out-
side the United States is subject to multilateral approval as dened in
DOT regulations Title 49, CFR §173.403; and
(iii) a serial number which uniquely identies each
packaging which conforms to the approved design is assigned to and
legibly and durably marked on the outside of each packaging.
(C) A Type B(U) package, a Type B(M) package, or
a ssile material package, previously approved by the NRC with the
designation "-85" in the identication number of the NRC CoC, may
be used in accordance with the general license of paragraph (1) of this
subsection with the following additional conditions:
(i) Fabrication of the package shall be satisfactorily
completed by December 31, 2006, as demonstrated by application of
its model number in accordance with subsection (k)(3) of this section.
(ii) After December 31, 2003, a package used for a
shipment to a location outside the United States is subject to multilat-
eral approval as dened in DOT regulations Title 49, CFR, §173.403.
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(3) DOT specication container.
(A) A general license is issued to any licensee to trans-
port, or to deliver to a carrier for transport, licensed material in a spec-
ication container for ssile material or for a Type B quantity of ra-
dioactive material as specied in Title 49, CFR, Parts 173 and 178.
(B) This general license applies only to a licensee who:
(i) has a quality assurance program required by sub-
sections (t), (u), and (v) of this section and Title 10, CFR, Part 71, Sub-
part H;
(ii) has a copy of the specication; and
(iii) complies with the terms and conditions of the
specication and the applicable requirements of this section.
(C) The general license in subparagraph (A) of this
paragraph is subject to the limitation that the specication container
may not be used for a shipment to a location outside the United States
except by multilateral approval as dened in Title 49, CFR, §173.403.
(4) Use of foreign approved package
(A) A general license is issued to any licensee to trans-
port, or to deliver to a carrier for transport, licensed material in a pack-
age the design of which has been approved in a foreign national compe-
tent authority certicate that has been revalidated by the DOT as meet-
ing the applicable requirements of Title 49, CFR, §171.12.
(B) Except as otherwise provided by this section, the
general license applies only to a licensee who has a quality assurance
program approved by the NRC as satisfying the applicable provisions
of Title 10, CFR, Part 71.
(C) This general license applies only to international
shipments.
(D) This general license applies only to a licensee who:
(i) has a copy of the applicable certicate, the reval-
idation, and the drawings and other documents referenced in the cer-
ticate relating to the use and maintenance of the packaging and to the
actions to be taken prior to shipment; and
(ii) complies with the terms and conditions of the
certicate and revalidation, and with the applicable requirements of
this section. With respect to the quality assurance provisions of Title
10, CFR, Part 71, the licensee is exempt from design, construction, and
fabrication considerations.
(5) Fissile material.
(A) A general license is issued to any licensee to trans-
port ssile material, or to deliver ssile material to a carrier for trans-
port, if the material is shipped in accordance with this section. The
ssile material need not be contained in a package that meets the stan-
dards of this section; however, the material shall be contained in a Type
A package. The Type A package shall also meet the DOT requirements
of Title 49, CFR, §173.417(a).
(B) The general license applies only to a licensee who
has a quality assurance program approved by the NRC as satisfying the
provisions of Title 10, CFR, Part 71.
(C) The general license applies only when a package’s
contents:
(i) contain no more than a Type A quantity of ra-
dioactive material; and
(ii) contain less than 500 total grams of beryllium,
graphite, or hydrogeneous material enriched in deuterium.
(D) The general license applies only to packages con-
taining ssile material that are labeled with a CSI that:
(i) has been determined in accordance with para-
graph (E) of this subsection;
(ii) has a value less than or equal to 10.0; and
(iii) for a shipment of multiple packages containing
ssile material, the sum of the CSIs shall be less than or equal to 50.0
(for shipment on a nonexclusive use conveyance) and less than or equal
to 100.0 (for shipment on an exclusive use conveyance).
(E) The CSI shall be as follows:
(i) the value for the CSI shall be greater than or equal
to the number calculated by the following equation:
Figure: 25 TAC §289.257(i)(5)(E)(i)
(ii) the calculated CSI shall be rounded up to the rst
decimal place;
(iii) the values of X, Y, and Z used in the CSI equa-
tion shall be taken from Tables 257-1 or 257-2 of this clause, as appro-
priate;
Figure: 25 TAC §289.257(i)(5)(E)(iii)
(iv) if Table 257-2 of clause (iii) of this subpara-
graph is used to obtain the value of X, then the values for the terms
in the equation for uranium-233 and plutonium shall be assumed to be
zero; and
(v) Table 257-2 values of clause (iii) of this subpara-
graph for X, Y, and Z shall be used to determine the CSI if:
(I) uranium-233 is present in the package;
(II) the mass of plutonium exceeds 1% of the
mass of uranium-235;
(III) the uranium is of unknown uranium-235 en-
richment, or greater than 24 weight percent enrichment; or
(IV) substances having a moderating effective-
ness (i.e. an average hydrogen density greater than H
2
0) (e.g. certain
hydrocarbon oils or plastics) are present in any form, except as poly-
ethylene used for packing or wrapping.
(6) Plutonium-beryllium special form material.
(A) A general license is issued to any licensee to trans-
port ssile material in the form of plutonium-beryllium (Pu-Be) spe-
cial form sealed sources, or to deliver Pu-Be sealed sources to a carrier
for transport, if the material is shipped in accordance with this sec-
tion. This material need not be contained in a package that meets the
standards of Title 10, CFR, Part 71, however, the material shall be con-
tained in a Type A package. The Type A package shall also meet the
DOT requirements of Title 49, CFR, §173.417(a).
(B) The general license applies only to a licensee who
has a quality assurance program approved by the NRC as satisfying the
provisions of Title 10, CFR, Part 71.
(C) The general license applies only when a package’s
contents:
(i) contain no more than a Type A quantity of mate-
rial; and
(ii) contain less than 1000g of plutonium, provided
that plutonium-239, plutonium-241, or any combination of these ra-
dionuclides, constitutes less than 240 g of the total quantity of pluto-
nium in the package.
32 TexReg 6262 September 14, 2007 Texas Register
(D) The general license applies only to packages
labeled with a CSI that:
(i) has been determined in accordance with subpara-
graph (E) of this paragraph;
(ii) has a value less than or equal to 100.0; and
(iii) for a shipment of multiple packages containing
Pu-Be sealed sources, the sum of the CSIs shall be less than or equal
to 50.0 (for shipment on a nonexclusive use conveyance) and less than
or equal to 100.0 (for shipment on or exclusive use conveyance).
(E) The value for the CSI shall be as follows:
(i) the CSI shall be greater than or equal to the num-
ber calculated by the following equation:
Figure: 25 TAC §289.257(i)(6)(E)(i)
(ii) the calculated CSI shall be rounded up to the rst
decimal place.
(j) Assumptions as to unknown properties. When the isotopic
abundance, mass, concentration, degree of irradiation, degree of mod-
eration, or other pertinent property of ssile material in any package
is not known, the licensee shall package the ssile material as if the
unknown properties have credible values that will cause the maximum
neutron multiplication.
(k) Preliminary determinations. Before the rst use of any
packaging for the shipment of licensed material the licensee shall:
(1) ascertain that there are no cracks, pinholes, uncon-
trolled voids, or other defects that could signicantly reduce the
effectiveness of the packaging;
(2) where the maximum normal operating pressure will ex-
ceed 35 kPa (5 lb/in2) gauge, test the containment system at an internal
pressure at least 50 percent higher than the maximum normal operating
pressure, to verify the capability of that system to maintain its structural
integrity at that pressure; and
(3) conspicuously and durably mark the packaging with its
model number, serial number, gross weight, and a package identica-
tion number assigned by NRC. Before applying the model number, the
licensee shall determine that the packaging has been fabricated in ac-
cordance with the design approved by the NRC.
(l) Routine determinations. Before each shipment of radioac-
tive material, the licensee shall ensure that the package with its contents
satises the applicable requirements of this section and of the license.
The licensee shall determine that:
(1) the package is proper for the contents to be shipped;
(2) the package is in unimpaired physical condition except
for supercial defects such as marks or dents;
(3) each closure device of the packaging, including any re-
quired gasket, is properly installed, secured, and free of defects;
(4) any system for containing liquid is adequately sealed
and has adequate space or other specied provision for expansion of
the liquid;
(5) any pressure relief device is operable and set in accor-
dance with written procedures;
(6) the package has been loaded and closed in accordance
with written procedures;
(7) for ssile material, any moderator or neutron absorber,
if required, is present and in proper condition;
(8) any structural part of the package that could be used
to lift or tie down the package during transport is rendered inoperable
for that purpose, unless it satises the design requirements of Title 10,
CFR, §71.45;
(9) the level of non-xed (removable) radioactive contam-
ination on the external surfaces of each package offered for shipment is
as low as reasonably achievable (ALARA), and within the limits spec-
ied in DOT regulations in Title 49, CFR, §173.443;
(10) external radiation levels around the package and
around the vehicle, if applicable, will not exceed the following limits
at any time during transportation:
(A) Except as provided in subparagraph (B) of this
paragraph, each package of radioactive materials offered for trans-
portation shall be designed and prepared for shipment so that under
conditions normally incident to transportation the radiation level does
not exceed 2 mSv/hr (200 mrem/hr) at any point on the external
surface of the package, and the transport index does not exceed 10.
(B) A package that exceeds the radiation level limits
specied in subparagraph (A) of this paragraph shall be transported by
exclusive use shipment only, and the radiation levels for such shipment
shall not exceed the following during transportation:
(i) 2 mSv/hr (200 mrem/hr) on the external surface
of the package, unless the following conditions are met, in which case
the limit is 10 mSv/hr (1,000 mrem/hr):
(I) the shipment is made in a closed transport ve-
hicle;
(II) the package is secured within the vehicle so
that its position remains xed during transportation; and
(III) there are no loading or unloading operations
between the beginning and end of the transportation;
(ii) 2 mSv/hr (200 mrem/hr) at any point on the outer
surface of the vehicle, including the top and underside of the vehicle; or
in the case of a at-bed style vehicle, at any point on the vertical planes
projected from the outer edges of the vehicle, on the upper surface of
the load or enclosure, if used, and on the lower external surface of the
vehicle; and
(iii) 0.1 mSv/hr (10 mrem/hr) at any point 2 meters
(m) (6.6 feet (ft)) from the outer lateral surfaces of the vehicle (exclud-
ing the top and underside of the vehicle); or in the case of a at-bed style
vehicle, at any point 2 m (6.6 ft) from the vertical planes projected by
the outer edges of the vehicle (excluding the top and underside of the
vehicle); and
(iv) 0.02 mSv/hr (2 mrem/hr) in any normally occu-
pied space, except that this provision does not apply to private carriers,
if exposed personnel under their control wear radiation dosimetry de-
vices in conformance with §289.202(q) of this title;
(C) For shipments made in accordance with the provi-
sions of subparagraph (B) of this paragraph, the shipper shall provide
specic written instructions to the carrier for maintenance of the exclu-
sive use shipment controls. The instructions shall be included with the
shipping paper information.
(D) The written instructions required for exclusive use
shipments shall be sufcient so that, when followed, they will cause
the carrier to avoid actions that will unnecessarily delay delivery or
unnecessarily result in increased radiation levels or radiation exposures
to transport workers or members of the general public.
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(11) a package shall be designed, constructed, and prepared
for transport so that in still air at 38 degrees Celsius (100 degrees
Fahrenheit) and in the shade, no accessible surface of a package would
have a temperature exceeding 50 degrees Celsius (122 degrees Fahren-
heit) in a nonexclusive use shipment, or 85 degrees Celsius (185 de-
grees Fahrenheit) in an exclusive use shipment. Accessible package
surface temperatures shall not exceed these limits at any time during
transportation.
(m) Air transport of plutonium.
(1) Notwithstanding the provisions of any general licenses
and notwithstanding any exemptions stated directly in this section or in-
cluded indirectly by citation of Title 49, CFR, Chapter I, as may be ap-
plicable, the licensee shall assure that plutonium in any form, whether
for import, export, or domestic shipment, is not transported by air or
delivered to a carrier for air transport unless:
(A) the plutonium is contained in a medical device de-
signed for individual human application; or
(B) the plutonium is contained in a material in which
the specic activity is less than or equal to the activity concentration
values for plutonium specied in Table 257-4 of subsection (aa)(7) of
this section, and in which the radioactivity is essentially uniformly dis-
tributed; or
(C) the plutonium is shipped in a single package con-
taining no more than an A
2
quantity of plutonium in any isotope or
form, and is shipped in accordance with subsection (e) of this section;
or
(D) the plutonium is shipped in a package specically
authorized for the shipment of plutonium by air in the Certicate of
Compliance for that package issued by the NRC.
(2) Nothing in paragraph (1) of this subsection is to be in-
terpreted as removing or diminishing the requirements of Title 10, CFR,
§73.24.
(3) For a shipment of plutonium by air which is subject
to paragraph (1) of this subsection, the licensee shall, through special
arrangement with the carrier, require compliance with Title 49, CFR,
§175.704, DOT regulations applicable to the air transport of plutonium.
(n) Opening instructions. Before delivery of a package to a
carrier for transport, the licensee shall ensure that any special instruc-
tions needed to safely open the package have been sent to, or otherwise
made available to, the consignee for the consignee’s use in accordance
with §289.202(ee)(5) of this title.
(o) Records. For a period of three years after shipment, each
licensee shall maintain, for inspection by the agency, a record of each
shipment of radioactive material showing the following where appli-
cable:
(1) identication of the packaging by model number and
serial number;
(2) verication that there are no signicant defects in the
packaging, as shipped;
(3) type and quantity of radioactive material in each pack-
age, and the total quantity of each shipment;
(4) date of the shipment;
(5) for ssile packages and for Type B packages, any spe-
cial controls exercised;
(6) name and address of the transferee;
(7) address to which the shipment was made; and
(8) surveys performed to determine compliance with sub-
section (l)(9) and (10) of this section.
(p) Reports. The shipper shall immediately report by tele-
phone, telegram, mailgram, or facsimile, all radioactive waste trans-
portation accidents to the agency and the local emergency planning
committees in the county where the radioactive waste accident occurs.
All other accidents involving radioactive material shall be reported in
accordance with §289.202(xx) and (yy) of this title.
(q) Advance notication of transport of irradiated reactor fuel
and certain radioactive waste
(1) As specied in paragraphs (2) - (4) of this subsection,
each licensee shall provide advance notication to the governor of a
state, or the governor’s designee, of the shipment of radioactive waste,
through, or across the boundary of the state, before the transport, or
delivery to a carrier, for transport, of radioactive waste outside the con-
nes of the licensee’s facility or other place of use or storage.
(2) Advance notication is required in accordance with this
section for shipment of irradiated reactor fuel in quantities less than that
subject to advance notication requirements of Title 10, CFR, §73.37.
Advanced notication is also required under this subsection for ship-
ments of radioactive material, other than irradiated fuel, meeting the
following three conditions:
(A) the radioactive waste is required by this section to
be in Type B packaging for transportation;
(B) the radioactive waste is being transported to or
across a state boundary en route to a disposal facility or to a collection
point for transport to a disposal facility; and
(C) the quantity of radioactive waste in a single package
exceeds the least of the following:
(i) 3000 times the A
1
value of the radionuclides as
specied in subsection (aa) of this section for special form radioactive
material;
(ii) 3000 times the A
2
value of the radionuclides as
specied in subsection (aa) of this section for normal form radioactive
material; or
(iii) 1000 terabecquerels (TBq) (27,000 curies (Ci)).
(3) The following are procedures for submitting advance
notication:
(A) The notication shall be made in writing to the of-
ce of each appropriate governor or governor’s designee and to the
agency.
(B) A notication delivered by mail shall be post-
marked at least seven days before the beginning of the seven-day
period during which departure of the shipment is estimated to occur.
(C) A notication delivered by any other means than
mail shall reach the ofce of the governor or of the governor’s designee
at least four days before the beginning of the seven-day period during
which departure of the shipment is estimated to occur.
(i) A list of the names and mailing addresses of the
governors’ designees receiving advance notication of transportation
of radioactive waste was published in the Federal Register on June 30,
1995 (60 FR 34306).
(ii) The list will be published annually in the Federal
Register on or about June 30 to reect any changes in information.
(iii) A list of the names and mailing addresses of
the governors’ designees is available on request from the Director, Of-
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ce of State Programs, United States Nuclear Regulatory Commission,
Washington, DC 20555-0001.
(D) The licensee shall retain a copy of the notication
as a record for three years.
(4) Each advance notication of shipment of irradiated re-
actor fuel or radioactive waste shall contain the following information:
(A) the name, address, and telephone number of the
shipper, carrier, and receiver of the irradiated reactor fuel or radioac-
tive waste shipment;
(B) a description of the irradiated reactor fuel or ra-
dioactive waste contained in the shipment, as specied in the regula-
tions of DOT in Title 49, CFR, §172.202 and §172.203(d);
(C) the point of origin of the shipment and the seven-
day period during which departure of the shipment is estimated to oc-
cur;
(D) the seven-day period during which arrival of the
shipment at state boundaries is estimated to occur;
(E) the destination of the shipment, and the seven-day
period during which arrival of the shipment is estimated to occur; and
(F) a point of contact, with a telephone number, for cur-
rent shipment information.
(5) A licensee who nds that schedule information previ-
ously furnished to a governor or governor’s designee, in accordance
with this section, will not be met, shall telephone a responsible indi-
vidual in the ofce of the governor of the state or of the governor’s
designee and inform that individual of the extent of the delay beyond
the schedule originally reported. The licensee shall maintain a record
of the name of the individual contacted for three years.
(6) The following are procedures for a cancellation notice.
(A) Each licensee who cancels an irradiated reactor fuel
or radioactive waste shipment for which advance notication has been
sent shall send a cancellation notice to the governor of each state or to
the governor’s designee previously notied, and to the agency.
(B) The licensee shall state in the notice that it is a can-
cellation and identify the advance notication that is being canceled.
The licensee shall retain a copy of the notice as a record for three years.
(r) Emergency plan. Each shipper and transporter of radioac-
tive waste shall adopt an emergency plan approved by the agency for
responding to transportation accidents.
(s) Inspections. Each shipment of LLRW to a licensed land
disposal facility in Texas shall be inspected by the agency prior to ship-
ment. The waste shipper shall notify the agency no less than 72 hours
prior to the scheduled shipment of the intent to transport waste to the
licensed land disposal facility.
(t) Quality assurance requirements.
(1) Purpose. This subsection describes quality assurance
requirements applying to design, purchase, fabrication, handling, ship-
ping, storing, cleaning, assembly, inspection, testing, operation, main-
tenance, repair, and modication of components of packaging that are
important to safety.
(A) Quality Assurance comprises all those planned and
systematic actions necessary to provide adequate condence that a sys-
tem or component will perform satisfactorily in service.
(B) Quality assurance includes quality control, which
comprises those quality assurance actions related to control of the phys-
ical characteristics and quality of the material or component to prede-
termined requirements.
(C) The license, certicate holder, and applicant for a
CoC are responsible for the following:
(i) the quality assurance requirements as they apply
to design, fabrication, testing, and modication of packaging; and
(ii) the quality assurance provision which applies to
its use of a packaging for the shipment of licensed material subject to
this subpart.
(2) Establishment of program. Each licensee, certicate
holder, and applicant for a CoC shall:
(A) Establish, maintain, and execute a quality assurance
program satisfying each of the applicable criteria of this subsection,
subsections (t) and (u) of this section and Title 10, CFR, §§71.101
through 71.137 and satisfying any specic provisions that are appli-
cable to the licensee’s activities including procurement of packaging;
and
(B) Execute the applicable criteria in a graded approach
to an extent that is commensurate with the quality assurance require-
ment’s importance to safety.
(3) Approval of program. Before the use of any package
for the shipment of licensed material subject to this subsection, each
licensee shall:
(A) obtain agency approval of its quality assurance pro-
gram; and
(B) le a description of its quality assurance program,
including a discussion of which requirements of this subsection and
subsections (u) and (v) are applicable and how they will be satised.
(4) Radiography containers. A program for transport con-
tainer inspection and maintenance limited to radiographic exposure
devices, source changers, or packages transporting these devices and
meeting the requirements of §289.255(m) of this title, is deemed to sat-
isfy the requirements of subsection (i)(B) of this section and paragraph
(2) of this subsection.
(u) Quality assurance organization. The licensee, certicate
holder, and applicant for a CoC shall:
(1) be responsible for the establishment and execution of
the quality assurance program. The licensee, certicate holder, and ap-
plicant for a CoC may delegate to others, such as contractors, agents, or
consultants, the work of establishing and executing the quality assur-
ance program, or any part of the quality assurance program, but shall
retain responsibility for the program; and
(2) clearly establish and delineate, in writing, the authority
and duties of persons and organizations performing activities affecting
the functions of structures, systems, and components that are important
to safety. These activities include performing the functions associated
with attaining quality objectives and the quality assurance functions.
(3) establish quality assurance functions as follows:
(A) assuring that an appropriate quality assurance pro-
gram is established and effectively executed; and
(B) verifying , by procedures such as checking, audit-
ing, and inspection, that activities affecting the functions that are im-
portant to safety have been correctly performed.
(4) assure that persons and organizations performing qual-
ity assurance functions have sufcient authority and organizational
freedom to:
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(A) identify quality problems;
(B) initiate, recommend, or provide solutions; and
(C) verify implementation of solutions.
(v) Quality assurance program. A quality assurance program
shall be maintained as follows:
(1) The licensee, certicate holder, and applicant for a CoC
shall:
(A) establish, at the earliest practicable time consistent
with the schedule for accomplishing the activities, a quality assurance
program that complies with the requirements of this section and Title
10, CFR, §§71.01 through 71.137;
(B) document the quality assurance program by written
procedures or instructions and shall carry out the program in accor-
dance with those procedures throughout the period during which the
packaging is used; and
(C) identify the material and components to be covered
by the quality assurance program, the major organizations participating
in the program, and the designated functions of these organizations.
(2) The licensee, certicate holder, and applicant for a
CoC, through its quality assurance program, shall:
(A) provide control over activities affecting the quality
of the identied materials and components to an extent consistent with
their importance to safety, and as necessary to assure conformance to
the approved design of each individual package used for the shipment
of radioactive material;
(B) assure that activities affecting quality are accom-
plished under suitable controlled conditions which include:
(i) the use of appropriate equipment;
(ii) suitable environmental conditions for accom-
plishing the activity, such as adequate cleanliness; and
(iii) all prerequisites for the given activity have been
satised; and
(C) take into account the need for special controls, pro-
cesses, test equipment, tools, and skills to attain the required quality,
and the need for verication of quality by inspection and test.
(3) The licensee, certicate holder, and applicant for a CoC
shall base the requirements and procedures of its quality assurance pro-
gram on the following considerations concerning the complexity and
proposed use of the package and its components.
(A) The impact of malfunction or failure of the item to
safety;
(B) The design and fabrication complexity or unique-
ness of the item;
(C) The need for special controls and surveillance over
processes and equipment;
(D) The degree to which functional compliance can be
demonstrated by inspection or test; and
(E) The quality history and degree of standardization of
the item.
(4) The licensee, certicate holder, and applicant for a CoC
shall provide for indoctrination and training of personnel performing
activities affecting quality, as necessary to assure that suitable pro-
ciency is achieved and maintained.
(5) The licensee, certicate holder, and applicant for a CoC
shall review the status and adequacy of the quality assurance program
at established intervals. Management of other organizations participat-
ing in the quality assurance program shall review regularly the status
and adequacy of that part of the quality assurance program they are ex-
ecuting.
(w) Quality control program. Each shipper shall adopt a qual-
ity control program to include verication of the following to ensure
that shipping containers are suitable for shipments to a licensed dis-
posal facility:
(1) identication of appropriate container(s);
(2) container testing documentation is adequate;
(3) appropriate container used;
(4) container packaged appropriately;
(5) container labeled appropriately;
(6) manifest lled out appropriately; and
(7) documentation maintained of each step.
(x) Audits. The licensee, certicate holder, and applicant for
a CoC shall carry out a comprehensive system of planned and periodic
audits, to verify compliance with all aspects of the quality assurance
program, and to determine the effectiveness of the program. The audit
program shall include:
(1) performance in accordance with written procedures or
checklists by appropriately trained personnel not having direct respon-
sibilities in the area being audited;
(2) documented results that are reviewed by management
having responsibility in the area audited; and
(3) follow-up action, including reaudit of decient areas,
shall be taken where indicated.
(y) Transfer for disposal and manifests.
(1) The requirements of this section and subsection (bb) of
this section are designed to:
(A) control transfers of LLRW by any waste generator,
waste collector, or waste processor licensee, as dened in this section,
who ships LLRW either directly, or indirectly through a waste collec-
tor or waste processor, to a licensed LLRW land disposal facility, as
dened in §289.201(b) of this title;
(B) establish a manifest tracking system; and
(C) supplement existing requirements concerning
transfers and recordkeeping for those wastes.
(2) Beginning March 1, 1998, all affected licensees shall
use subsection (bb) of this section.
(3) Each shipment of LLRW intended for disposal at a li-
censed land disposal facility shall be accompanied by a shipment man-
ifest in accordance with subsection (bb)(1) of this section.
(4) Any licensee shipping LLRW intended for ultimate dis-
posal at a licensed land disposal facility shall document the information
required on the uniform manifest and transfer this recorded manifest in-
formation to the intended consignee in accordance with subsection (bb)
of this section.
(5) Each shipment manifest shall include a certication by
the waste generator as specied in subsection (bb)(10) of this section,
as appropriate.
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(6) Each person involved in the transfer for disposal and
disposal of LLRW, including the waste generator, waste collector,
waste processor, and disposal facility operator, shall comply with the
requirements specied in subsection (bb) of this section, as appropri-
ate.
(7) Any licensee shipping LLRW to a licensed Texas
LLRW disposal facility shall comply with the waste acceptance criteria
in 30 Texas Administrative Code (TAC) Part 1, Chapter 336.
(z) Fees.
(1) Each shipper shall be assessed a fee for shipments of
LLRW originating in Texas or originating out-of-state being shipped
to a licensed Texas LLRW disposal facility and these fees shall be:
(A) $10 per cubic foot of shipped LLRW;
(B) collected by the compact waste disposal facility and
remitted to the TCEQ and deposited to the credit of the radiation and
perpetual care account; and
(C) used exclusively by the agency for emergency plan-
ning for and response to transportation accidents involving LLRW.
(2) Fee assessments in accordance with this section shall be
suspended when the amount of fees collected reaches $500,000, except
that if the balance of fees collected is reduced to $350,000 or less, the
assessments shall be reinstituted to bring the balance of fees collected
to $500,000.
(3) Money expended from the radiation and perpetual care
account to respond to accidents involving LLRW shall be reimbursed
to the radiation and perpetual care account by the responsible shipper
or transporter according to rules adopted by the board.














radionuclides, which are the bases for many activity limits elsewhere
in these rules are given in Table 257-3 of paragraph (6) of this subsec-
tion. The curie (Ci) values specied are obtained by converting from
the terabecquerel (TBq) gure. The Terabecquerel values are the reg-
ulatory standard. The curie values are for information only and are not





limited, it is for radiation control purposes only. For nuclear criticality
safety, some materials are subject to controls placed on ssile material.
(2) Values of radionuclides not listed.
(A) For individual radionuclides whose identities are





values contained in Table 257-5 of paragraph (8)
of this subsection may be used. Otherwise, the licensee shall obtain




values for radionuclides not listed
in Table 257-3 of paragraph (6) of this subsection, before shipping the
material.
(B) For individual radionuclides whose identities are
known, but that are not listed in Table 257-4 of paragraph (7) of this
subsection, the exempt material activity concentration and exempt con-
signment activity values contained in Table 257-5 of paragraph (8) of
this subsection may be used. Otherwise, the licensee shall obtain prior
approval of the exempt material activity concentration and exempt con-
signment activity values, for radionuclides not listed in Table 257-3 of
paragraph (6) of this subsection, before shipping the material.
(C) The licensee shall submit requests for prior ap-
proval, described in subparagraphs (A) and (B) of this paragraph to
the agency.




for a radionuclide not in Ta-





for a radionuclide not in Table 257-3 of paragraph (6) of this
subsection, a single radioactive decay chain, in which radionuclides are
present in their naturally occurring proportions, and in which no daugh-
ter radionuclide has a half-life either longer than ten days, or longer than
that of the parent radionuclide, shall be considered as a single radionu-





to be applied shall be those corresponding to the parent radionuclide of
that chain. In the case of radioactive decay chains in which any daugh-
ter radionuclide has a half-life either longer than ten days, or greater
than that of the parent radionuclide, the parent and those daughter ra-
dionuclides shall be considered as mixtures of different radionuclides.
(4) Determination for mixtures of radionuclides whose
identities and respective activities are known. For mixtures of ra-
dionuclides whose identities and respective activities are known, the
following conditions apply.
(A) For special form radioactive material, the maxi-
mum quantity transported in a Type A package is as follows:
Figure: 25 TAC §289.257(aa)(4)(A)
(B) For normal form radioactive material, the maxi-
mum quantity transported in a Type A package is as follows:
Figure: 25 TAC §289.257(aa)(4)(B)
(C) Alternatively, an A
1
value for mixtures of special
form material may be determined as follows:
Figure: 25 TAC §289.257(aa)(4)(C)
(D) An A
2
value for mixtures of normal form material
may be determined as follows:
Figure: 25 TAC §289.257(aa)(4)(D)
(E) The exempt activity concentration for mixtures of
nuclides may be determined as follows:
Figure: 25 TAC §289.257(aa)(4)(E)
(F) The activity limit for an exempt consignment for
mixtures of radionuclides may be determined as follows:
Figure: 25 TAC §289.257(aa)(4)(F)
(5) Determination when activities of some of the radionu-
clides are not known. When the identity of each radionuclide is known,
but the individual activities of some of the radionuclides are not known,





propriate, for the radionuclides in each group may be used in applying
the formulas in paragraph (4) of this subsection. Groups may be based
on the total alpha activity and the total beta/gamma activity when these
















Figure: 25 TAC §289.257(aa)(6)
(7) Exempt material activity concentrations and exempt
consignment activity limits for radionuclides. The following Table
257-4 contains exempt material activity concentrations and exempt
consignment activity limits for radionuclides:
Figure: 25 TAC §289.257(aa)(7)




. The following Table 257-





Figure: 25 TAC §289.257(aa)(8)
(9) Activity-mass relationships for uranium. The follow-
ing Table 257-6 contains activity-mass relationships for uranium:
Figure: 25 TAC §289.257(aa)(9)
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(bb) Appendices for the requirements for transfers of LLRW
intended for disposal at licensed land disposal facilities and manifests.
(1) Manifest. A waste generator, collector, or processor
who transports, or offers for transportation, LLRW intended for ulti-
mate disposal at a licensed LLRW land disposal facility shall prepare
a manifest reecting information requested on applicable BRC Forms
540 (Uniform Low-Level Radioactive Waste Manifest (Shipping Pa-
per)) and 541 (Uniform Low-Level Radioactive Waste Manifest (Con-
tainer and Waste Description)) and, if necessary, on an applicable BRC
Form 542 (Uniform Low-Level Radioactive Waste Manifest (Manifest
Index and Regional Compact Tabulation)) or their equivalent. BRC
Forms 540 and 540A shall be completed and shall physically accom-
pany the pertinent LLRW shipment. Upon agreement between shipper
and consignee, BRC Forms 541, 541A and 541B, and 542 and 542A
may be completed, transmitted, and stored in electronic media with the
capability for producing legible, accurate, and complete records on the
respective forms. Licensees are not required by the agency to comply
with the manifesting requirements of this section when they ship:
(A) LLRW for processing and expect its return (i.e., for
storage in accordance with their license) prior to disposal at a licensed
land disposal facility;
(B) LLRW that is being returned to the licensee who is
the waste generator or generator, as dened in this section; or
(C) radioactively contaminated material to a waste pro-
cessor that becomes the processor’s residual waste.
(2) Form instructions. For guidance in completing these
forms, refer to the instructions that accompany the forms. Copies of
manifests required by this subsection may be legible carbon copies,
photocopies, or computer printouts that reproduce the data in the format
of the uniform manifest.
(3) Forms. BRC Forms 540, 540A, 541, 541A, 541B, 542
and 542A, and the accompanying instructions, in hard copy, may be
obtained from the agency.
(4) Information requirements of the DOT. This subsection
includes information requirements of the DOT, as codied in Title 49,
CFR, Part 172. Information on hazardous, medical, or other waste,
required to meet EPA regulations, as codied in Title 40, CFR, Parts
259 and 261 or elsewhere, is not addressed in this section, and shall
be provided on the required EPA forms. However, the required EPA
forms shall accompany the uniform manifest required by this section.
(5) General information. The shipper of the LLRW, shall
provide the following information on the uniform manifest:
(A) the name, facility address, and telephone number of
the licensee shipping the waste;
(B) an explicit declaration indicating whether the ship-
per is acting as a waste generator, collector, processor, or a combination
of these identiers for purposes of the manifested shipment; and
(C) the name, address, and telephone number, or the
name and EPA identication number for the carrier transporting the
waste.
(6) Shipment information. The shipper of the LLRW shall
provide the following information regarding the waste shipment on the
uniform manifest:
(A) the date of the waste shipment;
(B) the total number of packages/disposal containers;
(C) the total disposal volume and disposal weight in the
shipment;
(D) the total radionuclide activity in the shipment;
(E) the activity of each of the radionuclides hydrogren-
3, carbon-14, technetium-99, iodine-129, radium-226 contained in the
shipment; and
(F) the total masses of uranium-233, uranium-235, and
plutonium in special nuclear material, and the total mass of uranium
and thorium in source material.
(7) Disposal container and waste information. The shipper
of the LLRW shall provide the following information on the uniform
manifest regarding the waste and each disposal container of waste in
the shipment:
(A) an alphabetic or numeric identication that
uniquely identies each disposal container in the shipment;
(B) a physical description of the disposal container, in-
cluding the manufacturer and model of any high integrity container;
(C) the volume displaced by the disposal container;
(D) the gross weight of the disposal container, including
the waste;
(E) for waste consigned to a disposal facility, the max-
imum radiation level at the surface of each disposal container;
(F) a physical and chemical description of the waste;
(G) the total weight percentage of chelating agent for
any waste containing more than 0.1% chelating agent by weight, plus
the identity of the principal chelating agent;
(H) the approximate volume of waste within a con-
tainer;
(I) the sorbing or solidication media, if any, and the
identity of the solidication media vendor and brand name;
(J) the identities and activities of individual radionu-
clides contained in each container, the masses of uranium-233, ura-
nium-235, and plutonium in special nuclear material, and the masses
of uranium and thorium in source material. For discrete waste types
(i.e., activated materials, contaminated equipment, mechanical lters,
sealed source/devices, and wastes in solidication/stabilization media),
the identities and activities of individual radionuclides associated with
or contained on these waste types within a disposal container shall be
reported;
(K) the total radioactivity within each container; and
(L) for wastes consigned to a disposal facility, the
classication of the waste in accordance with §289.202(ggg)(4)(A) of
this title. Waste not meeting the structural stability requirements of
§289.202(ggg)(4)(B)(ii) of this title shall be identied.
(8) Uncontainerized waste information. The shipper of the
LLRW shall provide the following information on the uniform manifest
regarding a waste shipment delivered without a disposal container:
(A) the approximate volume and weight of the waste;
(B) a physical and chemical description of the waste;
(C) the total weight percentage of chelating agent if the
chelating agent exceeds 0.1% by weight, plus the identity of the prin-
cipal chelating agent;
(D) for waste consigned to a disposal facility, the
classication of the waste in accordance with §289.202(ggg)(4)(A) of
this title. Waste not meeting the structural stability requirements of
§289.202(ggg)(4)(B)(ii) of this title shall be identied;
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(E) the identities and activities of individual radionu-
clides contained in the waste, the masses of uranium-233, uranium-235,
and plutonium in special nuclear material, and the masses of uranium
and thorium in source material; and
(F) for wastes consigned to a disposal facility, the max-
imum radiation levels at the surface of the waste.
(9) Multi-generator disposal container information. This
paragraph applies to disposal containers enclosing mixtures of waste
originating from different generators. (Note: The origin of the LLRW
resulting from a processor’s activities may be attributable to one or
more generators (including waste generators) as dened in this sec-
tion). It also applies to mixtures of wastes shipped in an uncontainer-
ized form, for which portions of the mixture within the shipment orig-
inate from different generators.
(A) For homogeneous mixtures of waste, such as incin-
erator ash, provide the waste description applicable to the mixture and
the volume of the waste attributed to each generator.
(B) For heterogeneous mixtures of waste, such as the
combined products from a large compactor, identify each generator
contributing waste to the disposal container, and, for discrete waste
types (i.e., activated materials, contaminated equipment, mechanical
lters, sealed source/devices, and wastes in solidication/stabilization
media), the identities and activities of individual radionuclides con-
tained on these waste types within the disposal container. For each
generator, provide the following:
(i) the volume of waste within the disposal con-
tainer;
(ii) a physical and chemical description of the waste,
including the solidication agent, if any;
(iii) the total weight percentage of chelating agents
for any disposal container containing more than 0.1% chelating agent
by weight, plus the identity of the principal chelating agent;
(iv) the sorbing or solidication media, if any,
and the identity of the solidication media vendor and brand
name if the media is claimed to meet stability requirements in
§289.202(ggg)(4)(B)(ii) of this title; and
(v) radionuclide identities and activities contained in
the waste, the masses of uranium-233, uranium-235, and plutonium in
special nuclear material, and the masses of uranium and thorium in
source material if contained in the waste.
(10) Certication. An authorized representative of the
waste generator, processor, or collector shall certify by signing and
dating the shipment manifest that the transported materials are properly
classied, described, packaged, marked, and labeled and are in proper
condition for transportation according to the applicable regulations
of the DOT and the agency. A collector in signing the certication is
certifying that nothing has been done to the collected waste that would
invalidate the waste generator’s certication.
(11) Control and tracking.
(A) Any licensee who transfers LLRW to a land dis-
posal facility or a licensed waste collector shall comply with the re-
quirements in clauses (i) - (ix) of this subparagraph. Any licensee who
transfers waste to a licensed waste processor for waste treatment or
repackaging shall comply with the requirements of clauses (iv) - (ix)
of this subparagraph. A licensee shall:
(i) prepare all wastes so that the waste is classied
according to §289.202(ggg)(4)(A) of this title and meets the waste char-
acteristic requirements in §289.202(ggg)(4)(B) of this title;
(ii) label each disposal container (or transport pack-
age if potential radiation hazards preclude labeling of the individual
disposal container) of waste to identify whether it is Class A waste,
Class B waste, Class C waste, or greater than Class C waste, in accor-
dance with §289.202(ggg)(4)(A) of this title;
(iii) conduct a quality assurance program to assure
compliance with §289.202(ggg)(4)(A) and (B) of this title;
(iv) prepare the uniform manifest as required by this
subsection;
(v) forward a copy or electronically transfer the uni-
form manifest to the intended consignee so that either:
(I) receipt of the manifest precedes the LLRW
shipment; or
(II) the manifest is delivered to the consignee
with the waste at the time the waste is transferred to the consignee.
Using both subclauses (I) and (II) of this clause are also acceptable;
(vi) include the uniform manifest with the shipment
regardless of the option chosen in clause (v) of this clause;
(vii) receive acknowledgement of the receipt of the
shipment in the form of a signed copy of the uniform manifest;
(viii) retain a copy of or electronically store the uni-
form manifest and documentation of acknowledgement of receipt as
the record of transfer of radioactive material as required by §289.251
of this title, §289.252 of this title, and §289.254 of this title; and
(ix) for any shipments or any part of a shipment for
which acknowledgement of receipt has not been received within the
times set forth in this subsection, conduct an investigation in accor-
dance with subparagraph (D) of this paragraph.
(B) Any waste collector licensee who handles only
prepackaged waste shall:
(i) acknowledge receipt of the waste from the ship-
per within one week of receipt by returning a signed copy of the uni-
form manifest;
(ii) prepare a new uniform manifest to reect con-
solidated shipments that meet the requirements of this subsection. The
waste collector shall ensure that, for each container of waste in the ship-
ment, the uniform manifest identies the generator of that container of
waste;
(iii) forward a copy or electronically transfer the
uniform manifest to the intended consignee so that either:
(I) receipt of the uniform manifest precedes the
LLRW shipment; or
(II) the uniform manifest is delivered to the con-
signee with the waste at the time the waste is transferred to the con-
signee. Using both subclauses (I) and (II) of this clause are also ac-
ceptable;
(iv) include the uniform manifest with the shipment
regardless of the option chosen in clause (iii) of this subparagraph;
(v) receive acknowledgement of the receipt of the
shipment in the form of a signed copy of the uniform manifest;
(vi) retain a copy of or electronically store the uni-
form manifest and documentation of acknowledgement of receipt as
the record of transfer of radioactive material as required by §289.251
of this title, §289.252 of this title, and §289.254 of this title;
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(vii) for any shipments or any part of a shipment for
which acknowledgement of receipt has not been received within the
times set forth in accordance with this clause, conduct an investigation
in accordance with subparagraph (D) of this paragraph; and
(viii) notify the shipper and the agency when any
shipment, or part of a shipment, has not arrived within 60 days after
receipt of an advance uniform manifest, unless notied by the shipper
that the shipment has been cancelled.
(C) Any licensed waste processor who treats or repack-
ages waste shall:
(i) acknowledge receipt of the waste from the ship-
per within one week of receipt by returning a signed copy of the uni-
form manifest;
(ii) prepare a new uniform manifest that meets the
requirements of this subsection. Preparation of the new uniform mani-
fest reects that the processor is responsible for meeting these require-
ments. For each container of waste in the shipment, the manifest shall
identify the waste generators, the preprocessed waste volume, and the
other information as required in clause (i) of this subparagraph;
(iii) prepare all wastes so that the waste is classied
according to §289.202(ggg)(4)(A) of this title and meets the waste char-
acteristics requirements in §289.202(ggg)(4)(B) of this title;
(iv) label each package of waste to identify whether
it is Class A waste, Class B waste, or Class C waste, in accordance with
§289.202(ggg)(4)(A) and (C) of this title;
(v) conduct a quality assurance program to assure
compliance with §289.202(ggg)(4)(A) and (B) of this title;
(vi) forward a copy or electronically transfer the uni-
form manifest to the intended consignee so that either:
(I) receipt of the uniform manifest precedes the
LLRW shipment; or
(II) the uniform manifest is delivered to the con-
signee with the waste at the time the waste is transferred to the con-
signee. Using both subclause (I) of this clause and this subclause is
also acceptable;
(vii) include the uniform manifest with the shipment
regardless of the option chosen in clause (vi) of this subparagraph;
(viii) receive acknowledgement of the receipt of the
shipment in the form of a signed copy of the uniform manifest;
(ix) retain a copy of or electronically store the uni-
form manifest and documentation of acknowledgement of receipt as
the record of transfer of radioactive material as required by §289.251
of this title, §289.252 of this title, and §289.254 of this title;
(x) for any shipment or any part of a shipment for
which acknowledgement of receipt has not been received within the
times set forth in accordance with this clause, conduct an investigation
in accordance with clause (v) of this subparagraph; and
(xi) notify the shipper and the agency when any
shipment, or part of a shipment, has not arrived within 60 days after
receipt of an advance uniform manifest, unless notied by the shipper
that the shipment has been cancelled.
(D) Any shipment or part of a shipment for which ac-
knowledgement is not received within the times set forth in accordance
with this section shall undergo the following:
(i) be investigated by the shipper if the shipper has
not received notication or receipt within 20 days after transfer; and
(ii) be traced and reported. The investigation shall
include tracing the shipment and ling a report with the agency. Each
licensee who conducts a trace investigation shall le a written report
with the agency within two weeks of completion of the investigation.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Department of State Health Services
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 458-7111 x6972
TITLE 28. INSURANCE
PART 1. TEXAS DEPARTMENT OF
INSURANCE
CHAPTER 19. AGENTS’ LICENSING
SUBCHAPTER I. LICENSING FEES
28 TAC §19.803
(Editor’s note: The text of the following section proposed for repeal
will not be published. The section may be examined in the ofces of the
Texas Department of Insurance or in the Texas Register ofce, Room
245, James Earl Rudder Building, 1019 Brazos Street, Austin.)
The Texas Department of Insurance proposes the repeal of
§19.803, concerning license renewal fees for agents, adjusters,
and other licensees. The proposed repeal is necessary to elim-
inate existing §19.803. That section was necessary to provide
for the continuation of certain renewal fees until new fees be-
came effective on November 1, 2002. As stated in §19.803(a),
the fee structure in §19.802 applies to all licenses renewed
on or after November 1, 2002. Therefore, §19.1803 has no
further continuing application and, as such, is unnecessary and
obsolete. Simultaneously but unrelated to this proposed repeal,
the Department is also proposing amendments to §§19.801,
19.802, and 19.1002, to implement SB 1263, 80th Legislature,
Regular Session, effective September 1, 2007, relating to
regulation and licensing of certain insurance agents. Although
both proposals concern Chapter 19, Subchapter I of this title
(relating to Licensing Fees), this proposal is not affected by the
proposed amendments, which were published in the September
7, 2007, issue of the Texas Register.
Matt Ray, Deputy Commissioner, Licensing Division, has deter-
mined that during the rst ve years that the proposed repeal is
in effect, there will be no scal impact on state or local govern-
ment. There will be no measurable effect on local employment
or the local economy as a result of the proposal.
Mr. Ray has determined that for each year of the rst ve years
the proposed repeal is in effect, the anticipated public benet
will be the removal of obsolete and potentially confusing provi-
sions from the Texas Administrative Code. There is no antici-
pated economic cost to persons who are required to comply with
the proposed repeal. There is no anticipated difference in cost of
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compliance between small or micro businesses and large busi-
nesses.
The Department has determined that no private real property in-
terests are affected by this proposal and that this proposal does
not restrict or limit an owner’s right to property that would other-
wise exist in the absence of government action and, therefore,
does not constitute a taking or require a takings impact assess-
ment under the Government Code §2007.043.
To be considered, written comments on the proposal must be
submitted no later than 5:00 p.m. on October 8, 2007 to Gene
C. Jarmon, General Counsel and Chief Clerk, Mail Code 113-2A,
Texas Department of Insurance, P.O. Box 149104, Austin, Texas
78714-9104. An additional copy of the comment must be simul-
taneously submitted to Matt Ray, Deputy Commissioner, Licens-
ing Division, Mail Code 107-1A, Texas Department of Insurance,
P.O. Box 149104, Austin, Texas 78714-9104. Any request for a
public hearing should be submitted separately to the Ofce of
the Chief Clerk before the close of the public comment period.
If a hearing is held, written and oral comments presented at the
hearing will be considered.
The repeal is proposed under Insurance Code §§4001.005,
4001.006, 4003.004, and 36.001. Section 4001.005 autho-
rizes the Commissioner to adopt rules necessary to implement
Insurance Code, Title 13. Section 4001.006 authorizes the
Department to set and collect a nonrefundable license fees from
agents licensed under the Insurance Code. Section 4003.004(a)
authorizes the Department to set license renewal fees. Section
36.001 provides that the Commissioner of Insurance may adopt
any rules necessary and appropriate to implement the powers
and duties of the Texas Department of Insurance under the
Insurance Code and other laws of the state.
The following statutes are affected by the proposal: Insurance
Code §§4001.005, 4001.006, and 4003.004
§19.803. License Renewal Fees.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Texas Department of Insurance
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 463-6327
TITLE 34. PUBLIC FINANCE
PART 1. COMPTROLLER OF PUBLIC
ACCOUNTS
CHAPTER 3. TAX ADMINISTRATION
SUBCHAPTER V. FRANCHISE TAX
34 TAC §3.581
The Comptroller of Public Accounts (Comptroller) proposes new
§3.581, concerning Margin: Taxable and Nontaxable Entities.
This proposed new section implements House Bill 3, 79th Leg-
islature, Third Called Session, 2006 and House Bill 3928, 80th
Legislature, 2007, which revise the franchise tax. This new sec-
tion establishes guidelines to determine the taxability of legal en-
tities under Tax Code, Chapter 171. Subsection (a) provides that
this new section only applies to franchise tax reports due on or
after January 1, 2008. Subsection (b) denes words and terms
used in this section. Subsection (c) provides a detailed list of
entities that are taxable. Subsection (d) provides a detailed list
of entities that are not taxable. Subsection (e) claries the taxa-
bility of a single member limited liability company.
John Heleman, Chief Revenue Estimator, has determined that,
for the rst ve-year period the proposed new rule will be in ef-
fect, there will be no signicant revenue impact on the state or
units of local government.
Mr. Heleman also has determined that, for each year of the rst
ve years the proposed new rule is in effect, the public benet
anticipated as a result of enforcing the rule will be in providing
guidance to businesses operating in Texas regarding their taxa-
bility status under Tax Code, Chapter 171. This new rule is pro-
posed under Tax Code, Title 2, and does not require a statement
of scal implications for small businesses. There is no signi-
cant anticipated economic cost to individuals who are required
to comply with the proposed new rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This new section is proposed under Tax Code, §111.002 and
§111.022, which provides the Comptroller with the authority to
prescribe, adopt, and enforce rules relating to the administration
and enforcement of the provisions of Tax Code, Title 2.
The proposed new section implements Tax Code, §171.0002.
§3.581. Margin: Taxable and Nontaxable Entities.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Banking corporation--Each state, national, domestic, or
foreign bank, whether organized under the laws of this state, another
state, or another country, or under federal law, including a limited bank-
ing association organized under Finance Code, Title 3, Subtitle A, and
each bank organized under §25(a), Federal Reserve Act (12 U.S.C.
§§611 - 631) (edge corporations), but does not include a bank hold-
ing company as that term is dened by Bank Holding Company Act of
1956, §2, (12 U.S.C. §1841).
(2) Business trust--An entity as dened by Internal Rev-
enue Code, Treasury Regulation, §301.7701-4(b).
(3) Corporation--An entity formed pursuant to Business
Corporation Act, Non-Prot Corporation Act, Professional Corpo-
ration Act, or Business Organizations Code, Title 2 or 7, or other
equivalent statute of this state or of another jurisdiction.
(4) Escrow--A legal arrangement whereby an asset is de-
livered to a third party to be held in trust or otherwise pending a con-
tingency or the fulllment of a condition or conditions in a contract.
(5) Estate of a natural person--An entity as dened by In-
ternal Revenue Code, §7701(a)(30)(D), excluding an estate taxable as
a business entity pursuant to Internal Revenue Code, Treasury Regula-
tion, §301.7701-4(b).
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(6) General partnership--A partnership as described in Re-
vised Partnership Act, Article 6132b-1.01 et. seq., or Business Organi-
zations Code, Title 4, Chapter 152, or an equivalent statute in another
jurisdiction.
(7) Grantor trust--A trust as dened by Internal Revenue
Code, §671 and §7701(a)(30)(E), excluding a trust taxable as a business
entity pursuant to Treasury Regulation, §301.7701-4(b).
(8) Holding company--An entity that connes its activities
to owning stock in, and supervising management of, other companies.
(9) Joint stock company--A common-law unincorporated
business enterprise of natural persons possessing common capital with
ownership interests represented by shares of stock.
(10) Joint Venture--A partnership engaged in the joint pros-
ecution of a particular transaction for mutual prot.
(11) Limited liability company--An entity formed pursuant
to Limited Liability Company Act, Article 1528n, or Business Organi-
zations Code, Title 3 or 7, or an equivalent statute in another jurisdic-
tion.
(12) Limited liability partnership--A partnership registered
pursuant to Revised Partnership Act, Article 6132b-3.08, or Business
Organizations Code, Title 4, Chapters 152 and 153, Subchapter H, or
an equivalent statute in another jurisdiction.
(13) Limited partnership--A partnership formed pursuant
to Revised Partnership Act, Article 6132a-1 or Business Organizations
Code, Title 4, Chapter 153, or an equivalent statute in another jurisdic-
tion.
(14) Natural person--A human being or the estate of a hu-
man being. The term does not include a purely legal entity given recog-
nition as the possessor of rights, privileges, and responsibilities, such
as a corporation, limited liability company, partnership, or trust.
(15) Partnership--A relationship referred to in Business
Organizations Code, §152.051, and Revised Partnership Act, Article
6132b-2.02.
(16) Passive entity--A general or limited partnership or
trust other than a business trust that meets the qualications in Tax
Code, §171.0003. See also §3.582 of this title (relating to Margin:
Passive Entities).
(17) Professional association--An entity organized under
Professional Association Act, Article 1528e, or Business Organizations
Code, Title 7, Chapter 302, or an equivalent statute in another jurisdic-
tion.
(18) Qualied REIT subsidiary--An entity as dened by In-
ternal Revenue Code, §856(i)(2).
(19) Real Estate Investment Trust or REIT--An entity as
dened by Internal Revenue Code, §856.
(20) Real Estate Mortgage Investment Conduit or REMIC-
-An entity as dened by Internal Revenue Code, §860D.
(21) Savings and loan association--A savings and loan as-
sociation or savings bank, whether organized under the laws of this
state, another state, or another country, or under federal law.
(22) Self-insurance trust--A trust created and operated ac-
cording to the provisions of Insurance Code, Chapter 2212, or a prede-
cessor statute.
(23) Sole proprietorship--A natural person carrying on
business, if the business is not formed in a manner that limits the
liability of the owner. It does not include single member limited
liability companies or other entities treated as sole proprietorships for
federal tax purposes.
(c) Taxable entities include:
(1) partnerships, both general and limited, unless excluded
in subsection (d)(2) of this section;
(2) limited liability partnerships;
(3) corporations;
(4) banking corporations;
(5) savings and loan associations;




(10) joint ventures, except joint operating or co-ownership
arrangements meeting the requirements of Treasury Regulation 1.761-
2(a)(3) that elect out of federal partnership treatment as provided by
Internal Revenue Code, §761(a);
(11) joint stock companies;
(12) holding companies;
(13) combined groups (also see §3.590 of this title (relating
to Margin: Combined Reporting)); and
(14) other legal entities.
(d) Nontaxable entities. The following entities are specically
excluded from the denition of taxable entities for purposes of impo-
sition of the franchise tax:
(1) sole proprietorships (does not include single member
limited liability companies);
(2) general partnerships where direct ownership is com-
posed entirely of natural persons, and the liability of those persons is
not limited (e.g. by registration as a limited liability partnership) under
a statute of this state or another state;
(3) passive entities, as determined on a year to year basis
(also see §3.582 of this title);
(4) entities exempt under Chapter 171, Subchapter B;
(5) grantor trusts, all of the grantors and beneciaries of
which are natural persons or charitable entities as described in Internal
Revenue Code, §501(c)(3);
(6) estates of a natural person;
(7) escrows;
(8) REITs or qualied REIT subsidiaries provided that:
(A) the REIT holds interests in limited partnerships or
other entities that are taxable entities and directly hold real estate; and
(B) the REIT does not directly hold real estate, other
than real estate it occupies for business purposes; or
(9) REMICs;
(10) nonprot self-insurance trusts;
(11) trusts qualied under Internal Revenue Code, §401(a);
or
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(12) trusts or other entities that are exempt under Internal
Revenue Code, §501(c)(9).
(e) Single member limited liability company. An entity treated
as a sole proprietorship for federal tax purposes is not a sole proprietor-
ship for the purposes of this rule if it is formed in a manner that limits
the liability of its owners or members.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.582
The Comptroller of Public Accounts proposes new §3.582,
concerning margin: passive entities. This section implements
House Bill 3, 79th Legislature, Third Called Session 2006 and
House Bill 3928, 80th Legislature, 2007, which revise the fran-
chise tax. This section establishes guidelines to determine the
qualication of an entity as passive under Tax Code, Chapter
171. Subsection (a) provides that this section only applies to
franchise tax reports originally due on or after January 1, 2008.
Subsection (b) denes words and terms used in the section.
Subsection (c) lists the types of entities that may qualify as
passive entities and the types of income that qualify as passive
income. Subsection (d) lists certain income that is not con-
sidered passive. Subsection (e) provides that a passive entity
may not receive more than 10% of its federal gross income
from conducting an active trade or business. Subsection (f)
lists activities that do not constitute an active trade or business.
Subsection (g) establishes the reporting requirements for a
passive entity.
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as a
result of enforcing the rule will be in providing guidance to enti-
ties that potentially qualify as passive entities under Tax Code,
Chapter 171. This rule is adopted under Tax Code, Title 2, and
does not require a statement of scal implications for small busi-
nesses. There is no signicant anticipated economic cost to in-
dividuals who are required to comply with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This new section is proposed under Tax Code, §111.002 and
§111.022, which provides the comptroller with the authority to
prescribe, adopt and enforce rules relating to the administration
and enforcement of the provisions of Tax Code, Title 2.
This new section implements Tax Code, §171.0003.
§3.582. Margin: Passive Entities.
(a) Effective Date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise:
(1) Active trade or business--For the purposes of this sec-
tion only:
(A) an entity conducts an active trade or business if the
activities include active operations that form a part of the process of
earning income or prot, and the entity performs active management
and operational functions;
(B) activities performed by the entity include activities
performed by persons outside the entity, including independent con-
tractors, to the extent that the persons perform services on behalf of the
entity and those services constitute all or part of the entity’s trade or
business; or
(C) an entity conducts an active trade or business if as-
sets, including royalties, patents, trademarks, and other intangible as-
sets, held by the entity are used in the active trade or business of one
or more related entities.
(2) Business trust--An entity as dened by Internal Rev-
enue Code, Treasury Regulation, §301.7701-4(b).
(3) Federal gross income--Gross income as dened in In-
ternal Revenue Code, §61(a).
(4) General partnership--A partnership as described in Re-
vised Partnership Act, Article 6132b-1.01 et. seq., or Business Organi-
zations Code, Title 4, Chapter 152, or an equivalent statute in another
jurisdiction.
(5) Limited partnership--A partnership formed pursuant to
Revised Partnership Act, Article 6132a-1, or Business Organizations
Code, Title 4, Chapter 153, or an equivalent statute in another jurisdic-
tion.
(6) Net capital gains--Net capital gains as dened under the
Internal Revenue Code.
(7) Net gains--Net gains as dened under the Internal Rev-
enue Code.
(8) Non-controlling interest--For the purposes of this sec-
tion only, a less than 50% interest that is held by an investor, either
directly or indirectly, in an investee.
(9) Security--
(A) an instrument dened by Internal Revenue Code,
§475(c)(2), where the holder of the instrument has a non-controlling
interest in the issuer/investee;
(B) an instrument described by Internal Revenue Code,
§475(e)(2)(B), (C), (D);
(C) an interest in a partnership where the investor has a
non-controlling interest in the investee;
(D) an interest in a limited liability company where the
investor has a non-controlling interest in the investee; or
(E) a benecial interest in a trust where the investor has
a non-controlling interest in the investee.
(c) Qualication as a passive entity:
(1) to qualify as a passive entity, the entity must be one of
the following:
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(A) general partnership;
(B) limited partnership; or
(C) trust, other than a business trust; and
(2) at least 90% of an entity’s federal gross income must
consist of the following sources of income:
(A) dividends, interest, foreign currency exchange gain,
periodic and nonperiodic payments with respect to notional principal
contracts, option premiums, cash settlements or termination payments
with respect to a nancial instrument, and income from a limited lia-
bility company;
(B) distributive shares of partnership income to the ex-
tent that those distributive shares of income are greater than zero;
(C) net capital gains from the sale of real property, net
gains from the sale of commodities traded on a commodities exchange,
and net gains from the sale of securities; and
(D) royalties from mineral properties, bonuses from
mineral properties, delay rental income from mineral properties and
income from other nonoperating mineral interests.
(d) The income described by subsection (c)(2) of this section,
does not include:
(1) rent; or
(2) income received by a nonoperator from mineral prop-
erties under a joint operating agreement if the nonoperator is a member
of an afliated group and another member of that group is the operator
under the same joint operating agreement.
(e) Conducting an active trade or business. To be considered
a passive entity, an entity may not receive more than 10% of its federal
gross income from conducting an active trade or business. Income
described by subsection (c)(2) of this section, may not be treated as
income from conducting an active trade or business.
(f) Activities that do not constitute an active trade or business:
(1) ownership of a royalty interest or a nonoperating work-
ing interest in mineral rights;
(2) payment of compensation to employees or independent
contractors for nancial or legal services reasonably necessary for the
operation of the entity; and
(3) holding a seat on the board of directors of an entity does
not, by itself, constitute conduct of an active trade or business.
(g) Reporting requirement for a passive entity. If an entity
meets all of the qualications of a passive entity for the reporting pe-
riod, the entity will owe no tax; however, the entity must le informa-
tion to verify that the passive entity qualications are met each year.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.583
The Comptroller of Public Accounts proposes new §3.583, con-
cerning margin: exemptions. This section implements House
Bill 3, 79th Legislature, Third Called Session 2006 and House Bill
3928, 80th Legislature, 2007, adding Tax Code, §171.088, which
extends to entities other than corporations certain specic ex-
emptions from franchise tax available to corporations, provided
the entity qualies for the exemption in the same manner and
under the same conditions as a corporation. Subsection (a) pro-
vides that this section only applies to franchise tax reports due
on or after January 1, 2008. Subsection (b) explains how to ap-
ply for a franchise tax exemption and identies the information
that must accompany the application. Subsection (c) describes
the possible actions that the comptroller will take after consider-
ing the application. Subsection (d) describes the qualications
necessary to qualify for exemption as: an entity subject to insur-
ance premiums taxes, an entity promoting the public interest, a
religious organization, a charitable organization, an educational
organization and a homeowners’ association. Subsection (e) ad-
dresses the effects of a revocation, withdrawal or loss of an ex-
emption and the notication responsibilities of the affected en-
tity. Subsection (f) provides that an entity that is exempt from
federal income tax under one of certain specied paragraphs
of Internal Revenue Code, §501(c) establishes its exempt sta-
tus by providing a copy of a current exemption letter from the
Internal Revenue Service to the comptroller. Subsection (g) de-
scribes the essential attributes of a solar energy device to qualify
for exemption under Tax Code, §171.056. Subsection (h) pro-
vides that an entity engaged solely in the business of recycling
sludge, as dened in the Health & Safety Code, is exempt from
franchise tax. Subsection (i) identies certain entities that may
apply for a provisional or temporary exemption and describes the
information that must accompany the application. Subsection (j)
addresses the requirements necessary for an entity to qualify for
the trade show exemption and provides for notication require-
ments in certain circumstances. Subsection (k) provides that an
entity organized under 12 U.S.C., §2071, or an agricultural credit
association regulated by the Farm Credit Administration is ex-
empt from franchise tax.
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as a
result of enforcing the rule will be in providing guidance to enti-
ties that are potentially exempt from the tax imposed under Tax
Code, Chapter 171. This rule is adopted under Tax Code, Title 2,
and does not require a statement of scal implications for small
businesses. There is no signicant anticipated economic cost to
individuals who are required to comply with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
The new section is proposed under Tax Code, §111.002 and
§111.022, which provides the comptroller with the authority to
prescribe, adopt and enforce rules relating to the administration
and enforcement of the provisions of Tax Code, Title 2.
The new section implements Tax Code, §171.0002 and
§171.088.
§3.583. Margin: Exemptions.
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(a) Effective date. This section applies to franchise tax reports
originally due on or after January 1, 2008.
(b) Application for exemption. An entity must apply for an
exemption from franchise tax. An entity that is not a corporation, but
whose activities would qualify it for a specic exemption under Tax
Code, Chapter 171, Subchapter B, if it were a corporation, may qualify
for the exemption from the tax in the same manner and under the same
conditions as a corporation. See Tax Code, §171.088. For provisional
exemptions for certain entities, see subsection (i) of this section; for
trade show exemptions, see subsection (j) of this section.
(1) An entity that believes it is exempt from payment of
franchise tax must furnish to the comptroller sufcient evidence to es-
tablish its exempt status. The entity claiming the exemption bears the
burden to establish its entitlement to exempt status and any doubts will
result in a denial of the application for exemption.
(2) Except as otherwise provided in subsections (e), (i), and
(j) of this section, each entity must submit to the comptroller:
(A) a request for exemption in writing, which may re-
quire using forms developed by the comptroller for requesting exemp-
tions, indicating the particular provision of Tax Code, Chapter 171, un-
der which exemption is claimed;
(B) a detailed statement of the entity’s past and current
activities, if any, and its future plan of activities, both in relation to the
manner in which the entity proposes to implement the purposes clause
in its certicate of formation or application for registration;
(C) if the entity is a non-Texas entity, a le-stamped
copy of the entity’s formation document or its governing documents,
and a current Certicate of Existence or other similar document from
the Secretary of State or other authorized ofcer of the entity’s home
jurisdiction; and
(D) any additional information the comptroller may re-
quire to make a determination whether the entity is eligible for a fran-
chise tax exemption.
(c) Actions by comptroller. Upon receipt of an application for
exemption, the comptroller’s representative will review the application
and send the applicant a notication either granting the exemption or
denying the exemption, or requesting additional information.
(1) If the exemption is granted, the exemption will be ef-
fective from the rst date the entity was eligible for exemption. If the
entity paid any franchise taxes prior to the comptroller’s notication
granting the exemption for a privilege period after the effective date of
the exemption, the entity may request a refund, subject to the applicable
statute of limitations. If the effective date of the exemption occurs af-
ter the beginning of a privilege period, the entity must pay through the
end of such privilege period. An entity that has been subject to the tax
and becomes eligible for exemption is liable for Tax Code, §171.0011,
additional tax.
(2) If the exemption is denied or revoked, the entity may
contest the denial or revocation by ling all reports due as required by
the comptroller; and
(A) paying all amounts of tax, penalty, and interest due
and requesting a refund hearing pursuant to the provisions of Tax Code,
Chapter 111;
(B) paying all amounts of tax, penalty, and interest due,
accompanying the payment with a written protest, and ling suit for
the recovery of amounts paid pursuant to the provisions of Tax Code,
Chapter 112; or
(C) requesting a redetermination hearing pursuant to
Tax Code, §111.009, if the comptroller issues a deciency determina-
tion.
(d) Qualication for exemption.
(1) Entities subject to insurance premium taxes. All insur-
ance, surety, guaranty, delity and title insurance companies, title in-
surance agents, and other insurance organizations that are subject to
the annual gross premiums tax levied by Insurance Code, Chapters
221 - 224, are exempt from payment of the franchise tax, regardless of
whether any gross premiums taxes are actually paid in any given year.
A non-admitted insurance company or organization that is required to
pay a gross premium receipts tax during a tax year is exempted from
the franchise tax for the same tax year. The exemption in this paragraph
covers the periods upon which the franchise tax is based, provided the
gross premium receipts tax is required to be paid on premiums received
or written, as applicable, during the same period. For example, an in-
surance organization’s gross premium receipts tax is due and payable
on March 1, 2009, for premiums received during calendar year 2008.
The entity would be exempt from franchise tax for the 2009 annual re-
port covering the January 1, 2009 - December 31, 2009, privilege pe-
riod, for margin attributable to calendar year 2008. An entity is subject
to the franchise tax, however, for a tax year in any portion of which it
is in violation of an order issued by the Texas Department of Insurance
under Insurance Code, §2254.003(b) that is nal after appeal or that is
no longer subject to appeal.
(2) Those entities organized for the exclusive purpose of
promoting the public interest of any county, city, town, or other area
within the state, must show that promotion of the public interest is the
exclusive purpose of the entity and not merely an incidental result. An
entity will not be considered to be promoting the public interest if it
engages in activities to promote or protect the private, business, or pro-
fessional interests of its members or patronage.
(3) A nonprot entity seeking franchise tax exemption as a
religious organization must be an organized group of people regularly
meeting for the primary purpose of holding, conducting, and sponsor-
ing religious worship services according to the rites of their sect. The
entity must be able to provide evidence of an established congregation
showing that there is an organized group of people regularly attending
these services. An entity that supports and encourages religion as an
incidental part of its overall purpose, or one whose general purpose is
furthering religious work or instilling its membership with a religious
understanding, will not qualify for exemption under this provision. No
part of the net earnings of the organization may inure to the benet of
any private party or individual other than as reasonable compensation
for services rendered to the organization. Some examples of entities
that do not meet the requirements for exemption under this denition
are conventions or associations of churches, evangelistic associations,
churches with membership consisting of family members only, mis-
sionary organizations, and groups that meet for the purpose of holding
prayer meetings, Bible study or revivals. Although these organizations
do not qualify for exemption under this category of exemption as re-
ligious organizations, they may qualify for the exemption under Tax
Code, §171.063, if they obtain an exemption from the Internal Rev-
enue Service (IRS) under Internal Revenue Code, §501(c).
(4) A nonprot entity seeking a franchise tax exemption as
organized for purely public charity must devote all or substantially all
of its activities to the alleviation of poverty, disease, pain, and suffering
by providing food, clothing, drugs, treatment, shelter, or psychological
counseling directly to indigent or similarly deserving members of so-
ciety with its funds derived primarily from sources other than fees or
charges for its services. If an entity engages in any substantial activ-
ity other than the activities that are described in this paragraph, it will
PROPOSED RULES September 14, 2007 32 TexReg 6275
not be considered as having been organized for purely public charity,
and therefore, will not qualify for exemption under this provision. No
part of the net earnings of the organization may inure to the benet of
any private party or individual other than as reasonable compensation
for services rendered to the organization. Some examples of organiza-
tions that do not meet the requirements for exemption under this deni-
tion are fraternal organizations, lodges, fraternities, sororities, service
clubs, veterans groups, mutual benet or social groups, professional
groups, trade or business groups, trade associations, medical associa-
tions, chambers of commerce, and similar organizations. Even though
not organized for prot and performing services that are often charita-
ble in nature, these types of organizations do not meet the requirements
for exemption under this provision. Although these organizations do
not qualify for exemption under this category of exemption as charita-
ble organizations, they may qualify for the exemption under Tax Code,
§171.063, if they obtain an exemption from the IRS under Internal Rev-
enue Code, §501(c).
(5) A nonprot entity seeking a franchise tax exemption as
an educational organization must show that its activities are devoted
solely to systematic instruction, particularly in the commonly accepted
arts, sciences, and vocations, and has a regularly scheduled curriculum,
using the commonly accepted methods of teaching, a faculty of quali-
ed instructors, and an enrolled student body or students in attendance
at a place where the educational activities are regularly conducted. An
entity that has activities consisting solely of presenting public discus-
sion groups, forums, panels, lectures, or other similar programs, may
qualify for exemption under this provision, if the presentations provide
instruction in the commonly accepted arts, sciences, and vocations.
The entity will not be considered for exemption under this provision if
the systematic instruction or educational classes are incidental to some
other facet of the organization’s activities. No part of the net earnings
of the organization may inure to the benet of any private party or indi-
vidual other than as reasonable compensation for services rendered to
the organization. Some examples of organizations that do not meet the
requirements for exemption under this denition are professional asso-
ciations, business leagues, information resource groups, research orga-
nizations, support groups, home schools, and organizations that merely
disseminate information by distributing printed publications. Although
these organizations do not qualify for exemption under this category of
exemption as educational organizations, they may qualify for the ex-
emption under Tax Code, §171.063, if they obtain an exemption from
the IRS under Internal Revenue Code, §501(c).
(6) A nonprot entity requesting franchise tax exemption
as a homeowners’ association must prove that it meets all requirements
to qualify for the exemption. The entity must show that it is organized
and operated to obtain, manage, construct, and maintain the property
in or of a residential condominium or residential real estate develop-
ment. The entity also must prove that the condominium project, or, for
a real estate development, the related property, is legally restricted for
use as residences. Furthermore, the entity must establish that the col-
lective resident owners of individual lots, residences or units control at
least 51% of the votes of the entity and that voting control, however
acquired, is not held by: a single individual or family; one or more
developers, declarants, banks, investors, or other similar parties. For
example, an association is formed for a residential condominium con-
sisting of 12 units with each unit being entitled to one vote. Each of ve
individuals separately owns and occupies one unit, a total of ve units.
A sixth individual owns two units, living in one unit and leasing the
other. A seventh individual owns and leases the remaining ve units.
None of the owners are related. In determining whether the collective
resident owners control at least 51% of the votes of the organization,
the sixth owner is a resident owner regarding the one unit in which the
owner lives and an investor regarding the other. The collective resi-
dent owners, therefore, have a total of six votes. Consequently, since
the collective resident owners only have 50% of the votes of the entity,
the association does not meet the requirement that the resident owners
must control at least 51% of the votes of the organization. Accordingly,
the entity does not qualify for the franchise tax exemption as a home-
owners’ association.
(e) Revocation, withdrawal, or loss of exemptions.
(1) An entity that no longer qualies for the franchise tax
exemption is required to notify the comptroller in writing of its change
in status. Except as provided in paragraph (2) of this subsection, if
at any time the comptroller has reason to believe that an exempt en-
tity no longer qualies for exemption, the comptroller’s representative
will notify the entity that its exempt status is under review. The comp-
troller’s representative may request additional information necessary
to ascertain the continued validity of the entity’s exempt status. If the
comptroller determines that an entity is no longer entitled to its exemp-
tion, notication to that effect will be sent to the entity. The effective
date of revocation is the date the entity no longer qualied for the ex-
emption. The day immediately following the date of withdrawal, loss,
or revocation shall be the beginning date for determining the entity’s
privilege period and for all other purposes related to franchise tax.
(2) For nonprot entities granted an exemption under Tax
Code, §171.063, the revocation, withdrawal, or loss of the federal in-
come tax exemption automatically terminates the franchise tax exemp-
tion. A nonprot entity that no longer qualies for the federal income
tax exemption which was the basis for obtaining the franchise tax ex-
emption must notify the comptroller in writing within 30 days of its
change in status and must provide a copy of the notice of such revo-
cation, withdrawal, or loss. The effective date of withdrawal or loss
is the date of withdrawal or loss of the federal tax exemption. The ef-
fective date of a revocation is the date the IRS serves written notice of
the revocation to the non-prot entity or the date the IRS serves written
notice of revocation to the comptroller, whichever is earlier. The day
immediately following the date of withdrawal, loss, or revocation shall
be the entity’s beginning date for determining its privilege periods and
for all other purposes of the franchise tax.
(3) An electric cooperative entity previously exempted
from franchise tax under Tax Code, §171.079, that subsequently
participates in a joint powers agency thereby loses its franchise tax
exemption. The commencing date of participation in the joint powers
agency shall be considered the entity’s beginning date for purposes of
determining the entity’s privilege periods and for all other purposes of
the franchise tax. The electric cooperative must notify the comptroller
in writing that it is a participant in a joint powers agency within 30
days after the commencing date of its participation.
(f) Federal exemption. A nonprot organization that has been
exempted from the federal income tax under the provisions of Internal
Revenue Code, §501(c)(2), (3), (4), (5), (6), (7), (8), (9), (10), (16), (19)
or (25), establishes its exempt status by furnishing to the comptroller a
copy of a current exemption letter from the IRS.
(g) Solar energy device. For purposes of Tax Code, §171.056,
the term "solar energy device" includes, but is not limited to:
(1) devices used in the conversion of solar thermal energy
into electrical or mechanical power;
(2) devices used in the photovoltaic (solar cell) generation
of electricity;
(3) systems used in the heating of water and the heating
and cooling of structures by use of solar collectors to gather the sun’s
energy; and
32 TexReg 6276 September 14, 2007 Texas Register
(4) heat pumps used as an integral part of a system designed
to make the best combined use of solar energy and conventional heat-
ing.
(h) Exemption for recycling operation. An entity engaged
solely in the business of recycling sludge as dened by Health and
Safety Code, Chapter 361, Solid Waste Disposal Act, §361.003, is
exempt from franchise tax.
(i) Provisional exemptions.
(1) If established with the comptroller, the following enti-
ties may be granted a temporary exemption from franchise tax:
(A) a nonprot entity that has applied for exemption
from federal income tax under Internal Revenue Code, §501(c)(3), (4),
(5), (6), (7), (8), (9), (10), (16), or (19); and
(B) an entity that has applied for exemption from fed-
eral income tax under Internal Revenue Code, §501(c)(2) or (25), if
the entity or entities for which it holds title to property is either exempt
from or not subject to the franchise tax.
(2) To obtain a temporary franchise tax exemption with the
comptroller, an entity that has applied for but has not yet received a
letter of exemption from the IRS must timely le with the comptroller:
(A) a copy of the application for recognition of exemp-
tion that has been led with the IRS; and
(B) a copy of:
(i) a written notice from the IRS stating that the ap-
plication for recognition of exemption has been received; or
(ii) a receipt as proof that the application has been
sent to the IRS by means of the United States Postal Service, other
carrier, or hand delivery to the IRS.
(3) Paragraphs (2)(A) and (2)(B)(ii) of this subsection, ap-
ply only if the organization has led its application for recognition of
exemption during the 14th or 15th month after its beginning date. Be-
ginning date means:
(A) for an entity organized under the laws of this state,
the date on which the entity’s certicate of formation or other similar
document takes effect; and
(B) for a foreign entity, the date on which the entity be-
gins doing business in this state.
(4) If the information required in paragraphs (2)(A) and
(2)(B)(i) of this subsection is provided in a timely manner, a 90-day
provisional franchise tax exemption will be granted.
(5) An entity qualifying under paragraphs (2)(A) and
(2)(B)(ii) of this subsection, will be granted a 90-day provisional
exemption with the condition that a copy of the notice required in
paragraph (2)(B)(i) of this subsection be provided to the comptroller
within 30 days from the date of the letter notifying the entity of the
provisional exemption. If the IRS notication is not provided within
the 30-day period, the provisional exemption will be canceled. An
entity whose provisional exemption is canceled will be subject to all
tax, penalty, and interest that has accrued since the entity’s beginning
date.
(6) The information necessary for obtaining a temporary
franchise tax exemption will be considered to be provided to the comp-
troller in a timely manner if:
(A) the application for recognition of exemption is pro-
vided to the IRS within their timely ling guidelines; and
(B) the information required in paragraphs (2)(A) and
(2)(B)(i) or (2)(B)(ii) of this subsection, is postmarked within 15
months after the day that is the last day of a calendar month and that
is nearest to the entity’s beginning date.
(7) Before the expiration of the 90-day provisional exemp-
tion, the entity must provide the comptroller a copy of the letter from
the IRS showing that the decision on the federal exemption is still pend-
ing or stating that the federal exemption is either granted or denied.
(8) If the comptroller is notied as required in paragraph
(7) of this subsection, that the decision on the federal exemption is still
pending, an extension of the provisional exemption may be considered.
(9) If the information in paragraph (7) of this subsection, is
not provided as required, the provisional exemption may be canceled.
If the provisional exemption is canceled, the entity will be responsible
for all franchise tax reports and payments that have become due since
its beginning date, and penalty and interest will be based on the original
due date of each report.
(10) An entity that provides the comptroller a copy of the
letter from the IRS stating that the federal exemption has been granted
will be considered for franchise tax exemption under subsection (e) of
this section.
(11) If the federal exemption is denied by the IRS, the en-
tity is responsible for all franchise tax reports and payments that have
become due since its beginning date and interest will be based on the
original due date of each report. Late ling and payment penalties will
be waived for any reports and payments postmarked within 90 days af-
ter the date of the nal denial of the federal exemption. The penalty
waiver process will begin when the entity submits a written request for
penalty waiver and a copy of the letter denying the federal exemption
when ling reports and payment.
(j) Trade show exemption. See Tax Code, §171.084, for the
requirements for exemption for certain foreign entities that participate
in trade shows in Texas.
(1) Notication to comptroller. Entities need not apply for
an exemption under Tax Code, §171.084.
(A) If a foreign entity has obtained a registration or has
already notied the comptroller that it is doing business in Texas, the
entity must notify the comptroller in writing by the due date of the rst
report for which the entity is exempt that the report and payment are
not due because the entity is exempt under Tax Code, §171.084. After
such notication, the entity must notify the comptroller in writing only
when the organization no longer qualies for exemption.
(B) If a foreign entity has not obtained a registration or
otherwise qualied to do business in the state, if applicable, and if the
entity has not notied the comptroller that it is doing business in Texas,
the entity must notify the comptroller in writing only when the entity
no longer qualies for exemption under Tax Code, §171.084. There is
no need to apply for exemption as long as the entity qualies for the
exemption.
(2) Solicitation periods. If the solicitation of orders is con-
ducted during more than ve periods during the business period upon
which tax is based as set out in Tax Code, §171.1532, the entity does
not qualify for exemption.
(A) An entity with its scal year ending December 31,
2008, that led a 2008 annual report, will not have to le and pay a
2009 annual report if it did not solicit orders for more than ve periods
during 2008.
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(B) Assume a foreign entity participated in its rst trade
show in Texas on April 1, 2008. It also participated in trade shows in
2009 on January 1, March 1, May 1, June 1, August 1, and October 1.
The entity’s scal year ends are December 31, 2008, and 2009. The
entity would be exempt for its initial report and payment (covering the
privilege periods from April 1, 2008 - December 31, 2009) because it
only solicited for one period from April 1, 2008 - December 31, 2008
(i.e., the business upon which the initial report is based). The entity
would be required to le a 2010 annual report and pay tax, however,
because it solicited for six periods from January 1, 2009 - December
31, 2009 (i.e., the period upon which the 2010 annual report is based).
(3) One hundred twenty hours. A solicitation period may
not exceed 120 consecutive hours. If the solicitation of orders is con-
ducted during a single period of more than 120 consecutive hours, the
entity does not qualify for exemption. For example, an entity that meets
the other requirements of Tax Code, §171.084, will meet the 120 hours
requirement if the solicitation occurs Monday - Friday, but will not
meet the 120 hours requirement if the solicitation occurs Monday -
Saturday. If none of the solicitation limits prescribed in this subsec-
tion are exceeded, an entity may qualify for the exemption even if it
leases space at a wholesale center for the entire period upon which the
tax is based.
(k) An entity organized under 12 U.S.C. §2071, or an agricul-
tural credit association regulated by the Farm Credit Administration is
exempt from franchise tax.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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34 TAC §3.584
The Comptroller of Public Accounts proposes new §3.584, con-
cerning margin: reports and payments. This section implements
House Bill 3, 79th Legislature, Third Called Special Session,
2006 and House Bill 3928, 80th Legislature, 2007, which revise
the franchise tax. This section establishes guidelines for the l-
ing of reports and payments under Tax Code, Chapter 171. Sub-
section (a) provides that this section only applies to franchise tax
reports originally due on or after January 1, 2008. Subsection (b)
details the ling requirements for nontaxable entities. Subsec-
tion (c) details the types of franchise tax reports due, due dates
and the accounting period to be used on the reports. Subsec-
tion (d) details the calculation of margin and the criteria for use
of the 0.5% tax rate. This subsection also provides qualications
for the no tax due threshold, the discount and the E-Z Compu-
tation. Subsection (e) relates to the calculation of penalty and
interest on delinquent taxes. Subsection (f) provides details on
ling amended reports. Subsection (g) relates to the examina-
tion of an entity’s records during a comptroller audit. Subsection
(h) relates to the payment of an estimated liability. Subsection
(i) provides requirements on ling a public information report or
an ownership information report.
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as a
result of enforcing the rule will be in providing guidance to entities
that are required to le reports and remit payments under Tax
Code, Chapter 171. This rule is adopted under Tax Code, Title 2,
and does not require a statement of scal implications for small
businesses. There is no signicant anticipated economic cost to
individuals who are required to comply with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
The new section is proposed under Tax Code, §111.002, which
provides the comptroller with the authority to prescribe, adopt,
and enforce rules relating to the administration and enforcement
of the provisions of Tax Code, Title 2.
The new section implements Tax Code, §§171.002, 171.0021,
171.101, 171.1016, 171.151, 171.152, 171.1532, 171.154,
171.201, 171.202, 171.203, and 171.212.
§3.584. Margin: Reports and Payments.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Nontaxable entities. See §3.581 of this title (relating to
Margin: Taxable and Nontaxable Entities) for information concerning
nontaxable entities. Notication to comptroller, except for passive en-
tities, see §3.582 (relating to Margin: Passive Entities):
(1) If a taxable entity has notied the comptroller that it
is doing business in Texas, the entity must notify the comptroller in
writing by the due date of the rst report for which the entity qualies
as a nontaxable entity that the report and payment are not due because
the entity qualies as a nontaxable entity. After such notication, the
entity must notify the comptroller in writing only when the entity no
longer qualies as a nontaxable entity.
(2) If a nontaxable entity has not notied the comptroller
that it is doing business in Texas, the nontaxable entity must notify the
comptroller in writing only when the entity no longer qualies as a
nontaxable entity.
(c) Reports and due dates.
(1) Each taxable entity subject to the franchise tax levied
by Tax Code, §171.001, must le an initial franchise tax report, and
thereafter an annual franchise tax report, and at the same time must
pay the franchise tax and any applicable penalties and interest due by
the taxable entity. It is the responsibility of a receiver to le franchise
tax reports and pay the franchise tax of a taxable entity in receivership.
A debtor in possession or the appointed trustee or receiver of a taxable
entity in reorganization or arrangement proceedings under the Bank-
ruptcy Act is responsible for ling franchise tax reports and paying the
franchise tax prior to conrming and consummating the plan of reor-
ganization or arrangement.
(A) "Beginning date" means:
(i) for a taxable entity chartered or organized in this
state, the date on which the taxable entity’s charter or organization takes
effect; and
(ii) for a foreign taxable entity, the date on which the
taxable entity begins doing business in this state.
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(B) Initial report. Both the initial report and payment of
the tax due, if any, are due no later than 89 days after the rst anniver-
sary date of the beginning date. The initial franchise tax report and
payment are for the privilege periods beginning on the beginning date
and ending on December 31 following the rst anniversary of the be-
ginning date. For example, if a Texas taxable entity is chartered on June
1, 2008, the payment due with the initial report will be for the privilege
periods from June 1, 2008 - December 31, 2009. In addition, when
the rst anniversary occurs during the period from October 4 - Decem-
ber 31, there must also be computed and paid with the initial report an
additional year’s tax for the privilege period beginning on January 1
following the rst anniversary and ending on the following December
31. For example, if a Texas taxable entity is chartered on November 1,
2008, the payment due with the initial report will be for the privilege
periods from November 1, 2008 - December 31, 2010. The taxable
margin computed on the initial report is based on the business done
during the period beginning on the beginning date and ending on the
last accounting period ending date for federal income tax purposes that
is at least 60 days before the original due date of the initial report, or,
if there is no such ending date, then ending on the day that is the last
day of the calendar month nearest to the end of the taxable entity’s rst
year of business.
(C) Annual report. The annual franchise tax report must
be led and the tax paid no later than May 15 of each year. The annual
tax is paid for the privilege period of the calendar year in which the re-
port is due. The taxable margin computed on an annual report is based
on the business done during the period beginning with the day after the
last date upon which tax was computed under Tax Code, Chapter 171
on a previous report, and ending with the last accounting period ending
date for federal income tax purposes ending in the calendar year before
the calendar year in which the report is originally due, or, if there is no
such ending date, then ending on December 31 of the calendar year be-
fore the calendar year in which the report is originally due. A taxable
entity that uses a 52 - 53 week accounting year end and has an account-
ing year ending the rst four days of January of the year in which the
annual report is originally due may use the preceding December 31 as
the date through which taxable margin is computed.
(D) Extensions. See §3.1 of this title (relating to Re-
quest for extension of Time in Which to File Report), for extensions of
time to le an initial or nal report. See §3.585 of this title (relating to
Margin: Extensions), for extensions of time to le an annual report.
(E) Final report. See §3.592 of this title (relating to
Margin: Additional Tax) for information concerning the additional tax
imposed by Tax Code, §171.0011.
(F) Transition. See §3.595 of this title (relating to Mar-
gin: Transition) for transitional information concerning tax rates and
privilege periods as a result of certain legislative changes.
(G) Passive entities. See §3.582 of this title (relating
to Margin: Passive Entities), for information concerning the reporting
requirements for a passive entity.
(H) Combined reporting. Taxable entities that are part
of an afliated group engaged in a unitary business must le a com-
bined group report in lieu of individual reports, except that a public
information report or ownership information report must be led for
each member of the combined group. See §3.590 of this title (relating
to Margin: Combined Reporting), for rules on ling a combined report.
(2) The postmark date (or meter-mark if there is no post-
mark) on the envelope in which the report or payment is received de-
termines the date of ling.
(3) An information report must be led, even if no tax is
due. A taxable entity must le a no tax due information report for the
privilege periods covered by an initial report or regular annual report
in which no tax is due, as authorized under Tax Code, §171.204.
(d) Calculation of margin.
(1) Calculation. If a taxable entity qualies to deduct cost
of goods sold the entity must make an annual election by the due date
of its return. This election may not be amended. A taxable entity’s
margin equals the least of three calculations:
(A) Total revenue minus cost of goods sold;
(B) Total revenue minus compensation; or
(C) Total revenue times 70%.
(2) Rate. A tax rate of 1.0% of taxable margin applies to
most taxable entities. A tax rate of 0.5% of taxable margin applies to
taxable entities primarily engaged in retail or wholesale trade under
division F or G of the 1987 Standard Industrial Classication Manual
published by the Federal Ofce of Management and Budget. A taxable
entity is primarily engaged in retail or wholesale trade only if:
(A) the total revenue from its activities in retail and
wholesale trade is greater than the total revenue from its activities in
trades other than the retail and wholesale trade;
(B) less than 50% of the total revenue from activities in
retail or wholesale trade comes from the sale of products it produces
or products produced by an entity that is part of an afliated group to
which the taxable entity also belongs, except for those businesses under
Major Group 58 (eating and drinking establishments); and
(C) the taxable entity does not provide retail or whole-
sale utilities, including telecommunications services, electricity or gas.
(3) No tax due. A taxable entity will owe no tax if its tax
due is less than $1,000 or its total revenue is less than or equal to
$300,000, or the amount determined under Tax Code, §171.006, per
12 month period on which the report is based. A taxable entity that
does not owe any tax under this subsection must le a no tax due infor-
mation report as authorized by subsection (c)(3) of this section.
(4) Discount. A taxable entity is entitled to a discount of
the tax imposed as follows:
(A) If total revenue is greater than $300,000 and less
than $400,000, the discount is 80% of tax due.
(B) If total revenue is greater than or equal to $400,000
and less than $500,000, the discount is 60% of tax due.
(C) If total revenue is greater than or equal to $500,000
and less than $700,000, the discount is 40% of tax due.
(D) If total revenue is greater than or equal to $700,000
and less than $900,000, the discount is 20% of tax due.
(5) E-Z Computation. A taxable entity with total revenue
of $10 million or less may elect to pay the franchise tax by using the
E-Z Computation method. Under the E-Z Computation a taxable en-
tity’s tax liability is computed by multiplying the taxable entity’s total
revenue times their apportionment factor times 0.575% (.00575) and
subtracting any applicable discount as provided by paragraph (4) of this
subsection. No other credits or adjustments are allowed if a taxable en-
tity elects to compute its tax liability under the E-Z Computation.
(e) Penalty and interest on delinquent taxes.
(1) Tax Code, §171.362, imposes a 5.0% penalty on the
amount of franchise tax due by a taxable entity that fails to report or
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pay the tax when due. If any part of the tax is not reported or paid
within 30 days after the due date, an additional 5.0% penalty is imposed
on the amount of tax unpaid. There is a minimum penalty of $1.00.
Delinquent taxes accrue interest beginning 60 days after the due date.
For example, if payment is made on the 61st day after the due date, one
day’s interest is due. The annual rate of interest on delinquent taxes is
the prime rate plus one percent, as published in The Wall Street Journal
on the rst day of each calendar year that is not a Saturday, Sunday, or
legal holiday.
(2) When a taxable entity is issued an audit assessment or
other underpayment notice based on a deciency, penalties under Tax
Code, §171.362, and interest are applied as of the date that the under-
paid tax was originally due, including any extensions, not from the date
of the deciency determination or date the deciency determination is
nal.
(3) A deciency determination is nal 30 days after the
date on which the service of the notice of the determination is com-
pleted. Service by mail is complete when the notice is deposited with
the United States Postal Service.
(A) The amount of a determination is due and payable
10 days after it becomes nal. If the amount of the determination is not
paid within 10 days after the day it became nal, a penalty under Tax
Code, §111.0081, of 10% of the tax assessed will be added. For ex-
ample, if a deciency determination is made in the amount of $1,000
tax (plus the initial penalty and interest), but the total amount of the
deciency is not paid until the 41st day after the deciency notice is
served, $1,200 plus interest would be due (i.e., $1,000 tax, $100 initial
penalty for not paying when originally due, $100 penalty for not pay-
ing deciency determination within 10 days after it became nal, plus
interest accrued to the date of payment at the applicable statutory rate).
(B) A petition for redetermination must be led within
30 days after the date on which the service of the notice of determina-
tion is completed, or the redetermination is barred.
(C) A decision on a petition for redetermination be-
comes nal 20 days after service on the petitioner of the notice of
the decision. The amount of a determination is due and payable 20
days after the decision is nal. If the amount of the determination is
not paid within 20 days after the day the decision becomes nal, a
penalty under Tax Code, §111.0081, of 10% of the tax assessed will
be added. Using the previous example, on the 41st day after service of
the decision, $1,200 plus interest would be due (i.e., $1,000 tax, $100
initial penalty, $100 additional penalty and the applicable accrued
interest).
(4) A jeopardy determination is nal 20 days after the date
on which the service of the notice is completed unless a petition for re-
determination is led before the determination becomes nal. Service
by mail is complete when the notice is deposited with the United States
Postal Service. The amount of the determination is due and payable im-
mediately. If the amount determined is not paid within 20 days from
the date of service, a penalty, under Tax Code, §111.022, of 10% of the
amount of tax and interest assessed will be added.
(5) If the comptroller determines that a taxable entity exer-
cised reasonable diligence to comply with the statutory ling or pay-
ment requirements, the comptroller may waive penalties or interest for
the late ling of a report or for a late payment. The taxable entity
requesting waiver must furnish a detailed description of the circum-
stances that caused the late ling or late payment and the diligence ex-
ercised by the taxable entity in attempting to comply with the statutory
requirements. See §3.5 of this title (relating to Waiver of Penalty or
Interest) for additional information.
(6) If a taxable entity fails to comply with Tax Code,
§171.212, the taxable entity is liable for a penalty of 10% of the tax
that should have been reported and had not previously been reported to
the comptroller under Tax Code, §171.212. This penalty is in addition
to any other penalty provided by law.
(f) Amended reports. In ling an amended report, the taxable
entity must type or print on the report, immediately above the taxable
entity name, the phrase "Amended Report." The report should be for-
warded with a cover letter of explanation, with enclosures necessary
to support the amendment. Applicable penalties and interest must be
reported and paid along with any additional amount of tax shown to be
due on the amended report.
(1) A taxable entity may le an amended report for the pur-
pose of correcting a mathematical or other error in a report or for the
purpose of supporting a claim for refund. An amended report may not
be led to change between a cost of goods sold deduction and a com-
pensation deduction.
(2) A taxable entity that has been audited by the Internal
Revenue Service must le an amended franchise tax report within 120
days after the Revenue Agent’s Report (RAR) is nal, if the RAR re-
sults in changes to taxable margin reported for franchise tax purposes.
An RAR is nal when all administrative appeals with the Internal Rev-
enue Service have been exhausted or waived. An administrative ap-
peal with the Internal Revenue Service does not include an action or
proceeding in the United States Tax Court or any other federal court.
(3) A taxable entity whose taxable margin is changed as a
result of an audit or other adjustment by a competent authority other
than the Internal Revenue Service must le an amended franchise tax
report within 120 days after the adjustment is nal. An adjustment
is nal when all administrative or other appeals have been exhausted
or waived. For the purposes of this section, a competent authority in-
cludes, but is not limited to, the United States Tax Court, United States
District Courts, United States Courts of Appeals, and United States
Supreme Court.
(4) A taxable entity must le an amended franchise tax re-
port within 120 days after the taxable entity les an amended federal
income tax return that changes the taxable entity’s taxable margin. A
taxable entity is considered to have led an amended federal income
tax return if the taxable entity is a member of an afliated group during
a period in which an amended consolidated federal income tax return
is led.
(5) A nal determination resulting from an Internal Rev-
enue Service administrative proceeding (including an audit), or a judi-
cial proceeding arising from an administrative proceeding, that affects
the amount of franchise tax liability must be reported to the comptroller
before the expiration of 120 days after the day on which the determi-
nation becomes nal. See Tax Code, §111.206.
(6) Because the 10% penalty provided for in Tax Code,
§171.212 only applies to deciencies, failure to le an amended re-
turn in which a refund would result will not cause a 10% penalty to be
imposed.
(g) Comptroller audit. During the course of an audit or other
examination of a taxable entity’s franchise tax account, the comptroller
may examine nancial statements, working papers, registers, memo-
randa, contracts, corporate minutes, and any other business papers used
in connection with its accounting system. In connection with the exam-
ination, the comptroller may also examine any of the taxable entity’s
ofcers or employees under oath.
(h) Payment of determination. The payment of a determina-
tion issued to a taxable entity for an estimated tax liability shall not
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satisfy the reporting requirements set forth in Tax Code, Chapter 171,
Subchapter E, concerning reports and records.
(i) Information report. Each taxable entity on which the fran-
chise tax is imposed must le an information report.
(1) For a taxable entity other than a corporation or limited
liability company, an ownership information report as described in Tax
Code, §171.201 and §171.202 is due at the same time each initial and
annual report is due.
(2) For a corporation or limited liability company a public
information report as described in Tax Code, §171.203, is due at the
same time each initial and annual report is due. An authorized person
must sign the public information report on behalf of the taxable entity
under a certication that:
(A) all information contained in the report is true and
correct to the best of the authorized person’s knowledge; and
(B) a copy of the report has been mailed to each person
named in the report who is an ofcer, director, or manager and who is
not employed by the taxable entity or a related (at least 10% ownership)
taxable entity on the date the report is led.
(C) A report that is led electronically complies with
the signature and certication requirements of this provision.
(3) Failure to le or sign a public information report or
ownership information report shall result in the forfeiture of corpo-
rate or business privileges as provided by Tax Code, §171.251 and
§171.2515. If the corporate or business privileges are forfeited, each
ofcer or director of the taxable entity may be liable for each debt of
the taxable entity that is created or incurred in Texas after the date on
which the report is due and before the corporate or business privileges
are revived, as provided by Tax Code, §171.255.
(4) The provisions of paragraph (3) of this subsection, con-
cerning forfeiture of corporate privileges do not apply to a banking tax-
able entity or a savings and loan association, as dened in Tax Code,
§171.001.
(5) For purposes of this subsection:
(A) authorized person means, in the case of a corpora-
tion, an ofcer, director or other authorized person of the corporation;
(B) authorized person means, in the case of a limited
liability company, a member, manager or other authorized person of
the limited liability company;
(C) authorized person means, in the case of a limited
partnership, a partner or other authorized person of the partnership;
(D) director includes a manager of a limited liability
company, a general partner in a limited partnership and a general part-
ner in a partnership registered as a limited liability partnership.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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The Comptroller of Public Accounts proposes new §3.585, con-
cerning margin: annual report extensions. This section imple-
ments House Bill 3, 79th Legislature, Third Called Session 2006
and House Bill 3928, 80th Legislature, 2007, which revise the
franchise tax. This section establishes guidelines for requesting
extensions under Tax Code, Chapter 171. Subsection (a) pro-
vides the effective date. Subsection (c) provides guidance for an
extension to November 15. Subsection (d) states an extension
will not be granted by paying 100% of the tax paid in the pre-
vious year if no report was led for the previous year, or due in
the previous year. Subsection (e) provides guidance for calculat-
ing penalty and interest. Subsections (f) - (h) provide guidance
for extensions for taxpayers required to le by electronic funds
transfer. Subsection (i) states no additional extensions will be
granted, other than those provided for in this section.
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as a
result of enforcing the rule will be in providing guidance to tax-
payers regarding obtaining extensions for ling annual reports
required under Tax Code, Chapter 171. This rule is adopted un-
der Tax Code, Title 2, and does not require a statement of scal
implications for small businesses. There is no signicant antic-
ipated economic cost to individuals who are required to comply
with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
The new section is proposed under Tax Code, §111.002, which
provides the comptroller with the authority to prescribe, adopt,
and enforce rules relating to the administration and enforcement
of the provisions of Tax Code, Title 2.
The new section implements Tax Code, §171.202.
§3.585. Margin: Annual Report Extensions.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Taxable and nontaxable entities. See §3.581 of this title
(relating to Margin: Taxable and Nontaxable Entities) for a list of tax-
able and nontaxable entities.
(c) Extension to November 15. Except for a taxable entity
which has been notied by the comptroller that it is required to make
its franchise tax payments by electronic funds transfer (see subsections
(d), (f), and (g) of this section), a taxable entity will be granted an ex-
tension to le an annual report on or before the next November 15, if
the taxable entity:
(1) requests the extension on or before May 15;
(2) requests the extension on a form provided by the comp-
troller; and
(3) remits with the extension request:
(A) 90% or more of the amount of tax reported as due
on the report led on or before November 15; or
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(B) 100% of the tax reported as due for the previous
calendar year on the report due in the previous calendar year and led
on or before May 14 of the year for which the extension is requested.
(d) No previous report. An extension shall not be granted un-
der subsections (c)(3)(B) or (f)(3)(B) of this section, if no report was
due in the previous calendar year or the report due in the previous cal-
endar year is not led on or before May 14 of the year for which the
extension is requested.
(e) Penalty and interest. Penalty and interest, except for a tax-
able entity which has been notied by the comptroller that it is required
to make its franchise tax a payments by electronic funds transfer (see
subsection (h) of this section), will be calculated as though the follow-
ing were due dates.
(1) If a taxable entity is granted an extension and pays, on
or before May 15, at least 100% of the tax reported as due for the pre-
vious calendar year on the report due in the previous calendar year and
led on or before May 14 of the year for which the extension is re-
quested, then November 15 will be the due date for any additional tax
due.
(2) If a taxable entity is granted an extension and pays on
or before May 15, 90% or more of the tax which will be reported as
due on or before November 15, then November 15 will be the due date
for any additional tax due.
(3) If a taxable entity, on or before May 15, requests an
extension but does not qualify for an extension under paragraphs (1) or
(2) of this subsection, then May 15 is the due date for 90% of the tax
nally determined to be due and November 15 is the due date for 10%
of the tax nally determined to be due.
(f) Required electronic funds transfer extension to August 15.
A taxable entity which has been notied by the comptroller that it is
required to make its franchise tax payments by electronic funds trans-
fer (see §3.9 of this title (relating to Electronic Filing of Returns and
Reports; Electronic Transfer of Certain Payments by Certain Taxpay-
ers)) will be granted an extension to le an annual report on or before
the next August 15, if the taxable entity:
(1) requests the extension on or before May 15;
(2) requests the extension on a form provided by the comp-
troller; and
(3) remits with the extension request:
(A) 90% or more of the amount of tax reported as due
on the report led on or before November 15; or
(B) 100% of the tax reported as due for the previous
calendar year on the report due in the previous calendar year and led
on or before May 14 of the year for which the extension is requested.
(g) Required electronic funds transfer extension to November
15. A taxable entity granted an extension under subsection (f) of this
section, will be granted an extension to le an annual report on or before
the next November 15, if the taxable entity:
(1) requests the extension on or before August 15;
(2) requests the extension on a form provided by the comp-
troller; and
(3) remits with the request the difference between the
amount paid previously for the current reporting period and 100%
of the amount of tax reported as due on the report led on or before
November 15.
(h) Required electronic funds transfer penalty and interest.
Penalty and interest will be calculated as though the following were
due dates.
(1) If a taxable entity is granted an extension until August
15 and pays, on or before May 15, at least 100% of the tax reported
as due for the previous calendar year on the report due in the previous
calendar year and led on or before May 14 of the year for which the
extension is requested, then August 15 will be the due date for any
additional tax due. However, if the taxable entity requests, on or before
August 15, an extension until November 15, and remits, on or before
August 15, 99% of the amount reported as due on or before November
15, then November 15 will be the due date for any additional tax due.
(2) If a taxable entity is granted an extension until August
15 and pays, on or before May 15, 90% or more of the tax which will be
reported as due on or before August 15, then August 15 will be the due
date for any additional tax due. However, if the taxable entity requests,
on or before August 15, an extension until November 15, and remits,
on or before August 15, 99% of the amount reported as due on or before
November 15, then November 15 will be the due date for any additional
tax due.
(3) If a taxable entity, on or before May 15, requests an
extension until August 15, but does not qualify for an extension under
paragraphs (1) or (2) of this subsection, then May 15 is the due date
for 90% of the tax nally determined to be due. August 15 is the due
date for the remaining 10% of the tax nally determined to be due.
However, if the taxable entity requests, on or before August 15, an
extension until November 15, and remits on or before August 15 at
least 99% of the amount reported as due on or before November 15,
then May 15 is the due date for 90% of the amount reported as due
on or before November 15, August 15 is the due date for 90% of the
amount reported as due on or before November 15, and November 15
is the due date for any additional tax due.
(i) No additional extensions. No additional extensions will
be granted for annual franchise tax reports pursuant to Tax Code,
§111.057.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.586
The Comptroller of Public Accounts proposes new §3.586,
concerning margin: nexus. This section implements House Bill
3, 79th Legislature, Third Called Session, 2006 and House Bill
3928, 80th Legislature, 2007, which revise the franchise tax.
This section establishes guidelines for determining nexus under
Tax Code, Chapter 171. Subsection (a) provides the effective
date. Subsection (b) states that Texas will nd nexus to the
limits of the United States Constitution. Subsection (c) provides
a non-exclusive list of common activities which will subject a
taxable entity to Texas franchise tax. Subsection (e) states
Public Law 86-272 does not apply to the franchise tax.
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John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as
a result of enforcing the rule will be in providing guidance to en-
tities regarding activities in Texas that would subject an entity
to franchise tax. This rule is adopted under Tax Code, Title 2,
and does not require a statement of scal implications for small
businesses. There is no signicant anticipated economic cost to
individuals who are required to comply with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
The new section is proposed under Tax Code, §111.002, which
provides the comptroller with the authority to prescribe, adopt,
and enforce rules relating to the administration and enforcement
of the provisions of Tax Code, Title 2.
The new section implements Tax Code, §171.001 and §171.106.
§3.586. Margin: Nexus.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) A taxable entity is subject to franchise tax in this state when
it has sufcient contact with this state to be taxed without violating the
United States Constitution.
(c) Some specic activities which subject a taxable entity to
Texas franchise tax include, but are not limited to, the following:
(1) advertising: entering Texas to purchase, place, or dis-
play advertising when the advertising is for the benet of another and in
the ordinary course of business (e.g., the foreign taxable entity makes
signs and brings them into Texas, sets them up, and maintains them);
(2) consignments: having consigned goods in Texas;
(3) contracting: performance of a contract in Texas regard-
less of whether the taxable entity brings its own employees into the
state, hires local labor, or subcontracts with another;
(4) delivering: delivering into Texas items it has sold;
(5) employees or representatives: having employees or
representatives in Texas doing the business of the taxable entity;
(6) federal enclaves: doing business in any area within
Texas, even if the area is leased by, owned by, ceded to, or under the
control of the federal government;
(7) franchisors: entering into one or more contracts with
persons, corporations, or other business entities located in Texas, by
which:
(A) the franchisee is granted the right to engage in the
business of offering, selling, or distributing goods or services under
a marketing plan or system prescribed in substantial part by the fran-
chisor; and
(B) the operation of a franchisee’s business pursuant to
such plan is substantially associated with the franchisor’s trademark,
service mark, trade name, logotype, advertising, or other commercial
symbol designating the franchisor or its afliate.
(8) holding companies: maintaining a place of business in
Texas or managing, directing, and/or performing services in Texas for
subsidiaries or investee entities;
(9) inventory: having an inventory in Texas or having spot
inventory for the convenient delivery to customers, even if the bulk of
orders are lled from out of state;
(10) leasing: leasing tangible personal property which is
used in Texas;
(11) loan production activities: soliciting sales contracts
or loans, gathering nancial data, making credit checks, collecting ac-
counts, repossessing property or performing other nancial activities in
Texas through employees, independent contractors, or agents, regard-
less of whether they reside in Texas;
(12) partners:
(A) acting as a general partner in a general partnership
which is doing business in Texas;
(B) acting as a general partner in a limited partnership
which is doing business in Texas (a foreign taxable entity which is a
limited partner in a limited partnership is not doing business in Texas,
if that is the limited partner’s only connection with Texas);
(13) place of business: maintaining a place of business in
Texas;
(14) processing: assembling, processing, manufacturing,
or storing goods in Texas;
(15) real estate: holding, acquiring, leasing, or disposing
of any property located in Texas;
(16) services, including, but not limited to the following:
(A) providing any service in Texas, regardless of
whether the employees, independent contractors, agents, or other
representatives performing the services reside in Texas;
(B) maintaining or repairing property located in Texas
whether under warranty or by separate contract;
(C) installing, erecting, or modifying property in Texas;
(D) conducting training classes, seminars or lectures in
Texas;
(E) providing any kind of technical assistance in Texas,
including, but not limited to, engineering services; or
(F) investigating, handling or otherwise assisting in re-
solving customer complaints in Texas.
(17) shipment: sending materials to Texas to be stored
awaiting orders for their shipment;
(18) shows and performances: the staging of or participat-
ing in shows, theatrical performances, sporting events, or other events
within Texas;
(19) solicitation: having employees, independent contrac-
tors, agents, or other representatives in Texas, regardless of whether
they reside in Texas, to promote or induce sales of the foreign taxable
entity’s goods or services;
(20) telephone listing: having a telephone number that is
answered in Texas; or
(21) transportation:
(A) carrying passengers or freight (any personal prop-
erty including oil and gas transmitted by pipeline) from one point in
Texas to another point within the state, if pickup and delivery, regard-
less of origination or ultimate destination, occurs within Texas; or
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(B) having facilities and/or employees, independent
contractors, agents, or other representatives in Texas, regardless of
whether they reside in Texas:
(i) for storage, delivery, or shipment of goods;
(ii) for servicing, maintaining, or repair of vehicles,
trailers, containers, and other equipment;
(iii) for coordinating and directing the transportation
of passengers or freight; or
(iv) for doing any other business of the taxable en-
tity.
(d) See §3.583 of this title (relating to Margin: Exemptions)
for information concerning exemption for certain trade show partici-
pants under Tax Code, §171.084.
(e) Public Law 86-272 (15 United States Code §§381 - 384)
does not apply to the franchise tax.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.587
The Comptroller of Public Accounts (Comptroller) proposes
new §3.587, concerning Margin: Total Revenue. This proposed
new section implements House Bill 3, 79th Legislature, Third
Called Session 2006 and House Bill 3928, 80th Legislature,
2007, which revise the franchise tax. This new section estab-
lishes guidelines for determining total revenue under Tax Code,
Chapter 171. Subsection (a) provides that this new section only
applies to franchise tax reports due on or after January 1, 2008.
Subsection (b) denes words and terms used in this section.
Subsection (c) provides general rules used in the calculation of
total revenue. Subsection (d) details the line items from federal
income tax forms that each type of entity will use in determining
total revenue and also details certain subtractions from total
revenue. Subsection (e) details items that are excluded from
total revenue.
John Heleman, Chief Revenue Estimator, has determined that,
for the rst ve-year period the proposed new rule will be in ef-
fect, there will be no signicant revenue impact on the state or
units of local government.
Mr. Heleman also has determined that, for each year of the rst
ve years proposed new the rule is in effect, the public benet
anticipated as a result of enforcing the rule will be in providing
guidance to taxpayers for computing total revenue under Tax
Code, Chapter 171. This new rule is proposed under Tax Code,
Title 2, and does not require a statement of scal implications for
small businesses. There is no signicant anticipated economic
cost to individuals who are required to comply with the proposed
new rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This new section is proposed under Tax Code, §111.002 and
§111.022, which provides the Comptroller with the authority to
prescribe, adopt and enforce rules relating to the administration
and enforcement of the provisions of Tax Code, Title 2.
This proposed new section implements Tax Code, §171.1011.
§3.587. Margin: Total Revenue.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Actual costs of uncompensated care--Uncompensated
care divided by total charges multiplied by the result of total operating
expenses less compensation.
(A) Total charges means all amounts for health care ser-
vices, including uncompensated care.
(B) Compensation includes amounts determined under
Tax Code, §171.1013, regardless of whether the taxable entity elects
to subtract compensation. See §3.589 (relating to Margin: Compensa-
tion).
(2) Federal obligations--
(A) stocks and other direct obligations of, and obliga-
tions unconditionally guaranteed by, the United States government and
United States government agencies; and
(B) direct obligations of a United States government-
sponsored agency.
(3) Health care institution--Any of the following types of
institutions: an ambulatory surgical center; an assisted living facility
licensed under Health and Safety Code, Chapter 247; an emergency
medical services provider; a home and community support services
agency; a hospice; a hospital; a hospital system; an intermediate care
facility for the mentally retarded or a home and community-based ser-
vices waiver program for persons with mental retardation adopted in
accordance with the federal Social Security Act, §1915(c) (42 U.S.C.
§1396n); a birthing center; a nursing home; an end stage renal disease
facility licensed under Health and Safety Code, §251.011; or a phar-
macy.
(4) Health care provider--Any taxable entity that partici-
pates in the Medicaid program, Medicare program, Children’s Health
Insurance Program (CHIP), state workers’ compensation program, or
TRICARE military health system as a provider of health care services.
(5) Lending institution--An entity that makes loans and;
(A) is regulated by the Federal Reserve Board, the Of-
ce of the Comptroller of the Currency, the Federal Deposit Insurance
Corporation, the Commodity Futures Trading Commission, the Ofce
of Thrift Supervision, the Texas Department of Banking, the Ofce of
Consumer Credit Commissioner, the Credit Union Department, or any
comparable regulatory body;
(B) is licensed by, registered with, or otherwise regu-
lated by the Department of Savings and Mortgage Lending;
(C) is a "broker" or "dealer" as dened by the Securities
Exchange Act of 1934 at 15 U.S.C. §78c; or
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(D) provides nancing to unrelated parties solely for
agricultural production.
(6) Management company--A corporation, limited liability
company, or other limited liability entity that conducts all or part of
the active trade or business of another entity ("the managed entity") in
exchange for:
(A) a management fee; and
(B) reimbursement of specied costs incurred in the
conduct of the active trade or business of the managed entity, includ-
ing wages and cash compensation as determined under Tax Code,
§171.1013(a) and (b).
(7) Net distributive income--The net amount of income,
gain, deduction, or loss relating to a pass-through entity or disregarded
entity reportable to the owners for the tax year of the entity.
(8) Obligation--Any bond, debenture, security, mortgage-
backed security, pass-through certicate, or other evidence of indebt-
edness of the issuing entity. The term does not include a deposit, a
repurchase agreement, a loan, a lease, a participation in a loan or pool
of loans, a loan collateralized by an obligation of a United States gov-
ernment agency, or a loan guaranteed by a United States government
agency.
(9) Pro bono services--The direct provision of legal ser-
vices to the poor, without an expectation of compensation.
(10) Product--Tangible personal property.
(11) Sales commission--
(A) any form of compensation paid to a person for en-
gaging in an act for which a license is required by Occupations Code,
Chapter 1101; or
(B) compensation paid to a sales representative by a
principal in an amount that is based on the amount or level of certain
orders for or sales of the principal’s product and that the principal is
required to report on Internal Revenue Service Form 1099-MISC (or
would have been reported if the amount had met the Internal Revenue
Service minimum reporting requirement).
(C) for purposes of dening sales commission, a prin-
cipal is a person who:
(i) manufactures, produces, imports, distributes, or
acts as an independent agent for the distribution of a product for sale;
(ii) uses a sales representative to solicit orders for
the product; and
(iii) compensates the sales representative wholly or
partly by sales commission.
(12) Security--The meaning assigned by Internal Revenue
Code, §475(c)(2), and includes instruments described by Internal Rev-
enue Code, §475(e)(2)(B), (C), and (D).
(13) Staff leasing services company--A business entity that
offers staff leasing services, as that term is dened by Labor Code,
§91.001, or a temporary employment service, as that term is dened
by Labor Code, §93.001.
(14) Tiered partnership arrangement--An ownership struc-
ture in which any of the interests in one taxable entity treated as a part-
nership or an S corporation for federal income tax purposes (a "lower
tier entity") are owned by one or more other taxable entities (an "upper
tier entity").
(15) Uncompensated care--Standard charges for the health
care services provided by a health care provider, where the provider
has not received any payment for health care provided to the patient.
(16) United States government--Any department or min-
istry of the federal government, including a federal reserve bank. The
term does not include a state or local government, a commercial en-
terprise owned wholly or partly by the United States government, or a
local governmental entity or commercial enterprise whose obligations
are guaranteed by the United States government.
(17) United States government agency--An instrumental-
ity of the United States government whose obligations are fully and
explicitly guaranteed as to the timely payment of principal and inter-
est by the full faith and credit of the United States government. The
term includes the Government National Mortgage Association, the De-
partment of Veterans Affairs, the Federal Housing Administration, the
Farmers Home Administration, the Export-Import Bank, the Overseas
Private Investment Corporation, the Commodity Credit Corporation,
the Small Business Administration, and any successor agency.
(18) United States government-sponsored agency--An
agency originally established or chartered by the United States govern-
ment to serve public purposes specied by the United States Congress
but whose obligations are not explicitly guaranteed by the full faith
and credit of the United States government. The term includes the
Federal Home Loan Mortgage Corporation, the Federal National
Mortgage Association, the Farm Credit System, the Federal Home
Loan Bank System, the Student Loan Marketing Association, and any
successor agency.
(c) General rules for reporting total revenue.
(1) Variant of form. Any reference to an Internal Revenue
Service form includes a variant of the form. For example, a reference
to Form 1120 includes Forms 1120-A, 1120-S, and other variants of
Form 1120. A reference to an Internal Revenue Service form also in-
cludes any subsequent form with a different number or designation that
substantially provides the same information as the original form.
(2) Amount reportable. Any reference to an amount re-
portable as income on a line number on an Internal Revenue Service
form is the amount entered to the extent the amount entered complies
with federal income tax law and includes the corresponding amount
entered on a variant of the form, or a subsequent form, with a different
line number to the extent the amount entered complies with federal in-
come tax law.
(3) Federal consolidated group. A taxable entity that is part
of a federal consolidated group or is a disregarded entity shall compute
its total revenue as if it had led a separate return for federal income tax
purposes. Further information on total revenue for combined entities
can be found in §3.590 of this title (relating to Margin: Combined
Reporting).
(4) Passive entity. A taxable entity will include its share of
net distributive income from a passive entity, but only to the extent the
net income of the passive entity was not generated by any other taxable
entity.
(5) Exclusions from total revenue. For any revenue that is
excluded from total revenue, the related costs may not be included in
the determination of cost of goods sold (see §3.588 of this title (relating
to Margin: Costs of Goods Sold)) or the determination of compensation
(see §3.589 of this title (relating to Margin: Compensation)).
(6) Contract services. Except as provided by subsection
(e)(2) of this section, a payment received under an ordinary contract
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for the provision of services in the ordinary course of business may not
be excluded from the calculation of total revenue.
(7) Revenue from afliated group members. If the taxable
entity belongs to an afliated group, the taxable entity may not exclude
from the calculation of total revenue any payments described by sub-
section (e)(1) - (6) of this section that are made to entities that are mem-
bers of the afliated group.
(8) Lower tier entities. A lower tier entity in a tiered part-
nership arrangement may not exclude from total revenue any revenue
reported to an upper tier entity, regardless of whether the upper tier
entity includes the revenue from the lower tier entity in the upper tier
entity’s calculation of taxable margin.
(9) Allocated revenue. Revenue that Texas cannot tax be-
cause the activities generating that item of revenue do not have suf-
cient unitary connection with the entity’s other activities conducted in
Texas under the United States Constitution is not included in total rev-
enue.
(10) No federal return. A taxable entity that is not exempt
under Tax Code, Chapter 171, and the State of Texas is not prohibited
from taxing because of treaty, federal law or the United States Con-
stitution, must calculate its franchise tax based on a proforma federal
return, if the taxable entity does not le a federal return.
(d) Reporting total revenue. The line items in this subsection
refer to line items on the 2006 Internal Revenue Service forms. In com-
puting total revenue for a subsequent report year, total revenue should
be based on the equivalent line numbers from the corresponding fed-
eral report and computed based on the Internal Revenue Code of 1986
in effect for the federal tax year beginning on January 1, 2007.
(1) Corporations. For the purpose of computing its taxable
margin, the total revenue of a taxable entity treated as a corporation for
federal income tax purposes is computed by:
(A) adding:
(i) the amount reportable as income on line 1c, In-
ternal Revenue Service Form 1120;
(ii) the amounts reportable as income on lines 4
through 10, Internal Revenue Service Form 1120; and
(iii) any total revenue reported by a lower tier en-
tity as includable in the taxable entity’s total revenue under Tax Code,
§171.1015(b); and
(B) subtracting, to the extent included in the calculation
under subparagraph (A) of this paragraph:
(i) bad debt expensed for federal income tax pur-
poses that corresponds to items of gross receipts included for the cur-
rent reporting period or a past reporting period;
(ii) foreign royalties and foreign dividends from an
afliated taxable entity that does not transact a substantial portion of its
business or regularly maintain a substantial portion of its assets in the
United States, including amounts determined under Internal Revenue
Code, §78 or §§951 - 964;
(iii) net distributive income from a taxable entity
treated as a partnership or as an S corporation for federal income tax
purposes, except as provided by subsection (c)(4) of this section;
(iv) allowable deductions from Internal Revenue
Service Form 1120, Schedule C, to the extent the relating dividend
income is included in total revenue;
(v) items of income attributable to an entity that is a
disregarded entity for federal income tax purposes; and
(vi) other amounts authorized by subsection (e) of
this section.
(2) S corporations. For the purpose of computing its tax-
able margin, the total revenue of a taxable entity treated as an S corpo-
ration for federal income tax purposes is computed by:
(A) adding:
(i) the amount reportable as income on line 1c, In-
ternal Revenue Service Form 1120S;
(ii) the amounts reportable as income on lines 4 and
5, Internal Revenue Service Form 1120S; and
(iii) the amounts reportable as income on lines 3a
and 4 through 10, Internal Revenue Service Form 1120S, Schedule K;
(iv) the amounts reportable as income on line 17, In-
ternal Revenue Service Form 8825;
(v) any total revenue reported by a lower tier en-
tity as includable in the taxable entity’s total revenue under Tax Code,
§171.1015(b); and
(B) subtracting, to the extent included in the calculation
under subparagraph (A) of this paragraph:
(i) bad debt expensed for federal income tax pur-
poses that corresponds to items of gross receipts included for the cur-
rent reporting period or a past reporting period;
(ii) foreign royalties and foreign dividends from an
afliated taxable entity that does not transact a substantial portion of its
business or regularly maintain a substantial portion of its assets in the
United States, including amounts determined under Internal Revenue
Code, §78 or §§951 - 964;
(iii) net distributive income from a taxable entity
treated as a partnership or as an S corporation for federal income tax
purposes, except as provided by subsection (c)(4) of this section;
(iv) items of income attributable to an entity that is
a disregarded entity for federal income tax purposes; and
(v) other amounts authorized by subsection (e) of
this section.
(3) Partnerships. For the purpose of computing its taxable
margin, the total revenue of a taxable entity treated as a partnership for
federal income tax purposes is computed by:
(A) adding:
(i) the amount reportable as income on line 1c, In-
ternal Revenue Service Form 1065;
(ii) the amounts reportable as income on lines 4, 6,
and 7, Internal Revenue Service Form 1065;
(iii) the amounts reportable as income on lines 3a
and 5 through 11, Internal Revenue Service Form 1065, Schedule K;
(iv) the amounts reportable as income on line 17, In-
ternal Revenue Service Form 8825;
(v) the amounts reportable as income on line 11, plus
line 2 or line 45, Internal Revenue Service Form 1040, Schedule F; and
(vi) any total revenue reported by a lower tier en-
tity as includable in the taxable entity’s total revenue under Tax Code,
§171.1015(b); and
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(B) subtracting, to the extent included in the calculation
under subparagraph (A) of this paragraph:
(i) bad debt expensed for federal income tax pur-
poses that corresponds to items of gross receipts included for the cur-
rent reporting period or a past reporting period;
(ii) foreign royalties and foreign dividends from an
afliated taxable entity that does not transact a substantial portion of its
business or regularly maintain a substantial portion of its assets in the
United States, including amounts determined under Internal Revenue
Code, §78 or §§951 - 964;
(iii) net distributive income from a taxable entity
treated as a partnership or as an S corporation for federal income tax
purposes, except as provided by subsection (c)(4) of this section;
(iv) items of income attributable to an entity that is
a disregarded entity for federal income tax purposes; and
(v) other amounts authorized by subsection (e) of
this section.
(4) Trusts. For the purpose of computing its taxable mar-
gin, the total revenue of a taxable entity treated as a trust for federal
income tax purposes is computed by:
(A) adding:
(i) the amount reportable as income on lines 1, 2a,
3, 4, 7, and 8 of Internal Revenue Service Form 1041;
(ii) the amount reportable as income on lines 3, 4,
32, and 37 of Internal Revenue Service Form 1040, Schedule E; and
(iii) the amounts reportable as income on line 11,
plus line 2 or line 45, Internal Revenue Service Form 1040, Schedule
F; and
(iv) any total revenue reported by a lower tier en-
tity as includable in the taxable entity’s total revenue under Tax Code,
§171.1015(b); and
(B) subtracting, to the extent included in the calculation
under subparagraph (A) of this paragraph:
(i) bad debt expensed for federal income tax pur-
poses that corresponds to items of gross receipts included for the cur-
rent reporting period or a past reporting period;
(ii) foreign royalties and foreign dividends from an
afliated taxable entity that does not transact a substantial portion of its
business or regularly maintain a substantial portion of its assets in the
United States, including amounts determined under Internal Revenue
Code, §78 or §§951 - 964;
(iii) net distributive income from a taxable entity
treated as a partnership or as an S corporation for federal income tax
purposes, except as provided by subsection (c)(4) of this section;
(iv) items of income attributable to an entity that is
a disregarded entity for federal income tax purposes; and
(v) other amounts authorized by subsection (e) of
this section.
(5) Single member limited liability company (LLC) ling
as a sole proprietorship. For the purpose of computing its taxable mar-
gin, the total revenue of a taxable entity registered as a single member
limited liability company and ling as a sole proprietorship for federal
income tax purposes is computed by:
(A) adding:
(i) the amount reportable as income on line 3 of In-
ternal Revenue Service, Form 1040, Schedule C;
(ii) the amount reportable as income on line 17, In-
ternal Revenue Service Form 4797, to the extent that it relates to the
LLC;
(iii) ordinary income or loss from partnerships, S
corporations, estates and trusts, Internal Revenue Service Form 1040,
Schedule E, to the extent that it relates to the LLC;
(iv) the amount reportable as income on line 16 of
Internal Revenue Service Form 1040, Schedule D, to the extent that it
relates to the LLC;
(v) the amounts reportable as income on lines 3 and
4, Internal Revenue Service Form 1040, Schedule E, to the extent that
it relates to the LLC;
(vi) the amounts reportable as income on line 11,
plus line 2 or line 45, Internal Revenue Service Form 1040, Schedule
F, to the extent that it relates to the LLC;
(vii) the amount reportable as income on line 6 of
Internal Revenue Service Form 1040, Schedule C, that has not already
been included in this subparagraph; and
(viii) any total revenue reported by a lower tier en-
tity as includable in the taxable entity’s total revenue under Tax Code,
§171.1015(b); and
(B) subtracting, to the extent included in the calculation
under subparagraph (A) of this paragraph:
(i) bad debt expensed for federal income tax pur-
poses that corresponds to items of gross receipts included for the cur-
rent reporting period or a past reporting period;
(ii) foreign royalties and foreign dividends from an
afliated taxable entity that does not transact a substantial portion of its
business or regularly maintain a substantial portion of its assets in the
United States, including amounts determined under Internal Revenue
Code, §78 or §§951 - 964;
(iii) net distributive income from a taxable entity
treated as a partnership or as an S corporation for federal income tax
purposes, except as provided by subsection (c)(4) of this section;
(iv) items of income attributable to an entity that is
a disregarded entity for federal income tax purposes; and
(v) other amounts authorized by subsection (e) of
this section.
(6) Other taxable entities. For a taxable entity other than
a taxable entity treated for federal income tax purposes as a corpora-
tion, S corporation, partnership, trust, or single member limited liabil-
ity company ling as a sole proprietorship, the total revenue will be an
amount determined in a manner substantially equivalent to the amount
calculated for the entities listed in this subsection.
(e) Exclusions from total revenue. Except as otherwise pro-
vided in this section and only to the extent included in the calculation
of total revenue under subsection (d)(1) - (6) of this section, the fol-
lowing items shall be excluded from total revenue:
(1) Flow-through funds mandated by law. Flow-through
funds that are mandated by law or duciary duty to be distributed to
other entities, including taxes collected from a third party by the taxable
entity and remitted by the taxable entity to a taxing authority;
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(2) Flow-through funds mandated by contract. Flow-
through funds that are mandated by contract to be distributed to other
entities, limited to:
(A) sales commissions, as that term is dened by sub-
section (b)(11) of this section, to non-employees, including split-fee
real estate commissions;
(B) the tax basis as determined under the Internal Rev-
enue Code of securities underwritten; and
(C) subcontracting payments handled by the taxable en-
tity to provide services, labor, or materials in connection with the ac-
tual or proposed design, construction, remodeling, or repair of improve-
ments on real property or the location of the boundaries of real property;
(3) Principal repayments. A taxable entity shall exclude
the principal repayment of loans;
(4) Tax basis of securities and loans. A taxable entity shall
exclude the tax basis, as determined under the Internal Revenue Code,
of securities and loans sold;
(5) Legal services. A taxable entity that provides legal ser-
vices shall exclude:
(A) the following ow-through funds that are mandated
by law, contract, or duciary duty to be distributed to the claimant by
the claimant’s attorney or to other entities on behalf of a claimant by
the claimant’s attorney:
(i) damages due the claimant;
(ii) funds subject to a lien or other contractual obli-
gation arising out of the representation, other than fees owed to the
attorney;
(iii) funds subject to a subrogation interest or other
third-party contractual claim; and
(iv) fees paid an attorney in the matter who is not a
member, partner, shareholder, or employee of the taxable entity;
(B) reimbursement of the taxable entity’s expenses in-
curred in prosecuting a claimant’s matter that are specic to the matter
and that are not general operating expenses; and
(C) regardless of whether it was included in the calcu-
lation of total revenue under subsection (d) of this section, $500 per
pro bono services case handled by the attorney, but only if the attorney
maintains records of the pro bono services for auditing purposes in ac-
cordance with the manner in which those services are reported to the
State Bar of Texas;
(6) Pharmacy cooperative. A taxable entity that is a phar-
macy cooperative shall exclude ow-through funds from rebates from
pharmacy wholesalers that are distributed to the pharmacy coopera-
tive’s shareholders;
(7) Staff leasing services company. A taxable entity that is
a staff leasing services company shall exclude payments received from
a client company for wages, payroll taxes on those wages, employee
benets, and workers’ compensation benets for the assigned employ-
ees of the client company;
(8) Dividends and interest from federal obligations. A tax-
able entity shall exclude dividends and interest received from federal
obligations;
(9) Management company. A taxable entity that is a man-
agement company shall exclude reimbursements of specied costs in-
curred in its conduct of the active trade or business of a managed en-
tity, including wages and cash compensation as determined under Tax
Code, §171.1013(a) and (b);
(10) Health care provider. A taxable entity that is a health
care provider shall exclude:
(A) the total amount of payments received:
(i) under the Medicaid program, Medicare program,
Indigent Health Care and Treatment Act (Health and Safety Code,
Chapter 61), and Children’s Health Insurance Program (CHIP);
(ii) for professional services provided in relation to
a workers’ compensation claim under Labor Code, Title 5; and
(iii) for professional services provided to a bene-
ciary rendered under the TRICARE military health system; and
(B) the actual costs, regardless of whether it was in-
cluded in the calculation of total revenue under subsection (d)(1) - (6)
of this section, of uncompensated care provided, but only if the provider
maintains records of the uncompensated care for auditing purposes and,
if the provider later receives payment for all or part of that care, the
provider adjusts the amount excluded for the tax year in which the pay-
ment is received.
(11) Health care institution. A health care provider that is
a health care institution shall exclude 50 percent of the exclusion de-
scribed in paragraph (10) of this subsection.
(12) Federal government and armed forces. A taxable en-
tity shall exclude all revenue received that is directly derived from the
operation of a facility that is:
(A) located on property owned or leased by the federal
government; and
(B) managed or operated primarily to house members
of the armed forces of the United States.
(13) Oil and gas. During the dates, certied by the comp-
troller, in which the monthly average closing price of West Texas Inter-
mediate crude oil is below $40 per barrel and the average closing price
of gas is below $5 per MMBtu, as recorded on the New York Mercan-
tile Exchange (NYMEX), a taxable entity shall exclude total revenue
received from oil or gas produced from:
(A) an oil well designated by the Railroad Commission
of Texas or similar authority of another state whose production aver-
ages less than 10 barrels a day over a 90-day period; and
(B) a gas well designated by the Railroad Commission
of Texas or similar authority of another state whose production aver-
ages less than 250 mcf a day over a 90-day period.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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The Comptroller of Public Accounts (Comptroller) proposes new
§3.588, concerning Margin: Cost of Goods Sold. This proposed
new section implements House Bill 3, 79th Legislature, Third
Called Session, 2006 and House Bill 3928, 80th Legislature,
2007, which revise the franchise tax. This new section estab-
lishes guidelines for computing cost of goods sold under Tax
Code, Chapter 171. Subsection (a) provides that this new sec-
tion only applies to franchise tax reports originally due on or after
January 1, 2008. Subsection (b) denes words and terms used
in the new section. Subsection (c) provides general rules for
computing cost of goods sold. Subsection (d) details the direct
costs includable in cost of goods sold. Subsection (e) details
additional costs includable in cost of goods sold. Subsection (f)
relates to indirect and administrative overhead costs includable
in costs of goods sold. Subsection (g) details those costs not
includable in cost of goods sold.
John Heleman, Chief Revenue Estimator, has determined that,
for the rst ve-year period the proposed new rule will be in ef-
fect, there will be no signicant revenue impact on the state or
units of local government.
Mr. Heleman also has determined that, for each year of the rst
ve years the proposed new rule is in effect, the public benet
anticipated as a result of enforcing the new rule will be in pro-
viding guidance to businesses subject to the franchise tax re-
garding the computation of cost of goods sold under Tax Code,
Chapter 171. This new rule is proposed under Tax Code, Title 2,
and does not require a statement of scal implications for small
businesses. There is no signicant anticipated economic cost to
individuals who are required to comply with the proposed new
rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This new section is proposed under Tax Code, §111.002 and
§111.022, which provides the Comptroller with the authority to
prescribe, adopt and enforce rules relating to the administration
and enforcement of the provisions of Tax Code, Title 2.
This proposed new section implements Tax Code, §171.1012.
§3.588. Margin: Cost of Goods Sold.
(a) Effective Date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Arm’s length--The standard of conduct under which en-
tities that are not related parties and that have substantially equal bar-
gaining power, each acting in its own interest, would negotiate or carry
out a particular transaction.
(2) Computer program--A series of instructions that are
coded for acceptance or use by a computer system and that are
designed to permit the computer system to process data and provide
results and information. The series of instructions may be contained
in or on magnetic tapes, printed instructions, or other tangible or
electronic media.
(3) Goods--Real or tangible personal property sold in the
ordinary course of business of a taxable entity. "Goods" includes:
(A) the husbandry of animals;
(B) the growing and harvesting of crops;
(C) the severance of timber from realty.
(4) Heavy construction equipment--Self-propelled,
self-powered, or pull-type equipment that weighs at least 3,000 pounds
and is intended to be used for construction. The term does not include
a motor vehicle required to be titled and registered.
(5) Lending institution--An entity that makes loans and:
(A) is regulated by the Federal Reserve Board, the Of-
ce of the Comptroller of the Currency, the Federal Deposit Insurance
Corporation, the Commodity Futures Trading Commission, the Ofce
of Thrift Supervision, the Texas Department of Banking, the Ofce of
Consumer Credit Commissioner, the Credit Union Department, or any
comparable regulatory body;
(B) is licensed by, registered with, or otherwise regu-
lated by the Department of Savings and Mortgage Lending;
(C) is a "broker" or "dealer" as dened by the Securities
Exchange Act of 1934 at 15 U.S.C. §78c; or
(D) provides nancing to unrelated parties solely for
agricultural production.
(6) Principal business activity--The activity in which a tax-
able entity derives the largest percentage of its "total revenue".
(7) Production--Construction, manufacture, installation
occurring during the manufacturing process, development, mining,
extraction, improvement, creation, raising, or growth.
(8) Related party--A person, corporation, or other entity,
including an entity that is treated as a pass-through or disregarded entity
for purposes of federal taxation, whether the person, corporation, or
entity is subject to the tax under this chapter or not, in which one person,
corporation, or entity, or set of related persons, corporations, or entities,
directly or indirectly owns or controls a controlling interest in another
entity.
(9) Tangible personal property--
(A) includes:
(i) personal property that can be seen, weighed,
measured, felt, or touched or that is perceptible to the senses in any
other manner;
(ii) lms, sound recordings, videotapes, live and
prerecorded television and radio programs, books, and other similar
property embodying words, ideas, concepts, images, or sound, without
regard to the means or methods of distribution or the medium in which
the property is embodied, for which, as costs are incurred in producing
the property, it is intended or is reasonably likely that any medium in
which the property is embodied will be mass-distributed by the creator
or any one or more third parties in a form that is not substantially
altered; and
(iii) a computer program, as dened in paragraph (2)
of this subsection.
(B) does not include:
(i) intangible property or
(ii) services.
(10) Undocumented worker--A person who is not lawfully
entitled to be present and employed in the United States.
(c) General rules for determining cost of goods sold.
(1) Afliated entities. Notwithstanding any other provi-
sion of this section, a payment made by one member of an afliated
PROPOSED RULES September 14, 2007 32 TexReg 6289
group to another member of that afliated group not included in the
combined group may be subtracted as a cost of goods sold only if it is
a transaction made at arm’s length.
(2) Capitalization or expensing of certain costs. A taxable
entity that is allowed a subtraction by this section for a cost of goods
sold and that is subject to Internal Revenue Code, §§263A, 460, or 471,
may:
(A) Capitalize that cost in the same manner and to the
same extent that the taxable entity capitalized that cost on its federal
income tax return, except for those costs excluded under subsection
(g) of this section, or in accordance with subsections (d), (e), and (f) of
this section.
(i) If the taxable entity elects to capitalize costs, it
must capitalize each cost allowed under this section that it capitalized
on its federal income tax return.
(ii) If the taxable entity later elects to begin expens-
ing a cost that may be allowed under this section as a cost of goods sold,
the entity may not deduct any cost in ending inventory from a previous
report.
(B) Expense those costs, except for those costs ex-
cluded under subsection (g) of this section, or in accordance with
subsections (d), (e), and (f) of this section.
(i) If the taxable entity elects to expense a cost of
goods sold that may be allowed under this section, a cost incurred be-
fore the rst day of the period on which the report is based may not be
subtracted as a cost of goods sold.
(ii) If the taxable entity later elects to begin capital-
izing a cost that may be allowed under this section as a cost of goods
sold, a cost expensed on a previous report may not be capitalized.
(3) Exclusions from total revenue. Costs related to revenue
that has been excluded from total revenue (see §3.587 of this title (re-
lating to Margin: Total Revenue)) may not be included in the determi-
nation of cost of goods sold. Costs must be allocated between included
and excluded revenue on a reasonable basis.
(4) Film and broadcasting. A taxable entity whose princi-
pal business activity is lm or television production or broadcasting
or the sale of broadcast rights or the distribution of tangible personal
property described by subsection (b)(9)(A)(ii) of this section, or any
combination of these activities, and who elects to use cost of goods
sold to determine margin, may include as cost of goods sold:
(A) the costs described in this section in relation to the
property;
(B) depreciation, amortization, and other expenses di-
rectly related to the acquisition, production, or use of the property, in-
cluding
(C) expenses for the right to broadcast or use the prop-
erty.
(5) Lending institutions. Notwithstanding any other pro-
vision of this section, if the taxable entity is a lending institution that
offers loans to the public and elects to subtract cost of goods sold, the
entity may subtract as a cost of goods sold an amount equal to interest
expense.
(A) This paragraph does not apply to entities primarily
engaged in an activity described by category 5932 of the 1987 Stan-
dard Industrial Classication Manual published by the federal Ofce
of Management and Budget.
(B) For purposes of this subsection, an entity engaged
in lending to unrelated parties solely for agricultural production offers
loans to the public.
(6) Owner of goods. A taxable entity may make a subtrac-
tion under this section in relation to the cost of goods sold only if that
entity owns the goods. The determination of whether a taxable entity
is an owner is based on all of the facts and circumstances, including
the various benets and burdens of ownership vested with the taxable
entity.
(A) A taxable entity furnishing labor or materials to a
project for the construction, improvement, remodeling, repair, or in-
dustrial maintenance (as the term "maintenance" is dened in §3.357
of this title (relating to Nonresidential Real Property Repair, Remod-
eling, and Restoration; Real Property Maintenance)), of real property
is considered to be an owner of the labor or materials and may include
the costs, as allowed by this section, in the computation of goods sold.
(B) Solely for the purposes of this section, a taxable en-
tity shall be treated as the owner of goods being manufactured or pro-
duced by the entity under a contract with the federal government, in-
cluding any subcontracts that support a contract with the federal gov-
ernment, notwithstanding that the Federal Acquisition Regulation may
require that title or risk of loss with respect to those goods be trans-
ferred to the federal government before the manufacture or production
of those goods is complete.
(7) Rentals and leases. Notwithstanding any other provi-
sion of this section, the following taxable entities may subtract as cost
of goods sold the costs otherwise allowed by this section in relation to
tangible personal property that the entity rents or leases in the ordinary
course of business of the entity:
(A) a motor vehicle rental or leasing company that re-
mits a tax on gross receipts imposed under Tax Code, §152.026;
(B) a heavy construction equipment rental or leasing
company; and
(C) a railcar rolling stock rental or leasing company.
(8) Reporting methods. A taxable entity shall determine
its cost of goods sold, except as otherwise provided by this section, in
accordance with the methods used on the federal income tax return on
which the report under this chapter is based. This subsection does not
affect the type or category of cost of goods sold that may be subtracted
under this section.
(9) Restaurants. Entities engaged in activities described in
Major Group 58 of the Standard Industrial Classication Manual may
deduct for cost of goods sold only those expenses allowed under sub-
sections (d), (e) and (f) of this section, that relate to the production of
food. Any costs related to both the production of food and to other ac-
tivities must be allocated to production on a reasonable basis.
(d) Cost of goods sold. The cost of goods sold includes all
direct costs of acquiring or producing the goods, including:
(1) labor costs including W-2 wages, IRS Form 1099
wages, temporary labor, payroll taxes and benets;
(2) cost of materials that are an integral part of specic
property produced;
(3) cost of materials that are consumed in course of per-
forming production activities;
(4) handling costs, including costs attributable to process-
ing, assembling, repackaging, and inbound transportation;
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(5) storage costs, including the costs of carrying, storing,
or warehousing property;
(6) depreciation, depletion, and amortization, reported on
the federal income tax return on which the report under this chapter is
based, to the extent associated with and necessary for the production of
goods, including recovery described by Internal Revenue Code, §197,
and property described in Internal Revenue Code, §179;
(7) the cost of renting or leasing equipment, facilities, or
real property used for the production of the goods, including pollution
control equipment and intangible drilling and dry hole costs;
(8) the cost of repairing and maintaining equipment, facil-
ities, or real property directly used for the production of the goods,
including pollution control devices;
(9) costs attributable to research, experimental, engineer-
ing, and design activities directly related to the production of the goods,
including all research or experimental expenditures described by Inter-
nal Revenue Code, §174;
(10) geological and geophysical costs incurred to identify
and locate property that has the potential to produce minerals;
(11) taxes paid in relation to acquiring or producing any
material, or taxes paid in relation to services that are a direct cost of
production;
(12) the cost of producing or acquiring electricity sold; and
(13) a contribution to a partnership in which the taxable
entity owns an interest that is used to fund activities, the costs of which
would otherwise be treated as cost of goods sold of the partnership, but
only to the extent that those costs are related to goods distributed to the
contributing taxable entity as goods-in-kind in the ordinary course of
production activities rather than being sold by the partnership.
(e) Additional costs. In addition to the amounts includable un-
der subsection (d) of this section, the cost of goods sold includes the
following costs in relation to the taxable entity’s goods:
(1) deterioration of the goods;
(2) obsolescence of the goods;
(3) spoilage and abandonment, including the costs of re-
work, reclamation, and scrap;
(4) if the property is held for future production, preproduc-
tion direct costs allocable to the property, including storage and han-
dling costs, as provided by subsection (d)(4) and (5) of this section;
(5) postproduction direct costs allocable to the property, in-
cluding storage and handling costs, as provided by subsection (d)(4)
and (5) of this section;
(6) the cost of insurance on a plant or a facility, machinery,
equipment, or materials directly used in the production of the goods;
(7) the cost of insurance on the produced goods;
(8) the cost of utilities, including electricity, gas, and water,
directly used in the production of the goods;
(9) the costs of quality control, including replacement of
defective components pursuant to standard warranty policies, inspec-
tion directly allocable to the production of the goods, and repairs and
maintenance of goods; and
(10) licensing or franchise costs, including fees incurred
in securing the contractual right to use a trademark, corporate plan,
manufacturing procedure, special recipe, or other similar right directly
associated with the goods produced.
(f) Indirect or administrative overhead costs. A taxable entity
may subtract as a cost of goods sold indirect or administrative overhead
costs that it can demonstrate are allocable to the acquisition or produc-
tion of goods. This amount may not exceed 4.0% of total indirect or
administrative overhead cost.
(1) Indirect or administrative overhead costs include, but
are not limited to, all mixed service costs, such as security services,
legal services, data processing services, accounting services, personnel
operations, and general nancial planning and nancial management
costs.
(2) Any costs already subtracted under subsections (d) or
(e) of this section, may not be subtracted under this subsection.
(3) Any costs excluded under subsection (g) of this section,
may not be subtracted under this subsection.
(g) Costs not included. The cost of goods sold does not include
the following costs in relation to the taxable entity’s goods:
(1) the cost of renting or leasing equipment, facilities, or
real property that is not used for the production of the goods;
(2) selling costs, including employee expenses related to
sales;
(3) distribution costs, including outbound transportation
costs;
(4) advertising costs;
(5) idle facility expenses;
(6) rehandling costs;
(7) bidding costs, which are the costs incurred in the solic-
itation of contracts ultimately awarded to the taxable entity;
(8) unsuccessful bidding costs, which are the costs incurred
in the solicitation of contracts not awarded to the taxable entity;
(9) interest, including interest on debt incurred or contin-
ued during the production period to nance the production of the goods;
(10) income taxes, including local, state, federal, and for-
eign income taxes, and franchise taxes that are assessed on the taxable
entity based on income;
(11) strike expenses, including costs associated with hiring
employees to replace striking personnel, but not including the wages of
the replacement personnel, costs of security, and legal fees associated
with settling strikes;
(12) ofcers’ compensation;
(13) costs of operation of a facility that is:
(A) located on property owned or leased by the federal
government; and
(B) managed or operated primarily to house members
of the armed forces of the United States;
(14) any compensation paid to an undocumented worker
used for the production of goods; and
(15) costs funded by a partnership contribution, to the ex-
tent that the contributing taxable entity made the cost of goods sold
deduction under subsection (d)(13) of this section.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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34 TAC §3.589
The Comptroller of Public Accounts (Comptroller) proposes
new §3.589, concerning Margin: Compensation. This proposed
new section implements House Bill 3, 79th Legislature, Third
Called Session, 2006 and House Bill 3928, 80th Legislature,
2007, which revise the franchise tax. This new section estab-
lishes guidelines for computing compensation under Tax Code,
Chapter 171. Subsection (a) provides that this new section
only applies to franchise tax reports due on or after January
1, 2008. Subsection (b) denes words and terms used in the
new section. Subsection (c) provides for general rules used in
the calculation of compensation. Subsection (d) provides for
exclusions from total compensation. Subsection (e) provides for
general rules used in the calculation of benets. Subsection (f)
provides for general rules for staff leasing companies. Subsec-
tion (g) provides for general rules for management companies.
Subsection (h) provides for rules applicable for small employers.
John Heleman, Chief Revenue Estimator, has determined that,
for the rst ve-year period the proposed new rule will be in ef-
fect, there will be no signicant revenue impact on the state or
units of local government.
Mr. Heleman also has determined that, for each year of the rst
ve years the proposed new rule is in effect, the public benet
anticipated as a result of enforcing the new rule will be in provid-
ing guidance to businesses subject to the franchise tax regarding
the computation of compensation under Tax Code, Chapter 171.
This new rule is proposed under Tax Code, Title 2, and does not
require a statement of scal implications for small businesses.
There is no signicant anticipated economic cost to individuals
who are required to comply with the proposed new rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This new rule is proposed under Tax Code, §111.002, which pro-
vides the Comptroller with the authority to prescribe, adopt, and
enforce rules relating to the administration and enforcement of
the provisions of Tax Code, Title 2.
The proposed new section implements Tax Code, §171.1011
and §171.1013.
§3.589. Margin: Compensation.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Assigned employee--Has the meaning assigned by La-
bor Code, §91.001.
(2) Client company--
(A) a person that contracts with a license holder un-
der Labor Code, Chapter 91, and is assigned employees by the license
holder under that contract; or
(B) a client of a temporary employment service, as that
term is dened by Labor Code, §93.001(2), to whom individuals are
assigned for a purpose described by that subdivision.
(3) Management company--A corporation, limited liability
company or other limited liability entity that conducts all or part of
the active trade or business of another entity (the managed entity) in
exchange for:
(A) a management fee; and
(B) reimbursement of specied costs incurred in the
conduct of the active trade or business of the managed entity.
(4) Natural person--A human being or the estate of a human
being. The term does not include a purely legal entity given recogni-
tion as the possessor of rights, privileges, or responsibilities, such as a
corporation, limited liability company, partnership, or trust.
(5) Net distributive income--The net amount of income,
gain, deduction, or loss relating to a pass-through entity or disregarded
entity reportable to the owners for the tax year of the entity.
(6) Small employer--An entity dened in Insurance Code,
§1501.002.
(7) Staff leasing services company--A business entity that
offers staff leasing services as that term is dened by Labor Code,
§91.001, or temporary employment service as that term is dened by
Labor Code, §93.001.
(8) Undocumented worker--A person who is not lawfully
entitled to be present and employed in the United States.
(9) Wages and cash compensation--
(A) the amount entered in the Medicare wages and tips
box of Internal Revenue Service Form W-2 or any subsequent form
with a different number or designation that substantially provides the
same information;
(B) the amount of net distributive income from one of
the following entities to partners or owners during the accounting pe-
riod but only if the person receiving the amount is a natural person:
(i) taxable entities treated as partnerships for federal
income tax purposes;
(ii) limited liability companies and corporations
treated as S corporations for federal income tax purposes; and
(iii) limited liability companies treated as sole pro-
prietorships for federal income tax purposes;
(C) stock awards and stock options deducted for federal
income tax purposes, to the extent not included in subparagraph (A) of
this paragraph.
(c) Compensation. Subject to Tax Code, §171.1014, a taxable
entity that elects to subtract compensation for the purpose of computing
its taxable margin under Tax Code, §171.101, may subtract an amount
equal to:
(1) subject to subsection (d) of this section, all wages and
cash compensation paid by a taxable entity to its ofcers, directors,
owners, partners and employees. The taxable entity cannot subtract
more than $300,000, or the amount determined under Tax Code,
§171.006, for any one person in wages and cash compensation it
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determines under Tax Code, §171.101. See §3.590 of this title (relating
to Margin: Combined Reporting); and
(2) subject to subsection (e) of this section, the cost of all
benets the taxable entity provides to its ofcers, directors, owners,
partners, and employees;
(d) Compensation- excluded items. Compensation does not
include:
(1) payments to independent contractors on Forms 1099;
(2) exclusions from revenue. See §3.587 of this title (relat-
ing to Margin: Total Revenue). Compensation related to any revenue
excluded from total revenue may not be included in the determination
of compensation. Compensation must be allocated between included
and excluded revenue on a reasonable basis;
(3) an employer’s share of payroll taxes;
(4) wages or cash compensation paid to an employee
whose primary employment is directly associated with the operation
of a facility that is located on property owned or leased by the federal
government, and managed or operated primarily to house members of
the armed forces of the United States. See §3.587 of this title; and
(5) wages or cash compensation paid to undocumented
workers.
(e) Benets. A taxable entity is allowed to subtract the cost of
all benets to the extent deductible for federal income tax purposes that
it provides to its ofcers, directors, owners, partners, and employees.
(1) The term "benets" includes employer contributions
made to:
(A) employees’ health savings accounts;
(B) health care (for example, this would include contri-
butions to the cost of health insurance);
(C) retirement; and
(D) workers’ compensation.
(2) The term "benets" does not include the following:
(A) amounts included in the denition of wages and
cash compensation;
(B) discounts on the price of the taxable entity’s mer-
chandise or services sold to the taxpayer’s employees, ofcers, or di-
rectors, partners, or owners that are not available to other customers;
(C) payroll taxes. (For example, "payroll taxes" would
include payments to state and federal unemployment compensation
funds and payments under the Federal Insurance Contributions Act,
Chapter 21 of Subtitle C of the Internal Revenue Code, §§3101 - 3128,
the Railroad Retirement Tax Act, Chapter 22 of Subtitle C of the Inter-
nal Revenue Code, §§3201 - 3233); and
(D) working condition amounts provided so employees
can perform their jobs. (Examples of working condition benets in-
clude an employee’s use of a company car for business, job-related
education provided to an employee, and travel reimbursement.)
(3) The cost of benets does not include the amount paid
by an employee.
(f) Staff leasing companies. See §3.587 of this title.
(1) A staff leasing company cannot subtract the following
payments for assigned employees:
(A) wages and cash compensation;
(B) payroll taxes; and
(C) employee benets including workers’ compensa-
tion.
(2) A client company can subtract the following amounts
for assigned employees:
(A) wages and cash compensation; and
(B) benets.
(3) A client company cannot subtract the following:
(A) an administrative fee; and
(B) other costs.
(4) A staff leasing company shall determine compensation
only for the taxable entity’s own employees who are not assigned em-
ployees.
(g) Management company. See §3.587 of this title.
(1) A taxable entity that is a management company may
not include as wages and cash compensation any amounts reimbursed
by a managed entity.
(2) A taxable entity that is a managed entity may subtract
wages and cash compensation that are reimbursed to the management
company.
(3) A management company shall determine compensation
for only those wages and compensation payments that are not reim-
bursed by a managed entity.
(h) Small employers. This subsection applies to a taxable en-
tity that is a small employer and that has not provided health care bene-
ts to any of its employees in the calendar year preceding the beginning
date of its reporting period. Subject to Tax Code, §171.1014, a taxable
entity to which this subsection applies that elects to subtract compen-
sation for the purpose of computing its taxable margin under Tax Code,
§171.101, may subtract the following health care benets:
(1) amounts as provided under subsection (c) of this sec-
tion;
(2) for the rst 12-month period on which margin is based
and in which the taxable entity provides health care benets to all of
its employees, an additional amount equal to 50% of the cost of health
care benets provided to its employees for that period; and
(3) for the second 12-month period on which margin is
based and in which the taxable entity provides health care benets to
all of its employees, an additional amount equal to 25% of the cost of
health care benets provided to its employees for that period.
(4) The term "provide" does not include amounts paid by
the employee, ofcer, director, etc.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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34 TAC §3.590
The Comptroller of Public Accounts (Comptroller) proposes
new §3.590, concerning Margin: Combined Reporting. This
proposed new section implements House Bill 3, 79th Legisla-
ture, Third Called Special Session, 2006 and House Bill 3928,
80th Legislature, 2007, which revise the franchise tax. This new
section establishes guidelines for combined reporting under
Tax Code, Chapter 171. Subsection (a) provides that this new
section only applies to franchise tax reports due on or after
January 1, 2008. Subsection (b) denes words and terms used
in the new section. Subsection (c) provides for mandatory
combined reporting. Subsection (d) provides general rules
for determining combined taxable margin and apportionment.
Subsection (e) provides general rules describing the reporting
entity’s responsibilities. Subsection (f) provides general rules
for determining the accounting period of the combined group.
Subsection (g) addresses the liability for tax, interest, and
penalty of the combined group and its members. Subsection (h)
provides general rules for the calculation of credits. Subsection
(i) provides general rules for calculating the tax rate.
John Heleman, Chief Revenue Estimator, has determined that,
for the rst ve-year period the proposed new rule will be in ef-
fect, there will be no signicant revenue impact on the state or
units of local government.
Mr. Heleman also has determined that, for each year of the rst
ve years the proposed new rule is in effect, the public benet
anticipated as a result of enforcing the new rule will be in provid-
ing guidance to businesses subject to the franchise tax regard-
ing combined reporting under Tax Code, Chapter 171. This new
rule is adopted under Tax Code, Title 2, and does not require a
statement of scal implications for small businesses. There is
no signicant anticipated economic cost to individuals who are
required to comply with the proposed new rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This new rule is proposed under Tax Code, §111.002, which pro-
vides the Comptroller with the authority to prescribe, adopt, and
enforce rules relating to the administration and enforcement of
the provisions of Tax Code, Title 2.
The proposed new section implements Tax Code, §§171.0001,
171.0002, 171.002, 171.101, 171.1011, 171.1014, 171.1016,
171.103, 171.105, 171.1055, and 171.0021.
§3.590. Margin: Combined Reporting.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Afliated group--Entities in which a controlling inter-
est is owned by a common owner or owners, either corporate or non-
corporate, or by one or more of the member entities.
(2) Combined group--Taxable entities that are part of an
afliated group engaged in a unitary business and that are required to
le a combined group report under Tax Code, §171.1014.
(A) A combined group may not include a taxable entity
that conducts business outside the United States if 80% or more of the
taxable entity’s property and payroll are assigned to locations outside
the United States. The combined group may not include a taxable entity
that conducts business outside the United States and has no property or
payroll if 80% or more of the taxable entity’s gross receipts are assigned
to locations outside the United States. See Tax Code, §171.1014.
(B) A combined group may not include an exempt en-
tity.
(C) A combined group must include eligible entities
even if those entities do not have nexus as described in §3.586 of this
title (relating to Margin: Nexus).
(D) Pass-through entities (including partnerships), lim-
ited liability companies taxed as partnerships under federal law, limited
liability companies that are disregarded under federal law, and S cor-
porations must be included in a combined group.
(E) Insurance companies that pay gross premiums tax
are not included in a combined group.
(F) Passive entities are not included in the combined
group; however, the pro rata share of net income from a passive en-
tity shall be included in total revenue to the extent it was not generated
by the margin of another taxable entity.
(3) Combined group report--A report that includes the
business of all members of the combined group.
(4) Controlling interest.
(A) Controlling interest means:
(i) for a corporation, either more than 50%, owned
directly or indirectly, of the total combined voting power of all classes
of stock of the corporation, or more than 50% owned directly or in-
directly, of the benecial ownership interest in the voting stock of the
corporation;
(ii) for a partnership, association, trust or other en-
tity other than a limited liability company, more than 50%, owned di-
rectly or indirectly, of the capital, prots, or benecial interest in the
partnership, association, trust, or other entity;
(iii) for a limited liability company, either more than
50%, owned directly or indirectly, of the total membership interest of
the limited liability company or more than 50%, owned directly or in-
directly, of the benecial ownership interest in the membership interest
of the limited liability company.
(B) Examples are as follows:
(i) Corporation A owns 10% of Corporation C and
60% of Corporation B, which owns 41% of Corporation C. Corporation
A has a controlling interest in Corporation B and a controlling interest
in Corporation C of 51% of stock ownership because it has control of
the stock owned by Corporation B.
(ii) Corporation A owns 10% of Limited Liability
Company C and 15% of Corporation B, which owns 90% of Limited
Liability Company C. Corporation A does not have controlling interest
in Limited Liability Company C and does not have a controlling interest
in Corporation B. Corporation B has a controlling interest in Limited
Liability Company C.
(iii) Individual A owns 100% of 10 corporations,
each of which owns 10% of Partnership B. Individual A has a control-
ling interest in each of the ten corporations and in Partnership B.
(iv) Corporation A holds a 70% interest in Partner-
ship B that owns 60% of Limited Liability Company C. Corporation A
owns the remaining 40% of Limited Liability Company C. Corporation
A owns a controlling interest in Partnership B and a 100% controlling
interest in Limited Liability Company C.
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(C) In addition to the foregoing tests, the comptroller
may consider any other circumstance that tends to demonstrate that the
more than 50% direct or indirect common ownership test was met or
was not met.
(D) Membership in an afliated group shall be treated
as terminated in any year, or fraction thereof, in which the conditions
listed in this paragraph are not met, except as follows:
(i) when an afliate is sold, exchanged, or otherwise
disposed of, the membership in an afliated group shall not be termi-
nated if the requirements of this paragraph are again met immediately
after the sale, exchange, or disposition.
(ii) The comptroller may treat the afliated group as
remaining in place if the conditions of this paragraph are again met
within a period not to exceed two years.
(5) Reporting entity--The combined group’s choice of an
entity that is the parent entity, if it is part of the unitary business, or the
entity that:
(A) is included within the combined group;
(B) is subject to Texas’ taxing jurisdiction; and
(C) has the greatest Texas business activity during the
rst year that a combined report is required to be led, as measured by
the total revenue for that year.
(6) Unitary business--A single economic enterprise that is
made up of separate parts of a single entity or of a commonly controlled
group of entities that are sufciently interdependent, integrated, and in-
terrelated through their activities so as to provide a synergy and mutual
benet that produces a sharing or exchange of value among them and a
signicant ow of value to the separate parts. In determining whether
a unitary business exists, the comptroller shall consider any relevant
factor, including:
(A) whether:
(i) activities of the group members are in the same
general line, such as manufacturing, wholesaling, retailing of tangible
personal property, transportation, or nance;
(ii) the activities of the group members are steps in
a vertically structured enterprise or process, such as the steps involved
in the production of natural resources, including exploration, mining,
rening, and marketing; or
(iii) the members are functionally integrated
through the exercise of strong centralized management, such as
authority over purchasing, nancing, product line, personnel, and
marketing.
(B) Other factors. In addition, the comptroller may
consider other factors that may be applicable, including guidelines
in Supreme Court decisions that presume activities are unitary. All
afliated entities are presumed to be engaged in a unitary business.
(C) New entities. When a taxable entity acquires an-
other entity, a presumption exists for nding a unitary relationship dur-
ing the rst reporting period. Any party may rebut such presumption by
proving that the taxable entities were not unitary. If such presumption
is rebutted, then the taxable entities shall not be considered unitary as
of the date of acquisition. When a taxable entity forms another taxable
entity, a unitary relationship exists as of the date of formation unless
the business is not unitary on a longer term basis.
(D) Non-arm’s-length prices. Goods or services or both
are supplied at non-arm’s length prices between or among entities. Ex-
istence of arm’s-length pricing between entities, however, does not in-
dicate lack of unity.
(E) Existence of benets from joint, shared or common
activity. A discount, cost-saving or other benet can be shown to re-
sult from joint purchases, leaseholds, or other forms of joint, shared or
common activities between or among entities.
(F) Relationships of joint, shared or common activity to
income-producing operations. In determining whether a joint, shared,
or common activity is indicative of a unitary relationship, considera-
tion shall be given to the nature and character of the basic operations
of each entity. Such consideration shall include, but not be limited to,
the entity’s sources of supply, its goods or services produced or sold,
its labor force, and market to determine whether the joint, shared, or
common activity is directly benecial to, related to, or reasonably nec-
essary to the income-producing activities of the unitary business.
(G) Holding entities. The tests for a unitary business
established by this section apply in determining whether a holding en-
tity is included or excluded from a unitary business.
(7) United States--The 50 states and the District of Colum-
bia. It also includes the territorial waters of the United States and the
seabed and subsoil of those submarine areas that are adjacent to the ter-
ritorial waters of the United States and over which the United States has
exclusive rights, in accordance with international law, with respect to
the exploration for or exploitation of natural resources. It also includes
the possessions and territories of the United States and the Common-
wealth of Puerto Rico.
(c) Mandatory combined reporting. A combined group shall
le a combined group report. A taxable entity that is not included in
a combined report must le a separate report if it is doing business in
Texas or is chartered or organized in Texas.
(d) Determination of combined taxable margin and apportion-
ment.
(1) Combined total revenue. A combined group shall de-
termine its total revenue by:
(A) determining the total revenue of each of its mem-
bers as provided by Tax Code, §171.1011 (including §171.1011(h)) and
§3.587 of this title (relating to Margin: Total Revenue) as if the mem-
ber were an individual taxable entity without regard to the $300,000
limitation provided by Tax Code, §171.002(d)(2);
(B) adding the total revenues of the members deter-
mined under subparagraph (A) of this paragraph, together; and
(C) subtracting, to the extent included under Tax Code,
§§171.1011(c)(1)(A), (c)(2)(A), or (c)(3), items of total revenue re-
ceived from a member of the combined group.
(2) Combined cost of goods sold.
(A) A combined group that elects to subtract costs of
goods sold shall determine that amount by:
(i) determining the cost of goods sold for each of its
members as provided by Tax Code, §171.1012 and §3.588 of this title
(relating to Margin: Cost of Goods Sold) as if the member were an
individual taxable entity;
(ii) adding the amounts of cost of goods sold deter-
mined under clause (i) of this subparagraph, together; and
(iii) subtracting from the amount determined under
clause (ii) of this subparagraph, any cost of goods sold amounts paid
from one member of the combined group to another member of the
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combined group, but only to the extent the corresponding item of total
revenue was subtracted under paragraph (1)(C) of this subsection.
(B) A member of a combined group may claim as cost
of goods sold those costs that qualify under Tax Code, §171.1012, if the
goods for which the costs are incurred are owned by another member
of the combined group.
(3) Combined compensation. The combined group may
not subtract in relation to a person, more than $300,000 or the amount
determined under Tax Code, §171.006, per 12-month period on which
margin is based. A combined group that elects to subtract compensa-
tion shall determine that amount by:
(A) determining the compensation for each of its mem-
bers as provided by Tax Code, §171.1013 and §3.589 of this title (relat-
ing to Margin: Compensation), as if each member were an individual
taxable entity;
(B) adding the amounts of compensation determined
under subparagraph (A) of this paragraph, together; and
(C) subtracting from the amount determined under sub-
paragraph (B) of this paragraph, any compensation amounts paid from
one member of the combined group to another member of the combined
group, but only to the extent the corresponding item of total revenue
was subtracted under paragraph (1)(C) of this subsection.
(4) Combined groups are eligible to elect to use the 70% of
revenue calculation pursuant to Tax Code, §171.101 or E-Z Computa-
tion pursuant to Tax Code, §171.1016. See §3.584 of this title (relating
to Margin: Reports and Payments).
(5) Combined apportionment.
(A) The combined margin is generally apportioned in
accordance with §3.591 of this title (relating to Margin: Apportion-
ment).
(B) Except as provided in subparagraph (D) of this
paragraph, gross receipts from business done in this state of taxable
entities without nexus individually in Texas are excluded from the
numerator. For example, sales of tangible personal property shipped
into Texas by a member that does not have nexus individually are
excluded from the numerator but are included in the denominator.
(C) For each member of the combined group that does
not have nexus individually with this state for purpose of taxation, a
combined group must, for information purposes only, include in a re-
port led under Tax Code, §171.201 or §171.202:
(i) the gross receipts computed under subparagraph
(B) of this paragraph; and
(ii) the gross receipts computed under subparagraph
(B) of this paragraph, that are subject to taxation in another state under
a throwback law or regulation.
(D) Receipts derived from transactions between
members of a combined group that are excluded under Tax Code,
§171.1014(c)(3), may not be included in the numerator or denominator
of the apportionment factor. However, the numerator of the appor-
tionment factor will include certain sales of tangible personal property
made to third party purchasers if the tangible personal property is
ultimately delivered to a purchaser in Texas without substantial modi-
cation. See Tax Code, §171.1055(b). For example, drop shipments
made from a Texas location to a Texas purchaser would be included in
Texas receipts based on the amount billed to the third party purchaser
if the seller is a member of the combined group and the seller does not
have nexus.
(6) When reporting revenue, cost of goods sold, compen-
sation and gross receipts for a disregarded entity, that information may
be included with the parent; in that event, both entities are presumed to
have nexus.
(e) Reporting entity.
(1) Responsibilities of the reporting entity.
(A) Access to records. In addition to the information
required to be included in the combined group report, upon request
of the comptroller, the reporting entity shall provide access to the tax,
nancial, and nonnancial records of entities that do and do not have
Texas nexus.
(B) Filing. The reporting entity shall le a combined
group report on behalf of the combined group together with all reports
and schedules required by the comptroller. Any elections required by
the combined group are binding on all members of the group.
(C) Payment. The reporting entity shall timely remit
to the comptroller the Texas franchise tax imposed on the combined
group.
(D) Authority. The reporting entity may le refund
claims, give waivers and execute agreements on behalf of the com-
bined group. Any refund claim, waiver given, agreement or any
document executed, shall be considered as having also been given or
executed by each combined group member.
(2) Notices. Notices mailed to the reporting entity shall
be deemed to have been mailed to each of the taxable entities in the
combined group.
(3) Change in the reporting entity. The reporting entity
shall change only when the entity (other than the parent) is no longer
subject to Texas’ jurisdiction to tax or the reporting entity is no longer
a member of the combined group, at which time the combined group
shall designate another entity that qualies as its reporting entity and
notify the comptroller of the designation.
(f) Accounting period of the combined group.
(1) The combined group’s accounting period is determined
as follows:
(A) if two or more members of a combined group le a
federal consolidated return, the group’s accounting period is the federal
taxable period of the federal consolidated group;
(B) in all other instances, the accounting period is the
federal taxable period of the reporting entity.
(2) Members with different accounting periods. If the fed-
eral taxable period of a member differs from the federal taxable period
of the combined group, the reporting entity will determine the portion
of that member’s revenue, cost of goods sold, compensation, etc. to be
included by preparing a separate income statement prepared from the
books and records for the months included in the group’s accounting
period.
(g) Liability for the combined tax, penalty, and interest. The
members of a combined group shall be jointly and severally liable for
the combined tax reported on the combined report and any interest and
penalty.
(h) Credits. Unless otherwise provided by law, credits gener-
ally may be applied against the combined tax liability of the combined
group. See §3.594 of this title (relating to Margin: Temporary Credit
for Business Loss Carryforwards), and §3.593 of this title (relating to
Margin: Credits).
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(i) Tax rate. The determination of whether a combined group
entity is eligible for a lower tax rate or to le a no tax due report under
Tax Code, §§171.002, 171.0021, and 171.1016, shall be made for the
combined group as a whole after eliminations. See §3.584 of this title
(relating to Reports and Payments).
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
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34 TAC §3.591
The Comptroller of Public Accounts (Comptroller) proposes new
§3.591, concerning Margin: Apportionment. This proposed new
section implements House Bill 3, 79th Legislature, Third Called
Special Session, 2006, and House Bill 3928, 80th Legislature,
2007, which revise the franchise tax. This new section estab-
lishes guidelines for the apportionment of the franchise tax. Sub-
section (a) provides that this new section only applies to fran-
chise tax reports originally due on or after January 1, 2008. Sub-
section (b) denes words and terms used in the new section.
Subsection (c) gives the apportionment formula and provides
for two exceptions to the apportionment formula. Subsection
(d) provides general rules for reporting gross receipts. Subsec-
tion (e) provides the treatment of specic items of revenue in the
computation of gross receipts. Subsection (f) provides guidance
in the determination of gross receipts for natural gas production.
John Heleman, Chief Revenue Estimator, has determined that,
for the rst ve-year period the proposed new rule will be in ef-
fect, there will be no signicant revenue impact on the state or
units of local government.
Mr. Heleman also has determined that, for each year of the rst
ve years the proposed new rule is in effect, the public benet
anticipated as a result of enforcing the new rule will be in provid-
ing guidance to businesses subject to the franchise tax regard-
ing the apportionment of margin under Tax Code, Chapter 171.
This new rule is proposed under Tax Code, Title 2, and does not
require a statement of scal implications for small businesses.
There is no signicant anticipated economic cost to individuals
who are required to comply with the proposed new rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This new rule is proposed under Tax Code, §111.002, which pro-
vides the Comptroller with the authority to prescribe, adopt, and
enforce rules relating to the administration and enforcement of
the provisions of Tax Code, Title 2.
The proposed new section implements Tax Code, §§171.103,
171.1055, 171.106, and 171.1121.
§3.591. Margin: Apportionment.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Capital asset--Any asset, other than an investment, that
is held for use in the production of income, and that is subject to depre-
ciation, depletion or amortization.
(2) Commercial domicile--The principal place from which
the trade or business of the entity is directed.
(3) Employee retirement plan--A plan or other arrange-
ment that qualies under Internal Revenue Code (IRC), §401(a), or
that satises the requirement of IRC, §403, or a government plan
described in IRC, §414(d).
(4) Gross receipts--The amount determined as total rev-
enue under §3.587 of this title (relating to Margin: Total Revenue),
except for a taxable entity taking a deduction for uncompensated care
or pro bono services or an entity for which subsection (e)(17) of this
section, applies.
(5) Internal Revenue Code--The Internal Revenue Code
of 1986 in effect for a specied tax year as provided by Tax Code,
§171.0001.
(6) Investment--Any non-cash asset that is not a capital as-
set.
(7) Legal domicile--The legal domicile of a corporation or
limited liability company is its state of formation. The legal domicile of
a partnership, trust, or joint venture is the principal place of business of
the partnership, trust, or joint venture. The principal place of business
of a partnership, trust, or joint venture is the location of its day-to-day
operations. If the day-to-day operations are conducted equally or fairly
evenly in more than one state, then the principal place of business is the
commercial domicile.
(8) Location of payor--The legal domicile of the payor.
(9) Security--An instrument dened under Internal
Revenue Code, §475(c)(2), and includes instruments described by
§475(e)(2)(B), (C), and (D) of that code.
(10) Tax reporting period--The period upon which the tax
is based under Tax Code, §171.1532 or §171.0011.
(11) Taxable entity--Any entity upon which tax is imposed
under Tax Code, §171.0002(a) and not specically excluded under Tax
Code, §171.0002(b) or §171.0002(c). See also §3.581 of this title (re-
lating to Taxable and Non-Taxable Entities).
(c) Apportionment formula. A taxable entity’s margin is ap-
portioned to this state to determine the amount of franchise tax due by
multiplying the taxable entity’s margin by a fraction, the numerator of
which is the taxable entity’s gross receipts from business done in this
state and the denominator of which is the taxable entity’s gross receipts
from its entire business except as provided by this subsection.
(1) Taxable entities that have margin that is derived, di-
rectly or indirectly from the sale of services to or on behalf of a regu-
lated investment company as dened by IRC, §851(a), should refer to
Tax Code, §171.106(b), relating to the apportionment of gross receipts
from services for regulated investment companies.
(2) Taxable entities that have margin that is derived, di-
rectly or indirectly, from the sale of management, administration, or
investment services to an employee retirement plan, as dened in sub-
section (b)(3) of this section, should refer to Tax Code, §171.106(c),
relating to the apportionment of gross receipts from services for em-
ployee retirement plans.
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(d) General rules for reporting gross receipts.
(1) A taxable entity that les an annual report must report
gross receipts based on the business done by the taxable entity begin-
ning with the day after the date upon which the previous report was
based, and ending with the last accounting period ending date for fed-
eral income tax purposes ending in the calendar year before the calen-
dar year in which the report is originally due. If the taxable entity has
not led a previous report and must le an annual report, see §3.595 of
this title (relating to Margin: Transition Rule).
(2) A taxable entity that les an initial report must report
gross receipts based on its activities commencing with the beginning
date, as described in §3.584 of this title (relating to Margin: Reports
and Payments), and ending on the last accounting period ending date for
federal income tax purposes that is at least 60 days before the original
due date of the initial report.
(3) Taxable entities that are members of an afliated group
that are part of a unitary business must le a combined franchise tax
report. See §3.590 of this title (relating to Margin: Combined Report-
ing), for determining gross receipts for a combined report.
(4) When a taxable entity computes gross receipts for ap-
portionment, the taxable entity is deemed to have elected to use the
same methods that the taxable entity used in ling its federal income
tax return.
(5) Any item of revenue that is excluded from total rev-
enue under Texas law or United States law is excluded from gross re-
ceipts everywhere and gross receipts in Texas as provided by Tax Code,
§171.1055(a). For example, any amount that is excluded from total rev-
enue under the Internal Revenue Code, §78 or §§951 - 964, is excluded
from gross receipts.
(6) A taxable entity that uses a 52-53 week accounting year
end and that has an accounting year that ends during the rst four days
of January of the year in which the report is originally due may use the
preceding December 31 as the date through which margin is computed.
(7) Any item of allocated revenue excluded under
§3.587(c)(9) of this title (relating to Margin: Total Revenue) is
excluded from Texas receipts and receipts everywhere.
(e) Treatment of specic items in the computation of gross re-
ceipts.
(1) Bad debt recoveries. Bad debt recoveries are gross re-
ceipts.
(2) Capital assets and investments. Except as provided by
paragraph (17) of this subsection, net gains and losses from sales of in-
vestments and capital assets must be added to determine the total gross
receipts from such transactions. If both Texas and out-of-state sales
have occurred, then a separate calculation of net gains and losses on
Texas sales must be made. If the combination of net gains and losses
results in a net loss, the taxable entity should net the loss against other
receipts, but not below zero. In no instance shall the apportionment
factor be greater than 1. Net gain on sales of intangibles held as capital
assets or investments is apportioned to the location of the payor. Exam-
ples of intangibles include, but are not limited to, stocks, bonds, com-
modities, futures contracts, patents, copyrights, licenses, trademarks,
franchises, goodwill, and general receivable rights.
(3) Computer software services and programs. Gross re-
ceipts from the sale of computer software services are apportioned to
the location where the services are performed. Gross receipts from the
sale of a computer program (as the term "computer program" is dened
in §3.308 of this title (relating to Computers - Hardware, Software, Ser-
vices and Sales)), are receipts from the sale of an intangible asset and
are apportioned to the legal domicile of the payor.
(4) Condemnation. Revenues from condemnation that re-
sult from the taking of property are gross receipts that are apportioned
based on the location of the property condemned.
(5) Debt forgiveness. If a creditor releases any part of a
debt, then the amount that the creditor forgives is a gross receipt that is
apportioned to the legal domicile of the creditor.
(6) Debt retirement. Revenues from the retirement of a tax-
able entity’s own indebtedness, such as through the taxable entity’s pur-
chase of its own bonds at a discount, are gross receipts that are appor-
tioned to the taxable entity’s legal domicile. The indebtedness is treated
as an investment in the determination of the amount of gross receipts.
(7) Deemed sales of assets under Internal Revenue Code,
§338. Amounts that are deemed to have been received by the target
taxable entity are treated as sales of assets by the target taxable entity,
and are apportioned according to rules that otherwise apply to sales of
such assets under Tax Code, Chapter 171, or this section. For the pur-
poses of this paragraph, the purchaser of the target’s stock is considered
the purchaser of the assets.
(8) Dividends and/or interest.
(A) Dividends that are recognized as a reduction of the
taxpayer’s basis in stock of a taxable entity for federal income tax pur-
poses are not gross receipts. Dividends that exceed the taxpayer’s basis
for federal income tax purposes that are recognized as a capital gain are
treated as dividends for apportionment purposes.
(B) The following are excluded from Texas receipts and
receipts everywhere:
(i) dividends from a subsidiary, associate, or afli-
ated taxable entity that does not transact a substantial portion of its
business or regularly maintain a substantial portion of its assets in the
United States;
(ii) schedule C special deductions that are excluded
from total revenue;
(iii) dividends and/or interest on federal obligations
that are excluded from total revenue;
(iv) interest that is exempt from federal income tax.
(C) Dividends and/or interest that are received from a
corporation or other sources are apportioned to the legal domicile of
the payor.
(D) Dividends and/or interest that are received from a
national bank are apportioned to Texas if the bank’s principal place of
business is located in Texas. Dividends and/or interest that are received
from a bank that is organized under the Texas Banking Code are appor-
tioned to Texas.
(E) A banking corporation may exclude from its Texas
gross receipts interest that is earned on federal funds and interest that
is earned on securities that are sold under an agreement to repurchase
and that are held in a correspondent bank that is domiciled in Texas, but
the banking corporation must include the interest in its gross receipts
everywhere.
(9) Exchanges of property. Exchanges of property are in-
cluded in gross receipts to the extent that the exchange is recognized as
a taxable transaction for federal income tax purposes. Such exchange
must be included in receipts based on the gross exchange value, unless
otherwise required under this section.
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(10) Federal enclave. All revenues from a taxable entity’s
sales, services, leases, or other business activities that are transacted
on a federal enclave that is located in Texas are Texas receipts, unless
otherwise excepted by this section.
(11) Insurance proceeds.
(A) Business interruption insurance proceeds are gross
receipts when the proceeds are intended to replace lost prots. Such
receipts are apportioned to the legal domicile of the payor of the pro-
ceeds.
(B) Revenues from re and casualty insurance proceeds
are apportioned to the location of the damaged or destroyed property.
(12) Internet access fee. A fee that is charged to obtain
access to the World Wide Web in Texas is a Texas gross receipt.
(13) Leases and subleases.
(A) Revenues from the lease or sublease (or rental or
subrental) of real property are apportioned to the location of the prop-
erty.
(B) Revenues from the lease or sublease (or rental or
subrental) of tangible personal property are apportioned to the location
of the property. If the property is used both inside and outside Texas,
then lease payments are apportioned based on the number of days that
the tangible personal property was used in Texas divided by the number
of days that the tangible personal property was used everywhere. If the
amount of revenue that is due under the lease is based on mileage, then
the lease payments are apportioned based on the number of miles in
Texas divided by the number of miles everywhere.
(C) If a lump sum is charged for leased or subleased (or
rented or subrented) property that is located both inside and outside
Texas, then the allocation of such revenue is based on the rental value
of each item of property.
(D) Revenues from the lease or sublease (or rental or
subrental) of a vessel that engages in commerce are apportioned to
Texas based on the number of days that the vessel is engaged in com-
merce in Texas waters divided by the number of days that the vessel is
engaged in commerce everywhere.
(E) If a lease, sublease, rental, or subrental of real prop-
erty or tangible personal property is treated as a sale for federal income
tax purposes, then the receipts from the transaction are apportioned in
the same manner as a sale. Any portion of the payments that the con-
tracting parties designate as interest is interest receipts.
(14) Litigation awards. Revenues that are realized from lit-
igation awards are gross receipts that are apportioned to the legal domi-
cile of the payor of the proceeds; however, if the litigation awards are
intended to replace receipts for which another apportionment rule is
provided in this section, then the apportionment must be made in accor-
dance with that rule. For example, if a taxable entity sues a Delaware
corporation to recover on a sale of goods delivered to a Texas location,
then a judgment for the amount of that sale would not convert the re-
ceipts from Texas receipts to Delaware receipts. See subsection (f) of
this section, for the apportionment of receipts from judgments, com-
promises, or settlements that relate to natural gas production.
(15) Loan servicing of real property. Receipts from the ser-
vicing of loans secured by real property are apportioned to the location
of the collateral real property that secures the loan being serviced.
(16) Loans and securities. If a loan or security is treated as
inventory of the seller for federal income tax purposes, the gross pro-
ceeds of the sale of that loan or security are considered gross receipts.
(17) Membership or enrollment fees paid for access to ben-
ets. Membership or enrollment fees paid for access to benets should
be considered gross receipts from the sale of an intangible asset and are
apportioned to the legal domicile of the payor.
(18) Mixed transactions. If a transaction involves elements
of both a sale of tangible personal property and a service, but no docu-
mentation exists to show separate charges for the sale and service ele-
ments, then the comptroller may determine the amounts that are alloca-
ble to each element based on fair values or on any available evidence.
(19) Net distributive income. The net distributive income
from a passive entity that is included in total revenue is apportioned to
the principal place of business of the passive entity.
(20) Newspapers or magazines. All advertising revenues
of a newspaper or magazine, including those revenues derived from
out-of-state advertisements, are apportioned to Texas based on the
number of newspapers or magazines distributed in Texas. All other
receipts must be apportioned in accordance with the apportionment
rules otherwise set out in this section. For example, receipts from sales
of newspapers or magazines are to be apportioned based on paragraph
(30) of this subsection.
(21) Patents, copyrights, and other intangible rights.
(A) Receipts from the use of intangibles.
(i) Revenues from a patent royalty are included in
Texas receipts to the extent that the patent is utilized in production,
fabrication, manufacturing, or other processing in Texas.
(ii) Revenues from a copyright royalty are included
in Texas receipts to the extent that the copyright is utilized in printing
or other publication in Texas.
(iii) Revenues that the owner of a trademark, fran-
chise, or license receives are included as Texas receipts to the extent
the trademark, franchise or license is used in Texas.
(iv) Royalties from an afliated taxable entity that
does not transact a substantial portion of its business or regularly main-
tain a substantial portion of its assets in the United States are excluded
from Texas receipts and receipts everywhere.
(B) Sales. Sales of intangibles are apportioned based
on the location of payor.
(22) Radio/television. All advertising revenues of a radio
or television station that broadcasts or transmits from a location in
Texas constitute Texas receipts, even though some of the listening or
viewing audiences are located outside Texas. All other receipts must
be apportioned in accordance with the apportionment rules otherwise
set out in this section.
(23) Real property. Revenues from the sale, lease, rental,
sublease, or subrental of real property, including mineral interests, are
apportioned to the location of the property. Royalties from mineral
interests are considered revenue from real property.
(24) Sales taxes. State or local sales taxes that are imposed
on the customer, but are collected by a seller are not gross receipts of the
seller. However, discounts that a seller is allowed to take in remittance
of the collected sales tax are gross receipts to the seller.
(25) Securities. Receipts from the sale of securities are ap-
portioned based on the location of the payor. If securities are sold
through an exchange, and the buyer cannot be identied, then 7.9%
of the revenue is a Texas receipt.
(26) Services. Receipts from a service are apportioned to
the location where the service is performed. If services are performed
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both inside and outside Texas, then such receipts are Texas receipts on
the basis of the fair value of the services that are rendered in Texas.
(A) Taxable entities that have margin that is derived,
directly or indirectly, from the sale of services to or on behalf of a
regulated investment company should refer to Tax Code, §171.106(b),
for information on apportionment of such margin.
(B) Taxable entities that have margin that is derived, di-
rectly or indirectly, from the sale of management, administration, or
investment services to an employee retirement plan as dened in sub-
section (b)(3) of this section, should refer to the Tax Code, §171.106(c),
for information on apportionment of such margin.
(C) Receipts from services that a defense readjustment
project performs in a defense economic readjustment zone are not
Texas receipts.
(27) Services procurement. Revenues for the procurement
of services are apportioned to the place where the service procurement
is performed.
(28) Subsidies or grants. Proceeds of subsidies or grants
that a taxable entity receives from a governmental agency are gross re-
ceipts, except when the funds are required to be expended dollar-for-
dollar (i.e., passed through) to third parties on behalf of the agency.
Receipts from a governmental subsidy or grant are apportioned in the
same manner as the item to which the subsidy or grant was attributed.
For example, if a taxable entity qualies for a grant to conduct research
for the government, then the receipts from that grant are receipts from
a service and are apportioned to the location where the research is per-
formed.
(29) Tangible personal property. Examples of transactions
that involve the sale of tangible personal property and result in Texas
receipts include, but are not limited to, the following:
(A) the sale of tangible personal property that is deliv-
ered in Texas to a purchaser. Delivery is complete upon transfer of
possession or control of the property to the purchaser, an employee of
the purchaser, or transportation vehicles that the purchaser leases or
owns. FOB point, location of title passage, and other conditions of the
sale are not relevant to the determination of Texas gross receipts;
(B) the sale of tangible personal property that is deliv-
ered in Texas to an employee or transportation agent of an out-of-state
purchaser. A carrier is an employee or agent of the purchaser if the car-
rier is under the supervision and control of the purchaser with respect
to the manner in which goods are transported;
(C) the sale and delivery in Texas of tangible personal
property that is loaded into a barge, truck, airplane, vessel, tanker, or
any other means of conveyance that the purchaser of the property leases
and controls or owns. The sale of tangible personal property that is
delivered in Texas to an independent contract carrier, common carrier,
or freight forwarder that a purchaser of the property hires results only
in gross receipts everywhere if the carrier transports or forwards the
property to the purchaser outside this state;
(D) the sale of tangible personal property with delivery
to a common carrier outside Texas, and shipment by that common car-
rier to a purchaser in Texas;
(E) the sale of oil or gas to an interstate pipeline com-
pany, with delivery in Texas;
(F) the sale of tangible personal property that is deliv-
ered in Texas to a warehouse or other storage facility that the purchaser
owns or leases;
(G) the sale of tangible personal property that is deliv-
ered to and stored in a warehouse or other storage facility in Texas at
the purchaser’s request, as opposed to a necessary delay in transit, even
though the property is subsequently shipped outside Texas;
(H) the drop shipment of tangible personal property in
Texas. A drop shipment is a shipment of tangible personal property
from a seller directly to a purchaser’s customer, at the request of the
purchaser, without passing through the hands of the purchaser. This
results in Texas gross receipts for the seller and the purchaser;
(30) Telephone companies.
(A) Revenues from telephone calls that both originate
and terminate in Texas are Texas receipts.
(B) Revenues from telephone calls that originate in
Texas but terminate outside of Texas or that originate outside of Texas
but terminate in Texas are excluded from Texas receipts.
(C) Revenues from telecommunication services other
than those services in subparagraph (A) or (B) of this paragraph are
Texas receipts if the services are performed in Texas. For example, a
telephone company that provides a long distance carrier access to the
telephone company’s local exchange network in Texas is performing a
service in Texas. Any fee that the telephone company charges the long
distance carrier for access to the local exchange network in Texas is a
Texas receipt regardless of whether the access is related to an interstate
call. A fee that is charged to obtain access to a local exchange network
in Texas and that is based on the duration of an interstate telephone call
may be excluded from Texas receipts.
(31) Texas waters. Revenues from transactions that occur
in Texas waters are Texas receipts. Texas waters are considered to
extend to 10.359 statute miles, or nine nautical miles, from the Texas
coastline.
(32) Transportation companies. Transportation companies
must report Texas receipts from transportation services in intrastate
commerce by:
(A) the inclusion of revenues that are derived from the
transportation of goods or passengers in intrastate commerce within
Texas; or
(B) the multiplication of total transportation receipts by
total mileage in the transportation of goods and passengers that move in
intrastate commerce within Texas divided by total mileage everywhere.
(f) Natural gas production.
(1) Revenues that a gas producer realizes from the contract
price of gas that the gas producer produces and that the purchaser takes
pursuant to the terms of sales are gross receipts and are apportioned to
Texas, if the gas is delivered in Texas.
(2) Revenues that a gas producer realizes from a pur-
chaser’s payment under a sale or purchase contract for gas to be
produced even if no gas is produced and delivered to the purchaser, are
gross receipts and are apportioned to the legal domicile of the payor.
(3) Revenues that a gas producer realizes from a pur-
chaser’s payments to terminate a gas purchase contract are gross
receipts and are apportioned to the legal domicile of the payor.
(4) Revenues that a gas producer realizes from a contract
amendment that relates to the price of the gas sold are gross receipts
from the sales of gas and are apportioned to Texas if delivery is made
to a location in Texas. Revenues that the gas producer realizes from a
contract amendment that relates to a provision other than the price of
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gas sold are gross receipts and are apportioned to the legal domicile of
the payor.
(5) Revenues that a gas producer realizes from litigation
awards for a breach of contract, reimbursements for litigation-related
expenses (e.g., documented attorney’s fees or court costs), or interest
(upon which the parties have agreed, that the records of the producer
reects, or in an amount that a court has ordered) are gross receipts and
are apportioned to the legal domicile of the payor.
(6) Revenues that a gas producer realizes from a judgment,
compromise, or settlement relating to the recovery of a contract price of
gas produced are gross receipts and are apportioned to Texas to the ex-
tent the contract specied delivery to a location in Texas. Revenues that
a gas producer realizes from a judgment, compromise, or settlement
that relates to several claims or causes of action shall be prorated based
upon the documented amounts due under the contract for each claim or
cause of action according to the records of the producer. For example,
a settlement sum of $100,000 for a pricing dispute of $25,000 and for
failure to pay for gas not taken in the amount of $225,000, would result
in receipts of $10,000 from gas sales (100,000 X 25,000/250,000) and
receipts from other business of $90,000 (100,000 X 225,000/250,000).
Records of the producer shall include, but are not limited to the follow-
ing: contracts, settlement agreements, accounting records and entries,
court pleadings and worksheets, including calculations reecting set-
tlement amounts.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.592
The Comptroller of Public Accounts proposes new §3.592, con-
cerning margin: additional tax. This section implements House
Bill 3, 79th Legislature, Third Called Session 2006 and House
Bill 3928, 80th Legislature, 2007, which revise the franchise tax.
This section establishes guidelines for computing additional tax
under Tax Code, Chapter 171. Subsection (a) provides the ef-
fective date. Subsection (b) provides the due date. Subsection
(c) provides the tax rate and period upon which the additional
tax is based. Subsections (d) and (e) refer to other sections for
more information.
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as a
result of enforcing the rule will be in providing guidance to tax-
able entities which no longer have sufcient nexus with Texas to
be subject to the franchise tax for computing and remitting addi-
tional tax under Tax Code, Chapter 171. This rule is adopted un-
der Tax Code, Title 2, and does not require a statement of scal
implications for small businesses. There is no signicant antic-
ipated economic cost to individuals who are required to comply
with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This rule is proposed under Tax Code, §111.002, which provides
the comptroller with the authority to prescribe, adopt, and en-
force rules relating to the administration and enforcement of the
provisions of Tax Code, Title 2.
The new section implements Tax Code, §171.0011.
§3.592. Margin: Additional Tax.
(a) Effective date. For reports originally due on or after Jan-
uary 1, 2008, the additional tax imposed by Tax Code, §171.0011, ap-
plies to a taxable entity which no longer has sufcient nexus with Texas
to be subject to the franchise tax. All provisions of Tax Code, Chapter
171, apply to the additional tax, unless they conict with a provision in
Tax Code, §171.0011.
(b) Due date. A nal report and payment of the additional tax
are due within 60 days after the taxable entity no longer has sufcient
nexus with Texas to be subject to the franchise tax. However, an es-
timated return and payment may need to be led and paid before a
taxable entity will receive clearance from the comptroller to terminate,
dissolve, merge, or withdraw. As long as the proper amount is paid and
an amended return, if needed, is led within 60 days after the taxable
entity terminates, dissolves, merges, or withdraws, then no penalty or
interest will be assessed.
(c) Rate and business based on. The additional tax rate is de-
termined by Tax Code, §171.002 and is applied to taxable margin for
the period from the day after the last day for which tax under Tax Code,
Chapter 171, was based on a previous report through the date the tax-
able entity no longer has sufcient nexus with Texas to be subject to
the franchise tax.
(d) Passive entities. See §3.582 of this title (relating to Margin:
Passive Entities).
(e) Combined reports. See §3.590 of this title (relating to Mar-
gin: Combined Reporting).
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.593
The Comptroller of Public Accounts proposes new §3.593, con-
cerning margin: franchise tax credits. This section implements
House Bill 3, 79th Legislature, Third Called Special Session,
2006 and House Bill 3928, 80th Legislature, 2007, which re-
vise the franchise tax. This section establishes guidelines for
the computation of franchise tax credits under Tax Code, Chap-
ter 171. Subsection (a) provides that this section only applies to
franchise tax reports originally due on or after January 1, 2008.
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Subsection (b) denes words and terms used in the section.
Subsection (c) details the requirement that a credit schedule
must be led. Subsection (d) details the tax limitations for the
credits. Subsection (e) details the carryforward and report lim-
itation for the research and development credit. Subsection (f)
details the carryforward and report limitation for the jobs creation
credit. Subsection (g) details the installment, carryforward and
report limitation for the investment credit. Subsection (h) relates
to an investment credit for certain enterprise projects and details
the calculation of the credit and the limitations.
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as
a result of enforcing the rule will be in providing guidance to
businesses subject to the franchise tax regarding the computa-
tion of franchise tax credits under Tax Code, Chapter 171. This
rule is adopted under Tax Code, Title 2, and does not require a
statement of scal implications for small businesses. There is
no signicant anticipated economic cost to individuals who are
required to comply with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This rule is proposed under Tax Code, §111.002, which provides
the comptroller with the authority to prescribe, adopt, and en-
force rules relating to the administration and enforcement of the
provisions of Tax Code, Title 2.
The new section implements Tax Code, Chapter 171, Subchap-
ter Q-1.
§3.593. Margin: Franchise Tax Credits.
(a) Effective date. The provisions of this section apply to fran-
chise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise
(1) Research and development credit--A research and de-
velopment credit established under Tax Code, Chapter 171, Subchapter
O, on a franchise tax report originally due prior to January 1, 2008.
(2) Jobs creation credit--A jobs creation credit established
under Tax Code, Chapter 171, Subchapter P, on a franchise tax report
originally due prior to January 1, 2008.
(3) Investment credit--An investment credit established
under Tax Code, Chapter 171, Subchapter Q, on a franchise tax report
originally due prior to January 1, 2008 and an investment credit
established under Tax Code, Chapter 171, Subchapter Q-1.
(4) Enterprise project--A person designated as an en-
terprise project under Government Code, Chapter 2303, on or after
September 1, 2001, but before January 1, 2005.
(5) Enterprise zone--An area designated as an enterprise
zone under Government Code, §2303.003.
(6) Qualied business--A person certied as a qualied
business under Government Code, §2303.402.
(7) Qualied capital investment--Tangible personal prop-
erty that is rst placed in service in an enterprise zone by a qualied
business that has been designated as an enterprise project and that is de-
ned in IRS Reg. §1.48-1(c) and described in Internal Revenue Code,
§1245(a), subject to depreciation or amortization including engines,
machinery, tools, and implements that are used in a trade or business,
or are held for investment. The term includes transportation costs and
direct labor costs necessary to fabricate, install or place the tangible
personal property in service. The term does not include real property
or buildings and their structural components. Property that is leased
under a capitalized lease is considered a "qualied capital investment,"
but property that is leased under an operating lease is not considered a
"qualied capital investment." Property that is expensed under Internal
Revenue Code, §179, is not considered a "qualied capital investment."
The term also does not include all costs included in the depreciable ba-
sis such as indirect labor costs, interest, intangibles and overhead.
(8) Tangible personal property rst placed in service in an
enterprise zone includes tangible personal property that is:
(A) purchased by an enterprise project for placement in
an incomplete improvement that is under active construction or other
physical preparation;
(B) identied by a purchase order, invoice, billing, sales
slip, or contract; and
(C) physically present at the enterprise project’s quali-
ed business site, as dened by Government Code, §2303.003, and in
use by the enterprise project on the original due date of the report on
which the credit is taken.
(c) Information required. A taxable entity that claims a credit
under this section must submit a credit schedule with each report that
a credit is claimed.
(d) Limitations.
(1) The total research and development credit, jobs creation
and investment credits that a taxable entity claims may not exceed the
amount of franchise tax due for the report after any other applicable
credits.
(2) A taxable entity may not convey, assign, or transfer to
another entity the credits that this section provides, unless all of the
assets of the taxable entity are conveyed, assigned, or transferred to the
entity in the same transaction.
(e) Research and development credit.
(1) Carryforward. If a taxable entity established a research
and development credit on a franchise tax report originally due prior
to January 1, 2008, that exceeded the tax limitations, then the taxable
entity may continue to carry the unused credit forward on each consec-
utive report until the earlier of the date the credit would have expired
under Tax Code, Chapter 171, Subchapter O, or December 31, 2027.
(2) Report limitation. The total research and development
credit carryforward that a taxable entity may claim for a report may
not exceed 50% of the amount of franchise tax that is due for the report
before any other tax credits are applied.
(f) Jobs creation credit.
(1) Carryforward. If a taxable entity established a jobs cre-
ation credit on a franchise tax report originally due prior to January
1, 2008, that exceeded the tax limitations, then the taxable entity may
continue to carry the unused credit forward on each consecutive report
until the earlier of the date the credit would have expired under Tax
Code, Chapter 171, Subchapter P, or December 31, 2012.
(2) Report limitation. The total jobs creation credit carry-
forward that a taxable entity may claim for a report may not exceed
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50% of the amount of franchise tax that is due for the report before any
other tax credits are applied.
(g) Investment credit.
(1) Installment. A taxable entity that has any unused in-
stallments from an investment credit established on a franchise tax re-
port originally due prior to January 1, 2008, may claim the remaining
installments on consecutive reports beginning with reports originally
due on or after January 1, 2008.
(2) Carryforward. A carryforward is the remaining portion
of an installment that cannot be claimed in the current year because of
the limitations that are stated in subsection (d)(1) of this section or this
paragraph. A carryforward is added to the next year’s installment of
the credit in determination of the limitations for that year. A credit car-
ryforward from a previous report must be used before the current year
installment. The taxable entity may carry the unused credit forward
on each consecutive report until the earlier of the date the credit would
have expired under Tax Code, Chapter 171, Subchapter Q, or Decem-
ber 31, 2012.
(3) Report limitation. The total investment credit that a tax-
able entity may claim for a report including any credit under subsection
(h) of this section, may not exceed 50% of the amount of franchise tax
that is due for the report before any other tax credits are applied.
(4) Ineligibility.
(A) A taxable entity may not take any remaining install-
ment of the credit, (except the taxable entity is permitted to take the
portion of an installment that accrued in a previous year and was car-
ried forward pursuant to paragraph (2) of this subsection), if, during
one of the periods used to determine margin for a report on which an
installment could be claimed, the taxable entity:
(i) disposes of the qualied capital investment;
(ii) takes the qualied capital investment out of ser-
vice;
(iii) moves the qualied capital investment out of
Texas; or
(iv) fails to pay an average weekly wage, at the lo-
cation for which the credit is claimed, that amounts to at least 110% of
the county average weekly wage.
(B) For purposes of subparagraph (A)(i) - (iii) of this
paragraph, an installment may still be taken if the qualied capital in-
vestment is replaced at the same location within 90 days with a new
qualied capital investment of equal or greater value.
(h) Enterprise projects. A taxable entity that has been desig-
nated an enterprise project on or after September 1, 2001, but before
January 1, 2005, may establish a credit that equals 7.5% of the qualied
capital investment made on or after January 1, 2005, and before Jan-
uary 1, 2007. Subject to paragraph (4) of this subsection, an enterprise
project may claim the entire credit established on a report originally
due on or after January 1, 2008, and before January 1, 2009.
(1) Carryforward. If an enterprise project is eligible for a
credit that exceeds the limitation under paragraph (4) of this subsection,
the enterprise project may carry the unused credit forward for not more
than ve consecutive reports.
(2) Ineligibility.
(A) An enterprise project is not eligible for a credit un-
der this subsection if the enterprise project claimed a credit under Tax
Code, Chapter 171, Subchapter Q, before the repeal of that subchapter
on January 1, 2008.
(B) A taxable entity, other than a combined group, may
not claim the credit under this subsection unless the taxable entity was,
on May 1, 2006, subject to the tax imposed by this chapter as it existed
on that date.
(C) A taxable entity that establishes its eligibility for an
investment credit is not eligible to claim a franchise tax reduction that
is authorized under Tax Code, §171.1015.
(3) Combined group. A taxable entity that is a combined
group may claim the credit for each member entity that was, on May
1, 2006, subject to the tax imposed by this chapter as it existed on that
date and shall compute the amount of the credit for that member as
provided by this subsection.
(4) Report limitation. The total investment credit that a tax-
able entity claims for a report, including the amount of any installment
or carryforward under subsection (g)(1) and (g)(2), of this section, may
not exceed 50% of the amount of franchise tax that is due for the report
before any other tax credits are applied.
(5) Expiration. This subsection expires on December 31,
2009. This expiration does not affect the carryforward of a credit that
was established on a report that was originally due before this expira-
tion date.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.594
The Comptroller of Public Accounts proposes an amendment
to §3.594, concerning margin: temporary credit for business
loss carryforwards. This section is being amended to imple-
ment House Bill 3, 79th Legislature, Third Called Session 2006
and House Bill 3928, 80th Legislature, 2007, which revise the
franchise tax. This amendment establishes guidelines for cal-
culating the temporary credit. Subsection (a) provides that this
section only applies to franchise tax reports due on or after Jan-
uary 1, 2008. Subsection (b) denes words and terms used in
the section. Subsection (c) outlines the entities eligible to take
this credit. Subsection (d) provides notice requirements. Sub-
section (e) provides for the election of the credit. Subsection (f)
describes the calculation of the credit. Tax Code, §171.111(a)
was amended to change the preservation date from September
1, 2007 to May 15, 2008. This amendment is found in new sub-
section (d)(1) of this proposed section.
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as
a result of enforcing the rule will be in providing guidance to
businesses subject to the franchise tax regarding the temporary
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credit for business loss carryforwards under Tax Code, Chapter
171. This rule is adopted under Tax Code, Title 2, and does not
require a statement of scal implications for small businesses.
There is no signicant anticipated economic cost to individuals
who are required to comply with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This rule is proposed under Tax Code §111.002, which provides
the comptroller with the authority to prescribe, adopt, and en-
force rules relating to the administration and enforcement of the
provisions of Tax Code, Title 2.
The amendment implements Tax Code, §171.111.
§3.594. Margin: Temporary Credit for Business Loss Carryforwards.
(a) Provisions [Effective Date]. The provisions of this section
apply to franchise tax reports originally due on or after January 1, 2008.
(b) Denitions. The following words and terms, when used
in this section, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Business loss--Any negative amount of earned surplus
after apportionment and allocation but before any deductions for solar
energy devices under Tax Code, §171.107, clean coal project under Tax
Code, §171.108, or investment in an enterprise zone under Tax Code,
§171.1015. Business losses must have been used to offset any positive
amount of earned surplus even in years when no tax was due.
(2) Business loss carryforward--Unused and unexpired
amounts of business losses created on the 2003 and subsequent
franchise tax report years.
(c) Eligibility.
(1) A taxable entity may claim the credit if the entity was,
on May 1, 2006, subject to franchise tax.
(2) A taxable entity that is a combined group may claim
the credit for each member entity that was, on May 1, 2006, subject to
the franchise tax and shall compute the amount of the credit for that
member as provided by this section.
(3) If a member of a combined group changes combined
groups after June 30, 2007, the business loss carryforward of that mem-
ber will no longer be included in the temporary credit calculation of the
group and the related share of any temporary credit carried over from
a previous year is lost to the group. There is no proration for a par-
tial year. In addition, the business loss carryforward does not follow
the member to a separately led report or another combined group. If
a member merges into another member of the group, that member’s
business loss carryforward will remain with the group. If the member
dissolves, terminates, or otherwise leaves the group, the business loss
carryover of that member is no longer eligible for use.
(4) Example. Corporation A, corporation B, corporation C
and corporation D are members of a combined group. They have busi-
ness loss carryforwards of $2,000,000, $2,000,000, $2,000,000, and
$4,000,000 respectively. In 2008, the combined group’s credit will
be $10,000,000 x 2.25% x 4.5% equaling $10,125. The combined
group’s tax due before the credit is $9,000 which results in a carryover
of $1,025. During 2008, corporation D leaves the group. On the 2009
report, the combined group is entitled to a credit of $6,000,000 x 2.25%
x 4.5% equaling $5,075. In addition, the group only has $615 of the
carryover credit. They lost the 40% that was related to corporation D.
However, if corporation D had merged into corporation C during 2008
instead of leaving the group, the combined group’s credit will remain
$10,125 for 2009 and there will still be a $1,025 carryover from 2008.
(5) The preservation of the right to claim the credit may not
be conveyed, assigned, or transferred to another entity.
(d) [(b)] Notice requirements[of intent].
(1) A[The] notice of intent to preserve the right to claim the
temporary credit for business loss carryforwards must be submitted to
the comptroller on or before May 15, 2008, on a form prescribed by
the comptroller. The postmark date (or meter-mark date, if there is no
postmark) on the envelope in which the form is received determines
the date of ling [under Tax Code, §171.111, must be submitted to the
comptroller on forms specied by the comptroller. The form must be
led on or before September 1, 2007. The postmark date (or meter-
mark date, if there is no postmark) on the envelope in which the form
is received determines the date of ling. The preservation of the right
to claim the credit may not be conveyed, assigned, or transferred to
another entity].
(2) The taxable entity must submit with the notice of intent
the amount of business loss that is being carried forward.
(3) If the amount of business loss carryforwards changes
after the initial preservation, the entity must notify the comptroller in
writing of the change. The notice must be received on or before the
original due date of an annual report on which the credit will be used
and must include the corrected amount of the eligible business loss
carryforwards.
(4) If, upon audit by the comptroller, an adjustment is made
to the business loss carryforward used on reports prior to 2008, then no
notice is required and the amount of business loss carryforwards that
were preserved and subsequently taken will be adjusted accordingly.
The taxable entity will be liable for any additional tax, penalty, and
interest due for years in which the credit was improperly claimed.
(e) Electing the credit. The election to claim the credit shall
be made on each report originally due on or after January 1, 2008 and
before September 1, 2027.
(1) A taxable entity elects the credit by:
(A) properly taking the credit on a report led on or be-
fore the original due date; or
(B) electing the credit on a timely led extension re-
quest and properly taking the credit on the report led on or before the
extended due date of the report.
(2) If an election to take the credit is not made on or before
the original due date of the report as indicated in paragraph (1) of this
subsection, the credit for that year is lost for that year and cannot be
carried over to a subsequent year.
(3) A taxable entity that uses the E-Z Computation to re-
port and pay its franchise tax may not elect to take the business loss
carryforward credit in that year. The unused credit may not be carried
over to subsequent years.
(f) Computation of the credit.
(1) For report years 2008 - 2017: Business loss carryfor-
ward amount x 2.25% x 4.5%.
(2) For report years 2018 - 2027: Business loss carryfor-
ward amount x 7.75% x 4.5%.
(g) Credit carryover. The amount of credit claimed on any
report may not exceed the amount of franchise tax due for that report
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year. Unused credits may be carried over to subsequent report years
unless subsection (e)(2) of this section applies.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
34 TAC §3.595
The Comptroller of Public Accounts proposes new §3.595, con-
cerning margin: transition. This section implements House Bill
3, 79th Legislature, Third Called Session, 2006 and House Bill
3928, 80th Legislature, 2007, which revise the franchise tax.
This section establishes guidelines for computing tax liability dur-
ing the transition period under Tax Code, Chapter 171. Subsec-
tion (a) states the effective date is as provided in the section.
Subsection (b) provides guidance to entities previously subject
to the franchise tax (e.g. corporations and limited liability com-
panies, etc.). Subsection (c) provides guidance to newly tax-
able entities (e.g. limited partnerships, professional associa-
tions, etc.).
John Heleman, Chief Revenue Estimator, has determined that
for the rst ve-year period the rule will be in effect, there will
be no signicant revenue impact on the state or units of local
government.
Mr. Heleman also has determined that for each year of the rst
ve years the rule is in effect, the public benet anticipated as
a result of enforcing the rule will be in providing guidance to
businesses subject to the franchise tax regarding the computa-
tion of franchise tax during the transition period under Tax Code,
Chapter 171. This rule is adopted under Tax Code, Title 2, and
does not require a statement of scal implications for small busi-
nesses. There is no signicant anticipated economic cost to in-
dividuals who are required to comply with the proposed rule.
Comments on the proposal may be submitted to Bryant K.
Lomax, Manager, Tax Policy Division, P.O. Box 13528, Austin,
Texas 78711.
This rule is proposed under Tax Code, §111.002, which provides
the comptroller with the authority to prescribe, adopt, and en-
force rules relating to the administration and enforcement of the
provisions of Tax Code, Title 2.
The new section implements House Bill 3, 79th Legislature, Third
Called Session, 2006, Section 22 and House Bill 3928, 80th Leg-
islature, 2007, Section 35.
§3.595. Margin: Transition.
(a) Effective date. The provisions of this section apply as pro-
vided in this section.
(b) Types of entities previously subject to franchise tax. If an
entity is a type of entity that would have been subject to the franchise
tax immediately before the passage of House Bill 3, 79th Legislature,
3rd Called Session, 2006, then the margin calculation, as opposed to
the taxable capital and earned surplus calculations, should be used for
reports originally due on or after January 1, 2008. If an entity is part
of a combined group, then the entity will be included in a combined
report due in 2008, even if the entity becomes no longer subject to the
franchise tax in 2007.
(1) Unless the entity is part of a combined group, if an ini-
tial report is due in 2008 or later and the entity becomes no longer sub-
ject to the franchise tax on or before November 1, 2007, then the initial
report based on margin will be based on the beginning date through the
date the entity became no longer subject to the franchise tax and no -
nal report will be due.
(2) If an entity was required to le a report based on earned
surplus, then the rst report due based on margin should be based on a
period beginning on the day after the last date used to calculate earned
surplus.
(3) If an entity led a report based on taxable capital, but
was not subject to the earned surplus component, then the rst report
due based on margin should be based on a period beginning on the day
after the last date used to calculate taxable capital.
(4) Except as provided in paragraph (1) of this subsection,
if the entity becomes no longer subject to the earned surplus component
of the tax on or before November 1, 2007, then the entity will owe a
nal report based on taxable earned surplus, unless the entity is part of
a combined group.
(c) Types of entities becoming subject to the franchise tax un-
der House Bill 3, 79th Legislature, 3rd Called Session, 2006.
(1) Margin or gross receipts occurring before June 1, 2006,
may not be considered for purposes of determining taxable margin or
for apportionment purposes.
(2) Extensions for 2008 annual reports will not be granted
based on 100% of the tax reported as due in the previous calendar year,
including combined reports which include at least one entity becoming
subject to the franchise tax under House Bill 3, 79th Legislature, 3rd
Called Session, 2006.
(3) If the entity becomes no longer subject to the franchise
tax before July 1, 2007, then it will not owe franchise tax and the en-
tity will not be included in a combined report. The entity may become
"no longer subject to the franchise tax" by terminating its existence. A
dissolution, merger out of existence or liquidation is considered a ter-
mination. A conversion is not considered a termination. A partnership
is considered terminated only if no part of any business, nancial op-
eration, or venture of the partnership continues to be carried on by any
of its partners in a partnership. For a merger or consolidation of two or
more partnerships, the resulting partnership is considered the continua-
tion of any merging or consolidating partnership whose members own
an interest of more than 50% in the capital and prots of the resulting
partnership. For a division of a partnership into two or more partner-
ships, the resulting partnerships, other than any resulting partnership
the members of which had an interest of 50% or less in the capital and
prots of the prior partnership, are considered a continuation of the
prior partnership.
(4) An entity doing business in this state at any time after
June 30, 2007, and before January 1, 2008, but not on January 1, 2008,
shall le a nal report based on margin as provided in subsection (b)(2)
of this section, of Section 35 of House Bill 3928, 80th Legislature,
2007. The nal report is due on the 60th day after the date the entity
becomes no longer subject to the franchise tax. The entity will not be
included in a combined report.
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(5) An entity subject to the franchise tax on January 1,
2008, for which January 1, 2008, is not the beginning date, shall le
an annual report due May 15, 2008, based on the period or periods:
(A) if the entity has an accounting period that ends on
or after January 1, 2007, and before June 1, 2007:
(i) beginning the later of:
(I) June 1, 2006; or
(II) the date the entity was organized in this state
or, if a foreign entity, the date it began doing business in this state; and
(ii) ending on the date that accounting period ends
in 2007;
(B) if the entity has an accounting period that ends on
or after June 1, 2007, and before December 31, 2007:
(i) beginning on the date that accounting period be-
gins; and
(ii) ending on the date that accounting period ends
in 2007; and
(C) if the entity has an accounting period that ends on
December 31, 2007, or if the entity does not have an accounting period
that ends in 2007:
(i) beginning the later of:
(I) January 1, 2007; or
(II) the date the entity was organized in this state
or, if a foreign entity, the date it began doing business in this state; and
(ii) ending on December 31, 2007.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.




Comptroller of Public Accounts
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0387
TITLE 40. SOCIAL SERVICES AND ASSIS-
TANCE
PART 20. TEXAS WORKFORCE
COMMISSION
CHAPTER 801. LOCAL WORKFORCE
DEVELOPMENT BOARDS
SUBCHAPTER B. ONE-STOP SERVICE
DELIVERY NETWORK
40 TAC §801.33
(Editor’s note: The text of the following section proposed for repeal
will not be published. The section may be examined in the ofces of
the Texas Workforce Commission or in the Texas Register ofce, Room
245, James Earl Rudder Building, 1019 Brazos Street, Austin.)
The Texas Workforce Commission (Commission) proposes the
repeal of the following section of Chapter 801 relating to Local
Workforce Development Boards:
Subchapter B. One-Stop Service Delivery Network, §801.33
PART I. PURPOSE, BACKGROUND, AND AUTHORITY
PART II. EXPLANATION OF INDIVIDUAL PROVISIONS
PART III. IMPACT STATEMENTS
PART IV. COORDINATION ACTIVITIES
PART I. PURPOSE, BACKGROUND, AND AUTHORITY
The purpose of this amendment is to remove §801.33 relating
to Advertising. This rule change implements the statutory provi-
sions in House Bill (HB) 3074, enacted by the 80th Texas Leg-
islature, Regular Session (2007). HB 3074 repeals Texas Gov-
ernment Code §2308.264(e)(4), which required the Commission
to establish rules to ensure that entities contracting with Boards
may use, display, and advertise the entity’s name when providing
workforce services for the Board. HB 3074 removes the require-
ment that contractor advertising must be allowed.
Texas Government Code, Chapter 2308, and this chapter govern
Boards. The repeal of Texas Government Code §2308.264(e)(4)
allows the Commission and the Boards the exibility to decide
whether contractors can use, display, and advertise their busi-
ness name when providing one-stop workforce services for the
Boards.
PART II. EXPLANATION OF INDIVIDUAL PROVISIONS
SUBCHAPTER B. ONE-STOP SERVICE DELIVERY NET-
WORK
The Commission proposes the following amendment to Sub-
chapter B:
§801.33. Advertising
Section 801.33 is deleted to reect HB 3074, which re-
peals Texas Government Code §2308.264(e)(4). Repealed
§2308.264(e)(4) allowed entities that contract with Boards to
use, display, and advertise their business name when providing
one-stop workforce services. By deleting this section, the
Commission provides Boards the opportunity to make a local
determination on whether to allow contractor advertising.
PART III. IMPACT STATEMENTS
Randy Townsend, Chief Financial Ofcer, has determined that
for each year of the rst ve years the rule is in effect, the follow-
ing statements will apply:
There are no additional estimated costs to the state and local
governments expected as a result of enforcing or administering
the rule.
There are no estimated reductions in costs to the state and to
local governments as a result of enforcing or administering the
rule.
There are no estimated losses or increases in revenue to the
state or to local governments as a result of enforcing or admin-
istering the rule.
There are no foreseeable implications relating to costs or rev-
enue of the state or local governments as a result of enforcing
or administering the rule.
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There are no anticipated economic costs to persons required to
comply with the rule.
There is no anticipated adverse economic impact on small or
microbusinesses as a result of enforcing or administering the
rule.
Mark Hughes, Director of Labor Market Information, has deter-
mined that there is no signicant negative impact upon employ-
ment conditions in the state as a result of the rule.
Laurence M. Jones, Director, Workforce Development Division,
has determined that for each year of the rst ve years the rule is
in effect, the public benet anticipated as a result of enforcing the
proposed rule will be to comply with the provisions of HB 3074.
The Agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the Agency’s legal au-
thority to adopt.
PART IV. COORDINATION ACTIVITIES
Comments on the proposal may be submitted to TWC Policy
Comments, Workforce and UI Policy, 101 East 15th Street,
Room 440T, Austin, Texas 78778; faxed to (512) 475-3577;
or e-mailed to TWCPolicyComments@twc.state.tx.us. The
Commission must receive comments postmarked no later than
30 days from the date this proposal is published in the Texas
Register.
The repeal is proposed under Texas Labor Code §301.0015 and
§302.002(d), which provide the Texas Workforce Commission
with the authority to adopt, amend, or repeal such rules as it
deems necessary for the effective administration of Agency ser-
vices and activities.
The proposed repeal affects Texas Labor Code, particularly
Chapters 301 and 302, as well as Texas Government Code
§2308.
§801.33. Advertising.
This agency hereby certies that the proposal has been reviewed
by legal counsel and found to be within the agency’s legal author-
ity to adopt.
Filed with the Ofce of the Secretary of State on August 28, 2007.
TRD-200703941
Reagan Miller
Deputy Division Director, Workforce Policy and Service Delivery Branch
Texas Workforce Commission
Earliest possible date of adoption: October 14, 2007
For further information, please call: (512) 475-0829
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TITLE 22. EXAMINING BOARDS
PART 9. TEXAS MEDICAL BOARD
CHAPTER 172. TEMPORARY AND LIMITED
LICENSES
SUBCHAPTER C. LIMITED LICENSES
22 TAC §172.14
The Texas Medical Board withdraws proposed new §172.14
which appeared in the May 4, 2007, issue of the Texas Register
(32 TexReg 2445).
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704038
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: August 31, 2007
For further information, please call: (512) 305-7016
CHAPTER 182. USE OF EXPERTS
22 TAC §182.9
The Texas Medical Board withdraws proposed new §182.9 which
appeared in the June 29, 2007, issue of the Texas Register (32
TexReg 3958).
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704039
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: August 31, 2007
For further information, please call: (512) 305-7016
CHAPTER 190. DISCIPLINARY GUIDELINES
SUBCHAPTER B. VIOLATION GUIDELINES
22 TAC §190.8
The Texas Medical Board withdraws the proposed amendment
to §190.8 which appeared in the July 20, 2007, issue of the Texas
Register (32 TexReg 4521).
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704040
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: August 31, 2007
For further information, please call: (512) 305-7016
PART 15. TEXAS STATE BOARD OF
PHARMACY
CHAPTER 291. PHARMACIES
SUBCHAPTER B. COMMUNITY PHARMACY
(CLASS A)
22 TAC §291.33
The Texas State Board of Pharmacy withdraws the proposed
amendments to §291.33 which appeared in the June 15, 2007,
issue of the Texas Register (32 TexReg 3473).




Texas State Board of Pharmacy
Effective date: August 29, 2007
For further information, please call: (512) 305-8028
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TITLE 19. EDUCATION
PART 2. TEXAS EDUCATION AGENCY
CHAPTER 89. ADAPTATIONS FOR SPECIAL
POPULATIONS
The Texas Education Agency (TEA) adopts amendments to
§§89.1205, 89.1220, 89.1225, 89.1250; new §89.1207; and
the repeal of §89.1260, concerning the state plan for edu-
cating limited English procient students. The amendments
to §§89.1205, 89.1220, and 89.1250; new §89.1207; and
the repeal of §89.1260 are adopted without changes to the
proposed text as published in the June 22, 2007, issue of the
Texas Register (32 TexReg 3825) and will not be republished.
The amendment to §89.1225 is adopted with changes to the
proposed text as published in the June 22, 2007, issue. The
adopted amendment to §89.1205 and adopted new §89.1207
revise the process of applying for a bilingual exception and/or
an English as a second language (ESL) waiver. The other
adopted amendments add language regarding the transfer of
students out of a special language program in accordance with
House Bill (HB) 1, 79th Texas Legislature, Third Called Session,
2006; provide clarication on serving students who receive both
special language and special education services; and address
submission of information for summer school programs. Section
89.1260 is also repealed to remove monitoring requirements no
longer authorized in statute.
In accordance with the Texas Education Code (TEC), Chapter
29, Subchapter B, Bilingual Education and Special Language
Programs, the commissioner exercised rulemaking authority es-
tablishing rules to guide the implementation of bilingual educa-
tion and special language programs. The commissioner’s rules
in 19 TAC Chapter 89, Subchapter BB, adopted to be effective
September 1, 1996, establish the policy that every student in
the state who has a home language other than English and who
is identied as limited English procient shall be provided a full
opportunity to participate in a bilingual education or ESL pro-
gram. These rules outline the requirements of the bilingual and
ESL programs including program content and design, home lan-
guage survey, the language prociency assessment committee
(LPAC), testing and classication, facilities, parental authority
and responsibility, stafng and staff development, required sum-
mer school programs, monitoring of programs, and evaluation.
Rules in 19 TAC Chapter 89, Subchapter BB, were amended to
be effective April 2002. During the statutorily-required rule re-
view of rules in 19 TAC Chapter 89 in 2006, staff identied the
need to update the rules. The adopted revisions to 19 TAC Chap-
ter 89, Subchapter BB, include the following rule changes.
Section 89.1205, Required Bilingual Education and English as a
Second Language Programs, is amended to delete subsections
(g) and (h) regarding bilingual education program exceptions and
ESL program waivers. This information is moved to adopted new
§89.1207, Exceptions and Waivers, and includes criteria upon
which approval would be granted and, if denied, provides for
an appeal. The adopted new section also allows for a special
accreditation investigation when a district is denied an exception
or waiver for more than three consecutive years or has excessive
numbers of allowable exemptions. No changes were made to
this section since published as proposed.
Section 89.1220, Language Prociency Assessment Commit-
tee, is amended by revising subsection (l) to indicate that a stu-
dent’s exit from a bilingual or ESL program will occur in accor-
dance with the TEC, §29.0561, as added by HB 1, Third Called
Session, 2006. A technical update is made for clarication in
subsection (i)(5) regarding reference to the state English lan-
guage prociency assessment in reading. No changes were
made to this section since published as proposed.
Section 89.1225, Testing and Classication of Students, is
amended to clarify the process by which testing will be deter-
mined for students who receive both special education and
special language services. Subsection (f) is revised to add
language for determining the appropriate assessment and
designated performance level by the admission, review, and
dismissal (ARD) committee in conjunction with the LPAC in
response to a student individual education program. Subsection
(h) is revised to establish exit criteria in accordance with HB 1,
Third Called Session, 2006. Subsection (k) is added to include
language clarifying the process by which students who receive
both special education and special language services are exited
from a bilingual education or ESL program. Changes were
made to this section since published as proposed. Language in
subsection (h)(2) was modied to clarify that English language
arts assessment instruments are also to be TEA approved.
Language in subsection (i) was modied to reect that a student
may not be exited from a bilingual education or an English as a
second language program in prekindergarten or kindergarten,
rather than prekindergarten through Grade 1, to be consistent
with new language adopted in subsection (h)(2) that allows for
students in Grades 1 and 2 to be exited.
Section 89.1250, Required Summer School Programs, is
amended to address requirements for district submission of
information and eligibility for funding in paragraph (4)(A). No
changes were made to this section since published as proposed.
Section 89.1260, Monitoring of Programs and Enforcing Law and
Commissioner’s Rules, is repealed since the state statute (TEC)
no longer authorizes monitoring in this manner. No changes
were made to this section since published as proposed.
The public comment period began June 22, 2007, and ended
July 22, 2007. Following is a summary of public comments re-
ceived and corresponding agency responses regarding the pro-
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posed revisions to 19 TAC Chapter 89, Adaptations for Special
Populations, Subchapter BB, Commissioner’s Rules Concerning
State Plan for Educating Limited English Procient Students.
Comment. Concerning §89.1225(h), a comment was received
from an educator from the Weatherford Independent School Dis-
trict (ISD) indicating the word "and" is missing between para-
graphs (1) and (2) of subsection (h). The comment further indi-
cated that language in paragraph (2) is ambiguous and would be
more straightforward if maintained as it was prior to the proposed
amendment. The comment also pointed out that, as written, the
rule indicates that any assessment instrument is acceptable as
long as it is administered in English.
Agency Response. The agency disagrees with the rst two
points and has maintained language as led as proposed. First,
the language in paragraphs (1) and (2) of subsection (h) are part
of a series of three with the word "and" correctly placed between
paragraphs (2) and (3). Second, the language in paragraph
(2) is consistent with language in the Texas Education Code.
The agency agrees with the third point. Language in 19 TAC
§89.1225(h)(2) was modied to clarify that English language
arts assessment instruments are also to be TEA approved.
Comment. Concerning §89.1225(i), a comment was received
from the director of Program Compliance, Division of Curriculum
Instruction, for the Carrollton-Farmers Branch ISD, that pointed
out a contradiction in the language in new §89.1225(h)(2) that
allows for students in Grades 1 and 2 to be exited from a bilin-
gual education or an English as a second language program and
§89.1225(i) that indicates a student may not be exited from a
bilingual education or an English as a second language program
in prekindergarten through Grade 1.
Agency Response. The agency agrees. Language in 19 TAC
§89.1225(i) was modied to reect that a student may not be
exited from a bilingual education or an English as a second lan-
guage program in prekindergarten or kindergarten.
Comment. Concerning §89.1225(k), a comment was received
from the director of Special Programs for the Fredericksburg ISD
expressing concern that it would be very difcult and unneces-
sary to convene a committee of all ARD committee members
and all LPAC members to make decisions regarding a student
who receives both special education and special language ser-
vices. The comment further expressed the belief that it is not in
the best interest of the student for the trained parent member of
the LPAC to be in attendance unless this member is the parent
of the child under consideration.
Agency Response. The agency disagrees with the comment
and has maintained language as led as proposed. The rule
indicates that the two committees must work in conjunction with
one another to make decisions. The rule does not require all
committee members of both committees to convene at the same
time. As written, the rule does not prohibit a district from deciding
not to include the trained parent member of the LPAC if it is not
in the best interest of the child.
SUBCHAPTER BB. COMMISSIONER’S
RULES CONCERNING STATE PLAN FOR
EDUCATING LIMITED ENGLISH PROFICIENT
STUDENTS
19 TAC §§89.1205, 89.1207, 89.1220, 89.1225, 89.1250
The amendments and new section are adopted under the Texas
Education Code, §29.056, which authorizes the agency to adopt
rules relating to the identication, assessment, and classica-
tion of students of limited English prociency eligible for entry
into the program or exit from the program. Texas Education
Code, §29.054, addresses exceptions to bilingual education pro-
grams. Texas Education Code, §29.0561, addresses evalua-
tion and reenrollment of exited bilingual students. Texas Educa-
tion Code, §29.060, establishes preschool, summer school, and
extended time programs for bilingual and special language pro-
grams.
The amendments and new section implement the Texas Educa-
tion Code, §§29.051, 29.054, 29.056, 29.0561, and 29.060.
§89.1225. Testing and Classication of Students.
(a) For identifying limited English procient students, districts
shall administer to each student who has a language other than English
as identied on the home language survey:
(1) in prekindergarten through Grade 1, an oral language
prociency test approved by the Texas Education Agency (TEA); and
(2) in Grades 2-12, a TEA-approved oral language pro-
ciency test and the English reading and English language arts sections
from a TEA-approved norm-referenced measure, or another test ap-
proved by TEA, unless the norm-referenced measure is not valid in
accordance with subsection (f)(2)(C) of this section.
(b) Districts which provide a bilingual education program
shall administer an oral language prociency test in the home language
of the students who are eligible for being served in the bilingual
education program. If the home language of the students is Spanish,
the district shall administer the Spanish version of the TEA-approved
oral language prociency test which was administered in English. If
the home language of the students is other than Spanish, the district
shall determine the students’ level of prociency using informal oral
language assessment measures.
(c) All the oral language prociency testing shall be admin-
istered by professionals or paraprofessionals who are procient in the
language of the test and trained in language prociency testing.
(d) The grade levels and the scores on each test which shall
identify a student as limited English procient shall be established by
TEA. The commissioner of education shall review the approved list of
tests, grade levels, and scores annually and update the list.
(e) Students with a language other than English shall be
administered the required oral language prociency test within four
weeks of their enrollment. Norm-referenced assessment instruments,
however, may be administered within the established norming period.
(f) For entry into a bilingual education or English as a second
language program, a student shall be identied as limited English pro-
cient using the following criteria.
(1) At prekindergarten through Grade 1, the score on the
English oral language prociency test is below the level designated
for indicating limited English prociency under subsection (d) of this
section.
(2) At Grades 2-12:
(A) the student’s score on the English oral language
prociency test is below the level designated for indicating limited
English prociency under subsection (d) of this section;
(B) the student’s score on the reading and language arts
sections of the TEA-approved norm-referenced measure at his or her
grade level is below the 40th percentile; or
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(C) the student’s ability in English is so limited that the
administration, at his or her grade level, of the reading and language
arts sections of a TEA-approved norm-referenced assessment instru-
ment or other test approved by TEA is not valid.
(3) In the absence of data required in paragraph (2)(B) of
this subsection, evidence that the student is not academically successful
as dened in subsection (j) of this section is required.
(4) The admission review and dismissal (ARD) commit-
tee in conjunction with the language prociency assessment commit-
tee shall determine an appropriate assessment instrument and desig-
nated level of performance for indicating limited English prociency
as required under subsection (d) of this section for students for whom
those tests would be inappropriate as part of the individualized educa-
tion program (IEP). The decision for entry into a bilingual education
or English as a second language program shall be determined by the
ARD committee in conjunction with the language prociency assess-
ment committee in accordance with §89.1220(g) of this title (relating
to Language Prociency Assessment Committee).
(g) Within the four weeks of their initial enrollment in the dis-
trict, students shall be identied as limited English procient and en-
rolled into the required bilingual education or English as a second lan-
guage program. Prekindergarten and kindergarten students preregis-
tered in the spring shall be identied as limited English procient and
enrolled in the required bilingual education or English as a second lan-
guage program within four weeks of the start of the school year in the
fall.
(h) For exit from a bilingual education or English as a second
language program, a student may be classied as English procient at
the end of the school year in which a student would be able to par-
ticipate equally in a regular, all-English, instructional program. This
determination shall be based upon all of the following:
(1) TEA-approved tests that measure the extent to which
the student has developed oral and written language prociency and
specic language skills in English;
(2) satisfactory performance on the reading assessment in-
strument under the Texas Education Code, §39.023(a), or a TEA-ap-
proved English language arts assessment instrument administered in
English, or a score at or above the 40th percentile on both the Eng-
lish reading and the English language arts sections of a TEA-approved
norm-referenced assessment instrument for a student who is enrolled
in Grade 1 or 2; and
(3) TEA-approved criterion-referenced written tests when
available and the results of a subjective teacher evaluation.
(i) A student may not be exited from the bilingual education
or English as a second language program in prekindergarten or kinder-
garten. A district must ensure that limited English procient students
are prepared to meet academic standards required by TEC, §28.0211.
(j) For determining whether a student who has been exited
from a bilingual education or English as a second language program
is academically successful, the following criteria shall be used at the
end of the school year:
(1) the student meets state performance standards in Eng-
lish of the criterion-referenced assessment instrument required in the
Texas Education Code, §39.023, for the grade level as applicable; and
(2) the student has passing grades in all subjects and
courses taken.
(k) The ARD committee in conjunction with the language pro-
ciency assessment committee shall determine an appropriate assess-
ment instrument and performance standard requirement for exit under
subsection (h) of this section for students for whom those tests would
be inappropriate as part of the IEP. The decision to exit a student who
receives both special education and special language services from the
bilingual education or English as a second language program is deter-
mined by the ARD committee in conjunction with the language pro-
ciency assessment committee in accordance with applicable provisions
of subsection (h) of this section.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 28, 2007.
TRD-200703950
Cristina De La Fuente-Valadez
Director, Policy Coordination
Texas Education Agency
Effective date: September 17, 2007
Proposal publication date: June 22, 2007
For further information, please call: (512) 475-1497
19 TAC §89.1260
The repeal is adopted under the Texas Education Code, §7.028,
which establishes a limitation on compliance monitoring.
The repeal implements the Texas Education Code, §7.028.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 28, 2007.
TRD-200703951
Cristina De La Fuente-Valadez
Director, Policy Coordination
Texas Education Agency
Effective date: September 17, 2007
Proposal publication date: June 22, 2007
For further information, please call: (512) 475-1497
TITLE 22. EXAMINING BOARDS
PART 1. TEXAS BOARD OF
ARCHITECTURAL EXAMINERS
CHAPTER 1. ARCHITECTS
SUBCHAPTER A. SCOPE; DEFINITIONS
22 TAC §1.12
The Texas Board of Architectural Examiners adopts an amend-
ment to §1.12, concerning the Joint Advisory Committee of the
Texas Board of Architectural Examiners and the Texas Board
of Professional Engineers. The amendment is adopted with
changes to the proposed text as published in the July 20, 2007,
issue of the Texas Register (32 TexReg 4519).
The amended rule extends the Joint Committee from its sched-
uled expiration date of September 1, 2007, to September 1, 2011
to make it possible for the Joint Committee to continue working
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on issues arising from the overlap of the jurisdiction of the agen-
cies. The change to the amendment as proposed is to replace
the phrase "is abolished on September 1, 2011" with "will expire
on September 1, 2011 unless extended by rule."
The agency received no comments concerning the proposal to
amend this rule.
There will be no change in the cost to persons required to comply
with the section. The rule continues the operations of an advisory
committee and imposes no required compliance upon anyone.
The amendment is adopted pursuant to §2110.008(a), Texas
Government Code, which allows a state agency to amend its
rules to allow an advisory committee to continue in existence af-
ter its scheduled abolishment date.
The amendment affects §1051.212 and §1001.216, Texas Oc-
cupations Code, which provides for the creation and function of
the Joint Advisory Committee.
§1.12. Joint Advisory Committee of the Texas Board of Architectural
Examiners and the Texas Board of Professional Engineers.
(a) The Chairman shall appoint three members of the Board
and one Architect who is not a member of the Board to serve on a
joint advisory committee on the practices of engineering, architecture,
and landscape architecture. The three members of the Board to be ap-
pointed by the Chairman shall include one Architect, one landscape
architect, and one other member of the Board.
(b) Members of the joint advisory committee shall serve stag-
gered six-year terms. The terms of one or two of the members ap-
pointed by the Chairman must expire each odd-numbered year.
(c) The joint advisory committee shall meet at least twice each
year to address issues resulting from the overlap between activities that
constitute the practices of engineering and architecture and the prac-
tices of engineering and landscape architecture.
(d) The joint advisory committee shall issue advisory opinions
to the Board and the Texas Board of Professional Engineers (TBPE) on
subjects including:
(1) whether certain activities constitute the practice of en-
gineering, the practice of architecture, and/or the practice of landscape
architecture;
(2) specic disciplinary proceedings initiated by the Board
or by TBPE; and
(3) the need for persons working on particular projects to
be registered by the Board or licensed by TBPE.
(e) The Board shall notify the joint advisory committee of the
nal action taken by the Board with regard to a matter addressed in an
advisory opinion issued to the Board.
(f) The Board shall enter into a memorandum of understanding
with TBPE regarding the joint advisory committee.
(g) The mission of the joint advisory committee shall be to as-
sist the Board and TBPE in protecting the public rather than advancing
the interests of either agency or the profession(s) it regulates.
(h) The joint advisory committee will expire on September 1,
2011, unless extended by rule.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas Board of Architectural Examiners
Effective date: September 20, 2007
Proposal publication date: July 20, 2007
For further information, please call: (512) 305-8544
PART 9. TEXAS MEDICAL BOARD
CHAPTER 161. GENERAL PROVISIONS
22 TAC §161.3
The Texas Medical Board (Board) adopts the amendments to
§161.3, relating to the organization and structure of the Board,
without changes to the proposed text as published in the June
29, 2007, issue of the Texas Register (32 TexReg 3955) and will
not be republished.
Prior to publishing the proposed amendments, the Board sought
stakeholder input through a stakeholder Group, which made
comments on the suggested changes to the rules at a meeting
held on May 16, 2007. Comments were incorporated into the
published proposed rules.
The Board received no public written comments and no one ap-
peared to testify at the public hearing held on August 24, 2007.
The amendments are adopted under the authority of Texas
Occupations Code, §153.001, which provides authority for the
Texas Medical Board to adopt rules and bylaws as necessary
to: govern its own proceedings; perform its duties; regulate
the practice of medicine in this state; enforce this subtitle; and
establish rules related to licensure.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704041
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: September 20, 2007
Proposal publication date: June 29, 2007
For further information, please call: (512) 305-7016
CHAPTER 176. HEALTH CARE LIABILITY
LAWSUITS AND SETTLEMENTS
22 TAC §§176.1, 176.2, 176.4, 176.6, 176.8, 176.9
The Texas Medical Board adopts amendments to §§176.1,
176.2, 176.4, 176.6, 176.8 and 176.9, concerning Health Care
Liability Lawsuits and Settlements, without changes to the
proposed text as published in the June 29, 2007, issue of the
Texas Register (32 TexReg 3956) and will not be republished.
The amendments provide statutory references to Chapter 74 of
the Texas Civil Practices and Remedies Code and Chapters 82
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and 1901 of the Insurance Code, and updates the name of the
Texas Medical Board.
Prior to publishing the proposed amendments, the Board sought
stakeholder input through a stakeholder Group, which made
comments on the suggested changes to the rules at a meeting
held on May 16, 2007. Comments were incorporated into the
published proposed rules.
The Board received no public written comments and no one ap-
peared to testify at the public hearing held on August 24, 2007.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously adopts the review of Chapter 176.
The amendments are adopted under the authority of the Texas
Occupations Code Annotated, §153.001 and §160.052, which
provides authority for the Texas Medical Board to adopt rules and
bylaws as necessary to: govern its own proceedings; perform its
duties; regulate the practice of medicine in this state; enforce this
subtitle; and establish rules related to licensure.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704042
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: September 20, 2007
Proposal publication date: June 29, 2007
For further information, please call: (512) 305-7016
CHAPTER 181. CONTACT LENS
PRESCRIPTIONS
22 TAC §§181.2, 181.3, 181.6
The Texas Medical Board adopts amendments to §§181.2,
181.3 and 181.6, concerning Contact Lens Prescriptions, with-
out changes to the proposed text as published in the June 29,
2007, issue of the Texas Register (32 TexReg 3957) and will
not be republished.
The amendments establish that the verication of a contact lens
prescription may substitute for an original signature to create a
valid contact lens prescription.
Prior to publishing the proposed amendments, the Board sought
stakeholder input through a stakeholder Group, which made
comments on the suggested changes to the rules at a meeting
held on May 16, 2007. Comments were incorporated into the
published proposed rules.
The Board received no public written comments and no one ap-
peared to testify at the public hearing held on August 24, 2007.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously adopts the review of Chapter 181.
The amendments are adopted under the authority of the Texas
Occupations Code Annotated, §153.001, which provides author-
ity for the Texas Medical Board to adopt rules and bylaws as
necessary to: govern its own proceedings; perform its duties;
regulate the practice of medicine in this state; enforce this subti-
tle; and establish rules related to licensure.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704043
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: September 20, 2007
Proposal publication date: June 29, 2007
For further information, please call: (512) 305-7016
CHAPTER 191. DISTRICT REVIEW
COMMITTEES
22 TAC §191.4
The Texas Medical Board adopts amendments to §191.4, con-
cerning Activities and Scope of Authority, without changes to the
proposed text as published in the June 29, 2007, issue of the
Texas Register (32 TexReg 3958) and will not be republished.
The amendment deletes the provision that allows District Review
Committee (DRC) members to serve as experts for the purpose
of evaluating the medical competency of physicians under inves-
tigation. The proposed amendment also establishes that DRC
members are allowed to participate in mediation and requires
DRC members to have the same qualications as expert panel
members; however they do not need to meet the same selection
criteria.
Prior to publishing the proposed amendments, the Board sought
stakeholder input through a stakeholder Group, which made
comments on the suggested changes to the rules at a meeting
held on May 16, 2007. Comments were incorporated into the
published proposed rules.
The Board received no public written comments and no one ap-
peared to testify at the public hearing held on August 24, 2007.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously adopts the review of Chapter 191.
The amendment is adopted under the authority of the Texas Oc-
cupations Code Annotated, §153.001 and §163.0045, which pro-
vides authority for the Texas Medical Board to adopt rules and
bylaws as necessary to: govern its own proceedings; perform
its duties; regulate the practice of medicine in this state; enforce
this subtitle; and establish rules related to licensure.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704044
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Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: September 20, 2007
Proposal publication date: June 29, 2007
For further information, please call: (512) 305-7016
CHAPTER 194. NON-CERTIFIED
RADIOLOGIC TECHNICIANS
22 TAC §§194.2 - 194.6
The Texas Medical Board adopts amendments to §§194.2 -
194.6, concerning Non-Certied Radiologic Technicians, without
changes to the proposed text as published in the June 29, 2007,
issue of the Texas Register (32 TexReg 3959) and will not be
republished.
The amendments provide updates regarding the names of the
Texas Medical Board and Department of State Health Services,
and clarify that NCT registrations that are not renewed within 90
days will be considered expired.
Prior to publishing the proposed amendments, the Board sought
stakeholder input through a stakeholder Group, which made
comments on the suggested changes to the rules at a meeting
held on May 16, 2007. Comments were incorporated into the
published proposed rules.
The Board received no public written comments and no one ap-
peared to testify at the public hearing held on August 24, 2007.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously adopts the review of Chapter 194.
The amendments are adopted under the authority of the Texas
Occupations Code Annotated, §153.001, which provides author-
ity for the Texas Medical Board to adopt rules and bylaws as
necessary to: govern its own proceedings; perform its duties;
regulate the practice of medicine in this state; enforce this subti-
tle; and establish rules related to licensure.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704045
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: September 20, 2007
Proposal publication date: June 29, 2007
For further information, please call: (512) 305-7016
CHAPTER 197. EMERGENCY MEDICAL
SERVICE
22 TAC §§197.1 - 197.4
The Texas Medical Board adopts amendments to §§197.1 -
197.4, concerning Emergency Medical Service. Sections 197.1,
197.2 and 197.4 are adopted without changes to the proposed
text as published in the June 29, 2007, issue of the Texas
Register (32 TexReg 3960) and will not be republished. Section
197.3 is adopted with changes to the proposed text as published
in the June 29, 2007, issue of the Texas Register (32 TexReg
3960). The text of the rule will be republished.
The amendments provide updates regarding the names of the
Texas Medical Board and Department of State Health Services,
require that EMS medical directors report to the board the names
and license numbers of all emergency medical personnel who
work under a medical director’s supervision, and remove the re-
quirement that on-line physicians be familiar with the capabilities
of the prehospital providers, as well as local EMS operational
policies and regional critical care referral protocols.
The amendment to §197.3 is adopted with changes. The pro-
posed amendment to (b)(15) isn’t adopted because after further
review, staff determined that including the reporting requirement
would be too burdensome to licensees and for staff who would
need to process the reports.
Prior to publishing the proposed amendments, the Board sought
stakeholder input through a stakeholder Group, which made
comments on the suggested changes to the rules at a meeting
held on May 16, 2007. Comments were incorporated into the
published proposed rules.
The Board received no public written comments and no one ap-
peared to testify at the public hearing held on August 24, 2007.
Elsewhere in this issue of the Texas Register, the Texas Medical
Board contemporaneously adopts the review of Chapter 197.
The amendments are adopted under the authority of the Texas
Occupations Code Annotated, §153.001 and §157.003, which
provides authority for the Texas Medical Board to adopt rules and
bylaws as necessary to: govern its own proceedings; perform its
duties; regulate the practice of medicine in this state; enforce this
subtitle; and establish rules related to licensure.
§197.3. Off-line Medical Director.
(a) An off-line medical director shall be:
(1) a physician licensed to practice in Texas and shall be
registered as an EMS medical director with the Texas Department of
State Health Services;
(2) familiar with the design and operation of EMS systems;
(3) experienced in prehospital emergency care and emer-
gency management of ill and injured patients;
(4) actively involved in:
(A) the training and/or continuing education of EMS
personnel, under his or her direct supervision, at their respective levels
of certication;
(B) the medical audit, review, and critique of the per-
formance of EMS personnel under his or her direct supervision;
(C) the administrative and legislative environments af-
fecting regional and/or state prehospital EMS organizations;
(5) knowledgeable about local multi-casualty plans;
(6) familiar with dispatch and communications operations
of prehospital emergency units; and
(7) knowledgeable about laws and regulations affecting lo-
cal, regional, and state EMS operations.
(b) The off-line medical director shall be required to:
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(1) approve the level of prehospital care which may be ren-
dered locally by each of the EMS personnel employed by and/or volun-
teering with the EMS under the medical director’s supervision, regard-
less of the level of state certication or licensure, before the certicant
or licensee is permitted to provide such care to the public;
(2) establish and monitor compliance with eld perfor-
mance guidelines for EMS personnel;
(3) establish and monitor compliance with training guide-
lines which meet or exceed the minimum standards set forth in the
Texas Department of State Health Services EMS certication regula-
tions;
(4) develop, implement, and revise protocols and/or stand-
ing delegation orders, if appropriate, governing prehospital care and
medical aspects of patient triage, transport, transfer, dispatch, extri-
cation, rescue, and radio-telephone-telemetry communication by the
EMS;
(5) direct an effective system audit and quality assurance
program;
(6) determine standards and objectives for all medically re-
lated aspects of operation of the EMS including the inspection, evalu-
ation, and approval of the system’s performance specications;
(7) function as the primary liaison between the EMS ad-
ministration and the local medical community, ascertaining and being
responsive to the needs of each;
(8) develop a letter or agreement or contract between the
medical director(s) and the EMS administration outlining the specic
responsibilities and authority of each. The agreement should describe
the process or procedure by which a medical director may withdraw
responsibility for EMS personnel for noncompliance with the Emer-
gency Medical Services Act, the Health and Safety Code, Chapter 773,
the rules adopted in this chapter, and/or accepted medical standards;
(9) take or recommend appropriate remedial or corrective
measures for EMS personnel, in conjunction with local EMS adminis-
tration, which may include, but are not limited to, counseling, retrain-
ing, testing, probation, and/or eld preceptorship;
(10) suspend a certied EMS individual from medical care
duties for due cause pending review and evaluation;
(11) establish the circumstances under which a patient
might not be transported;
(12) establish the circumstances under which a patient
may be transported against his or her will in accordance with state law,
including approval of appropriate procedures, forms, and a review
process;
(13) establish criteria for selection of a patient’s destina-
tion;
(14) develop and implement a comprehensive mechanism
for management of patient care incidents, including patient complaints,
allegations of substandard care, and deviations from established proto-
cols and patient care standards; and
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 31, 2007.
TRD-200704046
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Effective date: September 20, 2007
Proposal publication date: June 29, 2007
For further information, please call: (512) 305-7016
PART 15. TEXAS STATE BOARD OF
PHARMACY
CHAPTER 291. PHARMACIES
SUBCHAPTER A. ALL CLASSES OF
PHARMACIES
22 TAC §§291.2 - 291.4, 291.7, 291.12, 291.13, 291.15,
291.16, 291.20, 291.21, 291.25 - 291.27
The Texas State Board of Pharmacy adopts the repeal of
§291.2, concerning Change of Location and/or Name, §291.3,
concerning Change of Managing Ofcers, §291.4, concerning
Change of Ownership, §291.7, concerning Change of Pharma-
cist Employment, §291.12, concerning Fire or Other Disaster,
§291.13, concerning Emergency Remote Pharmacy License,
§291.15, concerning Notication of Theft or Loss of a Con-
trolled Substance or a Dangerous Drug, §291.16, concerning
Denitions, §291.20, concerning Remote Pharmacy Services,
§291.21, concerning Notication to Consumers, §291.25,
concerning Pharmacies Compounding Non-Sterile Pharmaceu-
ticals, §291.26, concerning Pharmacies Compounding Sterile
Pharmaceuticals, and §291.27, concerning Pharmacy Resi-
dency Programs. The repeal is adopted without changes to the
proposal as published in the June 15, 2007, issue of the Texas
Register (32 TexReg 3462).
The repeal provides a more organized Chapter 291, Subchapter
A regarding all classes of pharmacies.
No comments were received regarding the proposal.
The repeal is adopted under §551.002 and §554.051 of the
Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569, Texas
Occupations Code). The Board interprets §551.002 as autho-
rizing the agency to protect the public through the effective
control and regulation of the practice of pharmacy. The Board
interprets §554.051(a) as authorizing the agency to adopt rules
for the proper administration and enforcement of the Act.
The statutes affected by this repeal: Texas Pharmacy Act, Chap-
ters 551 - 566 and 568 - 569, Texas Occupations Code.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas State Board of Pharmacy
Effective date: September 18, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
ADOPTED RULES September 14, 2007 32 TexReg 6317
22 TAC §§291.2, 291.3, 291.8, 291.10, 291.18, 291.19, 291.22
- 291.24, 291.27
The Texas State Board of Pharmacy adopts new §291.2, con-
cerning Denitions, §291.3, concerning Required Notications,
§291.24, concerning Pharmacy Residency Programs, and
§291.27, concerning Condentiality; amendments to §291.8,
concerning Return of Prescription Drugs, §291.10, concerning
Pharmacy Balance Registration/Inspection, §291.18, concern-
ing Time Limit for Filing a Compliant, §291.19, concerning
Administrative Actions as a Result of a Compliance Inspection,
§291.22, concerning Petition to Establish an Additional Class
of Pharmacy, and §291.23, concerning Pilot or Demonstration
Research Projects for Innovative Applications in the Practice
of Pharmacy. The new rules and amendments are adopted
without changes to the proposed text as published in the June
15, 2007, issue of the Texas Register (32 TexReg 3462).
The amendments and new rules provide a more organized
Chapter 291, Subchapter A, regarding all classes of pharma-
cies.
No comments were received regarding the proposal.
The new rules and amendments are adopted under §§551.002,
554.051, and 562.1085 of the Texas Pharmacy Act (Chapters
551 - 566 and 568 - 569, Texas Occupations Code). The Board
interprets §551.002 as authorizing the agency to protect the pub-
lic through the effective control and regulation of the practice of
pharmacy. The Board interprets §554.051(a) as authorizing the
agency to adopt rules for the proper administration and enforce-
ment of the Act. The Board interprets §562.1085 as authorizing
the agency to adopt rules to implement the provisions of the sec-
tion.
The statutes affected by the new rules and amendments: Texas
Pharmacy Act, Chapters 551 - 566 and 568 - 569, Texas Occu-
pations Code.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas State Board of Pharmacy
Effective date: September 18, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
22 TAC §291.6
The Texas State Board of Pharmacy adopts amendments to
§291.6, concerning Pharmacy License Fees, with changes to
the proposed text as published in the June 15, 2007, issue of
the Texas Register (32 TexReg 3463). The changes to this
section are described in this preamble.
Written comments were received from the National Association
of Chain Drug Stores (NACDS) with regard to §291.6 which
raises pharmacy license fees based on increased expenses.
NACDS opposed the 35% fee increased. The Board disagrees
with this comment because the Board must be adequately
funded to carry out its mission. The Board was however, able to
substantially reduce the proposed fee increase for all licensees,
including reducing the proposed pharmacy initial and renewal
fees from $443, to $385, based on the nal appropriations to
the agency that were approved by the Texas Legislature.
The amendments are adopted under §§551.002, 554.051,
554.006, and 564.051 of the Texas Pharmacy Act (Chapters
551 - 566 and 568 - 569, Texas Occupations Code). The Board
interprets §551.002 as authorizing the agency to protect the
public through the effective control and regulation of the practice
of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and
enforcement of the Act. The Board interprets §564.006 as
authorizing the agency to adopt rules to establish reasonable
and necessary fees to produce sufcient revenue to cover the
cost of administering the Act. The Board interprets §564.051 as
authorizing the agency to collect a surcharge to fund a program
to aid impaired pharmacists and pharmacy students.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
§291.6. Pharmacy License Fees.
(a) Initial License Fee.
(1) The fee for an initial license shall be $385 for a two
year registration and for processing the application and issuance of the
pharmacy license as authorized by the Act §554.006.
(2) In addition, the following fees shall be collected:
(A) $15 surcharge to fund a program to aid impaired
pharmacists and pharmacy students as authorized by the Act §564.051;
(B) $10 surcharge to fund TexasOnline as authorized by
Chapter 2054, Subchapter I, Government Code; and
(C) $5 surcharge to fund the Ofce of Patient Protection
as authorized by Chapter 101, Subchapter G, Occupations Code.
(3) New pharmacy licenses shall be assigned an expiration
date and initial registration fee shall be prorated based on the assigned
expiration date.
(b) Biennial License Renewal. The Texas State Board of Phar-
macy shall require biennial renewal of all pharmacy licenses provided
under the Act §561.002.
(c) Renewal Fee.
(1) The fee for biennial renewal of a pharmacy license shall
be $385 for processing the application and issuance of the pharmacy
license as authorized by the Act §554.006;
(2) In addition, the following fees shall be collected:
(A) $15 surcharge to fund a program to aid impaired
pharmacists and pharmacy students as authorized by the Act §564.051;
(B) $10 surcharge to fund TexasOnline as authorized by
Chapter 2054, Subchapter I, Government Code; and
(C) $2 surcharge to fund the Ofce of Patient Protection
as authorized by Chapter 101, Subchapter G, Occupations Code.
(d) Duplicate or Amended Certicates. The fee for issuance
of an amended pharmacy license renewal certicate shall be $20.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
32 TexReg 6318 September 14, 2007 Texas Register




Texas State Board of Pharmacy
Effective date: October 1, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
SUBCHAPTER B. COMMUNITY PHARMACY
(CLASS A)
22 TAC §§291.31, 291.32, 291.34
The Texas State Board of Pharmacy adopts amendments to
§291.31, concerning Denitions; §291.32, concerning Person-
nel; and §291.34, concerning Records. The amendments are
adopted with changes to the proposed text as published in the
June 15, 2007, issue of the Texas Register (32 TexReg 3468).
The changes to the sections are described in this preamble.
The amendments to §291.31 clarify the denition for hot water,
update and clarify the denitions for pharmacy technicians and
pharmacy technician trainees, and clarify the denition of pre-
scription drug. The amendments to §291.32 clarify that a phar-
macist must check the data entry of a prescription, at the time of
data entry when the prescription is placed "on hold" and update
the rules to include pharmacy technician trainees. The amend-
ments to §291.34 require pharmacies to provide the board or its
representative with records in electronic format, if the records
are maintained in an electronic format, and update and correct
references.
The following comments were received regarding the amend-
ments.
The Texas Society of Health-System Pharmacists commented
that the denition of hot water in §291.31 should be consistent
with the requirements used for hospital construction standards
by the Texas Department of State Health Services (DSHS).
DSHS requires hot water to be between 105 and 120 degrees
Fahrenheit. The Board agrees with this comment and amended
the proposed language to reect that hot water be a minimum
of 105 degrees Fahrenheit.
The National Association of Chain Drug Stores (NACDS) com-
mented that §291.32, which requires a prescription entered into
a pharmacy’s data processing system be veried by a pharma-
cist at the time of data entry, would be burdensome and disrup-
tive to pharmacy workow. The Board disagrees with this com-
ment and believes that prescriptions placed must be checked at
the time of data entry in order to ensure that patients receive ac-
curately dispensed prescriptions.
NACDS commented that the amendments to §291.34, requir-
ing pharmacies to provide the Board or its representatives with
records in electronic format, would increase costs to pharma-
cies and would expend hours trying to adapt the pharmacies
computer system to meet the Board’s needed format. Medco
Health Solutions commented that §291.34 recommended that
the scope of the amendment be narrowed to only those records
relating to prescription records. The Board amended the pro-
posed language to reect that the records must be provided in a
mutually agreeable format.
The amendments are adopted under §551.002 and §554.051 of
the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569,
Texas Occupations Code). The Board interprets §551.002 as
authorizing the agency to protect the public through the effective
control and regulation of the practice of pharmacy. The Board
interprets §554.051(a) as authorizing the agency to adopt rules
for the proper administration and enforcement of the Act.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
§291.31. Denitions.
The following words and terms, when used in this subchapter, shall
have the following meanings, unless the context clearly indicates oth-
erwise.
(1) Accurately as prescribed--Dispensing, delivering,
and/or distributing a prescription drug order:
(A) to the correct patient (or agent of the patient) for
whom the drug or device was prescribed;
(B) with the correct drug in the correct strength, quan-
tity, and dosage form ordered by the practitioner; and
(C) with correct labeling (including directions for use)
as ordered by the practitioner. Provided, however, that nothing herein
shall prohibit pharmacist substitution if substitution is conducted in
strict accordance with applicable laws and rules, including Chapters
562 and 563 of the Texas Pharmacy Act.
(2) Act--The Texas Pharmacy Act, Chapters 551 - 566 and
568 - 569, Occupations Code, as amended.
(3) Advanced practice nurse--A registered nurse approved
by the Texas State Board of Nurse Examiners to practice as an advanced
practice nurse on the basis of completion of an advanced education
program. The term includes a nurse practitioner, a nurse midwife, a
nurse anesthetist, and a clinical nurse specialist.
(4) Automated compounding or counting device--An au-
tomated device that compounds, measures, counts, and/or packages a
specied quantity of dosage units of a designated drug product.
(5) Automated pharmacy dispensing systems--a mechani-
cal system that performs operations or activities, other than compound-
ing or administration, relative to the storage, packaging, counting, la-
beling, dispensing, and distribution of medications, and which collects,
controls, and maintains all transaction information. "Automated phar-
macy dispensing systems" does not mean "Automated compounding or
counting devices" or "Automated medication supply devices."
(6) Board--The Texas State Board of Pharmacy.
(7) Carrying out or signing a prescription drug order--The
completion of a prescription drug order presigned by the delegating
physician, or the signing of a prescription by an advanced practice
nurse or physician assistant after the person has been designated with
the Texas Medical Board by the delegating physician as a person del-
egated to sign a prescription. The following information shall be pro-
vided on each prescription:
(A) patient’s name and address;
(B) name, strength, and quantity of the drug to be dis-
pensed;
(C) directions for use;
(D) the intended use of the drug, if appropriate;
(E) the name, address, and telephone number of the
physician;
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(F) the name, address, telephone number, identication
number, and if the prescription is for a controlled substance, the DEA
number of the advanced practice nurse or physician assistant complet-
ing the prescription drug order;
(G) the date; and
(H) the number of rells permitted.
(8) Condential record--Any health-related record that
contains information that identies an individual and that is maintained
by a pharmacy or pharmacist, such as a patient medication record,
prescription drug order, or medication order.
(9) Controlled substance--A drug, immediate precursor, or
other substance listed in Schedules I - V or Penalty Groups 1-4 of the
Texas Controlled Substances Act, as amended, or a drug, immediate
precursor, or other substance included in Schedules I, II, III, IV, or V
of the Federal Comprehensive Drug Abuse Prevention and Control Act
of 1970, as amended (Public Law 91-513).
(10) Dangerous drug--A drug or device that:
(A) is not included in Penalty Group 1, 2, 3, or 4, Chap-
ter 481, Health and Safety Code, and is unsafe for self-medication; or
(B) bears or is required to bear the legend:
(i) "Caution: federal law prohibits dispensing with-
out prescription" or "Rx only" or another legend that complies with
federal law; or
(ii) "Caution: federal law restricts this drug to use
by or on the order of a licensed veterinarian."
(11) Data communication device--An electronic device
that receives electronic information from one source and transmits or
routes it to another (e.g., bridge, router, switch or gateway).
(12) Deliver or delivery--The actual, constructive, or at-
tempted transfer of a prescription drug or device or controlled sub-
stance from one person to another, whether or not for a consideration.
(13) Designated agent--
(A) a licensed nurse, physician assistant, pharmacist, or
other individual designated by a practitioner to communicate prescrip-
tion drug orders to a pharmacist;
(B) a licensed nurse, physician assistant, or pharmacist
employed in a health care facility to whom the practitioner communi-
cates a prescription drug order;
(C) an advanced practice nurse or physician assistant
authorized by a practitioner to carry out or sign a prescription drug
order for dangerous drugs under Chapter 157 of the Medical Practice
Act (Subtitle B, Occupations Code); or
(D) a person who is a licensed vocational nurse or has
an education equivalent to or greater than that required for a licensed
vocational nurse designated by the practitioner to communicate pre-
scriptions for an advanced practice nurse or physician assistant autho-
rized by the practitioner to sign prescription drug orders under Chapter
157 of the Medical Practice Act (Subtitle B, Occupations Code).
(14) Dispense--Preparing, packaging, compounding, or la-
beling for delivery a prescription drug or device in the course of pro-
fessional practice to an ultimate user or his agent by or pursuant to the
lawful order of a practitioner.
(15) Dispensing pharmacist--The pharmacist responsible
for the nal check of the dispensed prescription before delivery to the
patient.
(16) Distribute--The delivery of a prescription drug or de-
vice other than by administering or dispensing.
(17) Downtime--Period of time during which a data pro-
cessing system is not operable.
(18) Drug regimen review--An evaluation of prescription
drug orders and patient medication records for:
(A) known allergies;
(B) rational therapy-contraindications;
(C) reasonable dose and route of administration;
(D) reasonable directions for use;




(I) adverse drug reactions; and
(J) proper utilization, including overutilization or un-
derutilization.
(19) Electronic prescription drug order--A prescription
drug order which is transmitted by an electronic device to the receiver
(pharmacy).
(20) Electronic signature--A unique security code or other
identier which specically identies the person entering information
into a data processing system. A facility which utilizes electronic sig-
natures must:
(A) maintain a permanent list of the unique security
codes assigned to persons authorized to use the data processing
system; and
(B) have an ongoing security program which is capable
of identifying misuse and/or unauthorized use of electronic signatures.
(21) Full-time pharmacist--A pharmacist who works in a
pharmacy from 30 to 40 hours per week or, if the pharmacy is open
less than 60 hours per week, one-half of the time the pharmacy is open.
(22) Hard copy--A physical document that is readable
without the use of a special device (i.e., cathode ray tube (CRT),
microche reader, etc.).
(23) Hot water-The temperature of water from the phar-
macy’s sink maintained at a minimum of 105 degrees F (41 degrees
C).
(24) Medical Practice Act--The Texas Medical Practice
Act, Subtitle B, Occupations Code, as amended.
(25) Medication order--A written order from a practitioner
or a verbal order from a practitioner or his authorized agent for admin-
istration of a drug or device.
(26) New prescription drug order--A prescription drug or-
der that:
(A) has not been dispensed to the patient in the same
strength and dosage form by this pharmacy within the last year;
(B) is transferred from another pharmacy; and/or
(C) is a discharge prescription drug order. (Note: fur-
lough prescription drug orders are not considered new prescription drug
orders.)
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(27) Original prescription--The:
(A) original written prescription drug order; or
(B) original verbal or electronic prescription drug order
reduced to writing either manually or electronically by the pharmacist.
(28) Part-time pharmacist--A pharmacist who works less
than full-time.
(29) Patient counseling--Communication by the pharma-
cist of information to the patient or patient’s agent in order to improve
therapy by ensuring proper use of drugs and devices.
(30) Pharmaceutical care--The provision of drug therapy
and other pharmaceutical services intended to assist in the cure or pre-
vention of a disease, elimination or reduction of a patient’s symptoms,
or arresting or slowing of a disease process.
(31) Pharmacist-in-charge--The pharmacist designated on
a pharmacy license as the pharmacist who has the authority or respon-
sibility for a pharmacy’s compliance with laws and rules pertaining to
the practice of pharmacy.
(32) Pharmacy technician--An individual who is registered
with the board as a pharmacy technician and whose responsibility in a
pharmacy is to provide technical services that do not require profes-
sional judgment regarding preparing and distributing drugs and who
works under the direct supervision of and is responsible to a pharma-
cist.
(33) Pharmacy technician trainee--An individual who is
registered with the board as a pharmacy technician trainee and is
authorized to participate in a pharmacy’s technician training program.
(34) Physician assistant--A physician assistant recognized
by the Texas Medical Board as having the specialized education and
training required under Subtitle B, Chapter 157, Occupations Code,
and issued an identication number by the Texas Medical Board.
(35) Practitioner--
(A) a person licensed or registered to prescribe, distrib-
ute, administer, or dispense a prescription drug or device in the course
of professional practice in this state, including a physician, dentist, po-
diatrist, or veterinarian but excluding a person licensed under this sub-
title;
(B) a person licensed by another state, Canada, or the
United Mexican States in a health eld in which, under the law of this
state, a license holder in this state may legally prescribe a dangerous
drug;
(C) a person practicing in another state and licensed by
another state as a physician, dentist, veterinarian, or podiatrist, who has
a current federal Drug Enforcement Administration registration num-
ber and who may legally prescribe a Schedule II, III, IV, or V controlled
substance, as specied under Chapter 481, Health and Safety Code, in
that other state; or
(D) an advanced practice nurse or physician assistant to
whom a physician has delegated the authority to carry out or sign pre-
scription drug orders under §§157.0511, 157.052, 157.053, 157.054,
157.0541, or 157.0542, Occupations Code.
(36) Prepackaging--The act of repackaging and relabeling
quantities of drug products from a manufacturer’s original commercial
container into a prescription container for dispensing by a pharmacist
to the ultimate consumer.
(37) Prescription drug--
(A) a substance for which federal or state law requires
a prescription before the substance may be legally dispensed to the
public;
(B) a drug or device that under federal law is required,
before being dispensed or delivered, to be labeled with the statement:
(i) "Caution: federal law prohibits dispensing with-
out prescription" or "Rx only" or another legend that complies with
federal law; or
(ii) "Caution: federal law restricts this drug to use
by or on the order of a licensed veterinarian"; or
(C) a drug or device that is required by federal or state
statute or regulation to be dispensed on prescription or that is restricted
to use by a practitioner only.
(38) Prescription drug order--
(A) a written order from a practitioner or a verbal order
from a practitioner or his authorized agent to a pharmacist for a drug
or device to be dispensed; or
(B) a written order or a verbal order pursuant to Subtitle
B, Chapter 157, Occupations Code.
(39) Prospective drug use review--A review of the patient’s
drug therapy and prescription drug order or medication order prior to
dispensing or distributing the drug.
(40) State--One of the 50 United States of America, a U.S.
territory, or the District of Columbia.
(41) Texas Controlled Substances Act--The Texas Con-
trolled Substances Act, Health and Safety Code, Chapter 481, as
amended.
(42) Written protocol--A physician’s order, standing med-
ical order, standing delegation order, or other order or protocol as de-





(A) Each Class A pharmacy shall have one pharmacist-
in-charge who is employed on a full-time basis, who may be the phar-
macist-in-charge for only one such pharmacy; provided, however, such
pharmacist-in-charge may be the pharmacist-in-charge of:
(i) more than one Class A pharmacy, if the addi-
tional Class A pharmacies are not open to provide pharmacy services
simultaneously; or
(ii) up to two Class A pharmacies open simultane-
ously if the pharmacist-in-charge works at least 10 hours per week in
each pharmacy.
(B) The pharmacist-in-charge shall comply with the
provisions of §291.17 of this title (relating to Inventory Requirements).
(2) Responsibilities. The pharmacist-in-charge shall have
responsibility for the practice of pharmacy at the pharmacy for which
he or she is the pharmacist-in-charge. The pharmacist-in-charge may
advise the owner on administrative or operational concerns. The phar-
macist-in-charge shall have responsibility for, at a minimum, the fol-
lowing:
(A) education and training of pharmacy technicians and
pharmacy technician trainees;
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(B) supervising a system to assure appropriate procure-
ment of prescription drugs and devices and other products dispensed
from the Class A pharmacy;
(C) disposal and distribution of drugs from the Class A
pharmacy;
(D) storage of all materials, including drugs, chemicals,
and biologicals;
(E) maintaining records of all transactions of the Class
A pharmacy necessary to maintain accurate control over and account-
ability for all pharmaceutical materials required by applicable state and
federal laws and sections;
(F) supervising a system to assure maintenance of ef-
fective controls against the theft or diversion of prescription drugs, and
records for such drugs;
(G) adherence to policies and procedures regarding the
maintenance of records in a data processing system such that the data
processing system is in compliance with Class A (community) phar-
macy requirements;
(H) legal operation of the pharmacy, including meeting
all inspection and other requirements of all state and federal laws or
sections governing the practice of pharmacy; and
(I) if the pharmacy uses an automated pharmacy dis-
pensing system, shall be responsible for the following:
(i) consulting with the owner concerning and adher-
ence to the policies and procedures for system operation, safety, secu-
rity, accuracy and access, patient condentiality, prevention of unau-
thorized access, and malfunction;
(ii) inspecting medications in the automated phar-
macy dispensing system, at least monthly, for expiration date, mis-
branding, physical integrity, security, and accountability;
(iii) assigning, discontinuing, or changing personnel
access to the automated pharmacy dispensing system;
(iv) ensuring that pharmacy technicians, pharmacy
technician trainees, and licensed healthcare professionals performing
any services in connection with an automated pharmacy dispensing
system have been properly trained on the use of the system and can
demonstrate comprehensive knowledge of the written policies and pro-
cedures for operation of the system; and
(v) ensuring that the automated pharmacy dispens-
ing system is stocked accurately and an accountability record is main-
tained in accordance with the written policies and procedures of oper-
ation.
(b) Owner. The owner of a Class A pharmacy shall have re-
sponsibility for all administrative and operational functions of the phar-
macy. The pharmacist-in-charge may advise the owner on administra-
tive and operational concerns. The owner shall have responsibility for,
at a minimum, the following, and if the owner is not a Texas licensed
pharmacist, the owner shall consult with the pharmacist-in-charge or
another Texas licensed pharmacist:
(1) establishment of policies for procurement of prescrip-
tion drugs and devices and other products dispensed from the Class A
pharmacy;
(2) establishment and maintenance of effective controls
against the theft or diversion of prescription drugs;
(3) if the pharmacy uses an automated pharmacy dispens-
ing system, reviewing and approving all policies and procedures for
system operation, safety, security, accuracy and access, patient con-
dentiality, prevention of unauthorized access, and malfunction;
(4) providing the pharmacy with the necessary equipment
and resources commensurate with its level and type of practice; and
(5) establishment of policies and procedures regarding
maintenance, storage, and retrieval of records in a data processing




(A) The pharmacist-in-charge shall be assisted by suf-
cient number of additional licensed pharmacists as may be required
to operate the Class A pharmacy competently, safely, and adequately
to meet the needs of the patients of the pharmacy.
(B) All pharmacists shall assist the pharma-
cist-in-charge in meeting his or her responsibilities in ordering,
dispensing, and accounting for prescription drugs.
(C) Pharmacists are solely responsible for the direct su-
pervision of pharmacy technicians and pharmacy technician trainees
and for designating and delegating duties, other than those listed in
paragraph (2) of this subsection, to pharmacy technicians and phar-
macy technician trainees. Each pharmacist:
(i) shall verify the accuracy of all acts, tasks, and
functions performed by pharmacy technicians and pharmacy technician
trainees; and
(ii) shall be responsible for any delegated act per-
formed by pharmacy technicians and pharmacy technician trainees un-
der his or her supervision.
(D) Pharmacists shall directly supervise pharmacy
technicians and pharmacy technician trainees who are entering pre-
scription data into the pharmacy’s data processing system by one of
the following methods.
(i) Physically present supervision. A pharmacist
shall be physically present to directly supervise a pharmacy technician
or pharmacy technician trainee who is entering prescription data
into the data processing system. Each prescription entered into the
data processing system shall be veried at the time of data entry. If
the pharmacist is not physically present due to a temporary absence
as specied in §291.33(b)(4) of this title (relating to Operational
Standards), on return the pharmacist must:
(I) conduct a drug regimen review for the
prescriptions data entered during this time period as specied in
§291.33(c)(2) of this title; and
(II) verify that prescription data entered during
this time period was entered accurately.
(ii) Electronic supervision. A pharmacist may
electronically supervise a pharmacy technician or pharmacy technician
trainee who is entering prescription data into the data processing
system provided the pharmacist:
(I) is on-site, in the pharmacy where the techni-
cian/trainee is located;
(II) has immediate access to any original docu-
ment containing prescription information or other information related
to the dispensing of the prescription. Such access may be through imag-
ing technology provided the pharmacist has the ability to review the
original, hardcopy documents if needed for clarication; and
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(III) veries the accuracy of the data entered in-
formation prior to the release of the information to the system for stor-
age and/or generation of the prescription label.
(E) All pharmacists while on duty, shall be responsible
for complying with all state and federal laws or rules governing the
practice of pharmacy.
(F) A dispensing pharmacist shall ensure that the drug
is dispensed and delivered safely, and accurately as prescribed. In addi-
tion, if multiple pharmacists participate in the dispensing process, each
pharmacist shall ensure the safety and accuracy of the portion of the
process the pharmacist is performing. The dispensing process shall in-
clude, but not be limited to, drug regimen review and verication of
accurate prescription data entry, including data entry of prescriptions
placed on hold, packaging, preparation, compounding and labeling and
performance of the nal check of the dispensed prescription.
(2) Duties. Duties which may only be performed by a phar-
macist are as follows:
(A) receiving oral prescription drug orders and reduc-
ing these orders to writing, either manually or electronically;
(B) interpreting prescription drug orders;
(C) selection of drug products;
(D) performing the nal check of the dispensed pre-
scription before delivery to the patient to ensure that the prescription
has been dispensed accurately as prescribed;
(E) communicating to the patient or patient’s agent in-
formation about the prescription drug or device which in the exercise
of the pharmacist’s professional judgement, the pharmacist deems sig-
nicant, as specied in §291.33(c) of this title;
(F) communicating to the patient or the patient’s agent
on his or her request information concerning any prescription drugs
dispensed to the patient by the pharmacy;
(G) assuring that a reasonable effort is made to obtain,
record, and maintain patient medication records;
(H) interpreting patient medication records and per-
forming drug regimen reviews; and
(I) performing a specic act of drug therapy manage-
ment for a patient delegated to a pharmacist by a written protocol from
a physician licensed in this state in compliance with the Medical Prac-
tice Act.
(3) Special requirements for compounding.
(A) Non-Sterile Preparations. All pharmacists engaged
in compounding non-sterile preparations shall meet the training re-
quirements specied in §291.131 of this title (relating to Pharmacies
Compounding Non-Sterile Preparations).
(B) Sterile Preparations. All pharmacists engaged in
compounding sterile preparations shall meet the training requirements
specied in §291.133 of this title (relating to Pharmacies Compound-
ing Sterile Preparations).
(d) Pharmacy Technicians and Pharmacy Technician Trainees.
(1) General.
(A) All pharmacy technicians and pharmacy technician
trainees shall meet the training requirements specied in §297.6 of
this title (relating to Pharmacy Technician and Pharmacy Technician
Trainee Training).
(B) Special requirements for compounding.
(i) Non-Sterile Preparations. All pharmacy techni-
cians and pharmacy technician trainees engaged in compounding non-
sterile preparations shall meet the training requirements specied in
§291.131 of this title.
(ii) Sterile Preparations. All pharmacy technicians
and pharmacy technician trainees engaged in compounding sterile
preparations shall meet the training requirements specied in §291.133
of this title.
(2) Duties.
(A) Pharmacy technicians and pharmacy technician
trainees may not perform any of the duties listed in subsection (c)(2)
of this section.
(B) A pharmacist may delegate to pharmacy techni-
cians and pharmacy technician trainees any nonjudgmental technical
duty associated with the preparation and distribution of prescription
drugs provided:
(i) a pharmacist veries the accuracy of all acts,
tasks, and functions performed by pharmacy technicians and pharmacy
technician trainees;
(ii) pharmacy technicians and pharmacy technician
trainees are under the direct supervision of and responsible to a phar-
macist; and
(iii) only pharmacy technicians and pharmacy tech-
nician trainees who have been properly trained on the use of an auto-
mated pharmacy dispensing system and can demonstrate comprehen-
sive knowledge of the written policies and procedures for the operation
of the system may be allowed access to the system; and
(C) Pharmacy technicians and pharmacy technician
trainees may perform only nonjudgmental technical duties associated
with the preparation and distribution of prescription drugs, as follows:
(i) initiating and receiving rell authorization re-
quests;
(ii) entering prescription data into a data processing
system;
(iii) taking a stock bottle from the shelf for a pre-
scription;
(iv) preparing and packaging prescription drug
orders (i.e., counting tablets/capsules, measuring liquids and placing
them in the prescription container);
(v) afxing prescription labels and auxiliary labels
to the prescription container;
(vi) reconstituting medications;
(vii) prepackaging and labeling prepackaged drugs;
(viii) loading bulk unlabeled drugs into an au-
tomated dispensing system provided a pharmacist veries that the
system is properly loaded prior to use;
(ix) compounding non-sterile and sterile prescrip-
tion drug orders; and
(x) bulk compounding.
(3) Ratio of pharmacist to pharmacy technicians and phar-
macy technician trainees.
(A) Except as provided in subparagraph (B) of this
paragraph, the ratio of pharmacists to pharmacy technicians and
pharmacy technician trainees may be 1:3, provided at least one of the
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three is a pharmacy technician. The ratio of pharmacists to pharmacy
technician trainees may not exceed 1:2.
(B) As specied in §568.006 of the Act, a pharmacy that
primarily compounds non-sterile pharmaceuticals may have a ratio of
pharmacists to pharmacy technicians/pharmacy technician trainees of
1:5 provided:
(i) the pharmacy:
(I) dispenses no more than 20 different prescrip-
tion drugs; and
(II) does not produce sterile preparations includ-
ing intravenous or intramuscular drugs on-site; and
(ii) the following conditions are met:
(I) at least four are pharmacy technicians and not
pharmacy technician trainees; and
(II) The pharmacy has written policies and pro-
cedures regarding the supervision of pharmacy technicians and phar-
macy technician trainees, including requirements that the pharmacy
technicians and pharmacy technician trainees included in a 1:5 ratio
may be involved only in one process at a time. For example, a techni-
cian/trainee who is compounding non-sterile preparations may not also
call physicians for authorization of rells.
(e) Identication of pharmacy personnel. All pharmacy per-
sonnel shall be identied as follows.
(1) Pharmacy technicians. All pharmacy technicians shall
wear an identication tag or badge that bears the person’s name and
identies him or her as a pharmacy technician, or a certied pharmacy
technician, if the technician maintains current certication with the
Pharmacy Technician Certication Board or any other entity provid-
ing an examination approved by the board.
(2) Pharmacy technician trainees. All pharmacy technician
trainees shall wear an identication tag or badge that bears the person’s
name and identies him or her as a pharmacy technician trainee.
(3) Pharmacist interns. All pharmacist interns shall wear
an identication tag or badge that bears the person’s name and identies
him or her as a pharmacist intern.
(4) Pharmacists. All pharmacists shall wear an identica-
tion tag or badge that bears the person’s name and identies him or her
as a pharmacist.
§291.34. Records.
(a) Maintenance of records.
(1) Every inventory or other record required to be kept
under the provisions of §291.31 of this title (relating to Denitions),
§291.32 of this title (relating to Personnel), §291.33 of this title
(relating to Operational Standards), §291.34 of this title (relating to
Records), and §291.35 of this title (relating to Ofcial Prescription
Requirements), contained in Community Pharmacy (Class A) shall be:
(A) kept by the pharmacy and be available, for at least
two years from the date of such inventory or record, for inspecting and
copying by the board or its representative and to other authorized local,
state, or federal law enforcement agencies; and
(B) supplied by the pharmacy within 72 hours, if re-
quested by an authorized agent of the Texas State Board of Pharmacy.
If the pharmacy maintains the records in an electronic format, the re-
quested records must be provided in a mutually agreeable electronic
format if specically requested by the board or its representative. Fail-
ure to provide the records set out in this section, either on site or within
72 hours, constitutes prima facie evidence of failure to keep and main-
tain records in violation of the Act.
(2) Records of controlled substances listed in Schedules I
and II shall be maintained separately from all other records of the phar-
macy.
(3) Records of controlled substances, other than prescrip-
tion drug orders, listed in Schedules III - V shall be maintained sep-
arately or readily retrievable from all other records of the pharmacy.
For purposes of this subsection, readily retrievable means that the con-
trolled substances shall be asterisked, red-lined, or in some other man-
ner readily identiable apart from all other items appearing on the
record.
(4) Records, except when specically required to be main-
tained in original or hard-copy form, may be maintained in an alterna-
tive data retention system, such as a data processing system or direct
imaging system provided:
(A) the records maintained in the alternative system
contain all of the information required on the manual record; and
(B) the data processing system is capable of producing
a hard copy of the record upon the request of the board, its represen-




(A) Pharmacists shall exercise sound professional judg-
ment with respect to the accuracy and authenticity of any prescription
drug order they dispense. If the pharmacist questions the accuracy or
authenticity of a prescription drug order, he/she shall verify the order
with the practitioner prior to dispensing.
(B) Prior to dispensing a prescription, pharmacists shall
determine, in the exercise of sound professional judgment, that the pre-
scription is a valid prescription. A pharmacist may not dispense a pre-
scription drug if the pharmacist knows or should have known that the
prescription was issued on the basis of an Internet-based or telephonic
consultation without a valid patient-practitioner relationship.
(C) Subparagraph (B) of this paragraph does not pro-
hibit a pharmacist from dispensing a prescription when a valid pa-
tient-practitioner relationship is not present in an emergency situation
(e.g. a practitioner taking calls for the patient’s regular practitioner).
(2) Written prescription drug orders.
(A) Practitioner’s signature.
(i) Except as noted in clause (ii) of this subpara-
graph, written prescription drug orders shall be:
(I) manually signed by the practitioner; or
(II) electronically signed by the practitioner us-
ing a system which electronically replicates the practitioner’s manual
signature on the written prescription, provided:
(-a-) that security features of the system re-
quire the practitioner to authorize each use; and
(-b-) the prescription is printed on paper that
is designed to prevent unauthorized copying of a completed prescrip-
tion and to prevent the erasure or modication of information written
on the prescription by the prescribing practitioner. (For example, the
paper contains security provisions against copying that results in some
indication on the copy that it is a copy and therefore render the pre-
scription null and void.)
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(ii) Prescription drug orders for Schedule II con-
trolled substances shall be issued on an ofcial prescription form as
required by the Texas Controlled Substances Act, §481.075, and be
manually signed by the practitioner.
(iii) A practitioner may sign a prescription drug or-
der in the same manner as he would sign a check or legal document,
e.g. J.H. Smith or John H. Smith.
(iv) Rubber stamped or otherwise reproduced signa-
tures may not be used except as authorized in clause (i) of this subpara-
graph.
(v) The prescription drug order may not be signed by
a practitioner’s agent but may be prepared by an agent for the signature
of a practitioner. However, the prescribing practitioner is responsible
in case the prescription drug order does not conform in all essential
respects to the law and regulations.
(B) Prescription drug orders written by practitioners in
another state.
(i) Dangerous drug prescription orders. A pharma-
cist may dispense a prescription drug order for dangerous drugs issued
by practitioners in a state other than Texas in the same manner as pre-
scription drug orders for dangerous drugs issued by practitioners in
Texas are dispensed.
(ii) Controlled substance prescription drug orders.
(I) A pharmacist may dispense prescription drug
order for controlled substances in Schedule II issued by a practitioner
in another state provided:
(-a-) the prescription is lled in compliance
with a written plan approved by the Director of the Texas Department
of Public Safety in consultation with the Board, which provides the
manner in which the dispensing pharmacy may ll a prescription for a
Schedule II controlled substance;
(-b-) the prescription drug order is an original
written prescription issued by a person practicing in another state and
licensed by another state as a physician, dentist, veterinarian, or po-
diatrist, who has a current federal Drug Enforcement Administration
(DEA) registration number, and who may legally prescribe Schedule
II controlled substances in such other state; and
(-c-) the prescription drug order is not dis-
pensed after the end of the seventh day after the date on which the
prescription is issued.
(II) A pharmacist may dispense prescription
drug orders for controlled substances in Schedule III, IV, or V issued
by a practitioner in another state provided:
(-a-) the prescription drug order is an original
written prescription issued by a person practicing in another state and
licensed by another state as a physician, dentist, veterinarian, or po-
diatrist, who has a current federal Drug Enforcement Administration
(DEA) registration number, and who may legally prescribe Schedule
III, IV, or V controlled substances in such other state;
(-b-) the prescription drug order is not dis-
pensed or relled more than six months from the initial date of issuance
and may not be relled more than ve times; and
(-c-) if there are no rell instructions on the
original written prescription drug order (which shall be interpreted as
no rells authorized) or if all rells authorized on the original written
prescription drug order have been dispensed, a new written prescrip-
tion drug order is obtained from the prescribing practitioner prior to
dispensing any additional quantities of controlled substances.
(C) Prescription drug orders written by practitioners in
the United Mexican States or the Dominion of Canada.
(i) Controlled substance prescription drug orders. A
pharmacist may not dispense a prescription drug order for a Schedule
II, III, IV, or V controlled substance issued by a practitioner in the Do-
minion of Canada or the United Mexican States.
(ii) Dangerous drug prescription drug orders. A
pharmacist may dispense a dangerous drug prescription issued by a
person licensed in the Dominion of Canada or the United Mexican
States as a physician, dentist, veterinarian, or podiatrist provided:
(I) the prescription drug order is an original writ-
ten prescription; and
(II) if there are no rell instructions on the orig-
inal written prescription drug order (which shall be interpreted as no
rells authorized) or if all rells authorized on the original written pre-
scription drug order have been dispensed, a new written prescription
drug order shall be obtained from the prescribing practitioner prior to
dispensing any additional quantities of dangerous drugs.
(D) Prescription drug orders carried out or signed by an
advanced practice nurse or physician assistant.
(i) A pharmacist may dispense a prescription drug
order which is carried out or signed by an advanced practice nurse or
physician assistant provided the advanced practice nurse or physician
assistant is practicing in accordance with Subtitle B, Chapter 157, Oc-
cupations Code.
(ii) Each practitioner shall designate in writing the
name of each advanced practice nurse or physician assistant autho-
rized to carry out or sign a prescription drug order pursuant to Subtitle
B, Chapter 157, Occupations Code. A list of the advanced practice
nurses or physician assistants designated by the practitioner must be
maintained in the practitioner’s usual place of business. On request by
a pharmacist, a practitioner shall furnish the pharmacist with a copy
of the written authorization for a specic advanced practice nurse or
physician assistant.
(E) Prescription drug orders for Schedule II controlled
substances. No Schedule II controlled substance may be dispensed
without a written prescription drug order of a practitioner on an ofcial
prescription form as required by the Texas Controlled Substances Act,
§481.075.
(3) Verbal prescription drug orders.
(A) A verbal prescription drug order from a practitioner
or a practitioner’s designated agent may only be received by a pharma-
cist or a pharmacist-intern under the direct supervision of a pharmacist.
(B) A practitioner shall designate in writing the name of
each agent authorized by the practitioner to communicate prescriptions
verbally for the practitioner. The practitioner shall maintain at the prac-
titioner’s usual place of business a list of the designated agents. The
practitioner shall provide a pharmacist with a copy of the practitioner’s
written authorization for a specic agent on the pharmacist’s request.
(C) A pharmacist may not dispense a verbal prescrip-
tion drug order for a Schedule III, IV, or V controlled substance issued
by a practitioner licensed in another state unless the practitioner is also
registered under the Texas Controlled Substances Act.
(D) A pharmacist may not dispense a verbal prescrip-
tion drug order for a dangerous drug or a controlled substance issued
by a practitioner licensed in the Dominion of Canada or the United
Mexican States unless the practitioner is also licensed in Texas.
(4) Electronic prescription drug orders. For the purpose of
this subsection, prescription drug orders shall be considered the same
as verbal prescription drug orders.
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(A) An electronic prescription drug order may be trans-
mitted by a practitioner or a practitioner’s designated agent:
(i) directly to a pharmacy; or
(ii) through the use of a data communication device
provided:
(I) the condential prescription information is
not altered during transmission; and
(II) condential patient information is not ac-
cessed or maintained by the operator of the data communication device
other than for legal purposes under federal and state law.
(B) A practitioner shall designate in writing the name
of each agent authorized by the practitioner to electronically transmit
prescriptions for the practitioner. The practitioner shall maintain at the
practitioner’s usual place of business a list of the designated agents.
The practitioner shall provide a pharmacist with a copy of the practi-
tioner’s written authorization for a specic agent on the pharmacist’s
request.
(C) A pharmacist may not dispense an electronic pre-
scription drug order for a:
(i) Schedule II controlled substance, except as au-
thorized for faxed prescriptions in §481.074, Health and Safety Code;
(ii) Schedule III, IV, or V controlled substance is-
sued by a practitioner licensed in another state unless the practitioner
is also registered under the Texas Controlled Substances Act; or
(iii) dangerous drug or controlled substance issued
by a practitioner licensed in the Dominion of Canada or the United
Mexican States unless the practitioner is also licensed in Texas.
(5) Original prescription drug order records.
(A) Original prescriptions shall be maintained by the
pharmacy in numerical order and remain legible for a period of two
years from the date of lling or the date of the last rell dispensed.
(B) If an original prescription drug order is changed,
such prescription order shall be invalid and of no further force and
effect; if additional drugs are to be dispensed, a new prescription drug
order with a new and separate number is required.
(C) Original prescriptions shall be maintained in three
separate les as follows:
(i) prescriptions for controlled substances listed in
Schedule II;
(ii) prescriptions for controlled substances listed in
Schedules III - V; and
(iii) prescriptions for dangerous drugs and nonpre-
scription drugs.
(D) Original prescription records other than prescrip-
tions for Schedule II controlled substances may be stored on microlm,
microche, or other system which is capable of producing a direct im-
age of the original prescription record, e.g., digitalized imaging system.
If original prescription records are stored in a direct imaging system,
the following is applicable:
(i) the record of rells recorded on the original pre-
scription must also be stored in this system;
(ii) the original prescription records must be main-
tained in numerical order and separated in three les as specied in
subparagraph (C) of this paragraph; and
(iii) the pharmacy must provide immediate access to
equipment necessary to render the records easily readable.
(6) Prescription drug order information.
(A) All original prescriptions shall bear:
(i) name of the patient, or if such drug is for an ani-
mal, the species of such animal and the name of the owner;
(ii) address of the patient, provided, however, a pre-
scription for a dangerous drug is not required to bear the address of
the patient if such address is readily retrievable on another appropriate,
uniformly maintained pharmacy record, such as medication records;
(iii) name, and if for a controlled substance, the ad-
dress and DEA registration number of the practitioner;
(iv) name and strength of the drug prescribed;
(v) quantity prescribed;
(vi) directions for use;
(vii) intended use for the drug unless the practitioner
determines the furnishing of this information is not in the best interest
of the patient; and
(viii) date of issuance.
(B) All original electronic prescription drug orders shall
bear:
(i) name of the patient, if such drug is for an animal,
the species of such animal, and the name of the owner;
(ii) address of the patient, provided, however, a pre-
scription for a dangerous drug is not required to bear the address of
the patient if such address is readily retrievable on another appropriate,
uniformly maintained pharmacy record, such as medication records;
(iii) name, and if for a controlled substance, the ad-
dress and DEA registration number of the practitioner;
(iv) name and strength of the drug prescribed;
(v) quantity prescribed;
(vi) directions for use;
(vii) indications for use, unless the practitioner de-
termines the furnishing of this information is not in the best interest of
the patient;
(viii) date of issuance;
(ix) a statement which indicates that the prescrip-
tion has been electronically transmitted (e.g., Faxed to or electronically
transmitted to:);
(x) name, address, and electronic access number of
the pharmacy to which the prescription was transmitted;
(xi) telephone number of the prescribing practi-
tioner;
(xii) date the prescription drug order was electroni-
cally transmitted to the pharmacy, if different from the date of issuance
of the prescription; and
(xiii) if transmitted by a designated agent, the full
name of the designated agent.
(C) All original written prescriptions carried out or
signed by an advanced practice nurse or physician assistant in accor-
dance with Subtitle B, Chapter 157, Occupations Code, shall bear:
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(i) name and address of the patient;
(ii) name, address, telephone number, and if the pre-
scription is for a controlled substance, the DEA number of the super-
vising practitioner;
(iii) name, identication number, original signature
and if the prescription is for a controlled substance, the DEA number
of the advanced practice nurse or physician assistant;
(iv) address and telephone number of the clinic at
which the prescription drug order was carried out or signed;
(v) name, strength, and quantity of the drug;
(vi) directions for use;
(vii) indications for use, if appropriate;
(viii) date of issuance; and
(ix) number of rells authorized.
(D) At the time of dispensing, a pharmacist is respon-
sible for documenting the following information on either the original
hard-copy prescription or in the pharmacy’s data processing system:
(i) unique identication number of the prescription
drug order;
(ii) initials or identication code of the dispensing
pharmacist;
(iii) effective January 1, 2009, initials or identica-
tion code of the pharmacy technician or pharmacy technician trainee
performing data entry of the prescription, if applicable;
(iv) quantity dispensed, if different from the quantity
prescribed;
(v) date of dispensing, if different from the date of
issuance; and
(vi) brand name or manufacturer of the drug product
actually dispensed, if the drug was prescribed by generic name or if a
drug product other than the one prescribed was dispensed pursuant to
the provisions of the Act, Chapters 562 and 563.
(7) Rells.
(A) Rells may be dispensed only in accordance with
the prescriber’s authorization as indicated on the original prescription
drug order.
(B) If there are no rell instructions on the original pre-
scription drug order (which shall be interpreted as no rells authorized)
or if all rells authorized on the original prescription drug order have
been dispensed, authorization from the prescribing practitioner shall be
obtained prior to dispensing any rells.
(C) Rells of prescription drug orders for dangerous
drugs or nonprescription drugs.
(i) Prescription drug orders for dangerous drugs or
nonprescription drugs may not be relled after one year from the date
of issuance of the original prescription drug order.
(ii) If one year has expired from the date of issuance
of an original prescription drug order for a dangerous drug or non-
prescription drug, authorization shall be obtained from the prescribing
practitioner prior to dispensing any additional quantities of the drug.
(D) Rells of prescription drug orders for Schedules III
- V controlled substances.
(i) Prescription drug orders for Schedules III - V
controlled substances may not be relled more than ve times or after
six months from the date of issuance of the original prescription drug
order, whichever occurs rst.
(ii) If a prescription drug order for a Schedule III, IV,
or V controlled substance has been relled a total of ve times or if six
months have expired from the date of issuance of the original prescrip-
tion drug order, whichever occurs rst, a new and separate prescription
drug order shall be obtained from the prescribing practitioner prior to
dispensing any additional quantities of controlled substances.
(E) A pharmacist may exercise his professional judg-
ment in relling a prescription drug order for a drug, other than a con-
trolled substance listed in Schedule II, without the authorization of the
prescribing practitioner, provided:
(i) failure to rell the prescription might result in an
interruption of a therapeutic regimen or create patient suffering;
(ii) either:
(I) a natural or manmade disaster has occurred
which prohibits the pharmacist from being able to contact the practi-
tioner; or
(II) the pharmacist is unable to contact the prac-
titioner after a reasonable effort;
(iii) the quantity of prescription drug dispensed does
not exceed a 72-hour supply;
(iv) the pharmacist informs the patient or the pa-
tient’s agent at the time of dispensing that the rell is being provided
without such authorization and that authorization of the practitioner is
required for future rells;
(v) the pharmacist informs the practitioner of the
emergency rell at the earliest reasonable time;
(vi) the pharmacist maintains a record of the emer-
gency rell containing the information required to be maintained on a
prescription as specied in this subsection;
(vii) the pharmacist afxes a label to the dispensing
container as specied in §291.33(c)(7) of this title; and
(viii) if the prescription was initially lled at another
pharmacy, the pharmacist may exercise his professional judgment in
relling the prescription provided:
(I) the patient has the prescription container, la-
bel, receipt or other documentation from the other pharmacy which
contains the essential information;
(II) after a reasonable effort, the pharmacist is
unable to contact the other pharmacy to transfer the remaining prescrip-
tion rells or there are no rells remaining on the prescription;
(III) the pharmacist, in his professional judg-
ment, determines that such a request for an emergency rell is
appropriate and meets the requirements of clauses (i) and (ii) of this
subparagraph; and
(IV) the pharmacist complies with the require-
ments of clauses (iii) - (v) of this subparagraph.
(c) Patient medication records.
(1) A patient medication record system shall be maintained
by the pharmacy for patients to whom prescription drug orders are dis-
pensed.
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(2) The patient medication record system shall provide
for the immediate retrieval of information for the previous 12 months
which is necessary for the dispensing pharmacist to conduct a prospec-
tive drug regimen review at the time a prescription drug order is
presented for dispensing.
(3) The pharmacist-in-charge shall assure that a reasonable
effort is made to obtain and record in the patient medication record at
least the following information:
(A) full name of the patient for whom the drug is pre-
scribed;
(B) address and telephone number of the patient;
(C) patient’s age or date of birth;
(D) patient’s gender;
(E) any known allergies, drug reactions, idiosyncrasies,
and chronic conditions or disease states of the patient and the identity
of any other drugs currently being used by the patient which may relate
to prospective drug regimen review;
(F) pharmacist’s comments relevant to the individual’s
drug therapy, including any other information unique to the specic
patient or drug; and
(G) a list of all prescription drug orders dispensed (new
and rell) to the patient by the pharmacy during the last two years. Such
list shall contain the following information:
(i) date dispensed;
(ii) name, strength, and quantity of the drug dis-
pensed;
(iii) prescribing practitioner’s name;
(iv) unique identication number of the prescrip-
tion; and
(v) name or initials of the dispensing pharmacists.
(4) A patient medication record shall be maintained in the
pharmacy for two years. If patient medication records are maintained
in a data processing system, all of the information specied in this sub-
section shall be maintained in a retrievable form for two years and in-
formation for the previous 12 months shall be maintained on-line. Ef-
fective January 1, 2009, a patient medication record must contain doc-
umentation of any modication, change, or manipulation to a patient
prole.
(5) Nothing in this paragraph shall be construed as requir-
ing a pharmacist to obtain, record, and maintain patient information
other than prescription drug order information when a patient or pa-
tient’s agent refuses to provide the necessary information for such pa-
tient medication records.
(d) Prescription drug order records maintained in a manual
system.
(1) Original prescriptions shall be maintained in three les
as specied in subsection (b)(5)(C) of this section.
(2) Rells.
(A) Each time a prescription drug order is relled, a
record of such rell shall be made:
(i) on the back of the prescription by recording
the date of dispensing, the written initials or identication code of
the dispensing pharmacist, effective January 1, 2009, the initials or
identication code of the pharmacy technician or pharmacy technician
trainee preparing the prescription label, if applicable, and the amount
dispensed. (If the pharmacist merely initials and dates the back of the
prescription drug order, he or she shall be deemed to have dispensed a
rell for the full face amount of the prescription drug order); or
(ii) on another appropriate, uniformly maintained,
readily retrievable record, such as medication records, which indicates
by patient name the following information:
(I) unique identication number of the prescrip-
tion;
(II) name and strength of the drug dispensed;
(III) date of each dispensing;
(IV) quantity dispensed at each dispensing;
(V) initials or identication code of the dispens-
ing pharmacist;
(VI) effective January 1, 2009, initials or identi-
cation code of the pharmacy technician or pharmacy technician trainee
preparing the prescription label, if applicable; and
(VII) total number of rells for the prescription.
(B) If rell records are maintained in accordance with
subparagraph (A)(ii) of this paragraph, rell records for controlled sub-
stances in Schedules III - V shall be maintained separately from rell
records of dangerous drugs and nonprescription drugs.
(3) Authorization of rells. Practitioner authorization for
additional rells of a prescription drug order shall be noted on the orig-
inal prescription, in addition to the documentation of dispensing the
rell.
(4) Transfer of prescription drug order information. For the
purpose of rell or initial dispensing, the transfer of original prescrip-
tion drug order information is permissible between pharmacies, subject
to the following requirements:
(A) the transfer of original prescription drug order in-
formation for controlled substances listed in Schedule III, IV, or V is
permissible between pharmacies on a one-time basis;
(B) the transfer of original prescription drug order
information for dangerous drugs is permissible between pharmacies
without limitation up to the number of originally authorized rells;
(C) the transfer is communicated directly between phar-
macists and/or pharmacist interns;
(D) both the original and the transferred prescription
drug order are maintained for a period of two years from the date of
last rell;
(E) the pharmacist or pharmacist intern transferring the
prescription drug order information shall:
(i) write the word "void" on the face of the invali-
dated prescription drug order; and
(ii) record on the reverse of the invalidated prescrip-
tion drug order the following information:
(I) the name, address, and if a controlled sub-
stance, the DEA registration number of the pharmacy to which such
prescription drug order is transferred;
(II) the name of the pharmacist or pharmacist in-
tern receiving the prescription drug order information;
(III) the name of the pharmacist or pharmacist in-
tern transferring the prescription drug order information; and
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(IV) the date of the transfer;
(F) the pharmacist or pharmacist intern receiving the
transferred prescription drug order information shall:
(i) write the word "transfer" on the face of the trans-
ferred prescription drug order; and
(ii) record on the transferred prescription drug order
the following information:
(I) original date of issuance and date of dispens-
ing or receipt, if different from date of issuance;
(II) original prescription number and the number
of rells authorized on the original prescription drug order;
(III) number of valid rells remaining and the
date of last rell, if applicable;
(IV) name, address, and if a controlled substance,
the DEA registration number of the pharmacy from which such pre-
scription information is transferred; and
(V) name of the pharmacist or pharmacist intern
transferring the prescription drug order information.
(5) A pharmacist or pharmacist intern may not refuse to
transfer original prescription information to another pharmacist or
pharmacist intern who is acting on behalf of a patient and who is
making a request for this information as specied in paragraph (4) of
this subsection.
(6) Effective January 1, 2009, each time a modication,
change, or manipulation is made to a record of dispensing, documen-
tation of such change shall be recorded on the back of the prescription
or on another appropriate, uniformly maintained, readily retrievable
record, such as medication records. The documentation of any modi-
cation, change, or manipulation to a record of dispensing shall include
the identication of the individual responsible for the alteration.
(e) Prescription drug order records maintained in a data pro-
cessing system.
(1) General requirements for records maintained in a data
processing system.
(A) Compliance with data processing system require-
ments. If a Class A (community) pharmacy’s data processing system
is not in compliance with this subsection, the pharmacy must maintain
a manual recordkeeping system as specied in subsection (d) of this
section.
(B) Original prescriptions. Original prescriptions shall
be maintained in three les as specied in subsection (b)(5)(C) of this
section.
(C) Requirements for backup systems.
(i) The pharmacy shall maintain a backup copy of
information stored in the data processing system using disk, tape, or
other electronic backup system and update this backup copy on a reg-
ular basis, at least monthly, to assure that data is not lost due to system
failure.
(ii) Data processing systems shall have a workable
(electronic) data retention system which can produce an audit trail of
drug usage for the preceding two years as specied in paragraph (2)(G)
of this subsection.
(D) Change or discontinuance of a data processing sys-
tem.
(i) Records of dispensing. A pharmacy that changes
or discontinues use of a data processing system must:
(I) transfer the records of dispensing to the new
data processing system; or
(II) purge the records of dispensing to a printout
which contains the same information required on the daily printout as
specied in paragraph (2)(B) of this subsection. The information on
this hard-copy printout shall be sorted and printed by prescription num-
ber and list each dispensing for this prescription chronologically.
(ii) Other records. A pharmacy that changes or dis-
continues use of a data processing system must:
(I) transfer the records to the new data processing
system; or
(II) purge the records to a printout which con-
tains all of the information required on the original document.
(iii) Maintenance of purged records. Information
purged from a data processing system must be maintained by the
pharmacy for two years from the date of initial entry into the data
processing system.
(E) Loss of data. The pharmacist-in-charge shall report
to the board in writing any signicant loss of information from the data
processing system within 10 days of discovery of the loss.
(2) Records of dispensing.
(A) Each time a prescription drug order is lled or re-
lled, a record of such dispensing shall be entered into the data pro-
cessing system.
(B) Effective January 1, 2009, each time a modication,
change or manipulation is made to a record of dispensing, documen-
tation of such change shall be recorded in the data processing system.
The documentation of any modication, change, or manipulation to a
record of dispensing shall include the identication of the individual
responsible for the alteration. Should the data processing system not
be able to record a modication, change, or manipulation to a record of
dispensing, the information should be clearly documented on the hard-
copy prescription.
(C) The data processing system shall have the capacity
to produce a daily hard-copy printout of all original prescriptions dis-
pensed and relled. This hard-copy printout shall contain the following
information:
(i) unique identication number of the prescription;
(ii) date of dispensing;
(iii) patient name;
(iv) prescribing practitioner’s name;
(v) name and strength of the drug product actually
dispensed; if generic name, the brand name or manufacturer of drug
dispensed;
(vi) quantity dispensed;
(vii) initials or an identication code of the dispens-
ing pharmacist;
(viii) effective January 1, 2009, initials or an iden-
tication code of the pharmacy technician or pharmacy technician
trainee performing data entry of the prescription, if applicable;
(ix) if not immediately retrievable via CRT display,
the following shall also be included on the hard-copy printout:
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(I) patient’s address;
(II) prescribing practitioner’s address;
(III) practitioner’s DEA registration number, if
the prescription drug order is for a controlled substance;
(IV) quantity prescribed, if different from the
quantity dispensed;
(V) date of issuance of the prescription drug or-
der, if different from the date of dispensing; and
(VI) total number of rells dispensed to date for
that prescription drug order; and
(x) effective January 1, 2009, any changes made to
a record of dispensing.
(D) The daily hard-copy printout shall be produced
within 72 hours of the date on which the prescription drug orders were
dispensed and shall be maintained in a separate le at the pharmacy.
Records of controlled substances shall be readily retrievable from
records of noncontrolled substances.
(E) Each individual pharmacist who dispenses or rells
a prescription drug order shall verify that the data indicated on the daily
hard-copy printout is correct, by dating and signing such document in
the same manner as signing a check or legal document (e.g., J.H. Smith,
or John H. Smith) within seven days from the date of dispensing.
(F) In lieu of the printout described in subparagraph (C)
of this paragraph, the pharmacy shall maintain a log book in which
each individual pharmacist using the data processing system shall sign
a statement each day, attesting to the fact that the information entered
into the data processing system that day has been reviewed by him
or her and is correct as entered. Such log book shall be maintained
at the pharmacy employing such a system for a period of two years
after the date of dispensing; provided, however, that the data processing
system can produce the hard-copy printout on demand by an authorized
agent of the Texas State Board of Pharmacy. If no printer is available
on site, the hard-copy printout shall be available within 72 hours with
a certication by the individual providing the printout, which states
that the printout is true and correct as of the date of entry and such
information has not been altered, amended, or modied.
(G) The pharmacist-in-charge is responsible for the
proper maintenance of such records and responsible that such data
processing system can produce the records outlined in this section and
that such system is in compliance with this subsection.
(H) The data processing system shall be capable of pro-
ducing a hard-copy printout of an audit trail for all dispensings (original
and rell) of any specied strength and dosage form of a drug (by ei-
ther brand or generic name or both) during a specied time period.
(i) Such audit trail shall contain all of the informa-
tion required on the daily printout as set out in subparagraph (C) of this
paragraph.
(ii) The audit trail required in this subparagraph
shall be supplied by the pharmacy within 72 hours, if requested by an
authorized agent of the Texas State Board of Pharmacy.
(I) Failure to provide the records set out in this subsec-
tion, either on site or within 72 hours constitutes prima facie evidence
of failure to keep and maintain records in violation of the Act.
(J) The data processing system shall provide on-line re-
trieval (via CRT display or hard-copy printout) of the information set
out in subparagraph (C) of this paragraph of:
(i) the original controlled substance prescription
drug orders currently authorized for relling; and
(ii) the current rell history for Schedules III, IV,
and V controlled substances for the immediately preceding six-month
period.
(K) In the event that a pharmacy which uses a data pro-
cessing system experiences system downtime, the following is appli-
cable:
(i) an auxiliary procedure shall ensure that rells are
authorized by the original prescription drug order and that the maxi-
mum number of rells has not been exceeded or authorization from the
prescribing practitioner shall be obtained prior to dispensing a rell;
and
(ii) all of the appropriate data shall be retained for
on-line data entry as soon as the system is available for use again.
(3) Authorization of rells. Practitioner authorization for
additional rells of a prescription drug order shall be noted as follows:
(A) on the hard-copy prescription drug order;
(B) on the daily hard-copy printout; or
(C) via the CRT display.
(4) Transfer of prescription drug order information. For the
purpose of rell or initial dispensing, the transfer of original prescrip-
tion drug order information is permissible between pharmacies, subject
to the following requirements.
(A) The transfer of original prescription drug order in-
formation for controlled substances listed in Schedule III, IV, or V is
permissible between pharmacies on a one-time basis only. However,
pharmacies electronically sharing a real-time, on-line database may
transfer up to the maximum rells permitted by law and the prescriber’s
authorization.
(B) The transfer of original prescription drug order
information for dangerous drugs is permissible between pharmacies
without limitation up to the number of originally authorized rells.
(C) The transfer is communicated directly between
pharmacists and/or pharmacist interns orally by telephone or via
facsimile or as authorized in paragraph (5) of this subsection. A
transfer completed as authorized in paragraph (5) of this subsection
may be initiated by a pharmacy technician or pharmacy technician
trainee acting under the direct supervision of a pharmacist.
(D) Both the original and the transferred prescription
drug orders are maintained for a period of two years from the date of
last rell.
(E) The pharmacist or pharmacist intern transferring the
prescription drug order information shall:
(i) write the word "void" on the face of the invali-
dated prescription drug order; and
(ii) record on the reverse of the invalidated prescrip-
tion drug order the following information:
(I) the name, address, and if a controlled sub-
stance, the DEA registration number of the pharmacy to which such
prescription is transferred;
(II) the name of the pharmacist or pharmacist in-
tern receiving the prescription drug order information;
(III) the name of the pharmacist or pharmacist in-
tern transferring the prescription drug order information; and
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(IV) the date of the transfer.
(F) The pharmacist or pharmacist intern receiving the
transferred prescription drug order information shall:
(i) write the word "transfer" on the face of the trans-
ferred prescription drug order; and
(ii) record on the transferred prescription drug order
the following information:
(I) original date of issuance and date of dispens-
ing or receipt, if different from date of issuance;
(II) original prescription number and the number
of rells authorized on the original prescription drug order;
(III) number of valid rells remaining and the
date of last rell, if applicable;
(IV) name, address, and if a controlled substance,
the DEA registration number of the pharmacy from which such pre-
scription drug order information is transferred; and
(V) name of the pharmacist or pharmacist intern
transferring the prescription drug order information.
(G) Prescription drug orders may not be transferred by
non-electronic means during periods of downtime except on consul-
tation with and authorization by a prescribing practitioner; provided
however, during downtime, a hard copy of a prescription drug order
may be made available for informational purposes only, to the patient,
a pharmacist or pharmacist intern, and the prescription may be read to
a pharmacist or pharmacist intern by telephone.
(H) The original prescription drug order shall be inval-
idated in the data processing system for purposes of lling or relling,
but shall be maintained in the data processing system for rell history
purposes.
(I) If the data processing system has the capacity to
store all the information required in subparagraphs (E) and (F) of this
paragraph, the pharmacist is not required to record this information on
the original or transferred prescription drug order.
(J) The data processing system shall have a mechanism
to prohibit the transfer or relling of controlled substance prescription
drug orders which have been previously transferred.
(5) Electronic transfer of prescription drug order infor-
mation between pharmacies. Pharmacies electronically accessing
the same prescription drug order records may electronically transfer
prescription information if the following requirements are met.
(A) The original prescription is voided and the follow-
ing information is documented in the records of the transferring phar-
macy:
(i) the name, address, and if a controlled substance,
the DEA registration number of the pharmacy to which such prescrip-
tion is transferred;
(ii) the name of the pharmacist or pharmacist intern
receiving the prescription drug order information; and
(iii) the date of the transfer.
(B) Pharmacies not owned by the same person may
electronically access the same prescription drug order records, pro-
vided the owner or chief executive ofcer of each pharmacy signs an
agreement allowing access to such prescription drug order records.
(C) An electronic transfer between pharmacies may be
initiated by a pharmacy technician or pharmacy technician trainee act-
ing under the direct supervision of a pharmacist.
(6) A pharmacist or pharmacist intern may not refuse to
transfer original prescription information to another pharmacist or
pharmacist intern who is acting on behalf of a patient and who is
making a request for this information as specied in paragraphs (4)
and (5) of this subsection.
(f) Limitation to one type of recordkeeping system. When l-
ing prescription drug order information a pharmacy may use only one
of the two systems described in subsection (d) or (e) of this section.
(g) Distribution of controlled substances to another registrant.
A pharmacy may distribute controlled substances to a practitioner, an-
other pharmacy, or other registrant, without being registered to distrib-
ute, under the following conditions.
(1) The registrant to whom the controlled substance is to
be distributed is registered under the Controlled Substances Act to dis-
pense that controlled substance.
(2) The total number of dosage units of controlled sub-
stances distributed by a pharmacy may not exceed 5.0% of all con-
trolled substances dispensed and distributed by the pharmacy during
the 12-month period in which the pharmacy is registered; if at any time
it does exceed 5.0%, the pharmacy is required to obtain an additional
registration to distribute controlled substances.
(3) If the distribution is for a Schedule III, IV, or V con-
trolled substance, a record shall be maintained which indicates:
(A) the actual date of distribution;
(B) the name, strength, and quantity of controlled sub-
stances distributed;
(C) the name, address, and DEA registration number of
the distributing pharmacy; and
(D) the name, address, and DEA registration number of
the pharmacy, practitioner, or other registrant to whom the controlled
substances are distributed.
(4) If the distribution is for a Schedule I or II controlled
substance, the following is applicable.
(A) The pharmacy, practitioner, or other registrant who
is receiving the controlled substances shall issue Copy 1 and Copy 2 of
a DEA order form (DEA 222C) to the distributing pharmacy.
(B) The distributing pharmacy shall:
(i) complete the area on the DEA order form (DEA
222C) titled "To Be Filled in by Supplier";
(ii) maintain Copy 1 of the DEA order form (DEA
222C) at the pharmacy for two years; and
(iii) forward Copy 2 of the DEA order form (DEA
222C) to the Divisional Ofce of the Drug Enforcement Administra-
tion.
(h) Other records. Other records to be maintained by a phar-
macy:
(1) a permanent log of the initials or identication codes
which will identify each dispensing pharmacist by name (the initials or
identication code shall be unique to ensure that each pharmacist can
be identied, i.e., identical initials or identication codes shall not be
used);
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(2) Copy 3 of DEA order form (DEA 222C) which has been
properly dated, initialed, and led, and all copies of each unaccepted or
defective order form and any attached statements or other documents;
(3) a hard copy of the power of attorney to sign DEA 222C
order forms (if applicable);
(4) suppliers’ invoices of dangerous drugs and controlled
substances; a pharmacist shall verify that the controlled drugs listed on
the invoices were actually received by clearly recording his/her initials
and the actual date of receipt of the controlled substances;
(5) suppliers’ credit memos for controlled substances and
dangerous drugs;
(6) a hard copy of inventories required by §291.17 of this
title (relating to Inventory Requirements);
(7) hard-copy reports of surrender or destruction of con-
trolled substances and/or dangerous drugs to an appropriate state or
federal agency;
(8) a hard copy of the Schedule V nonprescription register
book;
(9) records of distribution of controlled substances and/or
dangerous drugs to other pharmacies, practitioners, or registrants; and
(10) a hard copy of any notication required by the Texas
Pharmacy Act or the sections in this chapter, including, but not limited
to, the following:
(A) reports of theft or signicant loss of controlled sub-
stances to DEA, Department of Public Safety, and the board;
(B) notications of a change in pharmacist-in-charge of
a pharmacy; and
(C) reports of a re or other disaster which may affect
the strength, purity, or labeling of drugs, medications, devices, or other
materials used in the diagnosis or treatment of injury, illness, and dis-
ease.
(i) Permission to maintain central records. Any pharmacy that
uses a centralized recordkeeping system for invoices and nancial data
shall comply with the following procedures.
(1) Controlled substance records. Invoices and nancial
data for controlled substances may be maintained at a central location
provided the following conditions are met.
(A) Prior to the initiation of central recordkeeping, the
pharmacy submits written notication by registered or certied mail
to the divisional director of the Drug Enforcement Administration as
required by Title 21, Code of Federal Regulations, §1304.04(a), and
submits a copy of this written notication to the Texas State Board of
Pharmacy. Unless the registrant is informed by the divisional direc-
tor of the Drug Enforcement Administration that permission to keep
central records is denied, the pharmacy may maintain central records
commencing 14 days after receipt of notication by the divisional di-
rector.
(B) The pharmacy maintains a copy of the notication
required in subparagraph (A) of this paragraph.
(C) The records to be maintained at the central record
location shall not include executed DEA order forms, prescription drug
orders, or controlled substance inventories, which shall be maintained
at the pharmacy.
(2) Dangerous drug records. Invoices and nancial data for
dangerous drugs may be maintained at a central location.
(3) Access to records. If the records are kept on microlm,
computer media, or in any form requiring special equipment to render
the records easily readable, the pharmacy shall provide access to such
equipment with the records.
(4) Delivery of records. The pharmacy agrees to deliver all
or any part of such records to the pharmacy location within two busi-
ness days of written request of a board agent or any other authorized
ofcial.
(j) Ownership of pharmacy records. For the purposes of these
sections, a pharmacy licensed under the Act is the only entity which
may legally own and maintain prescription drug records.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas State Board of Pharmacy
Effective date: September 18, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
22 TAC §291.37, §291.38
The Texas State Board of Pharmacy adopts the repeal of
§291.37, concerning Centralized Prescription Dispensing and
§291.38, concerning Central Prescription Drug or Medication
Order Processing. The repeal is adopted without changes to
the proposal as published in the June 15, 2007, issue of the
Texas Register (32 TexReg 3480).
The repeal of §291.37 and §291.38 are adopted as new rules in
new Subchapter G of Chapter 291 and are published elsewhere
in this issue of the Texas Register.
No comments were received regarding the proposal.
The repeal is adopted under §551.002 and §554.051 of the
Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569, Texas
Occupations Code). The Board interprets §551.002 as autho-
rizing the agency to protect the public through the effective
control and regulation of the practice of pharmacy. The Board
interprets §554.051(a) as authorizing the agency to adopt rules
for the proper administration and enforcement of the Act.
The statutes affected by the repeal: Texas Pharmacy Act, Chap-
ters 551 - 566 and 568 - 569, Texas Occupations Code.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
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SUBCHAPTER D. INSTITUTIONAL
PHARMACY (CLASS C)
22 TAC §§291.72 - 291.76
The Texas State Board of Pharmacy adopts amendments to
§291.72, concerning Denitions; §291.73, concerning Per-
sonnel; §291.74, concerning Operational Standards; §291.75,
concerning Records; and §291.76, concerning Class C Phar-
macies Located in a Freestanding Ambulatory Surgical Center.
The amendments to §291.73 and §291.74 are adopted without
changes to the proposed text as published in the June 15,
2007, issue of the Texas Register (32 TexReg 3481). The
amendments to §291.72, 291.75, and 291.76 are adopted with
changes to the proposed text. The changes are described in
this preamble.
The amendments to §291.72 clarify the denition for hot water
and update and clarify the denitions for pharmacy technicians
and pharmacy technician trainees. The amendments to §291.73
update the rules to include pharmacy technician trainees and
clarify the responsibilities of owners of Class C pharmacies. The
amendments to §291.74 allow Class C pharmacies to distrib-
ute repackaged drugs to other Class C pharmacies under com-
mon ownership in accordance with Senate Bill 492 passed by
the 79th Texas Legislature, Regular Session. The amendments
to §291.75 require pharmacies to provide the board or its rep-
resentative with records in electronic format, if the records are
maintained in an electronic format, and update and correct ref-
erences. The amendments to §291.76 update and clarify the
denitions for pharmacy technicians and pharmacy technician
trainees and clarify the responsibilities of owners of pharmacies
located in ambulatory surgical centers.
The following comments were received regarding adoption of the
amendments.
The Texas Society of Health-System Pharmacists (TSHP) com-
mented that the denition of hot water in §291.72 should be
consistent with the requirements used for hospital construction
standards by the Texas Department of State Health Services
(DSHS). DSHS requires hot water to be between 105 and 120
degrees Fahrenheit. The Board agrees with this comment and
amended the proposed language.
NACDS commented that the amendments to §291.75 and
§291.76, requiring pharmacies to provide the Board or its rep-
resentatives with records in electronic format, would increase
costs to pharmacies and would expend hours trying to adapt
the pharmacies computer system to meet the Board’s needed
format. The Board amended the proposed language to reect
that the records must be provided in a mutually agreeable
format.
TSHP provided grammatical corrections to §291.76. The Board
agrees with the recommendations and made the necessary cor-
rections.
The amendments are adopted under §551.002 and §554.051 of
the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569,
Texas Occupations Code). The Board interprets §551.002 as
authorizing the agency to protect the public through the effective
control and regulation of the practice of pharmacy. The Board
interprets §554.051(a) as authorizing the agency to adopt rules
for the proper administration and enforcement of the Act.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
§291.72. Denitions.
The following words and terms, when used in this subchapter, shall
have the following meanings, unless the context clearly indicates oth-
erwise.
(1) Accurately as prescribed--Distributing and/or deliver-
ing a medication drug order:
(A) to the correct patient (or agent of the patient) for
whom the drug or device was prescribed;
(B) with the correct drug in the correct strength, quan-
tity, and dosage form ordered by the practitioner; and
(C) with correct labeling as ordered by the practitioner
and required by rule.
(2) Act--The Texas Pharmacy Act, Chapters 551 - 566 and
568 - 569, Occupations Code, as amended.
(3) Administer--The direct application of a prescription
drug by injection, inhalation, ingestion, or any other means to the body
of a patient by:
(A) a practitioner, an authorized agent under his super-
vision, or other person authorized by law; or
(B) the patient at the direction of a practitioner.
(4) Automated compounding or counting device--An au-
tomated device that compounds, measures, counts and/or packages a
specied quantity of dosage units of a designated drug product.
(5) Automated medication supply system--a mechanical
system that performs operations or activities relative to the storage
and distribution of medications for administration and which collects,
controls, and maintains all transaction information.
(6) Board--The State Board of Pharmacy.
(7) Condential record--Any health-related record that
contains information that identies an individual and that is maintained
by a pharmacy or pharmacist, such as a patient medication record,
prescription drug order, or medication drug order.
(8) Consultant pharmacist--A pharmacist retained by a fa-
cility on a routine basis to consult with the facility in areas that pertain
to the practice of pharmacy.
(9) Controlled substance--A drug, immediate precursor, or
other substance listed in Schedules I - V or Penalty Groups 1 - 4 of the
Texas Controlled Substances Act, as amended, or a drug, immediate
precursor, or other substance included in Schedules I - V of the Federal
Comprehensive Drug Abuse Prevention and Control Act of 1970, as
amended (Public Law 91-513).
(10) Dangerous drug--A drug or device that:
(A) is not included in Penalty Group 1, 2, 3, or 4, Chap-
ter 481, Health and Safety Code, and is unsafe for self-medication; or
(B) bears or is required to bear the legend:
(i) "Caution: federal law prohibits dispensing with-
out prescription" or "Rx only" or another legend that complies with
federal law; or
(ii) "Caution: federal law restricts this drug to use
by or on the order of a licensed veterinarian."
(11) Device--An instrument, apparatus, implement, ma-
chine, contrivance, implant, in vitro reagent, or other similar or related
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article, including any component part or accessory, that is required
under federal or state law to be ordered or prescribed by a practitioner.
(12) Direct copy--Electronic copy or carbonized copy of
a medication order, including a facsimile (FAX), tele-autograph, or a
copy transmitted between computers.
(13) Dispense--Preparing, packaging, compounding, or la-
beling for delivery a prescription drug or device in the course of pro-
fessional practice to an ultimate user or his agent by or pursuant to the
lawful order of a practitioner.
(14) Distribute--The delivery of a prescription drug or de-
vice other than by administering or dispensing.
(15) Distributing pharmacist--The pharmacist who checks
the medication order prior to distribution.
(16) Downtime--Period of time during which a data pro-
cessing system is not operable.
(17) Drug regimen review--




(iii) reasonable dose and route of administration;
(iv) reasonable directions for use;




(ix) adverse drug reactions; and
(x) proper utilization, including overutilization or
underutilization.
(B) The drug regimen review may be conducted prior
to administration of the rst dose (prospective) or after administration
of the rst dose (retrospective).
(18) Electronic signature--A unique security code or other
identier which specically identies the person entering information
into a data processing system. A facility which utilizes electronic sig-
natures must:
(A) maintain a permanent list of the unique security
codes assigned to persons authorized to use the data processing
system; and
(B) have an ongoing security program which is capable
of identifying misuse and/or unauthorized use of electronic signatures.
(19) Expiration date--The date (and time, when applicable)
beyond which a product should not be used.
(20) Facility--
(A) a hospital or other in-patient facility that is licensed
under Chapter 241 or 577, Health and Safety Code;
(B) a hospice in-patient facility that is licensed under
Chapter 142, Health and Safety Code;
(C) an ambulatory surgical center licensed under Chap-
ter 243, Health and Safety Code; or
(D) a hospital maintained or operated by the state.
(21) Floor stock--Prescription drugs or devices not labeled
for a specic patient and maintained at a nursing station or other hos-
pital department (excluding the pharmacy) for the purpose of adminis-
tration to a patient of the facility.
(22) Formulary--List of drugs approved for use in the fa-
cility by the committee which performs the pharmacy and therapeutics
function for the facility.
(23) Full-time pharmacist--A pharmacist who works in a
pharmacy from 30 to 40 hours per week or if the pharmacy is open less
than 60 hours per week, one-half of the time the pharmacy is open.
(24) Hard copy--A physical document that is readable
without the use of a special device (i.e., cathode ray tube (CRT),
microche reader, etc).
(25) Hot water--The temperature of water from the phar-
macy’s sink maintained at a minimum of 105 degrees F (41 degrees
C).
(26) Inpatient--A person who is duly admitted to the li-
censed hospital, or other hospital or facility maintained or operated by
the state, or who is receiving long term care services or Medicare ex-
tended care services in a swing bed on the hospital premise or an ad-
jacent, readily accessible facility which is under the authority of the
hospital’s governing body. For the purposes of this denition, the term
"long term care services" means those services received in a skilled
nursing facility which is a distinct part of the hospital and the distinct
part is not licensed separately or formally approved as a nursing home
by the state, even though it is designated or certied as a skilled nurs-
ing facility. An inpatient includes a person conned in any correctional
institution operated by the state of Texas.
(27) Institutional pharmacy--Area or areas in a facility
where drugs are stored, bulk compounded, delivered, compounded,
dispensed, and distributed to other areas or departments of the facility,
or dispensed to an ultimate user or his or her agent.
(28) Investigational new drug--New drug intended for in-
vestigational use by experts qualied to evaluate the safety and effec-
tiveness of the drug as authorized by the Food and Drug Administra-
tion.
(29) Medical Practice Act--The Texas Medical Practice
Act, Subtitle B, Occupations Code, as amended.
(30) Medication order--A written order from a practitioner
or a verbal order from a practitioner or his authorized agent for admin-
istration of a drug or device.
(31) Part-time pharmacist--A pharmacist either employed
or under contract, who routinely works less than full-time.
(32) Perpetual inventory--An inventory which documents
all receipts and distributions of a drug product, such that an accurate,
current balance of the amount of the drug product present in the phar-
macy is indicated.
(33) Pharmaceutical care--The provision of drug therapy
and other pharmaceutical services intended to assist in the cure or pre-
vention of a disease, elimination or reduction of a patient’s symptoms,
or arresting or slowing of a disease process.
(34) Pharmacist-in-charge--Pharmacist designated on a
pharmacy license as the pharmacist who has the authority or respon-
sibility for a pharmacy’s compliance with laws and rules pertaining to
the practice of pharmacy.
(35) Pharmacy and therapeutics function--Committee
of the medical staff in the facility which assists in the formulation
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of broad professional policies regarding the evaluation, selection,
distribution, handling, use, and administration, and all other matters
relating to the use of drugs and devices in the facility.
(36) Pharmacy technician--An individual who is registered
with the board as a pharmacy technician and whose responsibility in a
pharmacy is to provide technical services that do not require profes-
sional judgment regarding preparing and distributing drugs and who
works under the direct supervision of and is responsible to a pharma-
cist.
(37) Pharmacy technician trainee--An individual who is
registered with the board as a pharmacy technician trainee and is
authorized to participate in a pharmacy’s technician training program.
(38) Pre-packaging--The act of re-packaging and re-label-
ing quantities of drug products from a manufacturer’s original con-
tainer into unit-dose packaging or a multiple dose container for dis-
tribution within the facility.
(39) Prescription drug--
(A) A substance for which federal or state law requires
a prescription before it may be legally dispensed to the public;
(B) A drug or device that under federal law is required,
prior to being dispensed or delivered, to be labeled with either of the
following statements:
(i) Caution: federal law prohibits dispensing with-
out prescription or "Rx only" or another legend that complies with fed-
eral law; or
(ii) Caution: federal law restricts this drug to use by
or on order of a licensed veterinarian; or
(C) A drug or device that is required by any applicable
federal or state law or regulation to be dispensed on prescription only
or is restricted to use by a practitioner only.
(40) Prescription drug order--
(A) a written order from a practitioner or a verbal order
from a practitioner or his authorized agent to a pharmacist for a drug
or device to be dispensed; or
(B) a written order or a verbal order pursuant to Subtitle
B, Chapter 157, Occupations Code.
(41) Quality assurance--The set of activities used to assure
that the process used in the preparation of sterile drug products lead to
products that meet predetermined standards of quality.
(42) Quality control--The set of testing activities used to
determine that the ingredients, components (e.g., containers), and -
nal sterile pharmaceuticals prepared meet predetermined requirements
with respect to identity, purity, non-pyrogenicity, and sterility.
(43) Sample--A prescription drug which is not intended to
be sold and is intended to promote the sale of the drug.
(44) Texas Controlled Substances Act--The Texas Con-
trolled Substances Act, the Health and Safety Code, Chapter 481, as
amended.
(45) Unit-dose packaging--The ordered amount of drug in
a dosage form ready for administration to a particular patient, by the
prescribed route at the prescribed time, and properly labeled with name,
strength, and expiration date of the drug.
(46) Unusable drugs--Drugs or devices that are unusable
for reasons, such as they are adulterated, misbranded, expired, defec-
tive, or recalled.
(47) Written protocol--A physician’s order, standing med-
ical order, standing delegation order, or other order or protocol as de-
ned by rule of the Texas Medical Board under the Texas Medical Prac-
tice Act Subtitle B, Chapter 157, Occupations Code.
§291.75. Records.
(a) Maintenance of records.
(1) Every inventory or other record required to be kept un-
der the provisions of §291.71 of this title (relating to Purpose), §291.72
of this title (relating to Denitions), §291.73 of this title (relating to Per-
sonnel), §291.74 of this title (relating to Operational Standards), and
this section contained in Institutional Pharmacy (Class C) shall be:
(A) kept by the institutional pharmacy and be available,
for at least two years from the date of such inventory or record, for
inspecting and copying by the board or its representative, and to other
authorized local, state, or federal law enforcement agencies; and
(B) supplied by the pharmacy within 72 hours, if re-
quested by an authorized agent of the Texas State Board of Pharmacy.
If the pharmacy maintains the records in an electronic format, the re-
quested records must be provided in a mutually agreeable electronic
format if specically requested by the board or its representative. Fail-
ure to provide the records set out in this subsection, either on site or
within 72 hours, constitutes prima facie evidence of failure to keep and
maintain records in violation of the Act.
(2) Records of controlled substances listed in Schedule I
and II shall be maintained separately from all other records of the phar-
macy.
(3) Records of controlled substances listed in Schedules III
- V shall be maintained separately or readily retrievable from all other
records of the pharmacy. For purposes of this subsection, readily re-
trievable means that the controlled substances shall be asterisked, red-
lined, or in some other manner readily identiable apart from all other
items appearing on the record.
(4) Records, except when specically required to be main-
tained in original or hard-copy form, may be maintained in an alterna-
tive data retention system, such as a data processing or direct imaging
system, e.g., microlm or microche, provided:
(A) the records in the alternative data retention system
contain all of the information required on the manual record; and
(B) the alternative data retention system is capable of
producing a hard copy of the record upon the request of the board, its
representative, or other authorized local, state, or federal law enforce-
ment or regulatory agencies.
(b) Outpatient records.
(1) Outpatient records shall be maintained as provided in
§291.34 of this title (relating to Records), and §291.35 of this title (re-
lating to Ofcial Prescription Records), contained in Community Phar-
macy (Class A).
(2) Outpatient prescriptions, including, but not limited to,
furlough and discharge prescriptions, that are written by the practitioner
must be written on a form which meets the requirements of the Act,
§562.006. Medication order forms or copies thereof do not meet the
requirements for outpatient forms.
(3) Controlled substances listed in Schedule II must be
written on an ofcial prescription form in accordance with the Texas
Controlled Substances Act, §481.075, and rules promulgated pursuant
to the Texas Controlled Substances Act, unless exempted by the
Texas controlled substances regulations, 37 TAC §13.74 (relating to
Exceptions to Use of Forms). Outpatient prescriptions for Schedule II
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controlled substances that are exempted from the ofcial prescription
requirement must be manually signed by the practitioner.
(c) Inpatient records.
(1) Original medication orders.
(A) Each original medication order shall bear the fol-
lowing information:
(i) patient name and room number or identication
number;
(ii) drug name, strength, and dosage form;
(iii) directions for use;
(iv) date; and
(v) signature or electronic signature of the practi-
tioner or that of his or her authorized agent.
(B) Original medication order shall be maintained with
the medication administration records of the patients.
(2) Patient medication records (PMR). A patient medica-
tion record shall be maintained for each inpatient of the facility. The
PMR shall contain at a minimum the following information.
(A) Patient information:
(i) patient name and room number or identication
number;
(ii) gender, and date of birth or age;
(iii) weight and height;
(iv) known drug sensitivities and allergies to drugs
and/or food;
(v) primary diagnoses and chronic conditions;
(vi) primary physician; and
(vii) other drugs the patient is receiving.
(B) Medication order information:
(i) date of distribution;
(ii) drug name, strength, and dosage form; and
(iii) directions for use.
(3) Controlled substances records. Controlled substances
records shall be maintained as follows.
(A) All records for controlled substances shall be main-
tained in a readily retrievable manner.
(B) Controlled substances records shall be maintained
in a manner to establish receipt and distribution of all controlled sub-
stances.
(4) Schedule II controlled substances records. Records of
controlled substances listed in Schedule II shall be maintained as fol-
lows.
(A) Records of controlled substances listed in Schedule
II shall be maintained separately from records of controlled substances
in Schedules III, IV, and V, and all other records.
(B) An institutional pharmacy shall maintain a perpet-
ual inventory of any controlled substance listed in Schedule II.
(C) Distribution records for controlled substances listed
in Schedule II shall bear the following information:
(i) patient’s name;
(ii) prescribing or attending practitioner;
(iii) name of drug, dosage form, and strength;
(iv) time and date of administration to patient and
quantity administered;
(v) signature (rst initial and last name or full sig-
nature) or electronic signature of the individual administering the con-
trolled substance;
(vi) returns to the pharmacy; and
(vii) waste (waste is required to be witnessed and
cosigned, electronically or manually, by another individual).
(5) Floor stock records.
(A) Distribution records for Schedule II - V controlled
substances oor stock shall include the following information:
(i) patient’s name;
(ii) prescribing or attending practitioner;
(iii) name of controlled substance, dosage form, and
strength;
(iv) time and date of administration to patient;
(v) quantity administered;
(vi) signature (rst initial and last name or full sig-
nature) or electronic signature of the individual administering drug;
(vii) returns to the pharmacy; and
(viii) waste (waste is required to be witnessed and
cosigned, manually or electronically, by another individual).
(B) The record required by subparagraph (A) of this
paragraph shall be maintained separately from patient records.
(C) A pharmacist shall review distribution records with
medication orders on a periodic basis to verify proper usage of drugs,
not to exceed 30 days between such reviews.
(6) General requirements for records maintained in a data
processing system.
(A) Noncompliance with data processing requirements.
If a hospital pharmacy’s data processing system is not in compliance
with the Board’s requirements, the pharmacy must maintain a manual
recordkeeping system.
(B) Requirements for back-up systems. The facility
shall maintain a back-up copy of information stored in the data
processing system using disk, tape, or other electronic back-up system
and update this back-up copy on a regular basis, at least monthly, to
assure that data is not lost due to system failure.
(C) Change or discontinuance of a data processing sys-
tem.
(i) Records of distribution and return for all con-
trolled substances, nalbuphine (e.g., Nubain), tripelennamine (e.g.,
PBZ) and carisoprodol (e.g., Soma). A pharmacy that changes or
discontinues use of a data processing system must:
(I) transfer the records to the new data processing
system; or
(II) purge the records to a printout which con-
tains the same information as required on the audit trail printout as
specied in paragraph (7)(B) of this subsection. The information on
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this printout shall be sorted and printed by drug name and list all dis-
tributions/returns chronologically.
(ii) Other records. A pharmacy that changes or dis-
continues use of a data processing system must:
(I) transfer the records to the new data processing
system; or
(II) purge the records to a printout which con-
tains all of the information required on the original document.
(iii) Maintenance of purged records. Information
purged from a data processing system must be maintained by the
pharmacy for two years from the date of initial entry into the data
processing system.
(D) Loss of data. The pharmacist-in-charge shall report
to the board in writing any signicant loss of information from the data
processing system within 10 days of discovery of the loss.
(7) Data processing system maintenance of records for the
distribution and return of all controlled substances, nalbuphine (e.g.,
Nubain), tripelennamine (e.g., PBZ), and carisoprodol (e.g., Soma) to
the pharmacy.
(A) Each time a controlled substance, nalbuphine (e.g.,
Nubain), tripelennamine (e.g., PBZ), or carisoprodol (e.g., Soma) is
distributed from or returned to the pharmacy, a record of such distribu-
tion or return shall be entered into the data processing system.
(B) The data processing system shall have the capacity
to produce a hard copy printout of an audit trail of drug distribution
and return for any strength and dosage form of a drug (by either brand
or generic name or both) during a specied time period. This printout
shall contain the following information:
(i) patient’s name and room number or patient’s fa-
cility identication number;
(ii) prescribing or attending practitioner’s name;
(iii) name, strength, and dosage form of the drug
product actually distributed;
(iv) total quantity distributed from and returned to
the pharmacy;
(v) if not immediately retrievable via CRT display,
the following shall also be included on the printout:
(I) prescribing or attending practitioner’s ad-
dress; and
(II) practitioner’s DEA registration number, if
the medication order is for a controlled substance.
(C) An audit trail printout for each strength and dosage
form of these drugs distributed during the preceding month shall be
produced at least monthly and shall be maintained in a separate le at
the facility. The information on this printout shall be sorted by drug
name and list all distributions/returns for that drug chronologically.
(D) The pharmacy may elect not to produce the monthly
audit trail printout if the data processing system has a workable (elec-
tronic) data retention system which can produce an audit trail of drug
distribution and returns for the preceding two years. The audit trail re-
quired in this paragraph shall be supplied by the pharmacy within 72
hours, if requested by an authorized agent of the Texas State Board of
Pharmacy, or other authorized local, state, or federal law enforcement
or regulatory agencies.
(8) Failure to maintain records. Failure to provide records
set out in this subsection, either on site or within 72 hours for whatever
reason, constitutes prima facie evidence of failure to keep and maintain
records.
(9) Data processing system downtime. In the event that a
hospital pharmacy which uses a data processing system experiences
system downtime, the pharmacy must have an auxiliary procedure
which will ensure that all data is retained for on-line data entry as soon
as the system is available for use again.
(d) Distribution of controlled substances to another registrant.
A pharmacy may distribute controlled substances to a practitioner, an-
other pharmacy or other registrant, without being registered to distrib-
ute, under the following conditions.
(1) The registrant to whom the controlled substance is to
be distributed is registered under the Controlled Substances Act to dis-
pense that controlled substance.
(2) The total number of dosage units of controlled sub-
stances distributed by a pharmacy may not exceed 5.0% of all con-
trolled substances dispensed or distributed by the pharmacy during the
12-month period in which the pharmacy is registered; if at any time
it does exceed 5.0%, the pharmacy is required to obtain an additional
registration to distribute controlled substances.
(3) If the distribution is for a Schedule III, IV, or V con-
trolled substance, a record shall be maintained which indicates:
(A) the actual date of distribution;
(B) the name, strength, and quantity of controlled sub-
stances distributed;
(C) the name, address, and DEA registration number of
the distributing pharmacy; and
(D) the name, address, and DEA registration number of
the pharmacy, practitioner, or other registrant to whom the controlled
substances are distributed.
(4) If the distribution is for a Schedule I or II controlled
substance, the following is applicable.
(A) The pharmacy, practitioner or other registrant who
is receiving the controlled substances shall issue copy 1 and copy 2 of
a DEA order form (DEA 222) to the distributing pharmacy.
(B) The distributing pharmacy shall:
(i) complete the area on the DEA order form (DEA
222) titled TO BE FILLED IN BY SUPPLIER;
(ii) maintain copy 1 of the DEA order form (DEA
222) at the pharmacy for two years; and
(iii) forward copy 2 of the DEA order form (DEA
222) to the divisional ofce of the Drug Enforcement Administration.
(e) Other records. Other records to be maintained by a phar-
macy:
(1) a permanent log of the initials or identication codes
which will identify pharmacy personnel by name (the initials or iden-
tication code shall be unique to ensure that each person can be iden-
tied, i.e., identical initials or identication codes cannot be used);
(2) copy 3 of DEA order form (DEA 222) which has been
properly dated, initialed, and led, and all copies of each unaccepted or
defective order form and any attached statements or other documents;
(3) a hard copy of the power of attorney to sign DEA 222
order forms (if applicable);
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(4) suppliers’ invoices of dangerous drugs and controlled
substances; a pharmacist shall verify that the controlled drugs listed on
the invoices were actually received by clearly recording his/her initials
and the actual date of receipt of the controlled substances;
(5) suppliers’ credit memos for controlled substances and
dangerous drugs;
(6) a hard copy of inventories required by §291.17 of this
title (relating to Inventory Requirements) except that a perpetual inven-
tory of controlled substances listed in Schedule II may be kept in a data
processing system if the data processing system is capable of produc-
ing a hard copy of the perpetual inventory on-site;
(7) hard copy reports of surrender or destruction of con-
trolled substances and/or dangerous drugs to an appropriate state or
federal agency;
(8) a hard copy Schedule V nonprescription register book;
(9) records of distribution of controlled substances and/or
dangerous drugs to other pharmacies, practitioners, or registrants; and
(10) a hard copy of any notication required by the Texas
Pharmacy Act or these sections including, but not limited to, the fol-
lowing:
(A) reports of theft or signicant loss of controlled sub-
stances to DEA, DPS, and the board;
(B) notications of a change in pharmacist-in-charge of
a pharmacy; and
(C) reports of a re or other disaster which may affect
the strength, purity, or labeling of drugs, medication, devices, or other
materials used in diagnosis or treatment of injury, illness, and disease.
(f) Permission to maintain central records. Any pharmacy that
uses a centralized recordkeeping system for invoices and nancial data
shall comply with the following procedures.
(1) Controlled substance records. Invoices and nancial
data for controlled substances may be maintained at a central location
provided the following conditions are met.
(A) Prior to the initiation of central recordkeeping, the
pharmacy submits written notication by registered or certied mail
to the divisional director of the Drug Enforcement Administration as
required by Title 21, Code of Federal Regulations, §1304.04(a), and
submits a copy of this written notication to the Texas State Board of
Pharmacy. Unless the registrant is informed by the divisional direc-
tor of the Drug Enforcement Administration that permission to keep
central records is denied, the pharmacy may maintain central records
commencing 14 days after receipt of notication by the divisional di-
rector.
(B) The pharmacy maintains a copy of the notication
required in subparagraph (A) of this paragraph.
(C) The records to be maintained at the central record
location shall not include executed DEA order forms, prescription drug
orders, or controlled substance inventories, which shall be maintained
at the pharmacy.
(2) Dangerous drug records. Invoices and nancial data for
dangerous drugs may be maintained at a central location.
(3) Access to records. If the records are kept on microlm,
computer media, or in any form requiring special equipment to render
the records easily readable, the pharmacy shall provide access to such
equipment with the records.
(4) Delivery of records. The pharmacy agrees to deliver all
or any part of such records to the pharmacy location within two busi-
ness days of written request of a board agent or any other authorized
ofcial.
§291.76. Class C Pharmacies Located in a Freestanding Ambulatory
Surgical Center.
(a) Purpose. The purpose of this section is to provide stan-
dards in the conduct, practice activities, and operation of a pharmacy
located in a freestanding ambulatory surgical center that is licensed by
the Texas Department of State Health Services. Class C pharmacies
located in a freestanding ambulatory surgical center shall comply with
this section, in lieu of §§291.71 - 291.75 of this title (relating to Pur-
pose; Denitions; Personnel; Operational Standards; and Records).
(b) Denitions. The following words and terms, when used in
these sections, shall have the following meanings, unless the context
clearly indicates otherwise.
(1) Act--The Texas Pharmacy Act, Chapters 551 - 566 and
568 - 569, Occupations Code, as amended.
(2) Ambulatory surgical center (ASC)--A freestanding fa-
cility that is licensed by the Texas Department of State Health Services
to provide surgical services to patients who do not require overnight
hospital care.
(3) Automated drug dispensing system--An automated de-
vice that measures, counts, and/or packages a specied quantity of
dosage units for a designated drug product.
(4) Board--The Texas State Board of Pharmacy.
(5) Consultant pharmacist--A pharmacist retained by a fa-
cility on a routine basis to consult with the ASC in areas that pertain to
the practice of pharmacy.
(6) Controlled substance--A drug, immediate precursor, or
other substance listed in Schedules I - V or Penalty Groups 1 - 4 of the
Texas Controlled Substances Act, as amended, or a drug immediate
precursor, or other substance included in Schedule I - V of the Federal
Comprehensive Drug Abuse Prevention and Control Act of 1970, as
amended (Public Law 91-513).
(7) Direct copy--Electronic copy or carbonized copy of
a medication order including a facsimile (FAX), tele-autograph, or a
copy transmitted between computers.
(8) Dispense--Preparing, packaging, compounding, or la-
beling for delivery a prescription drug or device in the course of pro-
fessional practice to an ultimate user or his agent by or pursuant to the
lawful order of a practitioner.
(9) Distribute--The delivery of a prescription drug or de-
vice other than by administering or dispensing.
(10) Downtime--Period of time during which a data pro-
cessing system is not operable.
(11) Electronic signature--A unique security code or other
identier which specically identies the person entering information
into a data processing system. A facility which utilizes electronic sig-
natures must:
(A) maintain a permanent list of the unique security
codes assigned to persons authorized to use the data processing
system; and
(B) have an ongoing security program which is capable
of identifying misuse and/or unauthorized use of electronic signatures.
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(12) Floor stock--Prescription drugs or devices not labeled
for a specic patient and maintained at a nursing station or other ASC
department (excluding the pharmacy) for the purpose of administration
to a patient of the ASC.
(13) Formulary--List of drugs approved for use in the ASC
by an appropriate committee of the ambulatory surgical center.
(14) Hard copy--A physical document that is readable
without the use of a special device (i.e., cathode ray tube (CRT),
microche reader, etc.).
(15) Investigational new drug--New drug intended for in-
vestigational use by experts qualied to evaluate the safety and effec-
tiveness of the drug as authorized by the federal Food and Drug Ad-
ministration.
(16) Medication order--A written order from a practitioner
or a verbal order from a practitioner or his authorized agent for admin-
istration of a drug or device.
(17) Pharmacist-in-charge--Pharmacist designated on a
pharmacy license as the pharmacist who has the authority or respon-
sibility for a pharmacy’s compliance with laws and rules pertaining to
the practice of pharmacy.
(18) Pharmacy--Area or areas in a facility, separate from
patient care areas, where drugs are stored, bulk compounded, deliv-
ered, compounded, dispensed, and/or distributed to other areas or de-
partments of the ASC, or dispensed to an ultimate user or his or her
agent.
(19) Prescription drug--
(A) A substance for which federal or state law requires
a prescription before it may be legally dispensed to the public;
(B) A drug or device that under federal law is required,
prior to being dispensed or delivered, to be labeled with either of the
following statements:
(i) Caution: federal law prohibits dispensing with-
out prescription or "Rx only" or another legend that complies with fed-
eral law; or
(ii) Caution: federal law restricts this drug to use by
or on order of a licensed veterinarian; or
(C) A drug or device that is required by any applicable
federal or state law or regulation to be dispensed on prescription only
or is restricted to use by a practitioner only.
(20) Prescription drug order--
(A) A written order from a practitioner or verbal order
from a practitioner or his authorized agent to a pharmacist for a drug
or device to be dispensed; or
(B) A written order or a verbal order pursuant to Subti-
tle B, Chapter 157, Occupations Code.
(21) Full-time pharmacist--A pharmacist who works in a
pharmacy from 30 to 40 hours per week or if the pharmacy is open less
than 60 hours per week, one-half of the time the pharmacy is open.
(22) Part-time pharmacist--A pharmacist who works less
than full-time.
(23) Pharmacy technician--An individual who is registered
with the board as a pharmacy technician and whose responsibility in a
pharmacy is to provide technical services that do not require profes-
sional judgment regarding preparing and distributing drugs and who
works under the direct supervision of and is responsible to a pharma-
cist.
(24) Pharmacy technician trainee--An individual who is
registered with the board as a pharmacy technician trainee and is
authorized to participate in a pharmacy’s technician training program.
(25) Texas Controlled Substances Act--The Texas Con-




(A) General. Each ambulatory surgical center shall
have one pharmacist-in-charge who is employed or under contract, at
least on a consulting or part-time basis, but may be employed on a
full-time basis.
(B) Responsibilities. The pharmacist-in-charge shall
have the responsibility for, at a minimum, the following:
(i) establishment of specications for procurement
and storage of all materials, including drugs, chemicals, and biologi-
cals;
(ii) participation in the development of a formulary
for the ASC, subject to approval of the appropriate committee of the
ASC;
(iii) distribution of drugs to be administered to inpa-
tients pursuant to an original or direct copy of the practitioner’s medi-
cation order;
(iv) lling and labeling all containers from which
drugs are to be distributed or dispensed;
(v) maintaining and making available a sufcient in-
ventory of antidotes and other emergency drugs, both in the pharmacy
and inpatient care areas, as well as current antidote information, tele-
phone numbers of regional poison control center and other emergency
assistance organizations, and such other materials and information as
may be deemed necessary by the appropriate committee of the ASC;
(vi) records of all transactions of the ASC pharmacy
as may be required by applicable state and federal law, and as may be
necessary to maintain accurate control over and accountability for all
pharmaceutical materials;
(vii) participation in those aspects of the ASC’s pa-
tient care evaluation program which relate to pharmaceutical material
utilization and effectiveness;
(viii) participation in teaching and/or research pro-
grams in the ASC;
(ix) implementation of the policies and decisions of
the appropriate committee(s) relating to pharmaceutical services of the
ASC;
(x) effective and efcient messenger and delivery
service to connect the ASC pharmacy with appropriate areas of the
ASC on a regular basis throughout the normal workday of the ASC;
(xi) labeling, storage, and distribution of investiga-
tional new drugs, including maintenance of information in the phar-
macy and nursing station where such drugs are being administered,
concerning the dosage form, route of administration, strength, actions,
uses, side effects, adverse effects, interactions, and symptoms of toxi-
city of investigational new drugs;
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(xii) meeting all inspection and other requirements
of the Texas Pharmacy Act and this subsection; and
(xiii) maintenance of records in a data processing
system such that the data processing system is in compliance with the
requirements for a Class C (institutional) pharmacy located in a free-
standing ASC.
(2) Consultant pharmacist.
(A) The consultant pharmacist may be the pharmacist-
in-charge.
(B) A written contract shall exist between the ASC and
any consultant pharmacist, and a copy of the written contract shall be
made available to the board upon request.
(3) Pharmacists.
(A) General.
(i) The pharmacist-in-charge shall be assisted by a
sufcient number of additional licensed pharmacists as may be required
to operate the ASC pharmacy competently, safely, and adequately to
meet the needs of the patients of the facility.
(ii) All pharmacists shall assist the pharmacist-in-
charge in meeting the responsibilities as outlined in paragraph (1)(B)
of this subsection and in ordering, administering, and accounting for
pharmaceutical materials.
(iii) All pharmacists shall be responsible for any del-
egated act performed by pharmacy technicians under his or her super-
vision.
(iv) All pharmacists while on duty shall be respon-
sible for complying with all state and federal laws or rules governing
the practice of pharmacy.
(B) Duties. Duties of the pharmacist-in-charge and all
other pharmacists shall include, but need not be limited to, the follow-
ing:
(i) receiving and interpreting prescription drug or-
ders and oral medication orders and reducing these orders to writing
either manually or electronically;
(ii) selection of prescription drugs and/or devices
and/or suppliers; and
(iii) interpreting patient proles.
(C) Special requirements for compounding.
(i) Non-Sterile Preparations. All pharmacists en-
gaged in compounding non-sterile preparations shall meet the training
requirements specied in §291.131 of this title (relating to Pharmacies
Compounding Non-Sterile Preparations).
(ii) Sterile Preparations. All pharmacists engaged in
compounding sterile preparations shall meet the training requirements
specied in §291.133 of this title (relating to Pharmacies Compounding
Sterile Preparations).
(4) Pharmacy technicians and pharmacy technician
trainees.
(A) General. All pharmacy technicians and pharmacy
technician trainees shall meet the training requirements specied in
§297.6 of this title (relating to Pharmacy Technician and Pharmacy
Technician Trainee Training).
(B) Duties. Duties may include, but need not be limited
to, the following functions, under the direct supervision of a pharma-
cist:
(i) prepacking and labeling unit and multiple dose
packages, provided a pharmacist supervises and conducts in-process
and nal checks and afxes his or her signature or electronic signature
to the appropriate quality control records;
(ii) preparing, packaging, compounding, or labeling
prescription drugs pursuant to medication orders, provided a pharma-
cist supervises and checks the preparation;
(iii) compounding non-sterile and sterile prepara-
tions pursuant to medication orders;
(I) have completed the training specied in
§291.26 of this title (relating to Pharmacies Compounding Sterile
Pharmaceuticals); and
(II) are supervised by a pharmacist who has com-
pleted the sterile products training specied in §291.26 of this title,
conducts in-process and nal checks, and afxes his or her initials to
the label or if batch prepared, to the appropriate quality control records.
(The initials are not required on the label if it is maintained in a perma-
nent record of the pharmacy.)
(iv) bulk compounding, provided a pharmacist su-
pervises and conducts in-process and nal checks and afxes his or her
initials to the appropriate quality control records;
(v) distributing routine orders for stock supplies to
patient care areas;
(vi) entering medication order and drug distribution
information into a data processing system, provided judgmental de-
cisions are not required and a pharmacist checks the accuracy of the
information entered into the system prior to releasing the order or in
compliance with the absence of pharmacist requirements contained in
subsection (d)(6)(E) and (F) of this section;
(vii) maintaining inventories of drug supplies;
(viii) maintaining pharmacy records; and
(ix) loading bulk unlabeled drugs into an automated
drug dispensing system provided a pharmacist supervises, veries that
the system was properly loaded prior to use, and afxes his or her sig-
nature or electronic signature to the appropriate quality control records.
(C) Procedures.
(i) Pharmacy technicians and pharmacy technician
trainees shall handle medication orders in accordance with standard
written procedures and guidelines.
(ii) Pharmacy technicians and pharmacy technician
trainees shall handle prescription drug orders in the same manner as
pharmacy technicians working in a Class A pharmacy.
(D) Special requirements for compounding.
(i) Non-Sterile Preparations. All pharmacy techni-
cians and pharmacy technician trainees engaged in compounding non-
sterile preparations shall meet the training requirements specied in
§291.131 of this title.
(ii) Sterile Preparations. All pharmacy technicians
and pharmacy technician trainees engaged in compounding sterile
preparations shall meet the training requirements specied in §291.131
of this title.
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(5) Owner. The owner of an ASC pharmacy shall have re-
sponsibility for all administrative and operational functions of the phar-
macy. The pharmacist-in-charge may advise the owner on administra-
tive and operational concerns. The owner shall have responsibility for,
at a minimum, the following, and if the owner is not a Texas licensed
pharmacist, the owner shall consult with the pharmacist-in-charge or
another Texas licensed pharmacist:
(A) establishment of policies for procurement of pre-
scription drugs and devices and other products dispensed from the ASC
pharmacy;
(B) establishment and maintenance of effective con-
trols against the theft or diversion of prescription drugs;
(C) if the pharmacy uses an automated pharmacy dis-
pensing system, reviewing and approving all policies and procedures
for system operation, safety, security, accuracy and access, patient con-
dentiality, prevention of unauthorized access, and malfunction;
(D) providing the pharmacy with the necessary equip-
ment and resources commensurate with its level and type of practice;
and
(E) establishment of policies and procedures regarding
maintenance, storage, and retrieval of records in a data processing sys-
tem such that the system is in compliance with state and federal re-
quirements.
(6) Identication of pharmacy personnel. All pharmacy
personnel shall be identied as follows:
(A) Pharmacy technicians. All pharmacy technicians
shall wear an identication tag or badge that bears the person’s name
and identies him or her as a pharmacy technician trainee a registered
pharmacy technician, or a certied pharmacy technician, if the techni-
cian maintains current certication with the Pharmacy Technician Cer-
tication Board or any other entity providing an examination approved
by the board.
(B) Pharmacy technician trainees. All pharmacy
technician trainees shall wear an identication tag or badge that bears
the person’s name and identies him or her as a pharmacy technician
trainee.
(C) Pharmacist interns. All pharmacist interns shall
wear an identication tag or badge that bears the person’s name and
identies him or her as a pharmacist intern.
(D) Pharmacists. All pharmacists shall wear an identi-
cation tag or badge that bears the person’s name and identies him or
her as a pharmacist.
(d) Operational standards.
(1) Licensing requirements.
(A) An ASC pharmacy shall register annually with the
board on a pharmacy license application provided by the board, follow-
ing the procedures specied in §291.1 of this title (relating to Pharmacy
License Application).
(B) If the ASC pharmacy is owned or operated by a
pharmacy management or consulting rm, the following conditions ap-
ply.
(i) The pharmacy license application shall list the
pharmacy management or consulting rm as the owner or operator.
(ii) The pharmacy management or consulting rm
shall obtain DEA and DPS controlled substances registrations that are
issued in the name of the rm, unless the following occur:
(I) the pharmacy management or consulting rm
and the facility cosign a contractual pharmacy service agreement which
assigns overall responsibility for controlled substances to the facility;
and
(II) such pharmacy management or consulting
rm maintains dual responsibility for the controlled substances.
(C) An ASC pharmacy which changes ownership shall
notify the board within 10 days of the change of ownership and apply
for a new and separate license as specied in §291.3 of this title (relat-
ing to Required Notications).
(D) An ASC pharmacy which changes location and/or
name shall notify the board of the change within 10 days and le for
an amended license as specied in §291.3 of this title.
(E) An ASC pharmacy owned by a partnership or cor-
poration which changes managing ofcers shall notify the board in
writing of the names of the new managing ofcers within 10 days of
the change, following the procedures in §291.3 of this title.
(F) An ASC pharmacy shall notify the board in writing
within 10 days of closing, following the procedures in §291.5 of this
title (relating to Closed Pharmacies).
(G) A fee as specied in §291.6 of this title (relating to
Pharmacy License Fees) will be charged for issuance and renewal of a
license and the issuance of an amended license.
(H) A separate license is required for each principal
place of business and only one pharmacy license may be issued to a
specic location.
(I) An ASC pharmacy, licensed under the Act,
§560.051(a)(3), concerning institutional pharmacy (Class C), which
also operates another type of pharmacy which would otherwise be
required to be licensed under the Act, §560.051(a)(1), concerning
community pharmacy (Class A), or the Act, §560.051(a)(2), concern-
ing nuclear pharmacy (Class B), is not required to secure a license
for the other type of pharmacy; provided, however, such license is
required to comply with the provisions of §291.31 of this title (relating
to Denitions), §291.32 of this title (relating to Personnel), §291.33
of this title (relating to Operational Standards), §291.34 of this title
(relating to Records), and §291.35 of this title (relating to Ofcial
Prescription Records), or §291.51 of this title (relating to Purpose),
§291.52 of this title (relating to Denitions), §291.53 of this title
(relating to Personnel), §291.54 of this title (relating to Operational
Standards), and §291.55 of this title (relating to Records), contained in
Nuclear Pharmacy (Class B), to the extent such sections are applicable
to the operation of the pharmacy.
(J) An ASC pharmacy engaged in non-sterile com-
pounding of drug products for inpatients of the hospital shall comply
with the provisions of §291.131 of this title.
(K) An ASC pharmacy engaged in the compounding of
sterile pharmaceuticals shall comply with the provisions of §291.133
of this title.
(L) An ASC pharmacy engaged in the provision of re-
mote pharmacy services, including storage and dispensing of prescrip-
tion drugs, shall comply with the provisions of §291.121 of this title
(relating to Remote Pharmacy Services).
(M) An ASC pharmacy engaged in centralized pre-
scription dispensing and/or prescription drug or medication order
processing shall comply with the provisions of §291.123 of this
title (relating to Centralized Prescription Drug or Medication Order
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(i) Each ambulatory surgical center shall have a des-
ignated work area separate from patient areas, and which shall have
space adequate for the size and scope of pharmaceutical services and
shall have adequate space and security for the storage of drugs.
(ii) The ASC pharmacy shall be arranged in an or-
derly fashion and shall be kept clean. All required equipment shall be
clean and in good operating condition.
(B) Special requirements.
(i) The ASC pharmacy shall have locked storage for
Schedule II controlled substances and other controlled drugs requiring
additional security.
(ii) The ASC pharmacy shall have a designated area
for the storage of poisons and externals separate from drug storage ar-
eas.
(C) Security.
(i) Only authorized personnel may have access to
storage areas for prescription drugs and/or devices.
(ii) All storage areas for prescription drugs and/or
devices shall be locked by key or combination, so as to prevent access
by unauthorized personnel.
(iii) The pharmacist-in-charge shall consult with
ASC personnel with respect to security of the drug storage areas,
including provisions for adequate safeguards against theft or diversion
of prescription drugs and/or devices.
(3) Equipment and supplies. Ambulatory surgical centers
supplying drugs for postoperative use shall have the following equip-
ment and supplies:
(A) typewriter or comparable equipment; and
(B) adequate supply of child-resistant, moisture-proof,
and light-proof containers;
(C) adequate supply of prescription labels and other ap-
plicable identication labels;
(4) Library. A reference library shall be maintained which
includes the following in hard-copy or electronic format:
(A) current copies of the following:
(i) Texas Pharmacy Act and rules;
(ii) Texas Dangerous Drug Act and rules;
(iii) Texas Controlled Substances Act and rules;
(iv) Federal Controlled Substances Act and rules or
ofcial publication describing the requirements of the Federal Con-
trolled Substances Act and rules;
(B) at least one current or updated reference from each
of the following categories:
(i) Drug interactions. A reference text on drug inter-
actions, such as Drug Interaction Facts. A separate reference is not re-
quired if other references maintained by the pharmacy contain drug in-
teraction information including information needed to determine sever-
ity or signicance of the interaction and appropriate recommendations
or actions to be taken;
(ii) General information. A general information ref-
erence text, such as:
(I) Facts and Comparisons with current supple-
ments;
(II) United States Pharmacopeia Dispensing In-
formation Volume I (Drug Information for the Healthcare Provider);
(III) AHFS Drug Information with current sup-
plements;
(IV) Remington’s Pharmaceutical Sciences; or
(V) Clinical Pharmacology;
(C) a current or updated reference on injectable drug
products, such as Handbook of Injectable Drugs;
(D) basic antidote information and the telephone num-
ber of the nearest regional poison control center.
(E) if the pharmacy compounds sterile preparations,
specialty references appropriate for the scope of services provided by
the pharmacy, e.g., if the pharmacy prepares cytotoxic drugs, a refer-
ence text on the preparation of cytotoxic drugs, such as Procedures for
Handling Cytotoxic Drugs.
(F) metric-apothecary weight and measure conversion
charts.
(5) Drugs.
(A) Procurement, preparation, and storage.
(i) The pharmacist-in-charge shall have the respon-
sibility for the procurement and storage of drugs, but may receive input
from other appropriate staff of the facility, relative to such responsibil-
ity.
(ii) The pharmacist-in-charge shall have the respon-
sibility for determining specications of all drugs procured by the fa-
cility.
(iii) ASC pharmacies may not sell, purchase, trade,
or possess prescription drug samples, unless the pharmacy meets all of
the following conditions:
(I) the pharmacy is owned by a charitable organ-
ization described in the Internal Revenue Code of 1986, or by a city,
state or county government;
(II) the pharmacy is a part of a health care entity
which provides health care primarily to indigent or low income patients
at no or reduced cost;
(III) the samples are for dispensing or provision
at no charge to patients of such health care entity; and
(IV) the samples are possessed in compliance
with the federal Prescription Drug Marketing Act of 1986.
(iv) All drugs shall be stored at the proper tempera-
tures, as dened by the following terms.
(I) Room temperature--temperature maintained
between 15 degrees Celsius (59 degrees Fahrenheit) and 30 degrees
Celsius (86 degrees Fahrenheit).
(II) Cool--temperature between 8 degrees Cel-
sius (46 degrees Fahrenheit) and 15 degrees Celsius (59 degrees
Fahrenheit). An article for which storage in a cool place is directed
may, alternatively, be stored in a refrigerator unless otherwise specied
on the labeling.
32 TexReg 6342 September 14, 2007 Texas Register
(III) Refrigerate--temperature that is thermostat-
ically maintained between 2 degrees Celsius (36 degrees Fahrenheit)
and 8 degrees Celsius (46 degrees Fahrenheit).
(IV) Freeze--temperature that is thermostatically
maintained between minus 20 degrees Celsius (minus 4 degrees
Fahrenheit) and minus 10 degrees Celsius (14 degrees Fahrenheit).
(v) Any drug bearing an expiration date may not be
dispensed or distributed beyond the expiration date of the drug.
(vi) Outdated drugs shall be removed from dispens-
ing stock and shall be quarantined together until such drugs are dis-
posed of.
(B) Formulary.
(i) A formulary may be developed by an appropriate
committee of the ambulatory surgical center.
(ii) The pharmacist-in-charge or consultant pharma-
cist shall be a full voting member of any committee which involves
pharmaceutical services.
(C) Prepackaging of drugs and loading of bulk unla-
beled drugs into automated drug dispensing system.
(i) Prepackaging of drugs.
(I) Drugs may be prepackaged in quantities suit-
able for internal distribution only by a pharmacist or by pharmacy tech-
nicians or pharmacy technician trainees under the direction and direct
supervision of a pharmacist.
(II) The label of a prepackaged unit shall indi-
cate:
(-a-) brand name and strength of the drug; or
if no brand name, then the generic name, strength, and name of the
manufacturer or distributor;
(-b-) facility’s lot number;
(-c-) expiration date; and
(-d-) quantity of the drug, if quantity is
greater than one.
(III) Records of prepackaging shall be main-
tained to show:
(-a-) the name of the drug, strength, and
dosage form;
(-b-) facility’s lot number;
(-c-) manufacturer or distributor;
(-d-) manufacturer’s lot number;
(-e-) expiration date;
(-f-) quantity per prepackaged unit;
(-g-) number of prepackaged units;
(-h-) date packaged;
(-i-) name, initials, or electronic signature of
the prepacker; and
(-j-) signature or electronic signature of the
responsible pharmacist.
(IV) Stock packages, repackaged units, and con-
trol records shall be quarantined together until checked/released by the
pharmacist.
(ii) Loading bulk unlabeled drugs into automated
drug dispensing systems.
(I) Automated drug dispensing systems may be
loaded with bulk unlabeled drugs only by a pharmacist or by pharmacy
technicians or pharmacy technician trainees under the direction and
direct supervision of a pharmacist.
(II) The label of an automated drug dispensing
system container shall indicate the brand name and strength of the drug;
or if no brand name, then the generic name, strength, and name of the
manufacturer or distributor.
(III) Records of loading bulk unlabeled drugs
into an automated drug dispensing system shall be maintained to show:
(-a-) name of the drug, strength, and dosage
form;
(-b-) manufacturer or distributor;
(-c-) manufacturer’s lot number;
(-d-) expiration date;
(-e-) date of loading;
(-f-) name, initials, or electronic signature of
the person loading the automated drug dispensing system; and
(-g-) signature or electronic signature of the
responsible pharmacist.
(IV) The automated drug dispensing system shall
not be used until a pharmacist veries that the system is properly loaded
and afxes his or her signature or electronic signature to the record
specied in subclause (III) of this clause.
(6) Medication orders.
(A) Drugs may be administered to patients in ASCs
only on the order of a practitioner. No change in the order for drugs
may be made without the approval of a practitioner.
(B) Drugs may be distributed only pursuant to the orig-
inal or a direct copy of the practitioner’s medication order.
(C) Pharmacy technicians and pharmacy technician
trainees may not receive oral medication orders.
(D) ASC pharmacies shall be exempt from the label-
ing provisions and patient notication requirements of §562.006 and
§562.009 of the Act, as respects drugs distributed pursuant to medica-
tion orders.
(E) In ASCs with a full-time pharmacist, if a practi-
tioner orders a drug for administration to a bona de patient of the fa-
cility when the pharmacy is closed, the following is applicable.
(i) Prescription drugs and devices only in sufcient
quantities for immediate therapeutic needs of a patient may be removed
from the ASC pharmacy.
(ii) Only a designated licensed nurse or practitioner
may remove such drugs and devices.
(iii) A record shall be made at the time of withdrawal
by the authorized person removing the drugs and devices. The record
shall contain the following information:
(I) name of the patient;




(V) time and date; and
(VI) signature or electronic signature of person
making withdrawal.
(iv) The original or direct copy of the medication or-
der may substitute for such record, provided the medication order meets
all the requirements of clause (iii) of this subparagraph.
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(v) The pharmacist shall verify the withdrawal as
soon as practical, but in no event more than 72 hours from the time
of such withdrawal.
(F) In ASCs with a part-time or consultant pharmacist,
if a practitioner orders a drug for administration to a bona de patient
of the ASC when the pharmacist is not on duty, or when the pharmacy
is closed, the following is applicable.
(i) Prescription drugs and devices only in sufcient
quantities for therapeutic needs may be removed from the ASC phar-
macy.
(ii) Only a designated licensed nurse or practitioner
may remove such drugs and devices.
(iii) A record shall be made at the time of withdrawal
by the authorized person removing the drugs and devices; the record
shall meet the same requirements as specied in subparagraph (E)(iii)
of this paragraph.
(iv) The pharmacist shall verify each distribution af-
ter a reasonable interval, but in no event may such interval exceed seven
days.
(7) Floor stock. In facilities using a oor stock method of
drug distribution, the following is applicable for removing drugs or
devices in the absence of a pharmacist.
(A) Prescription drugs and devices may be removed
from the pharmacy only in the original manufacturer’s container or
prepackaged container.
(B) Only a designated licensed nurse or practitioner
may remove such drugs and devices.
(C) A record shall be made at the time of withdrawal
by the authorized person removing the drug or device; the record shall
contain the following information:
(i) name of the drug, strength, and dosage form;
(ii) quantity removed;
(iii) location of oor stock;
(iv) date and time; and
(v) signature or electronic signature of person mak-
ing the withdrawal.
(D) A pharmacist shall verify the withdrawal according
to the following schedule.
(i) In facilities with a full-time pharmacist, the with-
drawal shall be veried as soon as practical, but in no event more than
72 hours from the time of such withdrawal.
(ii) In facilities with a part-time or consultant phar-
macist, the withdrawal shall be veried after a reasonable interval, but
in no event may such interval exceed seven days.
(8) Policies and procedures. Written policies and proce-
dures for a drug distribution system, appropriate for the ambulatory
surgical center, shall be developed and implemented by the pharma-
cist-in-charge with the advice of the appropriate committee. The writ-
ten policies and procedures for the drug distribution system shall in-
clude, but not be limited to, procedures regarding the following:
(A) controlled substances;
(B) investigational drugs;
(C) prepackaging and manufacturing;
(D) medication errors;
(E) orders of physician or other practitioner;
(F) oor stocks;
(G) adverse drug reactions;
(H) drugs brought into the facility by the patient;
(I) self-administration;
(J) emergency drug tray;
(K) formulary, if applicable;
(L) drug storage areas;
(M) drug samples;
(N) drug product defect reports;
(O) drug recalls;
(P) outdated drugs;
(Q) preparation and distribution of IV admixtures;
(R) procedures for supplying drugs for postoperative
use, if applicable;
(S) use of automated drug dispensing systems; and
(T) use of data processing systems.
(9) Drugs supplied for postoperative use. Drugs supplied
to patients for postoperative use shall be supplied according to the fol-
lowing procedures.
(A) Drugs may only be supplied to patients who have
been admitted to the ambulatory surgical center.
(B) Drugs may only be supplied in accordance with the
system of control and accountability established for drugs supplied
from the ambulatory surgical center; such system shall be developed
and supervised by the pharmacist-in-charge or staff pharmacist desig-
nated by the pharmacist-in-charge.
(C) Only drugs listed on the approved postoperative
drug list may be supplied; such list shall be developed by the phar-
macist-in-charge and the medical staff and shall consist of drugs of
the nature and type to meet the immediate postoperative needs of the
ambulatory surgical center patient.
(D) Drugs may only be supplied in prepackaged quanti-
ties not to exceed a 72-hour supply in suitable containers and appropri-
ately prelabeled (including necessary auxiliary labels) by the pharmacy,
provided, however that topicals and ophthalmics in original manufac-
turer’s containers may be supplied in a quantity exceeding a 72-hour
supply.
(E) At the time of delivery of the drug, the practitioner
shall complete the label, such that the prescription container bears a
label with at least the following information:
(i) date supplied;
(ii) name of practitioner;
(iii) name of patient;
(iv) directions for use;
(v) brand name and strength of the drug; or if no
brand name, then the generic name of the drug dispensed, strength,
and the name of the manufacturer or distributor of the drug; and
(vi) unique identication number.
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(F) After the drug has been labeled by the practitioner,
the practitioner or a licensed nurse under the supervision of the practi-
tioner shall give the appropriately labeled, prepackaged medication to
the patient.
(G) A perpetual record of drugs which are supplied
from the ASC shall be maintained which includes:
(i) name, address, and phone number of the facility;
(ii) date supplied;
(iii) name of practitioner;
(iv) name of patient;
(v) directions for use;
(vi) brand name and strength of the drug; or if no
brand name, then the generic name of the drug dispensed, strength,
and the name of the manufacturer or distributor of the drug; and
(vii) unique identication number.
(H) The pharmacist-in-charge, or a pharmacist desig-
nated by the pharmacist-in-charge, shall review the records at least once
every seven days.
(e) Records.
(1) Maintenance of records.
(A) Every inventory or other record required to be kept
under the provisions of this section (relating to Institutional Pharmacy
(Class C)) shall be:
(i) kept by the pharmacy and be available, for at least
two years from the date of such inventory or record, for inspecting and
copying by the board or its representative, and other authorized local,
state, or federal law enforcement agencies; and
(ii) supplied by the pharmacy within 72 hours, if re-
quested by an authorized agent of the Texas State Board of Pharmacy.
If the pharmacy maintains the records in an electronic format, the re-
quested records must be provided in a mutually agreeable electronic
format if specically requested by the board or its representative. Fail-
ure to provide the records set out in this subsection, either on site or
within 72 hours, constitutes prima facie evidence of failure to keep and
maintain records in violation of the Act.
(B) Records of controlled substances listed in Sched-
ules I and II shall be maintained separately from all other records of
the pharmacy.
(C) Records of controlled substances listed in Sched-
ules III - V shall be maintained separately or readily retrievable from
all other records of the pharmacy. For purposes of this subsection, read-
ily retrievable means that the controlled substances shall be asterisked,
red-lined, or in some other manner readily identiable apart from all
other items appearing on the record.
(D) Records, except when specically required to be
maintained in original or hard-copy form, may be maintained in an
alternative data retention system, such as a data processing or direct
imaging system, e.g., microlm or microche, provided:
(i) the records in the alternative data retention sys-
tem contain all of the information required on the manual record; and
(ii) the alternative data retention system is capable
of producing a hard copy of the record upon the request of the board,
its representative, or other authorized local, state, or federal law en-
forcement or regulatory agencies.
(2) Outpatient records.
(A) Only a registered pharmacist may receive, certify,
and receive prescription drug orders.
(B) Outpatient records shall be maintained as provided
in §291.34 and §291.35 of this title contained in Community Pharmacy
(Class A).
(C) Outpatient prescriptions, including, but not limited
to, discharge prescriptions, that are written by the practitioner, must be
written on a form which meets the requirements of the Act, §562.006.
Medication order forms or copies thereof do not meet the requirements
for outpatient forms.
(D) Controlled substances listed in Schedule II must be
written on an electronic prescription form in accordance with the Texas
Controlled Substances Act, §481.075, and rules promulgated pursuant
to the Texas Controlled Substances Act, unless exempted by the Texas
Controlled Substances Rules, 37 TAC §13.74. Outpatient prescriptions
for Schedule II controlled substances that are exempted from the of-
cial prescription requirement must be manually signed by the practi-
tioner.
(3) Inpatient records.
(A) Each original medication order or set of orders is-
sued together shall bear the following information:
(i) patient name;
(ii) drug name, strength, and dosage form;
(iii) directions for use;
(iv) date; and
(v) signature or electronic signature of the practi-
tioner or that of his or her authorized agent, dened as a licensed nurse
employee or consultant/full or part-time pharmacist of the ASC.
(B) Original medication orders shall be maintained with
the medication administration record in the medical records of the pa-
tient.
(C) Controlled substances records shall be maintained
as follows.
(i) All records for controlled substances shall be
maintained in a readily retrievable manner.
(ii) Controlled substances records shall be main-
tained in a manner to establish receipt and distribution of all controlled
substances.
(D) Records of controlled substances listed in Schedule
II shall be maintained as follows.
(i) Records of controlled substances listed in Sched-
ule II shall be maintained separately from records of controlled sub-
stances in Schedules III, IV, and V, and all other records.
(ii) An ASC pharmacy shall maintain a perpetual in-
ventory of any controlled substance listed in Schedule II.
(iii) Distribution records for Schedule II - V con-
trolled substances oor stock shall include the following information:
(I) patient’s name;
(II) practitioner who ordered drug;
(III) name of drug, dosage form, and strength;
(IV) time and date of administration to patient
and quantity administered;
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(V) signature or electronic signature of individ-
ual administering controlled substance;
(VI) returns to the pharmacy; and
(VII) waste (waste is required to be witnessed
and cosigned, manually or electronically, by another individual).
(E) Floor stock records shall be maintained as follows.
(i) Distribution records for Schedules III - V con-
trolled substances oor stock shall include the following information:
(I) patient’s name;
(II) practitioner who ordered controlled sub-
stance;
(III) name of controlled substance, dosage form,
and strength;
(IV) time and date of administration to patient;
(V) quantity administered;
(VI) signature or electronic signature of individ-
ual administering drug;
(VII) returns to the pharmacy; and
(VIII) waste (waste is required to be witnessed
and cosigned, manually or electronically, by another individual).
(ii) The record required by clause (i) of this subpara-
graph shall be maintained separately from patient records.
(iii) A pharmacist shall review distribution records
with medication orders on a periodic basis to verify proper usage of
drugs, not to exceed 30 days between such reviews.
(F) General requirements for records maintained in a
data processing system are as follows.
(i) If an ASC pharmacy’s data processing system is
not in compliance with the board’s requirements, the pharmacy must
maintain a manual recordkeeping system.
(ii) Requirements for backup systems. The facility
shall maintain a backup copy of information stored in the data pro-
cessing system using disk, tape, or other electronic backup system and
update this backup copy on a regular basis to assure that data is not lost
due to system failure.
(iii) Change or discontinuance of a data processing
system.
(I) Records of distribution and return for all con-
trolled substances, nalbuphine (Nubain), and tripelennamine (PBZ). A
pharmacy that changes or discontinues use of a data processing system
must:
(-a-) transfer the records to the new data pro-
cessing system; or
(-b-) purge the records to a printout which
contains the same information as required on the audit trail printout as
specied in subparagraph (G)(ii) of this paragraph. The information
on this printout shall be sorted and printed by drug name and list all
distributions/returns chronologically.
(II) Other records. A pharmacy that changes or
discontinues use of a data processing system must:
(-a-) transfer the records to the new data pro-
cessing system; or
(-b-) purge the records to a printout which
contains all of the information required on the original document.
(III) Maintenance of purged records. Informa-
tion purged from a data processing system must be maintained by the
pharmacy for two years from the date of initial entry into the data pro-
cessing system.
(iv) Loss of data. The pharmacist-in-charge shall re-
port to the board in writing any signicant loss of information from the
data processing system within 10 days of discovery of the loss.
(G) Data processing system maintenance of records
for the distribution and return of all controlled substances, nalbuphine
(Nubain), or tripelennamine (PBZ) to the pharmacy.
(i) Each time a controlled substance, nalbuphine
(Nubain), or tripelennamine (PBZ) is distributed from or returned to
the pharmacy, a record of such distribution or return shall be entered
into the data processing system.
(ii) The data processing system shall have the capac-
ity to produce a hard-copy printout of an audit trail of drug distribution
and return for any strength and dosage form of a drug (by either brand
or generic name or both) during a specied time period. This printout
shall contain the following information:
(I) patient’s name and room number or patient’s
facility identication number;
(II) prescribing or attending practitioner’s name;
(III) name, strength, and dosage form of the drug
product actually distributed;
(IV) total quantity distributed from and returned
to the pharmacy;
(V) if not immediately retrievable via CRT dis-
play, the following shall also be included on the printout:
(-a-) prescribing or attending practitioner’s
address; and
(-b-) practitioner’s DEA registration number,
if the medication order is for a controlled substance.
(iii) An audit trail printout for each strength and
dosage form of these drugs distributed during the preceding month
shall be produced at least monthly and shall be maintained in a
separate le at the facility. The information on this printout shall be
sorted by drug name and list all distributions/returns for that drug
chronologically.
(iv) The pharmacy may elect not to produce the
monthly audit trail printout if the data processing system has a work-
able (electronic) data retention system which can produce an audit
trail of drug distribution and returns for the preceding two years. The
audit trail required in this clause shall be supplied by the pharmacy
within 72 hours, if requested by an authorized agent of the Texas State
Board of Pharmacy, or other authorized local, state, or federal law
enforcement or regulatory agencies.
(H) Failure to maintain records. Failure to provide
records set out in this subsection, either on site or within 72 hours for
whatever reason, constitutes prima facie evidence of failure to keep
and maintain records.
(I) Data processing system downtime. In the event that
an ASC pharmacy which uses a data processing system experiences
system downtime, the pharmacy must have an auxiliary procedure
which will ensure that all data is retained for on-line data entry as soon
as the system is available for use again.
(4) Distribution of controlled substances to another regis-
trant. A pharmacy may distribute controlled substances to a practi-
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tioner, another pharmacy, or other registrant, without being registered
to distribute, under the following conditions.
(A) The registrant to whom the controlled substance is
to be distributed is registered under the Controlled Substances Act to
dispense that controlled substance.
(B) The total number of dosage units of controlled sub-
stances distributed by a pharmacy may not exceed 5.0% of all con-
trolled substances dispensed by the pharmacy during the 12-month pe-
riod in which the pharmacy is registered; if at any time it does exceed
5.0%, the pharmacy is required to obtain an additional registration to
distribute controlled substances.
(C) If the distribution is for a Schedule III, IV, or V con-
trolled substance, a record shall be maintained which indicates:
(i) the actual date of distribution;
(ii) the name, strength, and quantity of controlled
substances distributed;
(iii) the name, address, and DEA registration num-
ber of the distributing pharmacy; and
(iv) the name, address, and DEA registration num-
ber of the pharmacy, practitioner, or other registrant to whom the con-
trolled substances are distributed.
(D) If the distribution is for a Schedule I or II controlled
substance, the following is applicable.
(i) The pharmacy, practitioner, or other registrant
who is receiving the controlled substances shall issue Copy 1 and Copy
2 of a DEA order form (DEA 222C) to the distributing pharmacy.
(ii) The distributing pharmacy shall:
(I) complete the area on the DEA order form
(DEA 222C) titled "To Be Filled in by Supplier";
(II) maintain Copy 1 of the DEA order form
(DEA 222C) at the pharmacy for two years; and
(III) forward Copy 2 of the DEA order form
(DEA 222C) to the divisional ofce of the Drug Enforcement Admin-
istration.
(5) Other records. Other records to be maintained by the
pharmacy include:
(A) a permanent log of the initials or identication
codes which will identify each pharmacist by name. The initials or
identication code shall be unique to ensure that each pharmacist can
be identied, i.e., identical initials or identication codes cannot be
used;
(B) Copy 3 of DEA order form (DEA 222C), which has
been properly dated, initialed, and led, and all copies of each unac-
cepted or defective order form and any attached statements or other
documents;
(C) a hard copy of the power of attorney to sign DEA
222C order forms (if applicable);
(D) suppliers’ invoices of dangerous drugs and con-
trolled substances; a pharmacist shall verify that the controlled drugs
listed on the invoices were actually received by clearly recording
his/her initials and the actual date of receipt of the controlled sub-
stances;
(E) supplier’s credit memos for controlled substances
and dangerous drugs;
(F) a hard copy of inventories required by §291.17 of
this title (relating to Inventory Requirements) except that a perpetual
inventory of controlled substances listed in Schedule II may be kept
in a data processing system if the data processing system is capable of
producing a hard copy of the perpetual inventory on-site;
(G) hard-copy reports of surrender or destruction of
controlled substances and/or dangerous drugs to an appropriate state
or federal agency;
(H) a hard-copy Schedule V nonprescription register
book;
(I) records of distribution of controlled substances
and/or dangerous drugs to other pharmacies, practitioners, or regis-
trants; and
(J) a hard copy of any notication required by the Texas
Pharmacy Act or these rules, including, but not limited to, the follow-
ing:
(i) reports of theft or signicant loss of controlled
substances to DEA, DPS, and the board;
(ii) notication of a change in pharmacist-in-charge
of a pharmacy; and
(iii) reports of a re or other disaster which may af-
fect the strength, purity, or labeling of drugs, medications, devices, or
other materials used in the diagnosis or treatment of injury, illness, and
disease.
(6) Permission to maintain central records. Any pharmacy
that uses a centralized recordkeeping system for invoices and nancial
data shall comply with the following procedures.
(A) Controlled substance records. Invoices and nan-
cial data for controlled substances may be maintained at a central loca-
tion provided the following conditions are met.
(i) Prior to the initiation of central recordkeeping,
the pharmacy submits written notication by registered or certied mail
to the divisional director of the Drug Enforcement Administration as
required by the Code of Federal Regulations, Title 21, §1304(a), and
submits a copy of this written notication to the Texas State Board of
Pharmacy. Unless the registrant is informed by the divisional direc-
tor of the Drug Enforcement Administration that permission to keep
central records is denied, the pharmacy may maintain central records
commencing 14 days after receipt of notication by the divisional di-
rector.
(ii) The pharmacy maintains a copy of the notica-
tion required in this subparagraph.
(iii) The records to be maintained at the central
record location shall not include executed DEA order forms, prescrip-
tion drug orders, or controlled substance inventories, which shall be
maintained at the pharmacy.
(B) Dangerous drug records. Invoices and nancial
data for dangerous drugs may be maintained at a central location.
(C) Access to records. If the records are kept on micro-
lm, computer media, or in any form requiring special equipment to
render the records easily readable, the pharmacy shall provide access
to such equipment with the records.
(D) Delivery of records. The pharmacy agrees to de-
liver all or any part of such records to the pharmacy location within
two business days of written request of a board agent or any other au-
thorized ofcial.
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(7) Condentiality.
(A) A pharmacist shall provide adequate security of
prescription drug orders, medication orders, and patient medication
records to prevent indiscriminate or unauthorized access to conden-
tial health information.
(B) Condential records are privileged and may be re-
leased only to:
(i) the patient or the patient’s agent;
(ii) a practitioner or another pharmacist if, in the
pharmacist’s professional judgement, the release is necessary to
protect the patient’s health and well being;
(iii) the board or to a person or another state or fed-
eral agency authorized by law to receive the condential record;
(iv) a law enforcement agency engaged in investiga-
tion of a suspected violation of Chapter 481 or 483, Health and Safety
Code, or the Comprehensive Drug Abuse Prevention and Control Act
of 1970 (21 U.S.C. Section 801 et seq.);
(v) a person employed by a state agency that licenses
a practitioner, if the person is performing the person’s ofcial duties;
or
(vi) an insurance carrier or other third party payor
authorized by a patient to receive such information.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
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SUBCHAPTER E. CLINIC PHARMACY
(CLASS D)
22 TAC §291.92
The Texas State Board of Pharmacy adopts amendments to
§291.92, concerning Personnel without changes to the pro-
posed text as published in the June 15, 2007, issue of the Texas
Register (32 TexReg 3493).
The amendments clarify the responsibilities of owners of Class
D pharmacies
No comments were received regarding the proposal.
The amendments are adopted under §551.002 and §554.051 of
the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569,
Texas Occupations Code). The Board interprets §551.002 as
authorizing the agency to protect the public through the effective
control and regulation of the practice of pharmacy. The Board
interprets §554.051(a) as authorizing the agency to adopt rules
for the proper administration and enforcement of the Act.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas State Board of Pharmacy
Effective date: September 18, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
SUBCHAPTER F. NON-RESIDENT
PHARMACY (CLASS E)
22 TAC §291.104, §291.105
The Texas State Board of Pharmacy adopts amendments to
§291.104, concerning Operational Standards and §291.105,
concerning Records with changes to the proposed text as
published in the June 15, 2007, issue of the Texas Register (32
TexReg 3493). The changes to the sections are described in
this preamble.
The amendments to §291.104 update references to other rules
in this chapter and the amendments to §291.105 require phar-
macies to provide the board or its representative with records in
electronic format, if the records are maintained in an electronic
format.
NACDS commented that the amendments to §291.105, requir-
ing pharmacies to provide the Board or its representatives with
records in electronic format, would increase costs to pharmacies
and would expend hours trying to adapt the pharmacies com-
puter system to meet the Board’s needed format. The Board
amended the proposed language to reect that the records must
be provided in a mutually agreeable format.
The amendments are adopted under §551.002 and §554.051 of
the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569,
Texas Occupations Code). The Board interprets §551.002 as
authorizing the agency to protect the public through the effective
control and regulation of the practice of pharmacy. The Board
interprets §554.051(a) as authorizing the agency to adopt rules
for the proper administration and enforcement of the Act.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
§291.104. Operational Standards.
(a) Licensing requirements.
(1) A Class E pharmacy shall register annually or bienni-
ally with the board on a pharmacy license application provided by the
board.
(2) On initial application, the pharmacy shall follow the
procedures specied in §291.1 of this title (relating to Pharmacy Li-
cense Application) and the provide the following additional informa-
tion specied in §560.052(c) and (f) of the Act (relating to Qualica-
tions):
(A) evidence that the applicant holds a pharmacy li-
cense, registration, or permit issued by the state in which the pharmacy
is located;
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(B) the name of the owner and pharmacist-in-charge of
the pharmacy for service of process;
(C) evidence of the applicant’s ability to provide to the
board a record of a prescription drug order dispensed by the applicant
to a resident of this state not later than 72 hours after the time the board
requests the record;
(D) an afdavit by the pharmacist-in-charge which
states that the pharmacist has read and understands the laws and rules
relating to a Class E pharmacy;
(E) proof of creditworthiness; and
(F) an inspection report issued not more than two years
before the date the license application is received and conducted by
the pharmacy licensing board in the state of the pharmacy’s physical
location.
(i) A Class E pharmacy may submit an inspection
report issued by an entity other than the pharmacy licensing board of the
state in which the pharmacy is physically located if the state’s licensing
board does not conduct inspections as follows:
(I) an individual approved by the board who is
not employed by the pharmacy but acting as a consultant to inspect the
pharmacy;
(II) an agent of the National Association of
Boards of Pharmacy;
(III) an agent of another State Board of Phar-
macy; or
(IV) an agent of an accrediting body, such as the
Joint Commission on Accreditation of Healthcare Organizations.
(ii) The inspection must be substantively equivalent
to an inspection conducted by the board.
(3) On renewal of a license, the pharmacy shall complete
the renewal application provided by the board and, as specied in
§561.031 of the Act, provide an inspection report issued not more
than three years before the date the renewal application is received
and conducted by the pharmacy licensing board in the state of the
pharmacy’s physical location.
(A) A Class E pharmacy may submit an inspection re-
port issued by an entity other than the pharmacy licensing board of the
state in which the pharmacy is physically located if the state’s licensing
board does not conduct inspections as follows:
(i) an individual approved by the board who is not
employed by the pharmacy but acting as a consultant to inspect the
pharmacy;
(ii) an agent of the National Association of Boards
of Pharmacy;
(iii) an agent of another State Board of Pharmacy; or
(iv) an agent of an accrediting body, such as the Joint
Commission on Accreditation of Healthcare Organizations.
(B) The inspection must be substantively equivalent to
an inspection conducted by the board.
(4) A Class E pharmacy which changes ownership shall no-
tify the board within ten days of the change of ownership and apply for
a new and separate license as specied in §291.3 of this title (relating
to Required Notications).
(5) A Class E pharmacy which changes location and/or
name shall notify the board within ten days of the change and le for
an amended license as specied in §291.3 of this title.
(6) A Class E pharmacy owned by a partnership or corpo-
ration which changes managing ofcers shall notify the board in writ-
ing of the names of the new managing ofcers within ten days of the
change, following the procedures in §291.3 of this title.
(7) A Class E pharmacy shall notify the board in writing
within ten days of closing.
(8) A separate license is required for each principal place
of business and only one pharmacy license may be issued to a specic
location.
(9) A fee as specied in §291.6 of this title (relating to Phar-
macy License Fees) will be charged for the issuance and renewal of a
license and the issuance of an amended license.
(10) The board may grant an exemption from the licensing
requirements of this Act on the application of a pharmacy located in a
state of the United States other than this state that restricts its dispensing
of prescription drugs or devices to residents of this state to isolated
transactions.
(11) A Class E pharmacy engaged in the centralized dis-
pensing of prescription drug or medication orders shall comply with the
provisions of §291.125 of this title (relating to Centralized Prescription
Dispensing).
(12) A Class E pharmacy engaged in central processing of
prescription drug or medication orders shall comply with the provisions
of §291.123 of this title (relating to Central Prescription or Medication
Order Processing).
(13) A Class E (Non-Resident) pharmacy engaged in the
compounding of non-sterile preparations shall comply with the provi-
sions of §291.131 of this title (relating to Pharmacies Compounding
Non-Sterile Preparations).
(14) A Class E (Non-Resident) pharmacy engaged in the
compounding of sterile preparations shall comply with the provisions
of §291.133 of this title (relating to Pharmacies Compounding Sterile
Preparations).
(b) Prescription dispensing and delivery.
(1) General.
(A) All prescription drugs and/or devices shall be dis-
pensed and delivered safely and accurately as prescribed.
(B) The pharmacy shall maintain adequate storage or
shipment containers and use shipping processes to ensure drug stabil-
ity and potency. Such shipping processes shall include the use of pack-
aging material and devices to ensure that the drug is maintained at an
appropriate temperature range to maintain the integrity of the medica-
tion throughout the delivery process.
(C) The pharmacy shall utilize a delivery system which
is designed to assure that the drugs are delivered to the appropriate
patient.
(D) All Pharmacists shall exercise sound professional
judgment with respect to the accuracy and authenticity of any prescrip-
tion drug order they dispense. If the pharmacist questions the accuracy
or authenticity of a prescription drug order, he/she shall verify the or-
der with the practitioner prior to dispensing.
(E) Prior to dispensing a prescription, pharmacists shall
determine, in the exercise of sound professional judgment, that the pre-
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scription is a valid prescription. A pharmacist may not dispense a pre-
scription drug if the pharmacist knows or should have known that the
prescription was issued on the basis of an Internet-based or telephonic
consultation without a valid patient-practitioner relationship.
(F) Subparagraph (E) of this paragraph does not pro-
hibit a pharmacist from dispensing a prescription when a valid pa-
tient-practitioner relationship is not present in an emergency situation
(e.g. a practitioner taking calls for the patient’s regular practitioner).
(2) Drug regimen review.
(A) For the purpose of promoting therapeutic appropri-
ateness, a pharmacist shall prior to or at the time of dispensing a pre-
scription drug order, review the patient’s medication record. Such re-
view shall at a minimum identify clinically signicant:




(v) incorrect drug dosage or duration of drug treat-
ment;
(vi) drug-allergy interactions; and
(vii) clinical abuse/misuse.
(B) Upon identifying any clinically signicant condi-
tions, situations, or items listed in subparagraph (A) of this paragraph,
the pharmacist shall take appropriate steps to avoid or resolve the prob-
lem including consultation with the prescribing practitioner. The phar-
macist shall document such occurrences.
(3) Patient counseling and provision of drug information.
(A) To optimize drug therapy, a pharmacist shall com-
municate to the patient or the patient’s agent, information about the
prescription drug or device which in the exercise of the pharmacist’s
professional judgment the pharmacist deems signicant, such as the
following:
(i) the name and description of the drug or device;
(ii) dosage form, dosage, route of administration,
and duration of drug therapy;
(iii) special directions and precautions for prepara-
tion, administration, and use by the patient;
(iv) common severe side or adverse effects or inter-
actions and therapeutic contraindications that may be encountered, in-
cluding their avoidance, and the action required if they occur;
(v) techniques for self monitoring of drug therapy;
(vi) proper storage;
(vii) rell information; and
(viii) action to be taken in the event of a missed dose.
(B) Such communication:
(i) shall be provided with each new prescription
drug order;
(ii) shall be provided for any prescription drug order
dispensed by the pharmacy on the request of the patient or patient’s
agent;
(iii) shall be communicated orally in person unless
the patient or patient’s agent is not at the pharmacy or a specic com-
munication barrier prohibits such oral communication; and
(iv) shall be reinforced with written information.
The following is applicable concerning this written information:
(I) Written information designed for the con-
sumer, such as the USP DI patient information leaets, shall be
provided.
(II) When a compounded product is dispensed,
information shall be provided for the major active ingredient(s), if
available.
(III) For new drug entities, if no written infor-
mation is initially available, the pharmacist is not required to provide
information until such information is available, provided:
(-a-) the pharmacist informs the patient or the
patient’s agent that the product is a new drug entity and written infor-
mation is not available.
(-b-) the pharmacist documents the fact that
no written information was provided; and
(-c-) if the prescription is relled after written
information is available, such information is provided to the patient or
patient’s agent.
(C) Only a pharmacist may orally provide drug infor-
mation to a patient or patient’s agent and answer questions concerning
prescription drugs. Non-pharmacist personnel may not ask questions
of a patient or patient’s agent which are intended to screen and/or limit
interaction with the pharmacist.
(D) If prescriptions are routinely delivered outside the
area covered by the pharmacy’s local telephone service, the pharmacy
shall provide a toll-free telephone line which is answered during nor-
mal business hours to enable communication between the patient and
a pharmacist.
(E) The pharmacist shall place on the prescription con-
tainer or on a separate sheet delivered with the prescription container
in both English and Spanish the local and toll-free telephone number
of the pharmacy and the statement: "Written information about this
prescription has been provided for you. Please read this information
before you take the medication. If you have questions concerning this
prescription, a pharmacist is available during normal business hours
to answer these questions at (insert the pharmacy’s local and toll-free
telephone numbers)."
(F) The provisions of this paragraph do not apply to pa-
tients in facilities where drugs are administered to patients by a person
required to do so by the laws of the state (i.e., nursing homes).
(G) Upon delivery of a rell prescription, a pharmacist
shall ensure that the patient or patient’s agent is offered information
about the relled prescription and that a pharmacist is available to dis-
cuss the patient’s prescription and provide information.
(H) Nothing in this subparagraph shall be construed as
requiring a pharmacist to provide consultation when a patient or pa-
tient’s agent refuses such consultation. The pharmacist shall document
such refusal for consultation.
(c) Generic Substitution. Unless compliance would violate the
pharmacy or drug laws or rules in the state in which the pharmacy is
located:
(1) a pharmacist in a Class E pharmacy may dispense a
generically equivalent drug product if:
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(A) the generic product costs the patient less than the
prescribed drug product;
(B) the patient does not refuse the substitution; and
(C) the prescribing practitioner authorizes the substitu-
tion of a generically equivalent product; or
(D) the practitioner or practitioner’s agent does not
clearly indicate that the oral or electronic prescription drug order shall
be dispensed as ordered; and
(2) Pharmacists shall use as a basis for the determination
of generic equivalency as dened in the Subchapter A, Chapter 562 of
the Act, the following.
(A) For drugs listed in the publication, pharmacists
shall use Approved Drug Products with Therapeutic Equivalence
Evaluations (Orange Book) and current supplements published by
the Federal Food and Drug Administration, within the limitations
stipulated in that publication, to determine generic equivalency. Phar-
macists may only substitute products that are rated therapeutically
equivalent in the Orange Book and have an "A" rating. "A" rated drug
products include but are not limited to, those designated AA, AB, AN,
AO, AP, or AT in the Orange Book.
(B) For drugs not listed in the Orange Book, pharma-
cists shall use their professional judgment to determine generic equiv-
alency.
(3) The pharmacy must include on the prescription order
form completed by the patient or the patient’s agent information that
clearly and conspicuously:
(A) states that if a less expensive generically equiva-
lent drug is available for the brand prescribed, the patient or the pa-
tient’s agent may choose between the generically equivalent drug and
the brand prescribed; and
(B) allows the patient or the patient’s agent to indicate
the choice of the generically equivalent drug or the brand prescribed.
(d) Therapeutic Drug Interchange. A switch to a drug provid-
ing a similar therapeutic response to the one prescribed shall not be
made without prior approval of the prescribing practitioner. This sub-
section does not apply to generic substitution. For generic substitution,
see the requirements of subsection (c) of this section.
(1) The patient shall be notied of the therapeutic drug in-
terchange prior to, or upon delivery, of the dispensed prescription to
the patient. Such notication shall include:
(A) a description of the change;
(B) the reason for the change;
(C) whom to notify with questions concerning the
change; and
(D) instructions for return of the drug if not wanted by
the patient.
(2) The pharmacy shall maintain documentation of patient
notication of therapeutic drug interchange which shall include:
(A) the date of the notication;
(B) the method of notication;
(C) a description of the change; and
(D) the reason for the change.
(e) Transfer of Prescription Drug Order Information. Unless
compliance would violate the pharmacy or drug laws or rules in the
state in which the pharmacy is located, a pharmacist in a Class E phar-
macy may not refuse to transfer prescriptions to another pharmacy that
is making the transfer request on behalf of the patient.
(f) Prescriptions for Schedule II controlled substances. Un-
less compliance would violate the pharmacy or drug laws or rules in
the state in which the pharmacy is located, a pharmacist in a Class E
pharmacy who dispenses a prescription for a Schedule II controlled
substance issued on a Texas Ofcial Prescription Form shall:
(1) mail a copy of the form to the Texas Department of
Public Safety, Electronic Prescription Section, P.O. Box 4087, Austin,
Texas 78773 within 30 days of dispensing; or
(2) electronically send the prescription information to the
Texas Department of Public Safety per their requirements for electronic
submissions within 30 days of dispensing.
§291.105. Records.
(a) Maintenance of records.
(1) Every record required to be kept under this section shall
be:
(A) kept by the pharmacy and be available, for at least
two years from the date of such record, for inspecting and copying
by the board or its representative, and other authorized local, state, or
federal law enforcement agencies; and
(B) supplied by the pharmacy within 72 hours, if re-
quested by an authorized agent of the Texas State Board of Pharmacy.
If the pharmacy maintains the records in an electronic format, the re-
quested records must be provided in a mutually agreeable electronic
format if specically requested by the board or its representative. Fail-
ure to provide the records set out in this section, either on site or within
72 hours, constitutes prima facie evidence of failure to keep and main-
tain records in violation of the Act.
(2) Records, except when specically required to be main-
tained in original or hard-copy form, may be maintained in an alterna-
tive data retention system, such as a data processing system or direct
imaging system provided;
(A) the records maintained in the alternative system
contain all of the information required on the manual record; and
(B) the data processing system is capable of producing
a hard copy of the record upon the request of the board, its represen-
tative, or other authorized local, state, or federal law enforcement or
regulatory agencies.
(b) Civil litigation and complaint records. A Class E pharmacy
shall keep a permanent record of:
(1) any civil litigation commenced against the pharmacy
by a Texas resident; and
(2) complaints that arise out of a prescription for a Texas
resident lost during delivery.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 29, 2007.
TRD-200703988
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Executive Director/Secretary
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SUBCHAPTER G. SERVICES PROVIDED BY
PHARMACIES
22 TAC §§291.120, 291.121, 291.123, 291.125, 291.127,
291.129, 291.131, 291.133
The Texas State Board of Pharmacy adopts new §291.120,
concerning General; §291.121, concerning Remote Pharmacy
Services; §291.123, concerning Central Prescription Drug or
Medication Order Processing; §291.125, concerning Central-
ized Prescription Dispensing; §291.127, concerning Emergency
Remote Pharmacy License; §291.129, concerning Satellite
Pharmacy; §291.131, concerning Pharmacies Compounding
Non-Sterile Preparations; and §291.133, concerning Phar-
macies Compounding Sterile Preparations. New §§291.20,
291.121, 291.123, 291.125, 291.127, and 291.129 are adopted
without changes to the proposed text as published in the June
15, 2007, issue of the Texas Register (32 TexReg 3494). New
§291.131 and §291.133 are adopted with changes to the pro-
posed text and the changes are described in this preamble.
New §291.120 provides the purpose of the new subchapter to
reorganize rules for all pharmacy services which were previ-
ously located in the rules pertaining to specic classes of phar-
macy in a central location. New §291.121 contains the require-
ments for remote pharmacy services previously found in §291.20
which is adopted for repeal published elsewhere in this issue of
the Texas Register. New §291.123 provides the requirements
for Central Prescription Drug Order or Medication Order Pro-
cessing previously found in §291.38 which is adopted for repeal
published elsewhere in this issue of the Texas Register. New
§291.125 provides the requirements for Centralized Prescrip-
tion Dispensing previously found in §291.37 which is adopted
for repeal published elsewhere in this issue of the Texas Reg-
ister. New §291.127 provides the requirements for Emergency
Remote Pharmacy License previously found in §291.13 which is
adopted for repeal published elsewhere in this issue of the Texas
Register. New §§291.121, 291.123, 291.125, and 291.127 con-
tain formatting and grammar corrections, and require pharma-
cies to provide the board or its representative with records in
electronic format, if the records are maintained in an electronic
format.
New §291.129 provides rules for a new class of pharmacy
regarding the provision of pharmacy services by a satellite
pharmacy owned by a Class A or Class C pharmacy, in a
location that is not at the same location as a Class A or Class
C pharmacy. New §291.131 outlines operating standards for
pharmacies that compound non-sterile preparations, implement
the recommendations of the Texas State Board of Pharmacy’s
appointed Task Force on Compounding (Task Force), and
incorporate many of the provisions included in the United States
Pharmacopeia (USP) General Chapter 795 (Pharmaceutical
Compounding (Non-Sterile Preparations)) in accordance with
Senate Bill 492 passed during the 79th Regular Session of
the Texas Legislature regarding compounding. New §291.133
outlines operating standards for pharmacies that compound
sterile preparations, implement the recommendations of the
Texas State Board of Pharmacy’s appointed Task Force on
Compounding (Task Force), and incorporate provisions included
in the United States Pharmacopeia (USP) General Chapter
797 (Pharmaceutical Compounding (Sterile Preparations)) in
accordance with Senate Bill 492 passed during the 79th Regular
Session of the Texas Legislature regarding compounding.
The Texas Society of Health-System Pharmacists (TSHP) com-
mented on §291.121 with regard to the applications for pharma-
cies using automated pharmacy systems. TSHP recommended
that the resubmittal of applications every two years was not nec-
essary and that Class C pharmacies providing remote order en-
try to facilities under common ownership should be exempted
from the application requirements. The Board disagrees with
these comments because the amendments do not apply to Class
C pharmacies as interpreted by TSHP.
The National Association of Chain Drug Stores (NACDS) com-
mented that §291.129, that requires a prescription entered into a
pharmacy’s data processing system be veried by a pharmacist
at the time of data entry, would be burdensome and disruptive
to pharmacy workow. The Board disagrees with this comment
and believes that prescriptions must be checked at the time of
data entry in order to ensure that patients receive accurately dis-
pensed prescriptions.
TSHP commented that the denition of hot water in §291.131
should be consistent with the requirements used for hospital
construction standards by the Texas Department of State Health
Services (DSHS). DSHS requires hot water to be between 105
and 120 degrees Fahrenheit. The Board agrees with this com-
ment and amended the proposed language to reect that hot
water be a minimum of 105 degrees Fahrenheit.
NACDS commented that §291.131(c)(4) should be changed to
allow pharmacists to certify the required training for individuals
involved in the compounding of non-sterile preparations. The
Board disagrees with this comment and requires the documen-
tation of training to ensure that individual involved in compound-
ing are adequately trained.
TSHP provided a general comment regarding §291.133 and
the references to continuing education provided by "approved"
providers. The more contemporary term is "accredited"
providers. The Board agrees with the comment and amended
the rules as necessary to reect the change.
TSHP commented that the denition of buffer area found in
§291.133(a)(11) be amended to include buffer zone. The Board
agrees with this comment and amended the rules to reect the
change.
TSHP commented that the denition of clean room found in
§291.133(a)(12) be amended to include controlled area. The
Board agrees with this comment and amended the rules to
reect the change.
TSHP commented that the denition of hot water found in
§291.133(a)(21) should be consistent with the requirements
used for hospital construction standards by the Texas Depart-
ment of State Health Services (DSHS). DSHS requires hot
water to be between 105 and 120 degrees Fahrenheit. The
Board agrees with this comment and amended the proposed
language to reect that hot water be a minimum of 105 degrees
Fahrenheit.
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TSHP commented that the denition of Preparation or Com-
pounded Sterile Preparation be amended by deleting the
statement "the article may or may not contain sterile products."
The Board agrees with this comment and deleted the statement
from the rule.
TSHP commented that the word "products" in the denition of
quality assurance in §291.133(a)(36) be changed to "prepara-
tions" to be consistent with the rest of the rule. The board agrees
with this comment and amended the rules to reect the change.
TSHP commented that the reference to pharmacist found in
§291.133(c)(1)(B)(II) should be changed to personnel which
would also include pharmacy technicians and pharmacy tech-
nician trainees. The Board agrees with this comment and
amended the rules to reect the change.
TSHP commented that the word "continuing" education found in
§291.133(c)(1)(B)(II) and (4)(D) be deleted. The Board agrees
with this comment and amended the rules to reect the change.
Apothecure commented that §291.133(c)(2)(E) be change to re-
quire pharmacists to be available during normal business hours
and not 24 hours a day. The Board disagrees with this comment
and require that for patient safety, a pharmacist must be avail-
able by phone or pager in order to assist patients.
U.S. Oncology commented that §291.133(d)(4) be deleted from
the proposed rules. The Board disagrees with this comment in
that it claries the requirements for cytoxic drugs and these are
not considered immediate use drugs based on the denitions.
TSHP commented that the reference to a designated room found
in §291.133(d)(5)(A)(i) be changed to a clean room/controlled
area. The Board agrees with this comment and amended the
rules to reect the change.
U.S. Oncology commented that §291.133(d)(5)(A)(i)(X) should
reference an ante-zoon. The Board agrees with this comment
and amended the rules to reect the change.
U.S. Oncology commented that §291.133(d)(5)(A)(i)(XI)(-c-) be
deleted. The Board agrees with the comment and amended the
rules to reect the change.
TSHP, Texas Oncology, and U.S. Oncology commented that the
requirements for compounding cytotoxic preparations found in
§291.133 were contradictory and should be removed. The Board
agrees with the comment and amended the rules to reect the
change.
TSHP commented that the labeling requirements found in
§291.133(d)(7)(A)(ii) should not be applicable to inpatient
medication orders. The Board agrees with the comment and
amended the rules to reect the change.
TSHP commented that the beyond use date referenced in
§291.133(d)(7)(A)(iii) was not consistent with the denition of
beyond use date found elsewhere in this section. The Board
agrees with the comment and amended the rules to reect the
change.
TSHP commented that §291.133(d)(8) should not apply to
medication orders. The Board agrees with the comment and
amended the rules to reect the change.
TSHP commented that §291.133(d)(9)(B) should not apply to in-
patient medication orders. The Board agrees with the comment
and deleted the requirement.
Stephanie Erwin, R.Ph., commented that the requirement for
non-shedding disposable gowns in §291.133(d)(11)(C)(iv)(III) be
changed to allow for clean and sanitized gowns. The Board
agrees with the comment and amended the rules to allow for
"clean non-shedding" gowns to be used.
Texas Oncology commented on §291.133(d)(11)(C)(iv)(V) with
regard to gloves being required to sterilized with disinfectant
even if the pharmacy is using sterile gloves. The Board agrees
with the comment and amended the rules to not require phar-
macies using sterile gloves use a disinfectant except whenever
non-sterile surfaces are touched.
TSHP commented that the recordkeeping requirements for pa-
tient specic orders should not include medication orders. The
Board agrees with this comment and deleted the reference to
medication orders.
The new rules are adopted under §§551.002, 551.003, 554.001,
554.051, 560.053 of the Texas Pharmacy Act (Chapters 551 -
566 and 568 - 569, Texas Occupations Code). The Board in-
terprets §551.002 as authorizing the agency to protect the pub-
lic through the effective control and regulation of the practice
of pharmacy. The Board interprets §551.003(9) as authorizing
the agency to adopt rules concerning the compounding of pre-
scriptions. The Board interprets §551.003(33) as authorizing the
agency to adopt rules concerning the practice of pharmacy. The
Board interprets §554.001(a) as authorizing the agency to adopt
rules to administer and enforce the Act and rules adopted un-
der the Act as well as enforce other laws relating to the practice
of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and en-
forcement of the Act. The Board interprets §554.051(b) as au-
thorizing the agency to adopt rules concerning the operation of a
licensed pharmacy located in this state applicable to a pharmacy
licensed by the board that is located in another state, if the board
determines the rule is necessary to protect the health and wel-
fare of the citizens of this state. The Board interprets §560.053
as authorizing the agency to adopt rules establishing additional
pharmacy classications.
The statutes affected by the new rules: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
§291.131. Pharmacies Compounding Non-Sterile Preparations.
(a) Purpose. Pharmacies compounding non-sterile prepara-
tions, prepackaging pharmaceutical products and distributing those
products shall comply with all requirements for their specic license
classication and this section. The purpose of this section is to provide
standards for the:
(1) compounding of non-sterile preparations pursuant to a
prescription or medication order for a patient from a practitioner in
Class A (Community), Class C (Institutional), and Class E (Non-resi-
dent) pharmacies;
(2) compounding, dispensing, and delivery of a reasonable
quantity of a compounded non-sterile preparation in a Class A (Com-
munity), Class C (Institutional), and Class E (Non-resident) pharma-
cies to a practitioner’s ofce for ofce use by the practitioner;
(3) compounding and distribution of compounded
non-sterile preparations by a Class A (Community) pharmacy for a
Class C (Institutional) pharmacy; and
(4) compounding of non-sterile preparations by a Class C
(Institutional) pharmacy and the distribution of the compounded prepa-
rations to other Class C (Institutional) pharmacies under common own-
ership.
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(b) Denitions. In addition to the denitions for specic li-
cense classications, the following words and terms, when used in this
section, shall have the following meanings, unless the context clearly
indicates otherwise.
(1) Beyond-use date--The date or time after which the com-
pounded non-sterile preparation shall not be stored or transported or
begin to be administered to a patient. The beyond-use date is deter-
mined from the date or time when the preparation was compounded.
(2) Component--Any ingredient intended for use in the
compounding of a drug preparation, including those that may not
appear in such preparation.
(3) Compounding--The preparation, mixing, assembling,
packaging, or labeling of a drug or device:
(A) as the result of a practitioner’s prescription drug
or medication order, based on the practitioner-patient-pharmacist re-
lationship in the course of professional practice;
(B) for administration to a patient by a practitioner as
the result of a practitioner’s initiative based on the practitioner-patient-
pharmacist relationship in the course of professional practice;
(C) in anticipation of prescription drug or medication
orders based on routine, regularly observed prescribing patterns; or
(D) for or as an incident to research, teaching, or chem-
ical analysis and not for sale or dispensing, except as allowed under
§562.154 or Chapter 563 of the Occupations Code.
(4) Hot water-The temperature of water from the phar-
macy’s sink maintained at a minimum of 105 degrees F (41 degrees
C).
(5) Reasonable quantity--An amount of a compounded
drug that:
(A) does not exceed the amount a practitioner antici-
pates may be used in the practitioner’s ofce or facility before the be-
yond use date of the drug;
(B) is reasonable considering the intended use of the
compounded drug and the nature of the practitioner’s practice; and
(C) for any practitioner and all practitioners as a whole,
is not greater than an amount the pharmacy is capable of compound-
ing in compliance with pharmaceutical standards for identity, strength,
quality, and purity of the compounded drug that are consistent with
United States Pharmacopoeia guidelines and accreditation practices.
(6) SOPs--Standard operating procedures.
(7) USP/NF--The current edition of the United States Phar-
macopeia/National Formulary.
(c) Personnel.
(1) Pharmacist-in-charge. In addition to the responsibili-
ties for the specic class of pharmacy, the pharmacist-in-charge shall
have the responsibility for, at a minimum, the following concerning
non-sterile compounding:
(A) determining that all personnel involved in non-ster-
ile compounding possess the education, training, and prociency nec-
essary to properly and safely perform compounding duties undertaken
or supervised;
(B) determining that all personnel involved in non-ster-
ile compounding obtain continuing education appropriate for the type
of compounding done by the personnel;
(C) assuring that the equipment used in compounding
is properly maintained;
(D) maintaining an appropriate environment in areas
where non-sterile compounding occurs; and
(E) assuring that effective quality control procedures
are developed and followed.
(2) Pharmacists. Special requirements for non-sterile com-
pounding.
(A) All pharmacists engaged in compounding shall:
(i) possess the education, training, and prociency
necessary to properly and safely perform compounding duties under-
taken or supervised; and
(ii) obtain continuing education appropriate for the
type of compounding done by the pharmacist.
(B) A pharmacist shall inspect and approve all compo-
nents, drug product containers, closures, labeling, and any other mate-
rials involved in the compounding process.
(C) A pharmacist shall review all compounding records
for accuracy and conduct in-process and nal checks to ensure that
errors have not occurred in the compounding process.
(D) A pharmacist is responsible for the proper mainte-
nance, cleanliness, and use of all equipment used in the compounding
process.
(3) Pharmacy technicians and pharmacy technician
trainees. All pharmacy technicians and pharmacy technician trainees
engaged in non-sterile compounding shall:
(A) possess the education, training, and prociency
necessary to properly and safely perform compounding duties under-
taken;
(B) obtain continuing education appropriate for the type
of compounding done by the pharmacy technician or pharmacy tech-
nician trainee; and
(C) perform compounding duties under the direct su-
pervision of and responsible to a pharmacist.
(4) Training.
(A) All training activities shall be documented and cov-
ered by appropriate SOPs as outlined in subsection (d)(8)(A) of this
section.
(B) All personnel involved in non-sterile compounding




(A) Non-sterile drug preparations may be compounded
in licensed pharmacies:
(i) upon presentation of a practitioner’s prescription
drug or medication order based on a valid pharmacist/patient/prescriber
relationship;
(ii) in anticipation of future prescription drug or
medication orders based on routine, regularly observed prescribing
patterns; or
(iii) in reasonable quantities for ofce use by a prac-
titioner and for use by a veterinarian.
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(B) Non-sterile compounding in anticipation of future
prescription drug or medication orders must be based upon a history
of receiving valid prescriptions issued within an established pharma-
cist/patient/prescriber relationship, provided that in the pharmacist’s
professional judgment the quantity prepared is stable for the anticipated
shelf time.
(i) The pharmacist’s professional judgment shall be
based on the criteria used to determine a beyond-use date outlined in
paragraph (5)(C) of this subsection.
(ii) Documentation of the criteria used to determine
the stability for the anticipated shelf time must be maintained and be
available for inspection.
(iii) Any preparation compounded in anticipation of
future prescription drug or medication orders shall be labeled. Such
label shall contain:
(I) name and strength of the compounded prepa-
ration or list of the active ingredients and strengths;
(II) facility’s lot number;
(III) beyond-use date as determined by the phar-
macist using appropriate documented criteria as outlined in paragraph
(5)(C) of this subsection; and
(IV) quantity or amount in the container.
(C) Commercially available products may be com-
pounded for dispensing to individual patients provided the following
conditions are met:
(i) the commercial product is not reasonably avail-
able from normal distribution channels in a timely manner to meet pa-
tient’s needs;
(ii) the pharmacy maintains documentation that the
product is not reasonably available due to a drug shortage or unavail-
ability from the manufacturer; and
(iii) the prescribing practitioner has requested that
the drug be compounded as described in subparagraph (D) of this para-
graph.
(D) A pharmacy may not compound preparations that
are essentially copies of commercially available products (e.g., the
preparation is dispensed in a strength that is only slightly different from
a commercially available product) unless the prescribing practitioner
specically orders the strength or dosage form and species why the
patient needs the particular strength or dosage form of the preparation.
The prescribing practitioner shall provide documentation of a patient
specic medical need and the preparation produces a clinically sig-
nicant therapeutic response (e.g. the physician requests an alternate
product due to hypersensitivity to excipients or preservative in the
FDA-approved product, or the physician requests an effective alternate
dosage form) or if the drug product is not commercially available.
The unavailability of such drug product must be documented prior
to compounding. The methodology for documenting unavailability
includes maintaining a copy of the wholesaler’s notication showing
back-ordered, discontinued, or out-of-stock items. This documenta-
tion must be available in hard-copy or electronic format for inspection
by the board.
(E) A pharmacy may enter into an agreement to com-
pound and dispense prescription/medication orders for another phar-
macy provided the pharmacy complies with the provisions of §291.125
of this title (relating to Centralized Prescription Dispensing).
(F) Compounding pharmacies/pharmacists may adver-
tise and promote the fact that they provide non-sterile prescription
compounding services, which may include specic drug products and
classes of drugs.
(G) A pharmacy may not compound veterinary prepa-
rations for use in food producing animals except in accordance with
federal guidelines.
(2) Library. In addition to the library requirements of the
pharmacy’s specic license classication, a pharmacy shall maintain
a current copy, in hard-copy or electronic format, of Chapter 795 of
the USP/NF concerning Pharmacy Compounding Non-Sterile Prepa-
rations.
(3) Environment.
(A) Pharmacies regularly engaging in compounding
shall have a designated and adequate area for the safe and orderly
compounding of non-sterile preparations, including the placement
of equipment and materials. Pharmacies involved in occasional
compounding shall prepare an area prior to each compounding activity
which is adequate for safe and orderly compounding.
(B) Only personnel authorized by the responsible phar-
macist shall be in the immediate vicinity of a drug compounding oper-
ation.
(C) A sink with hot and cold running water, exclusive
of rest room facilities, shall be accessible to the compounding areas
and be maintained in a sanitary condition. Supplies necessary for ade-
quate washing shall be accessible in the immediate area of the sink and
include:
(i) soap or detergent; and
(ii) air-driers or single-use towels.
(D) If drug products which require special precau-
tions to prevent contamination, such as penicillin, are involved in a
compounding operation, appropriate measures, including dedication
of equipment for such operations or the meticulous cleaning of con-
taminated equipment prior to its use for the preparation of other drug
products, must be used in order to prevent cross-contamination.
(4) Equipment and Supplies. The pharmacy shall:
(A) have a Class A prescription balance, or analytical
balance and weights which shall be properly maintained and subject to
periodic inspection by the Texas State Board of Pharmacy; and
(B) have equipment and utensils necessary for the
proper compounding of prescription drug or medication orders. Such
equipment and utensils used in the compounding process shall be:
(i) of appropriate design and capacity, and be oper-
ated within designed operational limits;
(ii) of suitable composition so that surfaces that con-
tact components, in-process material, or drug products shall not be re-
active, additive, or absorptive so as to alter the safety, identity, strength,
quality, or purity of the drug product beyond the desired result;
(iii) cleaned and sanitized immediately prior and af-
ter to each use; and
(iv) routinely inspected, calibrated (if necessary), or
checked to ensure proper performance.
(5) Labeling. In addition to the labeling requirements of
the pharmacy’s specic license classication, the label dispensed or
distributed pursuant to a prescription drug or medication order shall
contain the following.
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(A) The generic name(s) or the ofcial name(s) of the
principal active ingredient(s) of the compounded preparation.
(B) A statement that the preparation has been com-
pounded by the pharmacy. (An auxiliary label may be used on the
container to meet this requirement).
(C) A beyond-use date after which the compounded
preparation should not be used. The beyond-use date shall be deter-
mined as outlined in Chapter 795 of the USP/NF concerning Pharmacy
Compounding Non-Sterile Preparations including the following:
(i) The pharmacist shall consider:
(I) physical and chemical properties of active in-
gredients;
(II) use of preservatives and/or stabilizing
agents;
(III) dosage form;
(IV) storage containers and conditions; and
(V) scientic, laboratory, or reference data from
a peer reviewed source and retained in the pharmacy. The reference
data should follow the same preparation instructions for combining raw
materials and packaged in a container with similar properties.
(ii) In the absence of stability information applicable
for a specic drug or preparation, the following maximum beyond-use
dates are to be used when the compounded preparation is packaged in
tight, light-resistant containers and stored at controlled room tempera-
tures.
(I) Nonaqueous liquids and solid formulations
(Where the manufactured drug product is the source of active ingre-
dient): 25% of the time remaining until the product’s expiration date
or 6 months, whichever is earlier.
(II) Water-containing formulations (Prepared
from ingredients in solid form): Not later than 14 days when refriger-
ated between 2 - 8 degrees Celsius (36 - 46 degrees Fahrenheit).
(III) All other formulations: Intended duration of
therapy or 30 days, whichever is earlier.
(iii) Beyond-use date limits may be exceeded when
supported by valid scientic stability information for the specic com-
pounded preparation.
(6) Written drug information. Written information about
the compounded preparation or its major active ingredient(s) shall be
given to the patient at the time of dispensing. A statement which in-
dicates that the preparation was compounded by the pharmacy must
be included in this written information. If there is no written infor-
mation available, the patient should be advised that the drug has been
compounded and how to contact a pharmacist, and if appropriate the
prescriber, concerning the drug.
(7) Drugs, components, and materials used in non-sterile
compounding.
(A) Drugs used in non-sterile compounding shall be a
USP/NF grade substances manufactured in an FDA-registered facility.
(B) If USP/NF grade substances are not available, or
when food, cosmetics, or other substances are, or must be used, the
substance shall be of a chemical grade in one of the following cate-
gories:
(i) Chemically Pure (CP);
(ii) Analytical Reagent (AR); or
(iii) American Chemical Society (ACS); or
(iv) Food Chemical Codex; or
(C) If a drug, component or material is not purchased
from a FDA-registered facility, the pharmacist shall establish purity
and stability by obtaining a Certicate of Analysis from the supplier
and the pharmacist shall compare the monograph of drugs in a similar
class to the Certicate of Analysis.
(D) A manufactured drug product may be a source of
active ingredient. Only manufactured drugs from containers labeled
with a batch control number and a future expiration date are acceptable
as a potential source of active ingredients. When compounding with
manufactured drug products, the pharmacist must consider all ingre-
dients present in the drug product relative to the intended use of the
compounded preparation.
(E) All components shall be stored in properly labeled
containers in a clean, dry area, under proper temperatures.
(F) Drug product containers and closures shall not
be reactive, additive, or absorptive so as to alter the safety, identity,
strength, quality, or purity of the compounded drug product beyond
the desired result.
(G) Components, drug product containers, and closures
shall be rotated so that the oldest stock is used rst.
(H) Container closure systems shall provide adequate
protection against foreseeable external factors in storage and use that
can cause deterioration or contamination of the compounded drug prod-
uct.
(I) A pharmacy may not compound a preparation that
contains ingredients appearing on a federal Food and Drug Adminis-
tration list of drug products withdrawn or removed from the market for
safety reasons.
(8) Compounding process.
(A) All signicant procedures performed in the com-
pounding area shall be covered by written SOPs designed to ensure
accountability, accuracy, quality, safety, and uniformity in the com-








(viii) storage of compounded preparations.
(B) Any compounded preparation with an ofcial
monograph in the USP/NF shall be compounded, labeled, and pack-
aged in conformity with the USP/NF monograph for the drug.
(C) Any person with an apparent illness or open lesion
that may adversely affect the safety or quality of a drug product being
compounded shall be excluded from direct contact with components,
drug product containers, closures, any materials involved in the com-
pounding process, and drug products until the condition is corrected.
(D) Personnel engaged in the compounding of drug
preparations shall wear clean clothing appropriate to the operation
being performed. Protective apparel, such as coats/jackets, aprons,
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hair nets, gowns, hand or arm coverings, or masks shall be worn
as necessary to protect personnel from chemical exposure and drug
preparations from contamination.
(E) At each step of the compounding process, the phar-
macist shall ensure that components used in compounding are accu-
rately weighed, measured, or subdivided as appropriate to conform to
the formula being prepared.
(9) Quality Assurance.
(A) Initial formula validation. Prior to routine com-
pounding of a non-sterile preparation, a pharmacy shall conduct an
evaluation that shows that the pharmacy is capable of compounding
a product that contains the stated amount of active ingredient(s).
(B) Finished preparation checks. The prescription drug
and medication orders, written compounding procedure, preparation
records, and expended materials used to make compounded non-ster-
ile preparations shall be inspected for accuracy of correct identities and
amounts of ingredients, packaging, labeling, and expected physical ap-
pearance before the non-sterile preparations are dispensed.
(10) Quality Control.
(A) The pharmacy shall follow established quality con-
trol procedures to monitor the quality of compounded drug preparations
for uniformity and consistency such as capsule weight variations, ad-
equacy of mixing, clarity, or pH of solutions. When developing these
procedures, pharmacy personnel shall consider the provisions of Chap-
ter 795, concerning Pharmacy Compounding Non-Sterile Preparations,
Chapter 1075, concerning Good Compounding Practices, and Chapter
1160, concerning Pharmaceutical Calculations in Prescription Com-
pounding contained in the current USP/NF. Such procedures shall be
documented and be available for inspection.
(B) Compounding procedures that are routinely per-
formed, including batch compounding, shall be completed and veried
according to written procedures. The act of verication of a com-
pounding procedure involves checking to ensure that calculations,
weighing and measuring, order of mixing, and compounding tech-
niques were appropriate and accurately performed.
(C) Unless otherwise indicated or appropriate, com-
pounded preparations are to be prepared to ensure that each preparation
shall contain not less than 90.0 percent and not more than 110.0
percent of the theoretically calculated and labeled quantity of active
ingredient per unit weight or volume and not less than 90.0 percent
and not more than 110.0 percent of the theoretically calculated weight
or volume per unit of the preparation.
(e) Records.
(1) Maintenance of records. Every record required by this
section shall be:
(A) kept by the pharmacy and be available, for at least
two years for inspecting and copying by the board or its representative
and to other authorized local, state, or federal law enforcement agen-
cies; and
(B) supplied by the pharmacy within 72 hours, if re-
quested by an authorized agent of the Texas State Board of Pharmacy.
If the pharmacy maintains the records in an electronic format, the re-
quested records must be provided in an electronic format. Failure to
provide the records set out in this section, either on site or within 72
hours, constitutes prima facie evidence of failure to keep and maintain
records in violation of the Act.
(2) Compounding records.
(A) Compounding pursuant to patient specic prescrip-
tion drug or medication orders. Compounding records for all com-
pounded preparations shall be maintained by the pharmacy electron-
ically or manually as part of the prescription drug or medication order,
formula record, formula book, or compounding log and shall include:
(i) the date of preparation;
(ii) a complete formula, including methodology and
necessary equipment which includes the brand name(s) of the raw ma-
terials, or if no brand name, the generic name(s) and name(s) of the
manufacturer(s) of the raw materials and the quantities of each;
(iii) signature or initials of the pharmacist or phar-
macy technician or pharmacy technician trainee performing the com-
pounding;
(iv) signature or initials of the pharmacist respon-
sible for supervising pharmacy technicians or pharmacy technician
trainees and conducting in-process and nal checks of compounded
preparations if pharmacy technicians or pharmacy technician trainees
perform the compounding function;
(v) the quantity in units of nished preparations or
amount of raw materials;
(vi) the container used and the number of units pre-
pared;
(vii) a reference to the location of the following doc-
umentation which may be maintained with other records, such as qual-
ity control records:
(I) the criteria used to determine the beyond-use
date; and
(II) documentation of performance of quality
control procedures. Documentation of the performance of quality
control procedures is not required if the compounding process is done
pursuant to a patient specic order and involves the mixing of two or
more commercially available oral liquids or commercially available
preparations when the nal product is intended for external use.
(B) Compounding records when batch compounding or
compounding in anticipation of future prescription drug or medication
orders.
(i) Master work sheet. A master work sheet shall be
developed and approved by a pharmacist for preparations prepared in
batch. Once approved, a duplicate of the master work sheet shall be
used as the preparation work sheet from which each batch is prepared
and on which all documentation for that batch occurs. The master work
sheet shall contain at a minimum:
(I) the formula;
(II) the components;
(III) the compounding directions;
(IV) a sample label;
(V) evaluation and testing requirements;
(VI) specic equipment used during preparation;
and
(VII) storage requirements.
(ii) Preparation work sheet. The preparation work
sheet for each batch of preparations shall document the following:
(I) identity of all solutions and ingredients and
their corresponding amounts, concentrations, or volumes;
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(II) lot number or each component;
(III) component manufacturer/distributor or suit-
able identifying number;
(IV) container specications;
(V) unique lot or control number assigned to
batch;
(VI) beyond use date of batch-prepared prepara-
tions;
(VII) date of preparation;
(VIII) name, initials, or electronic signature of
the person(s) involved in the preparation;
(IX) name, initials, or electronic signature of the
responsible pharmacist;
(X) nished preparation evaluation and testing
specications, if applicable; and
(XI) comparison of actual yield to anticipated or
theoretical yield, when appropriate.
(f) Ofce Use Compounding and Distribution of Compounded
Preparations to Class C Pharmacies or Veterinarians in Accordance
With §563.054 of the Act.
(1) General.
(A) A pharmacy may dispense and deliver a reasonable
quantity of a compounded preparation to a practitioner for ofce use
by the practitioner in accordance with this subsection.
(B) A Class A (Community) pharmacy is not required
to register or be licensed under Chapter 431, Health and Safety Code,
to distribute non-sterile compounded preparations to a Class C (Insti-
tutional) pharmacy.
(C) A Class C (Institutional) pharmacy is not required
to register or be licensed under Chapter 431, Health and Safety Code, to
distribute non-sterile compounded preparations that the Class C phar-
macy has compounded for other Class C pharmacies under common
ownership.
(D) To dispense and deliver a compounded preparation
under this subsection, a pharmacy must:
(i) verify the source of the raw materials to be used
in a compounded drug;
(ii) comply with applicable United States Pharma-
copoeia guidelines, including the testing requirements, and the Health
Insurance Portability and Accountability Act of 1996 (Pub. L. No.
104-191);
(iii) enter into a written agreement with a practi-
tioner for the practitioner’s ofce use of a compounded preparation;
(iv) comply with all applicable competency and ac-
crediting standards as determined by the board; and
(v) comply with the provisions of this subsection.
(2) Written Agreement. A pharmacy that provides non-
sterile compounded preparations to practitioners for ofce use or to
another pharmacy shall enter into a written agreement with the practi-
tioner or pharmacy. The written agreement shall:
(A) address acceptable standards of practice for a com-
pounding pharmacy and a practitioner and receiving pharmacy that
enter into the agreement including a statement that the compounded
preparations may only be administered to the patient and may not be
dispensed to the patient or sold to any other person or entity except as
authorized by §563.054 of the Act;
(B) require the practitioner or receiving pharmacy to in-
clude on a patient’s chart, medication order, or medication adminis-
tration record the lot number and beyond-use date of a compounded
preparation administered to a patient; and
(C) describe the scope of services to be performed by
the pharmacy and practitioner or receiving pharmacy, including a state-
ment of the process for:
(i) a patient to report an adverse reaction or submit
a complaint; and
(ii) the pharmacy to recall batches of compounded
preparations.
(3) Recordkeeping.
(A) Maintenance of Records.
(i) Records of orders and distribution of non-sterile
compounded preparations to a practitioner for ofce use or to a Class
C (Institutional) pharmacy for administration to a patient shall:
(I) be kept by the pharmacy and be available, for
at least two years from the date of the record, for inspecting and copying
by the board or its representative and to other authorized local, state,
or federal law enforcement agencies;
(II) maintained separately from the records of
products dispensed pursuant to a prescription or medication order; and
(III) supplied by the pharmacy within 72 hours,
if requested by an authorized agent of the Texas State Board of Phar-
macy or its representative. If the pharmacy maintains the records in an
electronic format, the requested records must be provided in an elec-
tronic format. Failure to provide the records set out in this subsection,
either on site or within 72 hours for whatever reason, constitutes prima
facie evidence of failure to keep and maintain records.
(ii) Records may be maintained in an alternative
data retention system, such as a data processing system or direct
imaging system provided the data processing system is capable of
producing a hard copy of the record upon the request of the board,
its representative, or other authorized local, state, or federal law
enforcement or regulatory agencies.
(B) Orders. The pharmacy shall maintain a record of
all non-sterile compounded preparations ordered by a practitioner for
ofce use or by a Class C pharmacy for administration to a patient. The
record shall include the following information:
(i) date of the order;
(ii) name, address, and phone number of the practi-
tioner who ordered the preparation and if applicable, the name, address
and phone number of the Class C pharmacy ordering the preparation;
and
(iii) name, strength, and quantity of the preparation
ordered.
(C) Distributions. The pharmacy shall maintain a
record of all non-sterile compounded preparations distributed pursuant
to an order to a practitioner for ofce use or by a Class C pharmacy
for administration to a patient. The record shall include the following
information:
(i) date the preparation was compounded;
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(ii) date the preparation was distributed;
(iii) name, strength and quantity in each container of
the preparation;
(iv) pharmacy’s lot number;
(v) quantity of containers shipped; and
(vi) name, address, and phone number of the practi-
tioner or Class C pharmacy to whom the preparation is distributed.
(D) Audit Trail.
(i) The pharmacy shall store the order and distribu-
tion records of preparations for all non-sterile compounded prepara-
tions ordered by and or distributed to a practitioner for ofce use or by
a Class C pharmacy for administration to a patient in such a manner as
to be able to provide a audit trail for all orders and distributions of any
of the following during a specied time period.
(I) any strength and dosage form of a preparation
(by either brand or generic name or both);
(II) any ingredient;
(III) any lot number;
(IV) any practitioner;
(V) any facility; and
(VI) any pharmacy, if applicable.
(ii) The audit trail shall contain the following infor-
mation:
(I) date of order and date of the distribution;
(II) practitioner’s name, address, and name of the
Class C pharmacy, if applicable;
(III) name, strength and quantity of the prepara-
tion in each container of the preparation;
(IV) name and quantity of each active ingredient;
(V) quantity of containers distributed; and
(VI) pharmacy’s lot number;
(4) Labeling. The pharmacy shall afx a label to the prepa-
ration containing the following information:
(A) name, address, and phone number of the com-
pounding pharmacy
(B) the statement: "For Institutional or Ofce Use
Only--Not for Resale"; or if the preparation is distributed to a veteri-
narian the statement: "Compounded Preparation";
(C) name and strength of the preparation or list of the
active ingredients and strengths;
(D) pharmacy’s lot number;
(E) beyond-use date as determined by the pharmacist
using appropriate documented criteria;
(F) quantity or amount in the container;
(G) appropriate ancillary instructions, such as storage
instructions or cautionary statements, including hazardous drug warn-
ing labels where appropriate; and
(H) device-specic instructions, where appropriate.
(g) Recall Procedures.
(1) The pharmacy shall have written procedure for the re-
call of any compounded non-sterile preparations provided to a patient,
to a practitioner for ofce use, or to a pharmacy for administration. The
recall procedures shall require:
(A) notication to each practitioner, facility, and/or
pharmacy to which the preparation was distributed;
(B) notication to each patient to whom the preparation
was dispensed;
(C) quarantine of the product if there is a suspicion of
harm to a patient; and
(D) a recall if there is probable or conrmed harm to a
patient.
(2) If the pharmacy identies a suspicion of, probable, or
conrmed harm to a patient, the pharmacy shall immediately notify and
provide information as required by the board to the following:
(A) the Texas Department of State Health Services,
Drugs and Medical Devices Group, if the preparation is distributed for
ofce use; and
(B) the board.
(3) The board may require a pharmacy to institute a recall
if there is probable or conrmed harm to a patient.
§291.133. Pharmacies Compounding Sterile Preparations.
(a) Purpose. Pharmacies compounding sterile preparations,
prepackaging pharmaceutical products, and distributing those products
shall comply with all requirements for their specic license classica-
tion and this section. The purpose of this section is to provide standards
for the:
(1) compounding of sterile preparations pursuant to a pre-
scription or medication order for a patient from a practitioner in Class
A (Community), Class C (Institutional), and Class E (Non-resident)
pharmacies;
(2) compounding, dispensing, and delivery of a reasonable
quantity of a compounded sterile preparation in a Class A (Commu-
nity), Class C (Institutional), and Class E (Non-resident) pharmacies
to a practitioner’s ofce for ofce use by the practitioner;
(3) compounding and distribution of compounded sterile
preparations by a Class A (Community) pharmacy for a Class C (Insti-
tutional) pharmacy; and
(4) compounding of sterile preparations by a Class C (In-
stitutional) pharmacy and the distribution of the compounded prepara-
tions to other Class C (Institutional) pharmacies under common own-
ership.
(b) Denitions. In addition to the denitions for specic li-
cense classications, the following words and terms, when used in this
section, shall have the following meanings, unless the context clearly
indicates otherwise.
(1) ACPE--Accreditation Council for Pharmacy Educa-
tion.
(2) Airborne particulate cleanliness class--The level of
cleanliness specied by the maximum allowable number of particles
per cubic meter of air as specied in the International Organization of
Standardization (ISO) Classication Air Cleanliness (ISO 14644-1).
For example:
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(A) ISO Class 5 (formerly Class 100) is an atmospheric
environment that contains less than 3,520 particles 0.5 microns in diam-
eter per cubic meter of air (formerly stated as 100 particles 0.5 microns
in diameter per cubic foot of air);
(B) ISO Class 7 (formerly Class 10,000) is an atmo-
spheric environment that contains less than 352,000 particles 0.5 mi-
crons in diameter per cubic meter of air (formerly stated as 10,000 par-
ticles 0.5 microns in diameter per cubic foot of air); and
(C) ISO Class 8 (formerly Class 100,000) is an atmo-
spheric environment that contains less than 3,520,000 particles 0.5 mi-
crons in diameter per cubic meter of air (formerly stated as 100,000
particles 0.5 microns in diameter per cubic foot of air).
(3) Ancillary supplies--Supplies necessary for the prepara-
tion and administration of compounded sterile preparations.
(4) Anteroom--An ISO Class 8 or better area where per-
sonnel may perform hand hygiene and garbing procedures, staging of
components, order entry, labeling, and other high-particulate generat-
ing activities. It is also a transition area that:
(A) provides assurance that pressure relationships are
constantly maintained so that air ows from clean to dirty areas; and
(B) reduces the need for the heating, ventilating and air
conditioning (HVAC) control system to respond to large disturbances.
(5) Aseptic Processing--The technique involving pro-
cedures designed to preclude contamination of drugs, packaging,
equipment, or supplies by microorganisms during preparation.
(6) Automated compounding device--An automated de-
vice that compounds, measures, and/or packages a specied quantity
of individual components in a predetermined sequence for a designated
sterile preparation.
(7) Batch--A specic quantity of a drug or other material
that is intended to have uniform character and quality, within specied
limits, and is produced during a single preparation cycle.
(8) Batch preparation compounding--Compounding of
multiple sterile preparation units, in a single discrete process, by the
same individual(s), carried out during one limited time period. Batch
preparation/compounding does not include the preparation of multiple
sterile preparation units pursuant to patient specic medication orders.
(9) Beyond-use date--The date or time after which the com-
pounded sterile preparation shall not be stored or transported or begin
to be administered to a patient. The beyond-use date is determined
from the date or time the preparation is compounded.
(10) Biological Safety Cabinet, Class II--A ventilated cab-
inet for personnel, product, and environmental protection having an
open front with inward airow for personnel protection, downward
HEPA ltered laminar airow for product protection, and HEPA l-
tered exhausted air for environmental protection.
(11) Buffer Area, Buffer or Core Room, Buffer or Clean
Room Areas, Buffer Room Area, Buffer or Clean Area, or Buffer Zone-
-An ISO Class 7 area where the primary engineering control area is
physically located. Activities that occur in this area include the prepa-
ration and staging of components and supplies used when compound-
ing sterile preparations.
(12) Clean room or controlled area--A room in which the
concentration of airborne particles is controlled to meet a specied air-
borne particulate cleanliness class. Microorganisms in the environment
are monitored so that a microbial level for air, surface, and personnel
gear are not exceeded for a specied cleanliness class.
(13) Component--Any ingredient intended for use in the
compounding of a drug preparation, including those that may not ap-
pear in such preparation.
(14) Compounding--The preparation, mixing, assembling,
packaging, or labeling of a drug or device:
(A) as the result of a practitioner’s prescription drug or
medication order based on the practitioner-patient-pharmacist relation-
ship in the course of professional practice;
(B) for administration to a patient by a practitioner as
the result of a practitioner’s initiative based on the practitioner-patient-
pharmacist relationship in the course of professional practice;
(C) in anticipation of prescription drug or medication
orders based on routine, regularly observed prescribing patterns; or
(D) for or as an incident to research, teaching, or chem-
ical analysis and not for sale or dispensing, except as allowed under
§562.154 or Chapter 563 of the Occupations Code.
(15) Compounding Aseptic Isolator--A form of barrier iso-
lator specically designed for compounding pharmaceutical ingredi-
ents or preparations. It is designed to maintain an aseptic compound-
ing environment within the isolator throughout the compounding and
material transfer processes. Air exchange into the isolator from the sur-
rounding environment shall not occur unless it has rst passed through
a microbial retentive lter (HEPA minimum).
(16) Critical Area--A critical area is an ISO Class 5 envi-
ronment.
(17) Critical Sites--Sterile ingredients of compounded ster-
ile preparations and locations on devices and components used to pre-
pare, package, and transfer compounded sterile preparations that pro-
vide opportunity for exposure to contamination.
(18) Cytotoxic--A pharmaceutical that has the capability of
killing living cells.
(19) Device--An instrument, apparatus, implement, ma-
chine, contrivance, implant, in-vitro reagent, or other similar or related
article, including any component part or accessory, that is required
under federal or state law to be ordered or prescribed by a practitioner.
(20) Disinfectant--A disinfectant is an agent that frees from
infection, usually a chemical agent but sometimes a physical one, and
that destroys disease-causing pathogens or other harmful microorgan-
isms but may not kill bacterial spores. It refers to substances applied
to inanimate objects.
(21) Hot water--The temperature of water from the phar-
macy’s sink maintained at a minimum of 105 degrees F (41 degrees
C).
(22) HVAC--Heating, ventilation, and air conditioning.
(23) Immediate use--A sterile preparation that is not pre-
pared according to USP 797 standards (i.e. outside the pharmacy and
most likely not by pharmacy personnel) which shall be stored for no
longer than one hour after completion of the preparation.
(24) IPA--Isopropyl alcohol (2-propanol).
(25) Media-Fill Test--A media-ll test is used to qualify
aseptic technique of compounding personnel or processes and to ensure
that the processes used are able to produce sterile preparation without
microbial contamination. During this test, a microbiological growth
medium such as Soybean--Casein Digest Medium (SCDM) is substi-
tuted for the actual drug product to simulate admixture compounding.
The issues to consider in the development of a media-ll test are the
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following: media-ll procedures, media selection, ll volume, incuba-
tion, time and temperature, inspection of lled units, documentation,
interpretation of results, and possible corrective actions required.
(26) Multiple-Dose Container--A multiple-unit container
for articles or preparations intended for potential administration only
and usually contains antimicrobial preservatives. The beyond-use
date for an opened or entered (e.g., needle-punctured) multiple-dose
container with antimicrobial preservatives is 28 days, unless otherwise
specied by the manufacturer.
(27) Negative Pressure Room--A room that is at a lower
pressure compared to adjacent spaces and, therefore, the net ow of air
is into the room.
(28) Ofce use--The administration of a compounded drug
to a patient by a practitioner in the practitioner’s ofce or by the practi-
tioner in a health care facility or treatment setting, including a hospital,
ambulatory surgical center, or pharmacy in accordance with Chapter
562 of the Act, or for administration or provision by a veterinarian in
accordance with §563.054 of the Act.
(29) Pharmacy Bulk Package--A container of a sterile
preparation for potential use that contains many single doses. The
contents are intended for use in a pharmacy admixture program and
are restricted to the preparation of admixtures for infusion or, through
a sterile transfer device, for the lling of empty sterile syringes. The
closure shall be penetrated only one time after constitution with a
suitable sterile transfer device or dispensing set, which allows mea-
sured dispensing of the contents. The pharmacy bulk package is to be
used only in a suitable work area such as a laminar ow hood (or an
equivalent clean air compounding area).
(30) Prepackaging--The act of repackaging and relabeling
quantities of drug products from a manufacturer’s original container
into unit dose packaging or a multiple dose container for distribution
within a facility licensed as a Class C pharmacy or to other pharmacies
under common ownership for distribution within those facilities. The
term as dened does not prohibit the prepackaging of drug products for
use within other pharmacy classes.
(31) Preparation or Compounded Sterile Preparation--A
sterile admixture compounded in a licensed pharmacy or other health-
care-related facility pursuant to the order of a licensed prescriber.
(32) Primary Engineering Control--A device or room that
provides an ISO Class 5 environment for the exposure of critical sites
when compounding sterile preparations. Such devices include, but may
not be limited to, laminar airow workbenches, biological safety cabi-
nets, and compounding aseptic isolators.
(33) Product--A product is a commercially manufactured
sterile drug or nutrient that has been evaluated for safety and efcacy
by the U.S. Food and Drug Administration (FDA). Products are accom-
panied by full prescribing information, which is commonly known as
the FDA-approved manufacturer’s labeling or product package insert.
(34) Positive Control--A quality assurance sample pre-
pared to test positive for microbial growth.
(35) Positive Pressure Room--A room that is at a higher
pressure compared to adjacent spaces and, therefore, the net airow is
out of the room.
(36) Quality assurance--The set of activities used to ensure
that the process used in the preparation of sterile drug preparations lead
to preparations that meet predetermined standards of quality.
(37) Quality control--The set of testing activities used to
determine that the ingredients, components (e.g., containers), and nal
compounded sterile preparations prepared meet predetermined require-
ments with respect to identity, purity, non-pyrogenicity, and sterility.
(38) Reasonable quantity--An amount of a compounded
drug that:
(A) does not exceed the amount a practitioner antici-
pates may be used in the practitioner’s ofce or facility before the be-
yond use date of the drug;
(B) is reasonable considering the intended use of the
compounded drug and the nature of the practitioner’s practice; and
(C) for any practitioner and all practitioners as a whole,
is not greater than an amount the pharmacy is capable of compound-
ing in compliance with pharmaceutical standards for identity, strength,
quality, and purity of the compounded drug that are consistent with
United States Pharmacopoeia guidelines and accreditation practices.
(39) Single-dose container--A container intended for a
single use, other than single-dose vials and single-dose large volume
potential solutions. Examples of single-dose containers include
pre-lled syringes, cartridges, and fusion-sealed containers without
preservatives.
(40) Single-dose vial--A vial intended for a single use. Ex-
ceptions to this denition would be single dose vials routinely used
to compound total potential nutrition (TPN) preparations (e.g., sodium
chloride, sodium acetate, sodium phosphate, potassium chloride, potas-
sium acetate, potassium phosphate, calcium glucontae, magnesium sul-
fate, multivitamin for injection, multi-trace elements, ascorbic acid,
folic acid, heparin, phytonadione, l-carnitine, cysteine, selenium, in-
jectable zinc).
(41) Single-dose large volume parenteral (LVP) solution-
-LVP solutions (i.e., containers of solution of at least 1000 mL) rou-
tinely used for compounding sterile TPN preparations or for batch com-
pounding (e.g., sterile water for injection (SWFI); 5%, 10%, and 70%
dextrose in SWFI; 0.9% sodium chloride; 0.45% sodium chloride; 5%
dextrose/0.9% sodium chloride; 5% dextrose/0.45% sodium chloride).
(42) SOPs--Standard operating procedures.
(43) Terminal Sterilization--The application of a lethal
process, e.g., steam under pressure or autoclaving, to sealed nal
preparation containers for the purpose of achieving a predetermined
sterility assurance level of usually less than 106, i.e., or a probability
of less than one in one million of a non-sterile unit.




(A) General. The pharmacy shall have a pharmacist-
in-charge in compliance with the specic license classication of the
pharmacy.
(B) Responsibilities. In addition to the responsibilities
for the specic class of pharmacy, the pharmacist-in-charge shall have
the responsibility for, at a minimum, the following concerning the com-
pounding of sterile preparations:
(i) developing a system to ensure that all pharmacy
personnel responsible for compounding and/or supervising the com-
pounding of sterile preparations within the pharmacy receive appropri-
ate education and training and competency evaluation;
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(ii) determining that all personnel involved in com-
pounding sterile preparations obtain continuing education appropriate
for the type of compounding done by the personnel;
(iii) supervising a system to ensure appropriate pro-
curement of drugs and devices and storage of all pharmaceutical mate-
rials including pharmaceuticals, components used in the compounding
of sterile preparations, and drug delivery devices;
(iv) ensuring that the equipment used in compound-
ing is properly maintained;
(v) developing a system for the disposal and distri-
bution of drugs from the pharmacy;
(vi) developing a system for bulk compounding or
batch preparation of drugs;
(vii) developing a system for the compounding,
sterility assurance, quality assurance, and quality control of sterile
preparations; and
(viii) if applicable, ensuring that the pharmacy has a
system to dispose of hazardous waste in a manner so as not to endanger
the public health.
(2) Pharmacists. Special requirements for compounding
sterile preparations.
(A) All pharmacists engaged in compounding sterile
preparations shall:
(i) possess the education, training, and prociency
necessary to properly and safely perform compounding duties under-
taken or supervised; and
(ii) obtain continuing education appropriate for the
type of compounding done by the pharmacist.
(B) A pharmacist shall inspect and approve all compo-
nents, drug preparation containers, closures, labeling, and any other
materials involved in the compounding process.
(C) A pharmacist shall review all compounding records
for accuracy and conduct in-process and nal checks to ensure that
errors have not occurred in the compounding process.
(D) A pharmacist is responsible for the proper mainte-
nance, cleanliness, and use of all equipment used in the compounding
process.
(E) A pharmacist shall be accessible at all times to re-
spond to patients’ and other health professionals’ questions and needs.
Such access may be through a telephone or pager which is answered
24 hours a day.
(3) Pharmacy technicians and pharmacy technician
trainees. Pharmacy technicians and pharmacy technician trainees may
compound sterile preparations provided the pharmacy technicians
and/or pharmacy technician trainees:
(A) have completed the education and training specied
in paragraph (4) of this subsection; and
(B) are supervised by a pharmacist who has completed
the training specied in paragraph (4) of this subsection, conducts in-
process and nal checks, and afxes his or her initials to the appropriate
quality control records.
(4) Special education, training, and evaluation require-
ments for pharmacy personnel compounding or responsible for the
direct supervision of pharmacy personnel compounding sterile prepa-
rations.
(A) General.
(i) All pharmacy personnel preparing sterile prepa-
rations shall receive didactic and experiential training and competency
evaluation through demonstration, testing (written and practical) as
outlined by the pharmacist-in-charge and described in the policy and
procedure or training manual. Such training shall include instruction
and experience in the following areas:
(I) aseptic technique;
(II) critical area contamination factors;
(III) environmental monitoring;
(IV) structure and engineering controls related to
facilities;
(V) equipment and supplies;
(VI) sterile preparation calculations and termi-
nology;
(VII) sterile preparation compounding documen-
tation;
(VIII) quality assurance procedures;
(IX) aseptic preparation procedures including
proper gowning and gloving technique;
(X) handling of cytotoxic and hazardous drugs,
if applicable; and
(XI) general conduct in the controlled area.
(ii) The aseptic technique of each person compound-
ing or responsible for the direct supervision of personnel compound-
ing sterile preparations shall be observed and evaluated as satisfactory
through written and practical tests, and media-ll challenge testing, and
such evaluation documented.
(iii) Although media-ll tests may be incorporated
into the experiential portion of a training program, media-ll tests must
be conducted at each pharmacy where an individual compounds sterile
preparations. No preparation intended for patient use shall be com-
pounded by an individual until the on-site media-ll tests test indicates
that the individual can competently perform aseptic procedures, ex-
cept that a pharmacist may temporarily compound sterile preparations
and supervise pharmacy technicians compounding sterile preparations
without media-ll tests provided the pharmacist:
(I) has completed a recognized course in an ac-
credited college of pharmacy or a course sponsored by an ACPE ac-
credited provider which provides 20 hours of instruction and experi-
ence in the areas listed in this subparagraph; and
(II) completes the on-site media-ll tests within
seven days of commencing work at the pharmacy.
(iv) Media-ll tests procedures for assessing the
preparation of specic types of sterile preparations shall be represen-
tative of all types of manipulations, products, risk levels, and batch
sizes that personnel preparing that type of sterile preparation are likely
to encounter.
(v) The pharmacist-in-charge shall ensure continu-
ing competency of pharmacy personnel through in-service education,
training, and media-ll tests to supplement initial training. Personnel
competency shall be evaluated:
(I) during orientation and training prior to the
regular performance of those tasks;
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(II) whenever the quality assurance program
yields an unacceptable result;
(III) whenever unacceptable techniques are ob-
served; and
(IV) at least on an annual basis for low- and
medium-risk level compounding, and every six months for high-risk
level compounding.
(B) Pharmacists.
(i) All pharmacists who compound sterile prepara-
tions for administration to patients or supervise pharmacy technicians
and pharmacy technician trainees compounding sterile preparations
shall:
(I) complete through a single course, a minimum
of 20 hours of instruction and experience in the areas listed in subpara-
graph (A) of this paragraph. Such training may be obtained through:
(-a-) completion of a structured on-the-job di-
dactic and experiential training program at this pharmacy which pro-
vides 20 hours of instruction and experience in the areas listed in para-
graph (1) of this subsection. Such training may not be transferred to
another pharmacy unless the pharmacies are under common ownership
and control and use a common training program; or
(-b-) completion of a recognized course in an
accredited college of pharmacy or a course sponsored by an ACPE ac-
credited provider which provides 20 hours of instruction and experi-
ence in the areas listed in subparagraph (A) of this paragraph.
(II) possess knowledge about:
(-a-) aseptic processing;
(-b-) quality control and quality assurance as
related to environmental, component, and nished preparation release
checks and tests;
(-c-) chemical, pharmaceutical, and clinical
properties of drugs;
(-d-) container, equipment, and closure sys-
tem selection; and
(-e-) sterilization techniques.
(ii) The required experiential portion of the training
programs specied in this subparagraph must be supervised by an indi-
vidual who has already completed training as specied in subparagraph
(B) or (C) of this paragraph.
(C) Pharmacy technicians and pharmacy technician
trainees. In addition to specic qualications for registration, all phar-
macy technicians and pharmacy technician trainees who compound
sterile preparations for administration to patients shall:
(i) have initial training obtained either through com-
pletion of:
(I) a single course, a minimum of 40 hours of in-
struction and experience in the areas listed in subparagraph (A) of this
paragraph. Such training may be obtained through:
(-a-) completion of a structured on-the-job di-
dactic and experiential training program at this pharmacy which pro-
vides 40 hours of instruction and experience in the areas listed in sub-
paragraph (A) of this paragraph. Such training may not be transferred
to another pharmacy unless the pharmacies are under common owner-
ship and control and use a common training program; or
(-b-) completion of a course sponsored by an
ACPE accredited provider which provides 40 hours of instruction and
experience in the areas listed in subparagraph (A) of this paragraph; or
(II) a training program which is accredited by the
American Society of Health-System Pharmacists. Individuals enrolled
in training programs accredited by the American Society of Health-
System Pharmacists may compound sterile preparations in a licensed
pharmacy provided:
(-a-) the compounding occurs only during
times the individual is assigned to a pharmacy as a part of the experien-
tial component of the American Society of Health-System Pharmacists
training program;
(-b-) the individual is under the direct super-
vision of and responsible to a pharmacist who has completed training
as specied in subparagraph (B) of this paragraph; and
(-c-) the supervising pharmacist conducts in-
process and nal checks.
(ii) acquire the required experiential portion of the
training programs specied in this subparagraph under the supervision
of an individual who has already completed training as specied in
subparagraph (B) or (C) of this paragraph.
(D) Documentation of Training. The pharmacy shall
maintain a record on each person who compounds sterile preparations.
The record shall contain, at a minimum, a written record of initial and
in-service training, education, and the results of written and practical
testing and media-ll testing of pharmacy personnel. The record shall
be maintained and contain the following information:
(i) name of the person receiving the training or com-
pleting the testing or media-ll tests;
(ii) date(s) of the training, testing, or media-ll chal-
lenge testing;
(iii) general description of the topics covered in the
training or testing or of the process validated;
(iv) name of the person supervising the training,
testing, or media-ll challenge testing; and
(v) signature or initials of the person receiving the
training or completing the testing or media-ll challenge testing and the
pharmacist-in-charge or other pharmacist employed by the pharmacy
and designated by the pharmacist-in-charge as responsible for training,
testing, or media-ll challenge testing of personnel.
(d) Operational Standards.
(1) General Requirements.
(A) Sterile preparations may be compounded in li-
censed pharmacies:
(i) upon presentation of a practitioner’s prescription
drug or medication order based on a valid pharmacist/patient/prescriber
relationship;
(ii) in anticipation of future prescription drug or
medication orders based on routine, regularly observed prescribing
patterns; or
(iii) in reasonable quantities for ofce use by a prac-
titioner and for use by a veterinarian.
(B) Sterile compounding in anticipation of future pre-
scription drug or medication orders must be based upon a history of re-
ceiving valid prescriptions issued within an established pharmacist/pa-
tient/prescriber relationship, provided that in the pharmacist’s profes-
sional judgment the quantity prepared is stable for the anticipated shelf
time.
(i) The pharmacist’s professional judgment shall be
based on the criteria used to determine a beyond-use date outlined in
paragraph (5)(G) of this subsection.
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(ii) Documentation of the criteria used to determine
the stability for the anticipated shelf time must be maintained and be
available for inspection.
(iii) Any preparation compounded in anticipation of
future prescription drug or medication orders shall be labeled. Such
label shall contain:
(I) name and strength of the compounded prepa-
ration or list of the active ingredients and strengths;
(II) facility’s lot number;
(III) beyond-use date as determined by the phar-
macist using appropriate documented criteria as outlined in paragraph
(5)(G) of this subsection;
(IV) quantity or amount in the container;
(V) appropriate ancillary instructions, such as
storage instructions or cautionary statements, including hazardous
drug warning labels where appropriate; and
(VI) device-specic instructions, where appro-
priate.
(C) Commercially available products may be com-
pounded for dispensing to individual patients provided the following
conditions are met:
(i) the commercial product is not reasonably avail-
able from normal distribution channels in a timely manner to meet pa-
tient’s needs;
(ii) the pharmacy maintains documentation that the
product is not reasonably available due to a drug shortage or unavail-
ability from the manufacturer; and
(iii) the prescribing practitioner has requested that
the drug be compounded as described in subparagraph (D) of this para-
graph.
(D) A pharmacy may not compound preparations that
are essentially copies of commercially available products (e.g., the
preparation is dispensed in a strength that is only slightly different from
a commercially available product) unless the prescribing practitioner
specically orders the strength or dosage form and species why the
patient needs the particular strength or dosage form of the preparation.
The prescribing practitioner shall provide documentation of a patient
specic medical need and the preparation produces a clinically sig-
nicant therapeutic response (e.g. the physician requests an alternate
product due to hypersensitivity to excipients or preservative in the
FDA-approved product, or the physician requests an effective alternate
dosage form) or if the drug product is not commercially available.
The unavailability of such drug product must be documented prior
to compounding. The methodology for documenting unavailability
includes maintaining a copy of the wholesaler’s notication showing
back-ordered, discontinued, or out-of-stock items. This documenta-
tion must be available in hard-copy or electronic format for inspection
by the board.
(E) A pharmacy may enter into an agreement to com-
pound and dispense prescription/medication orders for another phar-
macy provided the pharmacy complies with the provisions of §291.125
of this title (relating to Centralized Prescription Dispensing).
(F) Compounding pharmacies/pharmacists may adver-
tise and promote the fact that they provide sterile prescription com-
pounding services, which may include specic drug preparations and
classes of drugs.
(G) A pharmacy may not compound veterinary prepa-
rations for use in food producing animals except in accordance with
federal guidelines.
(2) Microbial Contamination Risk Levels. Risk Levels for
sterile compounded preparations shall be as outlined in Chapter 797,
Pharmacy Compounding--Sterile Preparations of the USP/NF and as
listed below.
(A) Low-risk level compounded sterile preparations.
(i) Low-Risk conditions. Low-risk level com-
pounded sterile preparations are those compounded under all of the
following conditions.
(I) The compounded sterile preparations are
compounded with aseptic manipulations entirely within ISO Class 5 or
better air quality using only sterile ingredients, products, components,
and devices.
(II) The compounding involves only transfer,
measuring, and mixing manipulations with closed or sealed packaging
systems that are preformed promptly and attentively.
(III) Manipulations are limited to aseptically
opening ampuls, penetrating sterile stoppers on vials with sterile
needles and syringes, and transferring sterile liquids in sterile syringes
to sterile administration devices and packages of other sterile products.
(IV) For a low-risk preparation, in the absence of
direct sterility testing results or appropriate information sources that
justify different limits, the storage periods may not exceed the follow-
ing periods: before administration, 48 hours at controlled room tem-
perature, for not more than 14 days if stored at a cold temperature, and
for 45 days if stored in a frozen state at minus 20 degrees Celsius or
colder). For delayed activation device systems, the storage period be-
gins when the device is activated.
(ii) Examples of Low-Risk Compounding. Exam-
ples of low-risk compounding include the following.
(I) Single volume transfers of sterile dosage
forms from ampuls, bottles, bags, and vials using sterile syringes
with sterile needles, other administration devices, and other sterile
containers. The solution content of ampules shall be passed through a
sterile lter to remove any glass particles.
(II) Manually measuring and mixing no more
than three manufactured products to compound drug admixtures.
(B) Medium-risk level compounded sterile prepara-
tions.
(i) Medium-Risk Conditions. Medium-risk level
compounded sterile preparations, are those compounded aseptically
under low-risk conditions and one or more of the following conditions
exists.
(I) Multiple individual or small doses of sterile
products are combined or pooled to prepare a compounded sterile
preparation that will be administered either to multiple patients or to
one patient on multiple occasions.
(II) The compounding process includes complex
aseptic manipulations other than the single-volume transfer.
(III) The compounding process requires unusu-
ally long duration, such as that required to complete the dissolution or
homogenous mixing (e.g., reconstitution of intravenous immunoglob-
ulin or other intravenous protein products).
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(IV) The compounded sterile preparations do not
contain broad spectrum bacteriostatic substances and they are admin-
istered over several days (e.g., an externally worn infusion device).
(V) For a medium-risk preparation, in the ab-
sence of direct sterility testing results or appropriate information
sources that justify different limits the beyond use dates may not
exceed the following time periods: before administration, the com-
pounded sterile preparations are properly stored and are exposed for
not more than 30 hours at controlled room temperature, for not more
than 7 days at a cold temperature, and for 45 days in solid frozen state
at minus 20 degrees Celsius or colder.
(ii) Examples of medium-risk compounding. Exam-
ples of medium-risk compounding include the following.
(I) Compounding of total parenteral nutrition u-
ids using a manual or automated device during which there are multiple
injections, detachments, and attachments of nutrient source products to
the device or machine to deliver all nutritional components to a nal
sterile container.
(II) Filling of reservoirs of injection and infusion
devices with multiple sterile drug products and evacuations of air from
those reservoirs before the lled device is dispensed.
(III) Filling of reservoirs of injection and infu-
sion devices with volumes of sterile drug solutions that will be admin-
istered over several days at ambient temperatures between 25 and 40
degrees Celsius (77 and 104 degrees Fahrenheit).
(IV) Transfer of volumes from multiple ampuls
or vials into a single, nal sterile container or product.
(C) High-risk level compounded sterile preparations.
(i) High-risk Conditions. High-risk level com-
pounded sterile preparations are those compounded under any of the
following conditions.
(I) Non-sterile ingredients, including manufac-
tured products are incorporated or a non-sterile device is employed be-
fore terminal sterilization.
(II) Sterile ingredients, components, devices,
and mixtures are exposed to air quality inferior to ISO Class 5. This
includes storage in environments inferior to ISO Class 5 of opened
or partially used packages of manufactured sterile products that lack
antimicrobial preservatives.
(III) Non-sterile preparations are exposed no
more than 6 hours before being sterilized.
(IV) It is assumed, and not veried by examina-
tion of labeling and documentation from suppliers or by direct determi-
nation, that the chemical purity and content strength of ingredients meet
their original or compendial specications in unopened or in opened
packages of bulk ingredients.
(V) For a high-risk preparation, in the absence of
direct sterility testing results or appropriate information sources that
justify different limits, the storage periods cannot exceed the following
time periods: before administration, the compounded sterile prepara-
tions are properly stored and are exposed for not more than 24 hours at
controlled room temperature, for not more than 3 days at a cold tem-
perature, and for 45 days in solid frozen state at minus 20 degrees or
colder.
(VI) All non-sterile measuring, mixing, and pu-
rifying equipment is rinsed thoroughly with sterile, pyrogen-free wa-
ter, and then thoroughly drained or dried immediately before use for
high-risk compounding while assuring cleanliness. All high-risk com-
pounded sterile aqueous solutions subjected to terminal sterilization are
passed through a lter with a nominal porosity not larger than 1.2 mi-
cron preceding or during lling into their nal containers to remove
particulate matter. Sterilization of high-risk level compounded ster-
ile preparations by ltration shall be performed entirely within an ISO
Class 5 or superior air quality environment.
(ii) Examples of high-risk compounding. Examples
of high-risk compounding include the following.
(I) Dissolving non-sterile bulk drug powders to
make solutions, which will be terminally sterilized.
(II) Exposing the sterile ingredients and compo-
nents used to prepare and package compounded sterile preparations to
room air quality worse than ISO Class 5.
(III) Measuring and mixing sterile ingredients in
non-sterile devices before sterilization is performed.
(IV) Assuming, without appropriate evidence or
direct determination, that packages of bulk ingredients contain at least
95% by weight of their active chemical moiety and have not been con-
taminated or adulterated between uses.
(3) Immediate Use Compounded Sterile Preparations. For
the purpose of emergency or immediate patient care, compounded ster-
ile preparations are exempted from the requirements described in this
paragraph for low-risk, medium-risk, and high-risk level compounded
sterile preparations when all of the following criteria are met.
(A) Only simple aseptic measuring and transfer manip-
ulations are performed with not more than three sterile non-hazardous
commercial drug and diagnostic radiopharmaceutical drug products,
including an infusion or diluent solution.
(B) Unless required for the preparation, the preparation
procedure occurs continuously without delays or interruptions and does
not exceed 1 hour.
(C) Administration begins not later than one hour fol-
lowing the completion of preparing the compounded sterile prepara-
tion.
(D) When the compounded sterile preparations is not
administered by the person who prepared it, or its administration is
not witnessed by the person who prepared it, the compounded sterile
preparation shall bear a label listing patient identication information
such as name and identication number(s), the names and amounts of
all ingredients, the name or initials of the person who prepared the
compounded sterile preparation, and the exact 1-hour beyond-use time
and date.
(E) If administration has not begun within one hour fol-
lowing the completion of preparing the compounded sterile prepara-
tion, the compounded sterile preparation is promptly and safely dis-
carded. Immediate use compounded sterile preparations shall not be
stored for later use.
(F) Cytotoxic drugs shall not be prepared as immediate
use compounded sterile preparations.
(4) Library. In addition to the library requirements of the
pharmacy’s specic license classication, a pharmacy shall maintain
current or updated copies in hard-copy or electronic format of each of
the following:
(A) a reference text on injectable drug preparations,
such as Handbook on Injectable Drug Products;
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(B) a specialty reference text appropriate for the scope
of pharmacy services provided by the pharmacy, e.g., if the pharmacy
prepares hazardous drugs, a reference text on the preparation of haz-
ardous drugs; and
(C) the United States Pharmacopeia/National Formu-
lary or the USP Pharmacist’s Pharmacopeia containing USP Chapter
797, Pharmaceutical Compounding--Sterile Preparations.
(5) Environment. Compounding facilities shall be physi-
cally designed and environmentally controlled to minimize airborne
contamination of critical sites.
(A) Prior to September 1, 2008.
(i) Controlled area.
(I) Low and Medium Risk Preparations. The
pharmacy shall have a designated controlled area for the compounding
of sterile pharmaceuticals that is functionally separate from areas for
the preparation of non-sterile pharmaceuticals and is constructed to
minimize the opportunities for particulate and microbial contamina-
tion. This controlled area for the preparation of sterile pharmaceuticals
shall:
(-a-) have a controlled environment that is
aseptic or contains an aseptic environmental control device(s). If the
aseptic environmental control device is located within the controlled
area, the controlled area must extend a minimum of six feet from
the device and clearly marked to identify the separation between the
controlled and non-controlled area;
(-b-) be clean, well lighted, and of sufcient
size to support sterile compounding activities;
(-c-) be used only for the compounding of
sterile pharmaceuticals;
(-d-) be designed to avoid outside trafc and
air ow;
(-e-) be designed such that hand sanitizing
and gowning occurs outside the controlled area but is accessible
without use of the hands of the compounding personnel;
(-f-) have non-porous and washable oors or
oor covering to enable regular disinfection;
(-g-) be ventilated in a manner not interfering
with aseptic environmental control conditions;
(-h-) have walls, ceilings, and xtures, shelv-
ing, counters, and cabinets that are smooth, impervious, free from
cracks and crevices, and nonshedding. (acoustical ceiling tiles that are
coated with an acrylic paint are acceptable);
(-i-) have drugs and supplies stored on shelv-
ing areas above the oor to permit adequate oor cleaning; and
(-j-) contain only the appropriate compound-
ing supplies and not be used for bulk storage for supplies and materials.
Objects that shed particles may not be brought into the controlled area.
(II) High-risk Preparations. In addition to the re-
quirements in subclause (I) of this clause, when high-risk preparations
are compounded, the aseptic environment control device(s) shall be
located in a controlled area that maintains at least an ISO Class 8 (for-
merly Class 100,000) environment.
(ii) Aseptic environment control device(s). The
pharmacy shall prepare sterile pharmaceuticals in an appropriate
aseptic environmental control device(s) or area, such as a laminar air
ow hood, biological safety cabinet, clean room which is capable of
maintaining at least ISO Class 5 (formerly Class 100) conditions dur-
ing normal activity, or other aseptic environmental control devices that
produce ISO Class 5 (formerly Class 100) environmental conditions
or better. The aseptic environmental control device(s) shall:
(I) be certied by an independent contractor
according to the International Organization of Standardization (ISO)
Classication of Particulate Matter in Room Air (ISO 14644-1) for
operational efciency at least every six months or when it is relocated;
and
(II) have pre-lters inspected periodically and
replaced as needed, in accordance with written policies and proce-
dures, and the inspection and/or replacement date documented.
(iii) Automated compounding or counting device. If
automated compounding or counting devices are used, the pharmacy
shall have a method to calibrate and verify the accuracy of automated
compounding or counting devices used in aseptic processing and doc-
ument the calibration and verication on a routine basis.
(B) Low and Medium Risk Preparations.
(i) Effective September 1, 2008, a pharmacy that
prepares low- and medium-risk preparations shall have a clean
room/controlled area for the compounding of sterile preparations
that is constructed to minimize the opportunities for particulate and
microbial contamination. The clean room/controlled area shall:
(I) be clean, well lit, and of sufcient size to sup-
port sterile compounding activities;
(II) be used only for the compounding of sterile
preparations;
(III) be designed such that hand sanitizing and
gowning occurs outside the buffer area but is accessible without use
of the hands of the compounding personnel;
(IV) have non-porous and washable oors or
oor covering to enable regular disinfection;
(V) be ventilated in a manner to avoid disruption
from the HVAC system and room cross-drafts;
(VI) have walls, ceilings, oors, xtures, shelv-
ing, counters, and cabinets that are smooth, impervious, free from
cracks and crevices (e.g., coved), nonshedding and resistant to damage
by disinfectant agents.
(VII) have junctures of ceilings to walls coved or
caulked to avoid cracks and crevices;
(VIII) have drugs and supplies stored on shelving
areas above the oor to permit adequate oor cleaning;
(IX) contain only the appropriate compounding
supplies and not be used for bulk storage for supplies and materials.
Objects that shed particles shall not be brought into the controlled area;
(X) contain an anteroom/ante-zone that provides
at least an ISO class 8 air quality which may contain a sink that enables
hands-free use with a closed system of soap dispensing to minimize the
risk of extrinsic contamination; and
(XI) contain a buffer zone or buffer room de-
signed to maintain at least ISO Class 7 conditions. The following is
applicable for the buffer area.
(-a-) There shall be some demarcation desig-
nation that delineates the anteroom or area from the buffer area.
(-b-) The buffer area shall be segregated from
surrounding, unclassied spaces to reduce the risk of contaminants be-
ing blown, dragged, or otherwise introduced into the ltered unidi-
rectional airow environment, and this segregation should be continu-
ously monitored.
(-c-) A buffer zone that is not physically sep-
arated from the anteroom shall employ the principle of displacement
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airow as dened in Chapter 797, Pharmaceutical Compounding--Ster-
ile Preparations, of the USP/NF, with limited access to personnel.
(-d-) The buffer area shall not contain sources
of water (i.e., sinks) or oor drains.
(ii) The pharmacy shall prepare sterile pharmaceuti-
cals in a primary engineering control device, such as a laminar air ow
hood, biological safety cabinet, compounding aseptic isolator which is
capable of maintaining at least ISO Class 5 conditions during normal
activity.
(I) The primary engineering control shall:
(-a-) be located in the buffer area or room and
placed in the buffer area in a manner as to avoid conditions that could
adversely affect its operation such as strong air currents from opened
doors, personnel trafc, or air streams from the heating, ventilating and
air condition system.
(-b-) be certied by an independent contrac-
tor according to the International Organization of Standardization
(ISO) Classication of Particulate Matter in Room Air (ISO 14644-1)
for operational efciency at least every six months and when it is
relocated, in accordance with the manufacturer’s specications; and
(-c-) have pre-lters inspected periodically
and replaced as needed, in accordance with written policies and
procedures and the manufacturer’s specication, and the inspection
and/or replacement date documented.
(II) The compounding aseptic isolator must be
placed in an ISO Class 7 cleanroom unless the compounding aseptic
isolator meets all of the following conditions.
(-a-) The isolator must provide isolation from
the room and maintain ISO Class 5 during dynamic operating condi-
tions including transferring ingredients, components, and devices into
and out of the isolator and during preparation of compounded sterile
preparations.
(-b-) Particle counts sampled approximately
6 to 12 inches upstream of the critical exposure site must maintain ISO
Class 5 levels during compounding operations.
(-c-) The pharmacy shall maintain documen-
tation from the manufacturer that the compounding aseptic isolator
meets this standard when located in worse than ISO Class 7 environ-
ments.
(C) High-risk Preparations. In addition to the require-
ments in subparagraph (B) of this paragraph, when high-risk prepara-
tions are compounded, the primary engineering control shall be located
in a buffer room that provides a physical separation, through the use of
walls, doors and pass-throughs and has a minimum differential positive
pressure of 0.02 to 0.05 inches water column.
(D) Automated compounding device. If automated
compounding devices are used, the pharmacy shall have a method to
calibrate and verify the accuracy of automated compounding devices
used in aseptic processing and document the calibration and verica-
tion on a routine basis, based on the manufacturer’s recommendations.
(E) Cytotoxic drugs. If the preparation is cytotoxic, the
following is also applicable.
(i) General.
(I) All personnel involved in the compounding
of cytotoxic products shall wear appropriate protective apparel, such
as gowns, face masks, eye protection, hair covers, shoe covers or ded-
icated shoes, and appropriate gloving.
(II) Appropriate safety and containment tech-
niques for compounding cytotoxic drugs shall be used in conjunction
with aseptic techniques required for preparing sterile preparations.
(III) Disposal of cytotoxic waste shall comply
with all applicable local, state, and federal requirements.
(IV) Prepared doses of cytotoxic drugs must be
dispensed, labeled with proper precautions inside and outside, and dis-
tributed in a manner to minimize patient contact with cytotoxic agents.
(ii) Primary engineering control device. Cytotoxic
drugs must be prepared in a Class II or III vertical ow biological safety
cabinet or compounding aseptic isolator.
(F) Cleaning and disinfecting the sterile compounding
areas. The following cleaning and disinfecting practices and frequen-
cies apply to direct and contiguous compounding areas, which include
ISO Class 5 compounding areas for exposure of critical sites as well as
buffer rooms, anterooms, and ante-areas.
(i) The pharmacist-in-charge is responsible for de-
veloping written procedures for cleaning and disinfecting the direct
and contiguous compounding areas and assuring the procedures are fol-
lowed.
(ii) These procedures shall be conducted prior to
and after each work shift (at a minimum of every 12 hours while the
pharmacy is open) and when there are spills or environmental quality
breaches.
(iii) Before compounding is performed, all items are
removed from the direct and contiguous compounding areas and all
surfaces are cleaned of loose material and residue from spills, followed
by an application of a residue-free disinfecting agent (e.g., IPA), that is
left on for a time sufcient to exert its antimicrobial effect.
(iv) Work surfaces near the direct and contiguous
compounding areas in the buffer or clean area are cleaned of loose ma-
terial and residue from spills, followed by an application of a residue-
free disinfecting agent that is left on for a time sufcient to exert its
antimicrobial effect.
(v) Floors in the buffer or clean area are cleaned by
mopping at least once daily when no aseptic operations are in progress
preceding from the buffer or clean room area to the anteroom area.
(vi) In the anteroom area, walls, ceilings, and shelv-
ing shall be cleaned monthly.
(vii) Supplies and equipment removed from ship-
ping cartons must be wiped with a disinfecting agent, such as IPA.
However, if supplies are received in sealed pouches, the pouches may
be removed as the supplies are introduced into the buffer or clean area
without the need to disinfect the individual supply items. No shipping
or other external cartons may be taken into the buffer or clean area.
(viii) Storage shelving, emptied of all supplies,
walls, and ceilings are cleaned and disinfected at planned intervals,
monthly, if not more frequently.
(G) Security requirements. The pharmacy may autho-
rize personnel to gain access to that area of the pharmacy containing
dispensed sterile preparations, in the absence of the pharmacist, for the
purpose of retrieving dispensed prescriptions to deliver to patients. If
the pharmacy allows such after-hours access, the area containing the
dispensed sterile pharmaceuticals shall be an enclosed and lockable
area separate from the area containing undispensed prescription drugs.
A list of the authorized personnel having such access shall be in the
pharmacy’s policy and procedure manual.
(H) Storage requirements and beyond-use dating.
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(i) Storage requirements. All drugs shall be stored
at the proper temperature and conditions, as dened in the USP/NF.
The most commonly used denitions are as follows:
(I) freezer--A place where the temperature is
maintained thermostatically between minus 25 degrees and minus
10 degrees Celsius (minus 13 degrees Fahrenheit and 14 degrees
Fahrenheit).
(II) cold temperature--A temperature not ex-
ceeding 8 degrees Celsius (46 degrees Fahrenheit). A refrigerator is
a cold place in which the temperature maintained thermostatically
between 2 degrees and 8 degrees Celsius (36 degrees and 46 degrees
Fahrenheit);
(III) cool--A temperature between 8 degrees and
15 degrees Celsius (46 degrees and 59 degrees Fahrenheit). An article
for which storage in a cool place is directed may, alternatively, be stored
in a refrigerator unless otherwise specied on the labeling; and
(IV) controlled room temperature--A tempera-
ture maintained thermostatically between 15 degrees and 30 degrees
Celsius (59 degrees and 86 degrees Fahrenheit).
(ii) Beyond-use dating.
(I) Beyond-use dates for compounded sterile
preparations shall be assigned based on professional experience, which
shall include careful interpretation of appropriate information sources
for the same or similar formulations.
(II) Beyond-use dates for compounded sterile
preparations that are prepared strictly in accordance with manufactur-
ers’ product labeling must be those specied in that labeling, or from
appropriate literature sources or direct testing.
(III) Beyond-use dates for compounded sterile
preparations that lack justication from either appropriate literature
sources or by direct testing evidence must be assigned as described in
Chapter 797, Pharmaceutical Compounding--Sterile Preparations of
the USP/NF.
(6) Equipment and supplies. Pharmacies compounding
sterile preparations shall have the following equipment and supplies:
(A) a calibrated system or device (i.e., thermometer) to
monitor the temperature to ensure that proper storage requirements are
met, if sterile pharmaceuticals are stored in the refrigerator;
(B) a calibrated system or device to monitor the tem-
perature where bulk chemicals are stored;
(C) if applicable, a Class A prescription balance, or an-
alytical balance and weights. Such balance shall be properly main-
tained and subject to periodic inspection by the Texas State Board of
Pharmacy;
(D) equipment and utensils necessary for the proper
compounding of sterile preparations. Such equipment and utensils
used in the compounding process shall be:
(i) of appropriate design, appropriate capacity, and
be operated within designed operational limits;
(ii) of suitable composition so that surfaces that con-
tact components, in-process material, or drug products shall not be re-
active, additive, or absorptive so as to alter the safety, identity, strength,
quality, or purity of the drug preparation beyond the desired result;
(iii) cleaned and sanitized immediately prior to and
after each use; and
(iv) routinely inspected, calibrated (if necessary), or
checked to ensure proper performance;
(E) appropriate disposal containers for used needles,
syringes, etc., and if applicable, hazardous waste from the preparation
of hazardous drugs and/or biohazardous waste;
(F) appropriate packaging or delivery containers to
maintain proper storage conditions for sterile preparations;
(G) infusion devices, if applicable; and
(H) all necessary supplies, including:
(i) disposable needles, syringes, and other supplies
for aseptic mixing;
(ii) disinfectant cleaning solutions;
(iii) hand washing agents with bactericidal action;
(iv) disposable, lint free towels or wipes;
(v) appropriate lters and ltration equipment;
(vi) cytotoxic spill kits, if applicable; and
(vii) masks, caps, coveralls or gowns with tight
cuffs, shoe covers, and gloves, as applicable.
(7) Labeling.
(A) Prescription drug or medication orders. In addition
to the labeling requirements for the pharmacy’s specic license clas-
sication, the label dispensed or distributed pursuant to a prescription
drug or medication order shall contain the following.
(i) The generic name(s) or the ofcial name(s) of the
principal active ingredient(s) of the compounded sterile preparation.
(ii) For outpatient prescription orders only, a state-
ment that the compounded sterile preparation has been compounded
by the pharmacy. (An auxiliary label may be used on the container to
meet this requirement).
(iii) A beyond-use date. The beyond-use date shall
be determined as outlined in Chapter 797, Pharmacy Compounding--
Sterile Preparations of the USP/NF, and paragraph (4) of this subsec-
tion.
(B) Batch. If the sterile pharmaceutical is compounded
in a batch, the following shall also be included on the batch label.
(i) unique lot number assigned to the batch;
(ii) quantity;
(iii) appropriate ancillary instructions, such as stor-
age instructions or cautionary statements, including hazardous drug
warning labels where appropriate; and
(iv) device-specic instructions, where appropriate.
(C) Pharmacy bulk package. The label of a pharmacy
bulk package shall:
(i) state prominently "Pharmacy Bulk Package--Not
for Direct Infusion;"
(ii) contain or refer to information on proper tech-
niques to help ensure safe use of the preparation; and
(iii) bear a statement limiting the time frame in
which the container may be used once it has been entered, provided it
is held under the labeled storage conditions.
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(8) Written drug information for prescription drug orders
only. Written information about the compounded preparation or its
major active ingredient(s) shall be given to the patient at the time of
dispensing a prescription drug order. A statement which indicates that
the preparation was compounded by the pharmacy must be included
in this written information. If there is no written information available,
the patient shall be advised that the drug has been compounded and how
to contact a pharmacist, and if appropriate, the prescriber, concerning
the drug.
(9) Pharmaceutical Care Services. In addition to the
pharmaceutical care requirements for the pharmacy’s specic license
classication, the following requirements for sterile preparations
compounded pursuant to prescription drug orders must be met.
(A) Primary provider. There shall be a designated
physician primarily responsible for the patient’s medical care. There
shall be a clear understanding between the physician, the patient, and
the pharmacy of the responsibilities of each in the areas of the delivery
of care, and the monitoring of the patient. This shall be documented in
the patient medication record (PMR).
(B) Patient training. The pharmacist-in-charge shall de-
velop policies to ensure that the patient and/or patient’s caregiver re-
ceives information regarding drugs and their safe and appropriate use,
including instruction when applicable, regarding:
(i) appropriate disposition of hazardous solutions
and ancillary supplies;
(ii) proper disposition of controlled substances in
the home;
(iii) self-administration of drugs, where appropriate;
(iv) emergency procedures, including how to con-
tact an appropriate individual in the event of problems or emergencies
related to drug therapy; and
(v) if the patient or patient’s caregiver prepares ster-
ile preparations in the home, the following additional information shall
be provided:
(I) safeguards against microbial contamination,
including aseptic techniques for compounding intravenous admixtures
and aseptic techniques for injecting additives to premixed intravenous
solutions;
(II) appropriate storage methods, including stor-
age durations for sterile pharmaceuticals and expirations of self-mixed
solutions;
(III) handling and disposition of premixed and
self-mixed intravenous admixtures; and
(IV) proper disposition of intravenous admixture
compounding supplies such as syringes, vials, ampules, and intra-
venous solution containers.
(C) Pharmacist-patient relationship. It is imperative
that a pharmacist-patient relationship be established and maintained
throughout the patient’s course of therapy. This shall be documented
in the patient’s medication record (PMR).
(D) Patient monitoring. The pharmacist-in-charge shall
develop policies to ensure that:
(i) the patient’s response to drug therapy is moni-
tored and conveyed to the appropriate health care provider; and
(ii) the rst dose of any new drug therapy is admin-
istered in the presence of an individual qualied to monitor for and
respond to adverse drug reactions.
(10) Drugs, components, and materials used in sterile com-
pounding.
(A) Drugs used in sterile compounding shall be a
USP/NF grade substances manufactured in an FDA-registered facility.
(B) If USP/NF grade substances are not available shall
be of a chemical grade in one of the following categories:
(i) Chemically Pure (CP);
(ii) Analytical Reagent (AR);
(iii) American Chemical Society (ACS); or
(iv) Food Chemical Codex.
(C) If a drug, component or material is not purchased
from a FDA-registered facility, the pharmacist shall establish purity
and stability by obtaining a Certicate of Analysis from the supplier
and the pharmacist shall compare the monograph of drugs in a similar
class to the Certicate of Analysis.
(D) All components shall:
(i) be manufactured in an FDA-registered facility; or
(ii) in the professional judgment of the pharmacist,
be of high quality and obtained from acceptable and reliable alternative
sources; and
(iii) stored in properly labeled containers in a clean,
dry area, under proper temperatures.
(E) Drug product containers and closures shall not
be reactive, additive, or absorptive so as to alter the safety, identity,
strength, quality, or purity of the compounded drug preparation beyond
the desired result.
(F) Components, drug preparation containers, and clo-
sures shall be rotated so that the oldest stock is used rst.
(G) Container closure systems shall provide adequate
protection against foreseeable external factors in storage and use that
can cause deterioration or contamination of the compounded drug
preparation.
(H) A pharmacy may not compound a preparation that
contains ingredients appearing on a federal Food and Drug Adminis-
tration list of drug products withdrawn or removed from the market for
safety reasons.
(11) Compounding process.
(A) Standard operating procedures (SOPs). All signif-
icant procedures performed in the compounding area shall be covered
by written SOPs designed to ensure accountability, accuracy, quality,
safety, and uniformity in the compounding process. At a minimum,
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(viii) storage of compounded sterile preparations.
(B) USP/NF. Any compounded formulation with an of-
cial monograph in the USP/NF shall be compounded, labeled, and
packaged in conformity with the USP/NF monograph for the drug.
(C) Personnel Cleansing and Garbing.
(i) Any person with an apparent illness or open le-
sion that may adversely affect the safety or quality of a drug preparation
being compounded shall be excluded from direct contact with compo-
nents, drug preparation containers, closures, any materials involved in
the compounding process, and drug products until the condition is cor-
rected.
(ii) Before entering the clean area, compounding
personnel must remove the following:
(I) personal outer garments (e.g., bandanas,
coats, hats, jackets, scarves, sweaters, vests);
(II) all cosmetics, because they shed akes and
particles; and
(III) all hand, wrist, and other body jewelry.
(iii) The wearing of articial nails or extenders is
prohibited while working in the sterile compounding environment.
(iv) Personnel must don personal protective equip-
ment and perform hand hygiene in an order that proceeds from the dirt-
iest to the cleanest activities as follows:
(I) Activities considered the dirtiest include don-
ning of dedicated shoes or shoe covers, head and facial hair covers (e.g.,
beard covers in addition to face masks), and face mask/eye shield. Eye
shields are optional unless working with irritants like germicidal disin-
fecting agents.
(II) After donning dedicated shoes or shoe cov-
ers, head and facial hair covers, and face masks, personnel shall per-
form a hand hygiene procedure by removing debris from underneath
ngernails using a nail cleaner under running warm water followed
by vigorous hand washing. Personnel shall begin washing arms at the
hands and continue washing to elbows for at least 30 seconds with ei-
ther a plain (non-antimicrobial) soap, or antimicrobial soap, and water
while in the anteroom/ante-area.
(III) After completion of hand washing, person-
nel shall don clean non-shedding gowns with sleeves that t snugly
around the wrists.
(IV) Gloves that form a continuous barrier with
the gown shall be the last item donned before compounding begins.
(V) Gloves, either those which are sterile or have
been disinfected by applying 70% IPA or appropriate disinfectant to all
contact surface areas and allowed to dry, that form a continuos barrier
with the gown shall be the last item donned before compounding be-
gins. Routine application of 70% IPA shall occur throughout the com-
pounding day and whenever nonsterile surfaces are touched.
(VI) When compounding personnel must tem-
porarily exit the ISO Class 7 environment during a work shift, the
exterior gown, if not visibly soiled, may be removed and retained
in the ISO Class 8 anteroom/ante-area, to be re-donned during that
same work shift only. However, shoe covers, hair and facial hair
covers, face mask/eye shield, and gloves must be replaced with new
ones before re-entering the ISO Class 7 clean environment along with
performing proper hand hygiene.
(D) At each step of the compounding process, the phar-
macist shall ensure that components used in compounding are accu-
rately weighed, measured, or subdivided as appropriate to conform to
the formula being prepared.
(12) Quality Assurance.
(A) Initial Formula Validation. Prior to routine com-
pounding of a sterile preparation, a pharmacy shall conduct an evalua-
tion that shows that the pharmacy is capable of compounding a product
that is sterile and that contains the stated amount of active ingredient(s).
(i) Low risk preparations.
(I) Quality assurance practices include, but are
not limited to the following:
(-a-) Routine disinfection and air quality test-
ing of the direct compounding environment to minimize microbial sur-
face contamination and maintain ISO Class 5 air quality.
(-b-) Visual conrmation that compounding
personnel are properly donning and wearing appropriate items and
types of protective garments and goggles.
(-c-) Review of all orders and packages of in-
gredients to ensure that the correct identity and amounts of ingredients
were compounded.
(-d-) Visual inspection of compounded sterile
preparations to ensure the absence of particulate matter in solutions, the
absence of leakage from vials and bags, and the accuracy and thorough-
ness of labeling.
(II) Example of a Media-Fill Test Procedure.
This, or an equivalent test, is performed at least annually by each
person authorized to compound in a low-risk level under conditions
that closely simulate the most challenging or stressful conditions
encountered during compounding of low-risk level sterile produce.
Once begun, this test is completed without interruption within an ISO
Class 5 air quality environment. Three sets of four 5-milliliter aliquots
of sterile Soybean--Casein Digest Medium are transferred with the
same sterile 10-milliliter syringe and vented needle combination into
separate sealed, empty, sterile 30-milliliter clear vials (i.e., four 5-mil-
liliter aliquots into each of three 30-milliliter vials). Sterile adhesive
seals are aseptically afxed to the rubber closures on the three lled
vials. The vials are incubated within a range of 20 - 35 degrees Celsius
for 14 days. Failure is indicated by visible turbidity in the medium on
or before 14 days. The media-ll test must include a positive-control
sample.
(ii) Medium risk preparations.
(I) Quality assurance procedures for medium-
risk level compounded sterile preparations include all those for
low-risk level compounded sterile preparations, as well as a more
challenging media-ll test passed annually, or more frequently.
(II) Example of a Media-Fill Test Procedure.
This, or an equivalent test, is performed at least annually under
conditions that closely simulate the most challenging or stressful
conditions encountered during compounding. This test is completed
without interruption within an ISO Class 5 air quality environment.
Six 100-milliliter aliquots of sterile Soybean--Casein Digest Medium
are aseptically transferred by gravity through separate tubing sets
into separate evacuated sterile containers. The six containers are then
arranged as three pairs, and a sterile 10-milliliter syringe and 18-gauge
needle combination is used to exchange two 5-milliliter aliquots of
medium from one container to the other container in the pair. For
example, after a 5-milliliter aliquot from the rst container is added
to the second container in the pair, the second container is agitated for
10 seconds, then a 5-milliliter aliquot is removed and returned to the
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rst container in the pair. The rst container is then agitated for 10
seconds, and the next 5-milliliter aliquot is transferred from it back to
the second container in the pair. Following the two 5-milliliter aliquot
exchanges in each pair of containers, a 5-milliliter aliquot of medium
from each container is aseptically injected into a sealed, empty, sterile
10-milliliter clear vial, using a sterile 10-milliliter syringe and vented
needle. Sterile adhesive seals are aseptically afxed to the rubber
closures on the three lled vials. The vials are incubated within a
range of 20 - 35 degrees Celsius for 14 days. Failure is indicated by
visible turbidity in the medium on or before 14 days. The media-ll
test must include a positive-control sample.
(iii) High risk preparations.
(I) Procedures for high-risk level compounded
sterile preparations include all those for low-risk level compounded
sterile preparations. In addition, a media-ll test that represents
high-risk level compounding is performed twice a year by each
person authorized to compound high-risk level compounded sterile
preparations.
(II) Example of a Media-Fill Test Procedure
Compounded Sterile Preparations Sterilized by Filtration. This test,
or an equivalent test, is performed under conditions that closely sim-
ulate the most challenging or stressful conditions encountered when
compounding high-risk level compounded sterile preparations. Note:
Sterility tests for autoclaved compounded sterile preparations are not
required unless they are prepared in batches of more than 25 units.
This test is completed without interruption in the following sequence:
(-a-) Dissolve 3 grams of nonsterile commer-
cially available Soybean--Casein Digest Medium in 100 milliliters of
non-bacteriostatic water to make a 3% nonsterile solution.
(-b-) Draw 25 milliliters of the medium into
each of three 30-milliliter sterile syringes. Transfer 5 milliliters from
each syringe into separate sterile 10-milliliter vials. These vials are the
positive controls to generate exponential microbial growth, which is
indicated by visible turbidity upon incubation.
(-c-) Under aseptic conditions and using
aseptic techniques, afx a sterile 0.2-micron porosity lter unit and a
20-gauge needle to each syringe. Inject the next 10 milliliters from
each syringe into three separate 10-milliliter sterile vials. Repeat the
process for three more vials. Label all vials, afx sterile adhesive seals
to the closure of the nine vials, and incubate them at 20 to 35 degrees
Celsius. Inspect for microbial growth over 14 days as described in
Chapter 797 Pharmaceutical Compounding--Sterile Preparations, of
the USP/NF.
(B) Finished preparation release checks and tests.
(i) High-risk level compounded sterile preparations.
All high-risk level compounded sterile preparations that are prepared
in groups of more than 25 identical individual single-dose packages
(such as ampuls, bags, syringes, and vials), or in multiple dose vials
for administration to multiple patients, or are exposed longer than 12
hours at 2 - 8 degrees Celsius (36 - 46 degrees Fahrenheit) and longer
than six hours at warmer than 8 degrees Celsius (46 degrees Fahrenheit)
before they are sterilized shall be tested to ensure they are sterile and
do not contain excessive bacterial endotoxins as specied in Chapter
71, Sterility Tests of the USP/NF.
(ii) All compounded sterile preparations that are in-
tended to be solutions must be visually examined for the presence of
particulate matter and not administered or dispensed when such matter
is observed.
(iii) The prescription drug and medication orders,
written compounding procedure, preparation records, and expended
materials used to make compounded sterile preparations at all contam-
ination risk levels shall be inspected for accuracy of correct identities
and amounts of ingredients, aseptic mixing and sterilization, packag-
ing, labeling, and expected physical appearance before they are admin-
istered or dispensed.
(13) Quality control.
(A) Quality control procedures. The pharmacy shall
follow established quality control procedures to monitor the com-
pounding environment and quality of compounded drug preparations
for conformity with the quality indicators established for the prepa-
ration. When developing these procedures, pharmacy personnel
shall consider the provisions of Chapter 797, Pharmaceutical Com-
pounding--Sterile Preparations, Chapter 1075, Good Compounding
Practices, and Chapter 1160, Pharmaceutical Calculations in Prescrip-
tion Compounding of the current USP/NF. Such procedures shall be
documented and be available for inspection.
(B) Verication of compounding accuracy and sterility.
(i) The accuracy of identities, concentrations,
amounts, and purities of ingredients in compounded sterile prepara-
tions shall be conrmed by reviewing labels on packages, observing
and documenting correct measurements with approved and correctly
standardized devices, and reviewing information in labeling and
certicates of analysis provided by suppliers.
(ii) If the correct identify, purity, strength, and steril-
ity of ingredients and components of compounded sterile preparations
cannot be conrmed such ingredients and components shall be dis-
carded immediately.
(iii) If individual ingredients, such as bulk drug sub-
stances, are not labeled with expiration dates, when the drug substances
are stable indenitely in their commercial packages under labeled stor-
age conditions, such ingredients may gain or lose moisture during stor-
age and use and shall require testing to determine the correct amount to
weigh for accurate content of active chemical moieties in compounded
sterile preparations.
(e) Records.
(1) Maintenance of records. Every record required under
this section must be:
(A) kept by the provider pharmacy and be available, for
at least two years for inspecting and copying by the board or its rep-
resentative and to other authorized local, state, or federal law enforce-
ment agencies; and
(B) supplied by the provider pharmacy within 72 hours,
if requested by an authorized agent of the Texas State Board of Phar-
macy. If the pharmacy maintains the records in an electronic format,
the requested records must be provided in an electronic format. Failure
to provide the records set out in this section, either on site or within 72
hours, constitutes prima facie evidence of failure to keep and maintain
records in violation of the Act.
(2) Compounding records.
(A) Compounding pursuant to patient specic prescrip-
tion drug orders. Compounding records for all compounded pharma-
ceuticals shall be maintained by the pharmacy electronically or manu-
ally as part of the prescription drug or medication order, formula record,
formula book, or compounding log and shall include:
(i) the date of preparation;
(ii) a complete formula, including methodology and
necessary equipment which includes the brand name(s) of the raw ma-
terials, or if no brand name, the generic name(s) or ofcial name and
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name(s) of the manufacturer(s) or distributor of the raw materials and
the quantities of each;
(iii) signature or initials of the pharmacist or phar-
macy technician or pharmacy technician trainee performing the com-
pounding;
(iv) signature or initials of the pharmacist respon-
sible for supervising pharmacy technicians or pharmacy technician
trainees and conducting in-process and nals checks of compounded
pharmaceuticals if pharmacy technicians or pharmacy technician
trainees perform the compounding function;
(v) the quantity in units of nished products or
amount of raw materials;
(vi) the container used and the number of units pre-
pared; and
(vii) a reference to the location of the following doc-
umentation which may be maintained with other records, such as qual-
ity control records:
(I) the criteria used to determine the beyond-use
date; and
(II) documentation of performance of quality
control procedures.
(B) Compounding records when batch compounding or
compounding in anticipation of future prescription drug or medication
orders.
(i) Master work sheet. A master work sheet shall be
developed and approved by a pharmacist for preparations prepared in
batch. Once approved, a duplicate of the master work sheet shall be
used as the preparation work sheet from which each batch is prepared
and on which all documentation for that batch occurs. The master work
sheet shall contain at a minimum:
(I) the formula;
(II) the components;
(III) the compounding directions;
(IV) a sample label;
(V) evaluation and testing requirements;
(VI) specic equipment used during preparation;
and
(VII) storage requirements.
(ii) Preparation work sheet. The preparation work
sheet for each batch of preparations shall document the following:
(I) identity of all solutions and ingredients and
their corresponding amounts, concentrations, or volumes;
(II) lot number for each component;
(III) component manufacturer/distributor or suit-
able identifying number;
(IV) container specications (e.g., syringe, pump
cassette);
(V) unique lot or control number assigned to
batch;
(VI) expiration date of batch-prepared prepara-
tions;
(VII) date of preparation;
(VIII) name, initials, or electronic signature of
the person(s) involved in the preparation;
(IX) name, initials, or electronic signature of the
responsible pharmacist;
(X) nished preparation evaluation and testing
specications, if applicable; and
(XI) comparison of actual yield to anticipated or
theoretical yield, when appropriate.
(f) Ofce Use Compounding and Distribution of Compounded
Preparations to Class C Pharmacies or Veterinarians in Accordance
with Section 563.054 of the Act.
(1) General.
(A) A pharmacy may dispense and deliver a reasonable
quantity of a compounded preparation to a practitioner for ofce use
by the practitioner in accordance with this subsection.
(B) A Class A (Community) pharmacy is not required
to register or be licensed under Chapter 431, Health and Safety Code, to
distribute sterile compounded preparations to a Class C (Institutional)
pharmacy.
(C) A Class C (Institutional) pharmacy is not required
to register or be licensed under Chapter 431, Health and Safety Code, to
distribute sterile compounded preparations that the Class C pharmacy
has compounded for other Class C pharmacies under common owner-
ship.
(D) To dispense and deliver a compounded preparation
under this subsection, a pharmacy must:
(i) verify the source of the raw materials to be used
in a compounded drug;
(ii) comply with applicable United States Pharma-
copoeia guidelines, including the testing requirements, and the Health
Insurance Portability and Accountability Act of 1996 (Pub. L. No.
104-191);
(iii) enter into a written agreement with a practi-
tioner for the practitioner’s ofce use of a compounded preparation;
(iv) comply with all applicable competency and ac-
crediting standards as determined by the board; and
(v) comply with the provisions of this subsection.
(2) Written Agreement. A pharmacy that provides sterile
compounded preparations to practitioners for ofce use or to another
pharmacy shall enter into a written agreement with the practitioner or
pharmacy. The written agreement shall:
(A) address acceptable standards of practice for a com-
pounding pharmacy and a practitioner and receiving pharmacy that en-
ter into the agreement including a statement that the compounded drugs
may only be administered to the patient and may not be dispensed to
the patient or sold to any other person or entity except as authorized by
§563.054 of the Act;
(B) require the practitioner or receiving pharmacy to in-
clude on a patient’s chart, medication order or medication administra-
tion record the lot number and beyond-use date of a compounded prepa-
ration administered to a patient;
(C) describe the scope of services to be performed by
the pharmacy and practitioner or receiving pharmacy, including a state-
ment of the process for:
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(i) a patient to report an adverse reaction or submit
a complaint; and
(ii) the pharmacy to recall batches of compounded
preparations.
(3) Recordkeeping.
(A) Maintenance of Records.
(i) Records of orders and distribution of sterile com-
pounded preparations to a practitioner for ofce use or to a Class C
pharmacy for administration to a patient shall:
(I) be kept by the pharmacy and be available, for
at least two years from the date of the record, for inspecting and copying
by the board or its representative and to other authorized local, state,
or federal law enforcement agencies;
(II) maintained separately from the records of
products dispensed pursuant to a prescription or medication order; and
(III) supplied by the pharmacy within 72 hours,
if requested by an authorized agent of the Texas State Board of Phar-
macy or its representative. If the pharmacy maintains the records in an
electronic format, the requested records must be provided in an elec-
tronic format. Failure to provide the records set out in this subsection,
either on site or within 72 hours for whatever reason, constitutes prima
facie evidence of failure to keep and maintain records.
(ii) Records may be maintained in an alternative
data retention system, such as a data processing system or direct
imaging system provided the data processing system is capable of
producing a hard copy of the record upon the request of the board,
its representative, or other authorized local, state, or federal law
enforcement or regulatory agencies.
(B) Orders. The pharmacy shall maintain a record of all
sterile compounded preparations ordered by a practitioner for ofce use
or by a Class C pharmacy for administration to a patient. The record
shall include the following information:
(i) date of the order;
(ii) name, address, and phone number of the practi-
tioner who ordered the preparation and if applicable, the name, address
and phone number of the Class C Pharmacy ordering the preparation;
and
(iii) name, strength, and quantity of the preparation
ordered.
(C) Distributions. The pharmacy shall maintain a
record of all sterile compounded preparations distributed pursuant to
an order to a practitioner for ofce use or by a Class C pharmacy for
administration to a patient. The record shall include the following
information:
(i) date the preparation was compounded;
(ii) date the preparation was distributed;
(iii) name, strength and quantity in each container of
the preparation;
(iv) pharmacy’s lot number;
(v) quantity of containers shipped; and
(vi) name, address, and phone number of the practi-
tioner or Class C Pharmacy to whom the preparation is distributed.
(D) Audit Trail.
(i) The pharmacy shall store the order and distribu-
tion records of preparations for all sterile compounded preparations or-
dered by and or distributed to a practitioner for ofce use or by a Class
C pharmacy for administration to a patient in such a manner as to be
able to provide a audit trail for all orders and distributions of any of the
following during a specied time period.
(I) any strength and dosage form of a preparation
(by either brand or generic name or both);
(II) any ingredient;
(III) any lot number;
(IV) any practitioner;
(V) any facility; and
(VI) any pharmacy, if applicable.
(ii) The audit trail shall contain the following infor-
mation:
(I) date of order and date of the distribution;
(II) practitioner’s name, address, and name of the
Class C pharmacy, if applicable;
(III) name, strength and quantity of the prepara-
tion in each container of the preparation;
(IV) name and quantity of each active ingredient;
(V) quantity of containers distributed; and
(VI) pharmacy’s lot number;
(4) Labeling. The pharmacy shall afx a label to the prepa-
ration containing the following information:
(A) name, address, and phone number of the com-
pounding pharmacy;
(B) the statement: "For Institutional or Ofce Use
Only--Not for Resale"; or if the preparation is distributed to a veteri-
narian the statement: "Compounded Preparation";
(C) name and strength of the preparation or list of the
active ingredients and strengths;
(D) pharmacy’s lot number;
(E) beyond-use date as determined by the pharmacist
using appropriate documented criteria;
(F) quantity or amount in the container;
(G) appropriate ancillary instructions, such as storage
instructions or cautionary statements, including hazardous drug warn-
ing labels where appropriate; and
(H) device-specic instructions, where appropriate.
(g) Recall Procedures.
(1) The pharmacy shall have written procedure for the re-
call of any compounded sterile preparations provided to a patient, to
a practitioner for ofce use, or to a pharmacy for administration. The
recall procedures shall require:
(A) notication to each practitioner, facility, and/or
pharmacy to which the preparation was distributed;
(B) notication to each patient to whom the preparation
was dispensed;
(C) quarantine of the product if there is a suspicion of
harm to a patient; and
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(D) a recall if there is probable or conrmed harm to a
patient.
(2) If the pharmacy identies a suspicion of, probable, or
conrmed harm to a patient, the pharmacy shall immediately notify and
provide information as required by the board to the following:
(A) the Texas Department of State Health Services,
Drugs and Medical Devices Group, if the preparation is distributed for
ofce use; and
(B) the board.
(3) The board may require a pharmacy to institute a recall
if there is probable or conrmed harm to a patient.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
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CHAPTER 295. PHARMACISTS
22 TAC §295.5
The Texas State Board of Pharmacy adopts amendments to
§295.5, concerning Pharmacist License or Renewal Fees. The
amendments are adopted with changes to the proposed text as
published in the June 15, 2007, issue of the Texas Register (32
TexReg 3531). The changes to the section are described in this
preamble.
The amendments to §295.5 will raise pharmacist license fees
based on increased expenses. The Board was able to substan-
tially reduce the proposed fee increase for all licensees, includ-
ing reducing the proposed pharmacist initial and renewal fees
from $239, to $214, based on the nal appropriations to the
agency that were approved by the Texas Legislature.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051,
554.006, and 564.051 of the Texas Pharmacy Act (Chapters
551 - 566 and 568 - 569, Texas Occupations Code). The Board
interprets §551.002 as authorizing the agency to protect the
public through the effective control and regulation of the practice
of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and
enforcement of the Act. The Board interprets §564.006 as
authorizing the agency to adopt rules to establish reasonable
and necessary fees to produce sufcient revenue to cover the
cost of administering the Act. The Board interprets §564.051 as
authorizing the agency to collect a surcharge to fund a program
to aid impaired pharmacists and pharmacy students.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
§295.5. Pharmacist License or Renewal Fees.
(a) Biennial Registration. The Texas State Board of Pharmacy
shall require biennial renewal of all pharmacist licenses provided under
the Pharmacy Act, §559.002.
(b) Initial License Fee.
(1) The fee for the initial license shall be $214 for a two
year registration and for processing the application and issuance of the
pharmacist license as authorized by the Act, §554.006.
(2) In addition, the following fees shall be collected:
(A) $13 surcharge to fund a program to aid impaired
pharmacists and pharmacy students as authorized by the Act, §564.051;
(B) $10 surcharge to fund TexasOnline as authorized by
Chapter 2054, Subchapter I, Government Code; and
(C) $5 surcharge to fund the Ofce of Patient Protection
as authorized by Chapter 101, Subchapter G, Occupations Code.
(3) New pharmacist licenses shall be assigned an expira-
tion date and initial fee shall be prorated based on the assigned expira-
tion date.
(c) Renewal Fee.
(1) The fee for biennial renewal of a pharmacist license
shall be $214 for processing the application and issuance of the phar-
macist license as authorized by the Act, §554.006.
(2) In addition, the following fees shall be collected:
(A) $13 surcharge to fund a program to aid impaired
pharmacists and pharmacy students as authorized by the Act, §564.051;
(B) $10 surcharge to fund TexasOnline as authorized by
Chapter 2054, Subchapter I, Government Code; and
(C) $2 surcharge to fund the Ofce of Patient Protection
as authorized by Chapter 101, Subchapter G, Occupations Code.
(d) Exemption from fee. The license of a pharmacist who has
been licensed by the Texas State Board of Pharmacy for at least 50 years
or who is at least 72 years old shall be renewed without payment of a
fee provided such pharmacist is not actively practicing pharmacy. The
renewal certicate of such pharmacist issued by the board shall reect
an inactive status. A person whose license is renewed pursuant to this
subsection may not engage in the active practice of pharmacy without
rst paying the renewal fee as set out in subsection (b) of this section.
(e) Duplicate or Amended Certicates.
(1) The fee for issuance of an amended pharmacist’s li-
cense renewal certicate shall be $20.
(2) The fee for issuance of an amended license to practice
pharmacy (wall certicate) only, or renewal certicate and wall certi-
cate shall be $35.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas State Board of Pharmacy
Effective date: October 1, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
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22 TAC §295.9
The Texas State Board of Pharmacy adopts amendments to
§295.9, concerning Inactive License. The amendments are
adopted without changes to the proposed text as published in
the June 15, 2007, issue of the Texas Register (32 TexReg
3531).
The amendments require pharmacists wanting to reactivate an
inactive license to submit proof of completion of 30 hours of ap-
proved continuing education.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051, and
559.101 of the Texas Pharmacy Act (Chapters 551 - 566 and 568
- 569, Texas Occupations Code). The Board interprets §551.002
as authorizing the agency to protect the public through the ef-
fective control and regulation of the practice of pharmacy. The
Board interprets §554.001(a) as authorizing the agency to adopt
rules to administer and enforce the Act and rules adopted un-
der the Act as well as enforce other laws relating to the practice
of pharmacy. The Board interprets §559.101 as authorizing the
agency to adopt rules regarding inactive licenses.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas State Board of Pharmacy
Effective date: September 18, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
CHAPTER 297. PHARMACY TECHNICIANS
AND PHARMACY TECHNICIAN TRAINEES
22 TAC §297.3
The Texas State Board of Pharmacy adopts amendments to
§297.3, concerning Registration Requirements. The amend-
ments are adopted without changes to the proposed text as
published in the June 15, 2007, issue of the Texas Register (32
TexReg 3532).
The amendments will recognize the abbreviation "Ph.T.R." to be
used by registered pharmacy technicians.
The Texas Society of Health-System Pharmacists submitted
comments supporting the amendments.
The National Association of Chain Drug Stores submitted com-
ments requesting that the Board allow pharmacy technicians
who have submitted their registration materials to the Board be
permitted to start work in a pharmacy while the Board process
the application. The Board disagrees with this comment. The
Board must ensure that individuals allowed to work in a phar-
macy meet the qualications and are safe to practice as phar-
macy technicians. Allowing individuals to work in a pharmacy
while the Board processes the registration application could po-
tentially allow unqualied individuals to work in a pharmacy.
The amendments are adopted under §551.002 and §554.051 of
the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569,
Texas Occupations Code). The Board interprets §551.002 as
authorizing the agency to protect the public through the effective
control and regulation of the practice of pharmacy. The Board
interprets §554.001(a) as authorizing the agency to adopt rules
to administer and enforce the Act and rules adopted under the
Act as well as enforce other laws relating to the practice of phar-
macy.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas State Board of Pharmacy
Effective date: September 18, 2007
Proposal publication date: June 15, 2007
For further information, please call: (512) 305-8028
22 TAC §297.4
The Texas State Board of Pharmacy adopts amendments to
§297.4, concerning Fees, with changes to the proposed text as
published in the June 15, 2007, issue of the Texas Register (32
TexReg 3532). The changes to this section are described in this
preamble.
The amendments will raise pharmacy technician registration
fees based on increased expenses. The Board was able to
substantially reduce the proposed fee increase for all licensees,
including reducing the proposed pharmacy technician initial and
renewal fees from $64 to $59, and $61 to $56, respectively,
based on the nal appropriations to the agency that were
approved by the Texas Legislature.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051,
554.006, and 564.051 of the Texas Pharmacy Act (Chapters
551 - 566 and 568 - 569, Texas Occupations Code). The Board
interprets §551.002 as authorizing the agency to protect the
public through the effective control and regulation of the practice
of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and
enforcement of the Act. The Board interprets §564.006 as
authorizing the agency to adopt rules to establish reasonable
and necessary fees to produce sufcient revenue to cover the
cost of administering the Act.
The statutes affected by the amendments: Texas Pharmacy Act,
Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
§297.4. Fees.
(a) Pharmacy technician trainee. There shall be no fee for reg-
istration as a pharmacy technician trainee.
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(b) Pharmacy technician.
(1) Biennial Registration. The board shall require biennial
renewal of all pharmacy technician registrations provided under Chap-
ter 568 of the Act.
(2) Initial Registration Fee.
(A) The fee for initial registration shall be $59 for a two
year registration and is composed of the following fees:
(i) $51 for processing the application and issuance
of the pharmacy technician registration as authorized by the Act,
§568.005;
(ii) a $3 surcharge to fund TexasOnline as autho-
rized by Chapter 2054, Subchapter I, Government Code; and
(iii) $5 surcharge to fund the Ofce of Patient
Protection as authorized by Chapter 101, Subchapter G, Occupations
Code.
(B) The initial registration fee shall be prorated based
on the assigned expiration date.
(3) Renewal Fee. The fee for biennial renewal of a phar-
macy technician registration shall be $56 and is composed of the fol-
lowing:
(A) $51 for processing the application and issuance
of the pharmacy technician registration as authorized by the Act,
§568.005;
(B) a $3 surcharge to fund TexasOnline as authorized
by Chapter 2054, Subchapter I, Government Code; and
(C) $2 surcharge to fund the Ofce of Patient Protection
as authorized by Chapter 101, Subchapter G, Occupations Code.
(c) Duplicate or Amended Certicates. The fee for issuance
of a duplicate or amended pharmacy technician trainee registration cer-
ticate or pharmacy technician registration renewal certicate shall be
$20.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
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Effective date: October 1, 2007
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TITLE 31. NATURAL RESOURCES AND
CONSERVATION
PART 10. TEXAS WATER
DEVELOPMENT BOARD




DIVISION 1. ECONOMICALLY DISTRESSED
AREAS PROGRAM
31 TAC §363.511
The Texas Water Development Board (board) adopts new 31
TAC §363.511 concerning temporary continuation of funding un-
der the Economically Distressed Areas Program (EDAP) model
subdivision Rules (model rules). Section 363.511 is adopted with
changes to the proposed text as published in the July 13, 2007,
Texas Register (32 TexReg 4329).
The rule implements Senate Bill 3, Article VI, 80th Legislature
relating to compliance with the model rules.
In the past few years, issues related to local entities’ under-
standing of and compliance with the model rules, along with the
board’s oversight of the model rules enforcement efforts by those
entities, have caused worthwhile projects to be halted, project
costs to increase, and, in some cases, homeowners to continue
living without adequate water and wastewater service. Recent
examples include the City of Laredo, the City of Odem, San Patri-
cio County, and the City of Donna. New §363.511, based on the
Legislative action in Senate Bill 3, ensures that existing EDAP
projects may move forward while maintaining compliance with
the model subdivision rules.
The board conducted a public hearing on the proposed rule on
August 7, 2007, in room E1.012 Capitol Extension, 1400 N. Con-
gress Ave., Austin, Texas. At the meeting, the board received
oral comments from the Senate Committee on International Re-
lations and Trade, the Secretary of State, and Texas Low Income
Housing Information Services. Written comments were submit-
ted by El Paso County and the Texas Commission on Environ-
mental Quality. In addition, a public hearing was held on August
2, 2007, in room E1.012 Capitol Extension, 1400 N. Congress
Ave., Austin, Texas, at which no comments were received. The
comment period closed on August 13, 2007.
Two commenters recommended that the rule enumerate certain
denitions and establish guidelines for the board in making de-
terminations of what constitute sufcient safeguards and what
actions are necessary and appropriate.
In developing the criteria suggested by the comments, the board
tries to provide guidance while not limiting the options for an en-
tity to demonstrate compliance going forward. Thus, the process
envisioned by the rule is that the board will analyze the condi-
tions that exist in the political subdivision at the time the request
for temporary continuation of funding is made.
Safeguards include indications of both adoption and enforce-
ment of the model rules. Adoption may mean adoption of the
text of the model rules as contained in 31 TAC Chapter 364, in
an open meeting with a quorum present, after due notice, in ac-
cordance with the Texas Open Meetings Act, Tex. Gov’t Code
Chapter 551. Adoption of the model rules can also mean mod-
ication of the political subdivision’s existing residential subdivi-
sion rules to include the elements of the model rules contained in
31 TAC Chapter 364. Adoption of the model rules is evidenced
by signed and sealed copies of the required notice, resolution,
and the adopted rules. The board accepts the comments and
has added clarifying language.
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One commenter suggested that having determining factors for
compliance would be helpful so that developers and political sub-
divisions would know what actions are needed to maintain com-
pliance.
Political subdivisions demonstrate compliance with the model
rules in a number of ways. For example, the political subdi-
vision may present approved residential subdivisions plats that
conform to the platting requirements of the model rules. In situ-
ations where the developer or subdivider is not meeting the re-
quirements for development of residential subdivisions in politi-
cal subdivisions that have adopted the model rules, deciencies
may be shown by the existence of plats that are approved with-
out the platting requirements set out in the model rules being in
place on the plat, by the purchase or sale of residential subdivi-
sion property that lacks adequate water or wastewater facilities,
or by violations under the Local Gov’t Code Chapters 212 or 232.
In such cases, enforcement may mean taking enforcement ac-
tion as allowed by Tex. Gov’t Code Chapters 212 or 232 or by
other law available to the political subdivision. Evidence of such
enforcement actions may be copies of such enforcement actions
and the legal determination or resolution of those actions by the
political subdivision. The board accepts the comment and has
provided basic guidelines for enforcement and compliance.
Subsection (a)(6) requires that the board consult with the At-
torney General, Secretary of State, and Texas Commission on
Environmental Quality before making a determination to grant a
request for temporary continuation of funding. One commenter
proposed language that would provide prompt notice by the
board and response by the other agencies under this require-
ment.
The language proposed by the commenter sets out an appropri-
ate procedure for the agencies’ actions to fulll their responsibili-
ties under the rule. The proposed language imposes reasonable
deadlines on the agencies and does not change the scope of the
rule. The board accepts the comment and has revised subsec-
tion (a)(6) accordingly.
In addition, the board has added a description of the contents
of the request for temporary continuation of funding. This was
done to facilitate submission of requests by political subdivisions
and to simplify initial processing of such requests by the board.
This amendment is adopted under Texas Water Code §6.101,
which provides the board with the authority to adopt rules neces-
sary to carry out its powers and duties under the provisions of the
Texas Water Code and other laws of this state, as well as under
the authority of Texas Water Code §16.343, which authorizes the
board to prepare and adopt model rules, §16.344, which autho-
rizes the board to monitor the performance of a political subdivi-
sion receiving nancial assistance from the EDAP, and §17.929,
which provides that the board must consider whether a political
subdivision has adopted and is enforcing the model rules.
§363.511. Temporary Continuation of Funding.
(a) A political subdivision may temporarily continue to
receive funds under Subchapter K, Chapter 17 of the Texas Water
Code, if the political subdivision submits a request for temporary
continuation of funding and the board determines that:
(1) the political subdivision’s initial funding application
and any amendments for a designated area were reviewed and ap-
proved by the board before January 1, 2007;
(2) withholding funds would result in an undue hardship
for occupants of the property to be served by unreasonably delaying
the provision of adequate water or wastewater services;
(3) withholding funds would result in inefcient use of lo-
cal, state, or federal funds under the program;
(4) the political subdivision has committed to taking the
necessary and appropriate actions to correct any deciencies in adop-
tion or enforcement of the model rules pursuant to Water Code §16.343
(model rules) within the time designated by the board, but not later than
the 90th day after the date the board makes the determinations under
this subsection;
(5) the political subdivision has sufcient safeguards in
place to prevent the proliferation of colonias; and
(6) during the 30 days after the date the board receives a
request under this subsection, the board, after consulting with the At-
torney General, Secretary of State, and Texas Commission on Environ-
mental Quality, has not received an objection from any of those entities
to the request for temporary continuation of funding.
(A) Within two days of receipt of the request, the board
shall forward the request from the political subdivision to the Attorney
General, Secretary of State, and Texas Commission on Environmental
Quality.
(B) The Ofce of Attorney General, Secretary of State,
and Texas Commission on Environmental Quality will provide their
response to the board, stating either objection or no objection, within
21 days of receipt of the request from the board
(b) In applying subsection (a) of this section to applications
for increased nancial assistance, the board shall only consider areas
that were included in the initial application, except that the board may
reconsider the eligibility of areas that were the subject of a facility plan
in the initial application and that may be determined to be eligible based
on criteria in effect September 1, 2005.
(c) The political subdivision shall take necessary and appropri-
ate actions to correct any deciencies in its adoption and enforcement
of the model rules within the time period required by the board, not
to exceed the 90-day period described by subsection (a)(4) of this sec-
tion, and provide evidence of compliance to the board. The board shall
discontinue funding unless the board makes a determination based on
the evidence provided that the political subdivision has demonstrated
sufcient compliance to continue funding.
(d) A request for temporary continuation of funding shall be in
the form and numbers prescribed by the executive administrator and, in
addition to any other information that may be required by the executive
administrator or the board, the applicant shall provide:
(1) a resolution from the governing body of the political
subdivision that shall
(A) request that funding be continued temporarily;
(B) state the nature and purpose of the request;
(C) express the commitment of the governing body to
taking the necessary actions to correct deciencies as described in sub-
section (a)(4) of this section;
(D) designate an authorized representative to act on be-
half of the governing body; and
(E) authorize the representative to submit the request,
appear before the board on behalf of the governing body, and submit
such other documentation as may be required; and
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(2) a notarized afdavit from the authorized representative
stating that:
(A) the decision to request temporary continuation of
funding was made in a public meeting held in accordance with Gov-
ernment Code §§551.001 et seq.;
(B) the information submitted in the application is true
and correct according to the best knowledge and belief of the represen-
tative; and
(C) the governing body warrants compliance with the
representations made in the request in the event that the board deter-
mines temporary continuation of funding is appropriate.
(e) The board shall make its determination that the political
subdivision has sufcient safeguards in place to prevent the prolifera-
tion of colonias based on such factors as:
(1) a review of the residential subdivision regulations in
place;
(2) enforcement actions taken related to subdivision devel-
opment;
(3) the number of colonias created since the last funding
grant by the board; and
(4) other information as the board may request.
(f) Evidence of compliance by the political subdivision may
include but is not limited to the consideration of such factors as:
(1) adoption of revised regulations or ordinances;
(2) approval of amended plats;
(3) documentation that minimum water or wastewater fa-
cilities are in place or that appropriate nancial guarantees for improve-
ments have been posted; or
(4) documentation of corrective actions taken by the gov-
erning board, planning commission, service provider or other authority.
(g) Except as provided by subsections (a) - (c) of this section,
if the board determines that a county or city that is required to adopt
and enforce the model rules is not enforcing the model rules, the board
shall discontinue funding for all projects within the county or city that
are funded under Subchapter K, Chapter 17.
(h) The board may not accept or grant applications for tempo-
rary funding under subsection (a) of this section after June 1, 2009.
(i) This section will expire September 1, 2009.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.




Texas Water Development Board
Effective date: September 18, 2007
Proposal publication date: July 13, 2007
For further information, please call: (512) 936-2414
TITLE 40. SOCIAL SERVICES AND ASSIS-
TANCE
PART 20. TEXAS WORKFORCE
COMMISSION
CHAPTER 807. CAREER SCHOOLS AND
COLLEGES
The Texas Workforce Commission (Commission) adopts the fol-
lowing new section to Chapter 807, relating to Career Schools
and Colleges, with changes, as published in the June 22, 2007,
issue of the Texas Register (32 TexReg 3840):
Subchapter A, General Provisions, §807.7
The Commission adopts amendments to the following section
of Chapter 807, relating to Career Schools and Colleges, with
changes, as published in the June 22, 2007, issue of the Texas
Register (32 TexReg 3840):
Subchapter I, Application Fees and Other Charges, §807.152
PART I. PURPOSE, BACKGROUND, AND AUTHORITY
PART II. EXPLANATION OF INDIVIDUAL PROVISIONS WITH
COMMENTS AND RESPONSES
PART I. PURPOSE, BACKGROUND, AND AUTHORITY
The purpose of new §807.7, Exemptions, is to set forth a proce-
dure for the Commission to grant exemptions and hear appeals
regarding denied exemptions from the requirement for a certi-
cate of approval. Texas Education Code, Chapter 132, provides
a list of schools and courses of instruction that may be exempted
from the requirements of the Texas Education Code and do not
require a certicate of approval. The statute requires a school
to apply to the Commission for approval of such an exemption.
The new rule establishes a procedure for approving, denying, or
revoking exemptions. In addition, the new rule sets forth a pro-
cedure for appealing the denial or revocation of an exemption in
the same manner as the denial or revocation of a certicate of
approval.
The purpose of amending §807.152 is to more closely track
Texas Education Code, Chapter 132, and the exibility it pro-
vides the Commission with regard to the range of renewal
fees collected annually from career schools and colleges for
purposes of program administration.
Currently, renewal fees are assessed by applying a percent-
age to the gross tuition and fees, excluding refunds, of a career
school or college. Texas Education Code §132.201 provides that
renewal fees may be set by the Commission in an amount "not
to exceed 150 percent" of an amount that is determined by ap-
plying a percentage "not to exceed" 0.3%. The rule in its present
form does not provide this full range of options and, as such, is
more restrictive than the statute.
In adapting to circumstances, as currently, where the Com-
mission may otherwise collect more in fees than necessary
to administer Texas Education Code, Chapter 132; amending
§807.152 to allow the Commission to annually establish the
renewal fee percentage will provide the Commission exibility
in adapting to changing circumstances. The Commission antici-
pates that the result of this rule amendment, in the near term, will
be a lower fee for many schools. Schools currently assessed
the minimum fee will not see a reduction as the minimum does
not change.
Conversely, by mirroring the provisions of Texas Education Code
§132.201, the Commission will have the full range of rate-set-
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ting mechanisms to address any increased need for fee income.
This change ensures that the collection of renewal fees for cer-
tication of career schools and colleges is appropriately set to
sufciently cover the costs of administering the chapter.
PART II. EXPLANATION OF INDIVIDUAL PROVISIONS WITH
COMMENTS AND RESPONSES
SUBCHAPTER A. GENERAL PROVISIONS
The Commission adopts the following amendments to Subchap-
ter A:
§807.7. Exemptions
New §807.7(a) provides that a school or educational institution
may apply to the Commission for an exemption under §132.002
or §132.003 of the Texas Education Code.
New §807.7(b) provides that the Commission must grant the re-
quested exemption if the Commission determines that the school
or educational institution meets the statutory requirements for an
exemption under §132.002 or §132.003 of the Texas Education
Code.
New §807.7(c) provides that the Commission may deny or re-
voke an exemption in the same manner as a denial or revocation
of a certicate of approval, if the Commission determines that the
school or educational institution does not meet the requirements
for the exemption under §132.002 or §132.003 of the Texas Ed-
ucation Code.
New §807.7(d) provides that a school or educational institution
may appeal the denial or revocation of an exemption in the same
manner as for appealing the denial or revocation of a certicate
of approval.
SUBCHAPTER I. APPLICATION FEES AND OTHER
CHARGES
The Commission adopts the following amendments to Subchap-
ter I:
§807.152. Renewal Fees
Section 807.152 is amended to annually establish the renewal
fee percentage, which will provide the Commission exibility in
ensuring that the collection of renewal fees for certication of
career schools and colleges is in balance with the cost of admin-
istering Chapter 132 of the Texas Education Code. In adapting
to circumstances, as currently, where the Commission may oth-
erwise collect more in fees than necessary to administer Texas
Education Code, Chapter 132, enactment of this amendment is
anticipated, in the near term, to allow the Commission to lower
the fees currently collected and more appropriately fund the pro-
gram’s administration.
Comment: The commenter agreed with establishing an annual
renewal fee percentage affording the Agency exibility in setting
future renewal fees-including but not limited to lowering fees for
many schools. However, the commenter stated that overages
in collected fees should be appropriated and spent to better ad-
minister Texas Education Code, Chapter 132. The commenter
also expressed concern in processing and disseminating certi-
cates of renewal, representative approvals, new program (and
other) applications, and addressing unlicensed school violations
are not timely due to the limited number of staff. The commenter
asked that the Agency be tasked with collecting enough fees to
increase appropriations and spending the full measure of those
appropriated dollars to better administer Texas Education Code,
Chapter 132, by adding additional staff to the Career Schools
and Colleges program.
Response: The Commission appreciates the commenter’s sup-
port of an annual renewal fee that allows the Commission exibil-
ity to adapt to changing circumstances. By amending §807.152
to establish an annual renewal fee rate, the Commission’s intent
is to avoid the over collection of funds necessary to administer
the Career Schools and Colleges program in order to provide
appropriate services. The Commission believes the rule clearly
sets forth a process that ensures the collection of renewal fees in
balance with the cost of adequately administering Chapter 132.
Further, the Commission recognizes the importance that staff
plays in the ongoing success of the program. Staff makes ev-
ery attempt at processing and disseminating all information in a
timely manner. The Commission notes that the 80th Texas Leg-
islature, Regular Session (2007) approved its Exceptional Item
Appropriation request of General Revenue funding for the Fiscal
Year 2008-2009 biennium, thereby increasing appropriations for
two additional full-time equivalents for the Career Schools and
Colleges program.
COMMENTS WERE RECEIVED FROM:
Skip Walls, Board Member and Texas Workforce Commission
liaison for Career College and Schools of Texas
SUBCHAPTER A. GENERAL PROVISIONS
40 TAC §807.7
The rules are adopted under Texas Labor Code §301.0015 and
§302.002(d), which provide the Texas Workforce Commission
with the authority to adopt, amend, or repeal such rules as it
deems necessary for the effective administration of Agency ser-
vices and activities.
The adopted rules affect Title 4, Texas Labor Code, particularly
Chapters 301 and 302, as well as Texas Education Code, Chap-
ter 132.
§807.7. Exemptions.
(a) A school or educational institution may apply to the Com-
mission for an exemption under §132.002 or §132.003 of the Texas
Education Code.
(b) The Commission shall grant the requested exemption if the
Commission determines that the school or educational institution meets
the requirements for an exemption under §132.002 or §132.003 of the
Texas Education Code.
(c) The Commission may deny or revoke an exemption in the
same manner as a denial or revocation of a certicate of approval, if
the Commission determines that the school or educational institution
does not meet the requirements for the exemption under §132.002 or
§132.003 of the Texas Education Code.
(d) A school or educational institution may appeal the denial
or revocation of an exemption in accordance with the provisions of
Subchapter D of the Texas Education Code.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 28, 2007.
TRD-200703939
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Reagan Miller
Deputy Division Director, Workforce Policy and Service Delivery Branch
Texas Workforce Commission
Effective date: September 17, 2007
Proposal publication date: June 22, 2007
For further information, please call: (512) 475-0829
SUBCHAPTER I. APPLICATION FEES AND
OTHER CHARGES
40 TAC §807.152
The rules are adopted under Texas Labor Code §301.0015 and
§302.002(d), which provide the Texas Workforce Commission
with the authority to adopt, amend, or repeal such rules as it
deems necessary for the effective administration of Agency ser-
vices and activities.
The adopted rules affect Title 4, Texas Labor Code, particularly
Chapters 301 and 302, as well as Texas Education Code, Chap-
ter 132.
§807.152. Renewal Fees.
(a) For small schools, if a certicate of approval is issued for
more than one year, the renewal fee is $1,001, which may be paid with
$501 the rst year and $250 on the anniversary date of the certicate
for each subsequent year.
(b) For all other schools, the renewal fee is based on the gross
amount minus refunds of annual student tuition and fees. The Com-
mission will establish the renewal fee on an annual basis, based upon
the cost of administration of the chapter. The renewal fee will be set
in accordance with the provisions of §132.201 of the Texas Education
Code.
(c) For all schools, the Commission shall assess a penalty of
10% of the renewal fee, not less than $200 or more than $1,000, if the
school fails to le a complete application for renewal at least 30 days
before the expiration date of the certicate of approval.
This agency hereby certies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency’s
legal authority.
Filed with the Ofce of the Secretary of State on August 28, 2007.
TRD-200703940
Reagan Miller
Deputy Division Director, Workforce Policy and Service Delivery Branch
Texas Workforce Commission
Effective date: September 17, 2007
Proposal publication date: June 22, 2007
For further information, please call: (512) 475-0829
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Texas Department of Insurance
Proposed Action on Rules
EXEMPT FILING NOTIFICATION PURSUANT TO THE INSUR-
ANCE CODE CHAPTER 5, SUBCHAPTER L, ARTICLE 5.96
The Commissioner of Insurance (Commissioner) will hold a public
hearing under Docket No. 2671 on October 3, 2007, at 9:30 a.m., in
Room 100 of the William P. Hobby Building, 333 Guadalupe Street
in Austin, Texas to consider a petition by the staff of the Texas De-
partment of Insurance (Department) proposing the adoption of revised
Texas Workers’ Compensation Classication Relativities (classica-
tion relativities) to replace those adopted pursuant to Commissioner’s
Order No. 06-1309, dated December 15, 2006; and the adoption of a
revised table to amend the Texas Basic Manual of Rules, Classication,
and Experience Rating Plan for Workers’ Compensation and Employ-
ers’ Liability Insurance (Basic Manual) concerning the Expected Loss
Rates and Discount Ratios used in experience rating. Staff’s petition
(Reference No. W-0907-10-I) was led on September 4, 2007.
Staff requests that the proposed revised classication relativities be
available for adoption by insurers immediately, but that their use be
mandatory for all policies with an effective date on or after January
1, 2008, unless the insurer makes an independent ling to justify in-
surer-specic classication relativities. Staff further requests that the
revised table amending the Basic Manual be made effective for work-
ers’ compensation experience modiers with an effective date on or
after January 1, 2008.
Texas Insurance Code §2053.051 requires the Department to determine
hazards by class and establish classication relativities applicable to
the payroll in each class for workers’ compensation insurance. Section
2053.052 requires the Commissioner to adopt a uniform experience rat-
ing plan for workers’ compensation insurance. Sections 2053.051 and
2053.052 further provide that the classication system and experience
rating plans be revised at least once every ve years.
The classication relativities currently in effect are based on experi-
ence data reecting workers’ compensation experience from policies
with effective dates in 1999 through 2003. The proposed classication
relativities are based on the analysis of experience data from policies
with effective dates in 2000 through 2004. Staff’s proposed classica-
tion relativities reect changes in experience that occur over time.
Current classication relativities are at an average level of 65% of the
overall average level of the 1994 classication relativities. This 65%
level was adopted pursuant to Commissioner’s Order No. 04-1001,
dated October 14, 2004, to better reect improvements in experience
that had occurred with the passage of time.
Recent data and projections show that Texas loss experience has con-
tinued to improve. Therefore, staff proposes that each of the revised
classication relativities be multiplied by a factor of 60/65, to bring
the relativities to 60% of the overall average of the 1994 classication
relativities.
Staff recommends capping changes in the proposed classication rel-
ativities to +25% and -25% of the current classication relativities
prior to the adjustment to reduce the classication relativities to 60%
of the 1994 classication relativities. After adjustment for the latter
change, the proposed classication relativities will range from +15.4%
to -30.8% of the current classication relativities.
Modications to the classication relativities require concurrent
changes in the expected loss rates and discount ratios, which are
contained in Table II of the Basic Manual. The proposed expected
loss rates are based on the anticipated level of the losses that were
used to experience rate the average policy effective in 2008. Such
a policy would be effective on July 1, 2008, and would reect the
proposed classication relativities. Staff also proposes to cap changes
in the expected loss rates to +25% and -25% from the current expected
loss rates. Staff also proposes to revise the discount ratios in Table II
to reect the ratios that will exist for losses used to experience rate
policies effective in 2008. The changes in the discount ratios are not
subject to capping.
Copies of the full text of the staff petition and a schedule of the pro-
posed revised classication relativities and a table of the proposed ex-
pected loss rates and discount ratios are available for review in the
Ofce of the Chief Clerk of the Texas Department of Insurance, 333
Guadalupe Street, Austin, Texas 78714-9104. For further information
or to request copies of the petition and proposed revised schedule and
table, please contact Sylvia Gutierrez at ChiefClerk@tdi.state.tx.us,
(512) 463-6327 (Reference No. W-0907-10-I).
Comments on the proposed changes may be submitted in writing by
5:00 p.m. on October 15, 2007, to Gene Jarmon, General Counsel
and Chief Clerk, P.O. Box 149104, MC 113-2A, Austin, Texas 78714-
9104. An additional copy of the comment should be simultaneously
submitted to J’ne Byckovski, Chief Actuary, Property and Casualty
Program, P.O. Box 149104, MC 105-5F, Austin, Texas 78714-9104.
Interested persons may also submit oral and/or written comments at
the hearing.
This notication is made pursuant to the Texas Insurance Code, Article
5.96, which exempts action taken under this article from the require-
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General Counsel and Chief Clerk
Texas Department of Insurance
Filed: September 4, 2007
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Proposed Rule Reviews
Texas Medical Board
Title 22, Part 9
The Texas Medical Board proposes to review Chapter 162, §162.1 and
§162.2, concerning Supervision of Medical School Students, pursuant
to the Texas Government Code, §2001.039.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously proposes an amendment to §162.1.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
Comments on the proposed review may be submitted to Sally
Durocher, P.O. Box 2018, Austin, Texas 78768-2018.
TRD-200704027
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board proposes to review Chapter 164, §§164.1 -
164.5, concerning Physician Advertising, pursuant to the Texas Gov-
ernment Code, §2001.039.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
Comments on the proposed review may be submitted to Sally
Durocher, P.O. Box 2018, Austin, Texas 78768-2018.
TRD-200704028
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board proposes to review Chapter 173, §§173.1 -
173.5 and 173.7, concerning Physician Proles, pursuant to the Texas
Government Code, §2001.039.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously proposes amendments to §§173.1, 173.2 and
173.5.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
Comments on the proposed review may be submitted to Sally
Durocher, P.O. Box 2018, Austin, Texas 78768-2018.
TRD-200704029
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board proposes to review Chapter 196, §§196.1 -
196.5, concerning Voluntary Relinquishment or Surrender of a Medical
License, pursuant to the Texas Government Code, §2001.039.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously proposes amendments to §196.2 and §196.3.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
Comments on the proposed review may be submitted to Sally
Durocher, P.O. Box 2018, Austin, Texas 78768-2018.
TRD-200704030
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board proposes to review Chapter 198, §§198.1 -
198.6, concerning Unlicensed Practice, pursuant to the Texas Govern-
ment Code, §2001.039.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously proposes amendments to §198.2 and §198.3.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
Comments on the proposed review may be submitted to Sally
Durocher, P.O. Box 2018, Austin, Texas 78768-2018.
TRD-200704031
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
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The Texas Medical Board proposes to review Chapter 199, §§199.1 -
199.5, concerning Public Information, pursuant to the Texas Govern-
ment Code, §2001.039.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously proposes amendments to §199.1 and §§199.3 -
199.5.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
Comments on the proposed review may be submitted to Sally
Durocher, P.O. Box 2018, Austin, Texas 78768-2018.
TRD-200704032
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
Adopted Rule Reviews
Texas Education Agency
Title 19, Part 2
The Texas Education Agency (TEA) adopts the review of 19 TAC
Chapter 53, Regional Education Service Centers, Subchapter AA,
Commissioner’s Rules, pursuant to the Texas Government Code,
§2001.039. The TEA proposed the review of 19 TAC Chapter 53,
Subchapter AA, in the May 4, 2007, issue of the Texas Register (32
TexReg 2483).
The TEA nds that the reasons for adopting 19 TAC Chapter 53, Sub-
chapter AA, continue to exist.
Comment. The Texas Classroom Teachers Association (TCTA) com-
mented that the rule prohibiting people engaged in public education
from serving on education service center (ESC) boards of directors
should be changed. The TCTA recommended that, with teachers as
the focus of much of the work conducted by ESCs, teachers should
be allowed on the boards in order to convey the best strategy for im-
proving services to teachers. The TCTA proposed an election process
whereby one of the regional teachers of the year would be selected to
serve on the ESC board of directors on a basis determined by the TEA.
The TCTA also stated that although legislation requiring this change
(Senate Bill (SB) 1644) was not passed by the 80th Texas Legislature,
2007, there was substantial support for such a change.
Agency Response. The agency disagrees. The TCTA noted that one
of the reasons it suggested changing the provision that no one engaged
in education should be considered for an ESC board of directors is that
the prohibition is too broad. The TCTA suggested that a non-voting
regional teacher of the year would bring a new perspective to the board
because much of the work of the education service centers is directed
at the provision of professional development for teachers. While this
may be the case, the concern expressed in the prohibition is still valid.
The prohibition is directed at the possibility that a board member en-
gaged in education could inuence the work of the centers in directing
business to a school district or institution of higher education or cor-
poration involved in the educational process. By adding a teacher to
the board even as a non-voting member, the interests of that group in-
crease. If a teacher is added, district administrators or faculty members
of institutions of higher education may also request a seat on the board.
Regional education service centers should function on a neutral basis.
The way to help guarantee that neutrality is to keep the membership of
the ESC boards of directors free of stakeholder inuence. The current
structure for ESC boards of directors is established in statute.
Finally, the TCTA stated that the Texas Senate, during the 80th Texas
Legislature, 2007, passed SB 1644 and sent it to the Texas House of
Representatives. The bill would have accomplished the restructuring
of the ESC boards of directors. The TCTA suggested that the wide-
spread support generated by the bill demonstrated the value in includ-
ing teachers on ESC boards. However, the House did not debate or
vote on the legislation, and it is unknown whether it would have had
the support of a majority of the members of the House.
No changes are being proposed as a result of the review.
This concludes the review of 19 TAC Chapter 53.
TRD-200704065
Cristina De La Fuente-Valadez
Director, Policy Division
Texas Education Agency
Filed: September 4, 2007
Texas Medical Board
Title 22, Part 9
The Texas Medical Board adopts the review of Chapter 176, §§176.1
- 176.9, concerning Health Care Liability Lawsuits and Settlements,
pursuant to the Texas Government Code, §2001.039.
The proposed review was published in the June 29, 2007, issue of the
Texas Register (32 TexReg 4016).
No comments were received regarding adoption of the review.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously adopts amendments to §§176.1, 176.2, 176.4,
176.6, 176.8 and 176.9.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
This concludes the review of Chapter 176, Health Care Liability Law-
suits and Settlements.
TRD-200704033
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board adopts the review of Chapter 181, §§181.1
- 181.7, concerning Contact Lens Prescriptions, pursuant to the Texas
Government Code, §2001.039.
The proposed review was published in the June 29, 2007, issue of the
Texas Register (32 TexReg 4016).
No comments were received regarding adoption of the review.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously adopts amendments to §§181.2, 181.3 and 181.6.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
This concludes the review of Chapter 181, Contact Lens Prescriptions.
TRD-200704034
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Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board adopts the review of Chapter 191, §§191.1 -
191.5, concerning District Review Committees, pursuant to the Texas
Government Code, §2001.039.
The proposed review was published in the June 29, 2007, issue of the
Texas Register (32 TexReg 4016).
No comments were received regarding adoption of the review.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously adopts amendments to §191.4.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
This concludes the review of Chapter 191, District Review Commit-
tees.
TRD-200704035
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board adopts the review of Chapter 194, §§194.1
- 194.9 and 194.11, concerning Non-Certied Radiologic Technicians,
pursuant to the Texas Government Code, §2001.039.
The proposed review was published in the June 29, 2007, issue of the
Texas Register (32 TexReg 4016).
No comments were received regarding adoption of the review.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously adopts amendments to §§194.2 - 194.6.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
This concludes the review of Chapter 194, Non-Certied Radiologic
Technicians.
TRD-200704069
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: September 4, 2007
The Texas Medical Board adopts the review of Chapter 197, §§197.1 -
197.6, concerning Emergency Medical Service, pursuant to the Texas
Government Code, §2001.039.
The proposed review was published in the June 29, 2007, issue of the
Texas Register (32 TexReg 4016).
No comments were received regarding adoption of the review.
Elsewhere in this issue of the Texas Register, the Texas Medical Board
contemporaneously adopts amendments to §§197.1 - 197.4.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
This concludes the review of Chapter 197, Emergency Medical Ser-
vice.
TRD-200704036
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
The Texas Medical Board adopts the review of Chapter 200, §§200.1 -
200.3, concerning Standards for Physicians Practicing Complementary
and Alternative Medicine, pursuant to the Texas Government Code,
§2001.039.
The proposed review was published in the June 29, 2007, issue of the
Texas Register (32 TexReg 4016).
No comments were received regarding adoption of the review.
The agency’s reason for adopting the rules contained in this chapter
continues to exist.
This concludes the review of Chapter 200, Standards for Physicians
Practicing Complementary and Alternative Medicine.
TRD-200704037
Donald W. Patrick, MD, JD
Executive Director
Texas Medical Board
Filed: August 31, 2007
Texas State Board of Pharmacy
Title 22, Part 15
The Texas State Board of Pharmacy adopts the review of Chapter 291,
Subchapter F (§§291.101 - 291.105), concerning Non-Resident Phar-
macy (Class E), pursuant to the Texas Government Code §2001.039,
regarding Agency Review of Existing Rules. The proposed review was
published in the May 25, 2007, issue of the Texas Register (32 TexReg
2883).
No comments were received regarding the proposed rule review.
The agency nds the reason for adopting the rules continues to exist;




Texas State Board of Pharmacy
Filed: August 29, 2007
The Texas State Board of Pharmacy adopts the review of Chapter 295
(§§295.1 - 295.9, 295.11, 295.13, 295.15), concerning Pharmacists,
pursuant to the Texas Government Code §2001.039, regarding Agency
Review of Existing Rules. The proposed review was published in the
May 25, 2007, issue of the Texas Register (32 TexReg 2883).
No comments were received regarding the proposed rule review.
The agency nds the reason for adopting the rules continues to exist;
therefore, the agency readopts Chapter 295.
TRD-200703997
RULE REVIEW September 14, 2007 32 TexReg 6385
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Filed: August 29, 2007
32 TexReg 6386 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6387
32 TexReg 6388 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6389
32 TexReg 6390 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6391
32 TexReg 6392 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6393
32 TexReg 6394 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6395
32 TexReg 6396 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6397
32 TexReg 6398 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6399
32 TexReg 6400 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6401
32 TexReg 6402 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6403
32 TexReg 6404 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6405
32 TexReg 6406 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6407
32 TexReg 6408 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6409
32 TexReg 6410 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6411
32 TexReg 6412 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6413
32 TexReg 6414 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6415
32 TexReg 6416 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6417
32 TexReg 6418 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6419
32 TexReg 6420 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6421
32 TexReg 6422 September 14, 2007 Texas Register
TABLES AND GRAPHICS September 14, 2007 32 TexReg 6423
Department of Aging and Disability Services
Public Notice Announcing Pre-application Orientation (PAO)
for Enrollment of Medicaid Waiver Program Providers
The Department of Aging and Disability Services (DADS) will hold a
Pre-Application Orientation (PAO) for persons seeking to participate
as a program contractor in the Home and Community-Based Services
(HCS) and/or the Texas Home Living (TxHmL) Medicaid Waiver Pro-
grams.
There will be a non-refundable processing fee of $25.00 per registering
legal entity. Legal entities that do not attend the PAO will not receive
a refund of the processing fee. This fee will cover two representatives
per legal entity. No more than two representatives may attend and rep-
resent a legal entity. The processing fee must be submitted with the
registration form either by money order or cashiers check payable to:
Texas Department of Aging and Disability Services. DADS will not
accept cash or personal checks.
In addition, DADS will no longer be accepting faxes or any other
forms of written requests for the registration form. The registra-
tion form must be completed online. Persons wanting to attend the
PAO must access the registration form from the DADS website at:
http://www.dads.state.tx.us/forms/8629/. The registration form will
only be available on the DADS website beginning Tuesday, Septem-
ber 18, 2007, through Friday, November 16, 2007. The registration
form must be completed, printed, signed by the authorized repre-
sentative and returned to DADS.
Registration forms received by DADS without the processing fee or
original signatures will not be processed and attendance at the PAO
will not be allowed. There will be no exceptions.
Persons wanting to attend the PAO must submit their registration form
to DADS by mail or courier. Registration forms must be sent to:
Texas Department of Aging and Disability Services
Rodrick Pollock, Contract Specialist
Community Services Contracts (MC W-517)
P.O. Box 149030
Austin, Texas 78714-9030
The PAO will be held at 8:45 a.m., Monday, December 17, 2007,
in Austin, Texas at the J. J. Pickle Center. Registration will close
promptly at 8:40 a.m. Arrivals after 8:40 a.m. will not be admit-
ted, and will not receive a PAO Certicate of Attendance. (No
Exceptions)
To attend the PAO, an applicant must submit a completed registration
form to DADS in a timely manner. A completed registration form is
submitted timely only under the following conditions:
(1) if mailed via the US Postal Service, the completed registration form
bears a postmark date no later than Friday, November 16, 2007;
(2) if sent via a common or contract carrier, a receipt by the carrier
shows that it was placed in the hands of the carrier no later than Friday,
November 16, 2007; or
(3) if hand delivered, it is delivered directly to the DADS, Commu-
nity Services Contracts Unit, 701 W. 51st Street (MC W-517), Austin,
Texas, no later than Friday, November 16, 2007.
Persons requiring an interpreter for the deaf or hearing impaired, or any
other accommodation, must contact Rodrick Pollock at least 72 hours
prior to the PAO at (512) 438- 5428.
For any additional information concerning the PAO, you may contact
Art G. Gonzales, Program Specialist, at (512) 438-5737. Further infor-
mation regarding the PAO application process may be obtained on the
DADS website at: http://www.dads.state.tx.us/business/mental_retar-
dation/hcs/index.html.
Criminal History Record Information
In accordance with 42 Code of Federal Regulations (CFR) §455.106,
all applicants must disclose to DADS criminal history record informa-
tion about "all persons with an ownership or control interest" in the
applicant, or an "agent" or "managing employee" of the applicant. Sub-
mission of the criminal history record information will be required with
the DADS Application for Participation.
National Provider Identier
The Health Insurance Portability and Accountability Act (HIPAA) of
1996 requires health care entities to begin using National Provider
Identiers (NPI) on standard health care transactions. DADS is requir-
ing all health care entities applying to contract with DADS to obtain
and report their NPI number. You will be required to submit a NPI as-
signment letter or email from the National Plan and Provider Enumer-
ation System (NPPES), along with your Application for Participation
packet, which will be provided at the PAO.
In order to comply with this HIPAA requirement, effective December
1, 2006, all new contract applicants must obtain and report their NPI




Department of Aging and Disability Services
Filed: August 30, 2007
Texas Department of Agriculture
Request for Proposals: Texas Agricultural Finance Authority
Financial Advisor
1. Purpose.
The Texas Agricultural Finance Authority (the Authority), a public au-
thority established within the Texas Department of Agriculture (the
Department), seeks proposals in response to this Request for Propos-
als (RFP) from rms with the qualications and experience required to
provide nancial advisory services to the Authority. This RFP is issued
for the purpose of selecting a nancial advisor for all nancing matters
as described herein.
IN ADDITION September 14, 2007 32 TexReg 6425
The Authority reserves the right to select one or more co-nancial ad-
visors from rms that respond to this RFP. The Authority’s decision
to select a co-nancial advisor, if any, will be determined by the eval-
uation of the responses to the RFP. Please indicate in Part 1 of your
response whether your rm would like to serve as only a nancial ad-
visor, only a co-nancial advisor, or either.
2. Background of the Authority.
The Authority was created by the Texas Legislature under Texas Agri-
culture Code (the Code), Chapter 58, for the purpose of nancing inno-
vative, diversied, or value-added production, processing, marketing,
or exporting businesses in Texas and for providing nancial assistance
for other rural economic development activities. The Authority is gov-
erned by a nine-member Board of Directors (the Board), appointed by
the Governor with the consent of the State Senate for two-year stag-
gered terms. Employees of the Department are designated by the Com-
missioner of Agriculture to administer the Authority. The Authority
provides nancing alternatives through instruments including direct
loans, loan guaranties, loan participation, insurance or co-insurance.
Chapter 58 and Chapter 59 of the Code provide for the issuance by the
Authority of revenue bonds and general obligation bonds. Chapter 58
and Chapter 59 of the Code also provide for the issuance by the Au-
thority of revenue bonds and general obligation bonds. Under Chapter
58 of the Code, the Authority is authorized to issue up to $230 million
in general obligation bonds and up to $500 million in revenue bonds
for rural agricultural development and agricultural related projects in
the state of Texas. Under Chapter 59 of the Code, the Authority may
issue up to $300 million of general obligation bonds for nancing agri-
cultural real estate.
The Board may approve eligible borrowers for nancing through di-
rect loans, loan guaranties, loan participation, direct issuance of obli-
gations, or other nancial instruments.
3. Scope of Services.
Upon request, the nancial advisor is to be responsible for all duties
and services necessary or advisable to facilitate the issuance of bonds
and other obligations, including but not limited to: devising and rec-
ommending to the Board a plan of nancing for bonds to be issued,
which plan shall include a maturity schedule and other terms and con-
ditions, as well result in the most advantageous terms to the Author-
ity, consistent with a minimum effective interest rate; determining the
timing of the offering and the sizing of the issue; participating in docu-
ment preparation and assisting bond counsel in the coordination of the
offering; preparing such information, as necessary, for the rating agen-
cies and upon Authority approval, assisting in the presentation to such
agencies; assisting the Authority in maintaining on-going relationships
with the credit rating agencies; participation in public offering state-
ment (POS) and offering statement (OS) preparation and delivery of
a camera- ready copy to the printer; advising the Authority concern-
ing the need for credit enhancement and assisting in the negotiations
regarding such; assisting in the approval process of the Bond Review
Board and any other agency as necessary to the issuance of the bonds;
assisting in closing details and post-closing duties, including the devel-
opment of a nal report to the Bond Review Board to include a veri-
cation of all costs of issuance and preparation of a complete bond tran-
script; answering questions or requests for additional information from
prospective purchasers; evaluating any bids submitted for the purchase
of the bonds; advising the Authority with respect to the investment
of bonds proceeds and the accounting of arbitrage earnings; assisting
the Authority in providing information to various legislators and other
state agencies; advising the staff of the Authority and the Board of on-
going development in the bond industry as they affect the Authority;
soliciting bids for, contracting with, and paying on behalf of the Au-
thority, fees associated with the printing of bond offering documents,
ratings, trustee and paying agent fees and related services when neces-
sary; monitoring and controlling the costs of fees and expenses incurred
in connection with the issuance of the bonds; monitoring, suggesting
and advising the Authority on refunding opportunities, derivatives and
other nancial products that would help the Authority lower its cost of
borrowing; and all other matters necessary or incidental to the issuance
and administration of debt obligations.
In addition, the nancial advisor shall advise the Authority on any mat-
ters that might have an affect on the Authority or any of its outstanding
issues. The Authority will be responsible for allocating duties and tasks
between the Financial Advisor and Co-Financial Advisor, if any, com-
mensurate with level of compensations.
The nancial advisor and co-nancial advisor, if any, will not be per-
mitted to underwrite any portion of an issue or program for the Author-
ity during the term of employment.
4. Form of Response.
a. Overview of the Firm.
Provide a description of the rm, including general experience and his-
tory in public nance, date founded, number of ofces, location and
number of professionals and employees in each ofce, total number of
employees and professionals in the rm, description of specialty prac-
tice areas and rm philosophy. Describe structure of rm ownership
(e.g., publicly held corporation, partnership, etc.) and any parents, af-
liates, or subsidiaries of the rm.
b. Qualications.
List the experience since January 1, 1997, of the rm and/or profes-
sionals proposed to be assigned to the Authority (see number 6 below
also), as nancial advisor, nancial consultant, or senior manager on a
negotiated underwriting for the following types of issuers and issues.
If listing experience of a professional while at a different rm, please
specify the name of the rm. Please include the name of the issuer, title
of the bonds, date of the bonds, par amount of the issue, type of sale,
and role the rm played. Tabular format is acceptable.
By Issuer Type as follows: State of Texas issuers; Other issuers in
the State of Texas; Regional authorities and state-level issuers in states
other than Texas.
By Issue Type as follows: State level General Obligation Bonds; State
Revenue Bonds; Tax Exempt Commercial Paper; Taxable Commercial
Paper.
Please select one transaction from the above list that you feel best
demonstrates your ability to serve the Authority and describe in de-
tail the nancial issues involved in the transaction and your rm’s ap-
proach to the analysis. (Please limit your discussion to no more than
two pages.)
c. Other Experience.
Please describe your experience with respect to the following topics.
Include any specic suggestions or practices that as nancial advisor
you would recommend for the Authority. The topics are: arbitrage
compliance; continuing disclosure compliance; investor relation pro-
grams; interest rate swaps and other derivatives.
d. Bond Sale Pricing.
Describe the steps your rm would take as nancial advisor to ensure
the bidding process on competitive sales and the pricing process on
negotiated sales renders the lowest true interest cost for the Authority.
What role do you suggest the Authority play in organizing the sales
effort of the bonds (i.e., establishing priority of orders, designation
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rules, etc.)? What techniques would be most effective for the State
to achieve its HUB participation goals on competitive and negotiated
transactions? What techniques would you employ to evaluate senior
and co-manager performance on a specic transaction?
e. Credit Relations.
Describe your rm’s proposed approach to maintaining rating agency
relationships for the Authority.
Describe your rm’s recommended approach, if any, to developing and
maintaining investor relations programs. Address the costs and benets
of such programs and how they relate to continuing disclosure require-
ments.
f. Resumes.
Provide brief resumes for those individuals who would be assigned to
serve the Authority. Indicate the individuals’ years of experience in
public nance, any relevant licenses they hold, and how any particular
area of expertise would benet the Authority. Specify who would be
assigned as the primary day-to- day contact for the Authority and indi-
cated the role they played in the transactions listed above.
g. Business Practices.
Please describe your rm’s previous experience and involvement work-
ing with Historically Underutilized Businesses (HUB) certied rms
(if your rm is not HUB certied) or as a HUB certied rm, in a
co-nancial advisor relationship. Please describe your rm’s approach
to working with co-nancial advisor, including level of effort, and di-
vision of duties.
Please describe efforts made by your rm to encourage and develop
the participation of minorities and women in your rm’s provision of
nancial advisory services or underwriting, if any.
h. Conict of Interest.
Please disclose any conicts of interest. Disclose all contractual or in-
formal business arrangement/agreements, including fee arrangements
and consulting agreements between your Firm and the Authority, its
staff and/or its Board, or any entity that provides services to the Au-
thority.
i. References.
Please provide names, addresses, and phone numbers of at least two
references.
j. Fee Structure.
Please provide your fee structure, including if applicable, hourly rates,
a per transaction maximum on hourly fees, at fees, and a per transac-
tion cap on expenses (not to be exceeded without prior approval from
the Authority). Fees based on a percentage of the par amount of the
bonds or on a per bond basis are discouraged.
5. Term of Agreement.
The contract term is to be for a period beginning with the date of hiring
by the Authority to October 31, 2008. The Board may renew the con-
tract, at its option, for up to (2) additional terms of one (1) year each.
The Board retains the right to terminate the contract for any reason and
at any time, upon the payment of then earned fees and expenses.
6. Proposal Modication.
Any proposal may be modied or withdrawn, even after received by
the Authority, at any time prior to the proposal due date. No material
changes will be allowed after the expiration of the proposed due date;
however, non-substantive correction or deletions may be made with
the approval of the Authority. The Authority also reserves the right to
make amendments to the RFP by giving written notice to all rms who
receive the RFP and publishing notice thereof in the Texas Register.
7. Time Schedule.
Proposals are due no later than 5:00 p.m. on October 15, 2007.
Proposal responses, modications or addenda to an original response
received by the Authority after the specied time and date for closing
will not be considered. Each rm is responsible for ensuring that its
response reaches the Authority before the proposed due date. Firms
should submit one unbound original and three (3) copies of their pro-
posal to: Mr. Rick Rhodes, Assistant Commissioner for Rural Eco-
nomic Development, IN RESPONSE TO RFP: FINANCIAL AD-
VISOR, Texas Agricultural Finance Authority, c/o Texas Department
of Agriculture, P.O. Box 12847, Austin, Texas 78711, Street, Address:
1700 N. Congress, Stephen F. Austin Bldg., 10th Floor, Austin, Texas
78701.
A duly authorized representative of the rm must execute the submit-
ted RFP response. An unsigned proposal will not be accepted. All
proposals become the property of the Authority. Proposals must set
forth accurate and complete information as required by this RFP. Oral
instruction of offers will not be considered. Contact with Board Mem-
bers regarding this RFP is expressly prohibited and will result in dis-
qualication of your proposal. Questions regarding this RFP should
be submitted, in writing, to Mr. Rick Rhodes, assistant commissioner
for rural economic development, at the address listed above or by fax,
(888) 216-9867.
8. Basis of Award.
Department staff designated to administer the Authority programs will
review the proposals as directed by the Board. The selection will be
based on demonstrated competence, experience, knowledge and qual-
ications, as well as the reasonableness of the proposed fee.
Firms responding are encouraged to maintain a Texas ofce staffed
with personnel who are responsible for providing nancial advisory
services to the Authority. By this RFP, however, the Authority has not
committed itself to employ a nancial advisor nor does the suggested
scope of service or term of agreement below require that the nancial
advisor be employed for any or all of those purposes. The Authority
reserves the right to make those decisions after receipt of proposals and
the Authority’s decision on these matters is nal.
The Authority reserves the right to negotiate individual elements of any
proposal and to reject any and all proposals.
9. Cost Incurred in Responding.
All costs directly or indirectly related to preparation of a response to
the RFP or any oral presentation required to supplement and/or clarify
the RFP which may be required by the Authority shall be the sole re-
sponsibility of, and shall be borne by the applicant.
10. Release of Information and Open Records.
All proposals shall be deemed, once submitted, to be the property of the
Authority and subject to the Texas Public Information Act (the Act).
Under the Act, information submitted in response to this RFP may not
be released by the Authority during the proposal evaluation process
or prior to the awarding of a contract. After the evaluation process is
completed by the Authority and a contract is awarded, proposals and
information included therein may be subject to public disclosure under
the Act.
TRD-200704080
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Dolores Alvarado Hibbs
General Counsel
Texas Department of Agriculture
Filed: September 5, 2007
Ofce of the Attorney General
Request for Applications (RFA) for the Sexual Assault
Prevention and Crisis Services (SAPCS-Federal) Program
The Crime Victim Services Division (CVSD) of the Ofce of the Attor-
ney General (OAG) is soliciting local and statewide applications from
programs that wish to utilize SAPCS-Federal funds for projects that
support the primary prevention of sexual assault or sexual violence.
Applicable Funding Source: The source of federal funds includes
the Federal Department of Health and Human Services, Preventative
Health and Health Services Block Grant, Catalog of Federal Domestic
Assistance (CFDA) Number 93.991 and Injury Prevention and Control
Research and State and Community Based Programs, CFDA Number
93.136. The federal funds are used for grant contracts supporting the
prevention of sexual assault or sexual violence. All funding is con-
tingent upon the appropriation of funds by the United States Congress
and the Texas Legislature. The OAG makes no commitment that an
application, once submitted, or a grant, once funded, will receive sub-
sequent funding.
Eligibility Requirements: Only agencies that have not already re-
ceived an SAPCS-Federal award for FY2008 are eligible to apply. Eli-
gible applicants are: local units of government, excluding law enforce-
ment agencies and prosecutor’s ofces; non-prot agencies with 26.
U.S.C. 501(c)(3) status; and state agencies.
Local Programs: Eligible local programs must meet the local program
eligibility requirements for a SAPCS-State grant, which means the lo-
cal program must offer the following minimum services for at least
nine months prior to receiving an SAPCS grant contract: 24-hour crisis
hotline; crisis intervention; public education; advocacy and accompa-
niment to hospitals, law enforcement ofces, prosecutor’s ofces, and
courts for survivors and their family members; and crisis intervention
volunteer training.
Statewide Program: A statewide program, to be eligible for special
project funding, must show that it supports efforts to maintain or ex-
pand existing services offered by local sexual assault programs; im-
proves services to survivors; or other activities consistent with Texas
Government Code, Chapter 420.
Eligibility: The OAG will initially screen each application for eligibil-
ity. Applications will be deemed ineligible if the application is submit-
ted by an ineligible applicant; the application is not led in the manner
and form required by the RFA; the application is led after the deadline
established in the RFA; or the application does not meet other require-
ments as stated in the RFA and the Application Kit.
How to Obtain Application Kit: The OAG will post the
Application Kit on the OAG’s ofcial agency Web site at
http://www.oag.state.tx.us/victims/grants2008.shtml. Updates and
other helpful reminders about the application process will also be
posted at this location. Potential applicants are encouraged to refer
regularly to this Web site.
Deadlines and Filing Instructions for the Grant Application:
Deadline: Applicants must submit their application, including all re-
quired attachments, to the OAG and the OAG must receive the submit-
ted application and all required attachments by 5:00 p.m. CST October
5, 2007 to be considered timely led.
Filing Instructions: To meet the deadline, the applicant must submit
both paper (hard copies) and electronic (e-mail) documents. An
application will be considered led when the OAG receives the paper
(hard copies) and the electronic (e-mail) application in the following
ways by the required deadline:
(1) Paper (hard copies) - Via Next Day Air Overnight delivery ser-
vice (Federal Express, United Parcel Service, DHL or Lone Star):
The applicant must submit one original and three hard copies of the
complete application (Excel workbook and all attachments).
The complete application (Excel workbook and all attachments) must
be sent to the following address:
CVS GRANTS APPLICATIONS - MC 005
OFFICE OF THE ATTORNEY GENERAL
300 W. 15th St. Room 102
Austin, TX 78701-1649
The original and three hard copies must be received by 5:00 p.m. CST
on October 5, 2007.
Applications hand-delivered by the applicant or submitted via any kind
of same day courier service will not be accepted.
(2) Electronic - Via e-mail:
The applicant must submit the Excel workbook.
The Excel workbook must be sent to the following e-mail address:
CVSGrantsApplications@oag.state.tx.us
The e-mail must be received by 5:00 p.m. CST on October 5, 2007.
The OAG will not consider an application if it is not led by the due
date, 5:00 p.m. CST on October 5, 2007.
Minimum and Maximum Amounts of Funding Available: The min-
imum amount of funding all programs may apply for is $20,000 per s-
cal year. The maximum amounts of funding are as follows: new local
or statewide programs--$25,000 per scal year; currently funded lo-
cal programs--$100,000 per scal year; and currently funded statewide
programs--$300,000 per scal year.
Regardless of the maximums stated above, a program may not apply,
per scal year, for an amount higher than the SAPCS-Federal funds it
received in FY2007. The amount of an award is determined solely by
the OAG. The OAG may award grants at amounts above or below the
established funding levels and is not obligated to fund a grant at the
amount requested.
Start Date and Length of Grant Contract Period: The grant contract
period (term) is up to eighteen months from December 1, 2007 through
August 31, 2009, subject to and contingent upon funding and/or OAG
approval.
No Match Requirements: There are no match requirements for
SAPCS-Federal projects.
Volunteer Requirements: All SAPCS-Federal projects must have a
volunteer component. Specic requirements for the volunteer compo-
nent will be stated in the Application Kit.
Award Criteria: The OAG will make funding decisions that support
the efcient and effective use of public funds. Scoring components will
include, but are not limited to, information provided by the applicant
on the proposed project activities and budget.
SAPCS Purpose Area: The purpose of the SAPCS-Federal program
is to fund strategies and activities that support the primary prevention
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of sexual assault or sexual violence and any other purposes consistent
with Texas Government Code, Chapter 420.
Stafng: The funding priority for the SAPCS-Federal program is to
support positions that work towards the development and implementa-
tion of primary prevention strategies and activities. All SAPCS-Fed-
eral projects must:
(a) Include a minimum of 75% of an applicant’s budget in the personnel
and fringe budget categories.
(b) Designate and request funding for a Primary Prevention Coordi-
nator that is responsible for the development and implementation of
primary prevention strategies and activities. This position must, at a
minimum, work 20 hours per week on primary prevention activities.
In addition, only those staff positions that are directly related to achiev-
ing the goals of this project will be funded (this includes staff that
has direct involvement in the planning, implementation, or delivery of
project activities and those who directly supervise such staff).
Preference: The OAG reserves the right to consider all other appropri-
ations or funding an applicant currently receives when making funding
decisions. The OAG may give priority to applicants that do not re-
ceive other sources of funding, including funding that originates from
the Texas Compensation to Victims of Crime Fund. The OAG reserves
the right to give priority to programs that provide services in certain ge-
ographic or programmatic areas.
Prohibitions on Use of Grant Funds: OAG grant funds may not be
used to support or pay the costs of overtime, dues, or lobbying; any
portion of the salary or any other compensation for an elected govern-
ment ofcial; the purchase of food and beverages except as allowed
under Texas State Travel Guidelines; the purchase or lease of vehi-
cles; the purchase of promotional items or recreational activities; costs
of travel that are unrelated to the direct delivery of services that sup-
port the OAG funded program; the costs for consultants or vendors
who participate directly in writing a grant application; or for any unal-
lowable costs set forth in applicable state or federal law, rules, regula-
tions, guidelines, policies, procedures or cost principles. Grant funds
may not be used to purchase any other products or services the OAG
identies as inappropriate or unallowable within this RFA or the Ap-
plication Kit. Additional prohibitions include, but are not limited to,
using grant funds for: construction and/or renovation; development of
major software applications; administrative costs and/or personnel; di-
rect counseling, treatment, or advocacy services to victims or perpetra-
tors of sexual violence; media or awareness campaigns that exclusively
promote awareness of where to receive victim services; research; and
out-of-state travel for local programs.
OAG Contact Person: If additional information is needed, contact





Of¿ce of the Attorney General
Filed: September 4, 2007
Request for Applications (RFA) for the Sexual Assault
Prevention and Crisis Services (SAPCS-State) Program
The Crime Victim Services Division (CVSD) of the Ofce of the Attor-
ney General (OAG) is soliciting local and statewide applications from
programs that provide services to victims of sexual assault.
Applicable Funding Source: The source of state funds is a biennial
appropriation by the Texas Legislature; these funds are constitutionally
dedicated. Texas Code of Criminal Procedure, Article 56.541(e) autho-
rizes the OAG to use money appropriated from the Texas Compensa-
tion to Victims of Crime Fund for grant contracts supporting victim-re-
lated services or assistance. Additional funding comes from parole fees
pursuant to Texas Code of Criminal Procedure, Article 42.12, Section
19(e) and Texas Government Code, Section 508.189. All funding is
contingent upon an appropriation to the OAG by the Texas Legislature.
The OAG makes no commitment that an application, once submitted,
or a grant, once funded, will receive subsequent funding.
Eligibility Requirements: Only agencies that have not already re-
ceived an SAPCS-State award for FY2008 are eligible to apply. Eligi-
ble applicants are: local units of government, excluding law enforce-
ment agencies and prosecutor’s ofces; non-prot agencies with 26.
U.S.C. 501(c)(3) status; and state agencies.
Local Programs: A local program must offer the following minimum
services for at least nine months prior to receiving a SAPCS-State grant
contract: 24-hour crisis hotline; crisis intervention; public education;
advocacy and accompaniment to hospitals, law enforcement ofces,
prosecutor ofces, and courts for survivors and their family members;
and crisis intervention volunteer training.
Statewide Program: A statewide program, to be eligible for special
project funding, must show that it supports efforts to maintain or ex-
pand existing services offered by local sexual assault programs; im-
prove services to survivors; or other activities consistent with Texas
Government Code, Chapter 420.
Eligibility: The OAG will initially screen each application for eligibil-
ity. Applications will be deemed ineligible if the application is submit-
ted by an ineligible applicant; the application is not led in the manner
and form required by the RFA; the application is led after the deadline
established in the RFA; or the application does not meet other require-
ments as stated in the RFA and the Application Kit.
How to Obtain Application Kit: The OAG will post the
Application Kit on the OAG’s ofcial agency Web site at
http://www.oag.state.tx.us/victims/grants2008.shtml. Updates and
other helpful reminders about the application process will also be
posted at this location. Potential applicants are encouraged to refer
regularly to this Web site.
Deadlines and Filing Instructions for the Grant Application:
Deadline: Applicants must submit their application, including all re-
quired attachments, to the OAG and the OAG must receive the submit-
ted application and all required attachments by 5:00 p.m. CST October
5, 2007 to be considered timely led.
Filing Instructions: To meet the deadline, the applicant must submit
both paper (hard copies) and electronic (e-mail) documents. An appli-
cation will be considered led when the OAG receives the paper (hard
copies) and the electronic (e-mail) application in the following ways
by the required deadline:
(1) Paper (hard copies) - Via Next Day Air Overnight delivery ser-
vice (Federal Express, United Parcel Service, DHL or Lone Star):
The applicant must submit one original and three hard copies of the
complete application (Excel workbook and all attachments). The com-
plete application (Excel workbook and all attachments) must be sent to
the following address:
CVS Grants Applications - MC 005
Ofce of the Attorney General
300 W. 15th St. Room 102
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Austin, TX 78701-1649
The original and three hard copies must be received by 5:00 p.m. CST
on October 5, 2007.
Applications hand-delivered by the applicant or submitted via any kind
of same day courier service will not be accepted.
(2) Electronic - Via e-mail:
The applicant must submit the Excel workbook.
The Excel workbook must be sent to the following e-mail address:
CVSGrantsApplications@oag.state.tx.us
The e-mail must be received by 5:00 p.m. CST on October 5, 2007.
The OAG will NOT consider an Application if it is not led by the due
date, 5:00 p.m. CST on October 5, 2007.
Minimum and Maximum Amounts of Funding Available: The min-
imum amount of funding all programs may apply for is $20,000 per s-
cal year. The maximum amounts of funding are as follows: new local
or statewide programs--$30,000 per scal year; currently funded lo-
cal programs--$200,000 per scal year; and currently funded statewide
programs--$300,000 per scal year.
Regardless of the maximums stated above, a program may not apply,
per scal year, for an amount higher than the SAPCS-State funds it
received in FY2007. The amount of an award is determined solely by
the OAG. The OAG may award grants at amounts above or below the
established funding levels and is not obligated to fund a grant at the
amount requested.
Start Date and Length of Grant Contract Period: The grant con-
tract period (term) is up to eighteen (18) months from December 1,
2007 through August 31, 2009, subject to and contingent upon funding
and/or OAG approval.
No Match Requirements: There are no match requirements for
SAPCS-State projects.
Volunteer Requirements: All SAPCS-State projects must have a vol-
unteer component. Specic requirements for the volunteer component
will be stated in the Application Kit.
Award Criteria: The OAG will make funding decisions that support
the efcient and effective use of public funds. Scoring components will
include, but are not limited to, information provided by the applicant
on the proposed project activities and budget.
SAPCS Purpose Area: The purpose of the SAPCS-State program is
to maintain or expand the existing services of local sexual assault pro-
grams and any other purposes consistent with Texas Government Code,
Chapter 420.
Stafng: All SAPCS-State projects must:
(a) Include one direct service staff person working at least 20 hours per
week or two direct service staff persons working at least 10 hours each
per week in the applicant’s budget.
(b) Include a minimum of 75% of an applicant’s budget in the personnel
and fringe budget categories.
In addition, an applicant may not include more than three adminis-
trative positions providing administrative support to the SAPCS-State
project.
Preference: The OAG reserves the right to consider all other appropri-
ations or funding an applicant currently receives when making funding
decisions. The OAG may give priority to applicants that do not re-
ceive other sources of funding, including funding that originates from
the Texas Compensation to Victims of Crime Fund. The OAG reserves
the right to give priority to programs that provide services in certain ge-
ographic or programmatic areas.
Prohibitions on Use of Grant Funds: OAG grant funds may not be
used to support or pay the costs of overtime, dues, or lobbying; any por-
tion of the salary or any other compensation for an elected government
ofcial; the purchase of food and beverages except as allowed under
Texas State Travel Guidelines; the purchase or lease of vehicles; the
purchase of promotional items or recreational activities; out-of-state
travel or costs of travel that are unrelated to the direct delivery of ser-
vices that support the OAG funded program; the costs for consultants
or vendors who participate directly in writing a grant application; or for
any unallowable costs set forth in applicable state or federal law, rules,
regulations, guidelines, policies, procedures or cost principles. Grant
funds may not be used to purchase any other products or services the
OAG identies as inappropriate or unallowable within this RFA or the
Application Kit.
OAG Contact Person: If additional information is needed, contact





Of¿ce of the Attorney General
Filed: September 4, 2007
Coastal Bend Workforce Development Board
Request for Proposal - Career Center Operation and
Management
Using the Request for Proposals (RFP) method of procurement, the
Coastal Bend Workforce Development Board, d.b.a. WorkSource, is
soliciting proposals for the management and operation of its Workforce
Centers for Program Year 2007. The Coastal Bend region consists of
Aransas, Bee, Brooks, Duval, Jim Wells, Kenedy, Kleberg, Live Oak,
McMullen, Nueces, Refugio, and San Patricio Counties.
The Workforce Service Delivery System incorporates at a minimum,
general workforce information and referral; customer, employer, and
job seeker services; customer intake, eligibility and assessment; case
management; training, job placement; counseling, support services,
follow-up, and retention services as funded by the Workforce Invest-
ment Act, Temporary Assistance to Needy Families/Choices, Food
Stamps Employment Retention and Advancement Project, Wagner
Peyser, Veterans, and Reintegration of Offenders (RIO) for the 12
county area.
Interested parties may obtain a copy of the RFP by calling or e-mailing
Blair McDavid at (361) 225-1098, Ext.109 or blair.mcdavid@coastal-
worksource.com on Tuesday, September 4, 2007.
The deadline for receipt of proposals is Wednesday, October 10, 2007,
at 12:00 noon CST. Proposals should be addressed to WorkSource, at-
tention Blair McDavid, Procurement Manager, 400 Mann Street, Suite
1000, Corpus Christi, Texas 78401. Proposals received without the
proper forms or after the deadline, will not be considered. Mailed or
hand delivered responses are acceptable. Faxed or e-mailed copies will
not be considered.
WorkSource is an Equal Opportunity employer/program. Historically
Underutilized Businesses (HUBs) are encouraged to apply. Auxiliary
aids and services are available upon request to individuals with disabil-
ities. Telephone access is available by dialing 711.
TRD-200704085
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Blair McDavid
Manager of Facilities and Procurement
Coastal Bend Workforce Development Board
Filed: September 5, 2007
Request for Proposal for Youth Services
Using the Request for Proposals (RFP) method of procurement, the
Coastal Bend Workforce Development Board, d.b.a. WorkSource, is
soliciting proposals for delivery of Youth services within WorkSource’s
Workforce Centers for Program Year 2007. The Coastal Bend region
consists of Aransas, Bee, Brooks, Duval, Jim Wells, Kenedy, Kleberg,
Live Oak, McMullen, Nueces, Refugio, and San Patricio Counties.
The Board is soliciting proposals from qualied organizations to pro-
vide Youth program services for in-school and out-of-school youth ages
14 through 21 as authorized under Title I of the Workforce Investment
Act, the Final Rule (20CFR) of the U.S. Department of Labor, Texas
Workforce Commission rules and regulations, Board plan, and poli-
cies.
Youth service delivery will incorporate at a minimum general work-
force information and referral; customer and job seeker services; cus-
tomer intake, eligibility and assessment; case management; training,
job placement; counseling, support services, follow-up, and retention
services as funded by the Workforce Investment Act for the 12 county
area.
Interested parties may obtain a copy of the RFP by calling or e-mailing
Blair McDavid at (361) 225-1098, Ext.109 or blair.mcdavid@coastal-
worksource.com on Tuesday, September 4, 2007.
The deadline for receipt of proposals is Wednesday, October 10, 2007,
at 12:00 noon CST. Proposals should be addressed to WorkSource, at-
tention Blair McDavid, Procurement Manager, 400 Mann Street, Suite
1000, Corpus Christi, Texas 78401. Proposals received without the
proper forms or after the deadline, will not be considered. Mailed or
hand delivered responses are acceptable. Faxed or e-mailed copies will
not be considered.
WorkSource is an Equal Opportunity employer/program. Historically
Underutilized Businesses (HUB’s) are encouraged to apply. Auxiliary
aids and services are available upon request to individuals with disabil-
ities. Telephone access is available by dialing 711.
TRD-200704086
Blair McDavid
Manager of Facilities and Procurement
Coastal Bend Workforce Development Board
Filed: September 5, 2007
Comptroller of Public Accounts
Notice of Request for Proposals
Pursuant to Chapters 403 and 2254, Subchapter A, Texas Government
Code, and Chapter 2305, §2305.038, Texas Government Code, the
Comptroller of Public Accounts (Comptroller), State Energy Conser-
vation Ofce (SECO), announces the issuance of its Request for Pro-
posals (RFP #180e) from qualied, independent rms and institutions
to provide professional energy engineering assistance and related ser-
vices (Services) to public schools, hospitals, colleges, and universi-
ties for the Schools & Local Government Program (Program). One or
more successful respondents will assist Comptroller in providing en-
ergy engineering assistance to public schools, hospitals, colleges, and
universities as directed by Comptroller. Comptroller reserves the right
to award one or more contracts under this RFP. The successful respon-
dent(s), if any, will be expected to begin performance of the contract(s),
if any, on or about October 16, 2007, or as soon thereafter as practical.
Contact: Parties interested in submitting a proposal should contact
William Clay Harris, Assistant General Counsel, Contracts, Comptrol-
ler of Public Accounts, 111 E. 17th St., ROOM G-24, Austin, Texas
78774 (Issuing Ofce), telephone number: (512) 305-8673, to obtain
a copy of the RFP. The Comptroller will mail copies of the RFP only
to those specically requesting a copy. The RFP will be available for
pick-up at the above-referenced address on or after Friday, Septem-
ber 14, 2007, after 10:00 a.m., Central Zone Time (CZT), and dur-
ing normal business hours thereafter. Comptroller will also make the
complete RFP available electronically on the Electronic State Business
Daily (ESBD) after 10:00 a.m. (CZT), Friday, September 14, 2007.
All written inquiries, questions, and Non-Mandatory Letters of Intent
to propose must be received in the Issuing Ofce prior to 2 p.m. (CZT)
on Friday, September 21, 2007. Prospective respondents are encour-
aged to fax Letters of Intent and Questions to (512) 475-0973 to ensure
timely receipt. The responses to questions and other information per-
taining to this procurement will be posted on September 28, 2007, or as
soon thereafter as practical, on the ESBD at: http://esbd.cpa.state.tx.us.
Questions and inquiries received after the deadline will not be consid-
ered; respondents are solely responsible for verifying timely receipt in
the Issuing Ofce of Non-Mandatory Letters of Intent and Questions.
Closing Date: Proposals must be received in the Issuing Ofce at the
location specied above no later than 2 p.m. (CZT), on Friday, October
5, 2007. Proposals received in the Issuing Ofce after this time and date
will not be considered; respondents are solely responsible for verifying
timely receipt of Proposals in the Issuing Ofce.
Evaluation and Award Procedure: All proposals will be subject to eval-
uation by a committee based on the evaluation criteria and procedures
set forth in the RFP. Comptroller will make the nal decision. Comp-
troller reserves the right to accept or reject any or all proposals sub-
mitted. Comptroller is under no legal or other obligation to execute
a contract on the basis of this notice or the distribution of any RFP.
Comptroller shall pay for no costs incurred by any entity in responding
to this notice or the RFP.
The anticipated schedule of events is as follows: Issuance of RFP -
September 14, 2007; Non-Mandatory Letters of Intent and Questions
Due - September 21, 2007, 2 p.m. CZT; Ofcial Questions and Re-
sponses posted - September 28, 2007 (or as soon thereafter as practi-
cal); Proposals Due - October 5, 2007, 2 p.m. CZT; Contract Execution
- October 16, 2007, or as soon thereafter as practical; Commencement




Deputy General Counsel for Contracts
Comptroller of Public Accounts
Filed: September 5, 2007
Ofce of Consumer Credit Commissioner
Correction of Error
The Finance Commission of Texas proposed new 7 TAC §89.101 and
§89.102, concerning Property Tax Lenders. The notice appeared in the
August 31, 2007, issue of the Texas Register (32 TexReg 5568).
Due to an error by the Texas Register, the agency’s fax number was
published instead of the telephone number on the last line of the notice
IN ADDITION September 14, 2007 32 TexReg 6431
on page 5569. The last line should read: "For further information,
please call: (512) 936-7640."
TRD-200704092
Notice of Rate Ceilings
The Consumer Credit Commissioner of Texas has ascertained the fol-
lowing rate ceilings by use of the formulas and methods described in
§§303.003, 303.005, and 303.009, Texas Finance Code.
The weekly ceiling as prescribed by §303.003 and §303.009
for the period of 09/10/07 - 09/16/07 is 18% for Con-
sumer1/Agricultural/Commercial2/credit through $250,000.
The weekly ceiling as prescribed by §303.003 and §303.009 for the
period of 09/10/07 - 09/16/07 is 18% for Commercial over $250,000.
The monthly ceiling as prescribed by §303.0053 for the period of
09/01/07 - 09/30/07 is 18% for Consumer/Agricultural/Commer-
cial/credit through $250,000.
The monthly ceiling as prescribed by §303.005 for the period of
09/01/07 - 09/30/07 is 18% for Commercial over $250,000.
1Credit for personal, family or household use.
2Credit for business, commercial, investment or other similar purpose.




Of¿ce of Consumer Credit Commissioner
Filed: September 4, 2007
Texas Council for Developmental Disabilities
Intent to Award
The Texas Council for Developmental Disabilities announces its intent
to award funds to the Baylor College of Medicine - Transition Medicine
Clinic (TMC) project.
Background: The combined Medicine-Pediatric Residency program
at Baylor College of Medicine responded to a TCDD Request for Pro-
posals for unsolicited project proposals that would implement activities
in the TCDD State Plan. This proposal was reviewed and approved for
funding by the Council in their meeting August 3, 2007.
Description of Project: The Baylor Transition Medicine Clinic was
established in January 2005 with the goal of delivering a medical home
to the growing population of patients, ages 14 - 25, with disabilities and
chronic illnesses and assisting them and their families as they transition
from pediatric to adult-subspecialist services. It is believed to be the
only program of its kind in Texas and perhaps the nation, and offers a
medical home to patients with serious medical conditions. Baylor Col-
lege of Medicine initiated the project with seed funding that will end
in January 2008 and has seen a rise in the number of patients it serves.
Therefore, the Clinic requested funding to maintain and expand its pro-
gram while permanent funding is secured. TCDD believes this to be a
promising practice innovation that is consistent with two objectives in
the current TCDD State Plan.
Terms and Funding: Funding for this grant will end December 31,
2010. Funds awarded will not exceed $75,000 per year for up to three
years.
For information regarding this announcement please contact Patrice A.





Texas Council for Developmental Disabilities
Filed: September 5, 2007
Texas Commission on Environmental Quality
2007 Pollution Prevention Advisory Committee Request for
Nominations
The Texas Commission on Environmental Quality (commission) is so-
liciting nominations to ll several positions on the Pollution Prevention
Advisory Committee (PPAC). The legislatively created advisory com-
mittee, established under Texas Health and Safety Code, §361.0215,
advises the commission on the state’s policy and goals for pollution
prevention and waste minimization.
The PPAC is composed of nine voting members who offer a balanced
representation of environmental and public interest groups and the
regulated community. The nine ofcial members include: four
members from an environmental or public interest organization; four
members from the regulated community; and one member represent-
ing academia.
The commission may appoint ex ofcio members to provide additional
participation from other members of the regulated community and the
public who work on pollution prevention and performance-based reg-
ulatory initiatives. The commission currently has designated eight ex
ofcio positions including one representative from each of the follow-
ing sectors: small business, local government, agriculture, Department
of Defense, labor, and the CLEAN TEXAS Program. The commission
also extends ex ofcio positions to the chairs of the House Environmen-
tal Regulation Committee and the Senate Natural Resources Commit-
tee.
Individuals interested in being considered by the commission should
submit a one-page letter of interest and brief resume or biography. All
materials must be received by the commission no later than 5:00
p.m. on October 5, 2007.
The PPAC advises the commission on: the appropriate organization of
state agencies and the nancial and technical resources required to aid
the state in its efforts to promote waste reduction and minimization; the
development of public awareness programs to educate citizens about
hazardous waste and the appropriate disposal of hazardous waste and
hazardous materials that are used and collected by households; the pro-
vision of technical assistance to local governments for the development
of waste management strategies designed to assist small quantity gen-
erators of hazardous waste; other possible programs to more effectively
implement the state’s hierarchy of preferred waste management tech-
nologies as set forth in Texas Health and Safety Code, §361.023(a);
and the development of state purchasing guidelines for "environmen-
tally preferable" products, under the authority provided in Texas Health
and Safety Code, §361.423.
The PPAC operates under the requirements of 30 TAC Chapter 5, Ad-
visory Committees and Groups. The PPAC meets a minimum of four
times per year and as needed. Members may not miss three consecu-
tive regularly scheduled meetings or more than half of all the regularly
scheduled meetings in a one-year period. Semi-annual meetings typi-
cally last one full day and are typically held at the commission head-
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quarters in Austin, Texas. The 79th Legislature, 2005, authorized re-
imbursement for committee members’ travel expenses.
The commissioners invite nominations for these positions. Nomina-
tions may be made for oneself. Each nomination should include a brief
cover letter and biographical summary that includes the individual’s
experience and qualications, and an agreement to serve on the com-
mittee if appointed. Advisory committee members may serve two- or
four-year terms, except as otherwise provided by law. Please submit
nomination(s) for consideration by the commission for the following
terms: two full member representatives from the regulated com-
munity (to ll four-year terms that expire on August 31, 2011); two
full member representatives from an environmental or public in-
terest group (to ll four-year terms that expire on August 31, 2011);
one ex ofcio representative from the agricultural community (to
ll a four-year term that expires on August 31, 2011); one ex ofcio
representative from a small business (to ll a four-year term that
expires on August 31, 2011); and one ex ofcio representative from
a city or county government (to ll a four-year term that expires
on August 31, 2011).
Written nominations must be received in the Small Business and En-
vironmental Assistance Division Ofce by 5:00 p.m. on October 5,
2007, via mail, hand delivery, e-mail, or fax. Nominations should
be directed to: Ted Hazen, Small Business and Environmental Assis-
tance Division (MC 112), Texas Commission on Environmental Qual-
ity, P.O. Box 13087, Austin, Texas 78711-3087. They can also be sent
via e-mail to thazen@tceq.state.tx.us, or they can be faxed to (512)
239-3165. Documents can be submitted via hand delivery to the Small
Business and Environmental Assistance Division, 12100 Park 35 Cir-
cle, Building F, Suite 1301, Austin, Texas 78753.
Questions regarding the PPAC and the current nominations process can
be directed to Ted Hazen at (512) 239-3100.
TRD-200704048
Robert Martinez
Director, Environmental Law Division
Texas Commission on Environmental Quality
Filed: August 31, 2007
Agreed Orders
The Texas Commission on Environmental Quality (TCEQ or commis-
sion) staff is providing an opportunity for written public comment on
the listed Agreed Orders (AOs) in accordance with Texas Water Code
(the Code), §7.075. Section 7.075 requires that before the commission
may approve the AOs, the commission shall allow the public an op-
portunity to submit written comments on the proposed AOs. Section
7.075 requires that notice of the proposed orders and the opportunity
to comment must be published in the Texas Register no later than the
30th day before the date on which the public comment period closes,
which in this case is October 15, 2007. Section 7.075 also requires that
the commission promptly consider any written comments received and
that the commission may withdraw or withhold approval of an AO if a
comment discloses facts or considerations that indicate that consent is
inappropriate, improper, inadequate, or inconsistent with the require-
ments of the statutes and rules within the commission’s jurisdiction
or the commission’s orders and permits issued in accordance with the
commission’s regulatory authority. Additional notice of changes to a
proposed AO is not required to be published if those changes are made
in response to written comments.
A copy of each proposed AO is available for public inspection at both
the commission’s central ofce, located at 12100 Park 35 Circle, Build-
ing C, 1st Floor, Austin, Texas 78753, (512) 239-1864 and at the ap-
plicable regional ofce listed as follows. Written comments about an
AO should be sent to the enforcement coordinator designated for each
AO at the commission’s central ofce at P.O. Box 13087, Austin, Texas
78711-3087 and must be received by 5:00 p.m. on October 15, 2007.
Written comments may also be sent by facsimile machine to the en-
forcement coordinator at (512) 239-2550. The commission enforce-
ment coordinators are available to discuss the AOs and/or the comment
procedure at the listed phone numbers; however, §7.075 provides that
comments on the AOs shall be submitted to the commission in writing.
(1) COMPANY: ATC Leasing Company LLC; DOCKET NUMBER:
2007-0886-PST-E; IDENTIFIER: RN105224919; LOCATION:
Denton, Denton County, Texas; TYPE OF FACILITY: trucking
terminal with underground storage tank (UST); RULE VIOLATED:
30 Texas Administrative Code (TAC) §334.50(a)(1)(A) and the Code,
§26.3475(c)(1), by failing to have a release detection method capable
of detecting a release from any portion of the UST system; 30 TAC
§334.7(d)(3), by failing to notify the agency of any change or addi-
tional information regarding the USTs; and 30 TAC §334.48(a), by
failing to prevent an unauthorized discharge of diesel fuel; PENALTY:
$11,250; ENFORCEMENT COORDINATOR: Philip DeFrancesco,
(817) 588-5800; REGIONAL OFFICE: 2301 Gravel Drive, Fort
Worth, Texas 76118-6951, (817) 588-5800.
(2) COMPANY: Cemex Construction Materials, L.P.; DOCKET
NUMBER: 2007-0825-AIR-E; IDENTIFIER: RN100219435; LO-
CATION: El Paso, El Paso County, Texas; TYPE OF FACILITY:
rock crushing plant; RULE VIOLATED: 30 TAC §116.115(c), Air
Permit Numbers 47915 and 48255, Special Condition Number 8, and
Texas Health & Safety Code (THSC), §382.085(b), by failing to keep
accurate records; PENALTY: $2,000; ENFORCEMENT COORDI-
NATOR: Jessica Rhodes, (512) 239-2879; REGIONAL OFFICE: 401
East Franklin Avenue, Suite 560, El Paso, Texas 79901-1206, (915)
834-4949.
(3) COMPANY: Priten Y. Patel dba Easy Stop; DOCKET NUMBER:
2007-0776-PST-E; IDENTIFIER: RN102047313; LOCATION: Cros-
byton, Crosby County, Texas; TYPE OF FACILITY: convenience
store with retail sales of gasoline; RULE VIOLATED: 30 TAC
§334.8(c)(4)(A)(vii) and (c)(5)(B)(ii), by failing to renew a delivery
certicate by timely and proper submission of a completed UST
registration and self-certication form; PENALTY: $900; ENFORCE-
MENT COORDINATOR: Judy Kluge, (817) 588-5800; REGIONAL
OFFICE: 4630 50th Street, Suite 600, Lubbock, Texas 79414-3520,
(806) 796-7092.
(4) COMPANY: Harris County Municipal Utility District No.
358; DOCKET NUMBER: 2007-0061-MWD-E; IDENTIFIER:
RN102844776; LOCATION: Harris County, Texas; TYPE OF FACIL-
ITY: wastewater treatment; RULE VIOLATED: 30 TAC §305.125(1),
Texas Pollutant Discharge Elimination System (TPDES) Permit
Number 13296002, Interim II Efuent Limitations and Monitoring
Requirements Number 1, and the Code, §26.121(a), by failing to
comply with permitted limits for total copper; PENALTY: $2,900;
ENFORCEMENT COORDINATOR: Catherine Albrecht, (713)
767-3500; REGIONAL OFFICE: 5425 Polk Avenue, Suite H, Hous-
ton, Texas 77023-1486, (713) 767-3500.
(5) COMPANY: K&M Broussard Co.; DOCKET NUMBER:
2007-0808-MSW-E; IDENTIFIER: RN104859376; LOCATION:
Beaumont, Jefferson County, Texas; TYPE OF FACILITY: general
automotive maintenance; RULE VIOLATED: 30 TAC §324.6 and
40 Code of Federal Regulations §279.22(d), by failing to report and
respond to releases of used oil; PENALTY: $262; ENFORCEMENT
COORDINATOR: Clinton Sims, (512) 239-6933; REGIONAL OF-
FICE: 3870 Eastex Freeway, Beaumont, Texas 77703-1892, (409)
898-3838.
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(6) COMPANY: Fred E. Kubitza Jr.; DOCKET NUMBER: 2007-1158-
WOC-E; IDENTIFIER: RN103518668; LOCATION: Waco, McLen-
nan County, Texas; TYPE OF FACILITY: public water supply; RULE
VIOLATED: 30 TAC §30.5(a), by failing to obtain a required occupa-
tional license; PENALTY: $210; ENFORCEMENT COORDINATOR:
Melissa Keller, (512) 239-1768; REGIONAL OFFICE: 6801 Sanger
Avenue, Suite 2500, Waco, Texas 76710-7826, (254) 751-0335.
(7) COMPANY: Lindsey Contractors, Inc.; DOCKET NUMBER:
2007-1036-WQ-E; IDENTIFIER: RN105222772; LOCATION: Real
County, Texas; TYPE OF FACILITY: road construction site; RULE
VIOLATED: 30 TAC §327.5(a) and the Code, §26.121(a)(1), by
failing to prevent the discharge of asphalt emulsion; and 30 TAC
§327.3(b), by failing to provide notication to the commission of
a reportable discharge or spill within 24 hours of discovery of the
discharge; PENALTY: $6,000; ENFORCEMENT COORDINATOR:
Michael Meyer, (512) 239-4492; REGIONAL OFFICE: 14250 Judson
Road, San Antonio, Texas 78233-4480, (210) 490-3096.
(8) COMPANY: Rall Management Inc. dba Sunmart 435; DOCKET
NUMBER: 2006-0943-PST-E; IDENTIFIER: RN102060092; LO-
CATION: Montgomery County, Texas; TYPE OF FACILITY:
convenience store with retail sales of gasoline; RULE VIOLATED:
30 TAC §334.50(b)(1)(A), by failing to provide release detection;
PENALTY: $1,750; ENFORCEMENT COORDINATOR: Melissa
Keller, (512) 239-1768; REGIONAL OFFICE: 5425 Polk Avenue,
Suite H, Houston, Texas 77023-1486, (713) 767-3500.
(9) COMPANY: Tesco Industries, L.P.; DOCKET NUMBER:
2007-1003-AIR-E; IDENTIFIER: RN101908994; LOCATION:
Bellville, Austin County, Texas; TYPE OF FACILITY: furniture
manufacturing; RULE VIOLATED: 30 TAC §116.110(a) and THSC,
§382.085(b) and §382.0518(a), by failing to obtain authorization to
operate; PENALTY: $4,000; ENFORCEMENT COORDINATOR:
Rebecca Johnson, (713) 767-3500; REGIONAL OFFICE: 5425 Polk
Avenue, Suite H, Houston, Texas 77023-1486, (713) 767-3500.
(10) COMPANY: West Harris County Municipal Utility Dis-
trict 4; DOCKET NUMBER: 2007-0565-MWD-E; IDENTIFIER:
RN102821279; LOCATION: Harris County, Texas; TYPE OF FACIL-
ITY: wastewater treatment; RULE VIOLATED: 30 TAC §305.125(1)
TPDES Permit Number 12119001, Final Efuent Limitations and
Monitoring Requirement Numbers 1 and 2, and the Code, §26.121(a),
by failing to comply with the permitted efuent limits; PENALTY:
$5,080; ENFORCEMENT COORDINATOR: Deana Holland, (512)
239-2504; REGIONAL OFFICE: 5425 Polk Avenue, Suite H, Hous-




Texas Commission on Environmental Quality
Filed: September 5, 2007
Notice of Comment Period and Announcement of Public
Meeting on Proposed Air Quality Standard Permit for Sawmills
The Texas Commission on Environmental Quality (TCEQ) is provid-
ing an opportunity for public comment and will conduct a public meet-
ing to receive testimony concerning the sawmill standard air permit
proposed for issuance under the Texas Clean Air Act, Texas Health
and Safety Code, §382.05195, Standard Permit, and 30 TAC Chapter
116, Subchapter F, Standard Permits.
PROPOSED STANDARD PERMIT
The proposed new air quality standard permit for sawmills would re-
place the current permit by rule (PBR) for sawmills available under 30
TAC §106.223, Saw Mills. The usefulness of the PBR as an authoriza-
tion method is limited by the lack of lumber drying provisions. The
proposed standard permit would authorize lumber drying using a vari-
ety of methods that have been evaluated for protection of public health.
All other activities common to sawmills were also evaluated for their
effect on air quality standards and potential for nuisance resulting in re-
quired internal setbacks for equipment and stockpiles from the sawmill
property line. The proposed standard permit also contains re preven-
tion requirements. In a separate commission action, 30 TAC §106.223
will be repealed and will be unavailable for use upon issuance of this
standard permit.
The New Source Review Program under 30 TAC Chapter 116, Control
of Air Pollution by Permits for New Construction or Modication, re-
quires any person who plans to construct any new facility or to engage
in the modication of any existing facility which may emit air contam-
inants into the air of the state to obtain a permit in accordance with 30
TAC §116.111, General Application, satisfy the de minimis criteria of
30 TAC §116.119, De Minimis Facilities or Sources, or satisfy the con-
ditions of a standard permit, a exible permit, or a permit by rule before
any actual work is begun on the facility. A standard permit authorizes
the construction of new facilities or modication of existing facilities
that are similar in terms of operations, processes, and emissions.
A standard permit is subject to the procedural requirements of 30 TAC
§116.603, Public Participation in Issuance of Standard Permits, which
includes a 30-day public comment period and a public meeting to pro-
vide an additional opportunity for public comment. Any person who
may be affected by the emission of air pollutants from facilities that
may be authorized under the standard permit is entitled to submit writ-
ten or verbal comments regarding the proposed standard permit.
PUBLIC MEETING
A public meeting on the proposed standard permit for sawmills will
be held in Austin, Texas. The meeting will be structured for the re-
ceipt of oral or written comments by interested persons. Individuals
may present oral statements when called upon in order of registration.
Open discussion with the audience will not occur during the meeting;
however, TCEQ staff will be available to discuss the standard permit
for sawmills 30 minutes prior to the meeting and staff will also answer
questions after the meeting. The public meeting will be held on Octo-
ber 17, 2007 at 2:00 p.m. at the Texas Commission on Environmental
Quality, Building C, Room 131E, 12100 Park 35 Circle, Austin.
PUBLIC COMMENT AND INFORMATION
Copies of the proposed standard permit for sawmills may be obtained
from the TCEQ Web site at http://www.tceq.state.tx.us/permit-
ting/air/nav/standard.html or by contacting the Texas Commission
on Environmental Quality, Ofce of Permitting, Remediation, and
Registration, Air Permits Division, at (512) 239-1250. Comments may
be mailed to Beecher Cameron, Texas Commission on Environmental
Quality, Ofce of Permitting, Remediation, and Registration, Air Per-
mits Division, MC 163, P.O. Box 13087, Austin, Texas 78711-3087 or
faxed to (512) 239-1070. All comments should reference the standard
permit for sawmills. Comments must be received by 5:00 p.m. on
October 19, 2007. To inquire about the submittal of comments or for
further information, contact Mr. Cameron at (512) 239-1495. Si desea
información en Español, puede llamar al (800) 687-4040.
Persons who have special communication or other accommodation
needs who are planning to attend the public meeting should contact the
TCEQ at (512) 239-1495. Requests should be made as far in advance
as possible.
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TRD-200704050
Robert Martinez
Director, Environmental Law Division
Texas Commission on Environmental Quality
Filed: August 31, 2007
Notice of Opportunity to Comment on Settlement Agreements
of Administrative Enforcement Actions
The Texas Commission on Environmental Quality (TCEQ or commis-
sion) staff is providing an opportunity for written public comment on
the listed Agreed Orders (AOs) in accordance with Texas Water Code
(TWC), §7.075. Section 7.075 requires that before the commission
may approve the AOs, the commission shall allow the public an op-
portunity to submit written comments on the proposed AOs. Section
7.075 requires that notice of the opportunity to comment must be pub-
lished in the Texas Register no later than the 30th day before the date on
which the public comment period closes, which in this case is October
15, 2007. Section 7.075 also requires that the commission promptly
consider any written comments received and that the commission may
withdraw or withhold approval of an AO if a comment discloses facts
or considerations that indicate that consent is inappropriate, improper,
inadequate, or inconsistent with the requirements of the statutes and
rules within the commission’s jurisdiction or the commission’s orders
and permits issued in accordance with the commission’s regulatory au-
thority. Additional notice of changes to a proposed AO is not required
to be published if those changes are made in response to written com-
ments.
A copy of each proposed AO is available for public inspection at both
the commission’s central ofce, located at 12100 Park 35 Circle, Build-
ing A, 3rd Floor, Austin, Texas 78753, (512) 2393400 and at the ap-
plicable regional ofce listed as follows. Written comments about an
AO should be sent to the attorney designated for the AO at the com-
mission’s central ofce at P.O. Box 13087, MC 175, Austin, Texas
78711-3087 and must be received by 5:00 p.m. on October 15, 2007.
Comments may also be sent by facsimile machine to the attorney at
(512) 239-3434. The designated attorney is available to discuss the
AO and/or the comment procedure at the listed phone number; how-
ever, §7.075 provides that comments on an AO shall be submitted to
the commission in writing.
(1) COMPANY: Donald Burkhardt dba Clearwood Recycling Center;
DOCKET NUMBER: 2005-0959-MLM-E; TCEQ ID NUMBER:
RN102952785; LOCATION: 9520 Easthaven Boulevard, Houston,
Harris County, Texas; TYPE OF FACILITY: recycling facility;
RULES VIOLATED: 30 TAC §328.5(c)(1), (f), and (g), by failing to
make available for commission review a written cost estimate to show
the cost of hiring a third party to close the facility by disposition of
all processed and unprocessed materials in accordance with applicable
regulations; 30 TAC §328.5(d), (f), and (g), by failing to make avail-
able for commission review records that show Mr. Burke established
and maintained nancial assurance for closure of the facility in accor-
dance with 30 TAC Chapter 37, Subchapter J (relating to Financial
Assurance for Recycling Facilities); 30 TAC §328.5(h), by failing to
make available for commission review a copy of the facility’s re
prevention and suppression plan to the local re prevention authority
having jurisdiction over the facility; 30 TAC §330.15(c), by failing
to prevent the dumping of municipal solid waste without the written
authorization of the commission; 30 TAC §324.6 and 40 Code of
Federal Regulations Parts 264 and 265 and §279.22(a) and (c)(1), by
failing to label or clearly mark containers containing used oil with
the words "Used Oil"; and 30 TAC §324.4(1), by failing to prevent
the discharge of disposal of used oil in a manner that endangers the
public health or welfare of the environment; PENALTY: $6,774;
STAFF ATTORNEY: Kari Gilbreth, Litigation Division, MC 175,
(512) 239-1320; REGIONAL OFFICE: Houston Regional Ofce,




Texas Commission on Environmental Quality
Filed: August 31, 2007
Notice of Water Quality Applications
The following notices were issued during the period of August 23, 2007
through August 30, 2007.
The following require the applicants to publish notice in a newspaper.
Public comments, requests for public meetings, or requests for a con-
tested case hearing may be submitted to TCEQ, Ofce of the Chief
Clerk, MC-105, P.O. Box 13087, Austin, Texas 78711-3087, WITHIN
30 DAYS OF THE DATE OF NEWSPAPER PUBLICATION OF THE
NOTICE.
INFORMATION SECTION
CITY OF BARDWELL has applied for a renewal of TPDES Permit
No. 13675-001, which authorizes the discharge of treated domestic
wastewater at a daily average ow not to exceed 80,000 gallons per day.
The facility is located approximately 1,500 feet northeast of the inter-
section of Farm-to-Market Road 984 and State Highway 34, approxi-
mately 1,000 feet northwest of State Highway 34 and Farm-to-Market
Road 985, and 1/4 mile east of Bardwell city limits on the north side of
State Highway 34 in Ellis County, Texas.
HARRIS COUNTY MUNICIPAL UTILITY DISTRICT NO. 180 has
applied to for a renewal of TPDES Permit No. 12127-001 which au-
thorizes the discharge of treated domestic wastewater at a daily average
ow not to exceed 950,000 gallons per day. The facility is located at
5042 Innsbruk Drive, approximately 1/4 mile east of the intersection of
Kleinsbrook Road and Bammel-North Houston Road in Harris County,
Texas.
HARRIS COUNTY MUNICIPAL UTILITY DISTRICT NO. 278 has
applied for a renewal of TPDES Permit No. WQ0014289001, which
authorizes the discharge of treated domestic wastewater at a daily av-
erage ow not to exceed 375,000 gallons per day. The facility is lo-
cated approximately 400 feet north of Will Clayton Parkway, and ap-
proximately 1.6 miles east of the intersection of Wilson Road and Will
Clayton Parkway in Harris County, Texas.
INVERNESS FOREST IMPROVEMENT DISTRICT has applied for
a renewal of TPDES Permit No. 10783-001, which authorizes the dis-
charge of treated domestic wastewater at a daily average ow not to ex-
ceed 500,000 gallons per day. The facility is located on the north side
of Cypress Creek, approximately 800 feet east of Hardy Road bridge
crossing Cypress Creek in Harris County, Texas.
LAREDO WLE, LP which operates Laredo Power Station, has applied
for a renewal of TPDES Permit No. WQ0001200000, which authorizes
the discharge of cooling tower blowdown commingled with low vol-
ume waste, previously monitored chemical metal cleaning waste, and
storm water runoff at a daily average ow not to exceed 1,300,000 gal-
lons per day via Outfall 001, and chemical metal cleaning waste on
an intermittent and ow variable basis via Outfall 101. The facility is
located adjacent to the Rio Grande, west of the intersection of Inter-
state Highway 35 and Del Mar Boulevard in the City of Laredo, Webb
County, Texas.
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NORTH MISSION GLEN MUNICIPAL UTILITY DISTRICT has ap-
plied to the Texas Commission on Environmental Quality (TCEQ) for
a renewal of TPDES Permit No. WQ0012379001, which authorizes
the discharge of treated domestic wastewater at an annual average ow
not to exceed 1,180,000 gallons per day. The facility is located ap-
proximately 1/2 mile west of Gaines Road and approximately 3/4 mile
south of the intersection of Addicks-Clodine Road and Beechnut street
in Fort Bend County, Texas.
NRG TEXAS POWER LLC which operates the T.H. Wharton Electric
Generating Station, a steam electric station, has applied for a renewal of
TPDES Permit No. WQ0001039000, which authorizes the discharge
of: cooling tower blowdown, storm water, ush water, and previously
monitored efuents (PME from Outfalls 101, 201, 301 and 401 at a
daily average ow not to exceed 3.95 million gallons per day via Out-
fall 001, low volume wastewater on an intermittent and ow variable
basis via internal Outfall 101, metal cleaning wastewater on an inter-
mittent and ow variable basis via internal Outfall 201; low volume
wastewater, storm water, and spill prevention and control coutermea-
sures (SPCC) sources on an intermittent and ow variable basis via
internal Outfall 301; and treated domestic wastewater on a ow vari-
able basis via internal Outfall 401. The facility is located at 16301
State Highway 249, approximately 1000 feet south of the intersection
of Mills Road and State Highway 249 in the City of Houston, Harris
County, Texas.
CITY OF POINT has applied for a renewal of TPDES Permit No.
14470-001, which authorizes the discharge of treated lter backwash
water at a daily average ow not to exceed 48,000 gallons per day. The
facility is located one mile west of the intersection of Farm-to-Market
Road 47 and County Road 1470, on the north side of County Road 1470
in Rains County, Texas.
TEXAS DEPARTMENT OF TRANSPORTATION has applied for a
new permit, proposed Texas Pollutant Discharge Elimination System
(TPDES) Permit No. WQ0014790001, to authorize the discharge of
treated domestic wastewater at a daily average ow not to exceed
11,000 gallons per day. The facility was previously permitted under
TPDES Permit No. 12951-001 which expired September 1, 2006.
The facility is located on the northbound Right-of-Way of Interstate
Highway 35W, approximately 0.8 mile north of the intersection of
Interstate Highway 35W and Farm-to-Market Road 917 in Johnson
County, Texas.
THE TEXAS DEPARTMENT OF TRANSPORTATION has applied
to the TCEQ for a new permit to authorize the discharge of treated
domestic wastewater at a daily average ow not to exceed 15,000 gal-
lons per day. This facility was previously authorized under permit No.
11643-001 which expired February 1, 2007. The facility is located
along the southbound lane of U.S. Highway 59 approximately 1.5 miles
north of the intersection of U.S. Highway 59 and Farm-to-Market Road
942 in Polk County, Texas.
WESTSIDE WATER, LLC has applied to the Texas Commission on
Environmental Quality (TCEQ) for a major amendment to TPDES Per-
mit No. 14434-001 to authorize an increase in the discharge of treated
domestic wastewater from a daily average ow not to exceed 120,000
gallons per day to a daily average ow not to exceed 240,000 gallons
per day. The facility is located at 21118 West Farwood Terrace, Cypress
(2.1 miles northeast of the intersection of Bauer Road and U.S. 290
and approximately 2,000 feet north of Schiel Road) in Harris County,
Texas.
To view the complete issued notices, view the notices on our web site at
www.tceq.state.tx.us/comm_exec/cc/pub_notice.html or call the Ofce
of the Chief Clerk at (512) 239-3300 to obtain a copy of the complete
notice. When searching the web site, type in the issued date range
shown at the top of this document to obtain search results.
If you need more information about these permit applications or the
permitting process, please call the TCEQ Ofce of Public Assistance,
Toll Free, at 1-800-687-4040. General information about the TCEQ
can be found at our web site at www.tceq.state.tx.us. Si desea informa-




Texas Commission on Environmental Quality
Filed: September 5, 2007
Notice of Water Rights Applications
Notices issued August 29, 2007.
APPLICATION NO 12206; Jefferson County Drainage District, No. 6,
P.O. Box 20078, Beaumont, Texas 77720-0078, Applicant, has applied
for a Water Use Permit to construct and maintain multiple xed crest
weirs and one ap-gate outlet structure and to divert ood ows from
the South Fork Taylors Bayou, Neches-Trinity Coastal Basin, into an
excavated diversion channel for storage and discharge into the Gulf
Intercoastal Waterway for ood control purposes in Jefferson County.
The application and fees were received on May 11, 2007, and additional
information and fees were received on July 9, 2007. The application
was declared administratively complete and accepted for ling with the
Ofce of the Chief Clerk on July 18, 2007. Written public comments
and requests for a public meeting should be submitted to the Ofce of
Chief Clerk, at the address provided in the information section below,
within 30 days of the date of newspaper publication of the notice.
APPLICATION NO. 5889A; TXU Mining Company L.P. 1601 Bryan
Street, Dallas, TX 75201-3411, Applicant, has applied for an amend-
ment to Water Use Permit 5889 to maintain an additional existing reser-
voir known as AIV-4 on an unnamed tributary of Martin Creek for
mining purposes and to divert and use 250 acre-feet of water per year
on a term basis from three reservoirs being the two currently autho-
rized (AI-50R and AI-129R) and the additional reservoir (AIV-4) on
unnamed tributaries of Martin Creek, tributary of the Sabine River,
Sabine River Basin for mining purposes in Panola and Rusk Coun-
ties. The application and partial fees were received on April 26, 2007.
Additional information and fees were received on June 25, 2007. The
application was accepted for ling and declared administratively com-
plete on July 13, 2007. Written public comments and requests for a
public meeting should be submitted to the Ofce of Chief Clerk, at the
address provided in the information section below, within 30 days of
the date of newspaper publication of the notice.
INFORMATION SECTION
To view the complete issued notice, view the notice on our web site at
www.tceq.state.tx.us/comm_exec/cc/pub_notice.html or call the Ofce
of the Chief Clerk at (512) 239-3300 to obtain a copy of the complete
notice. When searching the web site, type in the issued date range
shown at the top of this document to obtain search results.
A public meeting is intended for the taking of public comment, and is
not a contested case hearing.
The Executive Director can consider approval of an application unless
a written request for a contested case hearing is led. To request a con-
tested case hearing, you must submit the following: (1) your name (or
for a group or association, an ofcial representative), mailing address,
daytime phone number, and fax number, if any: (2) applicant’s name
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and permit number; (3) the statement "I/we request a contested case
hearing;" and (4) a brief and specic description of how you would be
affected by the application in a way not common to the general public.
You may also submit any proposed conditions to the requested applica-
tion which would satisfy your concerns. Requests for a contested case
hearing must be submitted in writing to the TCEQ Ofce of the Chief
Clerk at the address provided in the information section below.
If a hearing request is led, the Executive Director will not issue the re-
quested permit and may forward the application and hearing request to
the TCEQ Commissioners for their consideration at a scheduled Com-
mission meeting.
Written hearing requests, public comments or requests for a public
meeting should be submitted to TCEQ, Ofce of the Chief Clerk, MC-
105, TCEQ, P.O. Box 13087, Austin, TX 78711-3087. For informa-
tion concerning the hearing process, please contact the Public Interest
Counsel, MC 103, at the same address. For additional information, in-
dividual members of the general public may contact the Ofce of Pub-
lic Assistance at 1-800-687-4040. General information regarding the
TCEQ can be found at our web site at www.tceq.state.tx.us. Si desea




Texas Commission on Environmental Quality
Filed: September 5, 2007
Texas Health and Human Services Commission
Correction of Error
The Texas Health and Human Services Commission submitted a public
notice concerning Amendment 765, Transmittal Number TX 07-066
for publication in the August 17, 2007, issue of the Texas Register (32
TexReg 5212). The document was docketed as TRD-200703410 and
appeared in the "In Addition" portion of the issue. Due to a Texas
Register mistake, a typographical error appears in the rst line of the
notice on page 5212, second column. The number "07-0066" should
be "07-066". The rst line of the notice should read as follows:
"The Texas Health and Human Services Commission announces its in-
tent to submit Amendment 765, Transmittal Number TX 07-066. . . ."
TRD-200704093
Notice of Public Hearing on Proposed Medicaid Payment Rates
Hearing. The Texas Health and Human Services Commission (HHSC)
will conduct a public hearing on October 1, 2007, at 1:00 p.m. to re-
ceive public comment on the proposed Medicaid payment rates for pro-
cedure codes relating to physician-administered drugs and contracep-
tives. These additions to the Texas Medicaid program are at the re-
quest of the Ofce of the Medical Director (OMD). The public hearing
will be held in the Lone Star Conference Room of the Texas Health
and Human Services Commission, Braker Center, Building H, located
at 11209 Metric Boulevard, Austin, Texas. Entry is through Security
at the main entrance of the building, which faces Metric Boulevard.
The hearing will be held in compliance with Human Resources Code
§32.0282 and 1 Texas Administrative Code (TAC) §355.201(e) - (f),
which require public notice and hearings on proposed Medicaid reim-
bursements. Persons requiring Americans with Disability Act (ADA)
accommodation or auxiliary aids or services should contact Kimbra
Rawlings by calling (512) 491-1174, at least 72 hours prior to the hear-
ing so appropriate arrangements can be made.
Proposal. The proposed payment rates will be effective November
28, 2007. The proposed payment rates for the physician-administered
drugs and contraceptives procedure codes are as follows:
Methodology and Justication. The proposed payment rates are cal-
culated in accordance with 1 TAC §355.8085, which addresses the re-
imbursement methodology for physicians and certain other practition-
ers; and the specic fee guidelines published in Section 2.2.1.2 of the
2007 Texas Medicaid Provider Procedures Manual. 1 TAC §355.8085
requires HHSC to review the fees for individual services at least every
two years.
Brieng Package. A brieng package describing the proposed pay-
ment rates will be available on or after September 17, 2007. Interested
parties may obtain a copy of the brieng package prior to the hearing
by contacting Kimbra Rawlings by telephone at (512) 491-1174; by fax
at (512) 491-1998; or by e-mail at Kimbra.Rawlings@hhsc.state.tx.us.
The brieng package also will be available at the public hearing.
Written Comments. Written comments regarding the proposed pay-
ment rates may be submitted in lieu of, or in addition to, oral testimony
until 5:00 p.m. the day of the hearing. Written comments may be sent
by U.S. mail to the attention of Kimbra Rawlings, Texas Health and
Human Services Commission, Rate Analysis, Mail Code H-400, P.O.
Box 85200, Austin, Texas 78708-5200; by fax to Kimbra Rawlings at
(512) 491-1998; or by e-mail to Kimbra.Rawlings@hhsc.state.tx.us. In
addition, written comments may be sent by overnight mail or hand de-
livered to Kimbra Rawlings, HHSC, Rate Analysis, Mail Code H-400,
Braker Center, Building H, 11209 Metric Boulevard, Austin, Texas
78758-4021.
* Required Notice: The ve character codes included in this notice are
obtained from the Current Procedural Terminology (CPT®), copyright
2006 by the American Medical Association (AMA). CPT is developed
by the AMA as a listing of descriptive terms and ve character iden-
tifying codes and modiers for reporting medical services and proce-
dures performed by physicians. The responsibility for the content of
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this notice is with HHSC and no endorsement by the AMA is intended
or should be implied. The AMA disclaims responsibility for any con-
sequences or liability attributable or related to any use, nonuse or in-
terpretation of information contained in this notice. Fee schedules,
relative value units, conversion factors and/or related components are
not assigned by the AMA, are not part of CPT, and the AMA is not rec-
ommending their use. The AMA does not directly or indirectly practice
medicine or dispense medical services. The AMA assumes no liability
for data contained or not contained herein. Any use of CPT outside of
this notice should refer to the most recent Current Procedural Termi-
nology, which contains the complete and most current listing of CPT
codes and descriptive terms. Applicable FARS/DFARS apply. CPT is a




Texas Health and Human Services Commission
Filed: September 5, 2007
Texas Department of Insurance
Company Licensing
Application for admission to the State of Texas by ZURICH COMPA-
NIA DE SEGUROS, S.A., a foreign re and/or casualty company. The
home ofce is in Lomas de Chapultepec, 1100 Mexico, D.F.
Application to change the name of INDUSTRIAL-ALLIANCE
PACIFIC LIFE INSURANCE COMPANY to INDUSTRIAL AL-
LIANCE PACIFIC INSURANCE AND FINANCIAL SERVICES
INC., a foreign life, accident and/or health company. The home ofce
is in Vancouver, Canada.
Any objections must be led with the Texas Department of Insurance,
within twenty (20) calendar days from the date of the Texas Regis-
ter publication, addressed to the attention of Godwin Ohaechesi, 333
Guadalupe Street, M/C 305-2C, Austin, Texas 78701.
TRD-200704082
Gene C. Jarmon
Chief Clerk and General Counsel
Texas Department of Insurance
Filed: September 5, 2007
Texas Lottery Commission
Instant Game Number 1001 "X’s & O’s"
1.0 Name and Style of Game.
A. The name of Instant Game No. 1001 is "X’S & O’S". The play style
is "row/column/diagonal".
1.1 Price of Instant Ticket.
A. Tickets for Instant Game No. 1001 shall be $3.00 per ticket.
1.2 Denitions in Instant Game No. 1001.
A. Display Printing - That area of the instant game ticket outside of the
area where the Overprint and Play Symbols appear.
B. Latex Overprint - The removable scratch-off covering over the Play
Symbols on the front of the ticket.
C. Play Symbol - The printed data under the latex on the front of the
instant ticket that is used to determine eligibility for a prize. Each Play
Symbol is printed in Symbol font in black ink in positive except for
dual-image games. The possible black play symbols are: X SYMBOL
and O SYMBOL.
D. Play Symbol Caption - The printed material appearing below each
Play Symbol which explains the Play Symbol. One caption appears
under each Play Symbol and is printed in caption font in black ink
in positive. The Play Symbol Caption which corresponds with and
veries each Play Symbol is as follows:
E. Retailer Validation Code - Three (3) letters found under the remov-
able scratch-off covering in the play area, which retailers use to verify
and validate instant winners. These three (3) small letters are for val-
idation purposes and cannot be used to play the game. The possible
validation codes are:
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Low-tier winning tickets use the required codes listed in Figure 2. Non-
winning tickets and high-tier tickets use a non-required combination of
the required codes listed in Figure 2 with the exception of ∅, which will
only appear on low-tier winners and will always have a slash through
it.
F. Serial Number - A unique 13 (thirteen) digit number appearing un-
der the latex scratch-off covering on the front of the ticket. There is a
boxed four (4) digit Security Number placed randomly within the Se-
rial Number. The remaining nine (9) digits of the Serial Number are the
Validation Number. The Serial Number is positioned beneath the bot-
tom row of play data in the scratched-off play area. The Serial Number
is for validation purposes and cannot be used to play the game. The
format will be: 0000000000000.
G. Low-Tier Prize - A prize of $3.00, $6.00, $9.00, $12.00, $18.00 or
$20.00.
H. Mid-Tier Prize - A prize of $40.00, $100 or $500.
I. High-Tier Prize - A prize of $1,000 or $30,000.
J. Bar Code - A 22 (twenty-two) character interleaved two (2) of ve
(5) bar code which will include a three (3) digit game ID, the seven
(7) digit pack number, the three (3) digit ticket number and the nine
(9) digit Validation Number. The bar code appears on the back of the
ticket.
K. Pack-Ticket Number - A 13 (thirteen) digit number consisting of the
three (3) digit game number (1001), a seven (7) digit pack number, and
a three (3) digit ticket number. Ticket numbers start with 001 and end
with 125 within each pack. The format will be: 1001-0000001-001.
L. Pack - A pack of "X’S & O’S" Instant Game tickets contains 125
tickets, packed in plastic shrink-wrapping and fanfolded in pages of
one (1). There will be 2 fanfold congurations for this game. Cong-
uration A will show the front of ticket 001 and the back of ticket 125.
Conguration B will show the back of ticket 001 and the front of ticket
125.
M. Non-Winning Ticket - A ticket which is not programmed to be a
winning ticket or a ticket that does not meet all of the requirements
of these Game Procedures, the State Lottery Act (Texas Government
Code, Chapter 466), and applicable rules adopted by the Texas Lottery
pursuant to the State Lottery Act and referenced in 16 TAC, Chapter
401.
N. Ticket or Instant Game Ticket, or Instant Ticket - A Texas Lottery
"X’S & O’S" Instant Game No. 1001 ticket.
2.0 Determination of Prize Winners. The determination of prize win-
ners is subject to the general ticket validation requirements set forth in
Texas Lottery Rule 401.302, Instant Game Rules, these Game Proce-
dures, and the requirements set out on the back of each instant ticket. A
prize winner in the "X’S & O’S" Instant Game is determined once the
latex on the ticket is scratched off to expose 18 (eighteen) Play Sym-
bols. If a player reveals 3 (three) X’s or 3 (three) O’s in any one row,
column or diagonal line, the player wins the corresponding prize. Each
game plays separately. No portion of the display printing nor any ex-
traneous matter whatsoever shall be usable or playable as a part of the
Instant Game.
2.1 Instant Ticket Validation Requirements.
A. To be a valid Instant Game ticket, all of the following requirements
must be met:
1. Exactly 18 (eighteen) Play Symbols must appear under the latex
overprint on the front portion of the ticket;
2. Each of the Play Symbols must have a Play Symbol Caption under-
neath, unless specied, and each Play Symbol must agree with its Play
Symbol Caption;
3. Each of the Play Symbols must be present in its entirety and be fully
legible;
4. Each of the Play Symbols must be printed in black ink except for
dual image games;
5. The ticket shall be intact;
6. The Serial Number, Retailer Validation Code and Pack-Ticket Num-
ber must be present in their entirety and be fully legible;
7. The Serial Number must correspond, using the Texas Lottery’s
codes, to the Play Symbols on the ticket;
8. The ticket must not have a hole punched through it, be mutilated,
altered, unreadable, reconstituted or tampered with in any manner;
9. The ticket must not be counterfeit in whole or in part;
10. The ticket must have been issued by the Texas Lottery in an autho-
rized manner;
11. The ticket must not have been stolen, nor appear on any list of
omitted tickets or non-activated tickets on le at the Texas Lottery;
12. The Play Symbols, Serial Number, Retailer Validation Code and
Pack-Ticket Number must be right side up and not reversed in any man-
ner;
13. The ticket must be complete and not miscut, and have exactly 18
(eighteen) Play Symbols under the latex overprint on the front portion
of the ticket, exactly one Serial Number, exactly one Retailer Validation
Code, and exactly one Pack-Ticket Number on the ticket;
14. The Serial Number of an apparent winning ticket shall correspond
with the Texas Lottery’s Serial Numbers for winning tickets, and a
ticket with that Serial Number shall not have been paid previously;
15. The ticket must not be blank or partially blank, misregistered, de-
fective or printed or produced in error;
16. Each of the 18 (eighteen) Play Symbols must be exactly one of
those described in Section 1.2.C of these Game Procedures;
17. Each of the 18 (eighteen) Play Symbols on the ticket must be
printed in the Symbol font and must correspond precisely to the artwork
on le at the Texas Lottery; the ticket Serial Numbers must be printed
in the Serial font and must correspond precisely to the artwork on le
at the Texas Lottery; and the Pack-Ticket Number must be printed in
the Pack-Ticket Number font and must correspond precisely to the art-
work on le at the Texas Lottery;
18. The display printing on the ticket must be regular in every respect
and correspond precisely to the artwork on le at the Texas Lottery;
and
19. The ticket must have been received by the Texas Lottery by appli-
cable deadlines.
B. The ticket must pass all additional validation tests provided for in
these Game Procedures, the Texas Lottery’s Rules governing the award
of prizes of the amount to be validated, and any condential validation
and security tests of the Texas Lottery.
C. Any Instant Game ticket not passing all of the validation require-
ments is void and ineligible for any prize and shall not be paid. How-
ever, the Executive Director may, solely at the Executive Director’s
discretion, refund the retail sales price of the ticket. In the event a de-
fective ticket is purchased, the only responsibility or liability of the
Texas Lottery shall be to replace the defective ticket with another un-
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played ticket in that Instant Game (or a ticket of equivalent sales price
from any other current Instant Lottery game) or refund the retail sales
price of the ticket, solely at the Executive Director’s discretion.
2.2 Programmed Game Parameters.
A. Adjacent tickets within a pack will not have identical patterns. Two
tickets have identical patterns when they have the same symbols in the
same positions.
B. There will be a random distribution of all symbols on the ticket
unless affected by other constraints, play action or prize structure.
C. All games on the ticket will be unique. Identical games are dened
as two games having the same symbols in the same positions.
D. Each game will have either four (4) X’s and ve (5) O’s, or ve (5)
X’s and four (4) O’s, except when required by the prize structure.
E. In each game, play symbols will be used evenly to form winning
matches, unless affected by other constraints in this document.
F. In each game, winning patterns will be distributed randomly, except
as required by prize structure and other constraints. A pattern is the
complete Tic Tac Toe grid, example: XXXXOOOXO.
2.3 Procedure for Claiming Prizes.
A. To claim a "X’S & O’S" Instant Game prize of $3.00, $6.00, $9.00,
$12.00, $18.00, $20.00, $40.00, $100, or $500, a claimant shall sign
the back of the ticket in the space designated on the ticket and present
the winning ticket to any Texas Lottery Retailer. The Texas Lottery
Retailer shall verify the claim and, if valid, and upon presentation of
proper identication, make payment of the amount due the claimant
and physically void the ticket; provided that the Texas Lottery Retailer
may, but is not, in some cases, required to pay a $40.00, $100 or $500
ticket. In the event the Texas Lottery Retailer cannot verify the claim,
the Texas Lottery Retailer shall provide the claimant with a claim form
and instruct the claimant on how to le a claim with the Texas Lottery.
If the claim is validated by the Texas Lottery, a check shall be for-
warded to the claimant in the amount due. In the event the claim is not
validated, the claim shall be denied and the claimant shall be notied
promptly. A claimant may also claim any of the above prizes under the
procedure described in Section 2.3.B and Section 2.3.C of these Game
Procedures.
B. To claim a "X’S & O’S" Instant Game prize of $1,000 or $30,000,
the claimant must sign the winning ticket and present it at one of the
Texas Lottery’s Claim Centers. If the claim is validated by the Texas
Lottery, payment will be made to the bearer of the validated winning
ticket for that prize upon presentation of proper identication. When
paying a prize of $600 or more, the Texas Lottery shall le the appropri-
ate income reporting form with the Internal Revenue Service (IRS) and
shall withhold federal income tax at a rate set by the IRS if required. In
the event that the claim is not validated by the Texas Lottery, the claim
shall be denied and the claimant shall be notied promptly.
C. As an alternative method of claiming a "X’S & O’S" Instant Game
prize, the claimant must sign the winning ticket, thoroughly complete a
claim form, and mail both to: Texas Lottery Commission, Post Ofce
Box 16600, Austin, Texas 78761-6600. The risk of sending a ticket
remains with the claimant. In the event that the claim is not validated
by the Texas Lottery, the claim shall be denied and the claimant shall
be notied promptly.
D. Prior to payment by the Texas Lottery of any prize, the Texas Lottery
shall deduct a sufcient amount from the winnings of a person who has
been nally determined to be:
1. delinquent in the payment of a tax or other money collected by the
Comptroller, the Texas Workforce Commission, or Texas Alcoholic
Beverage Commission;
2. delinquent in making child support payments administered or col-
lected by the Attorney General;
3. delinquent in reimbursing the Texas Health and Human Services
Commission for a benet granted in error under the food stamp pro-
gram or the program of nancial assistance under Chapter 31, Human
Resources Code;
4. in default on a loan made under Chapter 52, Education Code; or
5. in default on a loan guaranteed under Chapter 57, Education Code.
E. If a person is indebted or owes delinquent taxes to the State, other
than those specied in the preceding paragraph, the winnings of a per-
son shall be withheld until the debt or taxes are paid.
2.4 Allowance for Delay of Payment. The Texas Lottery may delay
payment of the prize pending a nal determination by the Executive
Director, under any of the following circumstances:
A. if a dispute occurs, or it appears likely that a dispute may occur,
regarding the prize;
B. if there is any question regarding the identity of the claimant;
C. if there is any question regarding the validity of the ticket presented
for payment; or
D. if the claim is subject to any deduction from the payment otherwise
due, as described in Section 2.3.D of these Game Procedures. No lia-
bility for interest for any delay shall accrue to the benet of the claimant
pending payment of the claim.
2.5 Payment of Prizes to Persons Under 18. If a person under the age
of 18 years is entitled to a cash prize of less than $600 from the "X’S &
O’S" Instant Game, the Texas Lottery shall deliver to an adult member
of the minor’s family or the minor’s guardian a check or warrant in the
amount of the prize payable to the order of the minor.
2.6 If a person under the age of 18 years is entitled to a cash prize of
more than $600 from the "X’S & O’S" Instant Game, the Texas Lottery
shall deposit the amount of the prize in a custodial bank account, with
an adult member of the minor’s family or the minor’s guardian serving
as custodian for the minor.
2.7 Instant Ticket Claim Period. All Instant Game prizes must be
claimed within 180 days following the end of the Instant Game or
within the applicable time period for certain eligible military personnel
as set forth in Texas Government Code Section 466.408. Any prize not
claimed within that period, and in the manner specied in these Game
Procedures and on the back of each ticket, shall be forfeited.
2.8 Disclaimer. The number of prizes in a game is approximate based
on the number of tickets ordered. The number of actual prizes available
in a game may vary based on number of tickets manufactured, testing,
distribution, sales and number of prizes claimed. An Instant Game
ticket may continue to be sold even when all the top prizes have been
claimed.
3.0 Instant Ticket Ownership.
A. Until such time as a signature is placed upon the back portion of an
Instant Game ticket in the space designated, a ticket shall be owned by
the physical possessor of said ticket. When a signature is placed on the
back of the ticket in the space designated, the player whose signature
appears in that area shall be the owner of the ticket and shall be entitled
to any prize attributable thereto. Notwithstanding any name or names
submitted on a claim form, the Executive Director shall make payment
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to the player whose signature appears on the back of the ticket in the
space designated. If more than one name appears on the back of the
ticket, the Executive Director will require that one of those players
whose name appears thereon be designated by such players to receive
payment.
B. The Texas Lottery shall not be responsible for lost or stolen Instant
Game tickets and shall not be required to pay on a lost or stolen Instant
Game ticket.
4.0 Number and Value of Instant Prizes. There will be approximately
5,040,000 tickets in the Instant Game No. 1001. The approximate
number and value of prizes in the game are as follows:
A. The actual number of tickets in the game may be increased or de-
creased at the sole discretion of the Texas Lottery Commission.
5.0 End of the Instant Game. The Executive Director may, at any time,
announce a closing date (end date) for the Instant Game No. 1001
without advance notice, at which point no further tickets in that game
may be sold.
6.0 Governing Law. In purchasing an Instant Game ticket, the player
agrees to comply with, and abide by, these Game Procedures for In-
stant Game No. 1001, the State Lottery Act (Texas Government Code,
Chapter 466), applicable rules adopted by the Texas Lottery pursuant
to the State Lottery Act and referenced in 16 TAC, Chapter 401, and





Filed: September 4, 2007
Instant Game Number 1014 "Stocking Stuffer"
1.0 Name and Style of Game.
A. The name of Instant Game No. 1014 is "STOCKING STUFFER".
The play style is "match 3 of 9 with auto win".
1.1 Price of Instant Ticket.
A. Tickets for Instant Game No. 1014 shall be $1.00 per ticket.
1.2 Denitions in Instant Game No. 1014.
A. Display Printing - That area of the instant game ticket outside of the
area where the Overprint and Play Symbols appear.
B. Latex Overprint - The removable scratch-off covering over the Play
Symbols on the front of the ticket.
C. Play Symbol - The printed data under the latex on the front of the
instant ticket that is used to determine eligibility for a prize. Each Play
Symbol is printed in Symbol font in black ink in positive except for
dual-image games. The possible black play symbols are: $1.00, $2.00,
$4.00, $5.00, $10.00, $20.00, $40.00, $50.00, $100, $1,000 and STAR
SYMBOL.
D. Play Symbol Caption - the printed material appearing below each
Play Symbol which explains the Play Symbol. One caption appears
under each Play Symbol and is printed in caption font in black ink
in positive. The Play Symbol Caption which corresponds with and
veries each Play Symbol is as follows:
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E. Retailer Validation Code - Three (3) letters found under the remov-
able scratch-off covering in the play area, which retailers use to verify
and validate instant winners. These three (3) small letters are for val-
idation purposes and cannot be used to play the game. The possible
validation codes are:
Low-tier winning tickets use the required codes listed in Figure 2. Non-
winning tickets and high-tier tickets use a non-required combination of
the required codes listed in Figure 2 with the exception of ∅, which will
only appear on low-tier winners and will always have a slash through
it.
F. Serial Number - A unique 13 (thirteen) digit number appearing un-
der the latex scratch-off covering on the front of the ticket. There is a
boxed four (4) digit Security Number placed randomly within the Se-
rial Number. The remaining nine (9) digits of the Serial Number are the
Validation Number. The Serial Number is positioned beneath the bot-
tom row of play data in the scratched-off play area. The Serial Number
is for validation purposes and cannot be used to play the game. The
format will be: 0000000000000.
G. Low-Tier Prize - A prize of $1.00, $2.00, $4.00, $5.00, $10.00 or
$20.00.
H. Mid-Tier Prize - A prize of $40.00, $50.00 or $100.
I. High-Tier Prize - A prize of $1,000.
J. Bar Code - A 22 (twenty-two) character interleaved two (2) of ve
(5) bar code which will include a three (3) digit game ID, the seven
(7) digit pack number, the three (3) digit ticket number and the nine
(9) digit Validation Number. The bar code appears on the back of the
ticket.
K. Pack-Ticket Number - A 13 (thirteen) digit number consisting of the
three (3) digit game number (1014), a seven (7) digit pack number, and
a three (3) digit ticket number. Ticket numbers start with 001 and end
with 150 within each pack. The format will be: 1014-0000001-001.
L. Pack - A pack of "STOCKING STUFFER" Instant Game tickets
contains 150 tickets, packed in plastic shrink-wrapping and fanfolded
in pages of ve (5). Tickets 001 to 005 will be on the top page; tickets
006 to 010 on the next page; etc.; and tickets 146 to 150 will be on the
last page with backs exposed. Ticket 001 will be folded over so the
front of ticket 001 and 010 will be exposed.
M. Non-Winning Ticket - A ticket which is not programmed to be a
winning ticket or a ticket that does not meet all of the requirements
of these Game Procedures, the State Lottery Act (Texas Government
Code, Chapter 466), and applicable rules adopted by the Texas Lottery
pursuant to the State Lottery Act and referenced in 16 TAC, Chapter
401.
N. Ticket or Instant Game Ticket, or Instant Ticket - A Texas Lottery
"STOCKING STUFFER" Instant Game No. 1014 ticket.
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2.0 Determination of Prize Winners. The determination of prize win-
ners is subject to the general ticket validation requirements set forth in
Texas Lottery Rule 401.302, Instant Game Rules, these Game Proce-
dures, and the requirements set out on the back of each instant ticket.
A prize winner in the "STOCKING STUFFER" Instant Game is deter-
mined once the latex on the ticket is scratched off to expose 9 (nine)
Play Symbols. If a player reveals 3 matching dollar amounts, the player
wins that dollar amount. If a player reveals 2 matching dollar amounts
and a STAR play symbol, the player wins that dollar amount instantly!
No portion of the display printing nor any extraneous matter whatso-
ever shall be usable or playable as a part of the Instant Game.
2.1 Instant Ticket Validation Requirements.
A. To be a valid Instant Game ticket, all of the following requirements
must be met:
1. Exactly 9 (nine) Play Symbols must appear under the latex overprint
on the front portion of the ticket;
2. Each of the Play Symbols must have a Play Symbol Caption under-
neath, unless specied, and each Play Symbol must agree with its Play
Symbol Caption;
3. Each of the Play Symbols must be present in its entirety and be fully
legible;
4. Each of the Play Symbols must be printed in black ink except for
dual image games;
5. The ticket shall be intact;
6. The Serial Number, Retailer Validation Code and Pack-Ticket Num-
ber must be present in their entirety and be fully legible;
7. The Serial Number must correspond, using the Texas Lottery’s
codes, to the Play Symbols on the ticket;
8. The ticket must not have a hole punched through it, be mutilated,
altered, unreadable, reconstituted or tampered with in any manner;
9. The ticket must not be counterfeit in whole or in part;
10. The ticket must have been issued by the Texas Lottery in an autho-
rized manner;
11. The ticket must not have been stolen, nor appear on any list of
omitted tickets or non-activated tickets on le at the Texas Lottery;
12. The Play Symbols, Serial Number, Retailer Validation Code and
Pack-Ticket Number must be right side up and not reversed in any man-
ner;
13. The ticket must be complete and not miscut, and have exactly 9
(nine) Play Symbols under the latex overprint on the front portion of
the ticket, exactly one Serial Number, exactly one Retailer Validation
Code, and exactly one Pack-Ticket Number on the ticket;
14. The Serial Number of an apparent winning ticket shall correspond
with the Texas Lottery’s Serial Numbers for winning tickets, and a
ticket with that Serial Number shall not have been paid previously;
15. The ticket must not be blank or partially blank, misregistered, de-
fective or printed or produced in error;
16. Each of the 9 (nine) Play Symbols must be exactly one of those
described in Section 1.2.C of these Game Procedures.
17. Each of the 9 (nine) Play Symbols on the ticket must be printed
in the Symbol font and must correspond precisely to the artwork on
le at the Texas Lottery; the ticket Serial Numbers must be printed in
the Serial font and must correspond precisely to the artwork on le at
the Texas Lottery; and the Pack-Ticket Number must be printed in the
Pack-Ticket Number font and must correspond precisely to the artwork
on le at the Texas Lottery;
18. The display printing on the ticket must be regular in every respect
and correspond precisely to the artwork on le at the Texas Lottery;
and
19. The ticket must have been received by the Texas Lottery by appli-
cable deadlines.
B. The ticket must pass all additional validation tests provided for in
these Game Procedures, the Texas Lottery’s Rules governing the award
of prizes of the amount to be validated, and any condential validation
and security tests of the Texas Lottery.
C. Any Instant Game ticket not passing all of the validation require-
ments is void and ineligible for any prize and shall not be paid. How-
ever, the Executive Director may, solely at the Executive Director’s
discretion, refund the retail sales price of the ticket. In the event a de-
fective ticket is purchased, the only responsibility or liability of the
Texas Lottery shall be to replace the defective ticket with another un-
played ticket in that Instant Game (or a ticket of equivalent sales price
from any other current Instant Lottery game) or refund the retail sales
price of the ticket, solely at the Executive Director’s discretion.
2.2 Programmed Game Parameters.
A. Consecutive non-winning tickets will not have identical play data,
spot for spot.
B. No four or more matching play symbols.
C. No three or more pairs of play symbols.
D. When the "star" (auto win) play symbol appears, there will only be
one pair of matching play symbols on the ticket.
E. The top prize will appear on every ticket.
2.3 Procedure for Claiming Prizes.
A. To claim a "STOCKING STUFFER" Instant Game prize of $1.00,
$2.00, $4.00, $5.00, $10.00, $20.00, $40.00, $50.00 or $100, a claimant
shall sign the back of the ticket in the space designated on the ticket and
present the winning ticket to any Texas Lottery Retailer. The Texas
Lottery Retailer shall verify the claim and, if valid, and upon presen-
tation of proper identication, make payment of the amount due the
claimant and physically void the ticket; provided that the Texas Lot-
tery Retailer may, but is not, in some cases, required to pay a $40.00,
$50.00 or $100 ticket. In the event the Texas Lottery Retailer cannot
verify the claim, the Texas Lottery Retailer shall provide the claimant
with a claim form and instruct the claimant on how to le a claim with
the Texas Lottery. If the claim is validated by the Texas Lottery, a check
shall be forwarded to the claimant in the amount due. In the event the
claim is not validated, the claim shall be denied and the claimant shall
be notied promptly. A claimant may also claim any of the above prizes
under the procedure described in Section 2.3.B and Section 2.3.C of
these Game Procedures.
B. To claim a "STOCKING STUFFER" Instant Game prize of $1,000,
the claimant must sign the winning ticket and present it at one of the
Texas Lottery’s Claim Centers. If the claim is validated by the Texas
Lottery, payment will be made to the bearer of the validated winning
ticket for that prize upon presentation of proper identication. When
paying a prize of $600 or more, the Texas Lottery shall le the appropri-
ate income reporting form with the Internal Revenue Service (IRS) and
shall withhold federal income tax at a rate set by the IRS if required. In
the event that the claim is not validated by the Texas Lottery, the claim
shall be denied and the claimant shall be notied promptly.
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C. As an alternative method of claiming a "STOCKING STUFFER" In-
stant Game prize, the claimant must sign the winning ticket, thoroughly
complete a claim form, and mail both to: Texas Lottery Commission,
Post Ofce Box 16600, Austin, Texas 78761-6600. The risk of send-
ing a ticket remains with the claimant. In the event that the claim is
not validated by the Texas Lottery, the claim shall be denied and the
claimant shall be notied promptly.
D. Prior to payment by the Texas Lottery of any prize, the Texas Lottery
shall deduct a sufcient amount from the winnings of a person who has
been nally determined to be:
1. delinquent in the payment of a tax or other money collected by the
Comptroller, the Texas Workforce Commission, or Texas Alcoholic
Beverage Commission;
2. delinquent in making child support payments administered or col-
lected by the Attorney General; or
3. delinquent in reimbursing the Texas Health and Human Services
Commission for a benet granted in error under the food stamp pro-
gram or the program of nancial assistance under Chapter 31, Human
Resources Code;
4. in default on a loan made under Chapter 52, Education Code; or
5. in default on a loan guaranteed under Chapter 57, Education Code.
E. If a person is indebted or owes delinquent taxes to the State, other
than those specied in the preceding paragraph, the winnings of a per-
son shall be withheld until the debt or taxes are paid.
2.4 Allowance for Delay of Payment. The Texas Lottery may delay
payment of the prize pending a nal determination by the Executive
Director, under any of the following circumstances:
A. if a dispute occurs, or it appears likely that a dispute may occur,
regarding the prize;
B. if there is any question regarding the identity of the claimant;
C. if there is any question regarding the validity of the ticket presented
for payment; or
D. if the claim is subject to any deduction from the payment otherwise
due, as described in Section 2.3.D of these Game Procedures. No lia-
bility for interest for any delay shall accrue to the benet of the claimant
pending payment of the claim.
2.5 Payment of Prizes to Persons Under 18. If a person under the age of
18 years is entitled to a cash prize of less than $600 from the "STOCK-
ING STUFFER" Instant Game, the Texas Lottery shall deliver to an
adult member of the minor’s family or the minor’s guardian a check or
warrant in the amount of the prize payable to the order of the minor.
2.6 If a person under the age of 18 years is entitled to a cash prize of
more than $600 from the "STOCKING STUFFER" Instant Game, the
Texas Lottery shall deposit the amount of the prize in a custodial bank
account, with an adult member of the minor’s family or the minor’s
guardian serving as custodian for the minor.
2.7 Instant Ticket Claim Period. All Instant Game prizes must be
claimed within 180 days following the end of the Instant Game or
within the applicable time period for certain eligible military personnel
as set forth in Texas Government Code Section 466.408. Any prize not
claimed within that period, and in the manner specied in these Game
Procedures and on the back of each ticket, shall be forfeited.
2.8 Disclaimer. The number of prizes in a game is approximate based
on the number of tickets ordered. The number of actual prizes available
in a game may vary based on number of tickets manufactured, testing,
distribution, sales and number of prizes claimed. An Instant Game
ticket may continue to be sold even when all the top prizes have been
claimed.
3.0 Instant Ticket Ownership.
A. Until such time as a signature is placed upon the back portion of an
Instant Game ticket in the space designated, a ticket shall be owned by
the physical possessor of said ticket. When a signature is placed on the
back of the ticket in the space designated, the player whose signature
appears in that area shall be the owner of the ticket and shall be entitled
to any prize attributable thereto. Notwithstanding any name or names
submitted on a claim form, the Executive Director shall make payment
to the player whose signature appears on the back of the ticket in the
space designated. If more than one name appears on the back of the
ticket, the Executive Director will require that one of those players
whose name appears thereon be designated by such players to receive
payment.
B. The Texas Lottery shall not be responsible for lost or stolen Instant
Game tickets and shall not be required to pay on a lost or stolen Instant
Game ticket.
4.0 Number and Value of Instant Prizes. There will be approximately
13,200,000 tickets in the Instant Game No. 1014. The approximate
number and value of prizes in the game are as follows:
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A. The actual number of tickets in the game may be increased or de-
creased at the sole discretion of the Texas Lottery Commission.
5.0 End of the Instant Game. The Executive Director may, at any time,
announce a closing date (end date) for the Instant Game No. 1014
without advance notice, at which point no further tickets in that game
may be sold.
6.0 Governing Law. In purchasing an Instant Game ticket, the player
agrees to comply with, and abide by, these Game Procedures for In-
stant Game No. 1014, the State Lottery Act (Texas Government Code,
Chapter 466), applicable rules adopted by the Texas Lottery pursuant
to the State Lottery Act and referenced in 16 TAC, Chapter 401, and





Filed: September 4, 2007
Public Utility Commission of Texas
Announcement of Application for an Amendment to a
State-Issued Certicate of Franchise Authority
The Public Utility Commission of Texas (commission) received an ap-
plication on August 28, 2007, for an amendment to a state-issued cer-
ticate of franchise authority (CFA), pursuant to §§66.001 - 66.016 of
the Public Utility Regulatory Act (PURA).
Project Title and Number: Application of Marcus Cable Associates,
LLC, d/b/a Charter Communications, for an Amendment to a State-Is-
sued Certicate of Franchise Authority, Project Number 34678 before
the Public Utility Commission of Texas.
Information on the application may be obtained by contacting the Pub-
lic Utility Commission of Texas by mail at P.O. Box 13326, Austin,
Texas 78711-3326, or by phone at (512) 936-7120 or toll free at 1-
888-782-8477. Hearing and speech-impaired individuals with text tele-
phone (TTY) may contact the commission at (512) 936-7136 or toll





Public Utility Commission of Texas
Filed: September 4, 2007
Notice of Application for a Certicate to Provide Retail
Electric Service
Notice is given to the public of the ling with the Public Utility Com-
mission of Texas of an application on August 30, 2007, for retail elec-
tric provider (REP) certication, pursuant to §§39.101 - 39.109 of the
Public Utility Regulatory Act (PURA).
Docket Title and Number: Application of ESCO1, LLC for Retail Elec-
tric Provider (REP) Certication, Docket Number 34689 before the
Public Utility Commission of Texas.
Applicant’s requested service area by geography includes the entire
State of Texas.
Persons wishing to comment upon the action sought should contact
the Public Utility Commission of Texas by mail at P.O. Box 13326,
Austin, Texas 78711-3326, or by phone at (512) 936-7120 or toll free
at 1-888-782-8477 no later than September 21, 2007. Hearing and
speech-impaired individuals with text telephone (TTY) may contact
the commission at (512) 936-7136 or toll free at 1-800-735-2989. All
comments should reference Docket Number 34689.
TRD-200704076
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Adriana A. Gonzales
Rules Coordinator
Public Utility Commission of Texas
Filed: September 4, 2007
Notice of Application for a Certicate to Provide Retail
Electric Service
Notice is given to the public of the ling with the Public Utility Com-
mission of Texas of an application on August 30, 2007, for retail elec-
tric provider (REP) certication, pursuant to §§39.101 - 39.109 of the
Public Utility Regulatory Act (PURA).
Docket Title and Number: Application of TexRep2, LLC for Retail
Electric Provider (REP) Certication, Docket Number 34690 before
the Public Utility Commission of Texas.
Applicant’s requested service area by geography includes the entire
State of Texas.
Persons wishing to comment upon the action sought should contact
the Public Utility Commission of Texas by mail at P.O. Box 13326,
Austin, Texas 78711-3326, or by phone at (512) 936-7120 or toll free
at 1-888-782-8477 no later than September 21, 2007. Hearing and
speech-impaired individuals with text telephone (TTY) may contact
the commission at (512) 936-7136 or toll free at 1-800-735-2989. All




Public Utility Commission of Texas
Filed: September 4, 2007
Notice of Application for Amendment to Certicated Service
Area Boundary
Notice is given to the public of an application led on August 30,
2007, with the Public Utility Commission of Texas (commission) for
an amendment to a certicated service area boundary in Collin County,
Texas.
Docket Style and Number: Application of AT&T Texas to Amend
Certicate of Convenience and Necessity between the McKinney and
Anna Exchanges, Docket Number 34694.
The Application: The minor boundary amendment is being led to
realign the service boundaries of the McKinney and Anna exchanges
of AT&T Texas.
Persons wishing to comment on the action sought or intervene should
contact the Public Utility Commission of Texas by September 21, 2007,
by mail at P.O. Box 13326, Austin, Texas 78711-3326, or by phone at
(512) 936-7120 or toll-free at 1-888-782-8477. Hearing and speech-
impaired individuals with text telephone (TTY) may contact the com-
mission at (512) 936-7136 or use Relay Texas (toll-free) 1-800-735-




Public Utility Commission of Texas
Filed: September 4, 2007
Notice of Application for Sale, Transfer, or Merger
Notice is given to the public of a joint application for sale, transfer, or
merger led with the Public Utility Commission of Texas (commission)
on August 30, 2007, pursuant to the Public Utility Regulatory Act,
Texas Utilities Code Annotated §§14.101, 36.001, and 37.154 (Vernon
2007) (PURA).
Docket Style and Number: Joint Application of LCRA Transmission
Services Corporation and AEP Texas Central Company to Transfer
Certicate Rights and for Approval of Transfer of Facilities, Docket
Number 34684.
The Application: This transaction involves the transfer from AEP
Texas Central Company to LCRA Transmission Services Corporation
(collectively, Applicants) certain AEP Texas Central-owned 69-kv
transmission lines and related facilities and associated certicate of
convenience and necessity (CCN) rights. The transmission lines,
the total length of which is approximately 273 miles, are located
in Caldwell, Guadalupe, Gonzales, Karnes, Dewitt, Colorado, and
Wharton Counties. They are being transferred at their net book value,
which was approximately $3 million as of March 2007 and will be
updated when the transaction closes after regulatory approvals have
been obtained. The facilities proposed for transfer from AEP Texas
Central to LCRA TSC comprise the following: (a) the Glidden to El
Campo Loop; and (b) the Luling to Kenedy Loop.
Persons who wish to intervene in the proceeding or comment upon the
action sought should contact the Public Utility Commission of Texas,
P.O. Box 13326, Austin, Texas 78711-3326, or call the commission’s
Ofce of Customer Protection at (512) 936-7120 or (888) 782-8477.
Hearing- and speech-impaired individuals with text telephones (TTY)
may contact the Commission at (512) 936-7136 or use Relay Texas





Public Utility Commission of Texas
Filed: September 4, 2007
Notice of Application for Waiver
Notice is given to the public of the ling with the Public Utility Com-
mission of Texas of an application on August 28, 2007 for waiver
from the ling requirements in Project Number 34515 and a permanent
waiver from the requirements of P.U.C. Substantive Rule §22.223(g).
Docket Title and Number: Application of Panhandle Telephone Co-
operative, Inc. for Exemption from Project Number 34515 and P.U.C.
Substantive Rule §26.22(g); Docket Number 34679.
Persons who wish to comment upon the action sought should contact
the Public Utility Commission of Texas by mail at P.O. Box 13326,
Austin, Texas 78711-3326, or by phone at (512) 936-7120 or toll free
at 1-888-782-8477. Hearing and speech-impaired individuals with text
telephone (TTY) may contact the commission at (512) 936-7136 or





Public Utility Commission of Texas
Filed: September 4, 2007
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Texas Department of Transportation
Aviation Division - Request for Proposal for Aviation
Engineering Services
The City of Coleman, through its agent the Texas Department of Trans-
portation (TxDOT), intends to engage an aviation professional engi-
neering rm for services pursuant to Government Code, Chapter 2254,
Subchapter A. TxDOT Aviation Division will solicit and receive pro-
posals for professional aviation engineering design services described
below:
The following is a listing of proposed projects at the Coleman Munic-
ipal Airport during the course of the next ve years through multiple
grants.
Current Project: TxDOT CSJ No. 0823COLMN. Scope: Provide en-
gineering/design services to rehabilitate and mark Runway 15-33, re-
habilitate hangar access taxiway, rehabilitate and mark stub taxiway,
rehabilitate and mark taxiway to Runway 33 end, rehabilitate and mark
apron, rehabilitate and mark taxiway to Runway 15 end, install game
fencing at the Coleman Municipal Airport.
The DBE goal is set at 6%. TxDOT Project Manager is Clayton Brid-
well.
Future scope work items for engineering/design services within the
next ve years may include but are not necessarily limited to the fol-
lowing:
1. Expand terminal apron
The City of Coleman reserves the right to determine which of the above
scope of services may or may not be awarded to the successful rm and
to initiate additional procurement action for any of the services above.
To assist in your proposal preparation the criteria, 5010 draw-
ing and most recent airport layout plan are available online at
www.dot.state.tx.us/avn/avninfo/notice/consult/index.htm by se-
lecting Coleman Municipal Airport. The proposal should address
a technical approach for the current scope. Firms shall use page
4, Recent Airport Experience, to list relevant past projects for both
current and future scope.
Interested rms shall utilize the latest version of Form AVN-550, titled
"Aviation Engineering Services Proposal". The form may be requested
from TxDOT Aviation Division, 125 East 11th Street, Austin, Texas
78701-2483, phone number, 1-800-68-PILOT (74568). The form may
be emailed by request or downloaded from the TxDOT web site at
www.dot.state.tx.us/services/aviation/consultant.htm. The form
may not be altered in any way. All printing must be in black on white
paper, except for the optional illustration page. Firms must carefully
follow the instructions provided on each page of the form. Proposals
may not exceed the number of pages in the proposal format. The
proposal format consists of seven pages of data plus two optional
pages consisting of an illustration page and a proposal summary page.
Proposals shall be stapled but not bound in any other fashion. PRO-
POSALS WILL NOT BE ACCEPTED IN ANY OTHER FORMAT.
ATTENTION: To ensure utilization of the latest version of Form AVN-
550, rms are encouraged to download Form AVN-550 from the Tx-
DOT website as addressed above. Utilization of Form AVN-550 from a
previous download may not be the exact same format. Form AVN-550
is a PDF Template.
Please note:
Five completed, unfolded copies of Form AVN-550 must be received
by TxDOT Aviation Division at 150 East Riverside Drive, 5th Floor,
South Tower, Austin, Texas 78704 no later than October 9, 2007, 4:00
p.m. Electronic facsimiles or forms sent by email will not be accepted.
Please mark the envelope of the forms to the attention of Sheri Quinlan.
The consultant selection committee will be composed of local
government members. The nal selection by the committee will
generally be made following the completion of review of proposals.
The committee will review all proposals and rate and rank each.
The criteria for evaluating engineering proposals can be found at
http://www.dot.state.tx.us/services/aviation/consultant.htm. All
rms will be notied and the top rated rm will be contacted to begin
fee negotiations. The selection committee does, however, reserve the
right to conduct interviews for the top rated rms if the committee
deems it necessary. If interviews are conducted, selection will be
made following interviews.
If there are any procedural questions, please contact Sheri Quinlan,
Grant Manager at 1-800-68-PILOT at extension 4517. For technical





Texas Department of Transportation
Filed: August 30, 2007
Aviation Division - Request for Proposal for Aviation
Engineering Services
The City of Brady, through its agent the Texas Department of Trans-
portation (TxDOT), intends to engage an aviation professional engi-
neering rm for services pursuant to Government Code, Chapter 2254,
Subchapter A. TxDOT Aviation Division will solicit and receive pro-
posals for professional aviation engineering design services described
below:
The following is a listing of proposed projects at the Curtis Field Mu-
nicipal Airport during the course of the next ve years through multiple
grants.
Current Project: TxDOT CSJ No. 0823BRADY. Scope: Provide engi-
neering/design services to reconstruct outer Runway 17-35 edges, reha-
bilitate and mark adjacent runway pavement, regrade/compost runway
and taxiway shoulders, crack seal Runway 17-35, and parallel taxiway
at the Curtis Field Municipal Airport.
The DBE goal is set at 5%. TxDOT Project Manager is Harry Lorton,
P.E.
Future scope work items for engineering/design services within the
next ve years may include but are not necessarily limited to the fol-
lowing:
1. Rehabilitate Ag apron
2. Rehabilitate and mark partial taxiway
3. Rehabilitate/overlay Runway 17-35
4. Rehabilitate hangar access taxiway
5. Rehabilitate stub taxiway at intersection of Runway 17-35 and Run-
way 8-26
6. Mark Runway 17-35
7. Rehabilitate apron
8. Construct turnaround Runway 35
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9. Install lighting for existing helicopter pads
10. Extend runway and parallel taxiway
The City of Brady reserves the right to determine which of the above
scope of services may or may not be awarded to the successful rm and
to initiate additional procurement action for any of the services above.
To assist in your proposal preparation the criteria, 5010 draw-
ing, and most recent airport layout plan are available online at
www.dot.state.tx.us/avn/avninfo/notice/consult/index.htm by se-
lecting Brady/Curtis Field Airport. The proposal should address a
technical approach for the current scope. Firms shall use page 4,
Recent Airport Experience, to list relevant past projects for both
current and future scope.
Interested rms shall utilize the latest version of Form AVN-550, titled
"Aviation Engineering Services Proposal". The form may be requested
from TxDOT Aviation Division, 125 East 11th Street, Austin, Texas
78701-2483, phone number, 1-800-68-PILOT (74568). The form may
be emailed by request or downloaded from the TxDOT web site at
www.dot.state.tx.us/services/aviation/consultant.htm. The form
may not be altered in any way. All printing must be in black on white
paper, except for the optional illustration page. Firms must carefully
follow the instructions provided on each page of the form. Proposals
may not exceed the number of pages in the proposal format. The
proposal format consists of seven pages of data plus two optional
pages consisting of an illustration page and a proposal summary page.
Proposals shall be stapled but not bound in any other fashion. PRO-
POSALS WILL NOT BE ACCEPTED IN ANY OTHER FORMAT.
ATTENTION: To ensure utilization of the latest version of Form AVN-
550, rms are encouraged to download Form AVN-550 from the Tx-
DOT website as addressed above. Utilization of Form AVN-550 from a
previous download may not be the exact same format. Form AVN-550
is a PDF Template.
Please note:
Six completed, unfolded copies of Form AVN-550 must be received
by TxDOT Aviation Division at 150 East Riverside Drive, 5th Floor,
South Tower, Austin, Texas 78704 no later than October 9, 2007 at 4:00
p.m. Electronic facsimiles or forms sent by email will not be accepted.
Please mark the envelope of the forms to the attention of Sheri Quinlan.
The consultant selection committee will be composed of local
government members. The nal selection by the committee will
generally be made following the completion of review of proposals.
The committee will review all proposals and rate and rank each.
The criteria for evaluating engineering proposals can be found at
http://www.dot.state.tx.us/services/aviation/consultant.htm. All
rms will be notied and the top rated rm will be contacted to begin
fee negotiations. The selection committee does, however, reserve the
right to conduct interviews for the top rated rms if the committee
deems it necessary. If interviews are conducted, selection will be
made following interviews.
If there are any procedural questions, please contact Sheri Quinlan,
Grant Manager at 1-800-68-PILOT at extension 4517. For technical





Texas Department of Transportation
Filed: August 30, 2007
Aviation Division - Request for Proposal for Aviation
Engineering Services
The City of Bonham, through its agent the Texas Department of Trans-
portation (TxDOT), intends to engage an aviation professional engi-
neering rm for services pursuant to Government Code, Chapter 2254,
Subchapter A. TxDOT Aviation Division will solicit and receive pro-
posals for professional aviation engineering design services described
below:
The following is a listing of proposed projects at Jones Field Airport,
Bonham, Texas during the course of the next ve years through multi-
ple grants.
Current Project: TxDOT CSJ No. 08001BONHM. Scope: Provide
engineering/design services for design, construction, and marking of a
partial parallel taxiway.
The DBE goal is set at 11%. TxDOT Project Manager is Charles Gra-
ham.
Future scope work items for engineering/design services within the
next ve years may include but are not necessarily limited to the fol-
lowing:
1. Rehabilitate turnarounds
2. Rehabilitate and mark Runway 17-35
3. Rehabilitate apron
4. Construct and mark partial parallel taxiway
5. Overlay stub taxiway
6. Rehabilitate hangar access taxiways
7. Rehabilitate entrance road
8. Expand apron
9. Install taxiway reectors
10. Construct auto parking (10 spaces)
The City of Bonham reserves the right to determine which of the above
scope of services may or may not be awarded to the successful rm and
to initiate additional procurement action for any of the services above.
To assist in your proposal preparation the most recent Airport Lay-
out Plan, 5010 drawing, and sponsor’s criteria are available online
at www.dot.state.tx.us/avn/avninfo/notice/consult/index.htm by se-
lecting Jones Field Airport. The proposal should address a technical
approach for the current scope. Firms shall use page 4, Recent Airport
Experience, to list relevant past projects for both current and future
scope.
Interested rms shall utilize the latest version of Form AVN-550, titled
"Aviation Engineering Services Proposal". The form may be requested
from TxDOT Aviation Division, 125 East 11th Street, Austin, Texas
78701-2483, phone number, 1-800-68-PILOT (74568). The form may
be emailed by request or downloaded from the TxDOT web site at
www.dot.state.tx.us/services/aviation/consultant.htm. The form
may not be altered in any way. All printing must be in black on white
paper, except for the optional illustration page. Firms must carefully
follow the instructions provided on each page of the form. Proposals
may not exceed the number of pages in the proposal format. The
proposal format consists of seven pages of data plus two optional
pages consisting of an illustration page and a proposal summary page.
Proposals shall be stapled but not bound in any other fashion. PRO-
POSALS WILL NOT BE ACCEPTED IN ANY OTHER FORMAT.
ATTENTION: To ensure utilization of the latest version of Form AVN-
550, rms are encouraged to download Form AVN-550 from the Tx-
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DOT website as addressed above. Utilization of Form AVN-550 from a
previous download may not be the exact same format. Form AVN-550
is a PDF Template.
Please note:
Seven completed, unfolded copies of Form AVN-550 must be re-
ceived by TxDOT Aviation Division at 150 East Riverside Drive, 5th
Floor, South Tower, Austin, Texas 78704 no later than October 5,
2007, 4:00 p.m. Electronic facsimiles or forms sent by email will not
be accepted. Please mark the envelope of the forms to the attention of
Edie Stimach.
The consultant selection committee will be composed of local
government members. The nal selection by the committee will
generally be made following the completion of review of proposals.
The committee will review all proposals and rate and rank each.
The criteria for evaluating engineering proposals can be found at
http://www.dot.state.tx.us/services/aviation/consultant.htm. All
rms will be notied and the top rated rm will be contacted to begin
fee negotiations. The selection committee does, however, reserve the
right to conduct interviews for the top rated rms if the committee
deems it necessary. If interviews are conducted, selection will be
made following interviews.
If there are any procedural questions, please contact Edie Stimach,
Grant Manager, phone 1-800-68-PILOT, extension 4518. For tech-
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Aviation Division - Request for Proposal for Aviation
Engineering Services
The City of Gainesville, through its agent the Texas Department of
Transportation (TxDOT), intends to engage an aviation professional
engineering rm for services pursuant to Government Code, Chap-
ter 2254, Subchapter A. TxDOT Aviation Division will solicit and re-
ceive proposals for professional aviation engineering design services
described below:
The following is a listing of proposed projects at Gainesville Municipal
Airport during the course of the next ve years through multiple grants.
Current Project: TxDOT CSJ No. 0803GAINS. Scope: Provide engi-
neering/design services for design and construction of a hangar access
taxiway.
The DBE goal is set at 10%. TxDOT Project Manager is Charles Gra-
ham.
Future scope work items for engineering/design services within the
next ve years may include but are not necessarily limited to the fol-
lowing:
1. Rehabilitate concrete terminal apron
2. Rehabilitate Taxiways B and let
3. Rehabilitate Taxiway C
4. Rehabilitate Taxiway E
5. Rehabilitate and mark Runway 17-35
6. Rehabilitate and mark Runway 12-30
7. Rehabilitate Taxiway A and holding area
8. Rehabilitate Taxiway D and stub
The City of Gainesville reserves the right to determine which of the
above scope of services may or may not be awarded to the successful
rm and to initiate additional procurement action for any of the services
above.
To assist in your proposal preparation the most recent Airport Lay-
out Plan, 5010 drawing, and sponsor’s criteria are available online
at www.dot.state.tx.us/avn/avninfo/notice/consult/index.htm by se-
lecting Gainesville Municipal Airport. The proposal should address a
technical approach for the current scope. Firms shall use page 4, Re-
cent Airport Experience, to list relevant past projects for both current
and future scope.
Interested rms shall utilize the latest version of Form AVN-550, titled
"Aviation Engineering Services Proposal". The form may be requested
from TxDOT Aviation Division, 125 East 11th Street, Austin, Texas
78701-2483, phone number, 1-800-68-PILOT (74568). The form may
be emailed by request or downloaded from the TxDOT web site at
www.dot.state.tx.us/services/aviation/consultant.htm. The form
may not be altered in any way. All printing must be in black on white
paper, except for the optional illustration page. Firms must carefully
follow the instructions provided on each page of the form. Proposals
may not exceed the number of pages in the proposal format. The
proposal format consists of seven pages of data plus two optional
pages consisting of an illustration page and a proposal summary page.
Proposals shall be stapled but not bound in any other fashion. PRO-
POSALS WILL NOT BE ACCEPTED IN ANY OTHER FORMAT.
ATTENTION: To ensure utilization of the latest version of Form AVN-
550, rms are encouraged to download Form AVN-550 from the Tx-
DOT website as addressed above. Utilization of Form AVN-550 from a
previous download may not be the exact same format. Form AVN-550
is a PDF Template.
Please note:
Seven completed, unfolded copies of Form AVN-550 must be re-
ceived by TxDOT Aviation Division at 150 East Riverside Drive, 5th
Floor, South Tower, Austin, Texas 78704 no later than October 5,
2007, 4:00 p.m. Electronic facsimiles or forms sent by email will not
be accepted. Please mark the envelope of the forms to the attention of
Edie Stimach.
The consultant selection committee will be composed of Aviation
Division staff members. The nal selection by the committee will
generally be made following the completion of review of proposals.
The committee will review all proposals and rate and rank each.
The criteria for evaluating engineering proposals can be found at
http://www.dot.state.tx.us/services/aviation/consultant.htm. All
rms will be notied and the top rated rm will be contacted to begin
fee negotiations. The selection committee does, however, reserve the
right to conduct interviews for the top rated rms if the committee
deems it necessary. If interviews are conducted, selection will be
made following interviews.
If there are any procedural questions, please contact Edie Stimach,
Grant Manager, phone 1-800-68-PILOT, extension 4518. For tech-
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Aviation Division - Request for Proposal for Professional
Services
The City of Caddo Mills, through its agent the Texas Department of
Transportation (TxDOT), intends to engage an aviation professional
services rm for services pursuant to Government Code, Chapter 2254,
Subchapter A. TxDOT Aviation Division will solicit and receive pro-
posals for professional services as described below:
Airport Sponsor: The City of Caddo Mills, Caddo Mills Municipal
Airport. TxDOT CSJ No. 0801CADDO. Scope: Prepare an Airport
Development Plan which includes, but is not limited to, information re-
garding existing and future conditions, proposed facility development
to meet existing and future demand, constraints to develop, anticipated
capital needs, nancial considerations, management structure and op-
tions, as well as an updated Airport Layout Plan. The Airport Devel-
opment Plan should be tailored to the individual needs of the airport.
The HUB goal is race neutral. TxDOT Project Manager is Sandra
Braden.
Interested rms shall utilize the Form AVN-551, titled "Aviation Plan-
ning Services Proposal". The form may be requested from TxDOT
Aviation Division, 125 East 11th Street, Austin, Texas 78701-2483,
phone number, 1-800-68-PILOT (74568). The form may be emailed
by request or downloaded from the TxDOT web site, URL address
http://www.dot.state.tx.us/avn/avn551.doc. The form may not be al-
tered in any way. All printing must be in black on white paper, except
for the optional illustration page. Firms must carefully follow the in-
structions provided on each page of the form. Proposals may not ex-
ceed the number of pages in the proposal format. The proposal format
consists of seven pages of data plus two optional pages consisting of
an illustration page and a proposal summary page. Proposals shall be
stapled but not bound in any other fashion. PROPOSALS WILL NOT
BE ACCEPTED IN ANY OTHER FORMAT.
ATTENTION: To ensure utilization of the latest version of Form AVN-
551, rms are encouraged to download Form AVN-551 from the Tx-
DOT website as addressed above. Utilization of Form AVN-551 from a
previous download may not be the exact same format. Form AVN-551
is an MS Word Template.
Please note:
Eight completed, unfolded copies of Form AVN-551 must be re-
ceived by TxDOT Aviation at 150 East Riverside Drive, 5th Floor,
South Tower, Austin, Texas 78704 no later than October 9, 2007,
4:00 p.m. Electronic facsimiles or forms sent by email will not be
accepted. Please mark the envelope of the forms to the attention of
Sheri Quinlan.
The consultant selection committee will be composed of local govern-
ment members. The nal selection by the committee will generally be
made following the completion of review of proposals. The committee
will review all proposals and rate and rank each. Below is the criterion
for evaluating planning proposals. All rms will be notied and the
top rated rm will be contacted to begin fee negotiations. The selec-
tion committee does, however, reserve the right to conduct interviews
for the top rated rms if the committee deems it necessary. If inter-
views are conducted, selection will be made following interviews.
If there are any procedural questions, please contact Sheri Quinlan,
Grant Manager, or Sandra Braden, Project Manager for technical ques-
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How to Use the Texas Register
Information Available: The 14 sections of the Texas
Register represent various facets of state government.
Documents contained within them include:
Governor - Appointments, executive orders, and
proclamations.
Attorney General - summaries of requests for opinions,
opinions, and open records decisions.
Secretary of State - opinions based on the election laws.
Texas Ethics Commission - summaries of requests for
opinions and opinions.
Emergency Rules- sections adopted by state agencies on
an emergency basis.
Proposed Rules - sections proposed for adoption.
Withdrawn Rules - sections withdrawn by state agencies
from consideration for adoption, or automatically withdrawn by
the Texas Register six months after the proposal publication
date.
Adopted Rules - sections adopted following public
comment period.
Texas Department of Insurance Exempt Filings -
notices of actions taken by the Texas Department of Insurance
pursuant to Chapter 5, Subchapter L of the Insurance Code.
Texas Department of Banking - opinions and exempt
rules filed by the Texas Department of Banking.
Tables and Graphics - graphic material from the
proposed, emergency and adopted sections.
Transferred Rules- notice that the Legislature has
transferred rules within the Texas Administrative Code from
one state agency to another, or directed the Secretary of State to
remove the rules of an abolished agency.
In Addition - miscellaneous information required to be
published by statute or provided as a public service.
Review of Agency Rules - notices of state agency rules
review.
Specific explanation on the contents of each section can be
found on the beginning page of the section. The division also
publishes cumulative quarterly and annual indexes to aid in
researching material published.
How to Cite: Material published in the Texas Register is
referenced by citing the volume in which the document
appears, the words “TexReg” and the beginning page number
on which that document was published. For example, a
document published on page 2402 of Volume 30 (2005) is cited
as follows: 30 TexReg 2402.
In order that readers may cite material more easily, page
numbers are now written as citations. Example: on page 2 in
the lower-left hand corner of the page, would be written “30
TexReg 2 issue date,” while on the opposite page, page 3, in
the lower right-hand corner, would be written “issue date 30
TexReg 3.”
How to Research: The public is invited to research rules and
information of interest between 8 a.m. and 5 p.m. weekdays at
the Texas Register office, Room 245, James Earl Rudder
Building, 1019 Brazos, Austin. Material can be found using
Texas Register indexes, the Texas Administrative Code,
section numbers, or TRD number.
Both the Texas Register and the Texas Administrative
Code are available online through the Internet. The address is:
http://www.sos.state.tx.us. The Register is available in an .html
version as well as a .pdf (portable document format) version
through the Internet. For website subscription information, call
the Texas Register at (800) 226-7199.
Texas Administrative Code
The Texas Administrative Code (TAC) is the compilation
of all final state agency rules published in the Texas Register.
Following its effective date, a rule is entered into the Texas
Administrative Code. Emergency rules, which may be adopted
by an agency on an interim basis, are not codified within the
TAC.
The TAC volumes are arranged into Titles and Parts (using
Arabic numerals). The Titles are broad subject categories into
which the agencies are grouped as a matter of convenience.
Each Part represents an individual state agency.
The complete TAC is available through the Secretary of
State’s website at http://www.sos.state.tx.us/tac. The following
companies also provide complete copies of the TAC: Lexis-
Nexis (1-800-356-6548), and West Publishing Company (1-
800-328-9352).













31. Natural Resources and Conservation
34. Public Finance
37. Public Safety and Corrections
40. Social Services and Assistance
43. Transportation
How to Cite: Under the TAC scheme, each section is
designated by a TAC number. For example in the citation 1
TAC §27.15: 1 indicates the title under which the agency
appears in the Texas Administrative Code; TAC stands for the
Texas Administrative Code; §27.15 is the section number of
the rule (27 indicates that the section is under Chapter 27 of
Title 1; 15 represents the individual section within the chapter).
How to update: To find out if a rule has changed since the
publication of the current supplement to the Texas
Administrative Code, please look at the Table of TAC Titles
Affected. The table is published cumulatively in the blue-cover
quarterly indexes to the Texas Register (January 21, April 15,
July 8, and October 7, 2005). If a rule has changed during the
time period covered by the table, the rule’s TAC number will
be printed with one or more Texas Register page numbers, as
shown in the following example.
TITLE 40. SOCIAL SERVICES AND ASSISTANCE
Part I. Texas Department of Human Services
40 TAC §3.704..............950, 1820
The Table of TAC Titles Affected is cumulative for each
volume of the Texas Register (calendar year).
